<!DOCTYPE html>

<html xmlns="http://www.w3.org/1999/xhtml">

<head>

<meta charset="utf-8">
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />


<meta name="author" content="Kushal K Dey" />

<meta name="date" content="2016-06-17" />

<title>SFA extract features Deng et al 2014</title>

<script src="data:application/x-javascript;base64,/*! jQuery v1.11.3 | (c) 2005, 2015 jQuery Foundation, Inc. | jquery.org/license */
!function(a,b){"object"==typeof module&&"object"==typeof module.exports?module.exports=a.document?b(a,!0):function(a){if(!a.document)throw new Error("jQuery requires a window with a document");return b(a)}:b(a)}("undefined"!=typeof window?window:this,function(a,b){var c=[],d=c.slice,e=c.concat,f=c.push,g=c.indexOf,h={},i=h.toString,j=h.hasOwnProperty,k={},l="1.11.3",m=function(a,b){return new m.fn.init(a,b)},n=/^[\s\uFEFF\xA0]+|[\s\uFEFF\xA0]+$/g,o=/^-ms-/,p=/-([\da-z])/gi,q=function(a,b){return b.toUpperCase()};m.fn=m.prototype={jquery:l,constructor:m,selector:"",length:0,toArray:function(){return d.call(this)},get:function(a){return null!=a?0>a?this[a+this.length]:this[a]:d.call(this)},pushStack:function(a){var b=m.merge(this.constructor(),a);return b.prevObject=this,b.context=this.context,b},each:function(a,b){return m.each(this,a,b)},map:function(a){return this.pushStack(m.map(this,function(b,c){return a.call(b,c,b)}))},slice:function(){return this.pushStack(d.apply(this,arguments))},first:function(){return this.eq(0)},last:function(){return this.eq(-1)},eq:function(a){var b=this.length,c=+a+(0>a?b:0);return this.pushStack(c>=0&&b>c?[this[c]]:[])},end:function(){return this.prevObject||this.constructor(null)},push:f,sort:c.sort,splice:c.splice},m.extend=m.fn.extend=function(){var a,b,c,d,e,f,g=arguments[0]||{},h=1,i=arguments.length,j=!1;for("boolean"==typeof g&&(j=g,g=arguments[h]||{},h++),"object"==typeof g||m.isFunction(g)||(g={}),h===i&&(g=this,h--);i>h;h++)if(null!=(e=arguments[h]))for(d in e)a=g[d],c=e[d],g!==c&&(j&&c&&(m.isPlainObject(c)||(b=m.isArray(c)))?(b?(b=!1,f=a&&m.isArray(a)?a:[]):f=a&&m.isPlainObject(a)?a:{},g[d]=m.extend(j,f,c)):void 0!==c&&(g[d]=c));return g},m.extend({expando:"jQuery"+(l+Math.random()).replace(/\D/g,""),isReady:!0,error:function(a){throw new Error(a)},noop:function(){},isFunction:function(a){return"function"===m.type(a)},isArray:Array.isArray||function(a){return"array"===m.type(a)},isWindow:function(a){return null!=a&&a==a.window},isNumeric:function(a){return!m.isArray(a)&&a-parseFloat(a)+1>=0},isEmptyObject:function(a){var b;for(b in a)return!1;return!0},isPlainObject:function(a){var b;if(!a||"object"!==m.type(a)||a.nodeType||m.isWindow(a))return!1;try{if(a.constructor&&!j.call(a,"constructor")&&!j.call(a.constructor.prototype,"isPrototypeOf"))return!1}catch(c){return!1}if(k.ownLast)for(b in a)return j.call(a,b);for(b in a);return void 0===b||j.call(a,b)},type:function(a){return null==a?a+"":"object"==typeof a||"function"==typeof a?h[i.call(a)]||"object":typeof a},globalEval:function(b){b&&m.trim(b)&&(a.execScript||function(b){a.eval.call(a,b)})(b)},camelCase:function(a){return a.replace(o,"ms-").replace(p,q)},nodeName:function(a,b){return a.nodeName&&a.nodeName.toLowerCase()===b.toLowerCase()},each:function(a,b,c){var d,e=0,f=a.length,g=r(a);if(c){if(g){for(;f>e;e++)if(d=b.apply(a[e],c),d===!1)break}else for(e in a)if(d=b.apply(a[e],c),d===!1)break}else if(g){for(;f>e;e++)if(d=b.call(a[e],e,a[e]),d===!1)break}else for(e in a)if(d=b.call(a[e],e,a[e]),d===!1)break;return a},trim:function(a){return null==a?"":(a+"").replace(n,"")},makeArray:function(a,b){var c=b||[];return null!=a&&(r(Object(a))?m.merge(c,"string"==typeof a?[a]:a):f.call(c,a)),c},inArray:function(a,b,c){var d;if(b){if(g)return g.call(b,a,c);for(d=b.length,c=c?0>c?Math.max(0,d+c):c:0;d>c;c++)if(c in b&&b[c]===a)return c}return-1},merge:function(a,b){var c=+b.length,d=0,e=a.length;while(c>d)a[e++]=b[d++];if(c!==c)while(void 0!==b[d])a[e++]=b[d++];return a.length=e,a},grep:function(a,b,c){for(var d,e=[],f=0,g=a.length,h=!c;g>f;f++)d=!b(a[f],f),d!==h&&e.push(a[f]);return e},map:function(a,b,c){var d,f=0,g=a.length,h=r(a),i=[];if(h)for(;g>f;f++)d=b(a[f],f,c),null!=d&&i.push(d);else for(f in a)d=b(a[f],f,c),null!=d&&i.push(d);return e.apply([],i)},guid:1,proxy:function(a,b){var c,e,f;return"string"==typeof b&&(f=a[b],b=a,a=f),m.isFunction(a)?(c=d.call(arguments,2),e=function(){return a.apply(b||this,c.concat(d.call(arguments)))},e.guid=a.guid=a.guid||m.guid++,e):void 0},now:function(){return+new Date},support:k}),m.each("Boolean Number String Function Array Date RegExp Object Error".split(" "),function(a,b){h["[object "+b+"]"]=b.toLowerCase()});function r(a){var b="length"in a&&a.length,c=m.type(a);return"function"===c||m.isWindow(a)?!1:1===a.nodeType&&b?!0:"array"===c||0===b||"number"==typeof b&&b>0&&b-1 in a}var s=function(a){var b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u="sizzle"+1*new Date,v=a.document,w=0,x=0,y=ha(),z=ha(),A=ha(),B=function(a,b){return a===b&&(l=!0),0},C=1<<31,D={}.hasOwnProperty,E=[],F=E.pop,G=E.push,H=E.push,I=E.slice,J=function(a,b){for(var c=0,d=a.length;d>c;c++)if(a[c]===b)return c;return-1},K="checked|selected|async|autofocus|autoplay|controls|defer|disabled|hidden|ismap|loop|multiple|open|readonly|required|scoped",L="[\\x20\\t\\r\\n\\f]",M="(?:\\\\.|[\\w-]|[^\\x00-\\xa0])+",N=M.replace("w","w#"),O="\\["+L+"*("+M+")(?:"+L+"*([*^$|!~]?=)"+L+"*(?:'((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\"|("+N+"))|)"+L+"*\\]",P=":("+M+")(?:\\((('((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\")|((?:\\\\.|[^\\\\()[\\]]|"+O+")*)|.*)\\)|)",Q=new RegExp(L+"+","g"),R=new RegExp("^"+L+"+|((?:^|[^\\\\])(?:\\\\.)*)"+L+"+$","g"),S=new RegExp("^"+L+"*,"+L+"*"),T=new RegExp("^"+L+"*([>+~]|"+L+")"+L+"*"),U=new RegExp("="+L+"*([^\\]'\"]*?)"+L+"*\\]","g"),V=new RegExp(P),W=new RegExp("^"+N+"$"),X={ID:new RegExp("^#("+M+")"),CLASS:new RegExp("^\\.("+M+")"),TAG:new RegExp("^("+M.replace("w","w*")+")"),ATTR:new RegExp("^"+O),PSEUDO:new RegExp("^"+P),CHILD:new RegExp("^:(only|first|last|nth|nth-last)-(child|of-type)(?:\\("+L+"*(even|odd|(([+-]|)(\\d*)n|)"+L+"*(?:([+-]|)"+L+"*(\\d+)|))"+L+"*\\)|)","i"),bool:new RegExp("^(?:"+K+")$","i"),needsContext:new RegExp("^"+L+"*[>+~]|:(even|odd|eq|gt|lt|nth|first|last)(?:\\("+L+"*((?:-\\d)?\\d*)"+L+"*\\)|)(?=[^-]|$)","i")},Y=/^(?:input|select|textarea|button)$/i,Z=/^h\d$/i,$=/^[^{]+\{\s*\[native \w/,_=/^(?:#([\w-]+)|(\w+)|\.([\w-]+))$/,aa=/[+~]/,ba=/'|\\/g,ca=new RegExp("\\\\([\\da-f]{1,6}"+L+"?|("+L+")|.)","ig"),da=function(a,b,c){var d="0x"+b-65536;return d!==d||c?b:0>d?String.fromCharCode(d+65536):String.fromCharCode(d>>10|55296,1023&d|56320)},ea=function(){m()};try{H.apply(E=I.call(v.childNodes),v.childNodes),E[v.childNodes.length].nodeType}catch(fa){H={apply:E.length?function(a,b){G.apply(a,I.call(b))}:function(a,b){var c=a.length,d=0;while(a[c++]=b[d++]);a.length=c-1}}}function ga(a,b,d,e){var f,h,j,k,l,o,r,s,w,x;if((b?b.ownerDocument||b:v)!==n&&m(b),b=b||n,d=d||[],k=b.nodeType,"string"!=typeof a||!a||1!==k&&9!==k&&11!==k)return d;if(!e&&p){if(11!==k&&(f=_.exec(a)))if(j=f[1]){if(9===k){if(h=b.getElementById(j),!h||!h.parentNode)return d;if(h.id===j)return d.push(h),d}else if(b.ownerDocument&&(h=b.ownerDocument.getElementById(j))&&t(b,h)&&h.id===j)return d.push(h),d}else{if(f[2])return H.apply(d,b.getElementsByTagName(a)),d;if((j=f[3])&&c.getElementsByClassName)return H.apply(d,b.getElementsByClassName(j)),d}if(c.qsa&&(!q||!q.test(a))){if(s=r=u,w=b,x=1!==k&&a,1===k&&"object"!==b.nodeName.toLowerCase()){o=g(a),(r=b.getAttribute("id"))?s=r.replace(ba,"\\$&"):b.setAttribute("id",s),s="[id='"+s+"'] ",l=o.length;while(l--)o[l]=s+ra(o[l]);w=aa.test(a)&&pa(b.parentNode)||b,x=o.join(",")}if(x)try{return H.apply(d,w.querySelectorAll(x)),d}catch(y){}finally{r||b.removeAttribute("id")}}}return i(a.replace(R,"$1"),b,d,e)}function ha(){var a=[];function b(c,e){return a.push(c+" ")>d.cacheLength&&delete b[a.shift()],b[c+" "]=e}return b}function ia(a){return a[u]=!0,a}function ja(a){var b=n.createElement("div");try{return!!a(b)}catch(c){return!1}finally{b.parentNode&&b.parentNode.removeChild(b),b=null}}function ka(a,b){var c=a.split("|"),e=a.length;while(e--)d.attrHandle[c[e]]=b}function la(a,b){var c=b&&a,d=c&&1===a.nodeType&&1===b.nodeType&&(~b.sourceIndex||C)-(~a.sourceIndex||C);if(d)return d;if(c)while(c=c.nextSibling)if(c===b)return-1;return a?1:-1}function ma(a){return function(b){var c=b.nodeName.toLowerCase();return"input"===c&&b.type===a}}function na(a){return function(b){var c=b.nodeName.toLowerCase();return("input"===c||"button"===c)&&b.type===a}}function oa(a){return ia(function(b){return b=+b,ia(function(c,d){var e,f=a([],c.length,b),g=f.length;while(g--)c[e=f[g]]&&(c[e]=!(d[e]=c[e]))})})}function pa(a){return a&&"undefined"!=typeof a.getElementsByTagName&&a}c=ga.support={},f=ga.isXML=function(a){var b=a&&(a.ownerDocument||a).documentElement;return b?"HTML"!==b.nodeName:!1},m=ga.setDocument=function(a){var b,e,g=a?a.ownerDocument||a:v;return g!==n&&9===g.nodeType&&g.documentElement?(n=g,o=g.documentElement,e=g.defaultView,e&&e!==e.top&&(e.addEventListener?e.addEventListener("unload",ea,!1):e.attachEvent&&e.attachEvent("onunload",ea)),p=!f(g),c.attributes=ja(function(a){return a.className="i",!a.getAttribute("className")}),c.getElementsByTagName=ja(function(a){return a.appendChild(g.createComment("")),!a.getElementsByTagName("*").length}),c.getElementsByClassName=$.test(g.getElementsByClassName),c.getById=ja(function(a){return o.appendChild(a).id=u,!g.getElementsByName||!g.getElementsByName(u).length}),c.getById?(d.find.ID=function(a,b){if("undefined"!=typeof b.getElementById&&p){var c=b.getElementById(a);return c&&c.parentNode?[c]:[]}},d.filter.ID=function(a){var b=a.replace(ca,da);return function(a){return a.getAttribute("id")===b}}):(delete d.find.ID,d.filter.ID=function(a){var b=a.replace(ca,da);return function(a){var c="undefined"!=typeof a.getAttributeNode&&a.getAttributeNode("id");return c&&c.value===b}}),d.find.TAG=c.getElementsByTagName?function(a,b){return"undefined"!=typeof b.getElementsByTagName?b.getElementsByTagName(a):c.qsa?b.querySelectorAll(a):void 0}:function(a,b){var c,d=[],e=0,f=b.getElementsByTagName(a);if("*"===a){while(c=f[e++])1===c.nodeType&&d.push(c);return d}return f},d.find.CLASS=c.getElementsByClassName&&function(a,b){return p?b.getElementsByClassName(a):void 0},r=[],q=[],(c.qsa=$.test(g.querySelectorAll))&&(ja(function(a){o.appendChild(a).innerHTML="<a id='"+u+"'></a><select id='"+u+"-\f]' msallowcapture=''><option selected=''></option></select>",a.querySelectorAll("[msallowcapture^='']").length&&q.push("[*^$]="+L+"*(?:''|\"\")"),a.querySelectorAll("[selected]").length||q.push("\\["+L+"*(?:value|"+K+")"),a.querySelectorAll("[id~="+u+"-]").length||q.push("~="),a.querySelectorAll(":checked").length||q.push(":checked"),a.querySelectorAll("a#"+u+"+*").length||q.push(".#.+[+~]")}),ja(function(a){var b=g.createElement("input");b.setAttribute("type","hidden"),a.appendChild(b).setAttribute("name","D"),a.querySelectorAll("[name=d]").length&&q.push("name"+L+"*[*^$|!~]?="),a.querySelectorAll(":enabled").length||q.push(":enabled",":disabled"),a.querySelectorAll("*,:x"),q.push(",.*:")})),(c.matchesSelector=$.test(s=o.matches||o.webkitMatchesSelector||o.mozMatchesSelector||o.oMatchesSelector||o.msMatchesSelector))&&ja(function(a){c.disconnectedMatch=s.call(a,"div"),s.call(a,"[s!='']:x"),r.push("!=",P)}),q=q.length&&new RegExp(q.join("|")),r=r.length&&new RegExp(r.join("|")),b=$.test(o.compareDocumentPosition),t=b||$.test(o.contains)?function(a,b){var c=9===a.nodeType?a.documentElement:a,d=b&&b.parentNode;return a===d||!(!d||1!==d.nodeType||!(c.contains?c.contains(d):a.compareDocumentPosition&&16&a.compareDocumentPosition(d)))}:function(a,b){if(b)while(b=b.parentNode)if(b===a)return!0;return!1},B=b?function(a,b){if(a===b)return l=!0,0;var d=!a.compareDocumentPosition-!b.compareDocumentPosition;return d?d:(d=(a.ownerDocument||a)===(b.ownerDocument||b)?a.compareDocumentPosition(b):1,1&d||!c.sortDetached&&b.compareDocumentPosition(a)===d?a===g||a.ownerDocument===v&&t(v,a)?-1:b===g||b.ownerDocument===v&&t(v,b)?1:k?J(k,a)-J(k,b):0:4&d?-1:1)}:function(a,b){if(a===b)return l=!0,0;var c,d=0,e=a.parentNode,f=b.parentNode,h=[a],i=[b];if(!e||!f)return a===g?-1:b===g?1:e?-1:f?1:k?J(k,a)-J(k,b):0;if(e===f)return la(a,b);c=a;while(c=c.parentNode)h.unshift(c);c=b;while(c=c.parentNode)i.unshift(c);while(h[d]===i[d])d++;return d?la(h[d],i[d]):h[d]===v?-1:i[d]===v?1:0},g):n},ga.matches=function(a,b){return ga(a,null,null,b)},ga.matchesSelector=function(a,b){if((a.ownerDocument||a)!==n&&m(a),b=b.replace(U,"='$1']"),!(!c.matchesSelector||!p||r&&r.test(b)||q&&q.test(b)))try{var d=s.call(a,b);if(d||c.disconnectedMatch||a.document&&11!==a.document.nodeType)return d}catch(e){}return ga(b,n,null,[a]).length>0},ga.contains=function(a,b){return(a.ownerDocument||a)!==n&&m(a),t(a,b)},ga.attr=function(a,b){(a.ownerDocument||a)!==n&&m(a);var e=d.attrHandle[b.toLowerCase()],f=e&&D.call(d.attrHandle,b.toLowerCase())?e(a,b,!p):void 0;return void 0!==f?f:c.attributes||!p?a.getAttribute(b):(f=a.getAttributeNode(b))&&f.specified?f.value:null},ga.error=function(a){throw new Error("Syntax error, unrecognized expression: "+a)},ga.uniqueSort=function(a){var b,d=[],e=0,f=0;if(l=!c.detectDuplicates,k=!c.sortStable&&a.slice(0),a.sort(B),l){while(b=a[f++])b===a[f]&&(e=d.push(f));while(e--)a.splice(d[e],1)}return k=null,a},e=ga.getText=function(a){var b,c="",d=0,f=a.nodeType;if(f){if(1===f||9===f||11===f){if("string"==typeof a.textContent)return a.textContent;for(a=a.firstChild;a;a=a.nextSibling)c+=e(a)}else if(3===f||4===f)return a.nodeValue}else while(b=a[d++])c+=e(b);return c},d=ga.selectors={cacheLength:50,createPseudo:ia,match:X,attrHandle:{},find:{},relative:{">":{dir:"parentNode",first:!0}," ":{dir:"parentNode"},"+":{dir:"previousSibling",first:!0},"~":{dir:"previousSibling"}},preFilter:{ATTR:function(a){return a[1]=a[1].replace(ca,da),a[3]=(a[3]||a[4]||a[5]||"").replace(ca,da),"~="===a[2]&&(a[3]=" "+a[3]+" "),a.slice(0,4)},CHILD:function(a){return a[1]=a[1].toLowerCase(),"nth"===a[1].slice(0,3)?(a[3]||ga.error(a[0]),a[4]=+(a[4]?a[5]+(a[6]||1):2*("even"===a[3]||"odd"===a[3])),a[5]=+(a[7]+a[8]||"odd"===a[3])):a[3]&&ga.error(a[0]),a},PSEUDO:function(a){var b,c=!a[6]&&a[2];return X.CHILD.test(a[0])?null:(a[3]?a[2]=a[4]||a[5]||"":c&&V.test(c)&&(b=g(c,!0))&&(b=c.indexOf(")",c.length-b)-c.length)&&(a[0]=a[0].slice(0,b),a[2]=c.slice(0,b)),a.slice(0,3))}},filter:{TAG:function(a){var b=a.replace(ca,da).toLowerCase();return"*"===a?function(){return!0}:function(a){return a.nodeName&&a.nodeName.toLowerCase()===b}},CLASS:function(a){var b=y[a+" "];return b||(b=new RegExp("(^|"+L+")"+a+"("+L+"|$)"))&&y(a,function(a){return b.test("string"==typeof a.className&&a.className||"undefined"!=typeof a.getAttribute&&a.getAttribute("class")||"")})},ATTR:function(a,b,c){return function(d){var e=ga.attr(d,a);return null==e?"!="===b:b?(e+="","="===b?e===c:"!="===b?e!==c:"^="===b?c&&0===e.indexOf(c):"*="===b?c&&e.indexOf(c)>-1:"$="===b?c&&e.slice(-c.length)===c:"~="===b?(" "+e.replace(Q," ")+" ").indexOf(c)>-1:"|="===b?e===c||e.slice(0,c.length+1)===c+"-":!1):!0}},CHILD:function(a,b,c,d,e){var f="nth"!==a.slice(0,3),g="last"!==a.slice(-4),h="of-type"===b;return 1===d&&0===e?function(a){return!!a.parentNode}:function(b,c,i){var j,k,l,m,n,o,p=f!==g?"nextSibling":"previousSibling",q=b.parentNode,r=h&&b.nodeName.toLowerCase(),s=!i&&!h;if(q){if(f){while(p){l=b;while(l=l[p])if(h?l.nodeName.toLowerCase()===r:1===l.nodeType)return!1;o=p="only"===a&&!o&&"nextSibling"}return!0}if(o=[g?q.firstChild:q.lastChild],g&&s){k=q[u]||(q[u]={}),j=k[a]||[],n=j[0]===w&&j[1],m=j[0]===w&&j[2],l=n&&q.childNodes[n];while(l=++n&&l&&l[p]||(m=n=0)||o.pop())if(1===l.nodeType&&++m&&l===b){k[a]=[w,n,m];break}}else if(s&&(j=(b[u]||(b[u]={}))[a])&&j[0]===w)m=j[1];else while(l=++n&&l&&l[p]||(m=n=0)||o.pop())if((h?l.nodeName.toLowerCase()===r:1===l.nodeType)&&++m&&(s&&((l[u]||(l[u]={}))[a]=[w,m]),l===b))break;return m-=e,m===d||m%d===0&&m/d>=0}}},PSEUDO:function(a,b){var c,e=d.pseudos[a]||d.setFilters[a.toLowerCase()]||ga.error("unsupported pseudo: "+a);return e[u]?e(b):e.length>1?(c=[a,a,"",b],d.setFilters.hasOwnProperty(a.toLowerCase())?ia(function(a,c){var d,f=e(a,b),g=f.length;while(g--)d=J(a,f[g]),a[d]=!(c[d]=f[g])}):function(a){return e(a,0,c)}):e}},pseudos:{not:ia(function(a){var b=[],c=[],d=h(a.replace(R,"$1"));return d[u]?ia(function(a,b,c,e){var f,g=d(a,null,e,[]),h=a.length;while(h--)(f=g[h])&&(a[h]=!(b[h]=f))}):function(a,e,f){return b[0]=a,d(b,null,f,c),b[0]=null,!c.pop()}}),has:ia(function(a){return function(b){return ga(a,b).length>0}}),contains:ia(function(a){return a=a.replace(ca,da),function(b){return(b.textContent||b.innerText||e(b)).indexOf(a)>-1}}),lang:ia(function(a){return W.test(a||"")||ga.error("unsupported lang: "+a),a=a.replace(ca,da).toLowerCase(),function(b){var c;do if(c=p?b.lang:b.getAttribute("xml:lang")||b.getAttribute("lang"))return c=c.toLowerCase(),c===a||0===c.indexOf(a+"-");while((b=b.parentNode)&&1===b.nodeType);return!1}}),target:function(b){var c=a.location&&a.location.hash;return c&&c.slice(1)===b.id},root:function(a){return a===o},focus:function(a){return a===n.activeElement&&(!n.hasFocus||n.hasFocus())&&!!(a.type||a.href||~a.tabIndex)},enabled:function(a){return a.disabled===!1},disabled:function(a){return a.disabled===!0},checked:function(a){var b=a.nodeName.toLowerCase();return"input"===b&&!!a.checked||"option"===b&&!!a.selected},selected:function(a){return a.parentNode&&a.parentNode.selectedIndex,a.selected===!0},empty:function(a){for(a=a.firstChild;a;a=a.nextSibling)if(a.nodeType<6)return!1;return!0},parent:function(a){return!d.pseudos.empty(a)},header:function(a){return Z.test(a.nodeName)},input:function(a){return Y.test(a.nodeName)},button:function(a){var b=a.nodeName.toLowerCase();return"input"===b&&"button"===a.type||"button"===b},text:function(a){var b;return"input"===a.nodeName.toLowerCase()&&"text"===a.type&&(null==(b=a.getAttribute("type"))||"text"===b.toLowerCase())},first:oa(function(){return[0]}),last:oa(function(a,b){return[b-1]}),eq:oa(function(a,b,c){return[0>c?c+b:c]}),even:oa(function(a,b){for(var c=0;b>c;c+=2)a.push(c);return a}),odd:oa(function(a,b){for(var c=1;b>c;c+=2)a.push(c);return a}),lt:oa(function(a,b,c){for(var d=0>c?c+b:c;--d>=0;)a.push(d);return a}),gt:oa(function(a,b,c){for(var d=0>c?c+b:c;++d<b;)a.push(d);return a})}},d.pseudos.nth=d.pseudos.eq;for(b in{radio:!0,checkbox:!0,file:!0,password:!0,image:!0})d.pseudos[b]=ma(b);for(b in{submit:!0,reset:!0})d.pseudos[b]=na(b);function qa(){}qa.prototype=d.filters=d.pseudos,d.setFilters=new qa,g=ga.tokenize=function(a,b){var c,e,f,g,h,i,j,k=z[a+" "];if(k)return b?0:k.slice(0);h=a,i=[],j=d.preFilter;while(h){(!c||(e=S.exec(h)))&&(e&&(h=h.slice(e[0].length)||h),i.push(f=[])),c=!1,(e=T.exec(h))&&(c=e.shift(),f.push({value:c,type:e[0].replace(R," ")}),h=h.slice(c.length));for(g in d.filter)!(e=X[g].exec(h))||j[g]&&!(e=j[g](e))||(c=e.shift(),f.push({value:c,type:g,matches:e}),h=h.slice(c.length));if(!c)break}return b?h.length:h?ga.error(a):z(a,i).slice(0)};function ra(a){for(var b=0,c=a.length,d="";c>b;b++)d+=a[b].value;return d}function sa(a,b,c){var d=b.dir,e=c&&"parentNode"===d,f=x++;return b.first?function(b,c,f){while(b=b[d])if(1===b.nodeType||e)return a(b,c,f)}:function(b,c,g){var h,i,j=[w,f];if(g){while(b=b[d])if((1===b.nodeType||e)&&a(b,c,g))return!0}else while(b=b[d])if(1===b.nodeType||e){if(i=b[u]||(b[u]={}),(h=i[d])&&h[0]===w&&h[1]===f)return j[2]=h[2];if(i[d]=j,j[2]=a(b,c,g))return!0}}}function ta(a){return a.length>1?function(b,c,d){var e=a.length;while(e--)if(!a[e](b,c,d))return!1;return!0}:a[0]}function ua(a,b,c){for(var d=0,e=b.length;e>d;d++)ga(a,b[d],c);return c}function va(a,b,c,d,e){for(var f,g=[],h=0,i=a.length,j=null!=b;i>h;h++)(f=a[h])&&(!c||c(f,d,e))&&(g.push(f),j&&b.push(h));return g}function wa(a,b,c,d,e,f){return d&&!d[u]&&(d=wa(d)),e&&!e[u]&&(e=wa(e,f)),ia(function(f,g,h,i){var j,k,l,m=[],n=[],o=g.length,p=f||ua(b||"*",h.nodeType?[h]:h,[]),q=!a||!f&&b?p:va(p,m,a,h,i),r=c?e||(f?a:o||d)?[]:g:q;if(c&&c(q,r,h,i),d){j=va(r,n),d(j,[],h,i),k=j.length;while(k--)(l=j[k])&&(r[n[k]]=!(q[n[k]]=l))}if(f){if(e||a){if(e){j=[],k=r.length;while(k--)(l=r[k])&&j.push(q[k]=l);e(null,r=[],j,i)}k=r.length;while(k--)(l=r[k])&&(j=e?J(f,l):m[k])>-1&&(f[j]=!(g[j]=l))}}else r=va(r===g?r.splice(o,r.length):r),e?e(null,g,r,i):H.apply(g,r)})}function xa(a){for(var b,c,e,f=a.length,g=d.relative[a[0].type],h=g||d.relative[" "],i=g?1:0,k=sa(function(a){return a===b},h,!0),l=sa(function(a){return J(b,a)>-1},h,!0),m=[function(a,c,d){var e=!g&&(d||c!==j)||((b=c).nodeType?k(a,c,d):l(a,c,d));return b=null,e}];f>i;i++)if(c=d.relative[a[i].type])m=[sa(ta(m),c)];else{if(c=d.filter[a[i].type].apply(null,a[i].matches),c[u]){for(e=++i;f>e;e++)if(d.relative[a[e].type])break;return wa(i>1&&ta(m),i>1&&ra(a.slice(0,i-1).concat({value:" "===a[i-2].type?"*":""})).replace(R,"$1"),c,e>i&&xa(a.slice(i,e)),f>e&&xa(a=a.slice(e)),f>e&&ra(a))}m.push(c)}return ta(m)}function ya(a,b){var c=b.length>0,e=a.length>0,f=function(f,g,h,i,k){var l,m,o,p=0,q="0",r=f&&[],s=[],t=j,u=f||e&&d.find.TAG("*",k),v=w+=null==t?1:Math.random()||.1,x=u.length;for(k&&(j=g!==n&&g);q!==x&&null!=(l=u[q]);q++){if(e&&l){m=0;while(o=a[m++])if(o(l,g,h)){i.push(l);break}k&&(w=v)}c&&((l=!o&&l)&&p--,f&&r.push(l))}if(p+=q,c&&q!==p){m=0;while(o=b[m++])o(r,s,g,h);if(f){if(p>0)while(q--)r[q]||s[q]||(s[q]=F.call(i));s=va(s)}H.apply(i,s),k&&!f&&s.length>0&&p+b.length>1&&ga.uniqueSort(i)}return k&&(w=v,j=t),r};return c?ia(f):f}return h=ga.compile=function(a,b){var c,d=[],e=[],f=A[a+" "];if(!f){b||(b=g(a)),c=b.length;while(c--)f=xa(b[c]),f[u]?d.push(f):e.push(f);f=A(a,ya(e,d)),f.selector=a}return f},i=ga.select=function(a,b,e,f){var i,j,k,l,m,n="function"==typeof a&&a,o=!f&&g(a=n.selector||a);if(e=e||[],1===o.length){if(j=o[0]=o[0].slice(0),j.length>2&&"ID"===(k=j[0]).type&&c.getById&&9===b.nodeType&&p&&d.relative[j[1].type]){if(b=(d.find.ID(k.matches[0].replace(ca,da),b)||[])[0],!b)return e;n&&(b=b.parentNode),a=a.slice(j.shift().value.length)}i=X.needsContext.test(a)?0:j.length;while(i--){if(k=j[i],d.relative[l=k.type])break;if((m=d.find[l])&&(f=m(k.matches[0].replace(ca,da),aa.test(j[0].type)&&pa(b.parentNode)||b))){if(j.splice(i,1),a=f.length&&ra(j),!a)return H.apply(e,f),e;break}}}return(n||h(a,o))(f,b,!p,e,aa.test(a)&&pa(b.parentNode)||b),e},c.sortStable=u.split("").sort(B).join("")===u,c.detectDuplicates=!!l,m(),c.sortDetached=ja(function(a){return 1&a.compareDocumentPosition(n.createElement("div"))}),ja(function(a){return a.innerHTML="<a href='#'></a>","#"===a.firstChild.getAttribute("href")})||ka("type|href|height|width",function(a,b,c){return c?void 0:a.getAttribute(b,"type"===b.toLowerCase()?1:2)}),c.attributes&&ja(function(a){return a.innerHTML="<input/>",a.firstChild.setAttribute("value",""),""===a.firstChild.getAttribute("value")})||ka("value",function(a,b,c){return c||"input"!==a.nodeName.toLowerCase()?void 0:a.defaultValue}),ja(function(a){return null==a.getAttribute("disabled")})||ka(K,function(a,b,c){var d;return c?void 0:a[b]===!0?b.toLowerCase():(d=a.getAttributeNode(b))&&d.specified?d.value:null}),ga}(a);m.find=s,m.expr=s.selectors,m.expr[":"]=m.expr.pseudos,m.unique=s.uniqueSort,m.text=s.getText,m.isXMLDoc=s.isXML,m.contains=s.contains;var t=m.expr.match.needsContext,u=/^<(\w+)\s*\/?>(?:<\/\1>|)$/,v=/^.[^:#\[\.,]*$/;function w(a,b,c){if(m.isFunction(b))return m.grep(a,function(a,d){return!!b.call(a,d,a)!==c});if(b.nodeType)return m.grep(a,function(a){return a===b!==c});if("string"==typeof b){if(v.test(b))return m.filter(b,a,c);b=m.filter(b,a)}return m.grep(a,function(a){return m.inArray(a,b)>=0!==c})}m.filter=function(a,b,c){var d=b[0];return c&&(a=":not("+a+")"),1===b.length&&1===d.nodeType?m.find.matchesSelector(d,a)?[d]:[]:m.find.matches(a,m.grep(b,function(a){return 1===a.nodeType}))},m.fn.extend({find:function(a){var b,c=[],d=this,e=d.length;if("string"!=typeof a)return this.pushStack(m(a).filter(function(){for(b=0;e>b;b++)if(m.contains(d[b],this))return!0}));for(b=0;e>b;b++)m.find(a,d[b],c);return c=this.pushStack(e>1?m.unique(c):c),c.selector=this.selector?this.selector+" "+a:a,c},filter:function(a){return this.pushStack(w(this,a||[],!1))},not:function(a){return this.pushStack(w(this,a||[],!0))},is:function(a){return!!w(this,"string"==typeof a&&t.test(a)?m(a):a||[],!1).length}});var x,y=a.document,z=/^(?:\s*(<[\w\W]+>)[^>]*|#([\w-]*))$/,A=m.fn.init=function(a,b){var c,d;if(!a)return this;if("string"==typeof a){if(c="<"===a.charAt(0)&&">"===a.charAt(a.length-1)&&a.length>=3?[null,a,null]:z.exec(a),!c||!c[1]&&b)return!b||b.jquery?(b||x).find(a):this.constructor(b).find(a);if(c[1]){if(b=b instanceof m?b[0]:b,m.merge(this,m.parseHTML(c[1],b&&b.nodeType?b.ownerDocument||b:y,!0)),u.test(c[1])&&m.isPlainObject(b))for(c in b)m.isFunction(this[c])?this[c](b[c]):this.attr(c,b[c]);return this}if(d=y.getElementById(c[2]),d&&d.parentNode){if(d.id!==c[2])return x.find(a);this.length=1,this[0]=d}return this.context=y,this.selector=a,this}return a.nodeType?(this.context=this[0]=a,this.length=1,this):m.isFunction(a)?"undefined"!=typeof x.ready?x.ready(a):a(m):(void 0!==a.selector&&(this.selector=a.selector,this.context=a.context),m.makeArray(a,this))};A.prototype=m.fn,x=m(y);var B=/^(?:parents|prev(?:Until|All))/,C={children:!0,contents:!0,next:!0,prev:!0};m.extend({dir:function(a,b,c){var d=[],e=a[b];while(e&&9!==e.nodeType&&(void 0===c||1!==e.nodeType||!m(e).is(c)))1===e.nodeType&&d.push(e),e=e[b];return d},sibling:function(a,b){for(var c=[];a;a=a.nextSibling)1===a.nodeType&&a!==b&&c.push(a);return c}}),m.fn.extend({has:function(a){var b,c=m(a,this),d=c.length;return this.filter(function(){for(b=0;d>b;b++)if(m.contains(this,c[b]))return!0})},closest:function(a,b){for(var c,d=0,e=this.length,f=[],g=t.test(a)||"string"!=typeof a?m(a,b||this.context):0;e>d;d++)for(c=this[d];c&&c!==b;c=c.parentNode)if(c.nodeType<11&&(g?g.index(c)>-1:1===c.nodeType&&m.find.matchesSelector(c,a))){f.push(c);break}return this.pushStack(f.length>1?m.unique(f):f)},index:function(a){return a?"string"==typeof a?m.inArray(this[0],m(a)):m.inArray(a.jquery?a[0]:a,this):this[0]&&this[0].parentNode?this.first().prevAll().length:-1},add:function(a,b){return this.pushStack(m.unique(m.merge(this.get(),m(a,b))))},addBack:function(a){return this.add(null==a?this.prevObject:this.prevObject.filter(a))}});function D(a,b){do a=a[b];while(a&&1!==a.nodeType);return a}m.each({parent:function(a){var b=a.parentNode;return b&&11!==b.nodeType?b:null},parents:function(a){return m.dir(a,"parentNode")},parentsUntil:function(a,b,c){return m.dir(a,"parentNode",c)},next:function(a){return D(a,"nextSibling")},prev:function(a){return D(a,"previousSibling")},nextAll:function(a){return m.dir(a,"nextSibling")},prevAll:function(a){return m.dir(a,"previousSibling")},nextUntil:function(a,b,c){return m.dir(a,"nextSibling",c)},prevUntil:function(a,b,c){return m.dir(a,"previousSibling",c)},siblings:function(a){return m.sibling((a.parentNode||{}).firstChild,a)},children:function(a){return m.sibling(a.firstChild)},contents:function(a){return m.nodeName(a,"iframe")?a.contentDocument||a.contentWindow.document:m.merge([],a.childNodes)}},function(a,b){m.fn[a]=function(c,d){var e=m.map(this,b,c);return"Until"!==a.slice(-5)&&(d=c),d&&"string"==typeof d&&(e=m.filter(d,e)),this.length>1&&(C[a]||(e=m.unique(e)),B.test(a)&&(e=e.reverse())),this.pushStack(e)}});var E=/\S+/g,F={};function G(a){var b=F[a]={};return m.each(a.match(E)||[],function(a,c){b[c]=!0}),b}m.Callbacks=function(a){a="string"==typeof a?F[a]||G(a):m.extend({},a);var b,c,d,e,f,g,h=[],i=!a.once&&[],j=function(l){for(c=a.memory&&l,d=!0,f=g||0,g=0,e=h.length,b=!0;h&&e>f;f++)if(h[f].apply(l[0],l[1])===!1&&a.stopOnFalse){c=!1;break}b=!1,h&&(i?i.length&&j(i.shift()):c?h=[]:k.disable())},k={add:function(){if(h){var d=h.length;!function f(b){m.each(b,function(b,c){var d=m.type(c);"function"===d?a.unique&&k.has(c)||h.push(c):c&&c.length&&"string"!==d&&f(c)})}(arguments),b?e=h.length:c&&(g=d,j(c))}return this},remove:function(){return h&&m.each(arguments,function(a,c){var d;while((d=m.inArray(c,h,d))>-1)h.splice(d,1),b&&(e>=d&&e--,f>=d&&f--)}),this},has:function(a){return a?m.inArray(a,h)>-1:!(!h||!h.length)},empty:function(){return h=[],e=0,this},disable:function(){return h=i=c=void 0,this},disabled:function(){return!h},lock:function(){return i=void 0,c||k.disable(),this},locked:function(){return!i},fireWith:function(a,c){return!h||d&&!i||(c=c||[],c=[a,c.slice?c.slice():c],b?i.push(c):j(c)),this},fire:function(){return k.fireWith(this,arguments),this},fired:function(){return!!d}};return k},m.extend({Deferred:function(a){var b=[["resolve","done",m.Callbacks("once memory"),"resolved"],["reject","fail",m.Callbacks("once memory"),"rejected"],["notify","progress",m.Callbacks("memory")]],c="pending",d={state:function(){return c},always:function(){return e.done(arguments).fail(arguments),this},then:function(){var a=arguments;return m.Deferred(function(c){m.each(b,function(b,f){var g=m.isFunction(a[b])&&a[b];e[f[1]](function(){var a=g&&g.apply(this,arguments);a&&m.isFunction(a.promise)?a.promise().done(c.resolve).fail(c.reject).progress(c.notify):c[f[0]+"With"](this===d?c.promise():this,g?[a]:arguments)})}),a=null}).promise()},promise:function(a){return null!=a?m.extend(a,d):d}},e={};return d.pipe=d.then,m.each(b,function(a,f){var g=f[2],h=f[3];d[f[1]]=g.add,h&&g.add(function(){c=h},b[1^a][2].disable,b[2][2].lock),e[f[0]]=function(){return e[f[0]+"With"](this===e?d:this,arguments),this},e[f[0]+"With"]=g.fireWith}),d.promise(e),a&&a.call(e,e),e},when:function(a){var b=0,c=d.call(arguments),e=c.length,f=1!==e||a&&m.isFunction(a.promise)?e:0,g=1===f?a:m.Deferred(),h=function(a,b,c){return function(e){b[a]=this,c[a]=arguments.length>1?d.call(arguments):e,c===i?g.notifyWith(b,c):--f||g.resolveWith(b,c)}},i,j,k;if(e>1)for(i=new Array(e),j=new Array(e),k=new Array(e);e>b;b++)c[b]&&m.isFunction(c[b].promise)?c[b].promise().done(h(b,k,c)).fail(g.reject).progress(h(b,j,i)):--f;return f||g.resolveWith(k,c),g.promise()}});var H;m.fn.ready=function(a){return m.ready.promise().done(a),this},m.extend({isReady:!1,readyWait:1,holdReady:function(a){a?m.readyWait++:m.ready(!0)},ready:function(a){if(a===!0?!--m.readyWait:!m.isReady){if(!y.body)return setTimeout(m.ready);m.isReady=!0,a!==!0&&--m.readyWait>0||(H.resolveWith(y,[m]),m.fn.triggerHandler&&(m(y).triggerHandler("ready"),m(y).off("ready")))}}});function I(){y.addEventListener?(y.removeEventListener("DOMContentLoaded",J,!1),a.removeEventListener("load",J,!1)):(y.detachEvent("onreadystatechange",J),a.detachEvent("onload",J))}function J(){(y.addEventListener||"load"===event.type||"complete"===y.readyState)&&(I(),m.ready())}m.ready.promise=function(b){if(!H)if(H=m.Deferred(),"complete"===y.readyState)setTimeout(m.ready);else if(y.addEventListener)y.addEventListener("DOMContentLoaded",J,!1),a.addEventListener("load",J,!1);else{y.attachEvent("onreadystatechange",J),a.attachEvent("onload",J);var c=!1;try{c=null==a.frameElement&&y.documentElement}catch(d){}c&&c.doScroll&&!function e(){if(!m.isReady){try{c.doScroll("left")}catch(a){return setTimeout(e,50)}I(),m.ready()}}()}return H.promise(b)};var K="undefined",L;for(L in m(k))break;k.ownLast="0"!==L,k.inlineBlockNeedsLayout=!1,m(function(){var a,b,c,d;c=y.getElementsByTagName("body")[0],c&&c.style&&(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),typeof b.style.zoom!==K&&(b.style.cssText="display:inline;margin:0;border:0;padding:1px;width:1px;zoom:1",k.inlineBlockNeedsLayout=a=3===b.offsetWidth,a&&(c.style.zoom=1)),c.removeChild(d))}),function(){var a=y.createElement("div");if(null==k.deleteExpando){k.deleteExpando=!0;try{delete a.test}catch(b){k.deleteExpando=!1}}a=null}(),m.acceptData=function(a){var b=m.noData[(a.nodeName+" ").toLowerCase()],c=+a.nodeType||1;return 1!==c&&9!==c?!1:!b||b!==!0&&a.getAttribute("classid")===b};var M=/^(?:\{[\w\W]*\}|\[[\w\W]*\])$/,N=/([A-Z])/g;function O(a,b,c){if(void 0===c&&1===a.nodeType){var d="data-"+b.replace(N,"-$1").toLowerCase();if(c=a.getAttribute(d),"string"==typeof c){try{c="true"===c?!0:"false"===c?!1:"null"===c?null:+c+""===c?+c:M.test(c)?m.parseJSON(c):c}catch(e){}m.data(a,b,c)}else c=void 0}return c}function P(a){var b;for(b in a)if(("data"!==b||!m.isEmptyObject(a[b]))&&"toJSON"!==b)return!1;

return!0}function Q(a,b,d,e){if(m.acceptData(a)){var f,g,h=m.expando,i=a.nodeType,j=i?m.cache:a,k=i?a[h]:a[h]&&h;if(k&&j[k]&&(e||j[k].data)||void 0!==d||"string"!=typeof b)return k||(k=i?a[h]=c.pop()||m.guid++:h),j[k]||(j[k]=i?{}:{toJSON:m.noop}),("object"==typeof b||"function"==typeof b)&&(e?j[k]=m.extend(j[k],b):j[k].data=m.extend(j[k].data,b)),g=j[k],e||(g.data||(g.data={}),g=g.data),void 0!==d&&(g[m.camelCase(b)]=d),"string"==typeof b?(f=g[b],null==f&&(f=g[m.camelCase(b)])):f=g,f}}function R(a,b,c){if(m.acceptData(a)){var d,e,f=a.nodeType,g=f?m.cache:a,h=f?a[m.expando]:m.expando;if(g[h]){if(b&&(d=c?g[h]:g[h].data)){m.isArray(b)?b=b.concat(m.map(b,m.camelCase)):b in d?b=[b]:(b=m.camelCase(b),b=b in d?[b]:b.split(" ")),e=b.length;while(e--)delete d[b[e]];if(c?!P(d):!m.isEmptyObject(d))return}(c||(delete g[h].data,P(g[h])))&&(f?m.cleanData([a],!0):k.deleteExpando||g!=g.window?delete g[h]:g[h]=null)}}}m.extend({cache:{},noData:{"applet ":!0,"embed ":!0,"object ":"clsid:D27CDB6E-AE6D-11cf-96B8-444553540000"},hasData:function(a){return a=a.nodeType?m.cache[a[m.expando]]:a[m.expando],!!a&&!P(a)},data:function(a,b,c){return Q(a,b,c)},removeData:function(a,b){return R(a,b)},_data:function(a,b,c){return Q(a,b,c,!0)},_removeData:function(a,b){return R(a,b,!0)}}),m.fn.extend({data:function(a,b){var c,d,e,f=this[0],g=f&&f.attributes;if(void 0===a){if(this.length&&(e=m.data(f),1===f.nodeType&&!m._data(f,"parsedAttrs"))){c=g.length;while(c--)g[c]&&(d=g[c].name,0===d.indexOf("data-")&&(d=m.camelCase(d.slice(5)),O(f,d,e[d])));m._data(f,"parsedAttrs",!0)}return e}return"object"==typeof a?this.each(function(){m.data(this,a)}):arguments.length>1?this.each(function(){m.data(this,a,b)}):f?O(f,a,m.data(f,a)):void 0},removeData:function(a){return this.each(function(){m.removeData(this,a)})}}),m.extend({queue:function(a,b,c){var d;return a?(b=(b||"fx")+"queue",d=m._data(a,b),c&&(!d||m.isArray(c)?d=m._data(a,b,m.makeArray(c)):d.push(c)),d||[]):void 0},dequeue:function(a,b){b=b||"fx";var c=m.queue(a,b),d=c.length,e=c.shift(),f=m._queueHooks(a,b),g=function(){m.dequeue(a,b)};"inprogress"===e&&(e=c.shift(),d--),e&&("fx"===b&&c.unshift("inprogress"),delete f.stop,e.call(a,g,f)),!d&&f&&f.empty.fire()},_queueHooks:function(a,b){var c=b+"queueHooks";return m._data(a,c)||m._data(a,c,{empty:m.Callbacks("once memory").add(function(){m._removeData(a,b+"queue"),m._removeData(a,c)})})}}),m.fn.extend({queue:function(a,b){var c=2;return"string"!=typeof a&&(b=a,a="fx",c--),arguments.length<c?m.queue(this[0],a):void 0===b?this:this.each(function(){var c=m.queue(this,a,b);m._queueHooks(this,a),"fx"===a&&"inprogress"!==c[0]&&m.dequeue(this,a)})},dequeue:function(a){return this.each(function(){m.dequeue(this,a)})},clearQueue:function(a){return this.queue(a||"fx",[])},promise:function(a,b){var c,d=1,e=m.Deferred(),f=this,g=this.length,h=function(){--d||e.resolveWith(f,[f])};"string"!=typeof a&&(b=a,a=void 0),a=a||"fx";while(g--)c=m._data(f[g],a+"queueHooks"),c&&c.empty&&(d++,c.empty.add(h));return h(),e.promise(b)}});var S=/[+-]?(?:\d*\.|)\d+(?:[eE][+-]?\d+|)/.source,T=["Top","Right","Bottom","Left"],U=function(a,b){return a=b||a,"none"===m.css(a,"display")||!m.contains(a.ownerDocument,a)},V=m.access=function(a,b,c,d,e,f,g){var h=0,i=a.length,j=null==c;if("object"===m.type(c)){e=!0;for(h in c)m.access(a,b,h,c[h],!0,f,g)}else if(void 0!==d&&(e=!0,m.isFunction(d)||(g=!0),j&&(g?(b.call(a,d),b=null):(j=b,b=function(a,b,c){return j.call(m(a),c)})),b))for(;i>h;h++)b(a[h],c,g?d:d.call(a[h],h,b(a[h],c)));return e?a:j?b.call(a):i?b(a[0],c):f},W=/^(?:checkbox|radio)$/i;!function(){var a=y.createElement("input"),b=y.createElement("div"),c=y.createDocumentFragment();if(b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",k.leadingWhitespace=3===b.firstChild.nodeType,k.tbody=!b.getElementsByTagName("tbody").length,k.htmlSerialize=!!b.getElementsByTagName("link").length,k.html5Clone="<:nav></:nav>"!==y.createElement("nav").cloneNode(!0).outerHTML,a.type="checkbox",a.checked=!0,c.appendChild(a),k.appendChecked=a.checked,b.innerHTML="<textarea>x</textarea>",k.noCloneChecked=!!b.cloneNode(!0).lastChild.defaultValue,c.appendChild(b),b.innerHTML="<input type='radio' checked='checked' name='t'/>",k.checkClone=b.cloneNode(!0).cloneNode(!0).lastChild.checked,k.noCloneEvent=!0,b.attachEvent&&(b.attachEvent("onclick",function(){k.noCloneEvent=!1}),b.cloneNode(!0).click()),null==k.deleteExpando){k.deleteExpando=!0;try{delete b.test}catch(d){k.deleteExpando=!1}}}(),function(){var b,c,d=y.createElement("div");for(b in{submit:!0,change:!0,focusin:!0})c="on"+b,(k[b+"Bubbles"]=c in a)||(d.setAttribute(c,"t"),k[b+"Bubbles"]=d.attributes[c].expando===!1);d=null}();var X=/^(?:input|select|textarea)$/i,Y=/^key/,Z=/^(?:mouse|pointer|contextmenu)|click/,$=/^(?:focusinfocus|focusoutblur)$/,_=/^([^.]*)(?:\.(.+)|)$/;function aa(){return!0}function ba(){return!1}function ca(){try{return y.activeElement}catch(a){}}m.event={global:{},add:function(a,b,c,d,e){var f,g,h,i,j,k,l,n,o,p,q,r=m._data(a);if(r){c.handler&&(i=c,c=i.handler,e=i.selector),c.guid||(c.guid=m.guid++),(g=r.events)||(g=r.events={}),(k=r.handle)||(k=r.handle=function(a){return typeof m===K||a&&m.event.triggered===a.type?void 0:m.event.dispatch.apply(k.elem,arguments)},k.elem=a),b=(b||"").match(E)||[""],h=b.length;while(h--)f=_.exec(b[h])||[],o=q=f[1],p=(f[2]||"").split(".").sort(),o&&(j=m.event.special[o]||{},o=(e?j.delegateType:j.bindType)||o,j=m.event.special[o]||{},l=m.extend({type:o,origType:q,data:d,handler:c,guid:c.guid,selector:e,needsContext:e&&m.expr.match.needsContext.test(e),namespace:p.join(".")},i),(n=g[o])||(n=g[o]=[],n.delegateCount=0,j.setup&&j.setup.call(a,d,p,k)!==!1||(a.addEventListener?a.addEventListener(o,k,!1):a.attachEvent&&a.attachEvent("on"+o,k))),j.add&&(j.add.call(a,l),l.handler.guid||(l.handler.guid=c.guid)),e?n.splice(n.delegateCount++,0,l):n.push(l),m.event.global[o]=!0);a=null}},remove:function(a,b,c,d,e){var f,g,h,i,j,k,l,n,o,p,q,r=m.hasData(a)&&m._data(a);if(r&&(k=r.events)){b=(b||"").match(E)||[""],j=b.length;while(j--)if(h=_.exec(b[j])||[],o=q=h[1],p=(h[2]||"").split(".").sort(),o){l=m.event.special[o]||{},o=(d?l.delegateType:l.bindType)||o,n=k[o]||[],h=h[2]&&new RegExp("(^|\\.)"+p.join("\\.(?:.*\\.|)")+"(\\.|$)"),i=f=n.length;while(f--)g=n[f],!e&&q!==g.origType||c&&c.guid!==g.guid||h&&!h.test(g.namespace)||d&&d!==g.selector&&("**"!==d||!g.selector)||(n.splice(f,1),g.selector&&n.delegateCount--,l.remove&&l.remove.call(a,g));i&&!n.length&&(l.teardown&&l.teardown.call(a,p,r.handle)!==!1||m.removeEvent(a,o,r.handle),delete k[o])}else for(o in k)m.event.remove(a,o+b[j],c,d,!0);m.isEmptyObject(k)&&(delete r.handle,m._removeData(a,"events"))}},trigger:function(b,c,d,e){var f,g,h,i,k,l,n,o=[d||y],p=j.call(b,"type")?b.type:b,q=j.call(b,"namespace")?b.namespace.split("."):[];if(h=l=d=d||y,3!==d.nodeType&&8!==d.nodeType&&!$.test(p+m.event.triggered)&&(p.indexOf(".")>=0&&(q=p.split("."),p=q.shift(),q.sort()),g=p.indexOf(":")<0&&"on"+p,b=b[m.expando]?b:new m.Event(p,"object"==typeof b&&b),b.isTrigger=e?2:3,b.namespace=q.join("."),b.namespace_re=b.namespace?new RegExp("(^|\\.)"+q.join("\\.(?:.*\\.|)")+"(\\.|$)"):null,b.result=void 0,b.target||(b.target=d),c=null==c?[b]:m.makeArray(c,[b]),k=m.event.special[p]||{},e||!k.trigger||k.trigger.apply(d,c)!==!1)){if(!e&&!k.noBubble&&!m.isWindow(d)){for(i=k.delegateType||p,$.test(i+p)||(h=h.parentNode);h;h=h.parentNode)o.push(h),l=h;l===(d.ownerDocument||y)&&o.push(l.defaultView||l.parentWindow||a)}n=0;while((h=o[n++])&&!b.isPropagationStopped())b.type=n>1?i:k.bindType||p,f=(m._data(h,"events")||{})[b.type]&&m._data(h,"handle"),f&&f.apply(h,c),f=g&&h[g],f&&f.apply&&m.acceptData(h)&&(b.result=f.apply(h,c),b.result===!1&&b.preventDefault());if(b.type=p,!e&&!b.isDefaultPrevented()&&(!k._default||k._default.apply(o.pop(),c)===!1)&&m.acceptData(d)&&g&&d[p]&&!m.isWindow(d)){l=d[g],l&&(d[g]=null),m.event.triggered=p;try{d[p]()}catch(r){}m.event.triggered=void 0,l&&(d[g]=l)}return b.result}},dispatch:function(a){a=m.event.fix(a);var b,c,e,f,g,h=[],i=d.call(arguments),j=(m._data(this,"events")||{})[a.type]||[],k=m.event.special[a.type]||{};if(i[0]=a,a.delegateTarget=this,!k.preDispatch||k.preDispatch.call(this,a)!==!1){h=m.event.handlers.call(this,a,j),b=0;while((f=h[b++])&&!a.isPropagationStopped()){a.currentTarget=f.elem,g=0;while((e=f.handlers[g++])&&!a.isImmediatePropagationStopped())(!a.namespace_re||a.namespace_re.test(e.namespace))&&(a.handleObj=e,a.data=e.data,c=((m.event.special[e.origType]||{}).handle||e.handler).apply(f.elem,i),void 0!==c&&(a.result=c)===!1&&(a.preventDefault(),a.stopPropagation()))}return k.postDispatch&&k.postDispatch.call(this,a),a.result}},handlers:function(a,b){var c,d,e,f,g=[],h=b.delegateCount,i=a.target;if(h&&i.nodeType&&(!a.button||"click"!==a.type))for(;i!=this;i=i.parentNode||this)if(1===i.nodeType&&(i.disabled!==!0||"click"!==a.type)){for(e=[],f=0;h>f;f++)d=b[f],c=d.selector+" ",void 0===e[c]&&(e[c]=d.needsContext?m(c,this).index(i)>=0:m.find(c,this,null,[i]).length),e[c]&&e.push(d);e.length&&g.push({elem:i,handlers:e})}return h<b.length&&g.push({elem:this,handlers:b.slice(h)}),g},fix:function(a){if(a[m.expando])return a;var b,c,d,e=a.type,f=a,g=this.fixHooks[e];g||(this.fixHooks[e]=g=Z.test(e)?this.mouseHooks:Y.test(e)?this.keyHooks:{}),d=g.props?this.props.concat(g.props):this.props,a=new m.Event(f),b=d.length;while(b--)c=d[b],a[c]=f[c];return a.target||(a.target=f.srcElement||y),3===a.target.nodeType&&(a.target=a.target.parentNode),a.metaKey=!!a.metaKey,g.filter?g.filter(a,f):a},props:"altKey bubbles cancelable ctrlKey currentTarget eventPhase metaKey relatedTarget shiftKey target timeStamp view which".split(" "),fixHooks:{},keyHooks:{props:"char charCode key keyCode".split(" "),filter:function(a,b){return null==a.which&&(a.which=null!=b.charCode?b.charCode:b.keyCode),a}},mouseHooks:{props:"button buttons clientX clientY fromElement offsetX offsetY pageX pageY screenX screenY toElement".split(" "),filter:function(a,b){var c,d,e,f=b.button,g=b.fromElement;return null==a.pageX&&null!=b.clientX&&(d=a.target.ownerDocument||y,e=d.documentElement,c=d.body,a.pageX=b.clientX+(e&&e.scrollLeft||c&&c.scrollLeft||0)-(e&&e.clientLeft||c&&c.clientLeft||0),a.pageY=b.clientY+(e&&e.scrollTop||c&&c.scrollTop||0)-(e&&e.clientTop||c&&c.clientTop||0)),!a.relatedTarget&&g&&(a.relatedTarget=g===a.target?b.toElement:g),a.which||void 0===f||(a.which=1&f?1:2&f?3:4&f?2:0),a}},special:{load:{noBubble:!0},focus:{trigger:function(){if(this!==ca()&&this.focus)try{return this.focus(),!1}catch(a){}},delegateType:"focusin"},blur:{trigger:function(){return this===ca()&&this.blur?(this.blur(),!1):void 0},delegateType:"focusout"},click:{trigger:function(){return m.nodeName(this,"input")&&"checkbox"===this.type&&this.click?(this.click(),!1):void 0},_default:function(a){return m.nodeName(a.target,"a")}},beforeunload:{postDispatch:function(a){void 0!==a.result&&a.originalEvent&&(a.originalEvent.returnValue=a.result)}}},simulate:function(a,b,c,d){var e=m.extend(new m.Event,c,{type:a,isSimulated:!0,originalEvent:{}});d?m.event.trigger(e,null,b):m.event.dispatch.call(b,e),e.isDefaultPrevented()&&c.preventDefault()}},m.removeEvent=y.removeEventListener?function(a,b,c){a.removeEventListener&&a.removeEventListener(b,c,!1)}:function(a,b,c){var d="on"+b;a.detachEvent&&(typeof a[d]===K&&(a[d]=null),a.detachEvent(d,c))},m.Event=function(a,b){return this instanceof m.Event?(a&&a.type?(this.originalEvent=a,this.type=a.type,this.isDefaultPrevented=a.defaultPrevented||void 0===a.defaultPrevented&&a.returnValue===!1?aa:ba):this.type=a,b&&m.extend(this,b),this.timeStamp=a&&a.timeStamp||m.now(),void(this[m.expando]=!0)):new m.Event(a,b)},m.Event.prototype={isDefaultPrevented:ba,isPropagationStopped:ba,isImmediatePropagationStopped:ba,preventDefault:function(){var a=this.originalEvent;this.isDefaultPrevented=aa,a&&(a.preventDefault?a.preventDefault():a.returnValue=!1)},stopPropagation:function(){var a=this.originalEvent;this.isPropagationStopped=aa,a&&(a.stopPropagation&&a.stopPropagation(),a.cancelBubble=!0)},stopImmediatePropagation:function(){var a=this.originalEvent;this.isImmediatePropagationStopped=aa,a&&a.stopImmediatePropagation&&a.stopImmediatePropagation(),this.stopPropagation()}},m.each({mouseenter:"mouseover",mouseleave:"mouseout",pointerenter:"pointerover",pointerleave:"pointerout"},function(a,b){m.event.special[a]={delegateType:b,bindType:b,handle:function(a){var c,d=this,e=a.relatedTarget,f=a.handleObj;return(!e||e!==d&&!m.contains(d,e))&&(a.type=f.origType,c=f.handler.apply(this,arguments),a.type=b),c}}}),k.submitBubbles||(m.event.special.submit={setup:function(){return m.nodeName(this,"form")?!1:void m.event.add(this,"click._submit keypress._submit",function(a){var b=a.target,c=m.nodeName(b,"input")||m.nodeName(b,"button")?b.form:void 0;c&&!m._data(c,"submitBubbles")&&(m.event.add(c,"submit._submit",function(a){a._submit_bubble=!0}),m._data(c,"submitBubbles",!0))})},postDispatch:function(a){a._submit_bubble&&(delete a._submit_bubble,this.parentNode&&!a.isTrigger&&m.event.simulate("submit",this.parentNode,a,!0))},teardown:function(){return m.nodeName(this,"form")?!1:void m.event.remove(this,"._submit")}}),k.changeBubbles||(m.event.special.change={setup:function(){return X.test(this.nodeName)?(("checkbox"===this.type||"radio"===this.type)&&(m.event.add(this,"propertychange._change",function(a){"checked"===a.originalEvent.propertyName&&(this._just_changed=!0)}),m.event.add(this,"click._change",function(a){this._just_changed&&!a.isTrigger&&(this._just_changed=!1),m.event.simulate("change",this,a,!0)})),!1):void m.event.add(this,"beforeactivate._change",function(a){var b=a.target;X.test(b.nodeName)&&!m._data(b,"changeBubbles")&&(m.event.add(b,"change._change",function(a){!this.parentNode||a.isSimulated||a.isTrigger||m.event.simulate("change",this.parentNode,a,!0)}),m._data(b,"changeBubbles",!0))})},handle:function(a){var b=a.target;return this!==b||a.isSimulated||a.isTrigger||"radio"!==b.type&&"checkbox"!==b.type?a.handleObj.handler.apply(this,arguments):void 0},teardown:function(){return m.event.remove(this,"._change"),!X.test(this.nodeName)}}),k.focusinBubbles||m.each({focus:"focusin",blur:"focusout"},function(a,b){var c=function(a){m.event.simulate(b,a.target,m.event.fix(a),!0)};m.event.special[b]={setup:function(){var d=this.ownerDocument||this,e=m._data(d,b);e||d.addEventListener(a,c,!0),m._data(d,b,(e||0)+1)},teardown:function(){var d=this.ownerDocument||this,e=m._data(d,b)-1;e?m._data(d,b,e):(d.removeEventListener(a,c,!0),m._removeData(d,b))}}}),m.fn.extend({on:function(a,b,c,d,e){var f,g;if("object"==typeof a){"string"!=typeof b&&(c=c||b,b=void 0);for(f in a)this.on(f,b,c,a[f],e);return this}if(null==c&&null==d?(d=b,c=b=void 0):null==d&&("string"==typeof b?(d=c,c=void 0):(d=c,c=b,b=void 0)),d===!1)d=ba;else if(!d)return this;return 1===e&&(g=d,d=function(a){return m().off(a),g.apply(this,arguments)},d.guid=g.guid||(g.guid=m.guid++)),this.each(function(){m.event.add(this,a,d,c,b)})},one:function(a,b,c,d){return this.on(a,b,c,d,1)},off:function(a,b,c){var d,e;if(a&&a.preventDefault&&a.handleObj)return d=a.handleObj,m(a.delegateTarget).off(d.namespace?d.origType+"."+d.namespace:d.origType,d.selector,d.handler),this;if("object"==typeof a){for(e in a)this.off(e,b,a[e]);return this}return(b===!1||"function"==typeof b)&&(c=b,b=void 0),c===!1&&(c=ba),this.each(function(){m.event.remove(this,a,c,b)})},trigger:function(a,b){return this.each(function(){m.event.trigger(a,b,this)})},triggerHandler:function(a,b){var c=this[0];return c?m.event.trigger(a,b,c,!0):void 0}});function da(a){var b=ea.split("|"),c=a.createDocumentFragment();if(c.createElement)while(b.length)c.createElement(b.pop());return c}var ea="abbr|article|aside|audio|bdi|canvas|data|datalist|details|figcaption|figure|footer|header|hgroup|mark|meter|nav|output|progress|section|summary|time|video",fa=/ jQuery\d+="(?:null|\d+)"/g,ga=new RegExp("<(?:"+ea+")[\\s/>]","i"),ha=/^\s+/,ia=/<(?!area|br|col|embed|hr|img|input|link|meta|param)(([\w:]+)[^>]*)\/>/gi,ja=/<([\w:]+)/,ka=/<tbody/i,la=/<|&#?\w+;/,ma=/<(?:script|style|link)/i,na=/checked\s*(?:[^=]|=\s*.checked.)/i,oa=/^$|\/(?:java|ecma)script/i,pa=/^true\/(.*)/,qa=/^\s*<!(?:\[CDATA\[|--)|(?:\]\]|--)>\s*$/g,ra={option:[1,"<select multiple='multiple'>","</select>"],legend:[1,"<fieldset>","</fieldset>"],area:[1,"<map>","</map>"],param:[1,"<object>","</object>"],thead:[1,"<table>","</table>"],tr:[2,"<table><tbody>","</tbody></table>"],col:[2,"<table><tbody></tbody><colgroup>","</colgroup></table>"],td:[3,"<table><tbody><tr>","</tr></tbody></table>"],_default:k.htmlSerialize?[0,"",""]:[1,"X<div>","</div>"]},sa=da(y),ta=sa.appendChild(y.createElement("div"));ra.optgroup=ra.option,ra.tbody=ra.tfoot=ra.colgroup=ra.caption=ra.thead,ra.th=ra.td;function ua(a,b){var c,d,e=0,f=typeof a.getElementsByTagName!==K?a.getElementsByTagName(b||"*"):typeof a.querySelectorAll!==K?a.querySelectorAll(b||"*"):void 0;if(!f)for(f=[],c=a.childNodes||a;null!=(d=c[e]);e++)!b||m.nodeName(d,b)?f.push(d):m.merge(f,ua(d,b));return void 0===b||b&&m.nodeName(a,b)?m.merge([a],f):f}function va(a){W.test(a.type)&&(a.defaultChecked=a.checked)}function wa(a,b){return m.nodeName(a,"table")&&m.nodeName(11!==b.nodeType?b:b.firstChild,"tr")?a.getElementsByTagName("tbody")[0]||a.appendChild(a.ownerDocument.createElement("tbody")):a}function xa(a){return a.type=(null!==m.find.attr(a,"type"))+"/"+a.type,a}function ya(a){var b=pa.exec(a.type);return b?a.type=b[1]:a.removeAttribute("type"),a}function za(a,b){for(var c,d=0;null!=(c=a[d]);d++)m._data(c,"globalEval",!b||m._data(b[d],"globalEval"))}function Aa(a,b){if(1===b.nodeType&&m.hasData(a)){var c,d,e,f=m._data(a),g=m._data(b,f),h=f.events;if(h){delete g.handle,g.events={};for(c in h)for(d=0,e=h[c].length;e>d;d++)m.event.add(b,c,h[c][d])}g.data&&(g.data=m.extend({},g.data))}}function Ba(a,b){var c,d,e;if(1===b.nodeType){if(c=b.nodeName.toLowerCase(),!k.noCloneEvent&&b[m.expando]){e=m._data(b);for(d in e.events)m.removeEvent(b,d,e.handle);b.removeAttribute(m.expando)}"script"===c&&b.text!==a.text?(xa(b).text=a.text,ya(b)):"object"===c?(b.parentNode&&(b.outerHTML=a.outerHTML),k.html5Clone&&a.innerHTML&&!m.trim(b.innerHTML)&&(b.innerHTML=a.innerHTML)):"input"===c&&W.test(a.type)?(b.defaultChecked=b.checked=a.checked,b.value!==a.value&&(b.value=a.value)):"option"===c?b.defaultSelected=b.selected=a.defaultSelected:("input"===c||"textarea"===c)&&(b.defaultValue=a.defaultValue)}}m.extend({clone:function(a,b,c){var d,e,f,g,h,i=m.contains(a.ownerDocument,a);if(k.html5Clone||m.isXMLDoc(a)||!ga.test("<"+a.nodeName+">")?f=a.cloneNode(!0):(ta.innerHTML=a.outerHTML,ta.removeChild(f=ta.firstChild)),!(k.noCloneEvent&&k.noCloneChecked||1!==a.nodeType&&11!==a.nodeType||m.isXMLDoc(a)))for(d=ua(f),h=ua(a),g=0;null!=(e=h[g]);++g)d[g]&&Ba(e,d[g]);if(b)if(c)for(h=h||ua(a),d=d||ua(f),g=0;null!=(e=h[g]);g++)Aa(e,d[g]);else Aa(a,f);return d=ua(f,"script"),d.length>0&&za(d,!i&&ua(a,"script")),d=h=e=null,f},buildFragment:function(a,b,c,d){for(var e,f,g,h,i,j,l,n=a.length,o=da(b),p=[],q=0;n>q;q++)if(f=a[q],f||0===f)if("object"===m.type(f))m.merge(p,f.nodeType?[f]:f);else if(la.test(f)){h=h||o.appendChild(b.createElement("div")),i=(ja.exec(f)||["",""])[1].toLowerCase(),l=ra[i]||ra._default,h.innerHTML=l[1]+f.replace(ia,"<$1></$2>")+l[2],e=l[0];while(e--)h=h.lastChild;if(!k.leadingWhitespace&&ha.test(f)&&p.push(b.createTextNode(ha.exec(f)[0])),!k.tbody){f="table"!==i||ka.test(f)?"<table>"!==l[1]||ka.test(f)?0:h:h.firstChild,e=f&&f.childNodes.length;while(e--)m.nodeName(j=f.childNodes[e],"tbody")&&!j.childNodes.length&&f.removeChild(j)}m.merge(p,h.childNodes),h.textContent="";while(h.firstChild)h.removeChild(h.firstChild);h=o.lastChild}else p.push(b.createTextNode(f));h&&o.removeChild(h),k.appendChecked||m.grep(ua(p,"input"),va),q=0;while(f=p[q++])if((!d||-1===m.inArray(f,d))&&(g=m.contains(f.ownerDocument,f),h=ua(o.appendChild(f),"script"),g&&za(h),c)){e=0;while(f=h[e++])oa.test(f.type||"")&&c.push(f)}return h=null,o},cleanData:function(a,b){for(var d,e,f,g,h=0,i=m.expando,j=m.cache,l=k.deleteExpando,n=m.event.special;null!=(d=a[h]);h++)if((b||m.acceptData(d))&&(f=d[i],g=f&&j[f])){if(g.events)for(e in g.events)n[e]?m.event.remove(d,e):m.removeEvent(d,e,g.handle);j[f]&&(delete j[f],l?delete d[i]:typeof d.removeAttribute!==K?d.removeAttribute(i):d[i]=null,c.push(f))}}}),m.fn.extend({text:function(a){return V(this,function(a){return void 0===a?m.text(this):this.empty().append((this[0]&&this[0].ownerDocument||y).createTextNode(a))},null,a,arguments.length)},append:function(){return this.domManip(arguments,function(a){if(1===this.nodeType||11===this.nodeType||9===this.nodeType){var b=wa(this,a);b.appendChild(a)}})},prepend:function(){return this.domManip(arguments,function(a){if(1===this.nodeType||11===this.nodeType||9===this.nodeType){var b=wa(this,a);b.insertBefore(a,b.firstChild)}})},before:function(){return this.domManip(arguments,function(a){this.parentNode&&this.parentNode.insertBefore(a,this)})},after:function(){return this.domManip(arguments,function(a){this.parentNode&&this.parentNode.insertBefore(a,this.nextSibling)})},remove:function(a,b){for(var c,d=a?m.filter(a,this):this,e=0;null!=(c=d[e]);e++)b||1!==c.nodeType||m.cleanData(ua(c)),c.parentNode&&(b&&m.contains(c.ownerDocument,c)&&za(ua(c,"script")),c.parentNode.removeChild(c));return this},empty:function(){for(var a,b=0;null!=(a=this[b]);b++){1===a.nodeType&&m.cleanData(ua(a,!1));while(a.firstChild)a.removeChild(a.firstChild);a.options&&m.nodeName(a,"select")&&(a.options.length=0)}return this},clone:function(a,b){return a=null==a?!1:a,b=null==b?a:b,this.map(function(){return m.clone(this,a,b)})},html:function(a){return V(this,function(a){var b=this[0]||{},c=0,d=this.length;if(void 0===a)return 1===b.nodeType?b.innerHTML.replace(fa,""):void 0;if(!("string"!=typeof a||ma.test(a)||!k.htmlSerialize&&ga.test(a)||!k.leadingWhitespace&&ha.test(a)||ra[(ja.exec(a)||["",""])[1].toLowerCase()])){a=a.replace(ia,"<$1></$2>");try{for(;d>c;c++)b=this[c]||{},1===b.nodeType&&(m.cleanData(ua(b,!1)),b.innerHTML=a);b=0}catch(e){}}b&&this.empty().append(a)},null,a,arguments.length)},replaceWith:function(){var a=arguments[0];return this.domManip(arguments,function(b){a=this.parentNode,m.cleanData(ua(this)),a&&a.replaceChild(b,this)}),a&&(a.length||a.nodeType)?this:this.remove()},detach:function(a){return this.remove(a,!0)},domManip:function(a,b){a=e.apply([],a);var c,d,f,g,h,i,j=0,l=this.length,n=this,o=l-1,p=a[0],q=m.isFunction(p);if(q||l>1&&"string"==typeof p&&!k.checkClone&&na.test(p))return this.each(function(c){var d=n.eq(c);q&&(a[0]=p.call(this,c,d.html())),d.domManip(a,b)});if(l&&(i=m.buildFragment(a,this[0].ownerDocument,!1,this),c=i.firstChild,1===i.childNodes.length&&(i=c),c)){for(g=m.map(ua(i,"script"),xa),f=g.length;l>j;j++)d=i,j!==o&&(d=m.clone(d,!0,!0),f&&m.merge(g,ua(d,"script"))),b.call(this[j],d,j);if(f)for(h=g[g.length-1].ownerDocument,m.map(g,ya),j=0;f>j;j++)d=g[j],oa.test(d.type||"")&&!m._data(d,"globalEval")&&m.contains(h,d)&&(d.src?m._evalUrl&&m._evalUrl(d.src):m.globalEval((d.text||d.textContent||d.innerHTML||"").replace(qa,"")));i=c=null}return this}}),m.each({appendTo:"append",prependTo:"prepend",insertBefore:"before",insertAfter:"after",replaceAll:"replaceWith"},function(a,b){m.fn[a]=function(a){for(var c,d=0,e=[],g=m(a),h=g.length-1;h>=d;d++)c=d===h?this:this.clone(!0),m(g[d])[b](c),f.apply(e,c.get());return this.pushStack(e)}});var Ca,Da={};function Ea(b,c){var d,e=m(c.createElement(b)).appendTo(c.body),f=a.getDefaultComputedStyle&&(d=a.getDefaultComputedStyle(e[0]))?d.display:m.css(e[0],"display");return e.detach(),f}function Fa(a){var b=y,c=Da[a];return c||(c=Ea(a,b),"none"!==c&&c||(Ca=(Ca||m("<iframe frameborder='0' width='0' height='0'/>")).appendTo(b.documentElement),b=(Ca[0].contentWindow||Ca[0].contentDocument).document,b.write(),b.close(),c=Ea(a,b),Ca.detach()),Da[a]=c),c}!function(){var a;k.shrinkWrapBlocks=function(){if(null!=a)return a;a=!1;var b,c,d;return c=y.getElementsByTagName("body")[0],c&&c.style?(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),typeof b.style.zoom!==K&&(b.style.cssText="-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;display:block;margin:0;border:0;padding:1px;width:1px;zoom:1",b.appendChild(y.createElement("div")).style.width="5px",a=3!==b.offsetWidth),c.removeChild(d),a):void 0}}();var Ga=/^margin/,Ha=new RegExp("^("+S+")(?!px)[a-z%]+$","i"),Ia,Ja,Ka=/^(top|right|bottom|left)$/;a.getComputedStyle?(Ia=function(b){return b.ownerDocument.defaultView.opener?b.ownerDocument.defaultView.getComputedStyle(b,null):a.getComputedStyle(b,null)},Ja=function(a,b,c){var d,e,f,g,h=a.style;return c=c||Ia(a),g=c?c.getPropertyValue(b)||c[b]:void 0,c&&(""!==g||m.contains(a.ownerDocument,a)||(g=m.style(a,b)),Ha.test(g)&&Ga.test(b)&&(d=h.width,e=h.minWidth,f=h.maxWidth,h.minWidth=h.maxWidth=h.width=g,g=c.width,h.width=d,h.minWidth=e,h.maxWidth=f)),void 0===g?g:g+""}):y.documentElement.currentStyle&&(Ia=function(a){return a.currentStyle},Ja=function(a,b,c){var d,e,f,g,h=a.style;return c=c||Ia(a),g=c?c[b]:void 0,null==g&&h&&h[b]&&(g=h[b]),Ha.test(g)&&!Ka.test(b)&&(d=h.left,e=a.runtimeStyle,f=e&&e.left,f&&(e.left=a.currentStyle.left),h.left="fontSize"===b?"1em":g,g=h.pixelLeft+"px",h.left=d,f&&(e.left=f)),void 0===g?g:g+""||"auto"});function La(a,b){return{get:function(){var c=a();if(null!=c)return c?void delete this.get:(this.get=b).apply(this,arguments)}}}!function(){var b,c,d,e,f,g,h;if(b=y.createElement("div"),b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",d=b.getElementsByTagName("a")[0],c=d&&d.style){c.cssText="float:left;opacity:.5",k.opacity="0.5"===c.opacity,k.cssFloat=!!c.cssFloat,b.style.backgroundClip="content-box",b.cloneNode(!0).style.backgroundClip="",k.clearCloneStyle="content-box"===b.style.backgroundClip,k.boxSizing=""===c.boxSizing||""===c.MozBoxSizing||""===c.WebkitBoxSizing,m.extend(k,{reliableHiddenOffsets:function(){return null==g&&i(),g},boxSizingReliable:function(){return null==f&&i(),f},pixelPosition:function(){return null==e&&i(),e},reliableMarginRight:function(){return null==h&&i(),h}});function i(){var b,c,d,i;c=y.getElementsByTagName("body")[0],c&&c.style&&(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),b.style.cssText="-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box;display:block;margin-top:1%;top:1%;border:1px;padding:1px;width:4px;position:absolute",e=f=!1,h=!0,a.getComputedStyle&&(e="1%"!==(a.getComputedStyle(b,null)||{}).top,f="4px"===(a.getComputedStyle(b,null)||{width:"4px"}).width,i=b.appendChild(y.createElement("div")),i.style.cssText=b.style.cssText="-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;display:block;margin:0;border:0;padding:0",i.style.marginRight=i.style.width="0",b.style.width="1px",h=!parseFloat((a.getComputedStyle(i,null)||{}).marginRight),b.removeChild(i)),b.innerHTML="<table><tr><td></td><td>t</td></tr></table>",i=b.getElementsByTagName("td"),i[0].style.cssText="margin:0;border:0;padding:0;display:none",g=0===i[0].offsetHeight,g&&(i[0].style.display="",i[1].style.display="none",g=0===i[0].offsetHeight),c.removeChild(d))}}}(),m.swap=function(a,b,c,d){var e,f,g={};for(f in b)g[f]=a.style[f],a.style[f]=b[f];e=c.apply(a,d||[]);for(f in b)a.style[f]=g[f];return e};var Ma=/alpha\([^)]*\)/i,Na=/opacity\s*=\s*([^)]*)/,Oa=/^(none|table(?!-c[ea]).+)/,Pa=new RegExp("^("+S+")(.*)$","i"),Qa=new RegExp("^([+-])=("+S+")","i"),Ra={position:"absolute",visibility:"hidden",display:"block"},Sa={letterSpacing:"0",fontWeight:"400"},Ta=["Webkit","O","Moz","ms"];function Ua(a,b){if(b in a)return b;var c=b.charAt(0).toUpperCase()+b.slice(1),d=b,e=Ta.length;while(e--)if(b=Ta[e]+c,b in a)return b;return d}function Va(a,b){for(var c,d,e,f=[],g=0,h=a.length;h>g;g++)d=a[g],d.style&&(f[g]=m._data(d,"olddisplay"),c=d.style.display,b?(f[g]||"none"!==c||(d.style.display=""),""===d.style.display&&U(d)&&(f[g]=m._data(d,"olddisplay",Fa(d.nodeName)))):(e=U(d),(c&&"none"!==c||!e)&&m._data(d,"olddisplay",e?c:m.css(d,"display"))));for(g=0;h>g;g++)d=a[g],d.style&&(b&&"none"!==d.style.display&&""!==d.style.display||(d.style.display=b?f[g]||"":"none"));return a}function Wa(a,b,c){var d=Pa.exec(b);return d?Math.max(0,d[1]-(c||0))+(d[2]||"px"):b}function Xa(a,b,c,d,e){for(var f=c===(d?"border":"content")?4:"width"===b?1:0,g=0;4>f;f+=2)"margin"===c&&(g+=m.css(a,c+T[f],!0,e)),d?("content"===c&&(g-=m.css(a,"padding"+T[f],!0,e)),"margin"!==c&&(g-=m.css(a,"border"+T[f]+"Width",!0,e))):(g+=m.css(a,"padding"+T[f],!0,e),"padding"!==c&&(g+=m.css(a,"border"+T[f]+"Width",!0,e)));return g}function Ya(a,b,c){var d=!0,e="width"===b?a.offsetWidth:a.offsetHeight,f=Ia(a),g=k.boxSizing&&"border-box"===m.css(a,"boxSizing",!1,f);if(0>=e||null==e){if(e=Ja(a,b,f),(0>e||null==e)&&(e=a.style[b]),Ha.test(e))return e;d=g&&(k.boxSizingReliable()||e===a.style[b]),e=parseFloat(e)||0}return e+Xa(a,b,c||(g?"border":"content"),d,f)+"px"}m.extend({cssHooks:{opacity:{get:function(a,b){if(b){var c=Ja(a,"opacity");return""===c?"1":c}}}},cssNumber:{columnCount:!0,fillOpacity:!0,flexGrow:!0,flexShrink:!0,fontWeight:!0,lineHeight:!0,opacity:!0,order:!0,orphans:!0,widows:!0,zIndex:!0,zoom:!0},cssProps:{"float":k.cssFloat?"cssFloat":"styleFloat"},style:function(a,b,c,d){if(a&&3!==a.nodeType&&8!==a.nodeType&&a.style){var e,f,g,h=m.camelCase(b),i=a.style;if(b=m.cssProps[h]||(m.cssProps[h]=Ua(i,h)),g=m.cssHooks[b]||m.cssHooks[h],void 0===c)return g&&"get"in g&&void 0!==(e=g.get(a,!1,d))?e:i[b];if(f=typeof c,"string"===f&&(e=Qa.exec(c))&&(c=(e[1]+1)*e[2]+parseFloat(m.css(a,b)),f="number"),null!=c&&c===c&&("number"!==f||m.cssNumber[h]||(c+="px"),k.clearCloneStyle||""!==c||0!==b.indexOf("background")||(i[b]="inherit"),!(g&&"set"in g&&void 0===(c=g.set(a,c,d)))))try{i[b]=c}catch(j){}}},css:function(a,b,c,d){var e,f,g,h=m.camelCase(b);return b=m.cssProps[h]||(m.cssProps[h]=Ua(a.style,h)),g=m.cssHooks[b]||m.cssHooks[h],g&&"get"in g&&(f=g.get(a,!0,c)),void 0===f&&(f=Ja(a,b,d)),"normal"===f&&b in Sa&&(f=Sa[b]),""===c||c?(e=parseFloat(f),c===!0||m.isNumeric(e)?e||0:f):f}}),m.each(["height","width"],function(a,b){m.cssHooks[b]={get:function(a,c,d){return c?Oa.test(m.css(a,"display"))&&0===a.offsetWidth?m.swap(a,Ra,function(){return Ya(a,b,d)}):Ya(a,b,d):void 0},set:function(a,c,d){var e=d&&Ia(a);return Wa(a,c,d?Xa(a,b,d,k.boxSizing&&"border-box"===m.css(a,"boxSizing",!1,e),e):0)}}}),k.opacity||(m.cssHooks.opacity={get:function(a,b){return Na.test((b&&a.currentStyle?a.currentStyle.filter:a.style.filter)||"")?.01*parseFloat(RegExp.$1)+"":b?"1":""},set:function(a,b){var c=a.style,d=a.currentStyle,e=m.isNumeric(b)?"alpha(opacity="+100*b+")":"",f=d&&d.filter||c.filter||"";c.zoom=1,(b>=1||""===b)&&""===m.trim(f.replace(Ma,""))&&c.removeAttribute&&(c.removeAttribute("filter"),""===b||d&&!d.filter)||(c.filter=Ma.test(f)?f.replace(Ma,e):f+" "+e)}}),m.cssHooks.marginRight=La(k.reliableMarginRight,function(a,b){return b?m.swap(a,{display:"inline-block"},Ja,[a,"marginRight"]):void 0}),m.each({margin:"",padding:"",border:"Width"},function(a,b){m.cssHooks[a+b]={expand:function(c){for(var d=0,e={},f="string"==typeof c?c.split(" "):[c];4>d;d++)e[a+T[d]+b]=f[d]||f[d-2]||f[0];return e}},Ga.test(a)||(m.cssHooks[a+b].set=Wa)}),m.fn.extend({css:function(a,b){return V(this,function(a,b,c){var d,e,f={},g=0;if(m.isArray(b)){for(d=Ia(a),e=b.length;e>g;g++)f[b[g]]=m.css(a,b[g],!1,d);return f}return void 0!==c?m.style(a,b,c):m.css(a,b)},a,b,arguments.length>1)},show:function(){return Va(this,!0)},hide:function(){return Va(this)},toggle:function(a){return"boolean"==typeof a?a?this.show():this.hide():this.each(function(){U(this)?m(this).show():m(this).hide()})}});function Za(a,b,c,d,e){
return new Za.prototype.init(a,b,c,d,e)}m.Tween=Za,Za.prototype={constructor:Za,init:function(a,b,c,d,e,f){this.elem=a,this.prop=c,this.easing=e||"swing",this.options=b,this.start=this.now=this.cur(),this.end=d,this.unit=f||(m.cssNumber[c]?"":"px")},cur:function(){var a=Za.propHooks[this.prop];return a&&a.get?a.get(this):Za.propHooks._default.get(this)},run:function(a){var b,c=Za.propHooks[this.prop];return this.options.duration?this.pos=b=m.easing[this.easing](a,this.options.duration*a,0,1,this.options.duration):this.pos=b=a,this.now=(this.end-this.start)*b+this.start,this.options.step&&this.options.step.call(this.elem,this.now,this),c&&c.set?c.set(this):Za.propHooks._default.set(this),this}},Za.prototype.init.prototype=Za.prototype,Za.propHooks={_default:{get:function(a){var b;return null==a.elem[a.prop]||a.elem.style&&null!=a.elem.style[a.prop]?(b=m.css(a.elem,a.prop,""),b&&"auto"!==b?b:0):a.elem[a.prop]},set:function(a){m.fx.step[a.prop]?m.fx.step[a.prop](a):a.elem.style&&(null!=a.elem.style[m.cssProps[a.prop]]||m.cssHooks[a.prop])?m.style(a.elem,a.prop,a.now+a.unit):a.elem[a.prop]=a.now}}},Za.propHooks.scrollTop=Za.propHooks.scrollLeft={set:function(a){a.elem.nodeType&&a.elem.parentNode&&(a.elem[a.prop]=a.now)}},m.easing={linear:function(a){return a},swing:function(a){return.5-Math.cos(a*Math.PI)/2}},m.fx=Za.prototype.init,m.fx.step={};var $a,_a,ab=/^(?:toggle|show|hide)$/,bb=new RegExp("^(?:([+-])=|)("+S+")([a-z%]*)$","i"),cb=/queueHooks$/,db=[ib],eb={"*":[function(a,b){var c=this.createTween(a,b),d=c.cur(),e=bb.exec(b),f=e&&e[3]||(m.cssNumber[a]?"":"px"),g=(m.cssNumber[a]||"px"!==f&&+d)&&bb.exec(m.css(c.elem,a)),h=1,i=20;if(g&&g[3]!==f){f=f||g[3],e=e||[],g=+d||1;do h=h||".5",g/=h,m.style(c.elem,a,g+f);while(h!==(h=c.cur()/d)&&1!==h&&--i)}return e&&(g=c.start=+g||+d||0,c.unit=f,c.end=e[1]?g+(e[1]+1)*e[2]:+e[2]),c}]};function fb(){return setTimeout(function(){$a=void 0}),$a=m.now()}function gb(a,b){var c,d={height:a},e=0;for(b=b?1:0;4>e;e+=2-b)c=T[e],d["margin"+c]=d["padding"+c]=a;return b&&(d.opacity=d.width=a),d}function hb(a,b,c){for(var d,e=(eb[b]||[]).concat(eb["*"]),f=0,g=e.length;g>f;f++)if(d=e[f].call(c,b,a))return d}function ib(a,b,c){var d,e,f,g,h,i,j,l,n=this,o={},p=a.style,q=a.nodeType&&U(a),r=m._data(a,"fxshow");c.queue||(h=m._queueHooks(a,"fx"),null==h.unqueued&&(h.unqueued=0,i=h.empty.fire,h.empty.fire=function(){h.unqueued||i()}),h.unqueued++,n.always(function(){n.always(function(){h.unqueued--,m.queue(a,"fx").length||h.empty.fire()})})),1===a.nodeType&&("height"in b||"width"in b)&&(c.overflow=[p.overflow,p.overflowX,p.overflowY],j=m.css(a,"display"),l="none"===j?m._data(a,"olddisplay")||Fa(a.nodeName):j,"inline"===l&&"none"===m.css(a,"float")&&(k.inlineBlockNeedsLayout&&"inline"!==Fa(a.nodeName)?p.zoom=1:p.display="inline-block")),c.overflow&&(p.overflow="hidden",k.shrinkWrapBlocks()||n.always(function(){p.overflow=c.overflow[0],p.overflowX=c.overflow[1],p.overflowY=c.overflow[2]}));for(d in b)if(e=b[d],ab.exec(e)){if(delete b[d],f=f||"toggle"===e,e===(q?"hide":"show")){if("show"!==e||!r||void 0===r[d])continue;q=!0}o[d]=r&&r[d]||m.style(a,d)}else j=void 0;if(m.isEmptyObject(o))"inline"===("none"===j?Fa(a.nodeName):j)&&(p.display=j);else{r?"hidden"in r&&(q=r.hidden):r=m._data(a,"fxshow",{}),f&&(r.hidden=!q),q?m(a).show():n.done(function(){m(a).hide()}),n.done(function(){var b;m._removeData(a,"fxshow");for(b in o)m.style(a,b,o[b])});for(d in o)g=hb(q?r[d]:0,d,n),d in r||(r[d]=g.start,q&&(g.end=g.start,g.start="width"===d||"height"===d?1:0))}}function jb(a,b){var c,d,e,f,g;for(c in a)if(d=m.camelCase(c),e=b[d],f=a[c],m.isArray(f)&&(e=f[1],f=a[c]=f[0]),c!==d&&(a[d]=f,delete a[c]),g=m.cssHooks[d],g&&"expand"in g){f=g.expand(f),delete a[d];for(c in f)c in a||(a[c]=f[c],b[c]=e)}else b[d]=e}function kb(a,b,c){var d,e,f=0,g=db.length,h=m.Deferred().always(function(){delete i.elem}),i=function(){if(e)return!1;for(var b=$a||fb(),c=Math.max(0,j.startTime+j.duration-b),d=c/j.duration||0,f=1-d,g=0,i=j.tweens.length;i>g;g++)j.tweens[g].run(f);return h.notifyWith(a,[j,f,c]),1>f&&i?c:(h.resolveWith(a,[j]),!1)},j=h.promise({elem:a,props:m.extend({},b),opts:m.extend(!0,{specialEasing:{}},c),originalProperties:b,originalOptions:c,startTime:$a||fb(),duration:c.duration,tweens:[],createTween:function(b,c){var d=m.Tween(a,j.opts,b,c,j.opts.specialEasing[b]||j.opts.easing);return j.tweens.push(d),d},stop:function(b){var c=0,d=b?j.tweens.length:0;if(e)return this;for(e=!0;d>c;c++)j.tweens[c].run(1);return b?h.resolveWith(a,[j,b]):h.rejectWith(a,[j,b]),this}}),k=j.props;for(jb(k,j.opts.specialEasing);g>f;f++)if(d=db[f].call(j,a,k,j.opts))return d;return m.map(k,hb,j),m.isFunction(j.opts.start)&&j.opts.start.call(a,j),m.fx.timer(m.extend(i,{elem:a,anim:j,queue:j.opts.queue})),j.progress(j.opts.progress).done(j.opts.done,j.opts.complete).fail(j.opts.fail).always(j.opts.always)}m.Animation=m.extend(kb,{tweener:function(a,b){m.isFunction(a)?(b=a,a=["*"]):a=a.split(" ");for(var c,d=0,e=a.length;e>d;d++)c=a[d],eb[c]=eb[c]||[],eb[c].unshift(b)},prefilter:function(a,b){b?db.unshift(a):db.push(a)}}),m.speed=function(a,b,c){var d=a&&"object"==typeof a?m.extend({},a):{complete:c||!c&&b||m.isFunction(a)&&a,duration:a,easing:c&&b||b&&!m.isFunction(b)&&b};return d.duration=m.fx.off?0:"number"==typeof d.duration?d.duration:d.duration in m.fx.speeds?m.fx.speeds[d.duration]:m.fx.speeds._default,(null==d.queue||d.queue===!0)&&(d.queue="fx"),d.old=d.complete,d.complete=function(){m.isFunction(d.old)&&d.old.call(this),d.queue&&m.dequeue(this,d.queue)},d},m.fn.extend({fadeTo:function(a,b,c,d){return this.filter(U).css("opacity",0).show().end().animate({opacity:b},a,c,d)},animate:function(a,b,c,d){var e=m.isEmptyObject(a),f=m.speed(b,c,d),g=function(){var b=kb(this,m.extend({},a),f);(e||m._data(this,"finish"))&&b.stop(!0)};return g.finish=g,e||f.queue===!1?this.each(g):this.queue(f.queue,g)},stop:function(a,b,c){var d=function(a){var b=a.stop;delete a.stop,b(c)};return"string"!=typeof a&&(c=b,b=a,a=void 0),b&&a!==!1&&this.queue(a||"fx",[]),this.each(function(){var b=!0,e=null!=a&&a+"queueHooks",f=m.timers,g=m._data(this);if(e)g[e]&&g[e].stop&&d(g[e]);else for(e in g)g[e]&&g[e].stop&&cb.test(e)&&d(g[e]);for(e=f.length;e--;)f[e].elem!==this||null!=a&&f[e].queue!==a||(f[e].anim.stop(c),b=!1,f.splice(e,1));(b||!c)&&m.dequeue(this,a)})},finish:function(a){return a!==!1&&(a=a||"fx"),this.each(function(){var b,c=m._data(this),d=c[a+"queue"],e=c[a+"queueHooks"],f=m.timers,g=d?d.length:0;for(c.finish=!0,m.queue(this,a,[]),e&&e.stop&&e.stop.call(this,!0),b=f.length;b--;)f[b].elem===this&&f[b].queue===a&&(f[b].anim.stop(!0),f.splice(b,1));for(b=0;g>b;b++)d[b]&&d[b].finish&&d[b].finish.call(this);delete c.finish})}}),m.each(["toggle","show","hide"],function(a,b){var c=m.fn[b];m.fn[b]=function(a,d,e){return null==a||"boolean"==typeof a?c.apply(this,arguments):this.animate(gb(b,!0),a,d,e)}}),m.each({slideDown:gb("show"),slideUp:gb("hide"),slideToggle:gb("toggle"),fadeIn:{opacity:"show"},fadeOut:{opacity:"hide"},fadeToggle:{opacity:"toggle"}},function(a,b){m.fn[a]=function(a,c,d){return this.animate(b,a,c,d)}}),m.timers=[],m.fx.tick=function(){var a,b=m.timers,c=0;for($a=m.now();c<b.length;c++)a=b[c],a()||b[c]!==a||b.splice(c--,1);b.length||m.fx.stop(),$a=void 0},m.fx.timer=function(a){m.timers.push(a),a()?m.fx.start():m.timers.pop()},m.fx.interval=13,m.fx.start=function(){_a||(_a=setInterval(m.fx.tick,m.fx.interval))},m.fx.stop=function(){clearInterval(_a),_a=null},m.fx.speeds={slow:600,fast:200,_default:400},m.fn.delay=function(a,b){return a=m.fx?m.fx.speeds[a]||a:a,b=b||"fx",this.queue(b,function(b,c){var d=setTimeout(b,a);c.stop=function(){clearTimeout(d)}})},function(){var a,b,c,d,e;b=y.createElement("div"),b.setAttribute("className","t"),b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",d=b.getElementsByTagName("a")[0],c=y.createElement("select"),e=c.appendChild(y.createElement("option")),a=b.getElementsByTagName("input")[0],d.style.cssText="top:1px",k.getSetAttribute="t"!==b.className,k.style=/top/.test(d.getAttribute("style")),k.hrefNormalized="/a"===d.getAttribute("href"),k.checkOn=!!a.value,k.optSelected=e.selected,k.enctype=!!y.createElement("form").enctype,c.disabled=!0,k.optDisabled=!e.disabled,a=y.createElement("input"),a.setAttribute("value",""),k.input=""===a.getAttribute("value"),a.value="t",a.setAttribute("type","radio"),k.radioValue="t"===a.value}();var lb=/\r/g;m.fn.extend({val:function(a){var b,c,d,e=this[0];{if(arguments.length)return d=m.isFunction(a),this.each(function(c){var e;1===this.nodeType&&(e=d?a.call(this,c,m(this).val()):a,null==e?e="":"number"==typeof e?e+="":m.isArray(e)&&(e=m.map(e,function(a){return null==a?"":a+""})),b=m.valHooks[this.type]||m.valHooks[this.nodeName.toLowerCase()],b&&"set"in b&&void 0!==b.set(this,e,"value")||(this.value=e))});if(e)return b=m.valHooks[e.type]||m.valHooks[e.nodeName.toLowerCase()],b&&"get"in b&&void 0!==(c=b.get(e,"value"))?c:(c=e.value,"string"==typeof c?c.replace(lb,""):null==c?"":c)}}}),m.extend({valHooks:{option:{get:function(a){var b=m.find.attr(a,"value");return null!=b?b:m.trim(m.text(a))}},select:{get:function(a){for(var b,c,d=a.options,e=a.selectedIndex,f="select-one"===a.type||0>e,g=f?null:[],h=f?e+1:d.length,i=0>e?h:f?e:0;h>i;i++)if(c=d[i],!(!c.selected&&i!==e||(k.optDisabled?c.disabled:null!==c.getAttribute("disabled"))||c.parentNode.disabled&&m.nodeName(c.parentNode,"optgroup"))){if(b=m(c).val(),f)return b;g.push(b)}return g},set:function(a,b){var c,d,e=a.options,f=m.makeArray(b),g=e.length;while(g--)if(d=e[g],m.inArray(m.valHooks.option.get(d),f)>=0)try{d.selected=c=!0}catch(h){d.scrollHeight}else d.selected=!1;return c||(a.selectedIndex=-1),e}}}}),m.each(["radio","checkbox"],function(){m.valHooks[this]={set:function(a,b){return m.isArray(b)?a.checked=m.inArray(m(a).val(),b)>=0:void 0}},k.checkOn||(m.valHooks[this].get=function(a){return null===a.getAttribute("value")?"on":a.value})});var mb,nb,ob=m.expr.attrHandle,pb=/^(?:checked|selected)$/i,qb=k.getSetAttribute,rb=k.input;m.fn.extend({attr:function(a,b){return V(this,m.attr,a,b,arguments.length>1)},removeAttr:function(a){return this.each(function(){m.removeAttr(this,a)})}}),m.extend({attr:function(a,b,c){var d,e,f=a.nodeType;if(a&&3!==f&&8!==f&&2!==f)return typeof a.getAttribute===K?m.prop(a,b,c):(1===f&&m.isXMLDoc(a)||(b=b.toLowerCase(),d=m.attrHooks[b]||(m.expr.match.bool.test(b)?nb:mb)),void 0===c?d&&"get"in d&&null!==(e=d.get(a,b))?e:(e=m.find.attr(a,b),null==e?void 0:e):null!==c?d&&"set"in d&&void 0!==(e=d.set(a,c,b))?e:(a.setAttribute(b,c+""),c):void m.removeAttr(a,b))},removeAttr:function(a,b){var c,d,e=0,f=b&&b.match(E);if(f&&1===a.nodeType)while(c=f[e++])d=m.propFix[c]||c,m.expr.match.bool.test(c)?rb&&qb||!pb.test(c)?a[d]=!1:a[m.camelCase("default-"+c)]=a[d]=!1:m.attr(a,c,""),a.removeAttribute(qb?c:d)},attrHooks:{type:{set:function(a,b){if(!k.radioValue&&"radio"===b&&m.nodeName(a,"input")){var c=a.value;return a.setAttribute("type",b),c&&(a.value=c),b}}}}}),nb={set:function(a,b,c){return b===!1?m.removeAttr(a,c):rb&&qb||!pb.test(c)?a.setAttribute(!qb&&m.propFix[c]||c,c):a[m.camelCase("default-"+c)]=a[c]=!0,c}},m.each(m.expr.match.bool.source.match(/\w+/g),function(a,b){var c=ob[b]||m.find.attr;ob[b]=rb&&qb||!pb.test(b)?function(a,b,d){var e,f;return d||(f=ob[b],ob[b]=e,e=null!=c(a,b,d)?b.toLowerCase():null,ob[b]=f),e}:function(a,b,c){return c?void 0:a[m.camelCase("default-"+b)]?b.toLowerCase():null}}),rb&&qb||(m.attrHooks.value={set:function(a,b,c){return m.nodeName(a,"input")?void(a.defaultValue=b):mb&&mb.set(a,b,c)}}),qb||(mb={set:function(a,b,c){var d=a.getAttributeNode(c);return d||a.setAttributeNode(d=a.ownerDocument.createAttribute(c)),d.value=b+="","value"===c||b===a.getAttribute(c)?b:void 0}},ob.id=ob.name=ob.coords=function(a,b,c){var d;return c?void 0:(d=a.getAttributeNode(b))&&""!==d.value?d.value:null},m.valHooks.button={get:function(a,b){var c=a.getAttributeNode(b);return c&&c.specified?c.value:void 0},set:mb.set},m.attrHooks.contenteditable={set:function(a,b,c){mb.set(a,""===b?!1:b,c)}},m.each(["width","height"],function(a,b){m.attrHooks[b]={set:function(a,c){return""===c?(a.setAttribute(b,"auto"),c):void 0}}})),k.style||(m.attrHooks.style={get:function(a){return a.style.cssText||void 0},set:function(a,b){return a.style.cssText=b+""}});var sb=/^(?:input|select|textarea|button|object)$/i,tb=/^(?:a|area)$/i;m.fn.extend({prop:function(a,b){return V(this,m.prop,a,b,arguments.length>1)},removeProp:function(a){return a=m.propFix[a]||a,this.each(function(){try{this[a]=void 0,delete this[a]}catch(b){}})}}),m.extend({propFix:{"for":"htmlFor","class":"className"},prop:function(a,b,c){var d,e,f,g=a.nodeType;if(a&&3!==g&&8!==g&&2!==g)return f=1!==g||!m.isXMLDoc(a),f&&(b=m.propFix[b]||b,e=m.propHooks[b]),void 0!==c?e&&"set"in e&&void 0!==(d=e.set(a,c,b))?d:a[b]=c:e&&"get"in e&&null!==(d=e.get(a,b))?d:a[b]},propHooks:{tabIndex:{get:function(a){var b=m.find.attr(a,"tabindex");return b?parseInt(b,10):sb.test(a.nodeName)||tb.test(a.nodeName)&&a.href?0:-1}}}}),k.hrefNormalized||m.each(["href","src"],function(a,b){m.propHooks[b]={get:function(a){return a.getAttribute(b,4)}}}),k.optSelected||(m.propHooks.selected={get:function(a){var b=a.parentNode;return b&&(b.selectedIndex,b.parentNode&&b.parentNode.selectedIndex),null}}),m.each(["tabIndex","readOnly","maxLength","cellSpacing","cellPadding","rowSpan","colSpan","useMap","frameBorder","contentEditable"],function(){m.propFix[this.toLowerCase()]=this}),k.enctype||(m.propFix.enctype="encoding");var ub=/[\t\r\n\f]/g;m.fn.extend({addClass:function(a){var b,c,d,e,f,g,h=0,i=this.length,j="string"==typeof a&&a;if(m.isFunction(a))return this.each(function(b){m(this).addClass(a.call(this,b,this.className))});if(j)for(b=(a||"").match(E)||[];i>h;h++)if(c=this[h],d=1===c.nodeType&&(c.className?(" "+c.className+" ").replace(ub," "):" ")){f=0;while(e=b[f++])d.indexOf(" "+e+" ")<0&&(d+=e+" ");g=m.trim(d),c.className!==g&&(c.className=g)}return this},removeClass:function(a){var b,c,d,e,f,g,h=0,i=this.length,j=0===arguments.length||"string"==typeof a&&a;if(m.isFunction(a))return this.each(function(b){m(this).removeClass(a.call(this,b,this.className))});if(j)for(b=(a||"").match(E)||[];i>h;h++)if(c=this[h],d=1===c.nodeType&&(c.className?(" "+c.className+" ").replace(ub," "):"")){f=0;while(e=b[f++])while(d.indexOf(" "+e+" ")>=0)d=d.replace(" "+e+" "," ");g=a?m.trim(d):"",c.className!==g&&(c.className=g)}return this},toggleClass:function(a,b){var c=typeof a;return"boolean"==typeof b&&"string"===c?b?this.addClass(a):this.removeClass(a):this.each(m.isFunction(a)?function(c){m(this).toggleClass(a.call(this,c,this.className,b),b)}:function(){if("string"===c){var b,d=0,e=m(this),f=a.match(E)||[];while(b=f[d++])e.hasClass(b)?e.removeClass(b):e.addClass(b)}else(c===K||"boolean"===c)&&(this.className&&m._data(this,"__className__",this.className),this.className=this.className||a===!1?"":m._data(this,"__className__")||"")})},hasClass:function(a){for(var b=" "+a+" ",c=0,d=this.length;d>c;c++)if(1===this[c].nodeType&&(" "+this[c].className+" ").replace(ub," ").indexOf(b)>=0)return!0;return!1}}),m.each("blur focus focusin focusout load resize scroll unload click dblclick mousedown mouseup mousemove mouseover mouseout mouseenter mouseleave change select submit keydown keypress keyup error contextmenu".split(" "),function(a,b){m.fn[b]=function(a,c){return arguments.length>0?this.on(b,null,a,c):this.trigger(b)}}),m.fn.extend({hover:function(a,b){return this.mouseenter(a).mouseleave(b||a)},bind:function(a,b,c){return this.on(a,null,b,c)},unbind:function(a,b){return this.off(a,null,b)},delegate:function(a,b,c,d){return this.on(b,a,c,d)},undelegate:function(a,b,c){return 1===arguments.length?this.off(a,"**"):this.off(b,a||"**",c)}});var vb=m.now(),wb=/\?/,xb=/(,)|(\[|{)|(}|])|"(?:[^"\\\r\n]|\\["\\\/bfnrt]|\\u[\da-fA-F]{4})*"\s*:?|true|false|null|-?(?!0\d)\d+(?:\.\d+|)(?:[eE][+-]?\d+|)/g;m.parseJSON=function(b){if(a.JSON&&a.JSON.parse)return a.JSON.parse(b+"");var c,d=null,e=m.trim(b+"");return e&&!m.trim(e.replace(xb,function(a,b,e,f){return c&&b&&(d=0),0===d?a:(c=e||b,d+=!f-!e,"")}))?Function("return "+e)():m.error("Invalid JSON: "+b)},m.parseXML=function(b){var c,d;if(!b||"string"!=typeof b)return null;try{a.DOMParser?(d=new DOMParser,c=d.parseFromString(b,"text/xml")):(c=new ActiveXObject("Microsoft.XMLDOM"),c.async="false",c.loadXML(b))}catch(e){c=void 0}return c&&c.documentElement&&!c.getElementsByTagName("parsererror").length||m.error("Invalid XML: "+b),c};var yb,zb,Ab=/#.*$/,Bb=/([?&])_=[^&]*/,Cb=/^(.*?):[ \t]*([^\r\n]*)\r?$/gm,Db=/^(?:about|app|app-storage|.+-extension|file|res|widget):$/,Eb=/^(?:GET|HEAD)$/,Fb=/^\/\//,Gb=/^([\w.+-]+:)(?:\/\/(?:[^\/?#]*@|)([^\/?#:]*)(?::(\d+)|)|)/,Hb={},Ib={},Jb="*/".concat("*");try{zb=location.href}catch(Kb){zb=y.createElement("a"),zb.href="",zb=zb.href}yb=Gb.exec(zb.toLowerCase())||[];function Lb(a){return function(b,c){"string"!=typeof b&&(c=b,b="*");var d,e=0,f=b.toLowerCase().match(E)||[];if(m.isFunction(c))while(d=f[e++])"+"===d.charAt(0)?(d=d.slice(1)||"*",(a[d]=a[d]||[]).unshift(c)):(a[d]=a[d]||[]).push(c)}}function Mb(a,b,c,d){var e={},f=a===Ib;function g(h){var i;return e[h]=!0,m.each(a[h]||[],function(a,h){var j=h(b,c,d);return"string"!=typeof j||f||e[j]?f?!(i=j):void 0:(b.dataTypes.unshift(j),g(j),!1)}),i}return g(b.dataTypes[0])||!e["*"]&&g("*")}function Nb(a,b){var c,d,e=m.ajaxSettings.flatOptions||{};for(d in b)void 0!==b[d]&&((e[d]?a:c||(c={}))[d]=b[d]);return c&&m.extend(!0,a,c),a}function Ob(a,b,c){var d,e,f,g,h=a.contents,i=a.dataTypes;while("*"===i[0])i.shift(),void 0===e&&(e=a.mimeType||b.getResponseHeader("Content-Type"));if(e)for(g in h)if(h[g]&&h[g].test(e)){i.unshift(g);break}if(i[0]in c)f=i[0];else{for(g in c){if(!i[0]||a.converters[g+" "+i[0]]){f=g;break}d||(d=g)}f=f||d}return f?(f!==i[0]&&i.unshift(f),c[f]):void 0}function Pb(a,b,c,d){var e,f,g,h,i,j={},k=a.dataTypes.slice();if(k[1])for(g in a.converters)j[g.toLowerCase()]=a.converters[g];f=k.shift();while(f)if(a.responseFields[f]&&(c[a.responseFields[f]]=b),!i&&d&&a.dataFilter&&(b=a.dataFilter(b,a.dataType)),i=f,f=k.shift())if("*"===f)f=i;else if("*"!==i&&i!==f){if(g=j[i+" "+f]||j["* "+f],!g)for(e in j)if(h=e.split(" "),h[1]===f&&(g=j[i+" "+h[0]]||j["* "+h[0]])){g===!0?g=j[e]:j[e]!==!0&&(f=h[0],k.unshift(h[1]));break}if(g!==!0)if(g&&a["throws"])b=g(b);else try{b=g(b)}catch(l){return{state:"parsererror",error:g?l:"No conversion from "+i+" to "+f}}}return{state:"success",data:b}}m.extend({active:0,lastModified:{},etag:{},ajaxSettings:{url:zb,type:"GET",isLocal:Db.test(yb[1]),global:!0,processData:!0,async:!0,contentType:"application/x-www-form-urlencoded; charset=UTF-8",accepts:{"*":Jb,text:"text/plain",html:"text/html",xml:"application/xml, text/xml",json:"application/json, text/javascript"},contents:{xml:/xml/,html:/html/,json:/json/},responseFields:{xml:"responseXML",text:"responseText",json:"responseJSON"},converters:{"* text":String,"text html":!0,"text json":m.parseJSON,"text xml":m.parseXML},flatOptions:{url:!0,context:!0}},ajaxSetup:function(a,b){return b?Nb(Nb(a,m.ajaxSettings),b):Nb(m.ajaxSettings,a)},ajaxPrefilter:Lb(Hb),ajaxTransport:Lb(Ib),ajax:function(a,b){"object"==typeof a&&(b=a,a=void 0),b=b||{};var c,d,e,f,g,h,i,j,k=m.ajaxSetup({},b),l=k.context||k,n=k.context&&(l.nodeType||l.jquery)?m(l):m.event,o=m.Deferred(),p=m.Callbacks("once memory"),q=k.statusCode||{},r={},s={},t=0,u="canceled",v={readyState:0,getResponseHeader:function(a){var b;if(2===t){if(!j){j={};while(b=Cb.exec(f))j[b[1].toLowerCase()]=b[2]}b=j[a.toLowerCase()]}return null==b?null:b},getAllResponseHeaders:function(){return 2===t?f:null},setRequestHeader:function(a,b){var c=a.toLowerCase();return t||(a=s[c]=s[c]||a,r[a]=b),this},overrideMimeType:function(a){return t||(k.mimeType=a),this},statusCode:function(a){var b;if(a)if(2>t)for(b in a)q[b]=[q[b],a[b]];else v.always(a[v.status]);return this},abort:function(a){var b=a||u;return i&&i.abort(b),x(0,b),this}};if(o.promise(v).complete=p.add,v.success=v.done,v.error=v.fail,k.url=((a||k.url||zb)+"").replace(Ab,"").replace(Fb,yb[1]+"//"),k.type=b.method||b.type||k.method||k.type,k.dataTypes=m.trim(k.dataType||"*").toLowerCase().match(E)||[""],null==k.crossDomain&&(c=Gb.exec(k.url.toLowerCase()),k.crossDomain=!(!c||c[1]===yb[1]&&c[2]===yb[2]&&(c[3]||("http:"===c[1]?"80":"443"))===(yb[3]||("http:"===yb[1]?"80":"443")))),k.data&&k.processData&&"string"!=typeof k.data&&(k.data=m.param(k.data,k.traditional)),Mb(Hb,k,b,v),2===t)return v;h=m.event&&k.global,h&&0===m.active++&&m.event.trigger("ajaxStart"),k.type=k.type.toUpperCase(),k.hasContent=!Eb.test(k.type),e=k.url,k.hasContent||(k.data&&(e=k.url+=(wb.test(e)?"&":"?")+k.data,delete k.data),k.cache===!1&&(k.url=Bb.test(e)?e.replace(Bb,"$1_="+vb++):e+(wb.test(e)?"&":"?")+"_="+vb++)),k.ifModified&&(m.lastModified[e]&&v.setRequestHeader("If-Modified-Since",m.lastModified[e]),m.etag[e]&&v.setRequestHeader("If-None-Match",m.etag[e])),(k.data&&k.hasContent&&k.contentType!==!1||b.contentType)&&v.setRequestHeader("Content-Type",k.contentType),v.setRequestHeader("Accept",k.dataTypes[0]&&k.accepts[k.dataTypes[0]]?k.accepts[k.dataTypes[0]]+("*"!==k.dataTypes[0]?", "+Jb+"; q=0.01":""):k.accepts["*"]);for(d in k.headers)v.setRequestHeader(d,k.headers[d]);if(k.beforeSend&&(k.beforeSend.call(l,v,k)===!1||2===t))return v.abort();u="abort";for(d in{success:1,error:1,complete:1})v[d](k[d]);if(i=Mb(Ib,k,b,v)){v.readyState=1,h&&n.trigger("ajaxSend",[v,k]),k.async&&k.timeout>0&&(g=setTimeout(function(){v.abort("timeout")},k.timeout));try{t=1,i.send(r,x)}catch(w){if(!(2>t))throw w;x(-1,w)}}else x(-1,"No Transport");function x(a,b,c,d){var j,r,s,u,w,x=b;2!==t&&(t=2,g&&clearTimeout(g),i=void 0,f=d||"",v.readyState=a>0?4:0,j=a>=200&&300>a||304===a,c&&(u=Ob(k,v,c)),u=Pb(k,u,v,j),j?(k.ifModified&&(w=v.getResponseHeader("Last-Modified"),w&&(m.lastModified[e]=w),w=v.getResponseHeader("etag"),w&&(m.etag[e]=w)),204===a||"HEAD"===k.type?x="nocontent":304===a?x="notmodified":(x=u.state,r=u.data,s=u.error,j=!s)):(s=x,(a||!x)&&(x="error",0>a&&(a=0))),v.status=a,v.statusText=(b||x)+"",j?o.resolveWith(l,[r,x,v]):o.rejectWith(l,[v,x,s]),v.statusCode(q),q=void 0,h&&n.trigger(j?"ajaxSuccess":"ajaxError",[v,k,j?r:s]),p.fireWith(l,[v,x]),h&&(n.trigger("ajaxComplete",[v,k]),--m.active||m.event.trigger("ajaxStop")))}return v},getJSON:function(a,b,c){return m.get(a,b,c,"json")},getScript:function(a,b){return m.get(a,void 0,b,"script")}}),m.each(["get","post"],function(a,b){m[b]=function(a,c,d,e){return m.isFunction(c)&&(e=e||d,d=c,c=void 0),m.ajax({url:a,type:b,dataType:e,data:c,success:d})}}),m._evalUrl=function(a){return m.ajax({url:a,type:"GET",dataType:"script",async:!1,global:!1,"throws":!0})},m.fn.extend({wrapAll:function(a){if(m.isFunction(a))return this.each(function(b){m(this).wrapAll(a.call(this,b))});if(this[0]){var b=m(a,this[0].ownerDocument).eq(0).clone(!0);this[0].parentNode&&b.insertBefore(this[0]),b.map(function(){var a=this;while(a.firstChild&&1===a.firstChild.nodeType)a=a.firstChild;return a}).append(this)}return this},wrapInner:function(a){return this.each(m.isFunction(a)?function(b){m(this).wrapInner(a.call(this,b))}:function(){var b=m(this),c=b.contents();c.length?c.wrapAll(a):b.append(a)})},wrap:function(a){var b=m.isFunction(a);return this.each(function(c){m(this).wrapAll(b?a.call(this,c):a)})},unwrap:function(){return this.parent().each(function(){m.nodeName(this,"body")||m(this).replaceWith(this.childNodes)}).end()}}),m.expr.filters.hidden=function(a){return a.offsetWidth<=0&&a.offsetHeight<=0||!k.reliableHiddenOffsets()&&"none"===(a.style&&a.style.display||m.css(a,"display"))},m.expr.filters.visible=function(a){return!m.expr.filters.hidden(a)};var Qb=/%20/g,Rb=/\[\]$/,Sb=/\r?\n/g,Tb=/^(?:submit|button|image|reset|file)$/i,Ub=/^(?:input|select|textarea|keygen)/i;function Vb(a,b,c,d){var e;if(m.isArray(b))m.each(b,function(b,e){c||Rb.test(a)?d(a,e):Vb(a+"["+("object"==typeof e?b:"")+"]",e,c,d)});else if(c||"object"!==m.type(b))d(a,b);else for(e in b)Vb(a+"["+e+"]",b[e],c,d)}m.param=function(a,b){var c,d=[],e=function(a,b){b=m.isFunction(b)?b():null==b?"":b,d[d.length]=encodeURIComponent(a)+"="+encodeURIComponent(b)};if(void 0===b&&(b=m.ajaxSettings&&m.ajaxSettings.traditional),m.isArray(a)||a.jquery&&!m.isPlainObject(a))m.each(a,function(){e(this.name,this.value)});else for(c in a)Vb(c,a[c],b,e);return d.join("&").replace(Qb,"+")},m.fn.extend({serialize:function(){return m.param(this.serializeArray())},serializeArray:function(){return this.map(function(){var a=m.prop(this,"elements");return a?m.makeArray(a):this}).filter(function(){var a=this.type;return this.name&&!m(this).is(":disabled")&&Ub.test(this.nodeName)&&!Tb.test(a)&&(this.checked||!W.test(a))}).map(function(a,b){var c=m(this).val();return null==c?null:m.isArray(c)?m.map(c,function(a){return{name:b.name,value:a.replace(Sb,"\r\n")}}):{name:b.name,value:c.replace(Sb,"\r\n")}}).get()}}),m.ajaxSettings.xhr=void 0!==a.ActiveXObject?function(){return!this.isLocal&&/^(get|post|head|put|delete|options)$/i.test(this.type)&&Zb()||$b()}:Zb;var Wb=0,Xb={},Yb=m.ajaxSettings.xhr();a.attachEvent&&a.attachEvent("onunload",function(){for(var a in Xb)Xb[a](void 0,!0)}),k.cors=!!Yb&&"withCredentials"in Yb,Yb=k.ajax=!!Yb,Yb&&m.ajaxTransport(function(a){if(!a.crossDomain||k.cors){var b;return{send:function(c,d){var e,f=a.xhr(),g=++Wb;if(f.open(a.type,a.url,a.async,a.username,a.password),a.xhrFields)for(e in a.xhrFields)f[e]=a.xhrFields[e];a.mimeType&&f.overrideMimeType&&f.overrideMimeType(a.mimeType),a.crossDomain||c["X-Requested-With"]||(c["X-Requested-With"]="XMLHttpRequest");for(e in c)void 0!==c[e]&&f.setRequestHeader(e,c[e]+"");f.send(a.hasContent&&a.data||null),b=function(c,e){var h,i,j;if(b&&(e||4===f.readyState))if(delete Xb[g],b=void 0,f.onreadystatechange=m.noop,e)4!==f.readyState&&f.abort();else{j={},h=f.status,"string"==typeof f.responseText&&(j.text=f.responseText);try{i=f.statusText}catch(k){i=""}h||!a.isLocal||a.crossDomain?1223===h&&(h=204):h=j.text?200:404}j&&d(h,i,j,f.getAllResponseHeaders())},a.async?4===f.readyState?setTimeout(b):f.onreadystatechange=Xb[g]=b:b()},abort:function(){b&&b(void 0,!0)}}}});function Zb(){try{return new a.XMLHttpRequest}catch(b){}}function $b(){try{return new a.ActiveXObject("Microsoft.XMLHTTP")}catch(b){}}m.ajaxSetup({accepts:{script:"text/javascript, application/javascript, application/ecmascript, application/x-ecmascript"},contents:{script:/(?:java|ecma)script/},converters:{"text script":function(a){return m.globalEval(a),a}}}),m.ajaxPrefilter("script",function(a){void 0===a.cache&&(a.cache=!1),a.crossDomain&&(a.type="GET",a.global=!1)}),m.ajaxTransport("script",function(a){if(a.crossDomain){var b,c=y.head||m("head")[0]||y.documentElement;return{send:function(d,e){b=y.createElement("script"),b.async=!0,a.scriptCharset&&(b.charset=a.scriptCharset),b.src=a.url,b.onload=b.onreadystatechange=function(a,c){(c||!b.readyState||/loaded|complete/.test(b.readyState))&&(b.onload=b.onreadystatechange=null,b.parentNode&&b.parentNode.removeChild(b),b=null,c||e(200,"success"))},c.insertBefore(b,c.firstChild)},abort:function(){b&&b.onload(void 0,!0)}}}});var _b=[],ac=/(=)\?(?=&|$)|\?\?/;m.ajaxSetup({jsonp:"callback",jsonpCallback:function(){var a=_b.pop()||m.expando+"_"+vb++;return this[a]=!0,a}}),m.ajaxPrefilter("json jsonp",function(b,c,d){var e,f,g,h=b.jsonp!==!1&&(ac.test(b.url)?"url":"string"==typeof b.data&&!(b.contentType||"").indexOf("application/x-www-form-urlencoded")&&ac.test(b.data)&&"data");return h||"jsonp"===b.dataTypes[0]?(e=b.jsonpCallback=m.isFunction(b.jsonpCallback)?b.jsonpCallback():b.jsonpCallback,h?b[h]=b[h].replace(ac,"$1"+e):b.jsonp!==!1&&(b.url+=(wb.test(b.url)?"&":"?")+b.jsonp+"="+e),b.converters["script json"]=function(){return g||m.error(e+" was not called"),g[0]},b.dataTypes[0]="json",f=a[e],a[e]=function(){g=arguments},d.always(function(){a[e]=f,b[e]&&(b.jsonpCallback=c.jsonpCallback,_b.push(e)),g&&m.isFunction(f)&&f(g[0]),g=f=void 0}),"script"):void 0}),m.parseHTML=function(a,b,c){if(!a||"string"!=typeof a)return null;"boolean"==typeof b&&(c=b,b=!1),b=b||y;var d=u.exec(a),e=!c&&[];return d?[b.createElement(d[1])]:(d=m.buildFragment([a],b,e),e&&e.length&&m(e).remove(),m.merge([],d.childNodes))};var bc=m.fn.load;m.fn.load=function(a,b,c){if("string"!=typeof a&&bc)return bc.apply(this,arguments);var d,e,f,g=this,h=a.indexOf(" ");return h>=0&&(d=m.trim(a.slice(h,a.length)),a=a.slice(0,h)),m.isFunction(b)?(c=b,b=void 0):b&&"object"==typeof b&&(f="POST"),g.length>0&&m.ajax({url:a,type:f,dataType:"html",data:b}).done(function(a){e=arguments,g.html(d?m("<div>").append(m.parseHTML(a)).find(d):a)}).complete(c&&function(a,b){g.each(c,e||[a.responseText,b,a])}),this},m.each(["ajaxStart","ajaxStop","ajaxComplete","ajaxError","ajaxSuccess","ajaxSend"],function(a,b){m.fn[b]=function(a){return this.on(b,a)}}),m.expr.filters.animated=function(a){return m.grep(m.timers,function(b){return a===b.elem}).length};var cc=a.document.documentElement;function dc(a){return m.isWindow(a)?a:9===a.nodeType?a.defaultView||a.parentWindow:!1}m.offset={setOffset:function(a,b,c){var d,e,f,g,h,i,j,k=m.css(a,"position"),l=m(a),n={};"static"===k&&(a.style.position="relative"),h=l.offset(),f=m.css(a,"top"),i=m.css(a,"left"),j=("absolute"===k||"fixed"===k)&&m.inArray("auto",[f,i])>-1,j?(d=l.position(),g=d.top,e=d.left):(g=parseFloat(f)||0,e=parseFloat(i)||0),m.isFunction(b)&&(b=b.call(a,c,h)),null!=b.top&&(n.top=b.top-h.top+g),null!=b.left&&(n.left=b.left-h.left+e),"using"in b?b.using.call(a,n):l.css(n)}},m.fn.extend({offset:function(a){if(arguments.length)return void 0===a?this:this.each(function(b){m.offset.setOffset(this,a,b)});var b,c,d={top:0,left:0},e=this[0],f=e&&e.ownerDocument;if(f)return b=f.documentElement,m.contains(b,e)?(typeof e.getBoundingClientRect!==K&&(d=e.getBoundingClientRect()),c=dc(f),{top:d.top+(c.pageYOffset||b.scrollTop)-(b.clientTop||0),left:d.left+(c.pageXOffset||b.scrollLeft)-(b.clientLeft||0)}):d},position:function(){if(this[0]){var a,b,c={top:0,left:0},d=this[0];return"fixed"===m.css(d,"position")?b=d.getBoundingClientRect():(a=this.offsetParent(),b=this.offset(),m.nodeName(a[0],"html")||(c=a.offset()),c.top+=m.css(a[0],"borderTopWidth",!0),c.left+=m.css(a[0],"borderLeftWidth",!0)),{top:b.top-c.top-m.css(d,"marginTop",!0),left:b.left-c.left-m.css(d,"marginLeft",!0)}}},offsetParent:function(){return this.map(function(){var a=this.offsetParent||cc;while(a&&!m.nodeName(a,"html")&&"static"===m.css(a,"position"))a=a.offsetParent;return a||cc})}}),m.each({scrollLeft:"pageXOffset",scrollTop:"pageYOffset"},function(a,b){var c=/Y/.test(b);m.fn[a]=function(d){return V(this,function(a,d,e){var f=dc(a);return void 0===e?f?b in f?f[b]:f.document.documentElement[d]:a[d]:void(f?f.scrollTo(c?m(f).scrollLeft():e,c?e:m(f).scrollTop()):a[d]=e)},a,d,arguments.length,null)}}),m.each(["top","left"],function(a,b){m.cssHooks[b]=La(k.pixelPosition,function(a,c){return c?(c=Ja(a,b),Ha.test(c)?m(a).position()[b]+"px":c):void 0})}),m.each({Height:"height",Width:"width"},function(a,b){m.each({padding:"inner"+a,content:b,"":"outer"+a},function(c,d){m.fn[d]=function(d,e){var f=arguments.length&&(c||"boolean"!=typeof d),g=c||(d===!0||e===!0?"margin":"border");return V(this,function(b,c,d){var e;return m.isWindow(b)?b.document.documentElement["client"+a]:9===b.nodeType?(e=b.documentElement,Math.max(b.body["scroll"+a],e["scroll"+a],b.body["offset"+a],e["offset"+a],e["client"+a])):void 0===d?m.css(b,c,g):m.style(b,c,d,g)},b,f?d:void 0,f,null)}})}),m.fn.size=function(){return this.length},m.fn.andSelf=m.fn.addBack,"function"==typeof define&&define.amd&&define("jquery",[],function(){return m});var ec=a.jQuery,fc=a.$;return m.noConflict=function(b){return a.$===m&&(a.$=fc),b&&a.jQuery===m&&(a.jQuery=ec),m},typeof b===K&&(a.jQuery=a.$=m),m});
"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="data:text/css;charset=utf-8,html%7Bfont%2Dfamily%3Asans%2Dserif%3B%2Dwebkit%2Dtext%2Dsize%2Dadjust%3A100%25%3B%2Dms%2Dtext%2Dsize%2Dadjust%3A100%25%7Dbody%7Bmargin%3A0%7Darticle%2Caside%2Cdetails%2Cfigcaption%2Cfigure%2Cfooter%2Cheader%2Chgroup%2Cmain%2Cmenu%2Cnav%2Csection%2Csummary%7Bdisplay%3Ablock%7Daudio%2Ccanvas%2Cprogress%2Cvideo%7Bdisplay%3Ainline%2Dblock%3Bvertical%2Dalign%3Abaseline%7Daudio%3Anot%28%5Bcontrols%5D%29%7Bdisplay%3Anone%3Bheight%3A0%7D%5Bhidden%5D%2Ctemplate%7Bdisplay%3Anone%7Da%7Bbackground%2Dcolor%3Atransparent%7Da%3Aactive%2Ca%3Ahover%7Boutline%3A0%7Dabbr%5Btitle%5D%7Bborder%2Dbottom%3A1px%20dotted%7Db%2Cstrong%7Bfont%2Dweight%3A700%7Ddfn%7Bfont%2Dstyle%3Aitalic%7Dh1%7Bmargin%3A%2E67em%200%3Bfont%2Dsize%3A2em%7Dmark%7Bcolor%3A%23000%3Bbackground%3A%23ff0%7Dsmall%7Bfont%2Dsize%3A80%25%7Dsub%2Csup%7Bposition%3Arelative%3Bfont%2Dsize%3A75%25%3Bline%2Dheight%3A0%3Bvertical%2Dalign%3Abaseline%7Dsup%7Btop%3A%2D%2E5em%7Dsub%7Bbottom%3A%2D%2E25em%7Dimg%7Bborder%3A0%7Dsvg%3Anot%28%3Aroot%29%7Boverflow%3Ahidden%7Dfigure%7Bmargin%3A1em%2040px%7Dhr%7Bheight%3A0%3B%2Dwebkit%2Dbox%2Dsizing%3Acontent%2Dbox%3B%2Dmoz%2Dbox%2Dsizing%3Acontent%2Dbox%3Bbox%2Dsizing%3Acontent%2Dbox%7Dpre%7Boverflow%3Aauto%7Dcode%2Ckbd%2Cpre%2Csamp%7Bfont%2Dfamily%3Amonospace%2Cmonospace%3Bfont%2Dsize%3A1em%7Dbutton%2Cinput%2Coptgroup%2Cselect%2Ctextarea%7Bmargin%3A0%3Bfont%3Ainherit%3Bcolor%3Ainherit%7Dbutton%7Boverflow%3Avisible%7Dbutton%2Cselect%7Btext%2Dtransform%3Anone%7Dbutton%2Chtml%20input%5Btype%3Dbutton%5D%2Cinput%5Btype%3Dreset%5D%2Cinput%5Btype%3Dsubmit%5D%7B%2Dwebkit%2Dappearance%3Abutton%3Bcursor%3Apointer%7Dbutton%5Bdisabled%5D%2Chtml%20input%5Bdisabled%5D%7Bcursor%3Adefault%7Dbutton%3A%3A%2Dmoz%2Dfocus%2Dinner%2Cinput%3A%3A%2Dmoz%2Dfocus%2Dinner%7Bpadding%3A0%3Bborder%3A0%7Dinput%7Bline%2Dheight%3Anormal%7Dinput%5Btype%3Dcheckbox%5D%2Cinput%5Btype%3Dradio%5D%7B%2Dwebkit%2Dbox%2Dsizing%3Aborder%2Dbox%3B%2Dmoz%2Dbox%2Dsizing%3Aborder%2Dbox%3Bbox%2Dsizing%3Aborder%2Dbox%3Bpadding%3A0%7Dinput%5Btype%3Dnumber%5D%3A%3A%2Dwebkit%2Dinner%2Dspin%2Dbutton%2Cinput%5Btype%3Dnumber%5D%3A%3A%2Dwebkit%2Douter%2Dspin%2Dbutton%7Bheight%3Aauto%7Dinput%5Btype%3Dsearch%5D%7B%2Dwebkit%2Dbox%2Dsizing%3Acontent%2Dbox%3B%2Dmoz%2Dbox%2Dsizing%3Acontent%2Dbox%3Bbox%2Dsizing%3Acontent%2Dbox%3B%2Dwebkit%2Dappearance%3Atextfield%7Dinput%5Btype%3Dsearch%5D%3A%3A%2Dwebkit%2Dsearch%2Dcancel%2Dbutton%2Cinput%5Btype%3Dsearch%5D%3A%3A%2Dwebkit%2Dsearch%2Ddecoration%7B%2Dwebkit%2Dappearance%3Anone%7Dfieldset%7Bpadding%3A%2E35em%20%2E625em%20%2E75em%3Bmargin%3A0%202px%3Bborder%3A1px%20solid%20silver%7Dlegend%7Bpadding%3A0%3Bborder%3A0%7Dtextarea%7Boverflow%3Aauto%7Doptgroup%7Bfont%2Dweight%3A700%7Dtable%7Bborder%2Dspacing%3A0%3Bborder%2Dcollapse%3Acollapse%7Dtd%2Cth%7Bpadding%3A0%7D%40media%20print%7B%2A%2C%3Aafter%2C%3Abefore%7Bcolor%3A%23000%21important%3Btext%2Dshadow%3Anone%21important%3Bbackground%3A0%200%21important%3B%2Dwebkit%2Dbox%2Dshadow%3Anone%21important%3Bbox%2Dshadow%3Anone%21important%7Da%2Ca%3Avisited%7Btext%2Ddecoration%3Aunderline%7Da%5Bhref%5D%3Aafter%7Bcontent%3A%22%20%28%22%20attr%28href%29%20%22%29%22%7Dabbr%5Btitle%5D%3Aafter%7Bcontent%3A%22%20%28%22%20attr%28title%29%20%22%29%22%7Da%5Bhref%5E%3D%22javascript%3A%22%5D%3Aafter%2Ca%5Bhref%5E%3D%22%23%22%5D%3Aafter%7Bcontent%3A%22%22%7Dblockquote%2Cpre%7Bborder%3A1px%20solid%20%23999%3Bpage%2Dbreak%2Dinside%3Aavoid%7Dthead%7Bdisplay%3Atable%2Dheader%2Dgroup%7Dimg%2Ctr%7Bpage%2Dbreak%2Dinside%3Aavoid%7Dimg%7Bmax%2Dwidth%3A100%25%21important%7Dh2%2Ch3%2Cp%7Borphans%3A3%3Bwidows%3A3%7Dh2%2Ch3%7Bpage%2Dbreak%2Dafter%3Aavoid%7D%2Enavbar%7Bdisplay%3Anone%7D%2Ebtn%3E%2Ecaret%2C%2Edropup%3E%2Ebtn%3E%2Ecaret%7Bborder%2Dtop%2Dcolor%3A%23000%21important%7D%2Elabel%7Bborder%3A1px%20solid%20%23000%7D%2Etable%7Bborder%2Dcollapse%3Acollapse%21important%7D%2Etable%20td%2C%2Etable%20th%7Bbackground%2Dcolor%3A%23fff%21important%7D%2Etable%2Dbordered%20td%2C%2Etable%2Dbordered%20th%7Bborder%3A1px%20solid%20%23ddd%21important%7D%7D%40font%2Dface%7Bfont%2Dfamily%3A%27Glyphicons%20Halflings%27%3Bsrc%3Aurl%28data%3Aapplication%2Fvnd%2Ems%2Dfontobject%3Bbase64%2Cn04AAEFNAAACAAIABAAAAAAABQAAAAAAAAABAJABAAAEAExQAAAAAAAAAAIAAAAAAAAAAAEAAAAAAAAAJxJ%2FLAAAAAAAAAAAAAAAAAAAAAAAACgARwBMAFkAUABIAEkAQwBPAE4AUwAgAEgAYQBsAGYAbABpAG4AZwBzAAAADgBSAGUAZwB1AGwAYQByAAAAeABWAGUAcgBzAGkAbwBuACAAMQAuADAAMAA5ADsAUABTACAAMAAwADEALgAwADAAOQA7AGgAbwB0AGMAbwBuAHYAIAAxAC4AMAAuADcAMAA7AG0AYQBrAGUAbwB0AGYALgBsAGkAYgAyAC4ANQAuADUAOAAzADIAOQAAADgARwBMAFkAUABIAEkAQwBPAE4AUwAgAEgAYQBsAGYAbABpAG4AZwBzACAAUgBlAGcAdQBsAGEAcgAAAAAAQlNHUAAAAAAAAAAAAAAAAAAAAAADAKncAE0TAE0ZAEbuFM3pjM%2FSEdmjKHUbyow8ATBE40IvWA3vTu8LiABDQ%2BpexwUMcm1SMnNryctQSiI1K5ZnbOlXKmnVV5YvRe6RnNMFNCOs1KNVpn6yZhCJkRtVRNzEufeIq7HgSrcx4S8h%2Fv4vnrrKc6oCNxmSk2uKlZQHBii6iKFoH0746ThvkO1kJHlxjrkxs%2BLWORaDQBEtiYJIR5IB9Bi1UyL4Rmr0BNigNkMzlKQmnofBHviqVzUxwdMb3NdCn69hy%2BpRYVKGVS%2F1tnsqv4LL7wCCPZZAZPT4aCShHjHJVNuXbmMrY5LeQaGnvAkXlVrJgKRAUdFjrWEah9XebPeQMj7KS7DIBAFt8ycgC5PLGUOHSE3ErGZCiViNLL5ZARfywnCoZaKQCu6NuFX42AEeKtKUGnr%2FCm2Cy8tpFhBPMW5Fxi4Qm4TkDWh4IWFDClhU2hRWosUWqcKLlgyXB%2BlSHaWaHiWlBAR8SeSgSPCQxdVQgzUixWKSTrIQEbU94viDctkvX%2BVSjJuUmV8L4CXShI11esnp0pjWNZIyxKHS4wVQ2ime1P4RnhvGw0aDN1OLAXGERsB7buFpFGGBAre4QEQR0HOIO5oYH305G%2BKspT%2FFupEGGafCCwxSe6ZUa%2B073rXHnNdVXE6eWvibUS27XtRzkH838mYLMBmYysZTM0EM3A1fbpCBYFccN1B%2FEnCYu%2FTgCGmr7bMh8GfYL%2BBfcLvB0gRagC09w9elfldaIy%2FhNCBLRgBgtCC7jAF63wLSMAfbfAlEggYU0bUA7ACCJmTDpEmJtI78w4%2FBO7dN7JR7J7ZvbYaUbaILSQsRBiF3HGk5fEg6p9unwLvn98r%2BvnsV%2B372uf1xBLq4qU%2F45fTuqaAP%2BpssmCCCTF0mhEow8ZXZOS8D7Q85JsxZ%2BAzok7B7O%2Ff6J8AzYBySZQB%2FQHYUSA%2BEeQhEWiS6AIQzgcsDiER4MjgMBAWDV4AgQ3g1eBgIdweCQmCjJEMkJ%2BPKRWyFHHmg1Wi%2F6xzUgA0LREoKJChwnQa9B%2B5RQZRB3IlBlkAnxyQNaANwHMowzlYSMCBgnbpzvqpl0iTJNCQidDI9ZrSYNIRBhHtUa5YHMHxyGEik9hDE0AKj72AbTCaxtHPUaKZdAZSnQTyjGqGLsmBStCejApUhg4uBMU6mATujEl%2BKdDPbI6Ag4vLr%2BhjY6lbjBeoLKnZl0UZgRX8gTySOeynZVz1wOq7e1hFGYIq%2BMhrGxDLak0PrwYzSXtcuyhXEhwOYofiW%2BEcI%2Fjw8P6IY6ed%2BetAbuqKp5QIapT77LnAe505lMuqL79a0ut4rWexzFttsOsLDy7zvtQzcq3U1qabe7tB0wHWVXji%2BzDbo8x8HyIRUbXnwUcklFv51fvTymiV%2BMXLSmGH9d9%2BaXpD5X6lao41anWGig7IwIdnoBY2ht%2FpO9mClLo4NdXHAsefqWUKlXJkbqPOFhMoR4aiA1BXqhRNbB2Xwi%2B7u%2FjpAoOpKJ0UX24EsrzMfHXViakCNcKjBxuQX8BO0ZqjJ3xXzf%2B61t2VXOSgJ8xu65QKgtN6FibPmPYsXbJRHHqbgATcSZxBqGiDiU4NNNsYBsKD0MIP%2FOfKnlk%2FLkaid%2FO2NbKeuQrwOB2Gq3YHyr6ALgzym5wIBnsdC1ZkoBFZSQXChZvlesPqvK2c5oHHT3Q65jYpNxnQcGF0EHbvYqoFw60WNlXIHQF2HQB7zD6lWjZ9rVqUKBXUT6hrkZOle0RFYII0V5ZYGl1JAP0Ud1fZZMvSomBzJ710j4Me8mjQDwEre5Uv2wQfk1ifDwb5ksuJQQ3xt423lbuQjvoIQByQrNDh1JxGFkOdlJvu%2FgFtuW0wR4cgd%2BZKesSV7QkNE2kw6AV4hoIuC02LGmTomyf8PiO6CZzOTLTPQ%2BHW06H%2Btx%2BbQ8LmDYg1pTFrp2oJXgkZTyeRJZM0C8aE2LpFrNVDuhARsN543%2FFV6klQ6Tv1OoZGXLv0igKrl%2FCmJxRmX7JJbJ998VSIPQRyDBICzl4JJlYHbdql30NvYcOuZ7a10uWRrgoieOdgIm4rlq6vNOQBuqESLbXG5lzdJGHw2m0sDYmODXbYGTfSTGRKpssTO95fothJCjUGQgEL4yKoGAF%2F0SrpUDNn8CBgBcSDQByAeNkCXp4S4Ro2Xh4OeaGRgR66PVOsU8bc6TR5%2FxTcn4IVMLOkXSWiXxkZQCbvKfmoAvQaKjO3EDKwkwqHChCDEM5loQRPd5ACBki1TjF772oaQhQbQ5C0lcWXPFOzrfsDGUXGrpxasbG4iab6eByaQkQfm0VFlP0ZsDkvvqCL6QXMUwCjdMx1ZOyKhTJ7a1GWAdOUcJ8RSejxNVyGs31OKMyRyBVoZFjqIkmKlLQ5eHMeEL4MkUf23cQ%2F1SgRCJ1dk4UdBT7OoyuNgLs0oCd8RnrEIb6QdMxT2QjD4zMrJkfgx5aDMcA4orsTtKCqWb%2FVeyceqa5OGSmB28YwH4rFbkQaLoUN8OQQYnD3w2eXpI4ScQfbCUZiJ4yMOIKLyyTc7BQ4uXUw6Ee6%2FxM%2B4Y67ngNBknxIPwuppgIhFcwJyr6EIj%2BLzNj%2FmfR2vhhRlx0BILZoAYruF0caWQ7YxO66UmeguDREAFHYuC7HJviRgVO6ruJH59h%2FC%2FPkgSle8xNzZJULLWq9JMDTE2fjGE146a1Us6PZDGYle6ldWRqn%2FpdpgHKNGrGIdkRK%2BKPETT9nKT6kLyDI8xd9A1FgWmXWRAIHwZ37WyZHOVyCadJEmMVz0MadMjDrPho%2BEIochkVC2xgGiwwsQ6DMv2P7UXqT4x7CdcYGId2BJQQa85EQKmCmwcRejQ9Bm4oATENFPkxPXILHpMPUyWTI5rjNOsIlmEeMbcOCEqInpXACYQ9DDxmFo9vcmsDblcMtg4tqBerNngkIKaFJmrQAPnq1dEzsMXcwjcHdfdCibcAxxA%2Bq%2Fj9m3LM%2FO7WJka4tSidVCjsvo2lQ%2F2ewyoYyXwAYyr2PlRoR5MpgVmSUIrM3PQxXPbgjBOaDQFIyFMJvx3Pc5RSYj12ySVF9fwFPQu2e2KWVoL9q3Ayv3IzpGHUdvdPdrNUdicjsTQ2ISy7QU3DrEytIjvbzJnAkmANXjAFERA0MUoPF3%2F5KFmW14bBNOhwircYgMqoDpUMcDtCmBE82QM2YtdjVLB4kBuKho%2FbcwQdeboqfQartuU3CsCf%2BcXkgYAqp%2F0Ee3RorAZt0AvvOCSI4JICIlGlsV0bsSid%2FNIEALAAzb6HAgyWHBps6xAOwkJIGcB82CxRQq4sJf3FzA70A%2BTRqcqjEMETCoez3mkPcpnoALs0ugJY8kQwrC%2BJE5ik3w9rzrvDRjAQnqgEVvdGrNwlanR0SOKWzxOJOvLJhcd8Cl4AshACUkv9czdMkJCVQSQhp6kp7StAlpVRpK0t0SW6LHeBJnE2QchB5Ccu8kxRghZXGIgZIiSj7gEKMJDClcnX6hgoqJMwiQDigIXg3ioFLCgDgjPtYHYpsF5EiA4kcnN18MZtOrY866dEQAb0FB34OGKHGZQjwW%2FWDHA60cYFaI%2FPjpzquUqdaYGcIq%2BmLez3WLFFCtNBN2QJcrlcoELgiPku5R5dSlJFaCEqEZle1AQzAKC%2B1SotMcBNyQUFuRHRF6OlimSBgjZeTBCwLyc6A%2BP%2FoFRchXTz5ADknYJHxzrJ5pGuIKRQISU6WyKTBBjD8WozmVYWIsto1AS5rxzKlvJu4E%2FvwOiKxRtCWsDM%2BeTHUrmwrCK5BIfMzGkD%2B0Fk5LzBs0jMYXktNDblB06LMNJ09U8pzSLmo14MS0OMjcdrZ31pyQqxJJpRImlSvfYAK8inkYU52QY2FPEVsjoWewpwhRp5yAuNpkqhdb7ku9Seefl2D0B8SMTFD90xi4CSOwwZy9IKkpMtI3FmFUg3%2FkFutpQGNc3pCR7gvC4sgwbupDu3DyEN%2BW6YGLNM21jpB49irxy9BSlHrVDlnihGKHwPrbVFtc%2Bh1rVQKZduxIyojccZIIcOCmhEnC7UkY68WXKQgLi2JCDQkQWJRQuk60hZp0D3rtCTINSeY9Ej2kIKYfGxwOs4j9qMM7fYZiipzgcf7TamnehqdhsiMiCawXnz4xAbyCkLAx5EGbo3Ax1u3dUIKnTxIaxwQTHehPl3V491H0%2BbC5zgpGz7Io%2BmjdhKlPJ01EeMpM7UsRJMi1nGjmJg35i6bQBAAxjO%2FENJubU2mg3ONySEoWklCwdABETcs7ck3jgiuU9pcKKpbgn%2B3YlzV1FzIkB6pmEDOSSyDfPPlQskznctFji0kpgZjW5RZe6x9kYT4KJcXg0bNiCyif%2BpZACCyRMmYsfiKmN9tSO65F0R2OO6ytlEhY5Sj6uRKfFxw0ijJaAx%2Fk3QgnAFSq27%2F2i4GEBA%2BUvTJKK%2F9eISNvG46Em5RZfjTYLdeD8kdXHyrwId%2FDQZUaMCY4gGbke2C8vfjgV%2FY9kkRQOJIn%2FxM9INZSpiBnqX0Q9GlQPpPKAyO5y%2BW5NMPSRdBCUlmuxl40ZfMCnf2Cp044uI9WLFtCi4YVxKjuRCOBWIb4XbIsGdbo4qtMQnNOQz4XDSui7W%2FN6l54qOynCqD3DpWQ%2BmpD7C40D8BZEWGJX3tlAaZBMj1yjvDYKwCJBa201u6nBKE5UE%2B7QSEhCwrXfbRZylAaAkplhBWX50dumrElePyNMRYUrC99UmcSSNgImhFhDI4BXjMtiqkgizUGCrZ8iwFxU6fQ8GEHCFdLewwxYWxgScAYMdMLmcZR6b7rZl95eQVDGVoUKcRMM1ixXQtXNkBETZkVVPg8LoSrdetHzkuM7DjZRHP02tCxA1fmkXKF3VzfN1pc1cv%2F8lbTIkkYpqKM9VOhp65ktYk%2BQ46myFWBapDfyWUCnsnI00QTBQmuFjMZTcd0V2NQ768Fhpby04k2IzNR1wKabuGJqYWwSly6ocMFGTeeI%2BejsWDYgEvr66QgqdcIbFYDNgsm0x9UHY6SCd5%2B7tpsLpKdvhahIDyYmEJQCqMqtCF6UlrE5GXRmbu%2Bvtm3BFSxI6ND6UxIE7GsGMgWqghXxSnaRJuGFveTcK5ZVSPJyjUxe1dKgI6kNF7EZhIZs8y8FVqwEfbM0Xk2ltORVDKZZM40SD3qQoQe0orJEKwPfZwm3YPqwixhUMOndis6MhbmfvLBKjC8sKKIZKbJk8L11oNkCQzCgvjhyyEiQSuJcgCQSG4Mocfgc0Hkwcjal1UNgP0CBPikYqBIk9tONv4kLtBswH07vUCjEaHiFGlLf8MgXKzSgjp2HolRRccAOh0ILHz9qlGgIFkwAnzHJRjWFhlA7ROwINyB5HFj59PRZHFor6voq7l23EPNRwdWhgawqbivLSjRA4htEYUFkjESu67icTg5S0aW1sOkCiIysfJ9UnIWevOOLGpepcBxy1wEhd2WI3AZg7sr9WBmHWyasxMcvY%2FiOmsLtHSWNUWEGk9hScMPShasUA1AcHOtRZlqMeQ0OzYS9vQvYUjOLrzP07BUAFikcJNMi7gIxEw4pL1G54TcmmmoAQ5s7TGWErJZ2Io4yQ0ljRYhL8H5e62oDtLF8aDpnIvZ5R3GWJyAugdiiJW9hQAVTsnCBHhwu7rkBlBX6r3b7ejEY0k5GGeyKv66v%2B6dg7mcJTrWHbtMywbedYqCQ0FPwoytmSWsL8WTtChZCKKzEF7vP6De4x2BJkkniMgSdWhbeBSLtJZR9CTHetK1xb34AYIJ37OegYIoPVbXgJ%2FqDQK%2BbfCtxQRVKQu77WzOoM6SGL7MaZwCGJVk46aImai9fmam%2BWpHG%2B0BtQPWUgZ7RIAlPq6lkECUhZQ2gqWkMYKcYMYaIc4gYCDFHYa2d1nzp3%2BJ1eCBay8IYZ0wQRKGAqvCuZ%2FUgbQPyllosq%2BXtfKIZOzmeJqRazpmmoP%2F76YfkjzV2NlXTDSBYB04SVlNQsFTbGPk1t%2FI4Jktu0XSgifO2ozFOiwd%2F0SssJDn0dn4xqk4GDTTKX73%2FwQyBLdqgJ%2BWx6AQaba3BA9CKEzjtQYIfAsiYamapq80LAamYjinlKXUkxdpIDk0puXUEYzSalfRibAeDAKpNiqQ0FTwoxuGYzRnisyTotdVTclis1LHRQCy%2FqqL8oUaQzWRxilq5Mi0IJGtMY02cGLD69vGjkj3p6pGePKI8bkBv5evq8SjjyU04vJR2cQXQwSJyoinDsUJHCQ50jrFTT7yRdbdYQMB3MYCb6uBzJ9ewhXYPAIZSXfeEQBZZ3GPN3Nbhh%2FwkvAJLXnQMdi5NYYZ5GHE400GS5rXkOZSQsdZgIbzRnF9ueLnsfQ47wHAsirITnTlkCcuWWIUhJSbpM3wWhXNHvt2xUsKKMpdBSbJnBMcihkoDqAd1Zml%2FR4yrzow1Q2A5G%2Bkzo%2FRhRxQS2lCSDRV8LlYLBOOoo1bF4jwJAwKMK1tWLHlu9i0j4Ig8qVm6wE1DxXwAwQwsaBWUg2pOOol2dHxyt6npwJEdLDDVYyRc2D0HbcbLUJQj8gPevQBUBOUHXPrsAPBERICpnYESeu2OHotpXQxRGlCCtLdIsu23MhZVEoJg8Qumj%2FUMMc34IBqTKLDTp76WzL%2FdMjCxK7MjhiGjeYAC%2Fkj%2FjY%2FRde7hpSM1xChrog6yZ7OWTuD56xBJnGFE%2BpT2ElSyCnJcwVzCjkqeNLfMEJqKW0G7OFIp0G%2B9mh50I9o8k1tpCY0xYqFNIALgIfc2me4n1bmJnRZ89oepgLPT0NTMLNZsvSCZAc3TXaNB07vail36%2FdBySis4m9%2FDR8izaLJW6bWCkVgm5T%2Bius3ZXq4xI%2BGnbveLbdRwF2mNtsrE0JjYc1AXknCOrLSu7Te%2Fr4dPYMCl5qtiHNTn%2BTPbh1jCBHH%2BdMJNhwNgs3nT%2BOhQoQ0vYif56BMG6WowAcHR3DjQolxLzyVekHj00PBAaW7IIAF1EF%2BuRIWyXjQMAs2chdpaKPNaB%2BkSezYt0%2BCA04sOg5vx8Fr7Ofa9sUv87h7SLAUFSzbetCCZ9pmyLt6l6%2FTzoA1%2FZBG9bIUVHLAbi%2FkdBFgYGyGwRQGBpkqCEg2ah9UD6EedEcEL3j4y0BQQCiExEnocA3SZboh%2Bepgd3YsOkHskZwPuQ5OoyA0fTA5AXrHcUOQF%2BzkJHIA7PwCDk1gGVmGUZSSoPhNf%2BTklauz98QofOlCIQ%2FtCD4dosHYPqtPCXB3agggQQIqQJsSkB%2Bqn0rkQ1toJjON%2FOtCIB9RYv3PqRA4C4U68ZMlZn6BdgEvi2ziU%2BTQ6NIw3ej%2BAtDwMGEZk7e2IjxUWKdAxyaw9OCwSmeADTPPleyk6UhGDNXQb%2B%2BW6Uk4q6F7%2Frg6WVTo82IoCxSIsFDrav4EPHphD3u4hR53WKVvYZUwNCCeM4PMBWzK%2BEfIthZOkuAwPo5C5jgoZgn6dUdvx5rIDmd58cXXdKNfw3l%2BwM2UjgrDJeQHhbD7HW2QDoZMCujgIUkk5Fg8VCsdyjOtnGRx8wgKRPZN5dR0zPUyfGZFVihbFRniXZFOZGKPnEQzU3AnD1KfR6weHW2XS6KbPJxUkOTZsAB9vTVp3Le1F8q5l%2BDMcLiIq78jxAImD2pGFw0VHfRatScGlK6SMu8leTmhUSMy8Uhdd6xBiH3Gdman4tjQGLboJfqz6fL2WKHTmrfsKZRYX6BTDjDldKMosaSTLdQS7oDisJNqAUhw1PfTlnacCO8vl8706Km1FROgLDmudzxg%2BEWTiArtHgLsRrAXYWdB0NmToNCJdKm0KWycZQqb%2BMw76Qy29iQ5up%2FX7oyw8QZ75kP5F6iJAJz6KCmqxz8fEa%2FxnsMYcIO%2FvEkGRuMckhr4rIeLrKaXnmIzlNLxbFspOphkcnJdnz%2FChp%2FVlpj2P7jJQmQRwGnltkTV5dbF9fE3%2FfxoSqTROgq9wFUlbuYzYcasE0ouzBo%2BdDCDzxKAfhbAZYxQiHrLzV2iVexnDX%2FQnT1fsT%2Fxuhu1ui5qIytgbGmRoQkeQooO8eJNNZsf0iALur8QxZFH0nCMnjerYQqG1pIfjyVZWxhVRznmmfLG00BcBWJE6hzQWRyFknuJnXuk8A5FRDCulwrWASSNoBtR%2BCtGdkPwYN2o7DOw%2FVGlCZPusRBFXODQdUM5zeHDIVuAJBLqbO%2Ff9Qua%2BpDqEPk230Sob9lEZ8BHiCorjVghuI0lI4JDgHGRDD%2FprQ84B1pVGkIpVUAHCG%2Biz3Bn3qm2AVrYcYWhock4jso5%2BJ7HfHVj4WMIQdGctq3psBCVVzupQOEioBGA2Bk%2BUILT7%2BVoX5mdxxA5fS42gISQVi%2FHTzrgMxu0fY6hE1ocUwwbsbWcezrY2n6S8%2F6cxXkOH4prpmPuFoikTzY7T85C4T2XYlbxLglSv2uLCgFv8Quk%2FwdesUdWPeHYIH0R729JIisN9Apdd4eB10aqwXrPt%2BSu9mA8k8n1sjMwnfsfF2j3jMUzXepSHmZ%2FBfqXvzgUNQQWOXO8YEuFBh4QTYCkOAPxywpYu1VxiDyJmKVcmJPGWk%2Fgc3Pov02StyYDahwmzw3E1gYC9wkupyWfDqDSUMpCTH5e5N8B%2F%2FlHiMuIkTNw4USHrJU67bjXGqNav6PBuQSoqTxc8avHoGmvqNtXzIaoyMIQIiiUHIM64cXieouplhNYln7qgc4wBVAYR104kO%2BCvKqsg4yIUlFNThVUAKZxZt1XA34h3TCUUiXVkZ0w8Hh2R0Z5L0b4LZvPd%2Fp1gi%2F07h8qfwHrByuSxglc9cI4QIg2oqvC%2Fqm0i7tjPLTgDhoWTAKDO2ONW5oe%2B%2FeKB9vZB8K6C25yCZ9RFVMnb6NRdRjyVK57CHHSkJBfnM2%2Fj4ODUwRkqrtBBCrDsDpt8jhZdXoy%2F1BCqw3sSGhgGGy0a5Jw6BP%2FTExoCmNFYjZl248A0osgPyGEmRA%2BfAsqPVaNAfytu0vuQJ7rk3J4kTDTR2AlCHJ5cls26opZM4w3jMULh2YXKpcqGBtuleAlOZnaZGbD6DHzMd6i2oFeJ8z9XYmalg1Szd%2FocZDc1C7Y6vcALJz2lYnTXiWEr2wawtoR4g3jvWUU2Ngjd1cewtFzEvM1NiHZPeLlIXFbBPawxNgMwwAlyNSuGF3zizVeOoC9bag1qRAQKQE%2FEZBWC2J8mnXAN2aTBboZ7HewnObE8CwROudZHmUM5oZ%2FUgd%2FJZQK8lvAm43uDRAbyW8gZ%2BZGq0EVerVGUKUSm%2FIdn8AQHdR4m7bue88WBwft9mSCeMOt1ncBwziOmJYI2ZR7ewNMPiCugmSsE4EyQ%2BQATJG6qORMGd4snEzc6B4shPIo4G1T7PgSm8PY5eUkPdF8JZ0VBtadbHXoJgnEhZQaODPj2gpODKJY5Yp4DOsLBFxWbvXN755KWylJm%2BoOd4zEL9Hpubuy2gyyfxh8oEfFutnYWdfB8PdESLWYvSqbElP9qo3u6KTmkhoacDauMNNjj0oy40DFV7Ql0aZj77xfGl7TJNHnIwgqOkenruYYNo6h724%2BzUQ7%2BvkCpZB%2BpGA562hYQiDxHVWOq0oDQl%2FQsoiY%2BcuI7iWq%2FZIBtHcXJ7kks%2Bh2fCNUPA82BzjnqktNts%2BRLdk1VSu%2BtqEn7QZCCsvEqk6FkfiOYkrsw092J8jsfIuEKypNjLxrKA9kiA19mxBD2suxQKCzwXGws7kEJvlhUiV9tArLIdZW0IORcxEzdzKmjtFhsjKy%2F44XYXdI5noQoRcvjZ1RMPACRqYg2V1%2BOwOepcOknRLLFdYgTkT5UApt%2FJhLM3jeFYprZV%2BZow2g8fP%2BU68hkKFWJj2yBbKqsrp25xkZX1DAjUw52IMYWaOhab8Kp05VrdNftqwRrymWF4OQSjbdfzmRZirK8FMJELEgER2PHjEAN9pGfLhCUiTJFbd5LBkOBMaxLr%2FA1SY9dXFz4RjzoU9ExfJCmx%2FI9FKEGT3n2cmzl2X42L3Jh%2BAbQq6sA%2BSs1kitoa4TAYgKHaoybHUDJ51oETdeI%2F9ThSmjWGkyLi5QAGWhL0BG1UsTyRGRJOldKBrYJeB8ljLJHfATWTEQBXBDnQexOHTB%2BUn44zExFE4vLytcu5NwpWrUxO%2F0ZICUGM7hGABXym0V6ZvDST0E370St9MIWQOTWngeoQHUTdCJUP04spMBMS8LSker9cReVQkULFDIZDFPrhTzBl6sed9wcZQTbL%2BBDqMyaN3RJPh%2Fanbx%2BIv%2BqgQdAa3M9Z5JmvYlh4qop%2BHo1F1W5gbOE9YKLgAnWytXElU4G8GtW47lhgFE6gaSs%2Bgs37sFvi0PPVvA5dnCBgILTwoKd%2F%2BDoL9F6inlM7H4rOTzD79KJgKlZO%2FZgt22UsKhrAaXU5ZcLrAglTVKJEmNJvORGN1vqrcfSMizfpsgbIe9zno%2BgBoKVXgIL%2FVI8dB1O5o%2FR3Suez%2FgD7M781ShjKpIIORM%2FnxG%2BjjhhgPwsn2IoXsPGPqYHXA63zJ07M2GPEykQwJBYLK808qYxuIew4frk52nhCsnCYmXiR6CuapvE1IwRB4%2FQftDbEn%2BAucIr1oxrLabRj9q4ae0%2BfXkHnteAJwXRbVkR0mctVSwEbqhJiMSZUp9DNbEDMmjX22m3ABpkrPQQTP3S1sib5pD2VRKRd%2BeNAjLYyT0hGrdjWJZy24OYXRoWQAIhGBZRxuBFMjjZQhpgrWo8SiFYbojcHO8V5DyscJpLTHyx9Fimassyo5U6WNtquUMYgccaHY5amgR3PQzq3ToNM5ABnoB9kuxsebqmYZm0R9qxJbFXCQ1UPyFIbxoUraTJFDpCk0Wk9GaYJKz%2F6oHwEP0Q14lMtlddQsOAU9zlYdMVHiT7RQP3XCmWYDcHCGbVRHGnHuwzScA0BaSBOGkz3lM8CArjrBsyEoV6Ys4qgDK3ykQQPZ3hCRGNXQTNNXbEb6tDiTDLKOyMzRhCFT%2BmAUmiYbV3YQVqFVp9dorv%2BTsLeCykS2b5yyu8AV7IS9cxcL8z4Kfwp%2BxJyYLv1OsxQCZwTB4a8BZ%2F5EdxTBJthApqyfd9u3ifr%2FWILTqq5VqgwMT9SOxbSGWLQJUUWCVi4k9tho9nEsbUh7U6NUsLmkYFXOhZ0kmamaJLRNJzSj%2Fqn4Mso6zb6iLLBXoaZ6AqeWCjHQm2lztnejYYM2eubnpBdKVLORZhudH3JF1waBJKA9%2BW8EhMj3Kzf0L4vi4k6RoHh3Z5YgmSZmk6ns4fjScjAoL8GoOECgqgYEBYUGFVO4FUv4%2FYtowhEmTs0vrvlD%2FCrisnoBNDAcUi%2FteY7OctFlmARQzjOItrrlKuPO6E2Ox93L4O%2F4DcgV%2FdZ7qR3VBwVQxP1GCieA4RIpweYJ5FoYrHxqRBdJjnqbsikA2Ictbb8vE1GYIo9dacK0REgDX4smy6GAkxlH1yCGGsk%2BtgiDhNKuKu3yNrMdxafmKTF632F8Vx4BNK57GvlFisrkjN9WDAtjsWA0ENT2e2nETUb%2Fn7qwhvGnrHuf5bX6Vh%2Fn3xffU3PeHdR%2BFA92i6ufT3AlyAREoNDh6chiMWTvjKjHDeRhOa9YkOQRq1vQXEMppAQVwHCuIcV2g5rBn6GmZZpTR7vnSD6ZmhdSl176gqKTXu5E%2BYbfL0adwNtHP7dT7t7b46DVZIkzaRJOM%2BS6KcrzYVg%2BT3wSRFRQashjfU18NutrKa%2F7PXbtuJvpIjbgPeqd%2BpjmRw6YKpnANFSQcpzTZgpSNJ6J7uiagAbir%2F8tNXJ%2FOsOnRh6iuIexxrmkIneAgz8QoLmiaJ8sLQrELVK2yn3wOHp57BAZJhDZjTBzyoRAuuZ4eoxHruY1pSb7qq79cIeAdOwin4GdgMeIMHeG%2BFZWYaiUQQyC5b50zKjYw97dFjAeY2I4Bnl105Iku1y0lMA1ZHolLx19uZnRdILcXKlZGQx%2FGdEqSsMRU1BIrFqRcV1qQOOHyxOLXEGcbRtAEsuAC2V4K3p5mFJ22IDWaEkk9ttf5Izb2LkD1MnrSwztXmmD%2FQi%2FEmVEFBfiKGmftsPwVaIoZanlKndMZsIBOskFYpDOq3QUs9aSbAAtL5Dbokus2G4%2FasthNMK5UQKCOhU97oaOYNGsTah%2BjfCKsZnTRn5TbhFX8ghg8CBYt%2FBjeYYYUrtUZ5jVij%2Fop7V5SsbA4mYTOwZ46hqdpbB6Qvq3AS2HHNkC15pTDIcDNGsMPXaBidXYPHc6PJAkRh29Vx8KcgX46LoUQBhRM%2B3SW6Opll%2FwgxxsPgKJKzr5QCmwkUxNbeg6Wj34SUnEzOemSuvS2OetRCO8Tyy%2BQbSKVJcqkia%2BGvDefFwMOmgnD7h81TUtMn%2BmRpyJJ349HhAnoWFTejhpYTL9G8N2nVg1qkXBeoS9Nw2fB27t7trm7d%2FQK7Cr4uoCeOQ7%2F8JfKT77KiDzLImESHw%2F0wf73QeHu74hxv7uihi4fTX%2BXEwAyQG3264dwv17aJ5N335Vt9sdrAXhPOAv8JFvzqyYXwfx8WYJaef1gMl98JRFyl5Mv5Uo%2FoVH5ww5OzLFsiTPDns7fS6EURSSWd%2F92BxMYQ8sBaH%2Bj%2BwthQPdVgDGpTfi%2BJQIWMD8xKqULliRH01rTeyF8x8q%2FGBEEEBrAJMPf25UQwi0b8tmqRXY7kIvNkzrkvRWLnxoGYEJsz8u4oOyMp8cHyaybb1HdMCaLApUE%2B%2F7xLIZGP6H9xuSEXp1zLIdjk5nBaMuV%2FyTDRRP8Y2ww5RO6d2D94o%2B6ucWIqUAvgHIHXhZsmDhjVLczmZ3ca0Cb3PpKwt2UtHVQ0BgFJsqqTsnzZPlKahRUkEu4qmkJt%2Bkqdae76ViWe3STan69yaF9%2BfESD2lcQshLHWVu4ovItXxO69bqC5p1nZLvI8NdQB9s9UNaJGlQ5mG947ipdDA0eTIw%2FA1zEdjWquIsQXXGIVEH0thC5M%2BW9pZe7IhAVnPJkYCCXN5a32HjN6nsvokEqRS44tGIs7s2LVTvcrHAF%2BRVmI8L4HUYk4x%2B67AxSMJKqCg8zrGOgvK9kNMdDrNiUtSWuHFpC8%2Fp5qIQrEo%2FH%2B1l%2F0cAwQ2nKmpWxKcMIuHY44Y6DlkpO48tRuUGBWT0FyHwSKO72Ud%2BtJUfdaZ4CWNijzZtlRa8%2BCkmO%2FEwHYfPZFU%2FhzjFWH7vnzHRMo%2BaF9u8qHSAiEkA2HjoNQPEwHsDKOt6hOoK3Ce%2F%2B%2F9boMWDa44I6FrQhdgS7OnNaSzwxWKZMcyHi6LN4WC6sSj0qm2PSOGBTvDs%2FGWJS6SwEN%2FULwpb4LQo9fYjUfSXRwZkynUazlSpvX9e%2BG2zor8l%2BYaMxSEomDdLHGcD6YVQPegTaA74H8%2BV4WvJkFUrjMLGLlvSZQWvi8%2FQA7yzQ8GPno%2F%2F5SJHRP%2FOqKObPCo81s%2F%2B6WgLqykYpGAgQZhVDEBPXWgU%2FWzFZjKUhSFInufPRiMAUULC6T11yL45ZrRoB4DzOyJShKXaAJIBS9wzLYIoCEcJKQW8GVCx4fihqJ6mshBUXSw3wWVj3grrHQlGNGhIDNNzsxQ3M%2BGWn6ASobIWC%2BLbYOC6UpahVO13Zs2zOzZC8z7FmA05JhUGyBsF4tsG0drcggIFzgg%2Fkpf3%2BCnAXKiMgIE8Jk%2FMhpkc8DUJEUzDSnWlQFme3d0sHZDrg7LavtsEX3cHwjCYA17pMTfx8Ajw9hHscN67hyo%2BRJQ4458RmPywXykkVcW688oVUrQhahpPRvTWPnuI0B%2BSkQu7dCyvLRyFYlC1LG1gRCIvn3rwQeINzZQC2KXq31FaR9UmVV2QeGVqBHjmE%2BVMd3b1fhCynD0pQNhCG6%2FWCDbKPyE7NRQzL3BzQAJ0g09aUzcQA6mUp9iZFK6Sbp%2FYbHjo%2B%2B7%2FWj8S4YNa%2BZdqAw1hDrKWFXv9%2BzaXpf8ZTDSbiqsxnwN%2FCzK5tPkOr4tRh2kY3Bn9JtalbIOI4b3F7F1vPQMfoDcdxMS8CW9m%2FNCW%2FHILTUVWQIPiD0j1A6bo8vsv6P1hCESl2abrSJWDrq5sSzUpwoxaCU9FtJyYH4QFMxDBpkkBR6kn0LMPO%2B5EJ7Z6bCiRoPedRZ%2FP0SSdii7ZnPAtVwwHUidcdyspwncz5uq6vvm4IEDbJVLUFCn%2FLvIHfooUBTkFO130FC7CmmcrKdgDJcid9mvVzsDSibOoXtIf9k6ABle3PmIxejodc4aob0QKS432srrCMndbfD454q52V01G4q913mC5HOsTzWF4h2No1av1VbcUgWAqyoZl%2B11PoFYnNv2HwAODeNRkHj%2B8SF1fcvVBu6MrehHAZK1Gm69ICcTKizykHgGFx7QdowTVAsYEF2tVc0Z6wLryz2FI1sc5By2znJAAmINndoJiB4sfPdPrTC8RnkW7KRCwxC6YvXg5ahMlQuMpoCSXjOlBy0Kij%2BbsCYPbGp8BdCBiLmLSAkEQRaieWo1SYvZIKJGj9Ur%2FeWHjiB7SOVdqMAVmpBvfRiebsFjger7DC%2B8kRFGtNrTrnnGD2GAJb8rQCWkUPYHhwXsjNBSkE6lGWUj5QNhK0DMNM2l%2BkXRZ0KLZaGsFSIdQz%2FHXDxf3%2FTE30%2BDgBKWGWdxElyLccJfEpjsnszECNoDGZpdwdRgCixeg9L4EPhH%2BRptvRMVRaahu4cySjS3P5wxAUCPkmn%2BrhyASpmiTaiDeggaIxYBmtLZDDhiWIJaBgzfCsAGUF1Q1SFZYyXDt9skCaxJsxK2Ms65dmdp5WAZyxik%2FzbrTQk5KmgxCg%2Ff45L0jywebOWUYFJQAJia7XzCV0x89rpp%2Ff3AVWhSPyTanqmik2SkD8A3Ml4NhIGLAjBXtPShwKYfi2eXtrDuKLk4QlSyTw1ftXgwqA2jUuopDl%2B5tfUWZNwBpEPXghzbBggYCw%2Fdhy0ntds2yeHCDKkF%2FYxQjNIL%2FF%2F37jLPHCKBO9ibwYCmuxImIo0ijV2Wbg3kSN2psoe8IsABv3RNFaF9uMyCtCYtqcD%2BqNOhwMlfARQUdJ2tUX%2BMNJqOwIciWalZsmEjt07tfa8ma4cji9sqz%2BQ9hWfmMoKEbIHPOQORbhQRHIsrTYlnVTNvcq1imqmmPDdVDkJgRcTgB8Sb6epCQVmFZe%2BjGDiNJQLWnfx%2BdrTKYjm0G8yH0ZAGMWzEJhUEQ4Maimgf%2Fbkvo8PLVBsZl152y5S8%2BHRDfZIMCbYZ1WDp4yrdchOJw8k6R%2B%2F2pHmydK4NIK2PHdFPHtoLmHxRDwLFb7eB%2BM4zNZcB9NrAgjVyzLM7xyYSY13ykWfIEEd2n5%2FiYp3ZdrCf7fL%2Ben%2BsIJu2W7E30MrAgZBD1rAAbZHPgeAMtKCg3NpSpYQUDWJu9bT3V7tOKv%2BNRiJc8JAKqqgCA%2FPNRBR7ChpiEulyQApMK1AyqcWnpSOmYh6yLiWkGJ2mklCSPIqN7UypWj3dGi5MvsHQ87MrB4VFgypJaFriaHivwcHIpmyi5LhNqtem4q0n8awM19Qk8BOS0EsqGscuuydYsIGsbT5GHnERUiMpKJl4ON7qjB4fEqlGN%2FhCky89232UQCiaeWpDYCJINXjT6xl4Gc7DxRCtgV0i1ma4RgWLsNtnEBRQFqZggCLiuyEydmFd7WlogpkCw5G1x4ft2psm3KAREwVwr1Gzl6RT7FDAqpVal34ewVm3VH4qn5mjGj%2BbYL1NgfLNeXDwtmYSpwzbruDKpTjOdgiIHDVQSb5%2FzBgSMbHLkxWWgghIh9QTFSDILixVwg0Eg1puooBiHAt7DzwJ7m8i8%2Fi%2BjHvKf0QDnnHVkVTIqMvIQImOrzCJwhSR7qYB5gSwL6aWL9hERHCZc4G2%2BJrpgHNB8eCCmcIWIQ6rSdyPCyftXkDlErUkHafHRlkOIjxGbAktz75bnh50dU7YHk%2BMz7wwstg6RFZb%2BTZuSOx1qqP5C66c0mptQmzIC2dlpte7vZrauAMm%2F7RfBYkGtXWGiaWTtwvAQiq2oD4YixPLXE2khB2FRaNRDTk%2B9sZ6K74Ia9VntCpN4BhJGJMT4Z5c5FhSepRCRWmBXqx%2BwhVZC4me4saDs2iNqXMuCl6iAZflH8fscC1sTsy4PHeC%2BXYuqMBMUun5YezKbRKmEPwuK%2BCLzijPEQgfhahQswBBLfg%2FGBgBiI4QwAqzJkkyYAWtjzSg2ILgMAgqxYfwERRo3zruBL9WOryUArSD8sQOcD7fvIODJxKFS615KFPsb68USBEPPj1orNzFY2xoTtNBVTyzBhPbhFH0PI5AtlJBl2aSgNPYzxYLw7XTDBDinmVoENwiGzmngrMo8OmnRP0Z0i0Zrln9DDFcnmOoBZjABaQIbPOJYZGqX%2BRCMlDDbElcjaROLDoualmUIQ88Kekk3iM4OQrADcxi3rJguS4MOIBIgKgXrjd1WkbCdqxJk%2F4efRIFsavZA7KvvJQqp3Iid5Z0NFc5aiMRzGN3vrpBzaMy4JYde3wr96PjN90AYOIbyp6T4zj8LoE66OGcX1Ef4Z3KoWLAUF4BTg7ug%2FAbkG5UNQXAMkQezujSHeir2uTThgd3gpyzDrbnEdDRH2W7U6PeRvBX1ZFMP5RM%2BZu6UUZZD8hDPHldVWntTCNk7To8IeOW9yn2wx0gmurwqC60AOde4r3ETi5pVMSDK8wxhoGAoEX9NLWHIR33VbrbMveii2jAJlrxwytTHbWNu8Y4N8vCCyZjAX%2FpcsfwXbLze2%2BD%2Bu33OGBoJyAAL3jn3RuEcdp5If8O%2Ba4NKWvxOTyDltG0IWoHhwVGe7dKkCWFT%2B%2Btm%2BhaBCikRUUMrMhYKZJKYoVuv%2FbsJzO8DwfVIInQq3g3BYypiz8baogH3r3GwqCwFtZnz4xMjAVOYnyOi5HWbFA8n0qz1OjSpHWFzpQOpvkNETZBGpxN8ybhtqV%2FDMUxd9uFZmBfKXMCn%2FSqkWJyKPnT6lq%2B4zBZni6fYRByJn6OK%2BOgPBGRAJluwGSk4wxjOOzyce%2FPKODwRlsgrVkdcsEiYrqYdXo0Er2GXi2GQZd0tNJT6c9pK1EEJG1zgDJBoTVuCXGAU8BKTvCO%2FcEQ1Wjk3Zzuy90JX4m3O5IlxVFhYkSUwuQB2up7jhvkm%2BbddRQu5F9s0XftGEJ9JSuSk%2BZachCbdU45fEqbugzTIUokwoAKvpUQF%2FCvLbWW5BNQFqFkJg2f30E%2F48StNe5QwBg8zz3YAJ82FZoXBxXSv4QDooDo79NixyglO9AembuBcx5Re3CwOKTHebOPhkmFC7wNaWtoBhFuV4AkEuJ0J%2B1pT0tLkvFVZaNzfhs%2FKd3%2BA9YsImlO4XK4vpCo%2FelHQi%2F9gkFg07xxnuXLt21unCIpDV%2BbbRxb7FC6nWYTsMFF8%2B1LUg4JFjVt3vqbuhHmDKbgQ4e%2BRGizRiO8ky05LQGMdL2IKLSNar0kNG7lHJMaXr5mLdG3nykgj6vB%2FKVijd1ARWkFEf3yiUw1v%2FWaQivVUpIDdSNrrKbjO5NPnxz6qTTGgYg03HgPhDrCFyYZTi3XQw3HXCva39mpLNFtz8AiEhxAJHpWX13gCTAwgm9YTvMeiqetdNQv6IU0hH0G%2BZManTqDLPjyrOse7WiiwOJCG%2BJ0pZYULhN8NILulmYYvmVcV2MjAfA39sGKqGdjpiPo86fecg65UPyXDIAOyOkCx5NQsLeD4gGVjTVDwOHWkbbBW0GeNjDkcSOn2Nq4cEssP54t9D749A7M1AIOBl0Fi0sSO5v3P7LCBrM6ZwFY6kp2FX6AcbGUdybnfChHPyu6WlRZ2Fwv9YM0RMI7kISRgR8HpQSJJOyTfXj%2F6gQKuihPtiUtlCQVPohUgzfezTg8o1b3n9pNZeco1QucaoXe40Fa5JYhqdTspFmxGtW9h5ezLFZs3j%2FN46f%2BS2rjYNC2JySXrnSAFhvAkz9a5L3pza8eYKHNoPrvBRESpxYPJdKVUxBE39nJ1chrAFpy4MMkf0qKgYALctGg1DQI1kIymyeS2AJNT4X240d3IFQb%2F0jQbaHJ2YRK8A%2Bls6WMhWmpCXYG5jqapGs5%2FeOJErxi2%2F2KWVHiPellTgh%2FfNl%2F2KYPKb7DUcAg%2BmCOPQFCiU9Mq%2FWLcU1xxC8aLePFZZlE%2BPCLzf7ey46INWRw2kcXySR9FDgByXzfxiNKwDFbUSMMhALPFSedyjEVM5442GZ4hTrsAEvZxIieSHGSgkwFh%2FnFNdrrFD4tBH4Il7fW6ur4J8Xaz7RW9jgtuPEXQsYk7gcMs2neu3zJwTyUerHKSh1iTBkj2YJh1SSOZL5pLuQbFFAvyO4k1Hxg2h99MTC6cTUkbONQIAnEfGsGkNFWRbuRyyaEZInM5pij73EA9rPIUfU4XoqQpHT9THZkW%2BoKFLvpyvTBMM69tN1Ydwv1LIEhHsC%2BueVG%2Bw%2BkyCPsvV3erRikcscHjZCkccx6VrBkBRusTDDd8847GA7p2Ucy0y0HdSRN6YIBciYa4vuXcAZbQAuSEmzw%2BH%2FAuOx%2BaH%2BtBL88H57D0MsqyiZxhOEQkF%2F8DR1d2hSPMj%2FsNOa5rxcUnBgH8ictv2J%2Bcb4BA4v3MCShdZ2vtK30vAwkobnEWh7rsSyhmos3WC93Gn9C4nnAd%2FPjMMtQfyDNZsOPd6XcAsnBE%2FmRHtHEyJMzJfZFLE9OvQa0i9kUmToJ0ZxknTgdl%2FXPV8xoh0K7wNHHsnBdvFH3sv52lU7UFteseLG%2FVanIvcwycVA7%2BBE1Ulyb20BvwUWZcMTKhaCcmY3ROpvonVMV4N7yBXTL7IDtHzQ4CCcqF66LjF3xUqgErKzolLyCG6Kb7irP%2FMVTCCwGRxfrPGpMMGvPLgJ881PHMNMIO09T5ig7AzZTX%2F5PLlwnJLDAPfuHynSGhV4tPqR3gJ4kg4c06c%2FF1AcjGytKm2Yb5jwMotF7vro4YDLWlnMIpmPg36NgAZsGA0W1spfLSue4xxat0Gdwd0lqDBOgIaMANykwwDKejt5YaNtJYIkrSgu0KjIg0pznY0SCd1qlC6R19g97UrWDoYJGlrvCE05J%2F5wkjpkre727p5PTRX5FGrSBIfJqhJE%2FIS876PaHFkx9pGTH3oaY3jJRvLX9Iy3Edoar7cFvJqyUlOhAEiOSAyYgVEGkzHdug%2BoRHIEOXAExMiTSKU9A6nmRC8mp8iYhwWdP2U%2F5EkFAdPrZw03YA3gSyNUtMZeh7dDCu8pF5x0VORCTgKp07ehy7NZqKTpIC4UJJ89lnboyAfy5OyXzXtuDRbtAFjZRSyGFTpFrXwkpjSLIQIG3N0Vj4BtzK3wdlkBJrO18MNsgseR4BysJilI0wI6ZahLhBFA0XBmV8d4LUzEcNVb0xbLjLTETYN8OEVqNxkt10W614dd1FlFFVTIgB7%2FBQQp1sWlNolpIu4ekxUTBV7NmxOFKEBmmN%2BnA7pvF78%2FRII5ZHA09OAiE%2F66MF6HQ%2BqVEJCHxwymukkNvzqHEh52dULPbVasfQMgTDyBZzx4007YiKdBuUauQOt27Gmy8ISclPmEUCIcuLbkb1mzQSqIa3iE0PJh7UMYQbkpe%2BhXjTJKdldyt2mVPwywoODGJtBV1lJTgMsuSQBlDMwhEKIfrvsxGQjHPCEfNfMAY2oxvyKcKPUbQySkKG6tj9AQyEW3Q5rpaDJ5Sns9ScLKeizPRbvWYAw4bXkrZdmB7CQopCH8NAmqbuciZChHN8lVGaDbCnmddnqO1PQ4ieMYfcSiBE5zzMz%2BJV%2F4eyzrzTEShvqSGzgWimkNxLvUj86iAwcZuIkqdB0VaIB7wncLRmzHkiUQpPBIXbDDLHBlq7vp9xwuC9AiNkIptAYlG7Biyuk8ILdynuUM1cHWJgeB%2BK3wBP%2FineogxkvBNNQ4AkW0hvpBOQGFfeptF2YTR75MexYDUy7Q%2F9uocGsx41O4IZhViw%2F2FvAEuGO5g2kyXBUijAggWM08bRhXg5ijgMwDJy40QeY%2FcQpUDZiIzmvskQpO5G1zyGZA8WByjIQU4jRoFJt56behxtHUUE%2Fom7Rj2psYXGmq3llVOCgGYKNMo4pzwntITtapDqjvQtqpjaJwjHmDzSVGLxMt12gEXAdLi%2FcaHSM3FPRGRf7dB7YC%2BcD2ho6oL2zGDCkjlf%2FDFoQVl8GS%2F56wur3rdV6ggtzZW60MRB3g%2BU1W8o8cvqIpMkctiGVMzXUFI7FacFLrgtdz4mTEr4aRAaQ2AFQaNeG7GX0yOJgMRYFziXdJf24kg%2FgBQIZMG%2FYcPEllRTVNoDYR6oSJ8wQNLuihfw81UpiKPm714bZX1KYjcXJdfclCUOOpvTxr9AAJevTY4HK%2FG7F3mUc3GOAKqh60zM0v34v%2BELyhJZqhkaMA8UMMOU90f8RKEJFj7EqepBVwsRiLbwMo1J2zrE2UYJnsgIAscDmjPjnzI8a719Wxp757wqmSJBjXowhc46QN4RwKIxqEE6E5218OeK7RfcpGjWG1jD7qND%2B%2FGTk6M56Ig4yMsU6LUW1EWE%2BfIYycVV1thldSlbP6ltdC01y3KUfkobkt2q01YYMmxpKRvh1Z48uNKzP%2FIoRIZ%2FF6buOymSnW8gICitpJjKWBscSb9JJKaWkvEkqinAJ2kowKoqkqZftRqfRQlLtKoqvTRDi2vg%2FRrPD%2Fd3a09J8JhGZlEkOM6znTsoMCsuvTmywxTCDhw5dd0GJOHCMPbsj3QLkTE3MInsZsimDQ3HkvthT7U9VA4s6G07sID0FW4SHJmRGwCl%2BMu4xf0ezqeXD2PtPDnwMPo86sbwDV%2B9PWcgFcARUVYm3hrFQrHcgMElFGbSM2A1zUYA3baWfheJp2AINmTJLuoyYD%2FOwA4a6V0ChBN97E8YtDBerUECv0u0TlxR5yhJCXvJxgyM73Bb6pyq0jTFJDZ4p1Am1SA6sh8nADd1hAcGBMfq4d%2FUfwnmBqe0Jun1n1LzrgKuZMAnxA3NtCN7Klf4BH%2B14B7ibBmgt0TGUafVzI4uKlpF7v8NmgNjg90D6QE3tbx8AjSAC%2BOA1YJvclyPKgT27QpIEgVYpbPYGBsnyCNrGz9XUsCHkW1QAHgL2STZk12QGqmvAB0NFteERkvBIH7INDsNW9KKaAYyDMdBEMzJiWaJHZALqDxQDWRntumSDPcplyFiI1oDpT8wbwe01AHhW6%2BvAUUBoGhY3CT2tgwehdPqU%2F4Q7ZLYvhRl%2FogOvR9O2%2BwkkPKW5vCTjD2fHRYXONCoIl4Jh1bZY0ZE1O94mMGn%2FdFSWBWzQ%2FVYk%2BGezi46RgiDv3EshoTmMSlioUK6MQEN8qeyK6FRninyX8ZPeUWjjbMJChn0n%2FyJvrq5bh5UcCAcBYSafTFg7p0jDgrXo2QWLb3WpSOET%2FHh4oSadBTvyDo10IufLzxiMLAnbZ1vcUmj3w7BQuIXjEZXifwukVxrGa9j%2BDXfpi12m1RbzYLg9J2wFergEwOxFyD0%2FJstNK06ZN2XdZSGWxcJODpQHOq4iKqjqkJUmPu1VczL5xTGUfCgLEYyNBCCbMBFT%2FcUP6pE%2FmujnHsSDeWxMbhrNilS5MyYR0nJyzanWXBeVcEQrRIhQeJA6Xt4f2eQESNeLwmC10WJVHqwx8SSyrtAAjpGjidcj1E2FYN0LObUcFQhafUKTiGmHWRHGsFCB%2BHEXgrzJEB5bp0QiF8ZHh11nFX8AboTD0PS4O1LqF8XBks2MpjsQnwKHF6HgaKCVLJtcr0XjqFMRGfKv8tmmykhLRzu%2BvqQ02%2BKpJBjaLt9ye1Ab%2BBbEBhy4EVdIJDrL2naV0o4wU8YZ2Lq04FG1mWCKC%2BUwkXOoAjneU%2FxHplMQo2cXUlrVNqJYczgYlaOEczVCs%2FOCgkyvLmTmdaBJc1iBLuKwmr6qtRnhowngsDxhzKFAi02tf8bmET8BO27ovJKF1plJwm3b0JpMh38%2BxsrXXg7U74QUM8ZCIMOpXujHntKdaRtsgyEZl5MClMVMMMZkZLNxH9%2Bb8fH6%2Bb8Lev30A9TuEVj9CqAdmwAAHBPbfOBFEATAPZ2CS0OH1Pj%2F0Q7PFUcC8hDrxESWdfgFRm%2B7vvWbkEppHB4T%2F1ApWnlTIqQwjcPl0VgS1yHSmD0OdsCVST8CQVwuiew1Y%2Bg3QGFjNMzwRB2DSsAk26cmA8lp2wIU4p93AUBiUHFGOxOajAqD7Gm6NezNDjYzwLOaSXRBYcWipTSONHjUDXCY4mMI8XoVCR%2FRrs%2FJLKXgEx%2BqkmeDlFOD1%2FyTQNDClRuiUyKYCllfMiQiyFkmuTz2vLsBNyRW%2Bxz%2B5FElFxWB28VjYIGZ0Yd%2B5wIjkcoMaggxswbT0pCmckRAErbRlIlcOGdBo4djTNO8FAgQ%2BlT6vPS60BwTRSUAM3ddkEAZiwtEyArrkiDRnS7LJ%2B2hwbzd2YDQagSgACpsovmjil5wfPuXq3GuH0CyE7FK3M4FgRaFoIkaodORrPx1%2BJpI9psyNYIFuJogZa0%2F1AhOWdlHQxdAgbwacsHqPZo8u%2FngAH2GmaTdhYnBfSDbBfh8CHq6Bx5bttP2%2BRdM%2BMAaYaZ0Y%2FADkbNCZuAyAVQa2OcXOeICmDn9Q%2FeFkDeFQg5MgHEDXq%2FtVjj%2Bjtd26nhaaolWxs1ixSUgOBwrDhRIGOLyOVk2%2FBc0UxvseQCO2pQ2i%2BKrfhu%2FWeBovNb5dJxQtJRUDv2mCwYVpNl2efQM9xQHnK0JwLYt%2FU0Wf%2BphiA4uw8G91slC832pmOTCAoZXohg1fewCZqLBhkOUBofBWpMPsqg7XEXgPfAlDo2U5WXjtFdS87PIqClCK5nW6adCeXPkUiTGx0emOIDQqw1yFYGHEVx20xKjJVYe0O8iLmnQr3FA9nSIQilUKtJ4ZAdcTm7%2BExseJauyqo30hs%2B1qSW211A1SFAOUgDlCGq7eTIcMAeyZkV1SQJ4j%2Fe1Smbq4HcjqgFbLAGLyKxlMDMgZavK5NAYH19Olz3la%2FQCTiVelFnU6O%2FGCvykqS%2FwZJDhKN9gBtSOp%2F1SP5VRgJcoVj%2Bkmf2wBgv4gjrgARBWiURYx8xENV3bEVUAAWWD3dYDKAIWk5opaCFCMR5ZjJExiCAw7gYiSZ2rkyTce4eNMY3lfGn%2B8p6%2BvBckGlKEXnA6Eota69OxDO9oOsJoy28BXOR0UoXNRaJD5ceKdlWMJlOFzDdZNpc05tkMGQtqeNF2lttZqNco1VtwXgRstLSQ6tSPChgqtGV5h2DcDReIQadaNRR6AsAYKL5gSFsCJMgfsaZ7DpKh8mg8Wz8V7H%2BgDnLuMxaWEIUPevIbClgap4dqmVWSrPgVYCzAoZHIa5z2Ocx1D%2FGvDOEqMOKLrMefWIbSWHZ6jbgA8qVBhYNHpx0P%2BjAgN5TB3haSifDcApp6yymEi6Ij%2FGsEpDYUgcHATJUYDUAmC1SCkJ4cuZXSAP2DEpQsGUjQmKJfJOvlC2x%2FpChkOyLW7KEoMYc5FDC4v2FGqSoRWiLsbPCiyg1U5yiHZVm1XLkHMMZL11%2Fyxyw0UnGig3MFdZklN5FI%2FqiT65T%2BjOXOdO7XbgWurOAZR6Cv9uu1cm5LjkXX4xi6mWn5r5NjBS0gTliHhMZI2WNqSiSphEtiCAwnafS11JhseDGHYQ5%2BbqWiAYiAv6Jsf79%2FVUs4cIl%2Bn6%2BWOjcgB%2F2l5TreoAV2717JzZbQIR0W1cl%2FdEqCy5kJ3ZSIHuU0vBoHooEpiHeQWVkkkOqRX27eD1FWw4BfO9CJDdKoSogQi3hAAwsPRFrN5RbX7bqLdBJ9JYMohWrgJKHSjVl1sy2xAG0E3sNyO0oCbSGOxCNBRRXTXenYKuwAoDLfnDcQaCwehUOIDiHAu5m5hMpKeKM4sIo3vxACakIxKoH2YWF2QM84e6F5C5hJU4g8uxuFOlAYnqtwxmHyNEawLW%2FPhoawJDrGAP0JYWHgAVUByo%2FbGdiv2T2EMg8gsS14%2FrAdzlOYazFE7w4OzxeKiWdm3nSOnQRRKXSlVo8HEAbBfyJMKqoq%2BSCcTSx5NDtbFwNlh8VhjGGDu7JG5%2FTAGAvniQSSUog0pNzTim8Owc6QTuSKSTXlQqwV3eiEnklS3LeSXYPXGK2VgeZBqNcHG6tZHvA3vTINhV0ELuQdp3t1y9%2BogD8Kk%2FW7QoRN1UWPqM4%2BxdygkFDPLoTaumKReKiLWoPHOfY54m3qPx4c%2B4pgY3MRKKbljG8w4wvz8pxk3AqKsy4GMAkAtmRjRMsCxbb4Q2Ds0Ia9ci8cMT6DmsJG00XaHCIS%2Bo3F8YVVeikw13w%2BOEDaCYYhC0ZE54kA4jpjruBr5STWeqQG6M74HHL6TZ3lXrd99ZX%2B%2B7LhNatQaZosuxEf5yRA15S9gPeHskBIq3Gcw81AGb9%2FO53DYi%2F5CsQ51EmEh8Rkg4vOciClpy4d04eYsfr6fyQkBmtD%2BP8sNh6e%2BXYHJXT%2FlkXxT4KXU5F2sGxYyzfniMMQkb9OjDN2C8tRRgTyL7GwozH14PrEUZc6oz05Emne3Ts5EG7WolDmU8OB1LDG3VrpQxp%2BpT0KYV5dGtknU64JhabdqcVQbGZiAxQAnvN1u70y1AnmvOSPgLI6uB4AuDGhmAu3ATkJSw7OtS%2F2ToPjqkaq62%2F7WFG8advGlRRqxB9diP07JrXowKR9tpRa%2BjGJ91zxNTT1h8I2PcSfoUPtd7NejVoH03EUcqSBuFZPkMZhegHyo2ZAITovmm3zAIdGFWxoNNORiMRShgwdYwFzkPw5PA4a5MIIQpmq%2Bnsp3YMuXt%2FGkXxLx%2FP6%2BZJS0lFyz4MunC3eWSGE8xlCQrKvhKUPXr0hjpAN9ZK4PfEDrPMfMbGNWcHDzjA7ngMxTPnT7GMHar%2BgMQQ3NwHCv4zH4BIMYvzsdiERi6gebRmerTsVwZJTRsL8dkZgxgRxmpbgRcud%2BYlCIRpPwHShlUSwuipZnx9QCsEWziVazdDeKSYU5CF7UVPAhLer3CgJOQXl%2Fzh575R5rsrmRnKAzq4POFdgbYBuEviM4%2BLVC15ssLNFghbTtHWerS1hDt5s4qkLUha%2FqpZXhWh1C6lTQAqCNQnaDjS7UGFBC6wTu8yFnKJnExCnAs3Ok9yj5KpfZESQ4lTy5pTGTnkAUpxI%2ByjEldJfSo4y0QhG4i4IwkRFGcjWY8%2BEzgYYJUK7BXQksLxAww%2FYYWBMhJILB9e8ePEJ4OP7z%2B4%2FwOQDl64iOYDp26DaONPxpKtBxq%2FaTzRGarm3VkPYTLJKx6Z%2FMw2YbBGseJhPMwhhNswrIkyvV2BYzrvZbxLpKwcWJhYmFtVZ%2BlPEq91FzVp1HlQY1bZVLqeNR9SAUn6n0E28k%2FUuGkNpP1DBI5ch%2FEehZfjUQ9aE41NhETExoPT2gGQz0IhWJbEOvTQ4wgcXCHHFBhewYUiFHuhRSAUVmEHeCRQHQkXGFwkAgyzREJCVN7TRnTon36Zw3tPhx4EALwNdwDv%2BJ41YSP4B2CQqz0EFgARZ4ESgBHQgROwAVn9GTI%2BHYexTUevLUeta4%2FDqKrbMVS%2BYqb8hUwYCrlgKtmAq1YCrFgKrd4qpXiqZcKn1oqdWipjYKpWwVPVYqW6xUpVipKqFR3QKjagVEtAqHpxUMTitsnFaJOKx2cVhswq35RVpyiq9lFVNIKnOQVMkgqtYxVNxiqQjFS7GKlSIVIsQqPIhUWwioigFQ%2B%2BKkN8VHr49HDw9Ebo9EDo9DTo9Crg9BDg9%2FWx7gWx7YWwlobYrOGxWPNisAaAHEyALpkAVDIAeWAArsABVXACYuAD5cAF6wAKFQAQqgAbVAAsoAAlQAUaYAfkwAvogBWQACOgAD9AAHSAAKT4GUdMiOvFngBTwCn2AZ7Dv6B6k%2F90B8%2ByRnkV144AIBoAMTQATGgAjNAA4YABgwABZgB%2FmQCwyAVlwCguASlwCEuAQFwB4uAMlwBYuAJlQAUVAAhUD2KgdpUDaJgaRMDFJgX5MC1JgWJEAokQCWRAHxEAWkQBMRADpEAMkQAYROAEecC484DRpwBDTnwNOdw05tjTmiNOYwtswhYFwLA7BYG4LA2BYGOLAwRYFuLAsxYFQJAohIEyJAMwkAwiQC0JAJgkAeiQBkJAFokAPCQA0JABwcD4Dgc4cDdDgaYcDIDgYgUC6CgWgUClCgUYUAVBQBOFAEYMALgwAgDA9QYAdIn8AZzeBB2L5EcWrenUT1KXienEsuJJ7x5U8XlTjc1NVzUyXFTGb1LlpUtWlTDIjqwE4LsagowoCi2gJLKAkpoBgJQNpAIhNqaEoneI6kiiqQ6Go%2Fn6j0cS%2Ba2gEU8gIHJ%2BBwfgZX4GL%2BBd%2FgW34FZ%2BBS%2FgUH4FN6BTegTvoEv6BJegRnYEF2A79gOvYDl2BdEjCkqkGtwXp0LNToIskOTXzh%2FF062yJ7AAAAEDAWAAABWhJ%2BKPEIJgBFxMVP7w2QJBGHASQnOBKXKFIdUK4igKA9IEaYJg%29%3Bsrc%3Aurl%28data%3Aapplication%2Fvnd%2Ems%2Dfontobject%3Bbase64%2Cn04AAEFNAAACAAIABAAAAAAABQAAAAAAAAABAJABAAAEAExQAAAAAAAAAAIAAAAAAAAAAAEAAAAAAAAAJxJ%2FLAAAAAAAAAAAAAAAAAAAAAAAACgARwBMAFkAUABIAEkAQwBPAE4AUwAgAEgAYQBsAGYAbABpAG4AZwBzAAAADgBSAGUAZwB1AGwAYQByAAAAeABWAGUAcgBzAGkAbwBuACAAMQAuADAAMAA5ADsAUABTACAAMAAwADEALgAwADAAOQA7AGgAbwB0AGMAbwBuAHYAIAAxAC4AMAAuADcAMAA7AG0AYQBrAGUAbwB0AGYALgBsAGkAYgAyAC4ANQAuADUAOAAzADIAOQAAADgARwBMAFkAUABIAEkAQwBPAE4AUwAgAEgAYQBsAGYAbABpAG4AZwBzACAAUgBlAGcAdQBsAGEAcgAAAAAAQlNHUAAAAAAAAAAAAAAAAAAAAAADAKncAE0TAE0ZAEbuFM3pjM%2FSEdmjKHUbyow8ATBE40IvWA3vTu8LiABDQ%2BpexwUMcm1SMnNryctQSiI1K5ZnbOlXKmnVV5YvRe6RnNMFNCOs1KNVpn6yZhCJkRtVRNzEufeIq7HgSrcx4S8h%2Fv4vnrrKc6oCNxmSk2uKlZQHBii6iKFoH0746ThvkO1kJHlxjrkxs%2BLWORaDQBEtiYJIR5IB9Bi1UyL4Rmr0BNigNkMzlKQmnofBHviqVzUxwdMb3NdCn69hy%2BpRYVKGVS%2F1tnsqv4LL7wCCPZZAZPT4aCShHjHJVNuXbmMrY5LeQaGnvAkXlVrJgKRAUdFjrWEah9XebPeQMj7KS7DIBAFt8ycgC5PLGUOHSE3ErGZCiViNLL5ZARfywnCoZaKQCu6NuFX42AEeKtKUGnr%2FCm2Cy8tpFhBPMW5Fxi4Qm4TkDWh4IWFDClhU2hRWosUWqcKLlgyXB%2BlSHaWaHiWlBAR8SeSgSPCQxdVQgzUixWKSTrIQEbU94viDctkvX%2BVSjJuUmV8L4CXShI11esnp0pjWNZIyxKHS4wVQ2ime1P4RnhvGw0aDN1OLAXGERsB7buFpFGGBAre4QEQR0HOIO5oYH305G%2BKspT%2FFupEGGafCCwxSe6ZUa%2B073rXHnNdVXE6eWvibUS27XtRzkH838mYLMBmYysZTM0EM3A1fbpCBYFccN1B%2FEnCYu%2FTgCGmr7bMh8GfYL%2BBfcLvB0gRagC09w9elfldaIy%2FhNCBLRgBgtCC7jAF63wLSMAfbfAlEggYU0bUA7ACCJmTDpEmJtI78w4%2FBO7dN7JR7J7ZvbYaUbaILSQsRBiF3HGk5fEg6p9unwLvn98r%2BvnsV%2B372uf1xBLq4qU%2F45fTuqaAP%2BpssmCCCTF0mhEow8ZXZOS8D7Q85JsxZ%2BAzok7B7O%2Ff6J8AzYBySZQB%2FQHYUSA%2BEeQhEWiS6AIQzgcsDiER4MjgMBAWDV4AgQ3g1eBgIdweCQmCjJEMkJ%2BPKRWyFHHmg1Wi%2F6xzUgA0LREoKJChwnQa9B%2B5RQZRB3IlBlkAnxyQNaANwHMowzlYSMCBgnbpzvqpl0iTJNCQidDI9ZrSYNIRBhHtUa5YHMHxyGEik9hDE0AKj72AbTCaxtHPUaKZdAZSnQTyjGqGLsmBStCejApUhg4uBMU6mATujEl%2BKdDPbI6Ag4vLr%2BhjY6lbjBeoLKnZl0UZgRX8gTySOeynZVz1wOq7e1hFGYIq%2BMhrGxDLak0PrwYzSXtcuyhXEhwOYofiW%2BEcI%2Fjw8P6IY6ed%2BetAbuqKp5QIapT77LnAe505lMuqL79a0ut4rWexzFttsOsLDy7zvtQzcq3U1qabe7tB0wHWVXji%2BzDbo8x8HyIRUbXnwUcklFv51fvTymiV%2BMXLSmGH9d9%2BaXpD5X6lao41anWGig7IwIdnoBY2ht%2FpO9mClLo4NdXHAsefqWUKlXJkbqPOFhMoR4aiA1BXqhRNbB2Xwi%2B7u%2FjpAoOpKJ0UX24EsrzMfHXViakCNcKjBxuQX8BO0ZqjJ3xXzf%2B61t2VXOSgJ8xu65QKgtN6FibPmPYsXbJRHHqbgATcSZxBqGiDiU4NNNsYBsKD0MIP%2FOfKnlk%2FLkaid%2FO2NbKeuQrwOB2Gq3YHyr6ALgzym5wIBnsdC1ZkoBFZSQXChZvlesPqvK2c5oHHT3Q65jYpNxnQcGF0EHbvYqoFw60WNlXIHQF2HQB7zD6lWjZ9rVqUKBXUT6hrkZOle0RFYII0V5ZYGl1JAP0Ud1fZZMvSomBzJ710j4Me8mjQDwEre5Uv2wQfk1ifDwb5ksuJQQ3xt423lbuQjvoIQByQrNDh1JxGFkOdlJvu%2FgFtuW0wR4cgd%2BZKesSV7QkNE2kw6AV4hoIuC02LGmTomyf8PiO6CZzOTLTPQ%2BHW06H%2Btx%2BbQ8LmDYg1pTFrp2oJXgkZTyeRJZM0C8aE2LpFrNVDuhARsN543%2FFV6klQ6Tv1OoZGXLv0igKrl%2FCmJxRmX7JJbJ998VSIPQRyDBICzl4JJlYHbdql30NvYcOuZ7a10uWRrgoieOdgIm4rlq6vNOQBuqESLbXG5lzdJGHw2m0sDYmODXbYGTfSTGRKpssTO95fothJCjUGQgEL4yKoGAF%2F0SrpUDNn8CBgBcSDQByAeNkCXp4S4Ro2Xh4OeaGRgR66PVOsU8bc6TR5%2FxTcn4IVMLOkXSWiXxkZQCbvKfmoAvQaKjO3EDKwkwqHChCDEM5loQRPd5ACBki1TjF772oaQhQbQ5C0lcWXPFOzrfsDGUXGrpxasbG4iab6eByaQkQfm0VFlP0ZsDkvvqCL6QXMUwCjdMx1ZOyKhTJ7a1GWAdOUcJ8RSejxNVyGs31OKMyRyBVoZFjqIkmKlLQ5eHMeEL4MkUf23cQ%2F1SgRCJ1dk4UdBT7OoyuNgLs0oCd8RnrEIb6QdMxT2QjD4zMrJkfgx5aDMcA4orsTtKCqWb%2FVeyceqa5OGSmB28YwH4rFbkQaLoUN8OQQYnD3w2eXpI4ScQfbCUZiJ4yMOIKLyyTc7BQ4uXUw6Ee6%2FxM%2B4Y67ngNBknxIPwuppgIhFcwJyr6EIj%2BLzNj%2FmfR2vhhRlx0BILZoAYruF0caWQ7YxO66UmeguDREAFHYuC7HJviRgVO6ruJH59h%2FC%2FPkgSle8xNzZJULLWq9JMDTE2fjGE146a1Us6PZDGYle6ldWRqn%2FpdpgHKNGrGIdkRK%2BKPETT9nKT6kLyDI8xd9A1FgWmXWRAIHwZ37WyZHOVyCadJEmMVz0MadMjDrPho%2BEIochkVC2xgGiwwsQ6DMv2P7UXqT4x7CdcYGId2BJQQa85EQKmCmwcRejQ9Bm4oATENFPkxPXILHpMPUyWTI5rjNOsIlmEeMbcOCEqInpXACYQ9DDxmFo9vcmsDblcMtg4tqBerNngkIKaFJmrQAPnq1dEzsMXcwjcHdfdCibcAxxA%2Bq%2Fj9m3LM%2FO7WJka4tSidVCjsvo2lQ%2F2ewyoYyXwAYyr2PlRoR5MpgVmSUIrM3PQxXPbgjBOaDQFIyFMJvx3Pc5RSYj12ySVF9fwFPQu2e2KWVoL9q3Ayv3IzpGHUdvdPdrNUdicjsTQ2ISy7QU3DrEytIjvbzJnAkmANXjAFERA0MUoPF3%2F5KFmW14bBNOhwircYgMqoDpUMcDtCmBE82QM2YtdjVLB4kBuKho%2FbcwQdeboqfQartuU3CsCf%2BcXkgYAqp%2F0Ee3RorAZt0AvvOCSI4JICIlGlsV0bsSid%2FNIEALAAzb6HAgyWHBps6xAOwkJIGcB82CxRQq4sJf3FzA70A%2BTRqcqjEMETCoez3mkPcpnoALs0ugJY8kQwrC%2BJE5ik3w9rzrvDRjAQnqgEVvdGrNwlanR0SOKWzxOJOvLJhcd8Cl4AshACUkv9czdMkJCVQSQhp6kp7StAlpVRpK0t0SW6LHeBJnE2QchB5Ccu8kxRghZXGIgZIiSj7gEKMJDClcnX6hgoqJMwiQDigIXg3ioFLCgDgjPtYHYpsF5EiA4kcnN18MZtOrY866dEQAb0FB34OGKHGZQjwW%2FWDHA60cYFaI%2FPjpzquUqdaYGcIq%2BmLez3WLFFCtNBN2QJcrlcoELgiPku5R5dSlJFaCEqEZle1AQzAKC%2B1SotMcBNyQUFuRHRF6OlimSBgjZeTBCwLyc6A%2BP%2FoFRchXTz5ADknYJHxzrJ5pGuIKRQISU6WyKTBBjD8WozmVYWIsto1AS5rxzKlvJu4E%2FvwOiKxRtCWsDM%2BeTHUrmwrCK5BIfMzGkD%2B0Fk5LzBs0jMYXktNDblB06LMNJ09U8pzSLmo14MS0OMjcdrZ31pyQqxJJpRImlSvfYAK8inkYU52QY2FPEVsjoWewpwhRp5yAuNpkqhdb7ku9Seefl2D0B8SMTFD90xi4CSOwwZy9IKkpMtI3FmFUg3%2FkFutpQGNc3pCR7gvC4sgwbupDu3DyEN%2BW6YGLNM21jpB49irxy9BSlHrVDlnihGKHwPrbVFtc%2Bh1rVQKZduxIyojccZIIcOCmhEnC7UkY68WXKQgLi2JCDQkQWJRQuk60hZp0D3rtCTINSeY9Ej2kIKYfGxwOs4j9qMM7fYZiipzgcf7TamnehqdhsiMiCawXnz4xAbyCkLAx5EGbo3Ax1u3dUIKnTxIaxwQTHehPl3V491H0%2BbC5zgpGz7Io%2BmjdhKlPJ01EeMpM7UsRJMi1nGjmJg35i6bQBAAxjO%2FENJubU2mg3ONySEoWklCwdABETcs7ck3jgiuU9pcKKpbgn%2B3YlzV1FzIkB6pmEDOSSyDfPPlQskznctFji0kpgZjW5RZe6x9kYT4KJcXg0bNiCyif%2BpZACCyRMmYsfiKmN9tSO65F0R2OO6ytlEhY5Sj6uRKfFxw0ijJaAx%2Fk3QgnAFSq27%2F2i4GEBA%2BUvTJKK%2F9eISNvG46Em5RZfjTYLdeD8kdXHyrwId%2FDQZUaMCY4gGbke2C8vfjgV%2FY9kkRQOJIn%2FxM9INZSpiBnqX0Q9GlQPpPKAyO5y%2BW5NMPSRdBCUlmuxl40ZfMCnf2Cp044uI9WLFtCi4YVxKjuRCOBWIb4XbIsGdbo4qtMQnNOQz4XDSui7W%2FN6l54qOynCqD3DpWQ%2BmpD7C40D8BZEWGJX3tlAaZBMj1yjvDYKwCJBa201u6nBKE5UE%2B7QSEhCwrXfbRZylAaAkplhBWX50dumrElePyNMRYUrC99UmcSSNgImhFhDI4BXjMtiqkgizUGCrZ8iwFxU6fQ8GEHCFdLewwxYWxgScAYMdMLmcZR6b7rZl95eQVDGVoUKcRMM1ixXQtXNkBETZkVVPg8LoSrdetHzkuM7DjZRHP02tCxA1fmkXKF3VzfN1pc1cv%2F8lbTIkkYpqKM9VOhp65ktYk%2BQ46myFWBapDfyWUCnsnI00QTBQmuFjMZTcd0V2NQ768Fhpby04k2IzNR1wKabuGJqYWwSly6ocMFGTeeI%2BejsWDYgEvr66QgqdcIbFYDNgsm0x9UHY6SCd5%2B7tpsLpKdvhahIDyYmEJQCqMqtCF6UlrE5GXRmbu%2Bvtm3BFSxI6ND6UxIE7GsGMgWqghXxSnaRJuGFveTcK5ZVSPJyjUxe1dKgI6kNF7EZhIZs8y8FVqwEfbM0Xk2ltORVDKZZM40SD3qQoQe0orJEKwPfZwm3YPqwixhUMOndis6MhbmfvLBKjC8sKKIZKbJk8L11oNkCQzCgvjhyyEiQSuJcgCQSG4Mocfgc0Hkwcjal1UNgP0CBPikYqBIk9tONv4kLtBswH07vUCjEaHiFGlLf8MgXKzSgjp2HolRRccAOh0ILHz9qlGgIFkwAnzHJRjWFhlA7ROwINyB5HFj59PRZHFor6voq7l23EPNRwdWhgawqbivLSjRA4htEYUFkjESu67icTg5S0aW1sOkCiIysfJ9UnIWevOOLGpepcBxy1wEhd2WI3AZg7sr9WBmHWyasxMcvY%2FiOmsLtHSWNUWEGk9hScMPShasUA1AcHOtRZlqMeQ0OzYS9vQvYUjOLrzP07BUAFikcJNMi7gIxEw4pL1G54TcmmmoAQ5s7TGWErJZ2Io4yQ0ljRYhL8H5e62oDtLF8aDpnIvZ5R3GWJyAugdiiJW9hQAVTsnCBHhwu7rkBlBX6r3b7ejEY0k5GGeyKv66v%2B6dg7mcJTrWHbtMywbedYqCQ0FPwoytmSWsL8WTtChZCKKzEF7vP6De4x2BJkkniMgSdWhbeBSLtJZR9CTHetK1xb34AYIJ37OegYIoPVbXgJ%2FqDQK%2BbfCtxQRVKQu77WzOoM6SGL7MaZwCGJVk46aImai9fmam%2BWpHG%2B0BtQPWUgZ7RIAlPq6lkECUhZQ2gqWkMYKcYMYaIc4gYCDFHYa2d1nzp3%2BJ1eCBay8IYZ0wQRKGAqvCuZ%2FUgbQPyllosq%2BXtfKIZOzmeJqRazpmmoP%2F76YfkjzV2NlXTDSBYB04SVlNQsFTbGPk1t%2FI4Jktu0XSgifO2ozFOiwd%2F0SssJDn0dn4xqk4GDTTKX73%2FwQyBLdqgJ%2BWx6AQaba3BA9CKEzjtQYIfAsiYamapq80LAamYjinlKXUkxdpIDk0puXUEYzSalfRibAeDAKpNiqQ0FTwoxuGYzRnisyTotdVTclis1LHRQCy%2FqqL8oUaQzWRxilq5Mi0IJGtMY02cGLD69vGjkj3p6pGePKI8bkBv5evq8SjjyU04vJR2cQXQwSJyoinDsUJHCQ50jrFTT7yRdbdYQMB3MYCb6uBzJ9ewhXYPAIZSXfeEQBZZ3GPN3Nbhh%2FwkvAJLXnQMdi5NYYZ5GHE400GS5rXkOZSQsdZgIbzRnF9ueLnsfQ47wHAsirITnTlkCcuWWIUhJSbpM3wWhXNHvt2xUsKKMpdBSbJnBMcihkoDqAd1Zml%2FR4yrzow1Q2A5G%2Bkzo%2FRhRxQS2lCSDRV8LlYLBOOoo1bF4jwJAwKMK1tWLHlu9i0j4Ig8qVm6wE1DxXwAwQwsaBWUg2pOOol2dHxyt6npwJEdLDDVYyRc2D0HbcbLUJQj8gPevQBUBOUHXPrsAPBERICpnYESeu2OHotpXQxRGlCCtLdIsu23MhZVEoJg8Qumj%2FUMMc34IBqTKLDTp76WzL%2FdMjCxK7MjhiGjeYAC%2Fkj%2FjY%2FRde7hpSM1xChrog6yZ7OWTuD56xBJnGFE%2BpT2ElSyCnJcwVzCjkqeNLfMEJqKW0G7OFIp0G%2B9mh50I9o8k1tpCY0xYqFNIALgIfc2me4n1bmJnRZ89oepgLPT0NTMLNZsvSCZAc3TXaNB07vail36%2FdBySis4m9%2FDR8izaLJW6bWCkVgm5T%2Bius3ZXq4xI%2BGnbveLbdRwF2mNtsrE0JjYc1AXknCOrLSu7Te%2Fr4dPYMCl5qtiHNTn%2BTPbh1jCBHH%2BdMJNhwNgs3nT%2BOhQoQ0vYif56BMG6WowAcHR3DjQolxLzyVekHj00PBAaW7IIAF1EF%2BuRIWyXjQMAs2chdpaKPNaB%2BkSezYt0%2BCA04sOg5vx8Fr7Ofa9sUv87h7SLAUFSzbetCCZ9pmyLt6l6%2FTzoA1%2FZBG9bIUVHLAbi%2FkdBFgYGyGwRQGBpkqCEg2ah9UD6EedEcEL3j4y0BQQCiExEnocA3SZboh%2Bepgd3YsOkHskZwPuQ5OoyA0fTA5AXrHcUOQF%2BzkJHIA7PwCDk1gGVmGUZSSoPhNf%2BTklauz98QofOlCIQ%2FtCD4dosHYPqtPCXB3agggQQIqQJsSkB%2Bqn0rkQ1toJjON%2FOtCIB9RYv3PqRA4C4U68ZMlZn6BdgEvi2ziU%2BTQ6NIw3ej%2BAtDwMGEZk7e2IjxUWKdAxyaw9OCwSmeADTPPleyk6UhGDNXQb%2B%2BW6Uk4q6F7%2Frg6WVTo82IoCxSIsFDrav4EPHphD3u4hR53WKVvYZUwNCCeM4PMBWzK%2BEfIthZOkuAwPo5C5jgoZgn6dUdvx5rIDmd58cXXdKNfw3l%2BwM2UjgrDJeQHhbD7HW2QDoZMCujgIUkk5Fg8VCsdyjOtnGRx8wgKRPZN5dR0zPUyfGZFVihbFRniXZFOZGKPnEQzU3AnD1KfR6weHW2XS6KbPJxUkOTZsAB9vTVp3Le1F8q5l%2BDMcLiIq78jxAImD2pGFw0VHfRatScGlK6SMu8leTmhUSMy8Uhdd6xBiH3Gdman4tjQGLboJfqz6fL2WKHTmrfsKZRYX6BTDjDldKMosaSTLdQS7oDisJNqAUhw1PfTlnacCO8vl8706Km1FROgLDmudzxg%2BEWTiArtHgLsRrAXYWdB0NmToNCJdKm0KWycZQqb%2BMw76Qy29iQ5up%2FX7oyw8QZ75kP5F6iJAJz6KCmqxz8fEa%2FxnsMYcIO%2FvEkGRuMckhr4rIeLrKaXnmIzlNLxbFspOphkcnJdnz%2FChp%2FVlpj2P7jJQmQRwGnltkTV5dbF9fE3%2FfxoSqTROgq9wFUlbuYzYcasE0ouzBo%2BdDCDzxKAfhbAZYxQiHrLzV2iVexnDX%2FQnT1fsT%2Fxuhu1ui5qIytgbGmRoQkeQooO8eJNNZsf0iALur8QxZFH0nCMnjerYQqG1pIfjyVZWxhVRznmmfLG00BcBWJE6hzQWRyFknuJnXuk8A5FRDCulwrWASSNoBtR%2BCtGdkPwYN2o7DOw%2FVGlCZPusRBFXODQdUM5zeHDIVuAJBLqbO%2Ff9Qua%2BpDqEPk230Sob9lEZ8BHiCorjVghuI0lI4JDgHGRDD%2FprQ84B1pVGkIpVUAHCG%2Biz3Bn3qm2AVrYcYWhock4jso5%2BJ7HfHVj4WMIQdGctq3psBCVVzupQOEioBGA2Bk%2BUILT7%2BVoX5mdxxA5fS42gISQVi%2FHTzrgMxu0fY6hE1ocUwwbsbWcezrY2n6S8%2F6cxXkOH4prpmPuFoikTzY7T85C4T2XYlbxLglSv2uLCgFv8Quk%2FwdesUdWPeHYIH0R729JIisN9Apdd4eB10aqwXrPt%2BSu9mA8k8n1sjMwnfsfF2j3jMUzXepSHmZ%2FBfqXvzgUNQQWOXO8YEuFBh4QTYCkOAPxywpYu1VxiDyJmKVcmJPGWk%2Fgc3Pov02StyYDahwmzw3E1gYC9wkupyWfDqDSUMpCTH5e5N8B%2F%2FlHiMuIkTNw4USHrJU67bjXGqNav6PBuQSoqTxc8avHoGmvqNtXzIaoyMIQIiiUHIM64cXieouplhNYln7qgc4wBVAYR104kO%2BCvKqsg4yIUlFNThVUAKZxZt1XA34h3TCUUiXVkZ0w8Hh2R0Z5L0b4LZvPd%2Fp1gi%2F07h8qfwHrByuSxglc9cI4QIg2oqvC%2Fqm0i7tjPLTgDhoWTAKDO2ONW5oe%2B%2FeKB9vZB8K6C25yCZ9RFVMnb6NRdRjyVK57CHHSkJBfnM2%2Fj4ODUwRkqrtBBCrDsDpt8jhZdXoy%2F1BCqw3sSGhgGGy0a5Jw6BP%2FTExoCmNFYjZl248A0osgPyGEmRA%2BfAsqPVaNAfytu0vuQJ7rk3J4kTDTR2AlCHJ5cls26opZM4w3jMULh2YXKpcqGBtuleAlOZnaZGbD6DHzMd6i2oFeJ8z9XYmalg1Szd%2FocZDc1C7Y6vcALJz2lYnTXiWEr2wawtoR4g3jvWUU2Ngjd1cewtFzEvM1NiHZPeLlIXFbBPawxNgMwwAlyNSuGF3zizVeOoC9bag1qRAQKQE%2FEZBWC2J8mnXAN2aTBboZ7HewnObE8CwROudZHmUM5oZ%2FUgd%2FJZQK8lvAm43uDRAbyW8gZ%2BZGq0EVerVGUKUSm%2FIdn8AQHdR4m7bue88WBwft9mSCeMOt1ncBwziOmJYI2ZR7ewNMPiCugmSsE4EyQ%2BQATJG6qORMGd4snEzc6B4shPIo4G1T7PgSm8PY5eUkPdF8JZ0VBtadbHXoJgnEhZQaODPj2gpODKJY5Yp4DOsLBFxWbvXN755KWylJm%2BoOd4zEL9Hpubuy2gyyfxh8oEfFutnYWdfB8PdESLWYvSqbElP9qo3u6KTmkhoacDauMNNjj0oy40DFV7Ql0aZj77xfGl7TJNHnIwgqOkenruYYNo6h724%2BzUQ7%2BvkCpZB%2BpGA562hYQiDxHVWOq0oDQl%2FQsoiY%2BcuI7iWq%2FZIBtHcXJ7kks%2Bh2fCNUPA82BzjnqktNts%2BRLdk1VSu%2BtqEn7QZCCsvEqk6FkfiOYkrsw092J8jsfIuEKypNjLxrKA9kiA19mxBD2suxQKCzwXGws7kEJvlhUiV9tArLIdZW0IORcxEzdzKmjtFhsjKy%2F44XYXdI5noQoRcvjZ1RMPACRqYg2V1%2BOwOepcOknRLLFdYgTkT5UApt%2FJhLM3jeFYprZV%2BZow2g8fP%2BU68hkKFWJj2yBbKqsrp25xkZX1DAjUw52IMYWaOhab8Kp05VrdNftqwRrymWF4OQSjbdfzmRZirK8FMJELEgER2PHjEAN9pGfLhCUiTJFbd5LBkOBMaxLr%2FA1SY9dXFz4RjzoU9ExfJCmx%2FI9FKEGT3n2cmzl2X42L3Jh%2BAbQq6sA%2BSs1kitoa4TAYgKHaoybHUDJ51oETdeI%2F9ThSmjWGkyLi5QAGWhL0BG1UsTyRGRJOldKBrYJeB8ljLJHfATWTEQBXBDnQexOHTB%2BUn44zExFE4vLytcu5NwpWrUxO%2F0ZICUGM7hGABXym0V6ZvDST0E370St9MIWQOTWngeoQHUTdCJUP04spMBMS8LSker9cReVQkULFDIZDFPrhTzBl6sed9wcZQTbL%2BBDqMyaN3RJPh%2Fanbx%2BIv%2BqgQdAa3M9Z5JmvYlh4qop%2BHo1F1W5gbOE9YKLgAnWytXElU4G8GtW47lhgFE6gaSs%2Bgs37sFvi0PPVvA5dnCBgILTwoKd%2F%2BDoL9F6inlM7H4rOTzD79KJgKlZO%2FZgt22UsKhrAaXU5ZcLrAglTVKJEmNJvORGN1vqrcfSMizfpsgbIe9zno%2BgBoKVXgIL%2FVI8dB1O5o%2FR3Suez%2FgD7M781ShjKpIIORM%2FnxG%2BjjhhgPwsn2IoXsPGPqYHXA63zJ07M2GPEykQwJBYLK808qYxuIew4frk52nhCsnCYmXiR6CuapvE1IwRB4%2FQftDbEn%2BAucIr1oxrLabRj9q4ae0%2BfXkHnteAJwXRbVkR0mctVSwEbqhJiMSZUp9DNbEDMmjX22m3ABpkrPQQTP3S1sib5pD2VRKRd%2BeNAjLYyT0hGrdjWJZy24OYXRoWQAIhGBZRxuBFMjjZQhpgrWo8SiFYbojcHO8V5DyscJpLTHyx9Fimassyo5U6WNtquUMYgccaHY5amgR3PQzq3ToNM5ABnoB9kuxsebqmYZm0R9qxJbFXCQ1UPyFIbxoUraTJFDpCk0Wk9GaYJKz%2F6oHwEP0Q14lMtlddQsOAU9zlYdMVHiT7RQP3XCmWYDcHCGbVRHGnHuwzScA0BaSBOGkz3lM8CArjrBsyEoV6Ys4qgDK3ykQQPZ3hCRGNXQTNNXbEb6tDiTDLKOyMzRhCFT%2BmAUmiYbV3YQVqFVp9dorv%2BTsLeCykS2b5yyu8AV7IS9cxcL8z4Kfwp%2BxJyYLv1OsxQCZwTB4a8BZ%2F5EdxTBJthApqyfd9u3ifr%2FWILTqq5VqgwMT9SOxbSGWLQJUUWCVi4k9tho9nEsbUh7U6NUsLmkYFXOhZ0kmamaJLRNJzSj%2Fqn4Mso6zb6iLLBXoaZ6AqeWCjHQm2lztnejYYM2eubnpBdKVLORZhudH3JF1waBJKA9%2BW8EhMj3Kzf0L4vi4k6RoHh3Z5YgmSZmk6ns4fjScjAoL8GoOECgqgYEBYUGFVO4FUv4%2FYtowhEmTs0vrvlD%2FCrisnoBNDAcUi%2FteY7OctFlmARQzjOItrrlKuPO6E2Ox93L4O%2F4DcgV%2FdZ7qR3VBwVQxP1GCieA4RIpweYJ5FoYrHxqRBdJjnqbsikA2Ictbb8vE1GYIo9dacK0REgDX4smy6GAkxlH1yCGGsk%2BtgiDhNKuKu3yNrMdxafmKTF632F8Vx4BNK57GvlFisrkjN9WDAtjsWA0ENT2e2nETUb%2Fn7qwhvGnrHuf5bX6Vh%2Fn3xffU3PeHdR%2BFA92i6ufT3AlyAREoNDh6chiMWTvjKjHDeRhOa9YkOQRq1vQXEMppAQVwHCuIcV2g5rBn6GmZZpTR7vnSD6ZmhdSl176gqKTXu5E%2BYbfL0adwNtHP7dT7t7b46DVZIkzaRJOM%2BS6KcrzYVg%2BT3wSRFRQashjfU18NutrKa%2F7PXbtuJvpIjbgPeqd%2BpjmRw6YKpnANFSQcpzTZgpSNJ6J7uiagAbir%2F8tNXJ%2FOsOnRh6iuIexxrmkIneAgz8QoLmiaJ8sLQrELVK2yn3wOHp57BAZJhDZjTBzyoRAuuZ4eoxHruY1pSb7qq79cIeAdOwin4GdgMeIMHeG%2BFZWYaiUQQyC5b50zKjYw97dFjAeY2I4Bnl105Iku1y0lMA1ZHolLx19uZnRdILcXKlZGQx%2FGdEqSsMRU1BIrFqRcV1qQOOHyxOLXEGcbRtAEsuAC2V4K3p5mFJ22IDWaEkk9ttf5Izb2LkD1MnrSwztXmmD%2FQi%2FEmVEFBfiKGmftsPwVaIoZanlKndMZsIBOskFYpDOq3QUs9aSbAAtL5Dbokus2G4%2FasthNMK5UQKCOhU97oaOYNGsTah%2BjfCKsZnTRn5TbhFX8ghg8CBYt%2FBjeYYYUrtUZ5jVij%2Fop7V5SsbA4mYTOwZ46hqdpbB6Qvq3AS2HHNkC15pTDIcDNGsMPXaBidXYPHc6PJAkRh29Vx8KcgX46LoUQBhRM%2B3SW6Opll%2FwgxxsPgKJKzr5QCmwkUxNbeg6Wj34SUnEzOemSuvS2OetRCO8Tyy%2BQbSKVJcqkia%2BGvDefFwMOmgnD7h81TUtMn%2BmRpyJJ349HhAnoWFTejhpYTL9G8N2nVg1qkXBeoS9Nw2fB27t7trm7d%2FQK7Cr4uoCeOQ7%2F8JfKT77KiDzLImESHw%2F0wf73QeHu74hxv7uihi4fTX%2BXEwAyQG3264dwv17aJ5N335Vt9sdrAXhPOAv8JFvzqyYXwfx8WYJaef1gMl98JRFyl5Mv5Uo%2FoVH5ww5OzLFsiTPDns7fS6EURSSWd%2F92BxMYQ8sBaH%2Bj%2BwthQPdVgDGpTfi%2BJQIWMD8xKqULliRH01rTeyF8x8q%2FGBEEEBrAJMPf25UQwi0b8tmqRXY7kIvNkzrkvRWLnxoGYEJsz8u4oOyMp8cHyaybb1HdMCaLApUE%2B%2F7xLIZGP6H9xuSEXp1zLIdjk5nBaMuV%2FyTDRRP8Y2ww5RO6d2D94o%2B6ucWIqUAvgHIHXhZsmDhjVLczmZ3ca0Cb3PpKwt2UtHVQ0BgFJsqqTsnzZPlKahRUkEu4qmkJt%2Bkqdae76ViWe3STan69yaF9%2BfESD2lcQshLHWVu4ovItXxO69bqC5p1nZLvI8NdQB9s9UNaJGlQ5mG947ipdDA0eTIw%2FA1zEdjWquIsQXXGIVEH0thC5M%2BW9pZe7IhAVnPJkYCCXN5a32HjN6nsvokEqRS44tGIs7s2LVTvcrHAF%2BRVmI8L4HUYk4x%2B67AxSMJKqCg8zrGOgvK9kNMdDrNiUtSWuHFpC8%2Fp5qIQrEo%2FH%2B1l%2F0cAwQ2nKmpWxKcMIuHY44Y6DlkpO48tRuUGBWT0FyHwSKO72Ud%2BtJUfdaZ4CWNijzZtlRa8%2BCkmO%2FEwHYfPZFU%2FhzjFWH7vnzHRMo%2BaF9u8qHSAiEkA2HjoNQPEwHsDKOt6hOoK3Ce%2F%2B%2F9boMWDa44I6FrQhdgS7OnNaSzwxWKZMcyHi6LN4WC6sSj0qm2PSOGBTvDs%2FGWJS6SwEN%2FULwpb4LQo9fYjUfSXRwZkynUazlSpvX9e%2BG2zor8l%2BYaMxSEomDdLHGcD6YVQPegTaA74H8%2BV4WvJkFUrjMLGLlvSZQWvi8%2FQA7yzQ8GPno%2F%2F5SJHRP%2FOqKObPCo81s%2F%2B6WgLqykYpGAgQZhVDEBPXWgU%2FWzFZjKUhSFInufPRiMAUULC6T11yL45ZrRoB4DzOyJShKXaAJIBS9wzLYIoCEcJKQW8GVCx4fihqJ6mshBUXSw3wWVj3grrHQlGNGhIDNNzsxQ3M%2BGWn6ASobIWC%2BLbYOC6UpahVO13Zs2zOzZC8z7FmA05JhUGyBsF4tsG0drcggIFzgg%2Fkpf3%2BCnAXKiMgIE8Jk%2FMhpkc8DUJEUzDSnWlQFme3d0sHZDrg7LavtsEX3cHwjCYA17pMTfx8Ajw9hHscN67hyo%2BRJQ4458RmPywXykkVcW688oVUrQhahpPRvTWPnuI0B%2BSkQu7dCyvLRyFYlC1LG1gRCIvn3rwQeINzZQC2KXq31FaR9UmVV2QeGVqBHjmE%2BVMd3b1fhCynD0pQNhCG6%2FWCDbKPyE7NRQzL3BzQAJ0g09aUzcQA6mUp9iZFK6Sbp%2FYbHjo%2B%2B7%2FWj8S4YNa%2BZdqAw1hDrKWFXv9%2BzaXpf8ZTDSbiqsxnwN%2FCzK5tPkOr4tRh2kY3Bn9JtalbIOI4b3F7F1vPQMfoDcdxMS8CW9m%2FNCW%2FHILTUVWQIPiD0j1A6bo8vsv6P1hCESl2abrSJWDrq5sSzUpwoxaCU9FtJyYH4QFMxDBpkkBR6kn0LMPO%2B5EJ7Z6bCiRoPedRZ%2FP0SSdii7ZnPAtVwwHUidcdyspwncz5uq6vvm4IEDbJVLUFCn%2FLvIHfooUBTkFO130FC7CmmcrKdgDJcid9mvVzsDSibOoXtIf9k6ABle3PmIxejodc4aob0QKS432srrCMndbfD454q52V01G4q913mC5HOsTzWF4h2No1av1VbcUgWAqyoZl%2B11PoFYnNv2HwAODeNRkHj%2B8SF1fcvVBu6MrehHAZK1Gm69ICcTKizykHgGFx7QdowTVAsYEF2tVc0Z6wLryz2FI1sc5By2znJAAmINndoJiB4sfPdPrTC8RnkW7KRCwxC6YvXg5ahMlQuMpoCSXjOlBy0Kij%2BbsCYPbGp8BdCBiLmLSAkEQRaieWo1SYvZIKJGj9Ur%2FeWHjiB7SOVdqMAVmpBvfRiebsFjger7DC%2B8kRFGtNrTrnnGD2GAJb8rQCWkUPYHhwXsjNBSkE6lGWUj5QNhK0DMNM2l%2BkXRZ0KLZaGsFSIdQz%2FHXDxf3%2FTE30%2BDgBKWGWdxElyLccJfEpjsnszECNoDGZpdwdRgCixeg9L4EPhH%2BRptvRMVRaahu4cySjS3P5wxAUCPkmn%2BrhyASpmiTaiDeggaIxYBmtLZDDhiWIJaBgzfCsAGUF1Q1SFZYyXDt9skCaxJsxK2Ms65dmdp5WAZyxik%2FzbrTQk5KmgxCg%2Ff45L0jywebOWUYFJQAJia7XzCV0x89rpp%2Ff3AVWhSPyTanqmik2SkD8A3Ml4NhIGLAjBXtPShwKYfi2eXtrDuKLk4QlSyTw1ftXgwqA2jUuopDl%2B5tfUWZNwBpEPXghzbBggYCw%2Fdhy0ntds2yeHCDKkF%2FYxQjNIL%2FF%2F37jLPHCKBO9ibwYCmuxImIo0ijV2Wbg3kSN2psoe8IsABv3RNFaF9uMyCtCYtqcD%2BqNOhwMlfARQUdJ2tUX%2BMNJqOwIciWalZsmEjt07tfa8ma4cji9sqz%2BQ9hWfmMoKEbIHPOQORbhQRHIsrTYlnVTNvcq1imqmmPDdVDkJgRcTgB8Sb6epCQVmFZe%2BjGDiNJQLWnfx%2BdrTKYjm0G8yH0ZAGMWzEJhUEQ4Maimgf%2Fbkvo8PLVBsZl152y5S8%2BHRDfZIMCbYZ1WDp4yrdchOJw8k6R%2B%2F2pHmydK4NIK2PHdFPHtoLmHxRDwLFb7eB%2BM4zNZcB9NrAgjVyzLM7xyYSY13ykWfIEEd2n5%2FiYp3ZdrCf7fL%2Ben%2BsIJu2W7E30MrAgZBD1rAAbZHPgeAMtKCg3NpSpYQUDWJu9bT3V7tOKv%2BNRiJc8JAKqqgCA%2FPNRBR7ChpiEulyQApMK1AyqcWnpSOmYh6yLiWkGJ2mklCSPIqN7UypWj3dGi5MvsHQ87MrB4VFgypJaFriaHivwcHIpmyi5LhNqtem4q0n8awM19Qk8BOS0EsqGscuuydYsIGsbT5GHnERUiMpKJl4ON7qjB4fEqlGN%2FhCky89232UQCiaeWpDYCJINXjT6xl4Gc7DxRCtgV0i1ma4RgWLsNtnEBRQFqZggCLiuyEydmFd7WlogpkCw5G1x4ft2psm3KAREwVwr1Gzl6RT7FDAqpVal34ewVm3VH4qn5mjGj%2BbYL1NgfLNeXDwtmYSpwzbruDKpTjOdgiIHDVQSb5%2FzBgSMbHLkxWWgghIh9QTFSDILixVwg0Eg1puooBiHAt7DzwJ7m8i8%2Fi%2BjHvKf0QDnnHVkVTIqMvIQImOrzCJwhSR7qYB5gSwL6aWL9hERHCZc4G2%2BJrpgHNB8eCCmcIWIQ6rSdyPCyftXkDlErUkHafHRlkOIjxGbAktz75bnh50dU7YHk%2BMz7wwstg6RFZb%2BTZuSOx1qqP5C66c0mptQmzIC2dlpte7vZrauAMm%2F7RfBYkGtXWGiaWTtwvAQiq2oD4YixPLXE2khB2FRaNRDTk%2B9sZ6K74Ia9VntCpN4BhJGJMT4Z5c5FhSepRCRWmBXqx%2BwhVZC4me4saDs2iNqXMuCl6iAZflH8fscC1sTsy4PHeC%2BXYuqMBMUun5YezKbRKmEPwuK%2BCLzijPEQgfhahQswBBLfg%2FGBgBiI4QwAqzJkkyYAWtjzSg2ILgMAgqxYfwERRo3zruBL9WOryUArSD8sQOcD7fvIODJxKFS615KFPsb68USBEPPj1orNzFY2xoTtNBVTyzBhPbhFH0PI5AtlJBl2aSgNPYzxYLw7XTDBDinmVoENwiGzmngrMo8OmnRP0Z0i0Zrln9DDFcnmOoBZjABaQIbPOJYZGqX%2BRCMlDDbElcjaROLDoualmUIQ88Kekk3iM4OQrADcxi3rJguS4MOIBIgKgXrjd1WkbCdqxJk%2F4efRIFsavZA7KvvJQqp3Iid5Z0NFc5aiMRzGN3vrpBzaMy4JYde3wr96PjN90AYOIbyp6T4zj8LoE66OGcX1Ef4Z3KoWLAUF4BTg7ug%2FAbkG5UNQXAMkQezujSHeir2uTThgd3gpyzDrbnEdDRH2W7U6PeRvBX1ZFMP5RM%2BZu6UUZZD8hDPHldVWntTCNk7To8IeOW9yn2wx0gmurwqC60AOde4r3ETi5pVMSDK8wxhoGAoEX9NLWHIR33VbrbMveii2jAJlrxwytTHbWNu8Y4N8vCCyZjAX%2FpcsfwXbLze2%2BD%2Bu33OGBoJyAAL3jn3RuEcdp5If8O%2Ba4NKWvxOTyDltG0IWoHhwVGe7dKkCWFT%2B%2Btm%2BhaBCikRUUMrMhYKZJKYoVuv%2FbsJzO8DwfVIInQq3g3BYypiz8baogH3r3GwqCwFtZnz4xMjAVOYnyOi5HWbFA8n0qz1OjSpHWFzpQOpvkNETZBGpxN8ybhtqV%2FDMUxd9uFZmBfKXMCn%2FSqkWJyKPnT6lq%2B4zBZni6fYRByJn6OK%2BOgPBGRAJluwGSk4wxjOOzyce%2FPKODwRlsgrVkdcsEiYrqYdXo0Er2GXi2GQZd0tNJT6c9pK1EEJG1zgDJBoTVuCXGAU8BKTvCO%2FcEQ1Wjk3Zzuy90JX4m3O5IlxVFhYkSUwuQB2up7jhvkm%2BbddRQu5F9s0XftGEJ9JSuSk%2BZachCbdU45fEqbugzTIUokwoAKvpUQF%2FCvLbWW5BNQFqFkJg2f30E%2F48StNe5QwBg8zz3YAJ82FZoXBxXSv4QDooDo79NixyglO9AembuBcx5Re3CwOKTHebOPhkmFC7wNaWtoBhFuV4AkEuJ0J%2B1pT0tLkvFVZaNzfhs%2FKd3%2BA9YsImlO4XK4vpCo%2FelHQi%2F9gkFg07xxnuXLt21unCIpDV%2BbbRxb7FC6nWYTsMFF8%2B1LUg4JFjVt3vqbuhHmDKbgQ4e%2BRGizRiO8ky05LQGMdL2IKLSNar0kNG7lHJMaXr5mLdG3nykgj6vB%2FKVijd1ARWkFEf3yiUw1v%2FWaQivVUpIDdSNrrKbjO5NPnxz6qTTGgYg03HgPhDrCFyYZTi3XQw3HXCva39mpLNFtz8AiEhxAJHpWX13gCTAwgm9YTvMeiqetdNQv6IU0hH0G%2BZManTqDLPjyrOse7WiiwOJCG%2BJ0pZYULhN8NILulmYYvmVcV2MjAfA39sGKqGdjpiPo86fecg65UPyXDIAOyOkCx5NQsLeD4gGVjTVDwOHWkbbBW0GeNjDkcSOn2Nq4cEssP54t9D749A7M1AIOBl0Fi0sSO5v3P7LCBrM6ZwFY6kp2FX6AcbGUdybnfChHPyu6WlRZ2Fwv9YM0RMI7kISRgR8HpQSJJOyTfXj%2F6gQKuihPtiUtlCQVPohUgzfezTg8o1b3n9pNZeco1QucaoXe40Fa5JYhqdTspFmxGtW9h5ezLFZs3j%2FN46f%2BS2rjYNC2JySXrnSAFhvAkz9a5L3pza8eYKHNoPrvBRESpxYPJdKVUxBE39nJ1chrAFpy4MMkf0qKgYALctGg1DQI1kIymyeS2AJNT4X240d3IFQb%2F0jQbaHJ2YRK8A%2Bls6WMhWmpCXYG5jqapGs5%2FeOJErxi2%2F2KWVHiPellTgh%2FfNl%2F2KYPKb7DUcAg%2BmCOPQFCiU9Mq%2FWLcU1xxC8aLePFZZlE%2BPCLzf7ey46INWRw2kcXySR9FDgByXzfxiNKwDFbUSMMhALPFSedyjEVM5442GZ4hTrsAEvZxIieSHGSgkwFh%2FnFNdrrFD4tBH4Il7fW6ur4J8Xaz7RW9jgtuPEXQsYk7gcMs2neu3zJwTyUerHKSh1iTBkj2YJh1SSOZL5pLuQbFFAvyO4k1Hxg2h99MTC6cTUkbONQIAnEfGsGkNFWRbuRyyaEZInM5pij73EA9rPIUfU4XoqQpHT9THZkW%2BoKFLvpyvTBMM69tN1Ydwv1LIEhHsC%2BueVG%2Bw%2BkyCPsvV3erRikcscHjZCkccx6VrBkBRusTDDd8847GA7p2Ucy0y0HdSRN6YIBciYa4vuXcAZbQAuSEmzw%2BH%2FAuOx%2BaH%2BtBL88H57D0MsqyiZxhOEQkF%2F8DR1d2hSPMj%2FsNOa5rxcUnBgH8ictv2J%2Bcb4BA4v3MCShdZ2vtK30vAwkobnEWh7rsSyhmos3WC93Gn9C4nnAd%2FPjMMtQfyDNZsOPd6XcAsnBE%2FmRHtHEyJMzJfZFLE9OvQa0i9kUmToJ0ZxknTgdl%2FXPV8xoh0K7wNHHsnBdvFH3sv52lU7UFteseLG%2FVanIvcwycVA7%2BBE1Ulyb20BvwUWZcMTKhaCcmY3ROpvonVMV4N7yBXTL7IDtHzQ4CCcqF66LjF3xUqgErKzolLyCG6Kb7irP%2FMVTCCwGRxfrPGpMMGvPLgJ881PHMNMIO09T5ig7AzZTX%2F5PLlwnJLDAPfuHynSGhV4tPqR3gJ4kg4c06c%2FF1AcjGytKm2Yb5jwMotF7vro4YDLWlnMIpmPg36NgAZsGA0W1spfLSue4xxat0Gdwd0lqDBOgIaMANykwwDKejt5YaNtJYIkrSgu0KjIg0pznY0SCd1qlC6R19g97UrWDoYJGlrvCE05J%2F5wkjpkre727p5PTRX5FGrSBIfJqhJE%2FIS876PaHFkx9pGTH3oaY3jJRvLX9Iy3Edoar7cFvJqyUlOhAEiOSAyYgVEGkzHdug%2BoRHIEOXAExMiTSKU9A6nmRC8mp8iYhwWdP2U%2F5EkFAdPrZw03YA3gSyNUtMZeh7dDCu8pF5x0VORCTgKp07ehy7NZqKTpIC4UJJ89lnboyAfy5OyXzXtuDRbtAFjZRSyGFTpFrXwkpjSLIQIG3N0Vj4BtzK3wdlkBJrO18MNsgseR4BysJilI0wI6ZahLhBFA0XBmV8d4LUzEcNVb0xbLjLTETYN8OEVqNxkt10W614dd1FlFFVTIgB7%2FBQQp1sWlNolpIu4ekxUTBV7NmxOFKEBmmN%2BnA7pvF78%2FRII5ZHA09OAiE%2F66MF6HQ%2BqVEJCHxwymukkNvzqHEh52dULPbVasfQMgTDyBZzx4007YiKdBuUauQOt27Gmy8ISclPmEUCIcuLbkb1mzQSqIa3iE0PJh7UMYQbkpe%2BhXjTJKdldyt2mVPwywoODGJtBV1lJTgMsuSQBlDMwhEKIfrvsxGQjHPCEfNfMAY2oxvyKcKPUbQySkKG6tj9AQyEW3Q5rpaDJ5Sns9ScLKeizPRbvWYAw4bXkrZdmB7CQopCH8NAmqbuciZChHN8lVGaDbCnmddnqO1PQ4ieMYfcSiBE5zzMz%2BJV%2F4eyzrzTEShvqSGzgWimkNxLvUj86iAwcZuIkqdB0VaIB7wncLRmzHkiUQpPBIXbDDLHBlq7vp9xwuC9AiNkIptAYlG7Biyuk8ILdynuUM1cHWJgeB%2BK3wBP%2FineogxkvBNNQ4AkW0hvpBOQGFfeptF2YTR75MexYDUy7Q%2F9uocGsx41O4IZhViw%2F2FvAEuGO5g2kyXBUijAggWM08bRhXg5ijgMwDJy40QeY%2FcQpUDZiIzmvskQpO5G1zyGZA8WByjIQU4jRoFJt56behxtHUUE%2Fom7Rj2psYXGmq3llVOCgGYKNMo4pzwntITtapDqjvQtqpjaJwjHmDzSVGLxMt12gEXAdLi%2FcaHSM3FPRGRf7dB7YC%2BcD2ho6oL2zGDCkjlf%2FDFoQVl8GS%2F56wur3rdV6ggtzZW60MRB3g%2BU1W8o8cvqIpMkctiGVMzXUFI7FacFLrgtdz4mTEr4aRAaQ2AFQaNeG7GX0yOJgMRYFziXdJf24kg%2FgBQIZMG%2FYcPEllRTVNoDYR6oSJ8wQNLuihfw81UpiKPm714bZX1KYjcXJdfclCUOOpvTxr9AAJevTY4HK%2FG7F3mUc3GOAKqh60zM0v34v%2BELyhJZqhkaMA8UMMOU90f8RKEJFj7EqepBVwsRiLbwMo1J2zrE2UYJnsgIAscDmjPjnzI8a719Wxp757wqmSJBjXowhc46QN4RwKIxqEE6E5218OeK7RfcpGjWG1jD7qND%2B%2FGTk6M56Ig4yMsU6LUW1EWE%2BfIYycVV1thldSlbP6ltdC01y3KUfkobkt2q01YYMmxpKRvh1Z48uNKzP%2FIoRIZ%2FF6buOymSnW8gICitpJjKWBscSb9JJKaWkvEkqinAJ2kowKoqkqZftRqfRQlLtKoqvTRDi2vg%2FRrPD%2Fd3a09J8JhGZlEkOM6znTsoMCsuvTmywxTCDhw5dd0GJOHCMPbsj3QLkTE3MInsZsimDQ3HkvthT7U9VA4s6G07sID0FW4SHJmRGwCl%2BMu4xf0ezqeXD2PtPDnwMPo86sbwDV%2B9PWcgFcARUVYm3hrFQrHcgMElFGbSM2A1zUYA3baWfheJp2AINmTJLuoyYD%2FOwA4a6V0ChBN97E8YtDBerUECv0u0TlxR5yhJCXvJxgyM73Bb6pyq0jTFJDZ4p1Am1SA6sh8nADd1hAcGBMfq4d%2FUfwnmBqe0Jun1n1LzrgKuZMAnxA3NtCN7Klf4BH%2B14B7ibBmgt0TGUafVzI4uKlpF7v8NmgNjg90D6QE3tbx8AjSAC%2BOA1YJvclyPKgT27QpIEgVYpbPYGBsnyCNrGz9XUsCHkW1QAHgL2STZk12QGqmvAB0NFteERkvBIH7INDsNW9KKaAYyDMdBEMzJiWaJHZALqDxQDWRntumSDPcplyFiI1oDpT8wbwe01AHhW6%2BvAUUBoGhY3CT2tgwehdPqU%2F4Q7ZLYvhRl%2FogOvR9O2%2BwkkPKW5vCTjD2fHRYXONCoIl4Jh1bZY0ZE1O94mMGn%2FdFSWBWzQ%2FVYk%2BGezi46RgiDv3EshoTmMSlioUK6MQEN8qeyK6FRninyX8ZPeUWjjbMJChn0n%2FyJvrq5bh5UcCAcBYSafTFg7p0jDgrXo2QWLb3WpSOET%2FHh4oSadBTvyDo10IufLzxiMLAnbZ1vcUmj3w7BQuIXjEZXifwukVxrGa9j%2BDXfpi12m1RbzYLg9J2wFergEwOxFyD0%2FJstNK06ZN2XdZSGWxcJODpQHOq4iKqjqkJUmPu1VczL5xTGUfCgLEYyNBCCbMBFT%2FcUP6pE%2FmujnHsSDeWxMbhrNilS5MyYR0nJyzanWXBeVcEQrRIhQeJA6Xt4f2eQESNeLwmC10WJVHqwx8SSyrtAAjpGjidcj1E2FYN0LObUcFQhafUKTiGmHWRHGsFCB%2BHEXgrzJEB5bp0QiF8ZHh11nFX8AboTD0PS4O1LqF8XBks2MpjsQnwKHF6HgaKCVLJtcr0XjqFMRGfKv8tmmykhLRzu%2BvqQ02%2BKpJBjaLt9ye1Ab%2BBbEBhy4EVdIJDrL2naV0o4wU8YZ2Lq04FG1mWCKC%2BUwkXOoAjneU%2FxHplMQo2cXUlrVNqJYczgYlaOEczVCs%2FOCgkyvLmTmdaBJc1iBLuKwmr6qtRnhowngsDxhzKFAi02tf8bmET8BO27ovJKF1plJwm3b0JpMh38%2BxsrXXg7U74QUM8ZCIMOpXujHntKdaRtsgyEZl5MClMVMMMZkZLNxH9%2Bb8fH6%2Bb8Lev30A9TuEVj9CqAdmwAAHBPbfOBFEATAPZ2CS0OH1Pj%2F0Q7PFUcC8hDrxESWdfgFRm%2B7vvWbkEppHB4T%2F1ApWnlTIqQwjcPl0VgS1yHSmD0OdsCVST8CQVwuiew1Y%2Bg3QGFjNMzwRB2DSsAk26cmA8lp2wIU4p93AUBiUHFGOxOajAqD7Gm6NezNDjYzwLOaSXRBYcWipTSONHjUDXCY4mMI8XoVCR%2FRrs%2FJLKXgEx%2BqkmeDlFOD1%2FyTQNDClRuiUyKYCllfMiQiyFkmuTz2vLsBNyRW%2Bxz%2B5FElFxWB28VjYIGZ0Yd%2B5wIjkcoMaggxswbT0pCmckRAErbRlIlcOGdBo4djTNO8FAgQ%2BlT6vPS60BwTRSUAM3ddkEAZiwtEyArrkiDRnS7LJ%2B2hwbzd2YDQagSgACpsovmjil5wfPuXq3GuH0CyE7FK3M4FgRaFoIkaodORrPx1%2BJpI9psyNYIFuJogZa0%2F1AhOWdlHQxdAgbwacsHqPZo8u%2FngAH2GmaTdhYnBfSDbBfh8CHq6Bx5bttP2%2BRdM%2BMAaYaZ0Y%2FADkbNCZuAyAVQa2OcXOeICmDn9Q%2FeFkDeFQg5MgHEDXq%2FtVjj%2Bjtd26nhaaolWxs1ixSUgOBwrDhRIGOLyOVk2%2FBc0UxvseQCO2pQ2i%2BKrfhu%2FWeBovNb5dJxQtJRUDv2mCwYVpNl2efQM9xQHnK0JwLYt%2FU0Wf%2BphiA4uw8G91slC832pmOTCAoZXohg1fewCZqLBhkOUBofBWpMPsqg7XEXgPfAlDo2U5WXjtFdS87PIqClCK5nW6adCeXPkUiTGx0emOIDQqw1yFYGHEVx20xKjJVYe0O8iLmnQr3FA9nSIQilUKtJ4ZAdcTm7%2BExseJauyqo30hs%2B1qSW211A1SFAOUgDlCGq7eTIcMAeyZkV1SQJ4j%2Fe1Smbq4HcjqgFbLAGLyKxlMDMgZavK5NAYH19Olz3la%2FQCTiVelFnU6O%2FGCvykqS%2FwZJDhKN9gBtSOp%2F1SP5VRgJcoVj%2Bkmf2wBgv4gjrgARBWiURYx8xENV3bEVUAAWWD3dYDKAIWk5opaCFCMR5ZjJExiCAw7gYiSZ2rkyTce4eNMY3lfGn%2B8p6%2BvBckGlKEXnA6Eota69OxDO9oOsJoy28BXOR0UoXNRaJD5ceKdlWMJlOFzDdZNpc05tkMGQtqeNF2lttZqNco1VtwXgRstLSQ6tSPChgqtGV5h2DcDReIQadaNRR6AsAYKL5gSFsCJMgfsaZ7DpKh8mg8Wz8V7H%2BgDnLuMxaWEIUPevIbClgap4dqmVWSrPgVYCzAoZHIa5z2Ocx1D%2FGvDOEqMOKLrMefWIbSWHZ6jbgA8qVBhYNHpx0P%2BjAgN5TB3haSifDcApp6yymEi6Ij%2FGsEpDYUgcHATJUYDUAmC1SCkJ4cuZXSAP2DEpQsGUjQmKJfJOvlC2x%2FpChkOyLW7KEoMYc5FDC4v2FGqSoRWiLsbPCiyg1U5yiHZVm1XLkHMMZL11%2Fyxyw0UnGig3MFdZklN5FI%2FqiT65T%2BjOXOdO7XbgWurOAZR6Cv9uu1cm5LjkXX4xi6mWn5r5NjBS0gTliHhMZI2WNqSiSphEtiCAwnafS11JhseDGHYQ5%2BbqWiAYiAv6Jsf79%2FVUs4cIl%2Bn6%2BWOjcgB%2F2l5TreoAV2717JzZbQIR0W1cl%2FdEqCy5kJ3ZSIHuU0vBoHooEpiHeQWVkkkOqRX27eD1FWw4BfO9CJDdKoSogQi3hAAwsPRFrN5RbX7bqLdBJ9JYMohWrgJKHSjVl1sy2xAG0E3sNyO0oCbSGOxCNBRRXTXenYKuwAoDLfnDcQaCwehUOIDiHAu5m5hMpKeKM4sIo3vxACakIxKoH2YWF2QM84e6F5C5hJU4g8uxuFOlAYnqtwxmHyNEawLW%2FPhoawJDrGAP0JYWHgAVUByo%2FbGdiv2T2EMg8gsS14%2FrAdzlOYazFE7w4OzxeKiWdm3nSOnQRRKXSlVo8HEAbBfyJMKqoq%2BSCcTSx5NDtbFwNlh8VhjGGDu7JG5%2FTAGAvniQSSUog0pNzTim8Owc6QTuSKSTXlQqwV3eiEnklS3LeSXYPXGK2VgeZBqNcHG6tZHvA3vTINhV0ELuQdp3t1y9%2BogD8Kk%2FW7QoRN1UWPqM4%2BxdygkFDPLoTaumKReKiLWoPHOfY54m3qPx4c%2B4pgY3MRKKbljG8w4wvz8pxk3AqKsy4GMAkAtmRjRMsCxbb4Q2Ds0Ia9ci8cMT6DmsJG00XaHCIS%2Bo3F8YVVeikw13w%2BOEDaCYYhC0ZE54kA4jpjruBr5STWeqQG6M74HHL6TZ3lXrd99ZX%2B%2B7LhNatQaZosuxEf5yRA15S9gPeHskBIq3Gcw81AGb9%2FO53DYi%2F5CsQ51EmEh8Rkg4vOciClpy4d04eYsfr6fyQkBmtD%2BP8sNh6e%2BXYHJXT%2FlkXxT4KXU5F2sGxYyzfniMMQkb9OjDN2C8tRRgTyL7GwozH14PrEUZc6oz05Emne3Ts5EG7WolDmU8OB1LDG3VrpQxp%2BpT0KYV5dGtknU64JhabdqcVQbGZiAxQAnvN1u70y1AnmvOSPgLI6uB4AuDGhmAu3ATkJSw7OtS%2F2ToPjqkaq62%2F7WFG8advGlRRqxB9diP07JrXowKR9tpRa%2BjGJ91zxNTT1h8I2PcSfoUPtd7NejVoH03EUcqSBuFZPkMZhegHyo2ZAITovmm3zAIdGFWxoNNORiMRShgwdYwFzkPw5PA4a5MIIQpmq%2Bnsp3YMuXt%2FGkXxLx%2FP6%2BZJS0lFyz4MunC3eWSGE8xlCQrKvhKUPXr0hjpAN9ZK4PfEDrPMfMbGNWcHDzjA7ngMxTPnT7GMHar%2BgMQQ3NwHCv4zH4BIMYvzsdiERi6gebRmerTsVwZJTRsL8dkZgxgRxmpbgRcud%2BYlCIRpPwHShlUSwuipZnx9QCsEWziVazdDeKSYU5CF7UVPAhLer3CgJOQXl%2Fzh575R5rsrmRnKAzq4POFdgbYBuEviM4%2BLVC15ssLNFghbTtHWerS1hDt5s4qkLUha%2FqpZXhWh1C6lTQAqCNQnaDjS7UGFBC6wTu8yFnKJnExCnAs3Ok9yj5KpfZESQ4lTy5pTGTnkAUpxI%2ByjEldJfSo4y0QhG4i4IwkRFGcjWY8%2BEzgYYJUK7BXQksLxAww%2FYYWBMhJILB9e8ePEJ4OP7z%2B4%2FwOQDl64iOYDp26DaONPxpKtBxq%2FaTzRGarm3VkPYTLJKx6Z%2FMw2YbBGseJhPMwhhNswrIkyvV2BYzrvZbxLpKwcWJhYmFtVZ%2BlPEq91FzVp1HlQY1bZVLqeNR9SAUn6n0E28k%2FUuGkNpP1DBI5ch%2FEehZfjUQ9aE41NhETExoPT2gGQz0IhWJbEOvTQ4wgcXCHHFBhewYUiFHuhRSAUVmEHeCRQHQkXGFwkAgyzREJCVN7TRnTon36Zw3tPhx4EALwNdwDv%2BJ41YSP4B2CQqz0EFgARZ4ESgBHQgROwAVn9GTI%2BHYexTUevLUeta4%2FDqKrbMVS%2BYqb8hUwYCrlgKtmAq1YCrFgKrd4qpXiqZcKn1oqdWipjYKpWwVPVYqW6xUpVipKqFR3QKjagVEtAqHpxUMTitsnFaJOKx2cVhswq35RVpyiq9lFVNIKnOQVMkgqtYxVNxiqQjFS7GKlSIVIsQqPIhUWwioigFQ%2B%2BKkN8VHr49HDw9Ebo9EDo9DTo9Crg9BDg9%2FWx7gWx7YWwlobYrOGxWPNisAaAHEyALpkAVDIAeWAArsABVXACYuAD5cAF6wAKFQAQqgAbVAAsoAAlQAUaYAfkwAvogBWQACOgAD9AAHSAAKT4GUdMiOvFngBTwCn2AZ7Dv6B6k%2F90B8%2ByRnkV144AIBoAMTQATGgAjNAA4YABgwABZgB%2FmQCwyAVlwCguASlwCEuAQFwB4uAMlwBYuAJlQAUVAAhUD2KgdpUDaJgaRMDFJgX5MC1JgWJEAokQCWRAHxEAWkQBMRADpEAMkQAYROAEecC484DRpwBDTnwNOdw05tjTmiNOYwtswhYFwLA7BYG4LA2BYGOLAwRYFuLAsxYFQJAohIEyJAMwkAwiQC0JAJgkAeiQBkJAFokAPCQA0JABwcD4Dgc4cDdDgaYcDIDgYgUC6CgWgUClCgUYUAVBQBOFAEYMALgwAgDA9QYAdIn8AZzeBB2L5EcWrenUT1KXienEsuJJ7x5U8XlTjc1NVzUyXFTGb1LlpUtWlTDIjqwE4LsagowoCi2gJLKAkpoBgJQNpAIhNqaEoneI6kiiqQ6Go%2Fn6j0cS%2Ba2gEU8gIHJ%2BBwfgZX4GL%2BBd%2FgW34FZ%2BBS%2FgUH4FN6BTegTvoEv6BJegRnYEF2A79gOvYDl2BdEjCkqkGtwXp0LNToIskOTXzh%2FF062yJ7AAAAEDAWAAABWhJ%2BKPEIJgBFxMVP7w2QJBGHASQnOBKXKFIdUK4igKA9IEaYJg%29%20format%28%27embedded%2Dopentype%27%29%2Curl%28data%3Aapplication%2Fx%2Dfont%2Dwoff%3Bbase64%2Cd09GRgABAAAAAFuAAA8AAAAAsVwAAQAAAAAAAAAAAAAAAAAAAAAAAAAAAABGRlRNAAABWAAAABwAAAAcbSqX3EdERUYAAAF0AAAAHwAAACABRAAET1MvMgAAAZQAAABFAAAAYGe5a4ljbWFwAAAB3AAAAsAAAAZy2q3jgWN2dCAAAAScAAAABAAAAAQAKAL4Z2FzcAAABKAAAAAIAAAACP%2F%2FAANnbHlmAAAEqAAATRcAAJSkfV3Cb2hlYWQAAFHAAAAANAAAADYFTS%2FYaGhlYQAAUfQAAAAcAAAAJApEBBFobXR4AABSEAAAAU8AAAN00scgYGxvY2EAAFNgAAACJwAAAjBv%2B5XObWF4cAAAVYgAAAAgAAAAIAFqANhuYW1lAABVqAAAAZ4AAAOisyygm3Bvc3QAAFdIAAAELQAACtG6o%2BU1d2ViZgAAW3gAAAAGAAAABsMYVFAAAAABAAAAAMw9os8AAAAA0HaBdQAAAADQdnOXeNpjYGRgYOADYgkGEGBiYGRgZBQDkixgHgMABUgASgB42mNgZulmnMDAysDCzMN0gYGBIQpCMy5hMGLaAeQDpRCACYkd6h3ux%2BDAoPD%2FP%2FOB%2FwJAdSIM1UBhRiQlCgyMADGWCwwAAAB42u2UP2hTQRzHf5ekaVPExv6JjW3fvTQ0sa3QLA5xylBLgyBx0gzSWEUaXbIoBBQyCQGHLqXUqYNdtIIgIg5FHJxEtwqtpbnfaV1E1KFaSvX5vVwGEbW6OPngk8%2FvvXfv7pt3v4SImojIDw6BViKxRgIVBaZwVdSv%2BxvXA%2BIuzqcog2cOkkvDNE8Lbqs74k64i%2B5Sf3u8Z2AnIRLbyVCyTflVSEXVoEqrrMqrgiqqsqqqWQ5xlAc5zWOc5TwXucxVnuE5HdQhHdFRHdNJndZZndeFLc%2FzsKJLQ%2FWV6BcrCdWkwspVKZVROaw0qUqqoqZZcJhdTnGGxznHBS5xhad5VhNWCuturBTXKZ3RObuS98pb9c57k6ql9rp2v1as5deb1r6s9q1GV2IrHSt73T631424YXzjgPwqt%2BRn%2BVG%2BlRvyirwsS%2FKCPCfPytPypDwhj8mjctRZd9acF86y89x55jxxHjkPnXstXfbt%2FpNjj%2FnwXW%2BcHa6%2FSYvZ7yEwbDYazDcIgoUGzY3h2HtqgUcs1AFPWKgTXrRQF7xkoQhRf7uF9hPFeyzUTTSwY6EoUUJY6AC8bSGMS4Ys1Au3WaiPSGGsMtkdGH2rzJgYHAaYjxIwQqtB1CnYkEZ9BM6ALOpROAfyqI%2FDBQudgidBETXuqRIooz4DV0AV9UV4GsyivkTEyMMmw1UYGdhkuAYjA5sMGMvIwCbDDRgZeAz1TXgcmDy3YeRhk%2BcOjCxsMjyAkYFNhscwMrDJ8BQ2886gXoaRhedQvyTSkDZ7uA6HLLQBI5vGntAbGHugTc53cMxC7%2BE4SKL%2BACOzNpk3YWTWJid%2BiRo5NXIKM3fBItAPW55FdJLY3FeHBDr90606JCIU9Jk%2BMs3%2FY%2F8L8jUq3y79bJ%2F0%2F%2BROoP4v9v%2F4%2Fmj%2Bi7HBXUd0%2FelU6IHfHt8Aj9EPGAAoAvgAAAAB%2F%2F8AAnjaxb0JfBvVtTA%2BdxaN1hltI1m2ZVuSJVneLVlSHCdy9oTEWchqtrBEJRAgCYEsQNhC2EsbWmpI2dqkQBoSYgKlpaQthVL0yusrpW77aEubfq%2Fly%2BujvJampSTW5Dvnzmi1E%2Bjr%2F%2F3%2BXmbu3Llz77nnbuece865DMu0MAy5jGtiOEZkOp8lTNeUwyLP%2FDH%2BrEH41ZTDHAtB5lkOowWMPiwayNiUwwTjE46AI5xwhFrINPXYn%2F7ENY0dbWHfZAiTZbL8ID%2FInAd5xz2NpIH4STpDGonHIJNE3OP1KG4ISaSNeBuITAyRLgIxoiEUhFAnmUpEiXSRSGqAQEw0kuyFUIb0k2gnGSApyBFi0il2SI5YLGb5MdFjXCey4mNHzQ7WwLGEdZiPPgYR64we8THZHAt%2BwnT84D%2Fx8YTpGPgheKH4CMEDVF9xBOIeP3EbQgGH29BGgpGkIxCMTCW9qUTA0Zsir%2BQUP1mt%2BP2KusevwIO6Bx%2FIaj8%2FOD5O0VNrZW2EsqZBWbO1skRiEKE0DdlKKaSVO5VAuRpqk8VQJAqY7ydxaK44YJvrO2EWjOoDBoFYzQbDNkON%2BUbiKoRkywMWWf1j4bEY2iIY1AeMgvmEz%2FkVo9v4FSc%2FaMZMrFbjl4zWLL0%2BY5FlyzNlEVYDudJohg8gPUP7kcB%2Fmn%2BG6cd%2B5PV4Q72dXCgocWJADBgUuDTwiXiGSyZo14HOEQ2lE6k0XDIEusexDzZOMXwt1Dutz%2BtqmxTvlskNWXXUQIbhaurum9GrePqm9Yaeabjkiqf%2BbUvzDOvb2Y1E%2BEX2DnemcTP%2FzLcuu7xjQXdAtjR0Lo5n4%2FHs%2FGtntMlysHt%2B29NXbH6se%2F%2FWbFcyu%2Br28H0MwzI30DYeYTLMXIA2EG8QlHpAsyS0EfEToR0a3utIxFPJ3kiIHCCrZ66b0e2xEmL1dM9YN%2FMwS5p01N5jMX%2FBLKt%2F1R83l0LyC29M6%2BiYxo%2FUNg%2FEF7c2WyyW5tYl8WnhWg2%2FhyySbD5UhnDyS7OcU0dnrFw%2BDfGdI7v4QfYIIzOMq9hFtY55gmvC7jZ2FK7sEdrn6IXBuucYhjsGdQ8z0yEbWkkczjjsE5hNAIZrPx2zOLZDmKNXcXtg7EMqidAEEWg%2BSJCBBNwxvxJfc%2FbZa%2BKKf%2BxoKZybnq5vaqpPTye7CiF%2BZFjxZ8%2F7Qij0hfOG%2FcowPA1rT1l4ymWnrKmxxqfErTVrpgwPlz1kC%2BOy8NMDz6c%2BIO38K%2Fx0xkPnLW8Kx6qGAoQdL%2BTD9V9rb%2B%2Fctn%2F%2Ftrxz8dUrZrD%2Fzk%2FferF0cNt1BzctmX2FZPXt%2FjnFCQNz4Ah%2FiKllGiCMs1w5Lkg0kiEwj6VTXCDKsX9rMpnvIj9pcDecXAIXMnqn2dTUbN6w0XQ9ue6FV%2FnnXCH7S3lPWGltVcLsH75ub3ab7A8M28caNrIeOr3o5Q0yFsYL80xaa0EY%2FUEczV7icUMY5pnelAkmUAXmHYjvFWFGxuqlSaow3OM%2B%2FiYY7%2Fl%2FhVELF4EjRqNR%2FbvRbOY%2BDUGzGR%2FOh3EqmE%2FugIQQguGt%2FeMYz%2F%2BL0cimjeZfQDI3phXMbMQsqH%2BCjwVz%2Fhf4idHovgVmB8gLvjbicDcC%2FNypP536E%2F9N%2FpuMibExdohBmNwyiaZdJGoigos7GpF222xrfnZhML%2F7Z%2BylaqP63Hr%2Bm7bdUkQ6%2F2cXqdfmvwixY%2Bs2ksXFeXcE%2BiX0Z%2BIow76DBNgjJ7TOdUK18iPsPflfQD%2BDPsZG2Aj9VmKMMJ4fYRrhIaxhTDR0Elh2vA6h%2FAE6xUb29mj3sjmL72petXjejPy%2Boel60M99tFduCI59N3221xe7apOvxs6aHs7vab1IqY2tv7q2xsHeHGml%2FcV06u%2F8S%2FxTjJ%2BJYc0bWEX0ukW6YmIbGkJRMdjJ9mYIH5QIdJF4hvRGyK7cC7ctImQRcUET99fGXOoft35GYLMQu%2Bg2smnkgZUrH8AL%2F9Si217IssJ916nv14ZrJrvdxLkQvrvtBcjgPC0NXOicO8Qf4mcxPqh3hgUw3DDfdvLJXngg7N3dN2zbPJSaed3OfZnMU7dvmznp3C3bruO%2BNmue0LFsy7S%2B6265%2BfCKFYdvvuW6vmlblnUI8xCXp37CrOZv4B9gauDBlYp7adcUXB5DNCwYImlXOJJKkAdvExXxVvKEYnCo%2B3eIskP9qrrfIYs71CccBjfXRC52udTHHdaP1A1ui%2FVvH1otbrLrpNXBsGX5B89QghDyimlvNB2KfkxZ5C9%2Fem3%2Bd1%2Bd%2F%2FIfFp2%2B2Oxn%2Fs%2B9n%2F79p39S3s8idN6g0yZObwJOgKUpNB3GyU0Ls0PbRzIRq4lcarLKOJBkLRzJQD4j2090XrbA7DW8K3jNF5hlGS5e4V2D17zgss4T20egOJte5iD0bReM9yjTxnQxCRj3c5kFzGJmGbNKmwGw39IJDJcXJZGMkaAB4jyJAKw0jt5IAuIE%2BA%2BU3cVAZZrq9zhDyBrU8oosuxcGNTzCKJfla7JjNVmuSb%2F%2BtuzN2H%2BX4vlB%2BPpdfMXXmuVsNiub1T34SFbjYw5itEvVi0K0Nt9pNJUMI7SLGRhf2xipfCYf8z5OdlGKayOucFeVPeS%2Fdbo3lBrbSMmwUiQN5%2Fed7g0Ds1s17IuZC5kNzM3MZ6EWCa0DtekdJfAxz%2BR%2FOX28sND7yRMTBcf%2B%2Bs8mQCQWHya4qBv%2FufeMoWyslPA9DtMxUknxkH%2FyfTnm2CMYzs%2BCq3r7PxY%2FMXomrvTEsRpfEGHa%2BWN8E1AHjElb7d06ddA7oK%2F%2B5Mdsv9EtPms0jv0Z5kf1FqPxWdFtfFr0kHfgDX0Y%2B5PRSG7RUj0tQr7rmfX8DH4G5W28kKeJLtmQsQkuwMP1pk16EV4sl7vrMJATfyUWo%2FGwEco4rh4XFQgaiUX9qxZHrMQqKnz%2Fc2d8b9TysYrAuXpP%2FRf%2FGr8b1qwwc5a%2BeuLa6S6sneNXToG2XrEJi4R5SGs8Sq2S3d97bsfCRaTdaLwKClRHt37mkudvXbjwVrLhuYeGhh56bvfQkHpk2CwvwClqgWwuBfndC3c8dwmstj81KkagcUgbfPY8Zje0W%2F82VPWJHmSq6pP8hPWpotc%2FEexDOK3qU%2BwngPhOCiO9MJRm8TJefjelrzoKnG2Bn%2B1NCUmPE4gHFmBN9jrTigRIpsACrc9Gstg58ULkp9467%2BGf%2FeFnD5%2F31lNrt2967dhrm7bzI%2BVT5m%2BfzKhvf2MzpICEm79Bopkn07lt1762adNr127LwVqQLdJ5%2BlpQDcvHPQtVY5knhYrK6q8%2FJsiP6EuhGZdFdaNszjvpqvc%2BPI0CdjN0AXsFOC3ZfALDJwr4q2Xq%2BGF%2BGNbsxUg5NLLIEXi8otcDQcUts0D8eQ1iVDRAMBTsYiNdRIxE09EIBJO9A2xqgERTaW86BUFn0OD2xFO97FAgFhF6OoQ7prYt4XwSeUgQHiJyDbeke9IdQntciLQ1FlJMaYcUNvZBg%2BFB1ubjlnRNvl3o6IEU2w7fdNPhm%2Fhh%2BFLysUu6%2B%2BDLHkOkrSHYEjH0tEPe7WdD3uyDgvAgK%2Fm4szFFR7ch0toUgBTdWHr7EpaWru6%2B6dmbbnqWEbV2EtxAsXiZAPTtGPSbHsotI2leoM8TePEqgSQprs7AGFf8kuOkPdZPXGb55POAW1d%2FjLST9v5YflasP6v%2FCO7%2BGNAPC2BMZWmsOjp2NNbfHwMCJD%2BLPVL%2BD%2FOYlWEEI%2F9jpPddOFkB5d1GSuKZYggmCCd7JUxD7EXAzxyirYnNDLdDZoFdx14kivkvGc3579Jm36reTTvDgBnaO6vzyQ6chQmlsMoIkIQ2%2BbBDWBud1Va4pcCn8CPqxlh%2FfgtG8IPaPH8C5wk6%2FnZDv69jurV5QhtwE0x2iqOsj9Mx8B9%2F0EaUdiPfOYYDCi%2Fq9jhWRuupMDEU0%2BCtX0sDFxv07T%2FK5niBPqN9%2BtQjgEc31NGCXFeMcCEuQBIc%2FBK4CO78u7EPYvl3yaEfK3vcb6qP1R2tI7vUjVDDUdKubsSrNjYKY1qBEa2P50SJoaXiksIoLiCwnxS6EBuBde87botNfdEWwYvF%2FR0%2Fu5yCqhGeEOR2ynSeyXjt6ka7neyye8kryBSWE52y%2BRBgogrXPZ8E1yIHoHIFUM%2BAbJhE7lbMtt8ApL%2BxmZW7PwbjAO0fAVoXQOuiSP%2FksIVdFZ0aulsamKUzwPZ%2FNYDMJRBPCxsBqLzqHyneXF6Ej9HlIFo7%2Bpg%2BjUb3unRmGpstGkm6etOuDBGA5wCMefp1gTHcdZlvPBXlOslvYTp1cd8UjYLVd%2FJ5awNrIOKLnIt9MD9qdrKrWCvA6ALm3QV9VrsPm60Q7%2BRHJHP%2B2hqfugo%2FMvI2H%2Fmqr4b9tFnKSRY1Y5Ek80Nm%2FWIhr1ikKnxGz9TWXrokf9xwujfvcOTtNTWnxd0F37Y2W79tteBqZ4G5qLCuomw%2BnSr28QESCRVLTyYKILGJOPfcnaIFOsewhRdvv%2BrWa%2FWih0vlbX6Zb75T5C0qNKVFvH1QL%2FvazSWgC2s6oWXXIuUxQelKiJbowuJDQViatLmLijg9CQBMg8WiPgiw3LEeYRmm5f%2BXdnvkDnxLLjMLxtvX74C3OlwPQqx4xwIdpPx38LrlDphiyWUWHWKAzzxurS%2FxTo%2BP5wGFak62ap1PVFFN4v%2Fy%2BxuR39WnIO7lsWfwgVsK17wxrs9K8ltIKuhkw7f%2F6dhK6gQokFKhWX3urrjk%2FrnI0pgfpGMeuQIUaEM7%2BGF5q2iMkCaMQwxxOzcvU0eXbsnS9XknXvP7Gtw5dwPXlFu2ecvSHEZgNDsU6x%2FGdXBYXyOQjzZReSedeEPY6nEv9gJR4oBQJtFO6Kd0fwC6BO4LNHDeBujB6dSNcUQC9zIv2LnAzGk99bUDrdFY%2B9yGFQtEo0GQPNv6vS2drj4%2B1jHbv3aJSMUWP%2BQTZrmbNTjU8wyG%2FiXNNpskybLcJ3CiTF5Ir%2BJYzmJwE0mSVhlxbtbmvweB3ulB6Til5UuUZydpgiFVeobhU0WaBqpJ198d%2B%2FXeNRTZ9%2F1OPfG7%2B2hwzd5W3D%2BhmyjsRcUg%2F%2BCavb%2B%2BVh2ls3L7zT%2FetOnHNxeerv313vzLVqPai4nJv%2BK1FC6040%2F4udw7sAb3laSg0XCkAAs0npBO6VJabS4Elk%2FU%2BD4gTXW%2Bj0wnrMlqNamq4tMIYB87tE10i0FR3LZNhJsb7%2FR561btmes8YBCRkhYNByRtKd55mqTas9FYhJnbRGHuOh3M4QTdgQSqmgRxuzGdSvZGcbMxNQGk5C3ebLjoXIOFM4l%2BWKHmLTJwRv9E8GWJ6dYvf%2FFmEyEGr%2Bgyrr1p5zrgkz0Cw2j94Hv8Jdx7dIVegBSNtgsqGsRQEYiIBoXwD0LNvQ5d7s5Z00QzwNhqZA0b%2BtMG1tQq5nd84uq8R0zPvX35G8uRaze4jcOHzz0w1%2BQ2BIRvf6J6Kgatnrbiem%2BCFvAxfkrndzD9MFPP1GWTUHclpASUkCNAQkpCCcCgDSUDAhDZ%2BCuEkgn8J7i9nMA7pA4lISappxILKfAeSAbIcSDuN2bJcfZILqeO5rLs0MnngSHYRdrHjmaz7JEsEPw51ZqDJDmUIOZIe34WaQeegNsJn1qz8AIpT3yCjyEih%2FxELkuJ0lEMYTLVCiWpo5oYMleMH6USyYJcD%2BuOe%2BkWKpn1Qns34iyYDjkSLvgnZXcgVQNeqINXr48m3iS7cjm8tedyY0f1QvTnHHdsrKby%2F%2BSSbPY8%2FNH6vpl%2FEsq3Ae4ZU1HC44KFiI9o7CEgab%2FRqHbj7s5KAg06s39ZP%2FzxI%2FmVuF%2FTbTSy%2B3Fb8If9%2Fcv7%2Bwt91yy8RfP1QXtW5RzQn7qIiZyuFM5QfJ5E9uVnqT85TanFx0lkP3ukBAMprvsRyi%2FC8NAJL1xbIIirSvnSj4O5netb4JxmNANHPssHAcHMHsFRgEug816gDBeMbdfiuRcghqYcm0%2BXxx%2F5IAEtN3fqFF3LzAXqwoT0PN0OVTNqxo8sxMkd5Ig6k79Zk7VxxX6gMLOZFQgvpW2RrMW1D0BDihaXQ9wVRoBxPLfpknmkeMtoB%2FqM9cRc9IqmMD2XUmdZ7GSRKPUZvChf8BoykriM2MnKYbOHX8R7cLdNCxSFFVQqoYswnlWtlFS2mNkhswVpZiQW1J%2FUKFfipHGlUkM6UKBhMz1istELIHJLMSctu3ugzfaVSOjKvUgc%2FTHK4Sdg2Wscz69leKIkkrwuuWiOe9yGYKQXRumkC3qbRcMwrvhjNXgdZk3RxAUEhuSPvn3nnd%2B%2BU%2F3vlVOmrJzCD8JLxV1OHRjrZifbcFDOuRNTGqdgQm1tSNJ2OcQ04YiEXuxtII1ECSQRoQGYioEsgCfchB4ghAtw7FfJre4WZ9hkVi9MtjuWqtdNDlpMrfEG9fOT6q21okg%2Be4As38MfGquNt7oUws6Ysarj1%2FefE%2Byst86YUVNvDdts3Pv5c8m%2FaP0C%2Bf8%2FQb%2BIMnGq09BgwN01oIOAnAdagI8mBSrqk1gxTDUBOtk2ousEtBH2z4Ir2d3f6k8PXXVlt2qN9RODxRuoJT%2Fv27wm09jRYVc%2Fe%2B%2Biyx2tyzJb%2Fn3J0htXP87eSsQaf2Ly0s6Zmxela88REy1cf4273mI3iXNJ7KxrZibOm9xm6rl4fqy%2Ft27smU8tOfdW2ucBzg2UfmOIVyLIl3kpYlwphDISTXJXsctmiDtN7fNV6zelgxwnWxsVr83Aj%2FS5ki1jL%2Fa0GC6%2B2L6Um%2BaoddlNFuj%2BbJ8mH%2FiaLh8I0%2FU51NspIEfq0dohwyFXKgm4NggwQ4rRhCOUFtxxo8XnitT4cnGfT93IS8FaT85XE3H5LMY4zIEPL1hw443wz%2B1UmhTJyJGxZzw%2BwsKkKZgUiVtKOKMEb2AKHTv61FNc01PQFwKnvsZ%2F9pPA4RKTASWahmh%2B8MxwzHxKy74IRn5LGRjsPUUwTu64UYNY38caqd7HKucZ%2FtHnODtENw%2F2UfHRMaq1UUPDJQ0OKkWCeet5fYOhII1VRz8%2B%2FElg5j4Gxur3J8o2PJ4rg%2B2d08T%2FfwEzSVbyZ9XPro95T477lRKqUSRXQnauHNsISAl27oWi6Fv9z48JMv8r%2FaMMj8onCP%2FDuDZOuN%2BGPPr%2F%2Bp7bx%2B7JlbYdppcNhzKU%2F1Px5aiaGDn%2Fs1iGMaBcleKUo%2Fv9rcxkZj7DBEKOfrayytXNLYiUdBY%2BpleQXdnscKlQcpzuWluxsieeyuXIK6SdxozitWyGOV3vOHHjguyCQ6fpIYy2JwvrQEF%2FQa9Pdf%2FQqOSqCiE%2FEE1%2FXIVKTc2tzWbHnimrEd%2BVyz311Ml3P0GVTj7PD5aDnsvCvH36alEaPMePcMegXs7x8igTu4B9v7G9vTHvhCu%2FkzIdx%2BBxC0ay9zRSvoS0F2lIxI%2BX7klU63I40gLQ3w5ep5na%2BSFnba3z5D64zv%2BQtM4n4ffG3tq4aNHGRfxgrXPMim%2B5487abL7xhdseIRn1KDl%2B7aINixdv0OD%2BJSPwKf5%2BxoP6aiTeQIDVlIhMcL1H5R9PYXvprs3fv2bO7MOplCmweuiq2JRZ1zz%2B9a%2Fv2PH1Hfz9236w%2BZrPXvWfAxlj4NLLHpq3c%2FPQ3uvmvbrjG7fe%2Bo2y%2FcLdtE6VUlXi0ASb1VLUBVSUWSU4HdvAraTyS8xzM8NxvxFkXV6pUVRiJwcgC5zEeht4rwcp7ki0k41G0qlQhG1Vzlq8alEmnFi58caB5Q9vn988MLhqyVlHvLEWjtQFeupdiocF%2FtkkOGPW2ibWaBTkeZ%2FdvPWazXfOnnvL6jkRXpi85sFzZt%2B55ZptW3bl1cCCHZPD06MhySha7UFzjcjbp8fOecFCirzAG%2FyVjBX6OFIaadSjQq1nNhyIe8tVbaaSdHlXIWKacMeuZA1uxS95zILhyrxAdsXTL6m7kNQlx2P9uZf2qhufePFFbpI6%2FOU0WcP99RrCsrwseVot5mtytpf6Y0gm9sdeyKnPQ7onyK4nXlR%2Frg7H95M1upzu89DH6pgUcikoiihJ6NJKmRxV1x%2BMJiOA3YwhDRQrWU0u%2F0rvq0VYXnyCwsLeTJYBq3dAtJDavuzyoVpzZ99Z0%2Ba0uoiFH%2FxcqgDR7rUFeOrUn6Cywb8ZeNMbhLV5ugP9l0zv9UN5b5mFkjzxUcpPJCn3V402pRxtJd2GrnLdhtVk9ZSZh9W91fCSH5B7ofxPiWL%2Bj3D%2FuwhBRdyAyozeZwvQzs79soi%2BBKSnafLviZCcfrpBpLyimfLfTyJtbyruIQKD01tUwJyKEo%2FybaxkSNFUMdMkhQoJyRBQFhnUkDQSXhTM%2B3NmY0EDM7ffLIjqWEGt8lCO6mLia3PukFnghosJD5p5SIho%2FVDkzQfLE%2BIrYoJXkD19pdP7OwG%2FvoIUtagiWiZ4PAFTHHlTVhRZ7dYmPar%2BNJ%2B8JhmR6DFK5DV1foHoLNO%2FpHrvZfmWZ15RQlwvoVDKhCWNK3CCch9lfFBuAqUgpFSShmNaPj%2Bi5%2B%2BWZfKeViJfW5HnUakVL4UCNVkA4%2BETfIqx4B5xSaP2L1yn0zn2ltPn4%2BOqZGmwwEVCaCSqG53ldtL1oLGAhdMLd09MpCCF6tD6ZnAZBY9hDaYsP0jzZ0j5ZjKsF4i1UmLuhbJMCnYJPt5VwFNvmZawXjEvLJqIH8STonZjq7BZ8gKgR20C9MDFqJAX1H64QW2NEup6qgzLP8cvppL%2FNNTOBTCJABOHeWoXzLhw4Wuy7gaBtjKr9kgKq8ZlRYBS32Lpxc8vIhpNDTfyNXWybMJbn2RyQ5EmWc2QF9wmSZ0KYCE%2BcPuYO6b15Uotj2Kd4MItLS7gtFbkTdrFND6pvEZqv5Yv7jXAus7Pg7avo7KDot50NX3CPkP%2BKps8J9%2F3mGQIteY%2FLGPC%2BL7872SPR2br5fy8MtKBMHedGuM28%2FMZmPJMrGgi3Gb1S%2BSi1%2FL%2FzrZwO9XH1ce%2Fz7ZQ1WSoY%2F%2BpMb5FT4ua0Wm%2BJf%2F298nFmChEQ%2BTi71est4mq9VYI6RsymoRJKYidElT2FGnDTZvqtfhGAFTbeqEw68GqtfmbVa%2F1IFO1%2FjdWr%2F8BDRRtQh9XNjubEm4aWVpVonpTGR7PVGc%2BKJNoBIWF7kYi4gUV3r1U6723i6TxUl3n3%2FtM27aZfKb7THiHW9VzFSwHJ05VfK6Ar7kaB0XgPPE0BSkSFKsBUpaLihEWoA9wBt8qirh2VSOkZwXEwyrxZ5jyt2rJmSo9gX7cg6jsEUGJU9z9xJPOEM3uQQxKgkh35DNATnVyrmJ3mbCNyIB%2Fyox4wH1bg2DwN7q9kov4pFqny8oSm3RQbGgJ1QQTs6ZMLilOVYJ9v6Wha3HcJ9jddsXp9YhGUXLXt%2FqMDnvLpPNTXfNa60z5%2FyjXQOMq%2BlNmwh5egpYrdfZQZV9rI47xlRkuyTjpzsmCBSWNkAXVoK8sgYWqQJWbo1RLo6QH0YW6pxqfCnRgkd%2BRiFjUQUQ7poIaYoakgXxwFd9BuuI38H1xBxXSFb%2FpBDIKQFn7YB3dB36l7sG1FLaKiBdp1KxLvfswap%2F30lnVESgNnvjbUoT6w9N%2BXoio0qcYOIM%2Bheg940YimsucQVvli9NEcft2UZwGQwLuilj1fFr1i3NP94X%2BPE7Hpvtj6lBJfJ4R6NvWiaL6MgzWHxiN66DExa%2BdAdAbMYX6HVF8A%2B7rjEZIXAVbDe7PVI9rmN69JOLV1DOSvRPxWNPZBZf%2FNf%2BNy65BhYxxxV%2B77XJ2wfQ389%2FIQPgajXbwMsuAz%2F0IaQcXJavKbRqR2IqyZruXjVC2%2Bhdee%2F5vdnYOedpmVtR3NGXldxSzDSIiBVpkGb9by89UpEPKrSLZmyFDzMab%2FwXl2CNe7s%2FqCtTvWgG5kpBmCBlSzDS%2Fr8N4uwBwohRW63JTS1y32f0TQsPfXVGEHQrV8%2FNCfiOUVirYcBbIeA2%2BiF68rQIo3B%2FS628vYESr79ehzS7Q9LEL9UXmik9XVHb1yBO3Ngvt5935%2Bk1efkV51mzzrM0LL3%2F20avnwMeKuWyOUZg2TasSqZ%2BKcZQiOn1Iu2Vh497ALUVZiCKt%2Fgh6IvTIj1ZLRjWAkpHKOKovNwp00eqPROiAbiNEKieXwMLcXhVJ1%2FuzmLP4tfxaHR59cBdJVG1kTAgl9ze9QKUEQ946Hkb%2BokJ5JRDyf54Axur1D%2BWS49cLr0tTPEu7UmXrxcSr3XNvumv4yXzInXKH4F7Tc7p17Zt%2Bt%2FqW2%2B93k063X7VW6lALxTY7i1nBXMxcxmzQbabxz%2BtJo%2BwijYaIGMNS8AoSMgAPt84DdHOoMPfjXhF%2BkuH1tZvuFQrRCN07xGcXRX9MYxYchDe5BcHj%2BZ4i%2B42WyPc8Xofi7bbZJN5nJLJ5qr6IqRtzqNlM17SpFsnkEyTWoABEjz4JXOQvzWYuwdnV5LNGOwTM5v9r4RpQ8ZXsYodks3o31JBlzbYtNotisnm22MxiwGFXam5oN1n0TA%2FhRvshvTSDwHff4nNzRo9Dum6PaJbMXzDz%2Bx%2BFkj4L4bFNBb1asqsgH7Dyh4DvbkPtf5yMDKzEwyoaESMSNS9P9gJVA3%2FRTlwoMwZvxECFWxIPNw9gi01nOHjP32esZTtmXHnxvZd8ZtakqQ7ekajbXetpNa6ocTVxJtY%2BuSe69OLz77zh5bDR3xjZMzUz6fxrz1nqrZGcHQHfPVefN%2BfiK86LeXj%2BSc5lPKy%2Bk%2FvCUI%2FDaLFYCWHr6nbXuILTIsb5imNKY%2FrCm28fSMxPhkN1XbNMNZGuqwOBhtTSxWuTk6bw0ZaG86b1hKddePOKuBvmiguYBn4T%2FyOqOyGRBt7bKUI1GjioBC8aUKwF7Q319UgcmtFGIzCJGBqwQij0ynDsfdFGc3TS3BlNfJ25xmzniMkpXXTPvCaD3ZaZvyzjmZdudBostmhb0ORZNN2sJBeed1HXkrUsywueQH%2BL0eCPxmsa5ZpgRJSDZ11yDv%2Bjmbd86vxZfc1WcZJ3UkMq1BOOOVtvu%2F%2BpB%2Ben186d3GTwWAw2jheaJs09%2F%2BLNfZft37DALyrNj1wABMuUKbODyTVnT%2FKYbJ3Tpq8IrNh92dkxOj5P%2FYpZx4%2FycyiVcDYdn4JbEoKdQi9054iBKsygLW46FRGxAb0NPNCm8BSNCPjoKcj6EAus4SuP3rB%2BcV99%2FeTF6294dA8%2BTK6v74MHVpYNRt%2FI30e8QGTOOdfGWzzxcy%2B87a7bLjw37rHw1nPzp0KyyRSeZO%2BQQhInt3dYgvycjrPOv%2BT8s1rptaP84VeywdWX2T4ysr0%2F7TLIs6%2Bx9zib56ye1dM9e%2FXsZmePY3NDs9zlnNVt4%2BWgHJbbz3Livg4P9WWgviOMm4kCRT6I8vw0NbUUEnFvOuFKoxQW1gTsvFirsF5pb7qTUCx4i7VmtToveaDxvK9uOaedVvPRpVOnNz0Q6bry7uiSdQ8t7Vy4JQKVS%2BXPplV2ts4bvCwZu%2BKzgITtxepaPRzWdpv74muvv6RO0SorX6cu%2FdqKn%2FXWnrtp%2FZragz13DUCl5myiFW2Ycvb0PtsXnU%2Btx8pvLFbUspLX68mdegwmOif%2FNPDONajTGoUh6tU56HBJCTBASVvNUB5VIiKpc9kd7kludodSFz7xQbiOmMk5dOYk56gzL6uaf7N8a6MQOHm0ae6snZpFDfuT3%2FjdYzjzwkXXIVHoXNuCfQslQZqBZjTsoHMqrkE4jaYdgkGz2ATOgB3cPkSukD01DnV3ttb1wx%2B6arPqbkcNAHoFPzKUUQ%2BqL0k97pjbZv1I%2FegC9zTFbrrlFpNdmea%2BgIgfWW3wqkcis8ky5FAcRd1If5nNZrl2FFpungc8wpoCl1BpQV%2FScS%2BzjlASyUTVv%2FAJ46gkJI4bHX4lTnloctxPZE1ckS3%2BjG2fKIjkQFyzuo8jvYQG1OrGvJPSTu%2FnSp9PHNTl4z5hK%2F8gtXVKF6gEKiglgcKiRlCESsQCV5QIlKWKpr34lt%2FwkSx%2FJCmP5%2FcBKQfl%2F5gd%2BrOS%2F%2Bp91%2F%2BYCg5CXK2W4M9fu%2B%2F6xxX%2BvnelVuldIDCG0VQTpU9Dw4pRfei%2B6zWx0MLie0gPbyrkmRU7OwT16JGeyXLHqOLqAfVN1GPlBzWtFNzj0TRTCjogtP1NjIvu5habN5Aoa1k66wGpqriVetJgiGdwDZtKhnN0y4n9sXYnsqGmZfDSR15%2B5NLBlhoDaedEm7sxmpqRija6ZEEg2EAnTiAC8IrmFbGz1q08P9PSkjl%2F5bqzYqT9hMmptEXDgTqP3Wiye%2BsD4Wir4jCeoHbbp5hRfpB7BakUIppIlPCD30dR1GtslDz8OsqbXmejFC%2Fv8wu5X2myq7SJ8Avzv9DFUJySf5uNvq4%2BTi7W9D%2FOZrLChdwxmPNiBRqVjnpK%2FaGxRCDspVYKAW9AN1JANoo8wP4BJUlGqdgw6m1qPQ2QW3%2BOfU5%2FieLS%2FNuKpDU3uf8bcAXyBal5jMR2NEAbPAZt0K3hvxHBEDlUxfIGcD%2BN2gNSNx36nfqlAYow0puatNpRz0e4W2oahKzQHsjf2c16ad%2F3t2KTtPobnX6D8C8pd0MDP%2BKx7wnXqGGlLQcvikMErm6TmfsuxJXbSAxqNjOogJLQBLiKEHAE%2BJGTS3JoEhTrz8%2FCB%2B5YlupJ58aOat8Kv4JvregxwcU5Cp8GFAFm1FyOfto6GS2m1NGTS6CPNKkbsTdCBlnN9onMho55BX8IJZtEQ35lk%2BhtwN5A0V3RCPoD%2FyXAcv6pAtbZczRUA64JmcUf4q7Q89ZHLeJVZ5D1Ps%2Ft%2B0iCT3AHVtZC7JDCXfR7OSb%2FXja5H3zQbZL1B%2BULX1BMTEk3AseSpmnKEK4T9ekMIidUCRQFfcbj7z8gNLvzF7mbhQN8h6ZbRset%2BnQWdS%2FZX3k7WpS8P9sfo0iGS64wV516pOhjI6TZ2dApgI5%2BLhxywYoWxKUrykKJsIoDsR4mSrCTg0egMPnLW%2F3Q5Nn8BZEuzqEI7HK3n0%2BzFmuO3TtWQ5WJoG9YqCD6Gc32SxnbnVPfsxvrFXK2dILl7bLthDp6glhcsfp4bYvbSmj%2FmQ94uBTw0E73x2jbNRCvC6VL6GCFDwU7eWQDcC5FY5s0slieRDwtAbRsbLXbaXAuu14e2OJw1dc6jQ3ZdY8v7rv2%2FBWZLqvFWVvvcmwZkK9f5jS4muO9yR5res4kfkRxhV03L1RfPOiPtYi8pd7jNEsOpyTwxpaY%2FyCZu%2FAmd5Or9uS3DYaeqVOhH7gZN%2F8I%2Fwi1fEuLXvyNivibjuKvN%2B1Nc01HF%2F3h%2Bef%2FsOhox8MPd5SFucPjorQwXT%2BytA8EmA5mamHNFDVhBI5pjZbQpugBNkO8MvRub8KVDKST1Wag7D3xlin1ZF7LFP%2F79nbvCXFOY%2BPUjrT7%2FotsPXXZ4exdPzuhZuL5LUXVAn7k7PbhG89uz3b41X01gbjP1xwlu5rrvvf9%2Bpbs6E%2FVu7Nk642%2FPYRaAiUBdrmO6CDTBLPQFA1ur0uXoBR1INDMkypKpoTqnSMx5GiEdTEaSHLs0Alvu%2F19%2F5QW9Rv1U1ridT22i%2B53pzumbs%2BXFFXYC%2B%2BCGsTj5JUT%2FGCgRt3n78i2n71FHG4%2Fu6X%2B%2B9%2Braya7os3ZbDmgWfXun44e%2Bu2NZKuGZ0HiF8M4TlMPR%2BEU6rPKRJ8wOU2RFUFLex3egEsz3YqEAq0cqhAAW19dBZIlVzR61tuIdTnpXH7l%2BuXrbjPUyep%2B8cl6aXKWhPHpDcXl9KiTWDNr4mBQc8Tq%2BNzK%2FOKSbsfl79o9G20R%2BbrBXYvUg0rLHhtrc4TN81TTOWSZ0gL1ZVlOYH2ery%2F7XVUjFMbzYpg7UswcqJPQwBd0LKLabJ8IaCr2otcjSkIrGwootKECaUd4XH1%2BSdazRrfddkBU98t1htvWrbjqSqjaCguxrffM%2F5zDCpBALUycmajhd%2BR6ww4SWafuZ5eU%2BtPid4lgd3gt%2Bb%2FY9rQoZNmiXYPXyRHbRs8zX%2Ff4WIFjWZJtUdSD55AP3xtXH%2BZipC0EqdBGDA4CoYEU6gRLGPU11QhkLTBiEYPiqOeQgwTCl9aok1Qr5pFf71qEeNxjy%2F8F0GoqYPv75Yh9j3x4DuJ%2BuEzHRpAq2lMqb%2BqfTdiq6kGtzfOWsv0c7lSeMXDHBDe1MT%2BLUgx0Pg%2Fp87u2UicdIvqQi8DkxhcUwUXCedMpb4NQjwY3npTmgsURJavLwCRyEcN2HfWsDVGfv%2Fu9ZUWUx%2BPYFueUKwaNvbtu%2BXps3eVWbN1GcgVrdMnWJ7WmJz9SD66EBidag0NF1Ukep0t5A7sFCWdhzvYwHv6L%2FBehXuHqfaBwBEU7hfVLcXvS4VQv%2BT%2FvaSIl7cbeMc7ekv9i8S3e1L5xxpvMGcu1EYPbKyCiijjGXcDKckm43PqU2qNWlXusZMiqF82cuVzolUHN9NNR0HZPxFPV9V0wLtvq%2Bk4DqOwVWDlzuQLVdqFiP08cRX7aRlBVfR8cb55bWe5LExnlcsDp1vAP8Q9BucPMk1Ulh4GnN0SAdxcNHv3q9ohx1Ati4S%2FtkWjIDe3hQdkUGrGRaFBiUdiTSkI41UkMuuQHP%2BEaSQYlPQTFWJF03BNPpTu5KFAdkWgDukzsZKMG0Q1TAQQglScOaP%2FdsZ8%2BfP75D%2F9Uu5Gs3FY%2F2SxPld0DHOciXI9gqjcEidXjE%2B3BLosy0OcX3T7O5g65ROGyzQ2BZs7WbZVnO5ydLe32hMwTQ4wnnKXW6XW5LAa7oaXOIHoUl0FgLQLH2by8wSTWeAx2Y5PDazK3BqZbeJZwXGPaYhX87ZNszoDdaRxotXO1nNlpdvAPFWHDm8PqEE0sZxDEqGzxisFNnuCWetPcGrObN0p23tTZwMuRVodSV8%2BLTrOV3eRvzjQZiSjaLYS1WEJe0kNsJlZu9LFun7%2B%2BwW4gRDRbaxw2nrOGm%2BxOj9cmtbp9ZqeTM1m8UXfQQCSTVSQox6pvtjot%2FFpHvIUjJovFEoYvHYV9C5Y%2FxN9OfcalvII37UEhTbTg%2FAQIaPb4Vz6j5u8%2FaViycMod%2FfkDcpu8QZbZoeBi%2FvbzP3XPsZvOubMtaPHkD9jt6%2BU2O7vqU%2F9C9SMvgrXpQNG%2FE0oJxun%2BCiElUa0IKQSUwERxOntKSV7ekcuh9VBZBBo3VUcB58ofKBHCwLyf9qFosz9Ibf8dGqwaBMjRig4SGOZ2UkWI7UiO9OfUPdxOYFApUZyfpY7mgEc5rtNGGk2H1lPhAk1Hp%2FVAMqQEHEUfEYkkUQq1JMdzsX7kklRrTrUi1wMcDjmu1YYfATj7Y%2BpGpPEBXuoQIj8rR9mgCl4C9yqmF7xnVWxGVniNqtpVmXBvQ6iwni5YQ8a1jYrXtc2J13HvgkvqWxuva1sbr%2BP2S5ceKGyBwDv2DbrToe1u6BkAJV7xnVLUaq0sJB8pFqcUIPi3yuwxi4JuLr%2BP30f3OkPQ72aO0xYo3%2FEsmO3QO5qEF8S0qQH0UsKXv0brnl9%2B8M7jF174%2BDsfvPOl1au%2FRL5%2F9DsbNnwHL2pHR1NTRxMZhJtHktOOxLxErPF6YlLvpC9YP73x%2B4ofw%2B3xVdrHcDE0dQQCmCRgvt9b35xINDf1CDcRSfJ%2BpYl%2BSf8YcurfmXP5F%2Fkj6J82jNsrkWiEuhVlgFfyNkB3S5MUzLhoNiwSCYcxQ7Ui4J0Xh7fmqRbaPa1tzujxkBRlsEHy0%2FOM4pYLPb7g9O6BQJN6l9zQ0OGyCaZz0vMTbHOzXfQ7a2tsterTcqxeInODoemdktw%2B1SbVhKwtW9ffe8VKadK0OVuC3bWzyKm5LeddsWTeorWyY9IMtUFutdu5g%2BRn533qkocdvLs2HmhU75br%2FMmWtD8zA3OP2t1ea636jEzqYxJZGAwFiDEd61oTsrRuW3%2F3pYNi3bS%2BRd%2BGjOfVpAPNd6y64Gsz1GaZleWIPoYL%2Fv9mTeQBENVEguiF1aC4YeXxFETw6QyPfn0m9g8IrMFAvKM1EI11DARnbqibHk%2FIojy5rSdgCyZi06y8sS024PeuO4MfwQ5Y9yKRZCqyYaF30vzeHlmUprR21tR0t0yz8KZY66zWuGvxVQB%2F36kP%2BK38t2Hu6NQ9SFJfw0AdpqPEK2qTMpf2VCqJwqPoJezTL824b8akoL%2Bx03nhh%2BoNo5e77psxg9Q5LzebIKD%2BfsY34f2MtB9fk9v5b8PT6tYrgv4kRPwd0q9z3gdJSJ0653KjCYPwCaR5aUY63eW48O%2Fkdo33yxX9wCiMv2QTrk8eGSI6Ag6moG9t2P%2FF7GRNlDjl0gw7pJ5aOXXqyqn8SENnXBmbSwUYLyqJjv3UmY1nKr4t80no0faXsaIEiF%2FBRaIBnItSce4OUif7W6Vm9T9H1X9Vj71BEm%2BRdmIJQST%2FZfVdudUvh9S%2FqqNvqT98g9SQ3lHibZY0mRVHooyDN%2FFHmTgzjdozKw28NwQ0hwN6BCoPKaEk3YtKwNhwRLXuk076CGoZNXDQcRwZvreTZY9EZi%2Bd0s4%2Bztv8iei04JQl6ZbDD2eHV7X4uHuFVfPrOmcs6m6Kr7hssr%2B1VZFcEZ%2FPdJkn1hOs8SXS%2FNFFgqt94PIZzZ3tdaL6Q5vo6piSzdy737pwsX1VyxUrF15iJ4uNkq%2Brbyg1Z%2BO8VsNC1UmcvORPRfxtPrfRwL2p%2FoA1eZp6Z%2FaGffoewaXcA%2FxBlKlQLfhQL%2FoPgBGP3qsA7IQS8qDVNswHKRSheDUvA3Q7MZoRcJMxlEygujn1QdyzfPfq3dEp%2FbXh5e5YXW2Ngfvza0ZF6UgFL%2FE0fTq4LBlvTE2qb%2FKuuzYSXVnjTfM1osvqMHVbm9950quIZlbqaL6YP7jk3kUtA0GnX2nvq53f3WoSsvEdDRnULgo2fN7lNZJgI8%2FVWi33c3bBZnGY05%2Bdm%2B3qc7fNmj4YGKLj2nfqFP%2Bg7jdDlxEV5XsJQZP6hYrS1l0VQr4c69Xueixp90gnZPmE5OF22j%2BSYEWHlZ0K%2FHgsh%2FZtsbh6h2DNRlvv6jJh9XaJaHCZDiUDKNTMkvb8vsqCyf3ZNdSmO0fa0Y4baJTtpbKzuVzeeSI7fCKr2Z0WypapnXJ4gnoWy3PoUIlIQ1TXdqhQJIXp9Wx5fYdpeWh2TY5D%2BYVyKd0jw3iumwi%2FBC3cEy4o83QlZnW79MrCgCjbhWXBlRZVVZZv4rIKpXC01HFlHdHLoeWVl6UVc%2FJ5uGm6CViW5mulYMk%2BHqNYr0AyUPivLg2oMs2MPqtuhHyRyiwvNJej1Br%2BfcLyoAyu8D9B7bgmzUqfFobF5nKnK4%2Bt8MPJkI%2FxHUNWk117jugWF%2BxazTAALQn6%2BUE9lhoI5ApGA%2FiuJOsrlNP28SVVuBVajXmircLel46w2bJS1Q0Ft0KDuikDFL%2F3pYrid1Q4FvofwRIo4R9h2ftSwc6jHAMqLcCql8YPHtlzGoByNXYN6v8hXnRaOhUvx0sVLCexwupGDR4NOYC7PePa5keIPACnuAdD7dEadRuTIiS6Lb7uskb381My5yjzF8lGCjBRqdwrWJCagfB3yCy7XT1i92hbcZ5Ci1FJkgYMDf6n%2BjspIsHFjJrTOdzSMuOa9DbDcj%2FnH9N9bIoGVgzHPWIQuFuYtaMRaq8eCKI0gEF6lPOZjBz3EEvaaxwSUT9U%2F8JbJZPJJLBLolH1La%2FRbF9AbC8JJjv%2FmMnssKjLRBJyqj9QXxNko0Ux%2FX79epfiXkm6fmKwF%2Fen1HLc6LxloXWKvGa5rVCVL83VuiPcDEX%2FK5pTXOxHfx6HHB0t2FI0qI2rCZFTrvPWU67zVuS%2FkTsLnc7IKhFg30e4FOkqNSfH5PtkmUy6Cpiv%2F36k2sbqCeCFNa%2BURpoY0sZoYmCgCr3qgZz6s8I0gP1bYiR%2BD79H56NOz0EVWCTy2%2FfffvSCCx59W7uRV9995eqrX8GLesOXNm360iZ%2BT%2FEl3uZqL%2BFyzSZ8XxpTiI%2FG0nkT4zznFZ0t4ipMz5v4q9ssqbdKUZt6u82knPCrt6PZwsnn0XySVnyPR1ZXAn72yx48bWJsu7apnI3Hy8bygUK5Js32qcytapqgmn95uexccj205vGgJ%2BeuOeG2SORmKZr%2FqKzcx9SFctMJdwMUFZDJITs7dnOp1EKZCxg304Cevyfya%2BvlKqv6aXK1qIj3imL%2BL6hL%2ByvUlFfE0VKZ7E8gBY3M%2F8VoJCFgizH1W6VyC76nH6b7jiibYVxUmVIEspry%2FLgZIlCeP11Z4zs%2FAwvVwtGFEut5S1JY4lfyT0N%2FevOLo%2BrUEgjcqc9IkGpQbv3iW7Co5b%2BKgjvpzYdH85PLcc4X21ouwEGl%2FS4qnUAvoSlXUUhR1eKr2VWFTB%2BGMl6FsiQsVD1R3urlAAIoSn7JQkmiVVCHSpCwDH%2FqPepXQ0Db77CJOAImohB%2BRPWr31ev5g%2FkE%2BzTa4lbvZo8xdWPffQu9yJTPCNB66s%2BzXoJt%2F0L6hSoCuBIoK8fnBGG87OoRckJpLqyWe4YbpGi50g0%2B3I3UD85Oa0fzubfoXxPLbW3FDWzigmyJeM0tQkax7PqTy80%2BUxfUHPlBZIRVNQ%2Bv0xRm8REKPoLmNr0%2BUo48v9GFbXPKylqQ2IKm00QddgyWGMROCTxdLB9nCY8P7j2DjlsV%2F%2Bmfr0C0r%2FNkeXbbpPlOTBBwT0mVz1zx9S%2FwJecBF9Wgv3p032iP2v4VSgfgW2G%2BHUEdEXU6iq4CtpLJfIN9XQG8dwa1VoO8XC2SrPDDyCOQptXgbcPvlAgBfxBoGwftQKeKFrNTASPt3pGGqDt%2FQRasn2kri%2BH6L80MJRsmVYJrAKyDItpJUy3%2F15WYIJqcJ9Q5N%2FLFJ4c3dc1URpWl9hW6mu50MUIelg4ucTPf15zs5DFo1c0VSp1tKB9jkwIyuM45kb%2BIP8gHed%2B6jO3v0KbIknzLy636E8KPTdCuUpB0wLo9JKnAO6pv0vS31EtBha%2FfJemkgLVVnd8KCk4qBTpQ5m7FbifBKrPJcq0pZAFVG%2FXbOFz%2BTcq2MLrcmV28Nmi%2FOHskh82bau0k8eWCaPijQPWQ5lUvslwVCfHkXBMIehqUgtDNLeauH1huvZTbYmw%2BluPjyWoNGEuxRLR7LK5fSyXFUyK7PURQv2v8D3XOt2NJ6liBbmPGOsakw1kbeOs%2B31Wm5qpH%2BiJWSzqdPr2O7zc2TmtnrzCig6bBd%2FvgQmzOlz0STWIlmZEQfupogOZFHUZ7EkUnMn0RrpIMqAgHRJAOjIJ3yGw1I%2FMAp9q9S3Q%2FclADNm1wEeO%2Bxbwg5OIYHZLY3ehG5lJk2xhco%2B6JWybpEVz2wrR6hZyD0QXZbeDVB%2BonmlimpkWprdAs4WEZDSQppsDlcdCBJJESIYFuAtUnC4GIF2C3Uu2Kv7L1bdz6FxtqxpG4TqQOqOUNAJ2HLvPWA2GgDy4O4vaDrtyl6P%2B1fAll%2BSyFcQ28GHqh7fvvf37udylf0fNwhzgz87Y%2Bcf5x9GnF6ygHu18sAbipWeF0YPBgp2GaKeQduxxdEr3SgbH1kvH7tvqSLhedomOvZyts2dw8acu3dY%2Ff%2BucuMtCuP%2Fe4zC4XnH3OLZ8ZuxTWxy8dJfU5dhDeKPSlJy5pn%2F%2B7u3XrJhmr9C5CuleGflGQocKnlAUaRKp0BAHV0ZwUt9VCqk6zYOgRIuMfePJzdmBdpPJ7%2F6B23%2Bf%2Bsp9NMDZevovvfYHG5dGPISQq1DojqNckchVrCcCYz%2FQ0hI0m3NKDRfkgsrnamo%2Bp0CAq1FyvC3a3Nak%2Fs5VX282x9Ufy3E39VAx6o7LpCvO2wK%2Bch9jNqpJCutcIOooKnYWtDK8gTRVYygRQfwgzKM5%2BjP2jOZdx3r32Py7rQUPOzAnoRs95NvRAR0qLGU11Taqu1bUYSzMcWjMEir067JQQHfIrLBHsrgv00%2FWavd8HRLMEEYFSW3HCSNQehnrHztKqHcDyo4VfZ6gPKCR%2BgufwA8GegxUEo4A%2Bgd0BASHiH6jYMLIsUdQJTs%2FC641KN4oCHWolCMLlMfIdtWKScjx7SM5LD9HnfmhrGI0S139UWfUnxgOXdJFW%2BAMcGjKr6eHAttHF5sUoeArYKDcxMSYcKA%2FxUDhPiEOEAPafSIUFArN0r24ynI91EPARDXvIDYyvqZaWeroBOUABQA%2FE%2BDXC7PWafDLQY2oiwpUEyj4RQtVlUp1GrM7In2p2A7VuiOW6otMiGOo5Mrp05ejVuTy6dNX%2Fk%2F7mybZQ0nUmfrbx3U4KueDnlHm5wdh8FFeKnoaKKh%2FTK18StOPhwG9Xo5mqXAxvw%2F79YQwwDR%2BnAKQQ4izVXioB84qcppWB7IqjU45z4CE17OvF1Dw%2BoTFqxtz8dxwtogBnF9MjIl%2Fin%2BK8s3hM9laIn0TiCbTAXL0T798bPXqx36p3chrv0O%2BGC9Xaj48Ecv8U8UEeBvUEsDlTepiU5OvlpeNGvpnKF0RvUooWhIjnx6GeBapXCQYTw9DNg6%2FOC3gZjp76oNTj9Kz6Jqobxb9NDqc08vcKReOpcsQV2K8InXFaXW3aI6Ofr1k48rp7CX7rx%2Bv1UKPsfvzQU0Kc83i2VdILmd2%2FyX55zT9luN2%2BCu4nKfwPcK%2FCvDVU%2BpHh8%2BLaldIf1fA5h3ndT6Fln9%2FW%2F9Ce1vndfvJtnPVO2xhm3qbafHVCN1X363UXHq9xuVD8OSD29Z8pZ5cZrern9cAdGW%2Fuib%2Fud%2BVK0L9a42r6C90kL8KzxwLQw9NkIQJL0ASU8M%2BVG0KsUdgdvpgP%2F6NqqP0%2FgHZFUfGEijZLHpiIgvV5%2FBltrj8Qd7XQd5p4P%2B7tJo30NMO6VGBwahSPMYiaaBYoLY6uEnciyhhh1Z%2FvvacG%2Frjpsvnpzs0B1Id6fmX8119l88XnOxe%2FuGrzzHcdu7UtY3%2B2vmXN5zUyj3ZcPl8p1sZSs6%2FnGXtwrV7Ka0XZdz83fwjjINpZWYw85lL8BRK4nGyIir2RiOsEyipuEcIakpGjWgBjLiHWOgj0Yi34gW1kKPxHt2Na5q%2Blwg1RdRSpFDNzosb44YJXnAfoEOpZW%2F%2F6u1lhYA6leevezbI26zNHO811M2dc5HFxpk4i1jPC0s21%2FBWW5DnPQbn2X1WK43%2FaM2n18DfSoybbNHijFpamzXI31eRibGUOxSu%2FlT96YZlq1Yt20DaSBuG6knw2eusHs5EPBfNmVvHKdaQzcDfz9ZsXmLDWGXy2U5OsYSsIn8CS12jQIyD12KKqZrLPy7mSPdICmd6WGHG8NDZkkHuE4h9TU8FpmUO%2FVjC%2FEinToFyoNDz2p9XD6g78WgQdPG7Z3R0T%2FZ5dTM9lsL8Ktek7szl2L%2BgQwGgwkZHc2g5Su7NvVqwGy2Ua4KSXUwt1X4PaM5paaEu6jQ5zVFyNabxvUksVt2T%2F4VeamYPlLtffdQsk%2B2sUTY%2FzDXl%2F05W53%2FBz9UK3p7LjapZ2ZxOm%2BUlZXrL3HHGqO8%2BwVroDaCTTnTxitMxmiAAYQzVJQH%2Bnj3oIHnPaN6Zq6sNSLjBl8tKgVr2mj%2F9CWi9dnKca8rBQBsd5R1tzVlgrl5pbnPw6kZclCr2CHxMnHohLz%2B3KRQokzALyeIKFU1TNCiayJdoHvDYe7K6mZLm8S3uJ9dojuaJ62%2FqN%2FtjQxnSnhnKPw%2BLNrLi8ZKyJ3x1YhiI1aNAtP6NzCGzYv3DmaGh%2FLvQZnt0evgIhTFV0kE%2FPYxAnOHhCQUZdCWY5JWJwMzlAGl1mpNbDU7yyGnhRMILsYhH3VRAijrPcBU8%2FCj1Y9NY6cnGVW0CjTLaz7E3epvaT%2FLtTV72Rs%2B0WVVmd0dz%2FMGTI5F0OsIviaqDlbbO5X6xT3PeXbXHRtf%2Fz%2Bfdka%2BeKPr8KF7IF4vBsT9MFPuPJMBTBMq9hQxXelQ%2Bbewnf18ap4Ib%2BmSMrtDU5zqlD8QANa5MBGh%2FOwOvSDfcV2d66mfEWsbGWmIz6nsyZDWQSmqmxDneYyvjHPmRXHZxeueyRGLZzvRioKnGto9nIPkibAJA16adcOZRQr1iAP3bUyBR7T4RgAWTKxhkCYFwshq%2B7iV9r0whk50cmRcTg4fy5x4OmmNkHndIA2%2BYuMbmE9dwGYB4KFTsvnDE6Ah47r%2FfE3AYI%2BoXADpkdlENcZ8OZEEf8FFGZNxMs6ZLpG3SUFLL7Q2kcFU%2FA%2FJsw%2BvWDa%2F7emewLaoeibaF1B9qUNnuqWK3%2BUfXYVL1v%2FomD15xxeDkPnXTOKSVcCbDGtOu0YQNpGAP7U1HU58UrqGu8xIbHtkQ3LVhb7Dx46ET3Ffcm1q0YcOizNmf3bC3VjWfAcpSv3MyTlgJ23FHQgmgvk%2Bgk8pL0mcCDOn08MDAQlf%2B%2FSlTZ1z12fnqntOhbOTL9%2FZdevbAPN%2Byby1f%2FuUtC%2Fixm8ZBo59LTXEW060hGrTDplNprWd58fwB%2Fb%2FE27BdS%2Fs7U%2BrGVCeQ46nzaw9QccnmZerGZZs3Yw9aVHt%2BKh6HN4ti6lxIhT%2FwahnZtWwzlY9QHQ2c79C%2BdxzvVDKy8GqKWQERO9YAKbpsDUTLdWV5dE8PVPjvj9pqw7ah%2FPFVtkit7aj6G5xY9mfJrCz1j1e0BcnPol4UjtrCdbahIVtd2HaURujnFJR8CuOuUUfhrGhgKKgjCYNSvCc1WKlEp8wHUaAYynFNyzZn%2B2MnYv36dbMDBTonl%2FT%2Fma5IKAyEGz%2B4eRnVtaX6tss2o34u8mWorFtuFgm4A6qK%2Fyp%2FgLEBVat5WnPDdKA574ubuFJ%2FIUfZ%2FY2Nt6mN%2BZNNTSTaeI56gKwkXerTe9DDHUw8%2FH35FY3nNN7GGuBKWhrV9ep%2B0k1WjNWVaHkW1yA%2BQHWNu8rtBw2a5YXuE40rs7%2FGA%2Bj09V3hA98yRnFPOGr8ltGlsFdD%2F7tRce3LH6Trcneuiy7K7J3khKu%2B3qUaXPWaX7T6%2FKfj9BX2eZq2XAcZT79u1ClJzUtHUqfqSMWBcZS43Ena0cUGLgpkKxB1QM%2B0Fxz10wgg6r5rltnFpH05pepUq3Y2HfYqeKRntmUFNz%2BXmcOs1H31U6cC6RTVLfCg7RNBF1UF2%2FwBgu0fFQtPEU1sSg3VcNsR7dWq3af87tUFn1l3ltXpaJxpNvtcZkH2WmMst3JqRpxUH%2BWC0E1qOGtP66s1MYv%2BVLu8%2FXFXvV%2FZbunYYBeVN64ls0ur6NzpV9xzlmQwB5qC4Tq70WC0tk8dWJXeHvkD0h9zJOM0vD86%2F1NJMaIAolctvlByferCsqOKDKceOfUu1PsmoFCamV5mCrMUOCi6V6FJosMF22AcrKJgQDVhfYh6tepp%2FlYgvnCEAbJQ1L0rOpajEmRcasMiPfxhgGoVo4rwreQpV6fUJHH2e8fa1s2c13Apl1b89a58ozdoap2sjgLN9uISl7P1DrulyeIkt0zr6JjWocoPOZsaXPb6jtqBblsgsaRre2xHi4nELm0MhG1%2Bx1SXwLpFi53b%2BaHRYo%2FIrbZtuWAKu5cSEXfybnnmUCaXGTpQr0xK2O2WWY76f%2BnAjNVf7nCZHU5XqIkTnpt6VtvsFlPXg1031g%2FVRdpkkyVpD7jnmax88QwDvg%2F66NnMRdRXTcGTmQc3cuINwN5IQqi0yzb%2BYFVHuVqI5s4ADfg5oE4ybDLd28mFSFmYvRoomsWXEdLU2Wl3GJy93ZNb%2Fd5gqmNaqJZSO1l6PVRy0nZIj%2F45EetjLguh1rLqR%2BSK0hO6NrsqcNX8zoUdjQYDJ7tb4os6%2Bi%2BY0qpY2AWlnLRDWdGFTfGY1gV0zNAtJ7pdo24se0D88AwLY%2FgZmE9iuP4V5v7CSR%2FRThaHLh%2BUeBkXwU6BC7lGOevK65udTv%2BtS%2FPfW7qj3ljTcj3b9OkbV85t8xsMj7Ddj7DGpthZKwKPvso%2Fc%2F1K9aLE12fMWLV1y1D9ua8lyJdWXr%2FbG%2BnoCFutf%2FmLILe39ITUV4igr3876fpX5g2zeB52sWnIL4fXHlgeUzOx5QfIvJQyrKQE9wHUqVq%2BPEaOrz0wVvNbJZVSfsuMzxN4l9PkedFzw9V5Dj%2BnzpgoT4ZxCxJfC5RWLc74YVHxKlExCYt0JAOMatREhHBSCAtSfod6x6Ls8HCWECLwXZ9nd5Dz1T24JUdWs6fU3%2B%2BfcnT49Qe%2BkBs%2BwdsMZgPXMp3U5S958snPP%2FEE7bvkOPCuTUDTUQ%2FUzirLhML9yPahoe1D5Fj5jWsaoveyP00PehdUAHk%2FseDVWsvDWXXXsyn%2F4wfpXc2V3%2FQxli3jl%2F5hj%2F83avSCfpTNxOEKLmTjxOEKuxgNlsQn0xgct724mhynupNW1Ph6o3RYS3%2F%2B2TJrzLlkFz%2Bip3qCHKf6eqW02QJLjBYuuj4sobhCWqa%2FYHGEHpcnumuWSOhxeaL7sOakNR6vvmo%2BYcfFA8UFXEPZf9UjyudIOyNwx%2Fi90DdsujS%2FFX2UAwvWSVK4NxaMhAGw3oowp%2Fuc8CTi7D2rBgZWwb%2F60faR7SPsEbjkXy4G0XaqhXPwe2cePjxjxuHD6ssQuR1fq6PF0E%2Bo2t1nePTn8TUmxz%2FA3crMoCc7egESuoTHYc7mYdg6etORoOhR7BBGD%2BqJopELrl4S6cJNRtEAsLP%2FOdvnJq0Wo0GolY2Et9VFB2Kf%2B4bZvVyxfOMz3WdFfSIryj6DwWghre7aQbdiDrkTL3A3vNDuDpk93HqXwam%2BbWmUJZfNn5ozKV5Pmmq8PF%2FjVY%2B2Tlk2M2RzSXKjmbQ4RZcQavEYrN%2F9rlXwtIQqzxQNMzPPfHYLvuPoO9TbT8bpGw5CQPGd%2BSyX%2FCyf0Vxjd2R9NmsunnXYa8xGHzn%2BsSfM5J0y0DZEXWWxkXjcR75KBLNLHi7XvX2G8VOrf4Ykg0AMdBESIpo7MgAfyakA6rkqpI6UjNs0px7cMV%2BD5BF49Tez1VGnYmq0WIijp985m4Sn2gJR9b07riPPFo97OYbUZbxJCpot7H%2FlpZBicglCPN7WOfJkcHqc3ElWqvvz%2F1E6bIQrG%2Btz6WkM1SM9FBTR7FSs8KyBBytSmNEoquJNFN5EQyTiCrnKDx1h58yxCepPHU5nxGoxEQeeOZi2m80DxNxncVhr6BmEfUarxejw%2BWSiHhWk19bSY7aKR5MsteblJpfTLtjimBouXsm3d3djjYM%2BwEW0El9dM%2FueVRWIsXwe43R7SgbVZqrnqoJ1X%2FkuF7pcgf8duv4q6vayV5U9zMV91GxO59UUjW8rHV6u799WzKMT7umRCXbYUKM%2BfoaCcwgaoqZUtmodV3p%2BX7akb4dnU9B9La38RPFUG2SCC90tVA4XwEFhyOpZZrUCsgWYHsczLFBBVGNtstoN1bw0Z%2BO4fYIbvZVt4EUcJEKOhHeincWqONw%2Bq6w5Go%2BWGOSR7LhKV%2BKBqbBPpfUvOf9QqkpDyVhBeyyZQGMsdA5FBUqvFMtUyGq9vjnsAJU4UcrxldP1CCaofyDkSAifoP5QwWx%2BSyUGxp75BzGAvtG7uQ38LehlyEQMeh0TeE6Bm7tYdXqdkt0uOb3kfYlNwmOdDyacOq%2FqlFo1v%2BPTmTi3E%2FglC9W11b34A22zmLzvb231Q0L2Bgg60OTW4YdstO%2BYOJnO38TtpH7zy9ymokWyA79qlVSn38HtpFlImFnhu3b4boNWXklOXV0Iwo7lQ1hrZyPFcwtjwFP7iEKSHSSJw509kh8kj6pr%2BH1jR7km9vcvqN9657vffefkv%2BfKxge1X%2B7RdjYUPIESN7gTvRkB%2FRMYtEkaVkdHApmdBPpnKmz0n1xSWFOyVIuLrinZwpoCRe6kyiVZoHX088F%2BUX4%2BWKS4iBTP0IWxGtZgOdMaV4KTayqHQF%2FVihBwTbgDXTCmKoOBJeNhwJMzEVjtjIFLuU38fPR7hqNG1JS7g%2FqRCuy3vmQ3W9Vu8qbVbP%2BSzazGRJH83MzP90Ck2m31mMjP8TiLn5uwD2Ugr2PFvPQjB5BnSJvQxGQZZEB%2BLopqzGzDbMmbkAPkZVJjeO5FzOSBKCgJze2ZS4Gemc9twrwY6u9H61iUQTcRvtdT9RW3tRxAWwFs2tcuJRnI6xjmBdWjbgFNRHMHiF1uHYBfUR%2Fut5Ug2jXAaT96%2B9RH%2FFToRwIzGbKmVJ1AZQnoabSB1yyIg7ByAridHApPMjyw0OiV6RjSbCuzwLAvFizBliWJua1tsuAgvNPbmljYbpt8lkWam7b3XZiOiKJskMOtmfScnsbPW208knwjuXrXK4Q1iKIgNyYXXDVT9C2Ye%2F78GQ5BEEXfFdde2RwauOysdJNL5AzCy84ard%2FnGAVN8alecnFdgu5Gbd5DJTL%2BhHZK0vApVy3OfU8XTSJg1TlssivsPYUlIqvn66PzrVTymCc4wgF6SDNR0pDf%2B9Gp%2BVnsUH5WtpHYsuhOaey8zdwLN47V8MTbm78g687%2BP3cx6tcAeNpjYGRgYGBk8s0%2FzBIfz2%2FzlUGeZQNQhOFCWfF0GP0%2F8P8c1jusIkAuBwMTSBQAYwQM6HjaY2BkYGAV%2Bd8KJgP%2FXWG9wwAUQQGLAYqPBl942n1TvUoDQRCe1VM8kWARjNrZGIurBAsRBIuA2vkAFsJiKTYW4guIjT5ARMgTxCLoA1hcb5OgDyGHrY7f7M65e8fpLF%2B%2B2W%2FnZ2eTmGfaIJi5I0qGDlZZcD51QzTTJirZPAI9JIwVA%2BwT8L5nOdMaV0AuMJ%2BicRHq8of6LSD18fzq8ds7xjpwBnQiSI9V5QVl6NwPvgM15NXn%2FAtWZyj3W0HjEXitOc%2FdIdbetPdFTZ%2BP6t%2BX7xU0%2Fk6GJtOe1%2FB3arN0%2Fpmz1J4UZc%2BD6ExwjD7vioeGd5HvhvU%2BR%2BDZcGZ6YBPNfAi0G97iBPwFXqph2cW8%2BD7kjMfwtinHb6kLb6Wygk3cZytSEoptGrlScdHtLPeri1JKueACMZfU1ViJG1Sq5E43dIt7SZZFl1zuRhb%2FGOs44xFVDbrJzB5tYs35OmaXTrEmkv0DajnMWQB42mNgYNCCwk0MLxheMPrhgUuY2JiUmOqY2pjWMD1hdmPOY%2B5hPsLCwWLEksSyiOUOawzrLrYiti%2FsCuxJ7Kc45DiSOPZxmnG2cG7jvMelweXDNYXrEbcBdxf3KR4OngheLd443g18fHwZfFv4NfiX8T8TEBIIEZggsEpQS7BMcJsQl5CFUI3QAWEp4RLhCyJaIldEbURXiJ4RYxEzE0sQ2yD2TzxIfJkEk4SeRJbENIkNEg8k%2FklqSGZITpE8InlL8p2UmVSG1A6pb9Jx0ltkjGSmyDySlZF1kc2RnSK7R%2FaZnJ5cmdwB%2BST5SwpuCvsUjRTLFHcoOShNU9qhzKespGyhXKV8SPmBCpOKgUqcyjSVR6omqgmqe9RE1OrUnqkHqO9R%2F6FholGgsUZzgeYZLTUtL60WbS7tKh0OnQydXTpvdGV0O3S%2F6Gnopekt0ruhz6fvpl%2Bnv0n%2Fh4GdQYvBJUMhwwTDdYYvjFSM4oxmGd0zVjK2M84w3mYiYZJgssLkkqmO6TzTF2Z2ZjVmd8ylzP3MJ5lfsRCwcLJoszhhyWXpZdlhecZKxirHapbVPesF1ndsJGwCbBbZ%2FLA1sn1jZ2XXY3fFXsM%2Bz36V%2FS8HD4cGh2OOTI51ThJOK5zeOUs4OzmXOS9wPuUi4JLgss7lm2uU6zY3NrcSty1u39zN3Mvct7l%2F8xDzMPLw88jyaPM44ynkaeEZ59niucqLyUvPKwgAn3OqOQAAAQAAARcApwARAAAAAAACAAAAAQABAAAAQAAuAAAAAHjarZK9TgJBEMf%2Fd6CRaAyRhMLqCgsbL4ciglTGRPEjSiSKlnLycXJ86CEniU%2FhM9jYWPgIFkYfwd6nsDD%2Bd1mBIIUx3mZnfzs3MzszuwDCeIYG8UUwQxmAFgxxPeeuyxrmcaNYxzTuFAewi0fFQSTxqXgM11pC8TgS2oPiCUS1d8Uh8ofiSczpYcVT5LjiCPlY8Qui%2BncOr7D02y6%2FBTCrP%2Fm%2Bb5bdTrPi2I26Z9qNGtbRQBMdXMJBGRW0YOCecxEWYoiTCvxrYBunqHPdoX2bLOyrMKlZg8thDETw5K7Itci1TXlGy0124QRZZLDFU%2FexhxztMozlosTpMH6ZPge0L%2BOKGnFKjJ4WRwppHPL0PP3SI2P9jLQwFOu3GRhDfkeyDo%2F%2FG7IHgzllZQxLdquvrdCyBVvat3seJlYo06gxapUxhU2JWnFygR03sSxnEkvcpf5Y5eibGq315TDp7fKWm8zbUVl71Aqq%2FZtNnlkWmLnQtno9ycvXYbA6W2pF3aKfCayyC0Ja7Fr%2FPW70%2FHO4YM0OKxFvzf0C1MyPjwAAeNpt1VWUU2cYRuHsgxenQt1d8%2F3JOUnqAyR1d%2FcCLQVKO22pu7tQd3d3d3d3d3cXmGzumrWy3pWLs%2FNdPDMpZaWu1783l1Lpf14MnfzO6FbqVupfGkD30iR60JNe9KYP09CXfvRnAAMZxGCGMG3pW6ZjemZgKDMyEzMzC7MyG7MzB3MyF3MzD%2FMyH%2FOzAAuyEAuzCIuyGIuzBGWCRIUqOQU16jRYkqVYmmVYluVYng6GMZwRNGmxAiuyEiuzCquyGquzBmuyFmuzDuuyHuuzARuyERuzCZuyGZuzBVuyFVuzDduyHdszklGMZgd2ZAw7MZZxjGdnJrALu9LJbuzOHkxkT%2FZib%2FZhX%2FZjfw7gQA7iYA7hUA7jcI7gSI7iaI7hWI7jeE7gRE7iZE5hEqdyGqdzBmdyFmdzDudyHudzARdyERdzCZdyGZdzBVdyFVdzDddyHddzAzdyEzdzC7dyG7dzB3dyF3dzD%2FdyH%2FfzAA%2FyEA%2FzCI%2FyGI%2FzBE%2FyFE%2FzDM%2FyHM%2FzAi%2FyEi%2FzCq%2FyGq%2FzBm%2FyFm%2FzDu%2FyHu%2FzAR%2FyER%2FzCZ%2FyGZ%2FzBV%2FyFV%2FzDd%2FyHd%2FzAz%2FyEz%2FzC7%2FyG7%2FzB3%2FyF3%2FzD%2F9mpYwsy7pl3bMeWc%2BsV9Y765NNk%2FXN%2BmX9swHZwGxQNjgb0nPkmInjR0V7Uq%2FOsaPL5Y7ylE3l8tQNN7kVt%2BrmbuHW3LrbcDvam1rtzVvdm50TxrU%2FDBvRtZUY1rV5a3jXFn550Wo%2FXDNWK3dFmh7X9LimxzU9qulRTY9qelTTo5rlKLt2wk7YiaprL%2ByFvbAX9pK9ZC%2FZS%2FaSvWQv2Uv2kr1kr2KvYq9ir2KvYq9ir2KvYq9ir2Kvaq9qr2qvaq9qr2qvaq9qr2qvai%2B3l9vL7eX2cnu5vdxebi%2B3l9sr7BV2CjuFncJOYaewU9gp7NTs1LyrZq9mr2avZq9mr2avZq9mr26vbq9ur26vbq9ur26vbq9ur26vYa9hr2GvYa9hr2GvYa%2FR7oXuQ%2Feh%2B2j%2FUU7e3C3cqc%2FV3fYdof%2FQf%2Bg%2F9B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6D92H7kP3ofvQfeg%2BdB%2B6D92H7kP3ofvQfRT29B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6j6nuG3Ya7U5q%2F0hN3nCTW3Grbu4Wrs%2FrP%2Bk%2F6T%2FpP%2Bk%2F6T%2FpP%2Bk%2B6T7pPek86TzpPOk86TzpOuk66TrpOuk66TrpOlWmPu%2F36zrpOuk66TrpOuk66TrpOvl%2FPek76TvpO%2Bk76TvpO%2Bk76TvpO%2Bk76TvpO7V9t%2BqtVs%2FOaOURU6bo6PgPt6rZbwAAAAABVFDDFwAA%29%20format%28%27woff%27%29%2Curl%28data%3Aapplication%2Fx%2Dfont%2Dtruetype%3Bbase64%2CAAEAAAAPAIAAAwBwRkZUTW0ql9wAAAD8AAAAHEdERUYBRAAEAAABGAAAACBPUy8yZ7lriQAAATgAAABgY21hcNqt44EAAAGYAAAGcmN2dCAAKAL4AAAIDAAAAARnYXNw%2F%2F8AAwAACBAAAAAIZ2x5Zn1dwm8AAAgYAACUpGhlYWQFTS%2FYAACcvAAAADZoaGVhCkQEEQAAnPQAAAAkaG10eNLHIGAAAJ0YAAADdGxvY2Fv%2B5XOAACgjAAAAjBtYXhwAWoA2AAAorwAAAAgbmFtZbMsoJsAAKLcAAADonBvc3S6o%2BU1AACmgAAACtF3ZWJmwxhUUAAAsVQAAAAGAAAAAQAAAADMPaLPAAAAANB2gXUAAAAA0HZzlwABAAAADgAAABgAAAAAAAIAAQABARYAAQAEAAAAAgAAAAMEiwGQAAUABAMMAtAAAABaAwwC0AAAAaQAMgK4AAAAAAUAAAAAAAAAAAAAAAIAAAAAAAAAAAAAAFVLV04AQAAg%2F%2F8DwP8QAAAFFAB7AAAAAQAAAAAAAAAAAAAAIAABAAAABQAAAAMAAAAsAAAACgAAAdwAAQAAAAAEaAADAAEAAAAsAAMACgAAAdwABAGwAAAAaABAAAUAKAAgACsAoAClIAogLyBfIKwgvSISIxsl%2FCYBJvonCScP4APgCeAZ4CngOeBJ4FngYOBp4HngieCX4QnhGeEp4TnhRuFJ4VnhaeF54YnhleGZ4gbiCeIW4hniIeIn4jniSeJZ4mD4%2F%2F%2F%2FAAAAIAAqAKAApSAAIC8gXyCsIL0iEiMbJfwmASb6JwknD%2BAB4AXgEOAg4DDgQOBQ4GDgYuBw4IDgkOEB4RDhIOEw4UDhSOFQ4WDhcOGA4ZDhl%2BIA4gniEOIY4iHiI%2BIw4kDiUOJg%2BP%2F%2F%2F%2F%2Fj%2F9r%2FZv9i4Ajf5N%2B132nfWd4F3P3aHdoZ2SHZE9kOIB0gHCAWIBAgCiAEH%2F4f%2BB%2F3H%2FEf6x%2FlH3wfdh9wH2ofZB9jH10fVx9RH0sfRR9EHt4e3B7WHtUezh7NHsUevx65HrMIFQABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADAAAAAACjAAAAAAAAAA1AAAAIAAAACAAAAADAAAAKgAAACsAAAAEAAAAoAAAAKAAAAAGAAAApQAAAKUAAAAHAAAgAAAAIAoAAAAIAAAgLwAAIC8AAAATAAAgXwAAIF8AAAAUAAAgrAAAIKwAAAAVAAAgvQAAIL0AAAAWAAAiEgAAIhIAAAAXAAAjGwAAIxsAAAAYAAAl%2FAAAJfwAAAAZAAAmAQAAJgEAAAAaAAAm%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%2FAADiUAAA4lkAAAEJAADiYAAA4mAAAAETAAD4%2FwAA%2BP8AAAEUAAH1EQAB9REAAAEVAAH2qgAB9qoAAAEWAAYCCgAAAAABAAABAAAAAAAAAAAAAAAAAAAAAQACAAAAAAAAAAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAQAAAAAAAwAAAAAAAAAAAAAAAAAAAAAAAAAEAAUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAYAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAVAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAEUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAKAL4AAAAAf%2F%2FAAIAAgAoAAABaAMgAAMABwAusQEALzyyBwQA7TKxBgXcPLIDAgDtMgCxAwAvPLIFBADtMrIHBgH8PLIBAgDtMjMRIRElMxEjKAFA%2Fujw8AMg%2FOAoAtAAAQBkAGQETARMAFsAAAEyFh8BHgEdATc%2BAR8BFgYPATMyFhcWFRQGDwEOASsBFx4BDwEGJi8BFRQGBwYjIiYvAS4BPQEHDgEvASY2PwEjIiYnJjU0Nj8BPgE7AScuAT8BNhYfATU0Njc2AlgPJgsLCg%2BeBxYIagcCB57gChECBgMCAQIRCuCeBwIHaggWB54PCikiDyYLCwoPngcWCGoHAgee4AoRAgYDAgECEQrgngcCB2oIFgeeDwopBEwDAgECEQrgngcCB2oIFgeeDwopIg8mCwsKD54HFghqBwIHnuAKEQIGAwIBAhEK4J4HAgdqCBYHng8KKSIPJgsLCg%2BeBxYIagcCB57gChECBgAAAAABAAAAAARMBEwAIwAAATMyFhURITIWHQEUBiMhERQGKwEiJjURISImPQE0NjMhETQ2AcLIFR0BXhUdHRX%2Boh0VyBUd%2FqIVHR0VAV4dBEwdFf6iHRXIFR3%2BohUdHRUBXh0VyBUdAV4VHQAAAAABAHAAAARABEwARQAAATMyFgcBBgchMhYPAQ4BKwEVITIWDwEOASsBFRQGKwEiJj0BISImPwE%2BATsBNSEiJj8BPgE7ASYnASY2OwEyHwEWMj8BNgM5%2BgoFCP6UBgUBDAoGBngGGAp9ARMKBgZ4BhgKfQ8LlAsP%2Fu0KBgZ4BhgKff7tCgYGeAYYCnYFBv6UCAUK%2BhkSpAgUCKQSBEwKCP6UBgwMCKAIDGQMCKAIDK4LDw8LrgwIoAgMZAwIoAgMDAYBbAgKEqQICKQSAAABAGQABQSMBK4AOwAAATIXFhcjNC4DIyIOAwchByEGFSEHIR4EMzI%2BAzUzBgcGIyInLgEnIzczNjcjNzM%2BATc2AujycDwGtSM0QDkXEys4MjAPAXtk%2FtQGAZZk%2FtQJMDlCNBUWOUA0I64eYmunznYkQgzZZHABBdpkhhQ%2BH3UErr1oaS1LMCEPCx4uTzJkMjJkSnRCKw8PIjBKK6trdZ4wqndkLzVkV4UljQAAAgB7AAAETASwAD4ARwAAASEyHgUVHAEVFA4FKwEHITIWDwEOASsBFRQGKwEiJj0BISImPwE%2BATsBNSEiJj8BPgE7ARE0NhcRMzI2NTQmIwGsAV5DakIwFgwBAQwWMEJqQ7ICASAKBgZ4BhgKigsKlQoP%2FvUKBgZ4BhgKdf71CgYGeAYYCnUPtstALS1ABLAaJD8yTyokCwsLJCpQMkAlGmQMCKAIDK8LDg8KrwwIoAgMZAwIoAgMAdsKD8j%2B1EJWVEAAAAEAyAGQBEwCvAAPAAATITIWHQEUBiMhIiY9ATQ2%2BgMgFR0dFfzgFR0dArwdFcgVHR0VyBUdAAAAAgDIAAAD6ASwACUAQQAAARUUBisBFRQGBx4BHQEzMhYdASE1NDY7ATU0NjcuAT0BIyImPQEXFRQWFx4BFAYHDgEdASE1NCYnLgE0Njc%2BAT0BA%2BgdFTJjUVFjMhUd%2FOAdFTJjUVFjMhUdyEE3HCAgHDdBAZBBNxwgIBw3QQSwlhUdZFuVIyOVW5YdFZaWFR2WW5UjI5VbZB0VlshkPGMYDDI8MgwYYzyWljxjGAwyPDIMGGM8ZAAAAAEAAAAAAAAAAAAAAAAxAAAB%2F%2FIBLATCBEEAFgAAATIWFzYzMhYVFAYjISImNTQ2NyY1NDYB9261LCwueKqqeP0ST3FVQgLYBEF3YQ6teHmtclBFaw4MGZnXAAAAAgAAAGQEsASvABoAHgAAAB4BDwEBMzIWHQEhNTQ2OwEBJyY%2BARYfATc2AyEnAwL2IAkKiAHTHhQe%2B1AeFB4B1IcKCSAkCm9wCXoBebbDBLMTIxC7%2FRYlFSoqFSUC6rcQJBQJEJSWEPwecAIWAAAAAAQAAABkBLAETAALABcAIwA3AAATITIWBwEGIicBJjYXARYUBwEGJjURNDYJATYWFREUBicBJjQHARYGIyEiJjcBNjIfARYyPwE2MhkEfgoFCP3MCBQI%2FcwIBQMBCAgI%2FvgICgoDjAEICAoKCP74CFwBbAgFCvuCCgUIAWwIFAikCBQIpAgUBEwKCP3JCAgCNwgK2v74CBQI%2FvgIBQoCJgoF%2FvABCAgFCv3aCgUIAQgIFID%2BlAgKCggBbAgIpAgIpAgAAAAD%2F%2FD%2F8AS6BLoACQANABAAAAAyHwEWFA8BJzcTAScJAQUTA%2BAmDpkNDWPWXyL9mdYCZv4f%2FrNuBLoNmQ4mDlzWYP50%2FZrWAmb8anABTwAAAAEAAAAABLAEsAAPAAABETMyFh0BITU0NjsBEQEhArz6FR384B0V%2Bv4MBLACiv3aHRUyMhUdAiYCJgAAAAEADgAIBEwEnAAfAAABJTYWFREUBgcGLgE2NzYXEQURFAYHBi4BNjc2FxE0NgFwAoUnMFNGT4gkV09IQv2oWEFPiCRXT0hCHQP5ow8eIvzBN1EXGSltchkYEAIJm%2F2iKmAVGilucRoYEQJ%2FJioAAAACAAn%2F%2BAS7BKcAHQApAAAAMh4CFQcXFAcBFgYPAQYiJwEGIycHIi4CND4BBCIOARQeATI%2BATQmAZDItoNOAQFOARMXARY7GikT%2Fu13jgUCZLaDTk6DAXKwlFZWlLCUVlYEp06DtmQCBY15%2Fu4aJRg6FBQBEk0BAU6Dtsi2g1tWlLCUVlaUsJQAAQBkAFgErwREABkAAAE%2BAh4CFRQOAwcuBDU0PgIeAQKJMHt4dVg2Q3mEqD4%2Bp4V4Qzhadnh5A7VESAUtU3ZAOXmAf7JVVbJ%2FgHk5QHZTLQVIAAAAAf%2FTAF4EewSUABgAAAETNjIXEyEyFgcFExYGJyUFBiY3EyUmNjMBl4MHFQeBAaUVBhH%2BqoIHDxH%2Bqf6qEQ8Hgv6lEQYUAyABYRMT%2Fp8RDPn%2BbxQLDPb3DAsUAZD7DBEAAv%2FTAF4EewSUABgAIgAAARM2MhcTITIWBwUTFgYnJQUGJjcTJSY2MwUjFwc3Fyc3IycBl4MHFQeBAaUVBhH%2BqoIHDxH%2Bqf6qEQ8Hgv6lEQYUAfPwxUrBw0rA6k4DIAFhExP%2BnxEM%2Bf5vFAsM9vcMCxQBkPsMEWSO4ouM5YzTAAABAAAAAASwBLAAJgAAATIWHQEUBiMVFBYXBR4BHQEUBiMhIiY9ATQ2NyU%2BAT0BIiY9ATQ2Alh8sD4mDAkBZgkMDwr7ggoPDAkBZgkMJj6wBLCwfPouaEsKFwbmBRcKXQoPDwpdChcF5gYXCktoLvp8sAAAAA0AAAAABLAETAAPABMAIwAnACsALwAzADcARwBLAE8AUwBXAAATITIWFREUBiMhIiY1ETQ2FxUzNSkBIgYVERQWMyEyNjURNCYzFTM1BRUzNSEVMzUFFTM1IRUzNQchIgYVERQWMyEyNjURNCYFFTM1IRUzNQUVMzUhFTM1GQR%2BCg8PCvuCCg8PVWQCo%2F3aCg8PCgImCg8Pc2T8GGQDIGT8GGQDIGTh%2FdoKDw8KAiYKDw%2F872QDIGT8GGQDIGQETA8K%2B%2BYKDw8KBBoKD2RkZA8K%2FqIKDw8KAV4KD2RkyGRkZGTIZGRkZGQPCv6iCg8PCgFeCg9kZGRkZMhkZGRkAAAEAAAAAARMBEwADwAfAC8APwAAEyEyFhURFAYjISImNRE0NikBMhYVERQGIyEiJjURNDYBITIWFREUBiMhIiY1ETQ2KQEyFhURFAYjISImNRE0NjIBkBUdHRX%2BcBUdHQJtAZAVHR0V%2FnAVHR39vQGQFR0dFf5wFR0dAm0BkBUdHRX%2BcBUdHQRMHRX%2BcBUdHRUBkBUdHRX%2BcBUdHRUBkBUd%2FagdFf5wFR0dFQGQFR0dFf5wFR0dFQGQFR0AAAkAAAAABEwETAAPAB8ALwA%2FAE8AXwBvAH8AjwAAEzMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYhMzIWHQEUBisBIiY9ATQ2ATMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYhMzIWHQEUBisBIiY9ATQ2ATMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYhMzIWHQEUBisBIiY9ATQ2MsgVHR0VyBUdHQGlyBUdHRXIFR0dAaXIFR0dFcgVHR389cgVHR0VyBUdHQGlyBUdHRXIFR0dAaXIFR0dFcgVHR389cgVHR0VyBUdHQGlyBUdHRXIFR0dAaXIFR0dFcgVHR0ETB0VyBUdHRXIFR0dFcgVHR0VyBUdHRXIFR0dFcgVHf5wHRXIFR0dFcgVHR0VyBUdHRXIFR0dFcgVHR0VyBUd%2FnAdFcgVHR0VyBUdHRXIFR0dFcgVHR0VyBUdHRXIFR0ABgAAAAAEsARMAA8AHwAvAD8ATwBfAAATMzIWHQEUBisBIiY9ATQ2KQEyFh0BFAYjISImPQE0NgEzMhYdARQGKwEiJj0BNDYpATIWHQEUBiMhIiY9ATQ2ATMyFh0BFAYrASImPQE0NikBMhYdARQGIyEiJj0BNDYyyBUdHRXIFR0dAaUCvBUdHRX9RBUdHf6FyBUdHRXIFR0dAaUCvBUdHRX9RBUdHf6FyBUdHRXIFR0dAaUCvBUdHRX9RBUdHQRMHRXIFR0dFcgVHR0VyBUdHRXIFR3%2BcB0VyBUdHRXIFR0dFcgVHR0VyBUd%2FnAdFcgVHR0VyBUdHRXIFR0dFcgVHQAAAAABACYALAToBCAAFwAACQE2Mh8BFhQHAQYiJwEmND8BNjIfARYyAdECOwgUB7EICPzxBxUH%2FoAICLEHFAirBxYB3QI7CAixBxQI%2FPAICAGACBQHsQgIqwcAAQBuAG4EQgRCACMAAAEXFhQHCQEWFA8BBiInCQEGIi8BJjQ3CQEmND8BNjIXCQE2MgOIsggI%2FvUBCwgIsggVB%2F70%2FvQHFQiyCAgBC%2F71CAiyCBUHAQwBDAcVBDuzCBUH%2FvT%2B9AcVCLIICAEL%2FvUICLIIFQcBDAEMBxUIsggI%2FvUBDAcAAwAX%2F%2BsExQSZABkAJQBJAAAAMh4CFRQHARYUDwEGIicBBiMiLgI0PgEEIg4BFB4BMj4BNCYFMzIWHQEzMhYdARQGKwEVFAYrASImPQEjIiY9ATQ2OwE1NDYBmcSzgk1OASwICG0HFQj%2B1HeOYrSBTU2BAW%2BzmFhYmLOZWFj%2BvJYKD0sKDw8KSw8KlgoPSwoPDwpLDwSZTYKzYo15%2FtUIFQhsCAgBK01NgbTEs4JNWJmzmFhYmLOZIw8KSw8KlgoPSwoPDwpLDwqWCg9LCg8AAAMAF%2F%2FrBMUEmQAZACUANQAAADIeAhUUBwEWFA8BBiInAQYjIi4CND4BBCIOARQeATI%2BATQmBSEyFh0BFAYjISImPQE0NgGZxLOCTU4BLAgIbQcVCP7Ud45itIFNTYEBb7OYWFiYs5lYWP5YAV4KDw8K%2FqIKDw8EmU2Cs2KNef7VCBUIbAgIAStNTYG0xLOCTViZs5hYWJizmYcPCpYKDw8KlgoPAAAAAAIAFwAXBJkEsAAPAC0AAAEzMhYVERQGKwEiJjURNDYFNRYSFRQOAiIuAjU0EjcVDgEVFB4BMj4BNTQmAiZkFR0dFWQVHR0BD6fSW5vW6tabW9KnZ3xyxejFcnwEsB0V%2FnAVHR0VAZAVHeGmPv7ZuHXWm1tbm9Z1uAEnPqY3yHh0xXJyxXR4yAAEAGQAAASwBLAADwAfAC8APwAAATMyFhURFAYrASImNRE0NgEzMhYVERQGKwEiJjURNDYBMzIWFREUBisBIiY1ETQ2BTMyFh0BFAYrASImPQE0NgQBlgoPDwqWCg8P%2Ft6WCg8PCpYKDw%2F%2B3pYKDw8KlgoPD%2F7elgoPDwqWCg8PBLAPCvuCCg8PCgR%2BCg%2F%2BcA8K%2FRIKDw8KAu4KD%2F7UDwr%2BPgoPDwoBwgoPyA8K%2BgoPDwr6Cg8AAAAAAgAaABsElgSWAEcATwAAATIfAhYfATcWFwcXFh8CFhUUDwIGDwEXBgcnBwYPAgYjIi8CJi8BByYnNycmLwImNTQ%2FAjY%2FASc2Nxc3Nj8CNhIiBhQWMjY0AlghKSYFMS0Fhj0rUAMZDgGYBQWYAQ8YA1AwOIYFLDIFJisfISkmBTEtBYY8LFADGQ0ClwYGlwINGQNQLzqFBS0xBSYreLJ%2BfrJ%2BBJYFmAEOGQJQMDmGBSwxBiYrHiIoJgYxLAWGPSxRAxkOApcFBZcCDhkDUTA5hgUtMAYmKiAhKCYGMC0Fhj0sUAIZDgGYBf6ZfrF%2BfrEABwBkAAAEsAUUABMAFwAhACUAKQAtADEAAAEhMhYdASEyFh0BITU0NjMhNTQ2FxUhNQERFAYjISImNREXETMRMxEzETMRMxEzETMRAfQBLCk7ARMKD%2Fu0DwoBEzspASwBLDsp%2FUQpO2RkZGRkZGRkBRQ7KWQPCktLCg9kKTtkZGT%2B1PzgKTs7KQMgZP1EArz9RAK8%2FUQCvP1EArwAAQAMAAAFCATRAB8AABMBNjIXARYGKwERFAYrASImNREhERQGKwEiJjURIyImEgJsCBUHAmAIBQqvDwr6Cg%2F%2B1A8K%2BgoPrwoFAmoCYAcH%2FaAICv3BCg8PCgF3%2FokKDw8KAj8KAAIAZAAAA%2BgEsAARABcAAAERFBYzIREUBiMhIiY1ETQ2MwEjIiY9AQJYOykBLB0V%2FOAVHR0VA1L6FR0EsP5wKTv9dhUdHRUETBUd%2FnAdFfoAAwAXABcEmQSZAA8AGwAwAAAAMh4CFA4CIi4CND4BBCIOARQeATI%2BATQmBTMyFhURMzIWHQEUBisBIiY1ETQ2AePq1ptbW5vW6tabW1ubAb%2FoxXJyxejFcnL%2BfDIKD68KDw8K%2BgoPDwSZW5vW6tabW1ub1urWmztyxejFcnLF6MUNDwr%2B7Q8KMgoPDwoBXgoPAAAAAAL%2FnAAABRQEsAALAA8AACkBAyMDIQEzAzMDMwEDMwMFFP3mKfIp%2FeYBr9EVohTQ%2Fp4b4BsBkP5wBLD%2B1AEs%2FnD%2B1AEsAAAAAAIAZAAABLAEsAAVAC8AAAEzMhYVETMyFgcBBiInASY2OwERNDYBMzIWFREUBiMhIiY1ETQ2OwEyFh0BITU0NgImyBUdvxQLDf65DSYN%2FrkNCxS%2FHQJUMgoPDwr75goPDwoyCg8DhA8EsB0V%2Fj4XEP5wEBABkBAXAcIVHfzgDwr%2BogoPDwoBXgoPDwqvrwoPAAMAFwAXBJkEmQAPABsAMQAAADIeAhQOAiIuAjQ%2BAQQiDgEUHgEyPgE0JgUzMhYVETMyFgcDBiInAyY2OwERNDYB4%2BrWm1tbm9bq1ptbW5sBv%2BjFcnLF6MVycv58lgoPiRUKDd8NJg3fDQoViQ8EmVub1urWm1tbm9bq1ps7csXoxXJyxejFDQ8K%2Fu0XEP7tEBABExAXARMKDwAAAAMAFwAXBJkEmQAPABsAMQAAADIeAhQOAiIuAjQ%2BAQQiDgEUHgEyPgE0JiUTFgYrAREUBisBIiY1ESMiJjcTNjIB4%2BrWm1tbm9bq1ptbW5sBv%2BjFcnLF6MVycv7n3w0KFYkPCpYKD4kVCg3fDSYEmVub1urWm1tbm9bq1ps7csXoxXJyxejFAf7tEBf%2B7QoPDwoBExcQARMQAAAAAAIAAAAABLAEsAAZADkAABMhMhYXExYVERQGBwYjISImJyY1EzQ3Ez4BBSEiBgcDBhY7ATIWHwEeATsBMjY%2FAT4BOwEyNicDLgHhAu4KEwO6BwgFDBn7tAweAgYBB7kDEwKX%2FdQKEgJXAgwKlgoTAiYCEwr6ChMCJgITCpYKDAJXAhIEsA4K%2FXQYGf5XDB4CBggEDRkBqRkYAowKDsgOC%2F4%2BCw4OCpgKDg4KmAoODgsBwgsOAAMAFwAXBJkEmQAPABsAJwAAADIeAhQOAiIuAjQ%2BAQQiDgEUHgEyPgE0JgUXFhQPAQYmNRE0NgHj6tabW1ub1urWm1tbmwG%2F6MVycsXoxXJy%2Fov9ERH9EBgYBJlbm9bq1ptbW5vW6tabO3LF6MVycsXoxV2%2BDCQMvgwLFQGQFQsAAQAXABcEmQSwACgAAAE3NhYVERQGIyEiJj8BJiMiDgEUHgEyPgE1MxQOAiIuAjQ%2BAjMyA7OHBwsPCv6WCwQHhW2BdMVycsXoxXKWW5vW6tabW1ub1nXABCSHBwQL%2FpYKDwsHhUxyxejFcnLFdHXWm1tbm9bq1ptbAAAAAAIAFwABBJkEsAAaADUAAAE3NhYVERQGIyEiJj8BJiMiDgEVIzQ%2BAjMyEzMUDgIjIicHBiY1ETQ2MyEyFg8BFjMyPgEDs4cHCw8L%2FpcLBAeGboF0xXKWW5vWdcDrllub1nXAnIYHCw8LAWgKBQiFboJ0xXIEJIcHBAv%2BlwsPCweGS3LFdHXWm1v9v3XWm1t2hggFCgFoCw8LB4VMcsUAAAAKAGQAAASwBLAADwAfAC8APwBPAF8AbwB%2FAI8AnwAAEyEyFhURFAYjISImNRE0NgUhIgYVERQWMyEyNjURNCYFMzIWHQEUBisBIiY9ATQ2MyEyFh0BFAYjISImPQE0NgczMhYdARQGKwEiJj0BNDYzITIWHQEUBiMhIiY9ATQ2BzMyFh0BFAYrASImPQE0NjMhMhYdARQGIyEiJj0BNDYHMzIWHQEUBisBIiY9ATQ2MyEyFh0BFAYjISImPQE0Nn0EGgoPDwr75goPDwPA%2FK4KDw8KA1IKDw%2F9CDIKDw8KMgoPD9IBwgoPDwr%2BPgoPD74yCg8PCjIKDw%2FSAcIKDw8K%2Fj4KDw%2B%2BMgoPDwoyCg8P0gHCCg8PCv4%2BCg8PvjIKDw8KMgoPD9IBwgoPDwr%2BPgoPDwSwDwr7ggoPDwoEfgoPyA8K%2FK4KDw8KA1IKD2QPCjIKDw8KMgoPDwoyCg8PCjIKD8gPCjIKDw8KMgoPDwoyCg8PCjIKD8gPCjIKDw8KMgoPDwoyCg8PCjIKD8gPCjIKDw8KMgoPDwoyCg8PCjIKDwAAAAACAAAAAARMBLAAGQAjAAABNTQmIyEiBh0BIyIGFREUFjMhMjY1ETQmIyE1NDY7ATIWHQEDhHVT%2FtRSdmQpOzspA4QpOzsp%2FageFMgUHgMgyFN1dlLIOyn9qCk7OykCWCk7lhUdHRWWAAIAZAAABEwETAAJADcAABMzMhYVESMRNDYFMhcWFREUBw4DIyIuAScuAiMiBwYjIicmNRE%2BATc2HgMXHgIzMjc2fTIKD2QPA8AEBRADIUNAMRwaPyonKSxHHlVLBwgGBQ4WeDsXKC4TOQQpLUUdZ1AHBEwPCvvNBDMKDzACBhH%2BWwYGO1AkDQ0ODg8PDzkFAwcPAbY3VwMCAwsGFAEODg5XCAAAAwAAAAAEsASXACEAMQBBAAAAMh4CFREUBisBIiY1ETQuASAOARURFAYrASImNRE0PgEDMzIWFREUBisBIiY1ETQ2ITMyFhURFAYrASImNRE0NgHk6N6jYw8KMgoPjeT%2B%2BuSNDwoyCg9joyqgCAwMCKAIDAwCYKAIDAwIoAgMDASXY6PedP7UCg8PCgEsf9FyctF%2F%2FtQKDw8KASx03qP9wAwI%2FjQIDAwIAcwIDAwI%2FjQIDAwIAcwIDAAAAAACAAAA0wRHA90AFQA5AAABJTYWFREUBiclJisBIiY1ETQ2OwEyBTc2Mh8BFhQPARcWFA8BBiIvAQcGIi8BJjQ%2FAScmND8BNjIXAUEBAgkMDAn%2B%2FhUZ%2BgoPDwr6GQJYeAcUByIHB3h4BwciBxQHeHgHFAciBwd3dwcHIgcUBwMurAYHCv0SCgcGrA4PCgFeCg%2BEeAcHIgcUB3h4BxQHIgcHd3cHByIHFAd4eAcUByIICAAAAAACAAAA0wNyA90AFQAvAAABJTYWFREUBiclJisBIiY1ETQ2OwEyJTMWFxYVFAcGDwEiLwEuATc2NTQnJjY%2FATYBQQECCQwMCf7%2BFRn6Cg8PCvoZAdIECgZgWgYLAwkHHQcDBkhOBgMIHQcDLqwGBwr9EgoHBqwODwoBXgoPZAEJgaGafwkBAQYXBxMIZ36EaggUBxYFAAAAAAMAAADEBGID7AAbADEASwAAATMWFxYVFAYHBgcjIi8BLgE3NjU0JicmNj8BNgUlNhYVERQGJyUmKwEiJjURNDY7ATIlMxYXFhUUBwYPASIvAS4BNzY1NCcmNj8BNgPHAwsGh0RABwoDCQcqCAIGbzs3BgIJKgf9ggECCQwMCf7%2BFRn6Cg8PCvoZAdIECgZgWgYLAwkHHQcDBkhOBgMIHQcD7AEJs9lpy1QJAQYiBhQIlrJarEcJFAYhBb6sBgcK%2FRIKBwasDg8KAV4KD2QBCYGhmn8JAQEGFwcTCGd%2BhGoIFQYWBQAAAAANAAAAAASwBLAACQAVABkAHQAhACUALQA7AD8AQwBHAEsATwAAATMVIxUhFSMRIQEjFTMVIREjESM1IQURIREhESERBSM1MwUjNTMBMxEhETM1MwEzFSMVIzUjNTM1IzUhBREhEQcjNTMFIzUzASM1MwUhNSEB9GRk%2FnBkAfQCvMjI%2FtTIZAJY%2B7QBLAGQASz84GRkArxkZP1EyP4MyGQB9MhkyGRkyAEs%2FUQBLGRkZAOEZGT%2BDGRkAfT%2B1AEsA4RkZGQCWP4MZMgBLAEsyGT%2B1AEs%2FtQBLMhkZGT%2BDP4MAfRk%2FtRkZGRkyGTI%2FtQBLMhkZGT%2B1GRkZAAAAAAJAAAAAASwBLAAAwAHAAsADwATABcAGwAfACMAADcjETMTIxEzASMRMxMjETMBIxEzASE1IRcjNTMXIzUzBSM1M2RkZMhkZAGQyMjIZGQBLMjI%2FOD%2B1AEsyGRkyGRkASzIyMgD6PwYA%2Bj8GAPo%2FBgD6PwYA%2Bj7UGRkW1tbW1sAAAIAAAAKBKYEsAANABUAAAkBFhQHAQYiJwETNDYzBCYiBhQWMjYB9AKqCAj%2BMAgUCP1WAQ8KAUM7Uzs7UzsEsP1WCBQI%2FjAICAKqAdsKD807O1Q7OwAAAAADAAAACgXSBLAADQAZACEAAAkBFhQHAQYiJwETNDYzIQEWFAcBBiIvAQkBBCYiBhQWMjYB9AKqCAj%2BMAgUCP1WAQ8KAwYCqggI%2FjAIFAg4Aaj9RP7TO1M7O1M7BLD9VggUCP4wCAgCqgHbCg%2F9VggUCP4wCAg4AaoCvM07O1Q7OwAAAAABAGQAAASwBLAAJgAAASEyFREUDwEGJjURNCYjISIPAQYWMyEyFhURFAYjISImNRE0PwE2ASwDOUsSQAgKDwr9RBkSQAgFCgK8Cg8PCvyuCg8SixIEsEv8fBkSQAgFCgO2Cg8SQAgKDwr8SgoPDwoDzxkSixIAAAABAMj%2F%2FwRMBLAACgAAEyEyFhURCQERNDb6AyAVHf4%2B%2Fj4dBLAdFfuCAbz%2BQwR%2FFR0AAAAAAwAAAAAEsASwABUARQBVAAABISIGBwMGHwEeATMhMjY%2FATYnAy4BASMiBg8BDgEjISImLwEuASsBIgYVERQWOwEyNj0BNDYzITIWHQEUFjsBMjY1ETQmASEiBg8BBhYzITI2LwEuAQM2%2FkQLEAFOBw45BhcKAcIKFwY%2BDgdTARABVpYKFgROBBYK%2FdoKFgROBBYKlgoPDwqWCg8PCgLuCg8PCpYKDw%2F%2Bsf4MChMCJgILCgJYCgsCJgITBLAPCv7TGBVsCQwMCWwVGAEtCg%2F%2BcA0JnAkNDQmcCQ0PCv12Cg8PCpYKDw8KlgoPDwoCigoP%2FagOCpgKDg4KmAoOAAAAAAQAAABkBLAETAAdACEAKQAxAAABMzIeAh8BMzIWFREUBiMhIiY1ETQ2OwE%2BBAEVMzUEIgYUFjI2NCQyFhQGIiY0AfTIOF00JAcGlik7Oyn8GCk7OymWAgknM10ByGT%2Bz76Hh76H%2Fu9WPDxWPARMKTs7FRQ7Kf2oKTs7KQJYKTsIG0U1K%2F7UZGRGh76Hh74IPFY8PFYAAAAAAgA1AAAEsASvACAAIwAACQEWFx4BHwEVITUyNi8BIQYHBh4CMxUhNTY3PgE%2FAQEDIQMCqQGBFCgSJQkK%2Fl81LBFS%2Fnk6IgsJKjIe%2FpM4HAwaBwcBj6wBVKIEr%2FwaMioTFQECQkJXLd6RWSIuHAxCQhgcDCUNDQPu%2FVoByQAAAAADAGQAAAPwBLAAJwAyADsAAAEeBhUUDgMjITU%2BATURNC4EJzUFMh4CFRQOAgclMzI2NTQuAisBETMyNjU0JisBAvEFEzUwOyodN1htbDD%2BDCk7AQYLFyEaAdc5dWM%2BHy0tEP6Pi05pESpTPnbYUFJ9Xp8CgQEHGB0zOlIuQ3VONxpZBzMoAzsYFBwLEAkHRwEpSXNDM1s6KwkxYUopOzQb%2FK5lUFqBAAABAMgAAANvBLAAGQAAARcOAQcDBhYXFSE1NjcTNjQuBCcmJzUDbQJTQgeECSxK%2Fgy6Dq0DAw8MHxUXDQYEsDkTNSj8uTEoBmFhEFIDQBEaExAJCwYHAwI5AAAAAAL%2FtQAABRQEsAAlAC8AAAEjNC4FKwERFBYfARUhNTI%2BAzURIyIOBRUjESEFIxEzByczESM3BRQyCAsZEyYYGcgyGRn%2BcAQOIhoWyBkYJhMZCwgyA%2Bj7m0tLfX1LS30DhBUgFQ4IAwH8rhYZAQJkZAEFCRUOA1IBAwgOFSAVASzI%2FOCnpwMgpwACACH%2FtQSPBLAAJQAvAAABIzQuBSsBERQWHwEVITUyPgM1ESMiDgUVIxEhEwc1IRUnNxUhNQRMMggLGRMmGBnIMhkZ%2FnAEDiIaFsgZGCYTGQsIMgPoQ6f84KenAyADhBUgFQ4IAwH9dhYZAQJkZAEFCRUOAooBAwgOFSAVASz7gn1LS319S0sABAAAAAAEsARMAA8AHwAvAD8AABMhMhYdARQGIyEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2EyEyFh0BFAYjISImPQE0NhMhMhYdARQGIyEiJj0BNDYyAlgVHR0V%2FagVHR0VA%2BgVHR0V%2FBgVHR0VAyAVHR0V%2FOAVHR0VBEwVHR0V%2B7QVHR0ETB0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR0ABAAAAAAEsARMAA8AHwAvAD8AABMhMhYdARQGIyEiJj0BNDYDITIWHQEUBiMhIiY9ATQ2EyEyFh0BFAYjISImPQE0NgMhMhYdARQGIyEiJj0BNDb6ArwVHR0V%2FUQVHR2zBEwVHR0V%2B7QVHR3dArwVHR0V%2FUQVHR2zBEwVHR0V%2B7QVHR0ETB0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR0ABAAAAAAEsARMAA8AHwAvAD8AAAE1NDYzITIWHQEUBiMhIiYBNTQ2MyEyFh0BFAYjISImEzU0NjMhMhYdARQGIyEiJgE1NDYzITIWHQEUBiMhIiYB9B0VAlgVHR0V%2FagVHf5wHRUD6BUdHRX8GBUdyB0VAyAVHR0V%2FOAVHf7UHRUETBUdHRX7tBUdA7ZkFR0dFWQVHR3%2B6WQVHR0VZBUdHf7pZBUdHRVkFR0d%2FulkFR0dFWQVHR0AAAQAAAAABLAETAAPAB8ALwA%2FAAATITIWHQEUBiMhIiY9ATQ2EyEyFh0BFAYjISImPQE0NhMhMhYdARQGIyEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2MgRMFR0dFfu0FR0dFQRMFR0dFfu0FR0dFQRMFR0dFfu0FR0dFQRMFR0dFfu0FR0dBEwdFWQVHR0VZBUd%2FtQdFWQVHR0VZBUd%2FtQdFWQVHR0VZBUd%2FtQdFWQVHR0VZBUdAAgAAAAABLAETAAPAB8ALwA%2FAE8AXwBvAH8AABMzMhYdARQGKwEiJj0BNDYpATIWHQEUBiMhIiY9ATQ2ATMyFh0BFAYrASImPQE0NikBMhYdARQGIyEiJj0BNDYBMzIWHQEUBisBIiY9ATQ2KQEyFh0BFAYjISImPQE0NgEzMhYdARQGKwEiJj0BNDYpATIWHQEUBiMhIiY9ATQ2MmQVHR0VZBUdHQFBAyAVHR0V%2FOAVHR3%2B6WQVHR0VZBUdHQFBAyAVHR0V%2FOAVHR3%2B6WQVHR0VZBUdHQFBAyAVHR0V%2FOAVHR3%2B6WQVHR0VZBUdHQFBAyAVHR0V%2FOAVHR0ETB0VZBUdHRVkFR0dFWQVHR0VZBUd%2FtQdFWQVHR0VZBUdHRVkFR0dFWQVHf7UHRVkFR0dFWQVHR0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR0dFWQVHR0VZBUdAAAG%2F5wAAASwBEwAAwATACMAKgA6AEoAACEjETsCMhYdARQGKwEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2BQc1IzUzNQUhMhYdARQGIyEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2AZBkZJZkFR0dFWQVHR0VAfQVHR0V%2FgwVHR3%2B%2BqfIyAHCASwVHR0V%2FtQVHR0VAlgVHR0V%2FagVHR0ETB0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR36fUtkS68dFWQVHR0VZBUd%2FtQdFWQVHR0VZBUdAAAABgAAAAAFFARMAA8AEwAjACoAOgBKAAATMzIWHQEUBisBIiY9ATQ2ASMRMwEhMhYdARQGIyEiJj0BNDYFMxUjFSc3BSEyFh0BFAYjISImPQE0NhMhMhYdARQGIyEiJj0BNDYyZBUdHRVkFR0dA2dkZPyuAfQVHR0V%2FgwVHR0EL8jIp6f75gEsFR0dFf7UFR0dFQJYFR0dFf2oFR0dBEwdFWQVHR0VZBUd%2B7QETP7UHRVkFR0dFWQVHchkS319rx0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR0AAAAAAgAAAMgEsAPoAA8AEgAAEyEyFhURFAYjISImNRE0NgkCSwLuHywsH%2F0SHywsBIT%2B1AEsA%2BgsH%2F12HywsHwKKHyz9RAEsASwAAwAAAAAEsARMAA8AFwAfAAATITIWFREUBiMhIiY1ETQ2FxE3BScBExEEMhYUBiImNCwEWBIaGhL7qBIaGkr3ASpKASXs%2FNJwTk5wTgRMGhL8DBIaGhID9BIaZP0ftoOcAT7%2B4AH0dE5vT09vAAAAAAIA2wAFBDYEkQAWAB4AAAEyHgEVFAcOAQ8BLgQnJjU0PgIWIgYUFjI2NAKIdcZzRkWyNjYJIV5YbSk8RHOft7eCgreCBJF4ynVzj23pPz4IIWZomEiEdVijeUjDgriBgbgAAAACABcAFwSZBJkADwAXAAAAMh4CFA4CIi4CND4BAREiDgEUHgEB4%2BrWm1tbm9bq1ptbW5sBS3TFcnLFBJlbm9bq1ptbW5vW6tab%2FG8DVnLF6MVyAAACAHUAAwPfBQ8AGgA1AAABHgYVFA4DBy4DNTQ%2BBQMOAhceBBcWNj8BNiYnLgInJjc2IyYCKhVJT1dOPiUzVnB9P1SbfEokP0xXUEm8FykoAwEbITEcExUWAgYCCQkFEikMGiACCAgFD0iPdXdzdYdFR4BeRiYEBTpjl1lFh3ZzeHaQ%2Ff4hS4I6JUEnIw4IBwwQIgoYBwQQQSlZtgsBAAAAAwAAAAAEywRsAAwAKgAvAAABNz4CHgEXHgEPAiUhMhcHISIGFREUFjMhMjY9ATcRFAYjISImNRE0NgkBBzcBA%2BhsAgYUFR0OFgoFBmz9BQGQMje7%2FpApOzspAfQpO8i7o%2F5wpbm5Azj%2BlqE3AWMD9XMBAgIEDw4WKgsKc8gNuzsp%2FgwpOzsptsj%2BtKW5uaUBkKW5%2Ftf%2BljKqAWMAAgAAAAAEkwRMABsANgAAASEGByMiBhURFBYzITI2NTcVFAYjISImNRE0NgUBFhQHAQYmJzUmDgMHPgY3NT4BAV4BaaQ0wyk7OykB9Ck7yLml%2FnClubkCfwFTCAj%2BrAcLARo5ZFRYGgouOUlARioTAQsETJI2Oyn%2BDCk7OymZZ6W5uaUBkKW5G%2F7TBxUH%2Fs4GBAnLAQINFjAhO2JBNB0UBwHSCgUAAAAAAgAAAAAEnQRMAB0ANQAAASEyFwchIgYVERQWMyEyNj0BNxUUBiMhIiY1ETQ2CQE2Mh8BFhQHAQYiLwEmND8BNjIfARYyAV4BXjxDsv6jKTs7KQH0KTvIuaX%2BcKW5uQHKAYsHFQdlBwf97QcVB%2FgHB2UHFQdvCBQETBexOyn%2BDCk7OylFyNulubmlAZCluf4zAYsHB2UHFQf97AcH%2BAcVB2UHB28HAAAAAQAKAAoEpgSmADsAAAkBNjIXARYGKwEVMzU0NhcBFhQHAQYmPQEjFTMyFgcBBiInASY2OwE1IxUUBicBJjQ3ATYWHQEzNSMiJgE%2BAQgIFAgBBAcFCqrICggBCAgI%2FvgICsiqCgUH%2FvwIFAj%2B%2BAgFCq%2FICgj%2B%2BAgIAQgICsivCgUDlgEICAj%2B%2BAgKyK0KBAf%2B%2FAcVB%2F73BwQKrcgKCP74CAgBCAgKyK0KBAcBCQcVBwEEBwQKrcgKAAEAyAAAA4QETAAZAAATMzIWFREBNhYVERQGJwERFAYrASImNRE0NvpkFR0B0A8VFQ%2F%2BMB0VZBUdHQRMHRX%2BSgHFDggV%2FBgVCA4Bxf5KFR0dFQPoFR0AAAABAAAAAASwBEwAIwAAEzMyFhURATYWFREBNhYVERQGJwERFAYnAREUBisBIiY1ETQ2MmQVHQHQDxUB0A8VFQ%2F%2BMBUP%2FjAdFWQVHR0ETB0V%2FkoBxQ4IFf5KAcUOCBX8GBUIDgHF%2FkoVCA4Bxf5KFR0dFQPoFR0AAAABAJ0AGQSwBDMAFQAAAREUBicBERQGJwEmNDcBNhYVEQE2FgSwFQ%2F%2BMBUP%2FhQPDwHsDxUB0A8VBBr8GBUIDgHF%2FkoVCA4B4A4qDgHgDggV%2FkoBxQ4IAAAAAQDIABYEMwQ2AAsAABMBFhQHAQYmNRE0NvMDLhIS%2FNISGRkEMv4OCx4L%2Fg4LDhUD6BUOAAIAyABkA4QD6AAPAB8AABMzMhYVERQGKwEiJjURNDYhMzIWFREUBisBIiY1ETQ2%2BsgVHR0VyBUdHQGlyBUdHRXIFR0dA%2BgdFfzgFR0dFQMgFR0dFfzgFR0dFQMgFR0AAAEAyABkBEwD6AAPAAABERQGIyEiJjURNDYzITIWBEwdFfzgFR0dFQMgFR0DtvzgFR0dFQMgFR0dAAAAAAEAAAAZBBMEMwAVAAABETQ2FwEWFAcBBiY1EQEGJjURNDYXAfQVDwHsDw%2F%2BFA8V%2FjAPFRUPAmQBthUIDv4gDioO%2FiAOCBUBtv47DggVA%2BgVCA4AAAH%2F%2FgACBLMETwAjAAABNzIWFRMUBiMHIiY1AwEGJjUDAQYmNQM0NhcBAzQ2FwEDNDYEGGQUHgUdFWQVHQL%2BMQ4VAv4yDxUFFQ8B0gIVDwHSAh0ETgEdFfwYFR0BHRUBtf46DwkVAbX%2BOQ4JFAPoFQkP%2Fj4BthQJDv49AbYVHQAAAQEsAAAD6ARMABkAAAEzMhYVERQGKwEiJjURAQYmNRE0NhcBETQ2A1JkFR0dFWQVHf4wDxUVDwHQHQRMHRX8GBUdHRUBtv47DggVA%2BgVCA7%2BOwG2FR0AAAIAZADIBLAESAALABsAAAkBFgYjISImNwE2MgEhMhYdARQGIyEiJj0BNDYCrgH1DwkW%2B%2B4WCQ8B9Q8q%2FfcD6BUdHRX8GBUdHQQ5%2FeQPFhYPAhwP%2FUgdFWQVHR0VZBUdAAEAiP%2F8A3UESgAFAAAJAgcJAQN1%2FqABYMX92AIoA4T%2Bn%2F6fxgIoAiYAAAAAAQE7%2F%2FwEKARKAAUAAAkBJwkBNwQo%2FdnGAWH%2Bn8YCI%2F3ZxgFhAWHGAAIAFwAXBJkEmQAPADMAAAAyHgIUDgIiLgI0PgEFIyIGHQEjIgYdARQWOwEVFBY7ATI2PQEzMjY9ATQmKwE1NCYB4%2BrWm1tbm9bq1ptbW5sBfWQVHZYVHR0Vlh0VZBUdlhUdHRWWHQSZW5vW6tabW1ub1urWm7odFZYdFWQVHZYVHR0Vlh0VZBUdlhUdAAAAAAIAFwAXBJkEmQAPAB8AAAAyHgIUDgIiLgI0PgEBISIGHQEUFjMhMjY9ATQmAePq1ptbW5vW6tabW1ubAkX%2BDBUdHRUB9BUdHQSZW5vW6tabW1ub1urWm%2F5%2BHRVkFR0dFWQVHQACABcAFwSZBJkADwAzAAAAMh4CFA4CIi4CND4BBCIPAScmIg8BBhQfAQcGFB8BFjI%2FARcWMj8BNjQvATc2NC8BAePq1ptbW5vW6tabW1ubAeUZCXh4CRkJjQkJeHgJCY0JGQl4eAkZCY0JCXh4CQmNBJlbm9bq1ptbW5vW6tabrQl4eAkJjQkZCXh4CRkJjQkJeHgJCY0JGQl4eAkZCY0AAgAXABcEmQSZAA8AJAAAADIeAhQOAiIuAjQ%2BAQEnJiIPAQYUHwEWMjcBNjQvASYiBwHj6tabW1ub1urWm1tbmwEVVAcVCIsHB%2FIHFQcBdwcHiwcVBwSZW5vW6tabW1ub1urWm%2F4xVQcHiwgUCPEICAF3BxUIiwcHAAAAAAMAFwAXBJkEmQAPADsASwAAADIeAhQOAiIuAjQ%2BAQUiDgMVFDsBFjc%2BATMyFhUUBgciDgUHBhY7ATI%2BAzU0LgMTIyIGHQEUFjsBMjY9ATQmAePq1ptbW5vW6tabW1ubAT8dPEIyIRSDHgUGHR8UFw4TARkOGhITDAIBDQ6tBx4oIxgiM0Q8OpYKDw8KlgoPDwSZW5vW6tabW1ub1urWm5ELHi9PMhkFEBQQFRIXFgcIBw4UHCoZCBEQKDhcNi9IKhsJ%2FeMPCpYKDw8KlgoPAAADABcAFwSZBJkADwAfAD4AAAAyHgIUDgIiLgI0PgEFIyIGHQEUFjsBMjY9ATQmAyMiBh0BFBY7ARUjIgYdARQWMyEyNj0BNCYrARE0JgHj6tabW1ub1urWm1tbmwGWlgoPDwqWCg8PCvoKDw8KS0sKDw8KAV4KDw8KSw8EmVub1urWm1tbm9bq1ptWDwqWCg8PCpYKD%2F7UDwoyCg%2FIDwoyCg8PCjIKDwETCg8AAgAAAAAEsASwAC8AXwAAATMyFh0BHgEXMzIWHQEUBisBDgEHFRQGKwEiJj0BLgEnIyImPQE0NjsBPgE3NTQ2ExUUBisBIiY9AQ4BBzMyFh0BFAYrAR4BFzU0NjsBMhYdAT4BNyMiJj0BNDY7AS4BAg2WCg9nlxvCCg8PCsIbl2cPCpYKD2eXG8IKDw8KwhuXZw%2B5DwqWCg9EZheoCg8PCqgXZkQPCpYKD0RmF6gKDw8KqBdmBLAPCsIbl2cPCpYKD2eXG8IKDw8KwhuXZw8KlgoPZ5cbwgoP%2Fs2oCg8PCqgXZkQPCpYKD0RmF6gKDw8KqBdmRA8KlgoPRGYAAwAXABcEmQSZAA8AGwA%2FAAAAMh4CFA4CIi4CND4BBCIOARQeATI%2BATQmBxcWFA8BFxYUDwEGIi8BBwYiLwEmND8BJyY0PwE2Mh8BNzYyAePq1ptbW5vW6tabW1ubAb%2FoxXJyxejFcnKaQAcHfHwHB0AHFQd8fAcVB0AHB3x8BwdABxUHfHwHFQSZW5vW6tabW1ub1urWmztyxejFcnLF6MVaQAcVB3x8BxUHQAcHfHwHB0AHFQd8fAcVB0AHB3x8BwAAAAMAFwAXBJkEmQAPABsAMAAAADIeAhQOAiIuAjQ%2BAQQiDgEUHgEyPgE0JgcXFhQHAQYiLwEmND8BNjIfATc2MgHj6tabW1ub1urWm1tbmwG%2F6MVycsXoxXJyg2oHB%2F7ACBQIyggIagcVB0%2FFBxUEmVub1urWm1tbm9bq1ps7csXoxXJyxejFfWoHFQf%2BvwcHywcVB2oICE%2FFBwAAAAMAFwAXBJkEmQAPABgAIQAAADIeAhQOAiIuAjQ%2BAQUiDgEVFBcBJhcBFjMyPgE1NAHj6tabW1ub1urWm1tbmwFLdMVyQQJLafX9uGhzdMVyBJlbm9bq1ptbW5vW6tabO3LFdHhpAktB0P24PnLFdHMAAAAAAQAXAFMEsAP5ABUAABMBNhYVESEyFh0BFAYjIREUBicBJjQnAgoQFwImFR0dFf3aFxD99hACRgGrDQoV%2Ft0dFcgVHf7dFQoNAasNJgAAAAABAAAAUwSZA%2FkAFQAACQEWFAcBBiY1ESEiJj0BNDYzIRE0NgJ%2FAgoQEP32EBf92hUdHRUCJhcD8f5VDSYN%2FlUNChUBIx0VyBUdASMVCgAAAAEAtwAABF0EmQAVAAAJARYGIyERFAYrASImNREhIiY3ATYyAqoBqw0KFf7dHRXIFR3%2B3RUKDQGrDSYEif32EBf92hUdHRUCJhcQAgoQAAAAAQC3ABcEXQSwABUAAAEzMhYVESEyFgcBBiInASY2MyERNDYCJsgVHQEjFQoN%2FlUNJg3%2BVQ0KFQEjHQSwHRX92hcQ%2FfYQEAIKEBcCJhUdAAABAAAAtwSZBF0AFwAACQEWFAcBBiY1EQ4DBz4ENxE0NgJ%2FAgoQEP32EBdesKWBJAUsW4fHfhcEVf5VDSYN%2FlUNChUBIwIkRHVNabGdcUYHAQYVCgACAAAAAASwBLAAFQArAAABITIWFREUBi8BBwYiLwEmND8BJyY2ASEiJjURNDYfATc2Mh8BFhQPARcWBgNSASwVHRUOXvkIFAhqBwf5Xg4I%2FiH%2B1BUdFQ5e%2BQgUCGoHB%2FleDggEsB0V%2FtQVCA5e%2BQcHaggUCPleDhX7UB0VASwVCA5e%2BQcHaggUCPleDhUAAAACAEkASQRnBGcAFQArAAABFxYUDwEXFgYjISImNRE0Nh8BNzYyASEyFhURFAYvAQcGIi8BJjQ%2FAScmNgP2agcH%2BV4OCBX%2B1BUdFQ5e%2BQgU%2FQwBLBUdFQ5e%2BQgUCGoHB%2FleDggEYGoIFAj5Xg4VHRUBLBUIDl75B%2F3xHRX%2B1BUIDl75BwdqCBQI%2BV4OFQAAAAADABcAFwSZBJkADwAfAC8AAAAyHgIUDgIiLgI0PgEFIyIGFxMeATsBMjY3EzYmAyMiBh0BFBY7ATI2PQE0JgHj6tabW1ub1urWm1tbmwGz0BQYBDoEIxQ2FCMEOgQYMZYKDw8KlgoPDwSZW5vW6tabW1ub1urWm7odFP7SFB0dFAEuFB3%2BDA8KlgoPDwqWCg8AAAAABQAAAAAEsASwAEkAVQBhAGgAbwAAATIWHwEWHwEWFxY3Nj8BNjc2MzIWHwEWHwIeATsBMhYdARQGKwEiBh0BIREjESE1NCYrASImPQE0NjsBMjY1ND8BNjc%2BBAUHBhY7ATI2LwEuAQUnJgYPAQYWOwEyNhMhIiY1ESkBERQGIyERAQQJFAUFFhbEFQ8dCAsmxBYXERUXMA0NDgQZCAEPCj0KDw8KMgoP%2FnDI%2FnAPCjIKDw8KPQsOCRkFDgIGFRYfAp2mBwQK2woKAzMDEP41sQgQAzMDCgrnCwMe%2FokKDwGQAlgPCv6JBLAEAgIKDXYNCxUJDRZ2DQoHIREQFRh7LAkLDwoyCg8PCq8BLP7UrwoPDwoyCg8GBQQwgBkUAwgWEQ55ogcKDgqVCgSqnQcECo8KDgr8cg8KAXf%2BiQoPAZAAAAAAAgAAAAwErwSmACsASQAAATYWFQYCDgQuAScmByYOAQ8BBiY1NDc%2BATc%2BAScuAT4BNz4GFyYGBw4BDwEOBAcOARY2Nz4CNz4DNz4BBI0IGgItQmxhi2KORDg9EQQRMxuZGhYqCFUYEyADCQIQOjEnUmFch3vAJQgdHyaiPT44XHRZUhcYDhItIRmKcVtGYWtbKRYEBKYDEwiy%2Ft3IlVgxEQgLCwwBAQIbG5kYEyJAJghKFRE8Hzdff4U%2FM0o1JSMbL0QJGCYvcSEhHjZST2c1ODwEJygeW0AxJUBff1UyFAABAF0AHgRyBM8ATwAAAQ4BHgQXLgc%2BATceAwYHDgQHBicmNzY3PgQuAScWDgMmJy4BJyY%2BBDcGHgM3PgEuAicmPgMCjScfCic4R0IgBBsKGAoQAwEJEg5gikggBhANPkpTPhZINx8SBgsNJysiCRZOQQoVNU1bYC9QZwICBAUWITsoCAYdJzIYHw8YIiYHDyJJYlkEz0OAZVxEOSQMBzgXOB42IzElKRIqg5Gnl0o3Z0c6IAYWCwYNAwQFIDhHXGF1OWiqb0sdBxUknF0XNTQ8PEUiNWNROBYJDS5AQVUhVZloUSkAAAAAA%2F%2FcAGoE1ARGABsAPwBRAAAAMh4FFA4FIi4FND4EBSYGFxYVFAYiJjU0NzYmBwYHDgEXHgQyPgM3NiYnJgUHDgEXFhcWNj8BNiYnJicuAQIGpJ17bk85HBw6T257naKde25POhwcOU9uewIPDwYIGbD4sBcIBw5GWg0ECxYyWl%2BDiINfWjIWCwQMWv3%2FIw8JCSU4EC0OIw4DDywtCyIERi1JXGJcSSpJXGJcSS0tSVxiXEkqSVxiXEncDwYTOT58sLB8OzcTBg9FcxAxEiRGXkQxMEVeRSQSMRF1HiQPLxJEMA0EDyIPJQ8sSRIEAAAABP%2FcAAAE1ASwABQAJwA7AEwAACEjNy4ENTQ%2BBTMyFzczEzceARUUDgMHNz4BNzYmJyYlBgcOARceBBc3LgE1NDc2JhcHDgEXFhcWNj8CJyYnLgECUJQfW6l2WSwcOU9ue51SPUEglCYvbIknUGqYUi5NdiYLBAw2%2FVFGWg0ECxIqSExoNSlrjxcIB3wjDwkJJTgQLQ4MFgMsLQsieBRhdHpiGxVJXGJcSS0Pef5StVXWNBpacm5jGq0xiD8SMRFGckVzEDESHjxRQTkNmhKnbjs3EwZwJA8vEkQwDQQPC1YELEkSBAAAAAP%2FngAABRIEqwALABgAKAAAJwE2FhcBFgYjISImJSE1NDY7ATIWHQEhAQczMhYPAQ4BKwEiJi8BJjZaAoIUOBQCghUbJfryJRsBCgFZDwqWCg8BWf5DaNAUGAQ6BCMUNhQjBDoEGGQEKh8FIfvgIEdEhEsKDw8KSwLT3x0U%2FBQdHRT8FB0AAAABAGQAFQSwBLAAKAAAADIWFREBHgEdARQGJyURFh0BFAYvAQcGJj0BNDcRBQYmPQE0NjcBETQCTHxYAWsPFhgR%2FplkGhPNzRMaZP6ZERgWDwFrBLBYPv6t%2FrsOMRQpFA0M%2Bf75XRRAFRAJgIAJEBVAFF0BB%2FkMDRQpFDEOAUUBUz4AAAARAAAAAARMBLAAHQAnACsALwAzADcAOwA%2FAEMARwBLAE8AUwBXAFsAXwBjAAABMzIWHQEzMhYdASE1NDY7ATU0NjsBMhYdASE1NDYBERQGIyEiJjURFxUzNTMVMzUzFTM1MxUzNTMVMzUFFTM1MxUzNTMVMzUzFTM1MxUzNQUVMzUzFTM1MxUzNTMVMzUzFTM1A1JkFR0yFR37tB0VMh0VZBUdAfQdAQ8dFfwYFR1kZGRkZGRkZGRk%2FHxkZGRkZGRkZGT8fGRkZGRkZGRkZASwHRUyHRWWlhUdMhUdHRUyMhUd%2FnD9EhUdHRUC7shkZGRkZGRkZGRkyGRkZGRkZGRkZGTIZGRkZGRkZGRkZAAAAAMAAAAZBXcElwAZACUANwAAARcWFA8BBiY9ASMBISImPQE0NjsBATM1NDYBBycjIiY9ATQ2MyEBFxYUDwEGJj0BIyc3FzM1NDYEb%2FkPD%2FkOFZ%2F9qP7dFR0dFdECWPEV%2FamNetEVHR0VASMDGvkPD%2FkOFfG1jXqfFQSN5g4qDuYOCBWW%2FagdFWQVHQJYlhUI%2FpiNeh0VZBUd%2Fk3mDioO5g4IFZa1jXqWFQgAAAABAAAAAASwBEwAEgAAEyEyFhURFAYjIQERIyImNRE0NmQD6Ck7Oyn9rP7QZCk7OwRMOyn9qCk7%2FtQBLDspAlgpOwAAAAMAZAAABEwEsAAJABMAPwAAEzMyFh0BITU0NiEzMhYdASE1NDYBERQOBSIuBTURIRUUFRwBHgYyPgYmNTQ9AZbIFR3%2B1B0C0cgVHf7UHQEPBhgoTGacwJxmTCgYBgEsAwcNFB8nNkI2Jx8TDwUFAQSwHRX6%2BhUdHRX6%2BhUd%2FnD%2B1ClJalZcPigoPlxWakkpASz6CRIVKyclIRsWEAgJEBccISUnKhURCPoAAAAB%2F%2F8A1ARMA8IABQAAAQcJAScBBEzG%2Fp%2F%2Bn8UCJwGbxwFh%2Fp%2FHAicAAQAAAO4ETQPcAAUAAAkCNwkBBE392v3ZxgFhAWEDFf3ZAifH%2Fp8BYQAAAAAC%2F1EAZAVfA%2BgAFAApAAABITIWFREzMhYPAQYiLwEmNjsBESElFxYGKwERIRchIiY1ESMiJj8BNjIBlALqFR2WFQgO5g4qDuYOCBWW%2FoP%2BHOYOCBWWAYHX%2FRIVHZYVCA7mDioD6B0V%2FdkVDvkPD%2FkOFQGRuPkOFf5wyB0VAiYVDvkPAAABAAYAAASeBLAAMAAAEzMyFh8BITIWBwMOASMhFyEyFhQGKwEVFAYiJj0BIRUUBiImPQEjIiYvAQMjIiY0NjheERwEJgOAGB4FZAUsIf2HMAIXFR0dFTIdKh3%2B1B0qHR8SHQYFyTYUHh4EsBYQoiUY%2FiUVK8gdKh0yFR0dFTIyFR0dFTIUCQoDwR0qHQAAAAACAAAAAASwBEwACwAPAAABFSE1MzQ2MyEyFhUFIREhBLD7UMg7KQEsKTv9RASw%2B1AD6GRkKTs7Kcj84AACAAAAAAXcBEwADAAQAAATAxEzNDYzITIWFSEVBQEhAcjIyDspASwqOgH0ASz%2B1PtQASwDIP5wAlgpOzspyGT9RAK8AAEBRQAAA2sErwAbAAABFxYGKwERMzIWDwEGIi8BJjY7AREjIiY%2FATYyAnvmDggVlpYVCA7mDioO5g4IFZaWFQgO5g4qBKD5DhX9pxUO%2BQ8P%2BQ4VAlkVDvkPAAAAAQABAUQErwNrABsAAAEXFhQPAQYmPQEhFRQGLwEmND8BNhYdASE1NDYDqPkODvkPFf2oFQ%2F5Dg75DxUCWBUDYOUPKQ%2FlDwkUl5cUCQ%2FlDykP5Q8JFZWVFQkAAAAEAAAAAASwBLAACQAZAB0AIQAAAQMuASMhIgYHAwUhIgYdARQWMyEyNj0BNCYFNTMVMzUzFQSRrAUkFP1gFCQFrAQt%2FBgpOzspA%2BgpOzv%2Bq2RkZAGQAtwXLSgV%2FR1kOylkKTs7KWQpO8hkZGRkAAAAA%2F%2BcAGQEsARMAAsAIwAxAAAAMhYVERQGIiY1ETQDJSMTFgYjIisBIiYnAj0BNDU0PgE7ASUBFSIuAz0BND4CNwRpKh0dKh1k%2FV0mLwMRFQUCVBQdBDcCCwzIAqP8GAQOIhoWFR0dCwRMHRX8rhUdHRUDUhX8mcj%2B7BAIHBUBUQ76AgQQDw36%2FtT6AQsTKRwyGigUDAEAAAACAEoAAARmBLAALAA1AAABMzIWDwEeARcTFzMyFhQGBw4EIyIuBC8BLgE0NjsBNxM%2BATcnJjYDFjMyNw4BIiYCKV4UEgYSU3oPP3YRExwaEggeZGqfTzl0XFU%2BLwwLEhocExF2Pw96UxIGEyQyNDUxDDdGOASwFRMlE39N%2FrmtHSkoBwQLHBYSCg4REg4FBAgoKR2tAUdNfhQgExr7vgYGMT09AAEAFAAUBJwEnAAXAAABNwcXBxcHFycHJwcnBzcnNyc3Jxc3FzcDIOBO6rS06k7gLZubLeBO6rS06k7gLZubA7JO4C2bmy3gTuq0tOpO4C2bmy3gTuq0tAADAAAAZASwBLAAIQAtAD0AAAEzMhYdAQchMhYdARQHAw4BKwEiJi8BIyImNRE0PwI%2BARcPAREzFzMTNSE3NQEzMhYVERQGKwEiJjURNDYCijIoPBwBSCg8He4QLBf6B0YfHz0tNxSRYA0xG2SWZIjW%2Bv4%2BMv12ZBUdHRVkFR0dBLBRLJZ9USxkLR3%2BqBghMhkZJCcBkCQbxMYcKGTU1f6JZAF3feGv%2FtQdFf4MFR0dFQH0FR0AAAAAAwAAAAAEsARMACAAMAA8AAABMzIWFxMWHQEUBiMhFh0BFAYrASImLwImNRE0NjsBNgUzMhYVERQGKwEiJjURNDYhByMRHwEzNSchNQMCWPoXLBDuHTwo%2FrgcPCgyGzENYJEUNy09fP3pZBUdHRVkFR0dAl%2BIZJZkMjIBwvoETCEY%2FqgdLWQsUXYHlixRKBzGxBskAZAnJGRkHRX%2BDBUdHRUB9BUdZP6J1dSv4X0BdwADAAAAZAUOBE8AGwA3AEcAAAElNh8BHgEPASEyFhQGKwEDDgEjISImNRE0NjcXERchEz4BOwEyNiYjISoDLgQnJj8BJwUzMhYVERQGKwEiJjURNDYBZAFrHxZuDQEMVAEuVGxuVGqDBhsP%2FqoHphwOOmQBJYMGGw%2FLFRMSFv44AgoCCQMHAwUDAQwRklb9T2QVHR0VZBUdHQNp5hAWcA0mD3lMkE7%2BrRUoog0CDRElCkj%2BCVkBUxUoMjIBAgIDBQIZFrdT5B0V%2FgwVHR0VAfQVHQAAAAP%2FnABkBLAETwAdADYARgAAAQUeBBURFAYjISImJwMjIiY0NjMhJyY2PwE2BxcWBw4FKgIjIRUzMhYXEyE3ESUFMzIWFREUBisBIiY1ETQ2AdsBbgIIFBANrAf%2Bqg8bBoNqVW1sVAEuVQsBDW4WSpIRDAIDBQMHAwkDCgH%2BJd0PHAaCASZq%2FqoCUGQVHR0VZBUdHQRP5gEFEBEXC%2F3zDaIoFQFTTpBMeQ8mDXAWrrcWGQIFAwICAWQoFf6tWQH37OQdFf4MFR0dFQH0FR0AAAADAGEAAARMBQ4AGwA3AEcAAAAyFh0BBR4BFREUBiMhIiYvAQMmPwE%2BAR8BETQXNTQmBhURHAMOBAcGLwEHEyE3ESUuAQMhMhYdARQGIyEiJj0BNDYB3pBOAVMVKKIN%2FfMRJQoJ5hAWcA0mD3nGMjIBAgIDBQIZFrdT7AH3Wf6tFSiWAfQVHR0V%2FgwVHR0FDm5UaoMGGw%2F%2BqgemHA4OAWsfFm4NAQxUAS5U1ssVExIW%2FjgCCgIJAwcDBQMBDBGSVv6tZAElgwYb%2FQsdFWQVHR0VZBUdAAP%2F%2FQAGA%2BgFFAAPAC0ASQAAASEyNj0BNCYjISIGHQEUFgEVFAYiJjURBwYmLwEmNxM%2BBDMhMhYVERQGBwEDFzc2Fx4FHAIVERQWNj0BNDY3JREnAV4B9BUdHRX%2BDBUdHQEPTpBMeQ8mDXAWEOYBBRARFwsCDQ2iKBX9iexTtxYZAgUDAgIBMjIoFQFTWQRMHRVkFR0dFWQVHfzmalRubFQBLlQMAQ1uFh8BawIIEw8Mpgf%2Bqg8bBgHP%2Fq1WkhEMAQMFAwcDCQIKAv44FhITFcsPGwaDASVkAAIAFgAWBJoEmgAPACUAAAAyHgIUDgIiLgI0PgEBJSYGHQEhIgYdARQWMyEVFBY3JTY0AeLs1ptbW5vW7NabW1ubAob%2B7RAX%2Fu0KDw8KARMXEAETEASaW5vW7NabW1ub1uzWm%2F453w0KFYkPCpYKD4kVCg3fDSYAAAIAFgAWBJoEmgAPACUAAAAyHgIUDgIiLgI0PgENAQYUFwUWNj0BITI2PQE0JiMhNTQmAeLs1ptbW5vW7NabW1ubASX%2B7RAQARMQFwETCg8PCv7tFwSaW5vW7NabW1ub1uzWm%2BjfDSYN3w0KFYkPCpYKD4kVCgAAAAIAFgAWBJoEmgAPACUAAAAyHgIUDgIiLgI0PgEBAyYiBwMGFjsBERQWOwEyNjURMzI2AeLs1ptbW5vW7NabW1ubAkvfDSYN3w0KFYkPCpYKD4kVCgSaW5vW7NabW1ub1uzWm%2F5AARMQEP7tEBf%2B7QoPDwoBExcAAAIAFgAWBJoEmgAPACUAAAAyHgIUDgIiLgI0PgEFIyIGFREjIgYXExYyNxM2JisBETQmAeLs1ptbW5vW7NabW1ubAZeWCg%2BJFQoN3w0mDd8NChWJDwSaW5vW7NabW1ub1uzWm7sPCv7tFxD%2B7RAQARMQFwETCg8AAAMAGAAYBJgEmAAPAJYApgAAADIeAhQOAiIuAjQ%2BASUOAwcGJgcOAQcGFgcOAQcGFgcUFgcyHgEXHgIXHgI3Fg4BFx4CFxQGFBcWNz4CNy4BJy4BJyIOAgcGJyY2NS4BJzYuAQYHBicmNzY3HgIXHgMfAT4CJyY%2BATc%2BAzcmNzIWMjY3LgMnND4CJiceAT8BNi4CJwYHFB4BFS4CJz4BNxYyPgEB5OjVm1xcm9Xo1ZtcXJsBZA8rHDoKDz0PFD8DAxMBAzEFCRwGIgEMFhkHECIvCxU%2FOR0HFBkDDRQjEwcFaHUeISQDDTAMD0UREi4oLBAzDwQBBikEAQMLGhIXExMLBhAGKBsGBxYVEwYFAgsFAwMNFwQGCQcYFgYQCCARFwkKKiFBCwQCAQMDHzcLDAUdLDgNEiEQEgg%2FKhADGgMKEgoRBJhcm9Xo1ZtcXJvV6NWbEQwRBwkCAwYFBycPCxcHInIWInYcCUcYChQECA4QBAkuHgQPJioRFRscBAcSCgwCch0kPiAIAQcHEAsBAgsLIxcBMQENCQIPHxkCFBkdHB4QBgEBBwoMGBENBAMMJSAQEhYXDQ4qFBkKEhIDCQsXJxQiBgEOCQwHAQ0DBAUcJAwSCwRnETIoAwEJCwsLJQcKDBEAAAAAAQAAAAIErwSFABYAAAE2FwUXNxYGBw4BJwEGIi8BJjQ3ASY2AvSkjv79kfsGUE08hjv9rA8rD28PDwJYIk8EhVxliuh%2BWYcrIgsW%2FawQEG4PKxACV2XJAAYAAABgBLAErAAPABMAIwAnADcAOwAAEyEyFh0BFAYjISImPQE0NgUjFTMFITIWHQEUBiMhIiY9ATQ2BSEVIQUhMhYdARQGIyEiJj0BNDYFIRUhZAPoKTs7KfwYKTs7BBHIyPwYA%2BgpOzsp%2FBgpOzsEEf4MAfT8GAPoKTs7KfwYKTs7BBH%2B1AEsBKw7KWQpOzspZCk7ZGTIOylkKTs7KWQpO2RkyDspZCk7OylkKTtkZAAAAAIAZAAABEwEsAALABEAABMhMhYUBiMhIiY0NgERBxEBIZYDhBUdHRX8fBUdHQI7yP6iA4QEsB0qHR0qHf1E%2FtTIAfQB9AAAAAMAAABkBLAEsAAXABsAJQAAATMyFh0BITIWFREhNSMVIRE0NjMhNTQ2FxUzNQEVFAYjISImPQEB9MgpOwEsKTv%2BDMj%2BDDspASw7KcgB9Dsp%2FBgpOwSwOylkOyn%2BcGRkAZApO2QpO2RkZP1EyCk7OynIAAAABAAAAAAEsASwABUAKwBBAFcAABMhMhYPARcWFA8BBiIvAQcGJjURNDYpATIWFREUBi8BBwYiLwEmND8BJyY2ARcWFA8BFxYGIyEiJjURNDYfATc2MgU3NhYVERQGIyEiJj8BJyY0PwE2MhcyASwVCA5exwcHaggUCMdeDhUdAzUBLBUdFQ5exwgUCGoHB8deDgj%2BL2oHB8deDggV%2FtQVHRUOXscIFALLXg4VHRX%2B1BUIDl7HBwdqCBQIBLAVDl7HCBQIagcHx14OCBUBLBUdHRX%2B1BUIDl7HBwdqCBQIx14OFf0maggUCMdeDhUdFQEsFQgOXscHzl4OCBX%2B1BUdFQ5exwgUCGoHBwAAAAYAAAAABKgEqAAPABsAIwA7AEMASwAAADIeAhQOAiIuAjQ%2BAQQiDgEUHgEyPgE0JiQyFhQGIiY0JDIWFAYjIicHFhUUBiImNTQ2PwImNTQEMhYUBiImNCQyFhQGIiY0Advy3Z9fX5%2Fd8t2gXl6gAcbgv29vv%2BC%2Fb2%2F%2BLS0gIC0gAUwtICAWDg83ETNIMykfegEJ%2FoctICAtIAIdLSAgLSAEqF%2Bf3fLdoF5eoN3y3Z9Xb7%2Fgv29vv%2BC%2FBiAtISEtICAtIQqRFxwkMzMkIDEFfgEODhekIC0gIC0gIC0gIC0AAf%2FYAFoEuQS8AFsAACUBNjc2JicmIyIOAwcABw4EFx4BMzI3ATYnLgEjIgcGBwEOASY0NwA3PgEzMhceARcWBgcOBgcGIyImJyY2NwE2NzYzMhceARcWBgcBDgEnLgECIgHVWwgHdl8WGSJBMD8hIP6IDx4eLRMNBQlZN0ozAiQkEAcdEhoYDRr%2Bqw8pHA4BRyIjQS4ODyw9DQ4YIwwod26La1YOOEBGdiIwGkQB%2F0coW2tQSE5nDxE4Qv4eDyoQEAOtAdZbZWKbEQQUGjIhH%2F6JDxsdNSg3HT5CMwIkJCcQFBcMGv6uDwEcKQ4BTSIjIQEINykvYyMLKnhuiWZMBxtAOU6%2BRAH%2FSBg3ISSGV121Qv4kDwIPDyYAAAACAGQAWASvBEQAGQBEAAABPgIeAhUUDgMHLgQ1ND4CHgEFIg4DIi4DIyIGFRQeAhcWFx4EMj4DNzY3PgQ1NCYCiTB7eHVYNkN5hKg%2BPqeFeEM4WnZ4eQEjIT8yLSohJyktPyJDbxtBMjMPBw86KzEhDSIzKUAMBAgrKT8dF2oDtURIBS1TdkA5eYB%2FslVVsn%2BAeTlAdlMtBUgtJjY1JiY1NiZvTRc4SjQxDwcOPCouGBgwKEALBAkpKkQqMhNPbQACADn%2F8gR3BL4AFwAuAAAAMh8BFhUUBg8BJi8BNycBFwcvASY0NwEDNxYfARYUBwEGIi8BJjQ%2FARYfAQcXAQKru0KNQjgiHR8uEl%2F3%2FnvUaRONQkIBGxJpCgmNQkL%2B5UK6Qo1CQjcdLhJf9wGFBL5CjUJeKmsiHTUuEl%2F4%2FnvUahKNQrpCARv%2BRmkICY1CukL%2B5UJCjUK7Qjc3LxFf%2BAGFAAAAAAMAyAAAA%2BgEsAARABUAHQAAADIeAhURFAYjISImNRE0PgEHESERACIGFBYyNjQCBqqaZDo7Kf2oKTs8Zj4CWP7%2FVj09Vj0EsB4uMhX8Ryk7OykDuRUzLar9RAK8%2FRY9Vj09VgABAAAAAASwBLAAFgAACQEWFAYiLwEBEScBBRMBJyEBJyY0NjIDhgEbDx0qDiT%2B6dT%2BzP7oywEz0gEsAQsjDx0qBKH%2B5g8qHQ8j%2FvX%2B1NL%2BzcsBGAE01AEXJA4qHQAAAAADAScAEQQJBOAAMgBAAEsAAAEVHgQXIy4DJxEXHgQVFAYHFSM1JicuASczHgEXEScuBDU0PgI3NRkBDgMVFB4DFxYXET4ENC4CArwmRVI8LAKfBA0dMydAIjxQNyiym2SWVygZA4sFV0obLkJOMCAyVWg6HSoqFQ4TJhkZCWgWKTEiGBkzNwTgTgUTLD9pQiQuLBsH%2Fs0NBxMtPGQ%2Bi6oMTU8QVyhrVk1iEAFPCA4ZLzlYNkZwSCoGTf4SARIEDh02Jh0rGRQIBgPQ%2FsoCCRYgNEM0JRkAAAABAGQAZgOUBK0ASgAAATIeARUjNC4CIyIGBwYVFB4BFxYXMxUjFgYHBgc%2BATM2FjMyNxcOAyMiLgEHDgEPASc%2BBTc%2BAScjNTMmJy4CPgE3NgIxVJlemSc8OxolVBQpGxoYBgPxxQgVFS02ImIWIIwiUzUyHzY4HCAXanQmJ1YYFzcEGAcTDBEJMAwk3aYXFQcKAg4tJGEErVCLTig%2FIhIdFSw5GkowKgkFZDKCHj4yCg8BIh6TExcIASIfBAMaDAuRAxAFDQsRCjePR2QvORQrREFMIVgAAAACABn%2F%2FwSXBLAADwAfAAABMzIWDwEGIi8BJjY7AREzBRcWBisBESMRIyImPwE2MgGQlhUIDuYOKg7mDggVlsgCF%2BYOCBWWyJYVCA7mDioBLBYO%2Bg8P%2Bg4WA4QQ%2BQ4V%2FHwDhBUO%2BQ8AAAQAGf%2F%2FA%2BgEsAAHABcAGwAlAAABIzUjFSMRIQEzMhYPAQYiLwEmNjsBETMFFTM1EwczFSE1NyM1IQPoZGRkASz9qJYVCA7mDioO5g4IFZbIAZFkY8jI%2FtTIyAEsArxkZAH0%2FHwWDvoPD%2FoOFgOEZMjI%2FRL6ZJb6ZAAAAAAEABn%2F%2FwPoBLAADwAZACEAJQAAATMyFg8BBiIvASY2OwERMwUHMxUhNTcjNSERIzUjFSMRIQcVMzUBkJYVCA7mDioO5g4IFZbIAljIyP7UyMgBLGRkZAEsx2QBLBYO%2Bg8P%2Bg4WA4SW%2BmSW%2BmT7UGRkAfRkyMgAAAAEABn%2F%2FwRMBLAADwAVABsAHwAAATMyFg8BBiIvASY2OwERMwEjESM1MxMjNSMRIQcVMzUBkJYVCA7mDioO5g4IFZbIAlhkZMhkZMgBLMdkASwWDvoPD%2FoOFgOE%2FgwBkGT7UGQBkGTIyAAAAAAEABn%2F%2FwRMBLAADwAVABkAHwAAATMyFg8BBiIvASY2OwERMwEjNSMRIQcVMzUDIxEjNTMBkJYVCA7mDioO5g4IFZbIArxkyAEsx2QBZGTIASwWDvoPD%2FoOFgOE%2FgxkAZBkyMj7tAGQZAAAAAAFABn%2F%2FwSwBLAADwATABcAGwAfAAABMzIWDwEGIi8BJjY7AREzBSM1MxMhNSETITUhEyE1IQGQlhUIDuYOKg7mDggVlsgB9MjIZP7UASxk%2FnABkGT%2BDAH0ASwWDvoPD%2FoOFgOEyMj%2BDMj%2BDMj%2BDMgABQAZ%2F%2F8EsASwAA8AEwAXABsAHwAAATMyFg8BBiIvASY2OwERMwUhNSEDITUhAyE1IQMjNTMBkJYVCA7mDioO5g4IFZbIAyD%2BDAH0ZP5wAZBk%2FtQBLGTIyAEsFg76Dw%2F6DhYDhMjI%2FgzI%2FgzI%2FgzIAAIAAAAABEwETAAPAB8AAAEhMhYVERQGIyEiJjURNDYFISIGFREUFjMhMjY1ETQmAV4BkKK8u6P%2BcKW5uQJn%2FgwpOzspAfQpOzsETLuj%2FnClubmlAZClucg7Kf4MKTs7KQH0KTsAAAAAAwAAAAAETARMAA8AHwArAAABITIWFREUBiMhIiY1ETQ2BSEiBhURFBYzITI2NRE0JgUXFhQPAQYmNRE0NgFeAZClubml%2FnCju7wCZP4MKTs7KQH0KTs7%2Fm%2F9ERH9EBgYBEy5pf5wpbm5pQGQo7vIOyn%2BDCk7OykB9Ck7gr4MJAy%2BDAsVAZAVCwAAAAADAAAAAARMBEwADwAfACsAAAEhMhYVERQGIyEiJjURNDYFISIGFREUFjMhMjY1ETQmBSEyFg8BBiIvASY2AV4BkKO7uaX%2BcKW5uQJn%2FgwpOzspAfQpOzv%2BFQGQFQsMvgwkDL4MCwRMvKL%2BcKW5uaUBkKO7yDsp%2FgwpOzspAfQpO8gYEP0REf0QGAAAAAMAAAAABEwETAAPAB8AKwAAASEyFhURFAYjISImNRE0NgUhIgYVERQWMyEyNjURNCYFFxYGIyEiJj8BNjIBXgGQpbm5pf5wo7u5Amf%2BDCk7OykB9Ck7O%2F77vgwLFf5wFQsMvgwkBEy5pf5wo7u8ogGQpbnIOyn%2BDCk7OykB9Ck7z%2F0QGBgQ%2FREAAAAAAgAAAAAFFARMAB8ANQAAASEyFhURFAYjISImPQE0NjMhMjY1ETQmIyEiJj0BNDYHARYUBwEGJj0BIyImPQE0NjsBNTQ2AiYBkKW5uaX%2BcBUdHRUBwik7Oyn%2BPhUdHb8BRBAQ%2FrwQFvoVHR0V%2BhYETLml%2FnCluR0VZBUdOykB9Ck7HRVkFR3p%2FuQOJg7%2B5A4KFZYdFcgVHZYVCgAAAQDZAAID1wSeACMAAAEXFgcGAgclMhYHIggBBwYrAScmNz4BPwEhIicmNzYANjc2MwMZCQgDA5gCASwYEQ4B%2Fvf%2B8wQMDgkJCQUCUCcn%2FtIXCAoQSwENuwUJEASeCQoRC%2F5TBwEjEv7K%2FsUFDwgLFQnlbm4TFRRWAS%2FTBhAAAAACAAAAAAT%2BBEwAHwA1AAABITIWHQEUBiMhIgYVERQWMyEyFh0BFAYjISImNRE0NgUBFhQHAQYmPQEjIiY9ATQ2OwE1NDYBXgGQFR0dFf4%2BKTs7KQHCFR0dFf5wpbm5AvEBRBAQ%2FrwQFvoVHR0V%2BhYETB0VZBUdOyn%2BDCk7HRVkFR25pQGQpbnp%2FuQOJg7%2B5A4KFZYdFcgVHZYVCgACAAAAAASwBLAAFQAxAAABITIWFREUBi8BAQYiLwEmNDcBJyY2ASMiBhURFBYzITI2PQE3ERQGIyEiJjURNDYzIQLuAZAVHRUObf7IDykPjQ8PAThtDgj%2B75wpOzspAfQpO8i7o%2F5wpbm5pQEsBLAdFf5wFQgObf7IDw%2BNDykPAThtDhX%2B1Dsp%2FgwpOzsplMj%2B1qW5uaUBkKW5AAADAA4ADgSiBKIADwAbACMAAAAyHgIUDgIiLgI0PgEEIg4BFB4BMj4BNCYEMhYUBiImNAHh7tmdXV2d2e7ZnV1dnQHD5sJxccLmwnFx%2FnugcnKgcgSiXZ3Z7tmdXV2d2e7ZnUdxwubCcXHC5sJzcqBycqAAAAMAAAAABEwEsAAVAB8AIwAAATMyFhURMzIWBwEGIicBJjY7ARE0NgEhMhYdASE1NDYFFTM1AcLIFR31FAoO%2FoEOJw3%2BhQ0JFfod%2FoUD6BUd%2B7QdA2dkBLAdFf6iFg%2F%2BVg8PAaoPFgFeFR38fB0V%2BvoVHWQyMgAAAAMAAAAABEwErAAVAB8AIwAACQEWBisBFRQGKwEiJj0BIyImNwE%2BAQEhMhYdASE1NDYFFTM1AkcBeg4KFfQiFsgUGPoUCw4Bfw4n%2FfkD6BUd%2B7QdA2dkBJ7%2BTQ8g%2BhQeHRX6IQ8BrxAC%2FH8dFfr6FR1kMjIAAwAAAAAETARLABQAHgAiAAAJATYyHwEWFAcBBiInASY0PwE2MhcDITIWHQEhNTQ2BRUzNQGMAXEHFQeLBwf98wcVB%2F7cBweLCBUH1APoFR37tB0DZ2QC0wFxBweLCBUH%2FfMICAEjCBQIiwcH%2FdIdFfr6FR1kMjIABAAAAAAETASbAAkAGQAjACcAABM3NjIfAQcnJjQFNzYWFQMOASMFIiY%2FASc3ASEyFh0BITU0NgUVMzWHjg4qDk3UTQ4CFtIOFQIBHRX9qxUIDtCa1P49A%2BgVHfu0HQNnZAP%2Fjg4OTdRMDyqa0g4IFf2pFB4BFQ7Qm9T9Oh0V%2BvoVHWQyMgAAAAQAAAAABEwEsAAPABkAIwAnAAABBR4BFRMUBi8BByc3JyY2EwcGIi8BJjQ%2FAQEhMhYdASE1NDYFFTM1AV4CVxQeARUO0JvUm9IOCMNMDyoOjg4OTf76A%2BgVHfu0HQNnZASwAgEdFf2rFQgO0JrUmtIOFf1QTQ4Ojg4qDk3%2BWB0V%2BvoVHWQyMgACAAT%2F7ASwBK8ABQAIAAAlCQERIQkBFQEEsP4d%2Fsb%2BcQSs%2FTMCq2cBFP5xAacDHPz55gO5AAAAAAIAAABkBEwEsAAVABkAAAERFAYrAREhESMiJjURNDY7AREhETMHIzUzBEwdFZb9RJYVHR0V%2BgH0ZMhkZAPo%2FK4VHQGQ%2FnAdFQPoFB7%2B1AEsyMgAAAMAAABFBN0EsAAWABoALwAAAQcBJyYiDwEhESMiJjURNDY7AREhETMHIzUzARcWFAcBBiIvASY0PwE2Mh8BATYyBEwC%2FtVfCRkJlf7IlhUdHRX6AfRkyGRkAbBqBwf%2BXAgUCMoICGoHFQdPASkHFQPolf7VXwkJk%2F5wHRUD6BQe%2FtQBLMjI%2Fc5qBxUH%2FlsHB8sHFQdqCAhPASkHAAMAAAANBQcEsAAWABoAPgAAAREHJy4BBwEhESMiJjURNDY7AREhETMHIzUzARcWFA8BFxYUDwEGIi8BBwYiLwEmND8BJyY0PwE2Mh8BNzYyBExnhg8lEP72%2FreWFR0dFfoB9GTIZGQB9kYPD4ODDw9GDykPg4MPKQ9GDw%2BDgw8PRg8pD4ODDykD6P7zZ4YPAw7%2B9v5wHRUD6BQe%2FtQBLMjI%2FYxGDykPg4MPKQ9GDw%2BDgw8PRg8pD4ODDykPRg8Pg4MPAAADAAAAFQSXBLAAFQAZAC8AAAERISIGHQEhESMiJjURNDY7AREhETMHIzUzEzMyFh0BMzIWDwEGIi8BJjY7ATU0NgRM%2FqIVHf4MlhUdHRX6AfRkyGRklmQVHZYVCA7mDioO5g4IFZYdA%2Bj%2B1B0Vlv5wHRUD6BQe%2FtQBLMjI%2FagdFfoVDuYODuYOFfoVHQAAAAADAAAAAASXBLAAFQAZAC8AAAERJyYiBwEhESMiJjURNDY7AREhETMHIzUzExcWBisBFRQGKwEiJj0BIyImPwE2MgRMpQ4qDv75%2Fm6WFR0dFfoB9GTIZGTr5g4IFZYdFWQVHZYVCA7mDioD6P5wpQ8P%2Fvf%2BcB0VA%2BgUHv7UASzIyP2F5Q8V%2BhQeHhT6FQ%2FlDwADAAAAyASwBEwACQATABcAABMhMhYdASE1NDYBERQGIyEiJjURExUhNTIETBUd%2B1AdBJMdFfu0FR1kAZAETB0VlpYVHf7U%2FdoVHR0VAib%2B1MjIAAAGAAMAfQStBJcADwAZAB0ALQAxADsAAAEXFhQPAQYmPQEhNSE1NDYBIyImPQE0NjsBFyM1MwE3NhYdASEVIRUUBi8BJjQFIzU7AjIWHQEUBisBA6f4Dg74DhX%2BcAGQFf0vMhUdHRUyyGRk%2FoL3DhUBkP5wFQ73DwOBZGRkMxQdHRQzBI3mDioO5g4IFZbIlhUI%2FoUdFWQVHcjI%2FcvmDggVlsiWFQgO5g4qecgdFWQVHQAAAAACAGQAAASwBLAAFgBRAAABJTYWFREUBisBIiY1ES4ENRE0NiUyFh8BERQOAg8BERQGKwEiJjURLgQ1ETQ%2BAzMyFh8BETMRPAE%2BAjMyFh8BETMRND4DA14BFBklHRXIFR0EDiIaFiX%2B4RYZAgEVHR0LCh0VyBUdBA4iGhYBBwoTDRQZAgNkBQkVDxcZAQFkAQUJFQQxdBIUH%2FuuFR0dFQGNAQgbHzUeAWcfRJEZDA3%2BPhw%2FMSkLC%2F5BFR0dFQG%2FBA8uLkAcAcICBxENCxkMDf6iAV4CBxENCxkMDf6iAV4CBxENCwABAGQAAASwBEwAMwAAARUiDgMVERQWHwEVITUyNjURIREUFjMVITUyPgM1ETQmLwE1IRUiBhURIRE0JiM1BLAEDiIaFjIZGf5wSxn%2BDBlL%2FnAEDiIaFjIZGQGQSxkB9BlLBEw4AQUKFA78iBYZAQI4OA0lAYr%2BdiUNODgBBQoUDgN4FhkBAjg4DSX%2BdgGKJQ04AAAABgAAAAAETARMAAwAHAAgACQAKAA0AAABITIWHQEjBTUnITchBSEyFhURFAYjISImNRE0NhcVITUBBTUlBRUhNQUVFAYjIQchJyE3MwKjAXcVHWn%2B2cj%2BcGQBd%2F4lASwpOzsp%2FtQpOzspASwCvP5wAZD8GAEsArwdFf6JZP6JZAGQyGkD6B0VlmJiyGTIOyn%2BDCk7OykB9Ck7ZMjI%2FveFo4XGyMhm%2BBUdZGTIAAEAEAAQBJ8EnwAmAAATNzYWHwEWBg8BHgEXNz4BHwEeAQ8BBiIuBicuBTcRohEuDosOBhF3ZvyNdxEzE8ATBxGjAw0uMUxPZWZ4O0p3RjITCwED76IRBhPCFDERdo78ZXYRBA6IDi8RogEECBUgNUNjO0qZfHNVQBAAAAACAAAAAASwBEwAIwBBAAAAMh4EHwEVFAYvAS4BPQEmIAcVFAYPAQYmPQE%2BBRIyHgIfARUBHgEdARQGIyEiJj0BNDY3ATU0PgIB%2FLimdWQ%2FLAkJHRTKFB2N%2FsKNHRTKFB0DDTE7ZnTKcFImFgEBAW0OFR0V%2B7QVHRUOAW0CFiYETBUhKCgiCgrIFRgDIgMiFZIYGJIVIgMiAxgVyAQNJyQrIP7kExwcCgoy%2FtEPMhTUFR0dFdQUMg8BLzIEDSEZAAADAAAAAASwBLAADQAdACcAAAEHIScRMxUzNTMVMzUzASEyFhQGKwEXITcjIiY0NgMhMhYdASE1NDYETMj9qMjIyMjIyPyuArwVHR0VDIn8SokMFR0dswRMFR37UB0CvMjIAfTIyMjI%2FOAdKh1kZB0qHf7UHRUyMhUdAAAAAwBkAAAEsARMAAkAEwAdAAABIyIGFREhETQmASMiBhURIRE0JgEhETQ2OwEyFhUCvGQpOwEsOwFnZCk7ASw7%2FRv%2B1DspZCk7BEw7KfwYA%2BgpO%2F7UOyn9RAK8KTv84AGQKTs7KQAAAAAF%2F5wAAASwBEwADwATAB8AJQApAAATITIWFREUBiMhIiY1ETQ2FxEhEQUjFTMRITUzNSMRIQURByMRMwcRMxHIArx8sLB8%2FUR8sLAYA4T%2BDMjI%2FtTIyAEsAZBkyMhkZARMsHz%2BDHywsHwB9HywyP1EArzIZP7UZGQBLGT%2B1GQB9GT%2B1AEsAAAABf%2BcAAAEsARMAA8AEwAfACUAKQAAEyEyFhURFAYjISImNRE0NhcRIREBIzUjFSMRMxUzNTMFEQcjETMHETMRyAK8fLCwfP1EfLCwGAOE%2FgxkZGRkZGQBkGTIyGRkBEywfP4MfLCwfAH0fLDI%2FUQCvP2oyMgB9MjIZP7UZAH0ZP7UASwABP%2BcAAAEsARMAA8AEwAbACMAABMhMhYVERQGIyEiJjURNDYXESERBSMRMxUhESEFIxEzFSERIcgCvHywsHz9RHywsBgDhP4MyMj%2B1AEsAZDIyP7UASwETLB8%2Fgx8sLB8AfR8sMj9RAK8yP7UZAH0ZP7UZAH0AAAABP%2BcAAAEsARMAA8AEwAWABkAABMhMhYVERQGIyEiJjURNDYXESERAS0BDQERyAK8fLCwfP1EfLCwGAOE%2Fgz%2B1AEsAZD%2B1ARMsHz%2BDHywsHwB9HywyP1EArz%2BDJaWlpYBLAAAAAX%2FnAAABLAETAAPABMAFwAgACkAABMhMhYVERQGIyEiJjURNDYXESERAyERIQcjIgYVFBY7AQERMzI2NTQmI8gCvHywsHz9RHywsBgDhGT9RAK8ZIImOTYpgv4Mgik2OSYETLB8%2Fgx8sLB8AfR8sMj9RAK8%2FagB9GRWQUFUASz%2B1FRBQVYAAAAF%2F5wAAASwBEwADwATAB8AJQApAAATITIWFREUBiMhIiY1ETQ2FxEhEQUjFTMRITUzNSMRIQEjESM1MwMjNTPIArx8sLB8%2FUR8sLAYA4T%2BDMjI%2FtTIyAEsAZBkZMjIZGQETLB8%2Fgx8sLB8AfR8sMj9RAK8yGT%2B1GRkASz%2BDAGQZP4MZAAG%2F5wAAASwBEwADwATABkAHwAjACcAABMhMhYVERQGIyEiJjURNDYXESERBTMRIREzASMRIzUzBRUzNQEjNTPIArx8sLB8%2FUR8sLAYA4T9RMj%2B1GQCWGRkyP2oZAEsZGQETLB8%2Fgx8sLB8AfR8sMj9RAK8yP5wAfT%2BDAGQZMjIyP7UZAAF%2F5wAAASwBEwADwATABwAIgAmAAATITIWFREUBiMhIiY1ETQ2FxEhEQEHIzU3NSM1IQEjESM1MwMjNTPIArx8sLB8%2FUR8sLAYA4T%2BDMdkx8gBLAGQZGTIx2RkBEywfP4MfLCwfAH0fLDI%2FUQCvP5wyDLIlmT%2BDAGQZP4MZAAAAAMACQAJBKcEpwAPABsAJQAAADIeAhQOAiIuAjQ%2BAQQiDgEUHgEyPgE0JgchFSEVISc1NyEB4PDbnl5entvw255eXp4BxeTCcXHC5MJxcWz%2B1AEs%2FtRkZAEsBKdentvw255eXp7b8NueTHHC5MJxccLkwtDIZGTIZAAAAAAEAAkACQSnBKcADwAbACcAKwAAADIeAhQOAiIuAjQ%2BAQQiDgEUHgEyPgE0JgcVBxcVIycjFSMRIQcVMzUB4PDbnl5entvw255eXp4BxeTCcXHC5MJxcWwyZGRklmQBLMjIBKdentvw255eXp7b8NueTHHC5MJxccLkwtBkMmQyZGQBkGRkZAAAAv%2Fy%2F50EwgRBACAANgAAATIWFzYzMhYUBisBNTQmIyEiBh0BIyImNTQ2NyY1ND4BEzMyFhURMzIWDwEGIi8BJjY7ARE0NgH3brUsLC54qqp4gB0V%2FtQVHd5QcFZBAmKqepYKD4kVCg3fDSYN3w0KFYkPBEF3YQ6t8a36FR0dFfpzT0VrDhMSZKpi%2FbMPCv7tFxD0EBD0EBcBEwoPAAAAAAL%2F8v%2BcBMMEQQAcADMAAAEyFhc2MzIWFxQGBwEmIgcBIyImNTQ2NyY1ND4BExcWBisBERQGKwEiJjURIyImNzY3NjIB9m62LCsueaoBeFr%2Bhg0lDf6DCU9xVkECYqnm3w0KFYkPCpYKD4kVCg3HGBMZBEF3YQ%2BteGOkHAFoEBD%2Bk3NPRWsOExNkqWP9kuQQF%2F7tCg8PCgETFxDMGBMAAAABAGQAAARMBG0AGAAAJTUhATMBMwkBMwEzASEVIyIGHQEhNTQmIwK8AZD%2B8qr%2B8qr%2B1P7Uqv7yqv7yAZAyFR0BkB0VZGQBLAEsAU3%2Bs%2F7U%2FtRkHRUyMhUdAAAAAAEAeQAABDcEmwAvAAABMhYXHgEVFAYHFhUUBiMiJxUyFh0BITU0NjM1BiMiJjU0Ny4BNTQ2MzIXNCY1NDYCWF6TGll7OzIJaUo3LRUd%2FtQdFS03SmkELzlpSgUSAqMEm3FZBoNaPWcfHRpKaR77HRUyMhUd%2Bx5pShIUFVg1SmkCAhAFdKMAAAAGACcAFASJBJwAEQAqAEIASgBiAHsAAAEWEgIHDgEiJicmAhI3PgEyFgUiBw4BBwYWHwEWMzI3Njc2Nz4BLwEmJyYXIgcOAQcGFh8BFjMyNz4BNz4BLwEmJyYWJiIGFBYyNjciBw4BBw4BHwEWFxYzMjc%2BATc2Ji8BJhciBwYHBgcOAR8BFhcWMzI3PgE3NiYvASYD8m9PT29T2dzZU29PT29T2dzZ%2Fj0EBHmxIgQNDCQDBBcGG0dGYAsNAwkDCwccBAVQdRgEDA0iBAQWBhJROQwMAwkDCwf5Y4xjY4xjVhYGElE6CwwDCQMLBwgEBVB1GAQNDCIEjRcGG0dGYAsNAwkDCwcIBAR5sSIEDQwkAwPyb%2F7V%2FtVvU1dXU28BKwErb1NXVxwBIrF5DBYDCQEWYEZHGwMVDCMNBgSRAhh1UA0WAwkBFTpREgMVCyMMBwT6Y2OMY2MVFTpREQQVCyMMBwQCGHVQDRYDCQEkFmBGRxsDFQwjDQYEASKxeQwWAwkBAAAABQBkAAAD6ASwAAwADwAWABwAIgAAASERIzUhFSERNDYzIQEjNQMzByczNTMDISImNREFFRQGKwECvAEstP6s%2FoQPCgI%2FASzIZKLU1KJktP51Cg8DhA8KwwMg%2FoTIyALzCg%2F%2B1Mj84NTUyP4MDwoBi8jDCg8AAAAABQBkAAAD6ASwAAkADAATABoAIQAAASERCQERNDYzIQEjNRMjFSM1IzcDISImPQEpARUUBisBNQK8ASz%2Bov3aDwoCPwEsyD6iZKLUqv6dCg8BfAIIDwqbAyD9%2BAFe%2FdoERwoP%2FtTI%2FHzIyNT%2BZA8KNzcKD1AAAAAAAwAAAAAEsAP0AAgAGQAfAAABIxUzFyERIzcFMzIeAhUhFSEDETM0PgIBMwMhASEEiqJkZP7UotT9EsgbGiEOASz9qMhkDiEaAnPw8PzgASwB9AMgyGQBLNTUBBErJGT%2BogHCJCsRBP5w%2FnAB9AAAAAMAAAAABEwETAAZADIAOQAAATMyFh0BMzIWHQEUBiMhIiY9ATQ2OwE1NDYFNTIWFREUBiMhIic3ARE0NjMVFBYzITI2AQc1IzUzNQKKZBUdMhUdHRX%2B1BUdHRUyHQFzKTs7Kf2oARP2%2Fro7KVg%2BASw%2BWP201MjIBEwdFTIdFWQVHR0VZBUdMhUd%2BpY7KfzgKTsE9gFGAUQpO5Y%2BWFj95tSiZKIAAwBkAAAEvARMABkANgA9AAABMzIWHQEzMhYdARQGIyEiJj0BNDY7ATU0NgU1MhYVESMRMxQOAiMhIiY1ETQ2MxUUFjMhMjYBBzUjNTM1AcJkFR0yFR0dFf7UFR0dFTIdAXMpO8jIDiEaG%2F2oKTs7KVg%2BASw%2BWAGc1MjIBEwdFTIdFWQVHR0VZBUdMhUd%2BpY7Kf4M%2FtQkKxEEOykDICk7lj5YWP3m1KJkogAAAAP%2FogAABRYE1AALABsAHwAACQEWBiMhIiY3ATYyEyMiBhcTHgE7ATI2NxM2JgMVMzUCkgJ9FyAs%2BwQsIBcCfRZARNAUGAQ6BCMUNhQjBDoEGODIBK37sCY3NyYEUCf%2BTB0U%2FtIUHR0UAS4UHf4MZGQAAAAACQAAAAAETARMAA8AHwAvAD8ATwBfAG8AfwCPAAABMzIWHQEUBisBIiY9ATQ2EzMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYBMzIWHQEUBisBIiY9ATQ2ITMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYBMzIWHQEUBisBIiY9ATQ2ITMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYBqfoKDw8K%2BgoPDwr6Cg8PCvoKDw8BmvoKDw8K%2BgoPD%2Fzq%2BgoPDwr6Cg8PAZr6Cg8PCvoKDw8BmvoKDw8K%2BgoPD%2Fzq%2BgoPDwr6Cg8PAZr6Cg8PCvoKDw8BmvoKDw8K%2BgoPDwRMDwqWCg8PCpYKD%2F7UDwqWCg8PCpYKDw8KlgoPDwqWCg%2F%2B1A8KlgoPDwqWCg8PCpYKDw8KlgoPDwqWCg8PCpYKD%2F7UDwqWCg8PCpYKDw8KlgoPDwqWCg8PCpYKDw8KlgoPAAAAAwAAAAAEsAUUABkAKQAzAAABMxUjFSEyFg8BBgchJi8BJjYzITUjNTM1MwEhMhYUBisBFyE3IyImNDYDITIWHQEhNTQ2ArxkZAFePjEcQiko%2FPwoKUIcMT4BXmRkyP4%2BArwVHR0VDIn8SooNFR0dswRMFR37UB0EsMhkTzeEUzMzU4Q3T2TIZPx8HSodZGQdKh3%2B1B0VMjIVHQAABAAAAAAEsAUUAAUAGQArADUAAAAyFhUjNAchFhUUByEyFg8BIScmNjMhJjU0AyEyFhQGKwEVBSElNSMiJjQ2AyEyFh0BITU0NgIwUDnCPAE6EgMBSCkHIq%2F9WrIiCikBSAOvArwVHR0VlgET%2FEoBE5YVHR2zBEwVHftQHQUUOykpjSUmCBEhFpGRFiERCCb%2BlR0qHcjIyMgdKh39qB0VMjIVHQAEAAAAAASwBJ0ABwAUACQALgAAADIWFAYiJjQTMzIWFRQXITY1NDYzASEyFhQGKwEXITcjIiY0NgMhMhYdASE1NDYCDZZqapZqty4iKyf%2BvCcrI%2F7NArwVHR0VDYr8SokMFR0dswRMFR37UB0EnWqWamqW%2Fus5Okxra0w6Of5yHSodZGQdKh3%2B1B0VMjIVHQAEAAAAAASwBRQADwAcACwANgAAATIeARUUBiImNTQ3FzcnNhMzMhYVFBchNjU0NjMBITIWFAYrARchNyMiJjQ2AyEyFh0BITU0NgJYL1szb5xvIpBvoyIfLiIrJ%2F68Jysj%2Fs0CvBUdHRUNivxKiQwVHR2zBEwVHftQHQUUa4s2Tm9vTj5Rj2%2BjGv4KOTpMa2tMOjn%2Bch0qHWRkHSod%2FtQdFTIyFR0AAAADAAAAAASwBRIAEgAiACwAAAEFFSEUHgMXIS4BNTQ%2BAjcBITIWFAYrARchNyMiJjQ2AyEyFh0BITU0NgJYASz%2B1CU%2FP00T%2Fe48PUJtj0r%2BogK8FR0dFQ2K%2FEqJDBUdHbMETBUd%2B1AdBLChizlmUT9IGVO9VFShdksE%2FH4dKh1kZB0qHf7UHRUyMhUdAAIAyAAAA%2BgFFAAPACkAAAAyFh0BHgEdASE1NDY3NTQDITIWFyMVMxUjFTMVIxUzFAYjISImNRE0NgIvUjsuNv5wNi5kAZA2XBqsyMjIyMh1U%2F5wU3V1BRQ7KU4aXDYyMjZcGk4p%2Fkc2LmRkZGRkU3V1UwGQU3UAAAMAZP%2F%2FBEwETAAPAC8AMwAAEyEyFhURFAYjISImNRE0NgMhMhYdARQGIyEXFhQGIi8BIQcGIiY0PwEhIiY9ATQ2BQchJ5YDhBUdHRX8fBUdHQQDtgoPDwr%2B5eANGiUNWP30Vw0mGg3g%2Ft8KDw8BqmQBRGQETB0V%2FgwVHR0VAfQVHf1EDwoyCg%2FgDSUbDVhYDRslDeAPCjIKD2RkZAAAAAAEAAAAAASwBEwAGQAjAC0ANwAAEyEyFh0BIzQmKwEiBhUjNCYrASIGFSM1NDYDITIWFREhETQ2ExUUBisBIiY9ASEVFAYrASImPQHIAyBTdWQ7KfopO2Q7KfopO2R1EQPoKTv7UDvxHRVkFR0D6B0VZBUdBEx1U8gpOzspKTs7KchTdf4MOyn%2B1AEsKTv%2BDDIVHR0VMjIVHR0VMgADAAEAAASpBKwADQARABsAAAkBFhQPASEBJjQ3ATYyCQMDITIWHQEhNTQ2AeACqh8fg%2F4f%2FfsgIAEnH1n%2BrAFWAS%2F%2Bq6IDIBUd%2FHwdBI39VR9ZH4MCBh9ZHwEoH%2F5u%2FqoBMAFV%2FBsdFTIyFR0AAAAAAgCPAAAEIQSwABcALwAAAQMuASMhIgYHAwYWMyEVFBYyNj0BMzI2AyE1NDY7ATU0NjsBETMRMzIWHQEzMhYVBCG9CCcV%2FnAVJwi9CBMVAnEdKh19FROo%2Fa0dFTIdFTDILxUdMhUdAocB%2BhMcHBP%2BBhMclhUdHRWWHP2MMhUdMhUdASz%2B1B0VMh0VAAAEAAAAAASwBLAADQAQAB8AIgAAASERFAYjIREBNTQ2MyEBIzUBIREUBiMhIiY1ETQ2MyEBIzUDhAEsDwr%2Bif7UDwoBdwEsyP2oASwPCv12Cg8PCgF3ASzIAyD9wQoPAk8BLFQKD%2F7UyP4M%2FcEKDw8KA7YKD%2F7UyAAC%2F5wAZAUUBEcARgBWAAABMzIeAhcWFxY2NzYnJjc%2BARYXFgcOASsBDgEPAQ4BKwEiJj8BBisBIicHDgErASImPwEmLwEuAT0BNDY7ATY3JyY2OwE2BSMiBh0BFBY7ATI2PQE0JgHkw0uOakkMEhEfQwoKGRMKBQ8XDCkCA1Y9Pgc4HCcDIhVkFRgDDDEqwxgpCwMiFWQVGAMaVCyfExwdFXwLLW8QBxXLdAFF%2BgoPDwr6Cg8PBEdBa4pJDgYKISAiJRsQCAYIDCw9P1c3fCbqFB0dFEYOCEAUHR0UnUplNQcmFTIVHVdPXw4TZV8PCjIKDw8KMgoPAAb%2FnP%2FmBRQEfgAJACQANAA8AFIAYgAAASU2Fh8BFgYPASUzMhYfASEyFh0BFAYHBQYmJyYjISImPQE0NhcjIgYdARQ7ATI2NTQmJyYEIgYUFjI2NAE3PgEeARceAT8BFxYGDwEGJi8BJjYlBwYfAR4BPwE2Jy4BJy4BAoEBpxMuDiAOAxCL%2FCtqQ0geZgM3FR0cE%2F0fFyIJKjr%2B1D5YWLlQExIqhhALIAsSAYBALS1ALf4PmBIgHhMQHC0aPzANITNQL3wpgigJASlmHyElDR0RPRMFAhQHCxADhPcICxAmDyoNeMgiNtQdFTIVJgeEBBQPQ1g%2ByD5YrBwVODMQEAtEERzJLUAtLUD%2B24ITChESEyMgAwWzPUkrRSgJL5cvfRxYGyYrDwkLNRAhFEgJDAQAAAAAAwBkAAAEOQSwAFEAYABvAAABMzIWHQEeARcWDgIPATIeBRUUDgUjFRQGKwEiJj0BIxUUBisBIiY9ASMiJj0BNDY7AREjIiY9ATQ2OwE1NDY7ATIWHQEzNTQ2AxUhMj4CNTc0LgMjARUhMj4CNTc0LgMjAnGWCg9PaAEBIC4uEBEGEjQwOiodFyI2LUAjGg8KlgoPZA8KlgoPrwoPDwpLSwoPDwqvDwqWCg9kD9cBBxwpEwsBAQsTKRz%2B%2BQFrHCkTCwEBCxMpHASwDwptIW1KLk0tHwYGAw8UKDJOLTtdPCoVCwJLCg8PCktLCg8PCksPCpYKDwJYDwqWCg9LCg8PCktLCg%2F%2B1MgVHR0LCgQOIhoW%2FnDIFR0dCwoEDiIaFgAAAwAEAAIEsASuABcAKQAsAAATITIWFREUBg8BDgEjISImJy4CNRE0NgQiDgQPARchNy4FAyMT1AMMVnokEhIdgVL9xFKCHAgYKHoCIIx9VkcrHQYGnAIwnAIIIClJVSGdwwSuelb%2BYDO3QkJXd3ZYHFrFMwGgVnqZFyYtLSUMDPPzBQ8sKDEj%2FsIBBQACAMgAAAOEBRQADwAZAAABMzIWFREUBiMhIiY1ETQ2ARUUBisBIiY9AQHblmesVCn%2BPilUrAFINhWWFTYFFKxn%2FgwpVFQpAfRnrPwY4RU2NhXhAAACAMgAAAOEBRQADwAZAAABMxQWMxEUBiMhIiY1ETQ2ARUUBisBIiY9AQHbYLOWVCn%2BPilUrAFINhWWFTYFFJaz%2FkIpVFQpAfRnrPwY4RU2NhXhAAACAAAAFAUOBBoAFAAaAAAJASUHFRcVJwc1NzU0Jj4CPwEnCQEFJTUFJQUO%2FYL%2Bhk5klpZkAQEBBQQvkwKCAVz%2Bov6iAV4BXgL%2F%2FuWqPOCWx5SVyJb6BA0GCgYDKEEBG%2F1ipqaTpaUAAAMAZAH0BLADIAAHAA8AFwAAEjIWFAYiJjQkMhYUBiImNCQyFhQGIiY0vHxYWHxYAeh8WFh8WAHofFhYfFgDIFh8WFh8WFh8WFh8WFh8WFh8AAAAAAMBkAAAArwETAAHAA8AFwAAADIWFAYiJjQSMhYUBiImNBIyFhQGIiY0Aeh8WFh8WFh8WFh8WFh8WFh8WARMWHxYWHz%2ByFh8WFh8%2FshYfFhYfAAAAAMAZABkBEwETAAPAB8ALwAAEyEyFh0BFAYjISImPQE0NhMhMhYdARQGIyEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2fQO2Cg8PCvxKCg8PCgO2Cg8PCvxKCg8PCgO2Cg8PCvxKCg8PBEwPCpYKDw8KlgoP%2FnAPCpYKDw8KlgoP%2FnAPCpYKDw8KlgoPAAAABAAAAAAEsASwAA8AHwAvADMAAAEhMhYVERQGIyEiJjURNDYFISIGFREUFjMhMjY1ETQmBSEyFhURFAYjISImNRE0NhcVITUBXgH0ory7o%2F4Mpbm5Asv9qCk7OykCWCk7O%2F2xAfQVHR0V%2FgwVHR1HAZAEsLuj%2FgylubmlAfSlucg7Kf2oKTs7KQJYKTtkHRX%2B1BUdHRUBLBUdZMjIAAAAAAEAZABkBLAETAA7AAATITIWFAYrARUzMhYUBisBFTMyFhQGKwEVMzIWFAYjISImNDY7ATUjIiY0NjsBNSMiJjQ2OwE1IyImNDaWA%2BgVHR0VMjIVHR0VMjIVHR0VMjIVHR0V%2FBgVHR0VMjIVHR0VMjIVHR0VMjIVHR0ETB0qHcgdKh3IHSodyB0qHR0qHcgdKh3IHSodyB0qHQAAAAYBLAAFA%2BgEowAHAA0AEwAZAB8AKgAAAR4BBgcuATYBMhYVIiYlFAYjNDYBMhYVIiYlFAYjNDYDFRQGIiY9ARYzMgKKVz8%2FV1c%2FP%2F75fLB8sAK8sHyw%2FcB8sHywArywfLCwHSodKAMRBKNDsrJCQrKy%2FsCwfLB8fLB8sP7UsHywfHywfLD%2B05AVHR0VjgQAAAH%2FtQDIBJQDgQBCAAABNzYXAR4BBw4BKwEyFRQOBCsBIhE0NyYiBxYVECsBIi4DNTQzIyImJyY2NwE2HwEeAQ4BLwEHIScHBi4BNgLpRRkUASoLCAYFGg8IAQQNGyc%2FKZK4ChRUFQu4jjBJJxkHAgcPGQYGCAsBKhQaTBQVCiMUM7YDe7YsFCMKFgNuEwYS%2FtkLHw8OEw0dNkY4MhwBIBgXBAQYF%2F7gKjxTQyMNEw4PHwoBKBIHEwUjKBYGDMHBDAUWKCMAAAAAAgAAAAAEsASwACUAQwAAASM0LgUrAREUFh8BFSE1Mj4DNREjIg4FFSMRIQEjNC4DKwERFBYXMxUjNTI1ESMiDgMVIzUhBLAyCAsZEyYYGcgyGRn%2BcAQOIhoWyBkYJhMZCwgyA%2Bj9RBkIChgQEWQZDQzIMmQREBgKCBkB9AOEFSAVDggDAfyuFhkBAmRkAQUJFQ4DUgEDCA4VIBUBLP0SDxMKBQH%2BVwsNATIyGQGpAQUKEw%2BWAAAAAAMAAAAABEwErgAdACAAMAAAATUiJy4BLwEBIwEGBw4BDwEVITUiJj8BIRcWBiMVARsBARUUBiMhIiY9ATQ2MyEyFgPoGR4OFgUE%2Ft9F%2FtQSFQkfCwsBETE7EkUBJT0NISf%2B7IZ5AbEdFfwYFR0dFQPoFR0BLDIgDiIKCwLr%2FQ4jFQkTBQUyMisusKYiQTIBhwFW%2Fqr942QVHR0VZBUdHQADAAAAAASwBLAADwBHAEoAABMhMhYVERQGIyEiJjURNDYFIyIHAQYHBgcGHQEUFjMhMjY9ATQmIyInJj8BIRcWBwYjIgYdARQWMyEyNj0BNCYnIicmJyMBJhMjEzIETBUdHRX7tBUdHQJGRg0F%2FtUREhImDAsJAREIDAwINxAKCj8BCjkLEQwYCAwMCAE5CAwLCBEZGQ8B%2FuAFDsVnBLAdFfu0FR0dFQRMFR1SDP0PIBMSEAUNMggMDAgyCAwXDhmjmR8YEQwIMggMDAgyBwwBGRskAuwM%2FgUBCAAABAAAAAAEsASwAAMAEwAjACcAAAEhNSEFITIWFREUBiMhIiY1ETQ2KQEyFhURFAYjISImNRE0NhcRIREEsPtQBLD7ggGQFR0dFf5wFR0dAm0BkBUdHRX%2BcBUdHUcBLARMZMgdFfx8FR0dFQOEFR0dFf5wFR0dFQGQFR1k%2FtQBLAAEAAAAAASwBLAADwAfACMAJwAAEyEyFhURFAYjISImNRE0NgEhMhYVERQGIyEiJjURNDYXESEREyE1ITIBkBUdHRX%2BcBUdHQJtAZAVHR0V%2FnAVHR1HASzI%2B1AEsASwHRX8fBUdHRUDhBUd%2FgwdFf5wFR0dFQGQFR1k%2FtQBLP2oZAAAAAACAAAAZASwA%2BgAJwArAAATITIWFREzNTQ2MyEyFh0BMxUjFRQGIyEiJj0BIxEUBiMhIiY1ETQ2AREhETIBkBUdZB0VAZAVHWRkHRX%2BcBUdZB0V%2FnAVHR0CnwEsA%2BgdFf6ilhUdHRWWZJYVHR0Vlv6iFR0dFQMgFR3%2B1P7UASwAAAQAAAAABLAEsAADABMAFwAnAAAzIxEzFyEyFhURFAYjISImNRE0NhcRIREBITIWFREUBiMhIiY1ETQ2ZGRklgGQFR0dFf5wFR0dRwEs%2FqIDhBUdHRX8fBUdHQSwZB0V%2FnAVHR0VAZAVHWT%2B1AEs%2FgwdFf5wFR0dFQGQFR0AAAAAAgBkAAAETASwACcAKwAAATMyFhURFAYrARUhMhYVERQGIyEiJjURNDYzITUjIiY1ETQ2OwE1MwcRIRECWJYVHR0VlgHCFR0dFfx8FR0dFQFelhUdHRWWZMgBLARMHRX%2BcBUdZB0V%2FnAVHR0VAZAVHWQdFQGQFR1kyP7UASwAAAAEAAAAAASwBLAAAwATABcAJwAAISMRMwUhMhYVERQGIyEiJjURNDYXESERASEyFhURFAYjISImNRE0NgSwZGT9dgGQFR0dFf5wFR0dRwEs%2FK4DhBUdHRX8fBUdHQSwZB0V%2FnAVHR0VAZAVHWT%2B1AEs%2FgwdFf5wFR0dFQGQFR0AAAEBLAAwA28EgAAPAAAJAQYjIiY1ETQ2MzIXARYUA2H%2BEhcSDhAQDhIXAe4OAjX%2BEhcbGQPoGRsX%2FhIOKgAAAAABAUEAMgOEBH4ACwAACQE2FhURFAYnASY0AU8B7h0qKh3%2BEg4CewHuHREp%2FBgpER0B7g4qAAAAAAEAMgFBBH4DhAALAAATITIWBwEGIicBJjZkA%2BgpER3%2BEg4qDv4SHREDhCod%2FhIODgHuHSoAAAAAAQAyASwEfgNvAAsAAAkBFgYjISImNwE2MgJ7Ae4dESn8GCkRHQHuDioDYf4SHSoqHQHuDgAAAAACAAgAAASwBCgABgAKAAABFQE1LQE1ASE1IQK8%2FUwBnf5jBKj84AMgAuW2%2Fr3dwcHd%2B9jIAAAAAAIAAABkBLAEsAALADEAAAEjFTMVIREzNSM1IQEzND4FOwERFAYPARUhNSIuAzURMzIeBRUzESEEsMjI%2FtTIyAEs%2B1AyCAsZEyYYGWQyGRkBkAQOIhoWZBkYJhMZCwgy%2FOADhGRkASxkZP4MFSAVDggDAf3aFhkBAmRkAQUJFQ4CJgEDCA4VIBUBLAAAAgAAAAAETAPoACUAMQAAASM0LgUrAREUFh8BFSE1Mj4DNREjIg4FFSMRIQEjFTMVIREzNSM1IQMgMggLGRMmGBlkMhkZ%2FnAEDiIaFmQZGCYTGQsIMgMgASzIyP7UyMgBLAK8FSAVDggDAf3aFhkCAWRkAQUJFQ4CJgEDCA4VIBUBLPzgZGQBLGRkAAABAMgAZgNyBEoAEgAAATMyFgcJARYGKwEiJwEmNDcBNgK9oBAKDP4wAdAMChCgDQr%2BKQcHAdcKBEoWDP4w%2FjAMFgkB1wgUCAHXCQAAAQE%2BAGYD6ARKABIAAAEzMhcBFhQHAQYrASImNwkBJjYBU6ANCgHXBwf%2BKQoNoBAKDAHQ%2FjAMCgRKCf4pCBQI%2FikJFgwB0AHQDBYAAAEAZgDIBEoDcgASAAAAFh0BFAcBBiInASY9ATQ2FwkBBDQWCf4pCBQI%2FikJFgwB0AHQA3cKEKANCv4pBwcB1woNoBAKDP4wAdAAAAABAGYBPgRKA%2BgAEgAACQEWHQEUBicJAQYmPQE0NwE2MgJqAdcJFgz%2BMP4wDBYJAdcIFAPh%2FikKDaAQCgwB0P4wDAoQoA0KAdcHAAAAAgDZ%2F%2FkEPQSwAAUAOgAAARQGIzQ2BTMyFh8BNjc%2BAh4EBgcOBgcGIiYjIgYiJy4DLwEuAT4EHgEXJyY2A%2BiwfLD%2BVmQVJgdPBQsiKFAzRyorDwURAQQSFyozTSwNOkkLDkc3EDlfNyYHBw8GDyUqPjdGMR%2BTDA0EsHywfLDIHBPCAQIGBwcFDx81S21DBxlLR1xKQhEFBQcHGWt0bCQjP2hJNyATBwMGBcASGAAAAAACAMgAFQOEBLAAFgAaAAATITIWFREUBisBEQcGJjURIyImNRE0NhcVITX6AlgVHR0Vlv8TGpYVHR2rASwEsB0V%2FnAVHf4MsgkQFQKKHRUBkBUdZGRkAAAAAgDIABkETASwAA4AEgAAEyEyFhURBRElIREjETQ2ARU3NfoC7ic9%2FUQCWP1EZB8BDWQEsFEs%2FFt1A7Z9%2FBgEARc0%2FV1kFGQAAQAAAAECTW%2FDBF9fDzz1AB8EsAAAAADQdnOXAAAAANB2c5f%2FUf%2BcBdwFFAAAAAgAAgAAAAAAAAABAAAFFP%2BFAAAFFP9R%2FtQF3AABAAAAAAAAAAAAAAAAAAAAowG4ACgAAAAAAZAAAASwAAAEsABkBLAAAASwAAAEsABwAooAAAUUAAACigAABRQAAAGxAAABRQAAANgAAADYAAAAogAAAQQAAABIAAABBAAAAUUAAASwAGQEsAB7BLAAyASwAMgB9AAABLD%2F8gSwAAAEsAAABLD%2F8ASwAAAEsAAOBLAACQSwAGQEsP%2FTBLD%2F0wSwAAAEsAAABLAAAASwAAAEsAAABLAAJgSwAG4EsAAXBLAAFwSwABcEsABkBLAAGgSwAGQEsAAMBLAAZASwABcEsP%2BcBLAAZASwABcEsAAXBLAAAASwABcEsAAXBLAAFwSwAGQEsAAABLAAZASwAAAEsAAABLAAAASwAAAEsAAABLAAAASwAAAEsAAABLAAZASwAMgEsAAABLAAAASwADUEsABkBLAAyASw%2F7UEsAAhBLAAAASwAAAEsAAABLAAAASwAAAEsP%2BcBLAAAASwAAAEsAAABLAA2wSwABcEsAB1BLAAAASwAAAEsAAABLAACgSwAMgEsAAABLAAnQSwAMgEsADIBLAAyASwAAAEsP%2F%2BBLABLASwAGQEsACIBLABOwSwABcEsAAXBLAAFwSwABcEsAAXBLAAFwSwAAAEsAAXBLAAFwSwABcEsAAXBLAAAASwALcEsAC3BLAAAASwAAAEsABJBLAAFwSwAAAEsAAABLAAXQSw%2F9wEsP%2FcBLD%2FnwSwAGQEsAAABLAAAASwAAAEsABkBLD%2F%2FwSwAAAEsP9RBLAABgSwAAAEsAAABLABRQSwAAEEsAAABLD%2FnASwAEoEsAAUBLAAAASwAAAEsAAABLD%2FnASwAGEEsP%2F9BLAAFgSwABYEsAAWBLAAFgSwABgEsAAABMQAAASwAGQAAAAAAAD%2F2ABkADkAyAAAAScAZAAZABkAGQAZABkAGQAZAAAAAAAAAAAAAADZAAAAAAAOAAAAAAAAAAAAAAAEAAAAAAAAAAAAAAAAAAMAZABkAAAAEAAAAAAAZP%2Bc%2F5z%2FnP%2Bc%2F5z%2FnP%2Bc%2F5wACQAJ%2F%2FL%2F8gBkAHkAJwBkAGQAAAAAAGT%2FogAAAAAAAAAAAAAAAADIAGQAAAABAI8AAP%2Bc%2F5wAZAAEAMgAyAAAAGQBkABkAAAAZAEs%2F7UAAAAAAAAAAAAAAAAAAABkAAABLAFBADIAMgAIAAAAAADIAT4AZgBmANkAyADIAAAAKgAqACoAKgCyAOgA6AFOAU4BTgFOAU4BTgFOAU4BTgFOAU4BTgFOAU4BpAIGAiICfgKGAqwC5ANGA24DjAPEBAgEMgRiBKIE3AVcBboGcgb0ByAHYgfKCB4IYgi%2BCTYJhAm2Cd4KKApMCpQK4gswC4oLygwIDFgNKg1eDbAODg5oDrQPKA%2BmD%2BYQEhBUEJAQqhEqEXYRthIKEjgSfBLAExoTdBPQFCoU1BU8FagVzBYEFjYWYBawFv4XUhemGAIYLhhqGJYYsBjgGP4ZKBloGZQZxBnaGe4aNhpoGrga9hteG7QcMhyUHOIdHB1EHWwdlB28HeYeLh52HsAfYh%2FSIEYgviEyIXYhuCJAIpYiuCMOIyIjOCN6I8Ij4CQCJDAkXiSWJOIlNCVgJbwmFCZ%2BJuYnUCe8J%2FgoNChwKKwpoCnMKiYqSiqEKworeiwILGgsuizsLRwtiC30LiguZi6iLtgvDi9GL34vsi%2F4MD4whDDSMRIxYDGuMegyJDJeMpoy3jMiMz4zaDO2NBg0YDSoNNI1LDWeNeg2PjZ8Ntw3GjdON5I31DgQOEI4hjjIOQo5SjmIOcw6HDpsOpo63jugO9w8GDxQPKI8%2BD0yPew%2BOj6MPtQ%2FKD9uP6o%2F%2BkBIQIBAxkECQX5CGEKoQu5DGENCQ3ZDoEPKRBBEYESuRPZFWkW2RgZGdEa0RvZHNkd2R7ZH9kgWSDJITkhqSIZIzEkSSThJXkmESapKAkouSlIAAQAAARcApwARAAAAAAACAAAAAQABAAAAQAAuAAAAAAAAABAAxgABAAAAAAATABIAAAADAAEECQAAAGoAEgADAAEECQABACgAfAADAAEECQACAA4ApAADAAEECQADAEwAsgADAAEECQAEADgA%2FgADAAEECQAFAHgBNgADAAEECQAGADYBrgADAAEECQAIABYB5AADAAEECQAJABYB%2BgADAAEECQALACQCEAADAAEECQAMACQCNAADAAEECQATACQCWAADAAEECQDIABYCfAADAAEECQDJADACkgADAAEECdkDABoCwnd3dy5nbHlwaGljb25zLmNvbQBDAG8AcAB5AHIAaQBnAGgAdAAgAKkAIAAyADAAMQA0ACAAYgB5ACAASgBhAG4AIABLAG8AdgBhAHIAaQBrAC4AIABBAGwAbAAgAHIAaQBnAGgAdABzACAAcgBlAHMAZQByAHYAZQBkAC4ARwBMAFkAUABIAEkAQwBPAE4AUwAgAEgAYQBsAGYAbABpAG4AZwBzAFIAZQBnAHUAbABhAHIAMQAuADAAMAA5ADsAVQBLAFcATgA7AEcATABZAFAASABJAEMATwBOAFMASABhAGwAZgBsAGkAbgBnAHMALQBSAGUAZwB1AGwAYQByAEcATABZAFAASABJAEMATwBOAFMAIABIAGEAbABmAGwAaQBuAGcAcwAgAFIAZQBnAHUAbABhAHIAVgBlAHIAcwBpAG8AbgAgADEALgAwADAAOQA7AFAAUwAgADAAMAAxAC4AMAAwADkAOwBoAG8AdABjAG8AbgB2ACAAMQAuADAALgA3ADAAOwBtAGEAawBlAG8AdABmAC4AbABpAGIAMgAuADUALgA1ADgAMwAyADkARwBMAFkAUABIAEkAQwBPAE4AUwBIAGEAbABmAGwAaQBuAGcAcwAtAFIAZQBnAHUAbABhAHIASgBhAG4AIABLAG8AdgBhAHIAaQBrAEoAYQBuACAASwBvAHYAYQByAGkAawB3AHcAdwAuAGcAbAB5AHAAaABpAGMAbwBuAHMALgBjAG8AbQB3AHcAdwAuAGcAbAB5AHAAaABpAGMAbwBuAHMALgBjAG8AbQB3AHcAdwAuAGcAbAB5AHAAaABpAGMAbwBuAHMALgBjAG8AbQBXAGUAYgBmAG8AbgB0ACAAMQAuADAAVwBlAGQAIABPAGMAdAAgADIAOQAgADAANgA6ADMANgA6ADAANwAgADIAMAAxADQARgBvAG4AdAAgAFMAcQB1AGkAcgByAGUAbAAAAAIAAAAAAAD%2FtQAyAAAAAAAAAAAAAAAAAAAAAAAAAAABFwAAAQIBAwADAA0ADgEEAJYBBQEGAQcBCAEJAQoBCwEMAQ0BDgEPARABEQESARMA7wEUARUBFgEXARgBGQEaARsBHAEdAR4BHwEgASEBIgEjASQBJQEmAScBKAEpASoBKwEsAS0BLgEvATABMQEyATMBNAE1ATYBNwE4ATkBOgE7ATwBPQE%2BAT8BQAFBAUIBQwFEAUUBRgFHAUgBSQFKAUsBTAFNAU4BTwFQAVEBUgFTAVQBVQFWAVcBWAFZAVoBWwFcAV0BXgFfAWABYQFiAWMBZAFlAWYBZwFoAWkBagFrAWwBbQFuAW8BcAFxAXIBcwF0AXUBdgF3AXgBeQF6AXsBfAF9AX4BfwGAAYEBggGDAYQBhQGGAYcBiAGJAYoBiwGMAY0BjgGPAZABkQGSAZMBlAGVAZYBlwGYAZkBmgGbAZwBnQGeAZ8BoAGhAaIBowGkAaUBpgGnAagBqQGqAasBrAGtAa4BrwGwAbEBsgGzAbQBtQG2AbcBuAG5AboBuwG8Ab0BvgG%2FAcABwQHCAcMBxAHFAcYBxwHIAckBygHLAcwBzQHOAc8B0AHRAdIB0wHUAdUB1gHXAdgB2QHaAdsB3AHdAd4B3wHgAeEB4gHjAeQB5QHmAecB6AHpAeoB6wHsAe0B7gHvAfAB8QHyAfMB9AH1AfYB9wH4AfkB%2BgH7AfwB%2FQH%2BAf8CAAIBAgICAwIEAgUCBgIHAggCCQIKAgsCDAINAg4CDwIQAhECEgZnbHlwaDEGZ2x5cGgyB3VuaTAwQTAHdW5pMjAwMAd1bmkyMDAxB3VuaTIwMDIHdW5pMjAwMwd1bmkyMDA0B3VuaTIwMDUHdW5pMjAwNgd1bmkyMDA3B3VuaTIwMDgHdW5pMjAwOQd1bmkyMDBBB3VuaTIwMkYHdW5pMjA1RgRFdXJvB3VuaTIwQkQHdW5pMjMxQgd1bmkyNUZDB3VuaTI2MDEHdW5pMjZGQQd1bmkyNzA5B3VuaTI3MEYHdW5pRTAwMQd1bmlFMDAyB3VuaUUwMDMHdW5pRTAwNQd1bmlFMDA2B3VuaUUwMDcHdW5pRTAwOAd1bmlFMDA5B3VuaUUwMTAHdW5pRTAxMQd1bmlFMDEyB3VuaUUwMTMHdW5pRTAxNAd1bmlFMDE1B3VuaUUwMTYHdW5pRTAxNwd1bmlFMDE4B3VuaUUwMTkHdW5pRTAyMAd1bmlFMDIxB3VuaUUwMjIHdW5pRTAyMwd1bmlFMDI0B3VuaUUwMjUHdW5pRTAyNgd1bmlFMDI3B3VuaUUwMjgHdW5pRTAyOQd1bmlFMDMwB3VuaUUwMzEHdW5pRTAzMgd1bmlFMDMzB3VuaUUwMzQHdW5pRTAzNQd1bmlFMDM2B3VuaUUwMzcHdW5pRTAzOAd1bmlFMDM5B3VuaUUwNDAHdW5pRTA0MQd1bmlFMDQyB3VuaUUwNDMHdW5pRTA0NAd1bmlFMDQ1B3VuaUUwNDYHdW5pRTA0Nwd1bmlFMDQ4B3VuaUUwNDkHdW5pRTA1MAd1bmlFMDUxB3VuaUUwNTIHdW5pRTA1Mwd1bmlFMDU0B3VuaUUwNTUHdW5pRTA1Ngd1bmlFMDU3B3VuaUUwNTgHdW5pRTA1OQd1bmlFMDYwB3VuaUUwNjIHdW5pRTA2Mwd1bmlFMDY0B3VuaUUwNjUHdW5pRTA2Ngd1bmlFMDY3B3VuaUUwNjgHdW5pRTA2OQd1bmlFMDcwB3VuaUUwNzEHdW5pRTA3Mgd1bmlFMDczB3VuaUUwNzQHdW5pRTA3NQd1bmlFMDc2B3VuaUUwNzcHdW5pRTA3OAd1bmlFMDc5B3VuaUUwODAHdW5pRTA4MQd1bmlFMDgyB3VuaUUwODMHdW5pRTA4NAd1bmlFMDg1B3VuaUUwODYHdW5pRTA4Nwd1bmlFMDg4B3VuaUUwODkHdW5pRTA5MAd1bmlFMDkxB3VuaUUwOTIHdW5pRTA5Mwd1bmlFMDk0B3VuaUUwOTUHdW5pRTA5Ngd1bmlFMDk3B3VuaUUxMDEHdW5pRTEwMgd1bmlFMTAzB3VuaUUxMDQHdW5pRTEwNQd1bmlFMTA2B3VuaUUxMDcHdW5pRTEwOAd1bmlFMTA5B3VuaUUxMTAHdW5pRTExMQd1bmlFMTEyB3VuaUUxMTMHdW5pRTExNAd1bmlFMTE1B3VuaUUxMTYHdW5pRTExNwd1bmlFMTE4B3VuaUUxMTkHdW5pRTEyMAd1bmlFMTIxB3VuaUUxMjIHdW5pRTEyMwd1bmlFMTI0B3VuaUUxMjUHdW5pRTEyNgd1bmlFMTI3B3VuaUUxMjgHdW5pRTEyOQd1bmlFMTMwB3VuaUUxMzEHdW5pRTEzMgd1bmlFMTMzB3VuaUUxMzQHdW5pRTEzNQd1bmlFMTM2B3VuaUUxMzcHdW5pRTEzOAd1bmlFMTM5B3VuaUUxNDAHdW5pRTE0MQd1bmlFMTQyB3VuaUUxNDMHdW5pRTE0NAd1bmlFMTQ1B3VuaUUxNDYHdW5pRTE0OAd1bmlFMTQ5B3VuaUUxNTAHdW5pRTE1MQd1bmlFMTUyB3VuaUUxNTMHdW5pRTE1NAd1bmlFMTU1B3VuaUUxNTYHdW5pRTE1Nwd1bmlFMTU4B3VuaUUxNTkHdW5pRTE2MAd1bmlFMTYxB3VuaUUxNjIHdW5pRTE2Mwd1bmlFMTY0B3VuaUUxNjUHdW5pRTE2Ngd1bmlFMTY3B3VuaUUxNjgHdW5pRTE2OQd1bmlFMTcwB3VuaUUxNzEHdW5pRTE3Mgd1bmlFMTczB3VuaUUxNzQHdW5pRTE3NQd1bmlFMTc2B3VuaUUxNzcHdW5pRTE3OAd1bmlFMTc5B3VuaUUxODAHdW5pRTE4MQd1bmlFMTgyB3VuaUUxODMHdW5pRTE4NAd1bmlFMTg1B3VuaUUxODYHdW5pRTE4Nwd1bmlFMTg4B3VuaUUxODkHdW5pRTE5MAd1bmlFMTkxB3VuaUUxOTIHdW5pRTE5Mwd1bmlFMTk0B3VuaUUxOTUHdW5pRTE5Nwd1bmlFMTk4B3VuaUUxOTkHdW5pRTIwMAd1bmlFMjAxB3VuaUUyMDIHdW5pRTIwMwd1bmlFMjA0B3VuaUUyMDUHdW5pRTIwNgd1bmlFMjA5B3VuaUUyMTAHdW5pRTIxMQd1bmlFMjEyB3VuaUUyMTMHdW5pRTIxNAd1bmlFMjE1B3VuaUUyMTYHdW5pRTIxOAd1bmlFMjE5B3VuaUUyMjEHdW5pRTIyMwd1bmlFMjI0B3VuaUUyMjUHdW5pRTIyNgd1bmlFMjI3B3VuaUUyMzAHdW5pRTIzMQd1bmlFMjMyB3VuaUUyMzMHdW5pRTIzNAd1bmlFMjM1B3VuaUUyMzYHdW5pRTIzNwd1bmlFMjM4B3VuaUUyMzkHdW5pRTI0MAd1bmlFMjQxB3VuaUUyNDIHdW5pRTI0Mwd1bmlFMjQ0B3VuaUUyNDUHdW5pRTI0Ngd1bmlFMjQ3B3VuaUUyNDgHdW5pRTI0OQd1bmlFMjUwB3VuaUUyNTEHdW5pRTI1Mgd1bmlFMjUzB3VuaUUyNTQHdW5pRTI1NQd1bmlFMjU2B3VuaUUyNTcHdW5pRTI1OAd1bmlFMjU5B3VuaUUyNjAHdW5pRjhGRgZ1MUY1MTEGdTFGNkFBAAAAAAFUUMMXAAA%3D%29%20format%28%27truetype%27%29%2Curl%28data%3Aimage%2Fsvg%2Bxml%3Bbase64%2CPD94bWwgdmVyc2lvbj0iMS4wIiBzdGFuZGFsb25lPSJubyI%2FPgo8IURPQ1RZUEUgc3ZnIFBVQkxJQyAiLS8vVzNDLy9EVEQgU1ZHIDEuMS8vRU4iICJodHRwOi8vd3d3LnczLm9yZy9HcmFwaGljcy9TVkcvMS4xL0RURC9zdmcxMS5kdGQiID4KPHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPgo8bWV0YWRhdGE%2BPC9tZXRhZGF0YT4KPGRlZnM%2BCjxmb250IGlkPSJnbHlwaGljb25zX2hhbGZsaW5nc3JlZ3VsYXIiIGhvcml6LWFkdi14PSIxMjAwIiA%2BCjxmb250LWZhY2UgdW5pdHMtcGVyLWVtPSIxMjAwIiBhc2NlbnQ9Ijk2MCIgZGVzY2VudD0iLTI0MCIgLz4KPG1pc3NpbmctZ2x5cGggaG9yaXotYWR2LXg9IjUwMCIgLz4KPGdseXBoIGhvcml6LWFkdi14PSIwIiAvPgo8Z2x5cGggaG9yaXotYWR2LXg9IjQwMCIgLz4KPGdseXBoIHVuaWNvZGU9IiAiIC8%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%2BCjxnbHlwaCB1bmljb2RlPSImI3gyMDAzOyIgaG9yaXotYWR2LXg9IjEzMDAiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3gyMDA0OyIgaG9yaXotYWR2LXg9IjQzMyIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeDIwMDU7IiBob3Jpei1hZHYteD0iMzI1IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4MjAwNjsiIGhvcml6LWFkdi14PSIyMTYiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3gyMDA3OyIgaG9yaXotYWR2LXg9IjIxNiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeDIwMDg7IiBob3Jpei1hZHYteD0iMTYyIiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4MjAwOTsiIGhvcml6LWFkdi14PSIyNjAiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3gyMDBhOyIgaG9yaXotYWR2LXg9IjcyIiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4MjAyZjsiIGhvcml6LWFkdi14PSIyNjAiIC8%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3gyNmZhOyIgZD0iTTc3NCAxMTkzLjVxMTYgLTkuNSAyMC41IC0yN3QtNS41IC0zMy41bC0xMzYgLTE4N2w0NjcgLTc0NmgzMHEyMCAwIDM1IC0xOC41dDE1IC0zOS41di00MmgtMTIwMHY0MnEwIDIxIDE1IDM5LjV0MzUgMTguNWgzMGw0NjggNzQ2bC0xMzUgMTgzcS0xMCAxNiAtNS41IDM0dDIwLjUgMjh0MzQgNS41dDI4IC0yMC41bDExMSAtMTQ4bDExMiAxNTBxOSAxNiAyNyAyMC41dDM0IC01ek02MDAgMjAwaDM3N2wtMTgyIDExMmwtMTk1IDUzNHYtNjQ2eiAiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3gyNzA5OyIgZD0iTTI1IDExMDBoMTE1MHExMCAwIDEyLjUgLTV0LTUuNSAtMTNsLTU2NCAtNTY3cS04IC04IC0xOCAtOHQtMTggOGwtNTY0IDU2N3EtOCA4IC01LjUgMTN0MTIuNSA1ek0xOCA4ODJsMjY0IC0yNjRxOCAtOCA4IC0xOHQtOCAtMThsLTI2NCAtMjY0cS04IC04IC0xMyAtNS41dC01IDEyLjV2NTUwcTAgMTAgNSAxMi41dDEzIC01LjV6TTkxOCA2MThsMjY0IDI2NHE4IDggMTMgNS41dDUgLTEyLjV2LTU1MHEwIC0xMCAtNSAtMTIuNXQtMTMgNS41IGwtMjY0IDI2NHEtOCA4IC04IDE4dDggMTh6TTgxOCA0ODJsMzY0IC0zNjRxOCAtOCA1LjUgLTEzdC0xMi41IC01aC0xMTUwcS0xMCAwIC0xMi41IDV0NS41IDEzbDM2NCAzNjRxOCA4IDE4IDh0MTggLThsMTY0IC0xNjRxOCAtOCAxOCAtOHQxOCA4bDE2NCAxNjRxOCA4IDE4IDh0MTggLTh6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4MjcwZjsiIGQ9Ik0xMDExIDEyMTBxMTkgMCAzMyAtMTNsMTUzIC0xNTNxMTMgLTE0IDEzIC0zM3QtMTMgLTMzbC05OSAtOTJsLTIxNCAyMTRsOTUgOTZxMTMgMTQgMzIgMTR6TTEwMTMgODAwbC02MTUgLTYxNGwtMjE0IDIxNGw2MTQgNjE0ek0zMTcgOTZsLTMzMyAtMTEybDExMCAzMzV6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTAwMTsiIGQ9Ik03MDAgNjUwdi01NTBoMjUwcTIxIDAgMzUuNSAtMTQuNXQxNC41IC0zNS41di01MGgtODAwdjUwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNWgyNTB2NTUwbC01MDAgNTUwaDEyMDB6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTAwMjsiIGQ9Ik0zNjggMTAxN2w2NDUgMTYzcTM5IDE1IDYzIDB0MjQgLTQ5di04MzFxMCAtNTUgLTQxLjUgLTk1LjV0LTExMS41IC02My41cS03OSAtMjUgLTE0NyAtNC41dC04NiA3NXQyNS41IDExMS41dDEyMi41IDgycTcyIDI0IDEzOCA4djUyMWwtNjAwIC0xNTV2LTYwNnEwIC00MiAtNDQgLTkwdC0xMDkgLTY5cS03OSAtMjYgLTE0NyAtNS41dC04NiA3NS41dDI1LjUgMTExLjV0MTIyLjUgODIuNXE3MiAyNCAxMzggN3Y2MzlxMCAzOCAxNC41IDU5IHQ1My41IDM0eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUwMDM7IiBkPSJNNTAwIDExOTFxMTAwIDAgMTkxIC0zOXQxNTYuNSAtMTA0LjV0MTA0LjUgLTE1Ni41dDM5IC0xOTFsLTEgLTJsMSAtNXEwIC0xNDEgLTc4IC0yNjJsMjc1IC0yNzRxMjMgLTI2IDIyLjUgLTQ0LjV0LTIyLjUgLTQyLjVsLTU5IC01OHEtMjYgLTIwIC00Ni41IC0yMHQtMzkuNSAyMGwtMjc1IDI3NHEtMTE5IC03NyAtMjYxIC03N2wtNSAxbC0yIC0xcS0xMDAgMCAtMTkxIDM5dC0xNTYuNSAxMDQuNXQtMTA0LjUgMTU2LjV0LTM5IDE5MSB0MzkgMTkxdDEwNC41IDE1Ni41dDE1Ni41IDEwNC41dDE5MSAzOXpNNTAwIDEwMjJxLTg4IDAgLTE2MiAtNDN0LTExNyAtMTE3dC00MyAtMTYydDQzIC0xNjJ0MTE3IC0xMTd0MTYyIC00M3QxNjIgNDN0MTE3IDExN3Q0MyAxNjJ0LTQzIDE2MnQtMTE3IDExN3QtMTYyIDQzeiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUwMDU7IiBkPSJNNjQ5IDk0OXE0OCA2OCAxMDkuNSAxMDR0MTIxLjUgMzguNXQxMTguNSAtMjB0MTAyLjUgLTY0dDcxIC0xMDAuNXQyNyAtMTIzcTAgLTU3IC0zMy41IC0xMTcuNXQtOTQgLTEyNC41dC0xMjYuNSAtMTI3LjV0LTE1MCAtMTUyLjV0LTE0NiAtMTc0cS02MiA4NSAtMTQ1LjUgMTc0dC0xNTAgMTUyLjV0LTEyNi41IDEyNy41dC05My41IDEyNC41dC0zMy41IDExNy41cTAgNjQgMjggMTIzdDczIDEwMC41dDEwNCA2NHQxMTkgMjAgdDEyMC41IC0zOC41dDEwNC41IC0xMDR6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTAwNjsiIGQ9Ik00MDcgODAwbDEzMSAzNTNxNyAxOSAxNy41IDE5dDE3LjUgLTE5bDEyOSAtMzUzaDQyMXEyMSAwIDI0IC04LjV0LTE0IC0yMC41bC0zNDIgLTI0OWwxMzAgLTQwMXE3IC0yMCAtMC41IC0yNS41dC0yNC41IDYuNWwtMzQzIDI0NmwtMzQyIC0yNDdxLTE3IC0xMiAtMjQuNSAtNi41dC0wLjUgMjUuNWwxMzAgNDAwbC0zNDcgMjUxcS0xNyAxMiAtMTQgMjAuNXQyMyA4LjVoNDI5eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUwMDc7IiBkPSJNNDA3IDgwMGwxMzEgMzUzcTcgMTkgMTcuNSAxOXQxNy41IC0xOWwxMjkgLTM1M2g0MjFxMjEgMCAyNCAtOC41dC0xNCAtMjAuNWwtMzQyIC0yNDlsMTMwIC00MDFxNyAtMjAgLTAuNSAtMjUuNXQtMjQuNSA2LjVsLTM0MyAyNDZsLTM0MiAtMjQ3cS0xNyAtMTIgLTI0LjUgLTYuNXQtMC41IDI1LjVsMTMwIDQwMGwtMzQ3IDI1MXEtMTcgMTIgLTE0IDIwLjV0MjMgOC41aDQyOXpNNDc3IDcwMGgtMjQwbDE5NyAtMTQybC03NCAtMjI2IGwxOTMgMTM5bDE5NSAtMTQwbC03NCAyMjlsMTkyIDE0MGgtMjM0bC03OCAyMTF6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTAwODsiIGQ9Ik02MDAgMTIwMHExMjQgMCAyMTIgLTg4dDg4IC0yMTJ2LTI1MHEwIC00NiAtMzEgLTk4dC02OSAtNTJ2LTc1cTAgLTEwIDYgLTIxLjV0MTUgLTE3LjVsMzU4IC0yMzBxOSAtNSAxNSAtMTYuNXQ2IC0yMS41di05M3EwIC0xMCAtNy41IC0xNy41dC0xNy41IC03LjVoLTExNTBxLTEwIDAgLTE3LjUgNy41dC03LjUgMTcuNXY5M3EwIDEwIDYgMjEuNXQxNSAxNi41bDM1OCAyMzBxOSA2IDE1IDE3LjV0NiAyMS41djc1cS0zOCAwIC02OSA1MiB0LTMxIDk4djI1MHEwIDEyNCA4OCAyMTJ0MjEyIDg4eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUwMDk7IiBkPSJNMjUgMTEwMGgxMTUwcTEwIDAgMTcuNSAtNy41dDcuNSAtMTcuNXYtMTA1MHEwIC0xMCAtNy41IC0xNy41dC0xNy41IC03LjVoLTExNTBxLTEwIDAgLTE3LjUgNy41dC03LjUgMTcuNXYxMDUwcTAgMTAgNy41IDE3LjV0MTcuNSA3LjV6TTEwMCAxMDAwdi0xMDBoMTAwdjEwMGgtMTAwek04NzUgMTAwMGgtNTUwcS0xMCAwIC0xNy41IC03LjV0LTcuNSAtMTcuNXYtMzUwcTAgLTEwIDcuNSAtMTcuNXQxNy41IC03LjVoNTUwIHExMCAwIDE3LjUgNy41dDcuNSAxNy41djM1MHEwIDEwIC03LjUgMTcuNXQtMTcuNSA3LjV6TTEwMDAgMTAwMHYtMTAwaDEwMHYxMDBoLTEwMHpNMTAwIDgwMHYtMTAwaDEwMHYxMDBoLTEwMHpNMTAwMCA4MDB2LTEwMGgxMDB2MTAwaC0xMDB6TTEwMCA2MDB2LTEwMGgxMDB2MTAwaC0xMDB6TTEwMDAgNjAwdi0xMDBoMTAwdjEwMGgtMTAwek04NzUgNTAwaC01NTBxLTEwIDAgLTE3LjUgLTcuNXQtNy41IC0xNy41di0zNTBxMCAtMTAgNy41IC0xNy41IHQxNy41IC03LjVoNTUwcTEwIDAgMTcuNSA3LjV0Ny41IDE3LjV2MzUwcTAgMTAgLTcuNSAxNy41dC0xNy41IDcuNXpNMTAwIDQwMHYtMTAwaDEwMHYxMDBoLTEwMHpNMTAwMCA0MDB2LTEwMGgxMDB2MTAwaC0xMDB6TTEwMCAyMDB2LTEwMGgxMDB2MTAwaC0xMDB6TTEwMDAgMjAwdi0xMDBoMTAwdjEwMGgtMTAweiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUwMTA7IiBkPSJNNTAgMTEwMGg0MDBxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTQwMHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtNDAwcS0yMSAwIC0zNS41IDE0LjV0LTE0LjUgMzUuNXY0MDBxMCAyMSAxNC41IDM1LjV0MzUuNSAxNC41ek02NTAgMTEwMGg0MDBxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTQwMHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtNDAwcS0yMSAwIC0zNS41IDE0LjV0LTE0LjUgMzUuNXY0MDAgcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXpNNTAgNTAwaDQwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtNDAwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC00MDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djQwMHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjV6TTY1MCA1MDBoNDAwcTIxIDAgMzUuNSAtMTQuNXQxNC41IC0zNS41di00MDBxMCAtMjEgLTE0LjUgLTM1LjV0LTM1LjUgLTE0LjVoLTQwMCBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djQwMHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjV6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTAxMTsiIGQ9Ik01MCAxMTAwaDIwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtMjAwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC0yMDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djIwMHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjV6TTQ1MCAxMTAwaDIwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtMjAwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC0yMDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djIwMCBxMCAyMSAxNC41IDM1LjV0MzUuNSAxNC41ek04NTAgMTEwMGgyMDBxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTIwMHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtMjAwcS0yMSAwIC0zNS41IDE0LjV0LTE0LjUgMzUuNXYyMDBxMCAyMSAxNC41IDM1LjV0MzUuNSAxNC41ek01MCA3MDBoMjAwcTIxIDAgMzUuNSAtMTQuNXQxNC41IC0zNS41di0yMDBxMCAtMjEgLTE0LjUgLTM1LjV0LTM1LjUgLTE0LjVoLTIwMCBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djIwMHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjV6TTQ1MCA3MDBoMjAwcTIxIDAgMzUuNSAtMTQuNXQxNC41IC0zNS41di0yMDBxMCAtMjEgLTE0LjUgLTM1LjV0LTM1LjUgLTE0LjVoLTIwMHEtMjEgMCAtMzUuNSAxNC41dC0xNC41IDM1LjV2MjAwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXpNODUwIDcwMGgyMDBxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTIwMCBxMCAtMjEgLTE0LjUgLTM1LjV0LTM1LjUgLTE0LjVoLTIwMHEtMjEgMCAtMzUuNSAxNC41dC0xNC41IDM1LjV2MjAwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXpNNTAgMzAwaDIwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtMjAwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC0yMDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djIwMHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjV6TTQ1MCAzMDBoMjAwIHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtMjAwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC0yMDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djIwMHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjV6TTg1MCAzMDBoMjAwcTIxIDAgMzUuNSAtMTQuNXQxNC41IC0zNS41di0yMDBxMCAtMjEgLTE0LjUgLTM1LjV0LTM1LjUgLTE0LjVoLTIwMHEtMjEgMCAtMzUuNSAxNC41dC0xNC41IDM1LjV2MjAwcTAgMjEgMTQuNSAzNS41IHQzNS41IDE0LjV6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTAxMjsiIGQ9Ik01MCAxMTAwaDIwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtMjAwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC0yMDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djIwMHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjV6TTQ1MCAxMTAwaDcwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtMjAwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC03MDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djIwMCBxMCAyMSAxNC41IDM1LjV0MzUuNSAxNC41ek01MCA3MDBoMjAwcTIxIDAgMzUuNSAtMTQuNXQxNC41IC0zNS41di0yMDBxMCAtMjEgLTE0LjUgLTM1LjV0LTM1LjUgLTE0LjVoLTIwMHEtMjEgMCAtMzUuNSAxNC41dC0xNC41IDM1LjV2MjAwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXpNNDUwIDcwMGg3MDBxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTIwMHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtNzAwIHEtMjEgMCAtMzUuNSAxNC41dC0xNC41IDM1LjV2MjAwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXpNNTAgMzAwaDIwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtMjAwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC0yMDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djIwMHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjV6TTQ1MCAzMDBoNzAwcTIxIDAgMzUuNSAtMTQuNXQxNC41IC0zNS41di0yMDAgcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC03MDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djIwMHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjV6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTAxMzsiIGQ9Ik00NjUgNDc3bDU3MSA1NzFxOCA4IDE4IDh0MTcgLThsMTc3IC0xNzdxOCAtNyA4IC0xN3QtOCAtMThsLTc4MyAtNzg0cS03IC04IC0xNy41IC04dC0xNy41IDhsLTM4NCAzODRxLTggOCAtOCAxOHQ4IDE3bDE3NyAxNzdxNyA4IDE3IDh0MTggLThsMTcxIC0xNzFxNyAtNyAxOCAtN3QxOCA3eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUwMTQ7IiBkPSJNOTA0IDEwODNsMTc4IC0xNzlxOCAtOCA4IC0xOC41dC04IC0xNy41bC0yNjcgLTI2OGwyNjcgLTI2OHE4IC03IDggLTE3LjV0LTggLTE4LjVsLTE3OCAtMTc4cS04IC04IC0xOC41IC04dC0xNy41IDhsLTI2OCAyNjdsLTI2OCAtMjY3cS03IC04IC0xNy41IC04dC0xOC41IDhsLTE3OCAxNzhxLTggOCAtOCAxOC41dDggMTcuNWwyNjcgMjY4bC0yNjcgMjY4cS04IDcgLTggMTcuNXQ4IDE4LjVsMTc4IDE3OHE4IDggMTguNSA4dDE3LjUgLTggbDI2OCAtMjY3bDI2OCAyNjhxNyA3IDE3LjUgN3QxOC41IC03eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUwMTU7IiBkPSJNNTA3IDExNzdxOTggMCAxODcuNSAtMzguNXQxNTQuNSAtMTAzLjV0MTAzLjUgLTE1NC41dDM4LjUgLTE4Ny41cTAgLTE0MSAtNzggLTI2MmwzMDAgLTI5OXE4IC04IDggLTE4LjV0LTggLTE4LjVsLTEwOSAtMTA4cS03IC04IC0xNy41IC04dC0xOC41IDhsLTMwMCAyOTlxLTExOSAtNzcgLTI2MSAtNzdxLTk4IDAgLTE4OCAzOC41dC0xNTQuNSAxMDN0LTEwMyAxNTQuNXQtMzguNSAxODh0MzguNSAxODcuNXQxMDMgMTU0LjUgdDE1NC41IDEwMy41dDE4OCAzOC41ek01MDYuNSAxMDIzcS04OS41IDAgLTE2NS41IC00NHQtMTIwIC0xMjAuNXQtNDQgLTE2NnQ0NCAtMTY1LjV0MTIwIC0xMjB0MTY1LjUgLTQ0dDE2NiA0NHQxMjAuNSAxMjB0NDQgMTY1LjV0LTQ0IDE2NnQtMTIwLjUgMTIwLjV0LTE2NiA0NHpNNDI1IDkwMGgxNTBxMTAgMCAxNy41IC03LjV0Ny41IC0xNy41di03NWg3NXExMCAwIDE3LjUgLTcuNXQ3LjUgLTE3LjV2LTE1MHEwIC0xMCAtNy41IC0xNy41IHQtMTcuNSAtNy41aC03NXYtNzVxMCAtMTAgLTcuNSAtMTcuNXQtMTcuNSAtNy41aC0xNTBxLTEwIDAgLTE3LjUgNy41dC03LjUgMTcuNXY3NWgtNzVxLTEwIDAgLTE3LjUgNy41dC03LjUgMTcuNXYxNTBxMCAxMCA3LjUgMTcuNXQxNy41IDcuNWg3NXY3NXEwIDEwIDcuNSAxNy41dDE3LjUgNy41eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUwMTY7IiBkPSJNNTA3IDExNzdxOTggMCAxODcuNSAtMzguNXQxNTQuNSAtMTAzLjV0MTAzLjUgLTE1NC41dDM4LjUgLTE4Ny41cTAgLTE0MSAtNzggLTI2MmwzMDAgLTI5OXE4IC04IDggLTE4LjV0LTggLTE4LjVsLTEwOSAtMTA4cS03IC04IC0xNy41IC04dC0xOC41IDhsLTMwMCAyOTlxLTExOSAtNzcgLTI2MSAtNzdxLTk4IDAgLTE4OCAzOC41dC0xNTQuNSAxMDN0LTEwMyAxNTQuNXQtMzguNSAxODh0MzguNSAxODcuNXQxMDMgMTU0LjUgdDE1NC41IDEwMy41dDE4OCAzOC41ek01MDYuNSAxMDIzcS04OS41IDAgLTE2NS41IC00NHQtMTIwIC0xMjAuNXQtNDQgLTE2NnQ0NCAtMTY1LjV0MTIwIC0xMjB0MTY1LjUgLTQ0dDE2NiA0NHQxMjAuNSAxMjB0NDQgMTY1LjV0LTQ0IDE2NnQtMTIwLjUgMTIwLjV0LTE2NiA0NHpNMzI1IDgwMGgzNTBxMTAgMCAxNy41IC03LjV0Ny41IC0xNy41di0xNTBxMCAtMTAgLTcuNSAtMTcuNXQtMTcuNSAtNy41aC0zNTBxLTEwIDAgLTE3LjUgNy41IHQtNy41IDE3LjV2MTUwcTAgMTAgNy41IDE3LjV0MTcuNSA3LjV6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTAxNzsiIGQ9Ik01NTAgMTIwMGgxMDBxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTQwMHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtMTAwcS0yMSAwIC0zNS41IDE0LjV0LTE0LjUgMzUuNXY0MDBxMCAyMSAxNC41IDM1LjV0MzUuNSAxNC41ek04MDAgOTc1djE2NnExNjcgLTYyIDI3MiAtMjA5LjV0MTA1IC0zMzEuNXEwIC0xMTcgLTQ1LjUgLTIyNHQtMTIzIC0xODQuNXQtMTg0LjUgLTEyM3QtMjI0IC00NS41dC0yMjQgNDUuNSB0LTE4NC41IDEyM3QtMTIzIDE4NC41dC00NS41IDIyNHEwIDE4NCAxMDUgMzMxLjV0MjcyIDIwOS41di0xNjZxLTEwMyAtNTUgLTE2NSAtMTU1dC02MiAtMjIwcTAgLTExNiA1NyAtMjE0LjV0MTU1LjUgLTE1NS41dDIxNC41IC01N3QyMTQuNSA1N3QxNTUuNSAxNTUuNXQ1NyAyMTQuNXEwIDEyMCAtNjIgMjIwdC0xNjUgMTU1eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUwMTg7IiBkPSJNMTAyNSAxMjAwaDE1MHExMCAwIDE3LjUgLTcuNXQ3LjUgLTE3LjV2LTExNTBxMCAtMTAgLTcuNSAtMTcuNXQtMTcuNSAtNy41aC0xNTBxLTEwIDAgLTE3LjUgNy41dC03LjUgMTcuNXYxMTUwcTAgMTAgNy41IDE3LjV0MTcuNSA3LjV6TTcyNSA4MDBoMTUwcTEwIDAgMTcuNSAtNy41dDcuNSAtMTcuNXYtNzUwcTAgLTEwIC03LjUgLTE3LjV0LTE3LjUgLTcuNWgtMTUwcS0xMCAwIC0xNy41IDcuNXQtNy41IDE3LjV2NzUwIHEwIDEwIDcuNSAxNy41dDE3LjUgNy41ek00MjUgNTAwaDE1MHExMCAwIDE3LjUgLTcuNXQ3LjUgLTE3LjV2LTQ1MHEwIC0xMCAtNy41IC0xNy41dC0xNy41IC03LjVoLTE1MHEtMTAgMCAtMTcuNSA3LjV0LTcuNSAxNy41djQ1MHEwIDEwIDcuNSAxNy41dDE3LjUgNy41ek0xMjUgMzAwaDE1MHExMCAwIDE3LjUgLTcuNXQ3LjUgLTE3LjV2LTI1MHEwIC0xMCAtNy41IC0xNy41dC0xNy41IC03LjVoLTE1MHEtMTAgMCAtMTcuNSA3LjV0LTcuNSAxNy41IHYyNTBxMCAxMCA3LjUgMTcuNXQxNy41IDcuNXoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDE5OyIgZD0iTTYwMCAxMTc0cTMzIDAgNzQgLTVsMzggLTE1Mmw1IC0xcTQ5IC0xNCA5NCAtMzlsNSAtMmwxMzQgODBxNjEgLTQ4IDEwNCAtMTA1bC04MCAtMTM0bDMgLTVxMjUgLTQ0IDM5IC05M2wxIC02bDE1MiAtMzhxNSAtNDMgNSAtNzNxMCAtMzQgLTUgLTc0bC0xNTIgLTM4bC0xIC02cS0xNSAtNDkgLTM5IC05M2wtMyAtNWw4MCAtMTM0cS00OCAtNjEgLTEwNCAtMTA1bC0xMzQgODFsLTUgLTNxLTQ0IC0yNSAtOTQgLTM5bC01IC0ybC0zOCAtMTUxIHEtNDMgLTUgLTc0IC01cS0zMyAwIC03NCA1bC0zOCAxNTFsLTUgMnEtNDkgMTQgLTk0IDM5bC01IDNsLTEzNCAtODFxLTYwIDQ4IC0xMDQgMTA1bDgwIDEzNGwtMyA1cS0yNSA0NSAtMzggOTNsLTIgNmwtMTUxIDM4cS02IDQyIC02IDc0cTAgMzMgNiA3M2wxNTEgMzhsMiA2cTEzIDQ4IDM4IDkzbDMgNWwtODAgMTM0cTQ3IDYxIDEwNSAxMDVsMTMzIC04MGw1IDJxNDUgMjUgOTQgMzlsNSAxbDM4IDE1MnE0MyA1IDc0IDV6TTYwMCA4MTUgcS04OSAwIC0xNTIgLTYzdC02MyAtMTUxLjV0NjMgLTE1MS41dDE1MiAtNjN0MTUyIDYzdDYzIDE1MS41dC02MyAxNTEuNXQtMTUyIDYzeiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUwMjA7IiBkPSJNNTAwIDEzMDBoMzAwcTQxIDAgNzAuNSAtMjkuNXQyOS41IC03MC41di0xMDBoMjc1cTEwIDAgMTcuNSAtNy41dDcuNSAtMTcuNXYtNzVoLTExMDB2NzVxMCAxMCA3LjUgMTcuNXQxNy41IDcuNWgyNzV2MTAwcTAgNDEgMjkuNSA3MC41dDcwLjUgMjkuNXpNNTAwIDEyMDB2LTEwMGgzMDB2MTAwaC0zMDB6TTExMDAgOTAwdi04MDBxMCAtNDEgLTI5LjUgLTcwLjV0LTcwLjUgLTI5LjVoLTcwMHEtNDEgMCAtNzAuNSAyOS41dC0yOS41IDcwLjUgdjgwMGg5MDB6TTMwMCA4MDB2LTcwMGgxMDB2NzAwaC0xMDB6TTUwMCA4MDB2LTcwMGgxMDB2NzAwaC0xMDB6TTcwMCA4MDB2LTcwMGgxMDB2NzAwaC0xMDB6TTkwMCA4MDB2LTcwMGgxMDB2NzAwaC0xMDB6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTAyMTsiIGQ9Ik0xOCA2MThsNjIwIDYwOHE4IDcgMTguNSA3dDE3LjUgLTdsNjA4IC02MDhxOCAtOCA1LjUgLTEzdC0xMi41IC01aC0xNzV2LTU3NXEwIC0xMCAtNy41IC0xNy41dC0xNy41IC03LjVoLTI1MHEtMTAgMCAtMTcuNSA3LjV0LTcuNSAxNy41djM3NWgtMzAwdi0zNzVxMCAtMTAgLTcuNSAtMTcuNXQtMTcuNSAtNy41aC0yNTBxLTEwIDAgLTE3LjUgNy41dC03LjUgMTcuNXY1NzVoLTE3NXEtMTAgMCAtMTIuNSA1dDUuNSAxM3oiIC8%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDI0OyIgZD0iTTEzMDAgMGgtNTM4bC00MSA0MDBoLTI0MmwtNDEgLTQwMGgtNTM4bDQzMSAxMjAwaDIwOWwtMjEgLTMwMGgxNjJsLTIwIDMwMGgyMDh6TTUxNSA4MDBsLTI3IC0zMDBoMjI0bC0yNyAzMDBoLTE3MHoiIC8%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%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%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%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%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%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%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDQyOyIgZD0iTTUwMCAxMjAwbDY4MiAtNjgycTggLTggOCAtMTh0LTggLTE4bC00NjQgLTQ2NHEtOCAtOCAtMTggLTh0LTE4IDhsLTY4MiA2ODJsMSA0NzVxMCAxMCA3LjUgMTcuNXQxNy41IDcuNWg0NzR6TTgwMCAxMjAwbDY4MiAtNjgycTggLTggOCAtMTh0LTggLTE4bC00NjQgLTQ2NHEtOCAtOCAtMTggLTh0LTE4IDhsLTU2IDU2bDQyNCA0MjZsLTcwMCA3MDBoMTUwek0zMTkuNSAxMDI0LjVxLTI5LjUgMjkuNSAtNzEgMjkuNXQtNzEgLTI5LjUgdC0yOS41IC03MS41dDI5LjUgLTcxLjV0NzEgLTI5LjV0NzEgMjkuNXQyOS41IDcxLjV0LTI5LjUgNzEuNXoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDQzOyIgZD0iTTMwMCAxMjAwaDgyNXE3NSAwIDc1IC03NXYtOTAwcTAgLTI1IC0xOCAtNDNsLTY0IC02NHEtOCAtOCAtMTMgLTUuNXQtNSAxMi41djk1MHEwIDEwIC03LjUgMTcuNXQtMTcuNSA3LjVoLTcwMHEtMjUgMCAtNDMgLTE4bC02NCAtNjRxLTggLTggLTUuNSAtMTN0MTIuNSAtNWg3MDBxMTAgMCAxNy41IC03LjV0Ny41IC0xNy41di05NTBxMCAtMTAgLTcuNSAtMTcuNXQtMTcuNSAtNy41aC04NTBxLTEwIDAgLTE3LjUgNy41dC03LjUgMTcuNXY5NzUgcTAgMjUgMTggNDNsMTM5IDEzOXExOCAxOCA0MyAxOHoiIC8%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDQ5OyIgZD0iTTg3NyAxMjAwbDIgLTU3cS04MyAtMTkgLTExNiAtNDUuNXQtNDAgLTY2LjVsLTEzMiAtODM5cS05IC00OSAxMyAtNjl0OTYgLTI2di05N2gtNTAwdjk3cTE4NiAxNiAyMDAgOThsMTczIDgzMnEzIDE3IDMgMzB0LTEuNSAyMi41dC05IDE3LjV0LTEzLjUgMTIuNXQtMjEuNSAxMHQtMjYgOC41dC0zMy41IDEwcS0xMyAzIC0xOSA1djU3aDQyNXoiIC8%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDU1OyIgZD0iTTUwIDExMDBoMTEwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtMTAwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC0xMTAwcS0yMSAwIC0zNS41IDE0LjV0LTE0LjUgMzUuNXYxMDBxMCAyMSAxNC41IDM1LjV0MzUuNSAxNC41ek01MCA4MDBoMTEwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtMTAwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC0xMTAwcS0yMSAwIC0zNS41IDE0LjV0LTE0LjUgMzUuNXYxMDAgcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXpNNTAgNTAwaDExMDBxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTEwMHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtMTEwMHEtMjEgMCAtMzUuNSAxNC41dC0xNC41IDM1LjV2MTAwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXpNNTAgMjAwaDExMDBxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTEwMHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtMTEwMCBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djEwMHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjV6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTA1NjsiIGQ9Ik01MCAxMTAwaDEwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtMTAwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC0xMDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djEwMHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjV6TTM1MCAxMTAwaDgwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtMTAwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC04MDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djEwMCBxMCAyMSAxNC41IDM1LjV0MzUuNSAxNC41ek01MCA4MDBoMTAwcTIxIDAgMzUuNSAtMTQuNXQxNC41IC0zNS41di0xMDBxMCAtMjEgLTE0LjUgLTM1LjV0LTM1LjUgLTE0LjVoLTEwMHEtMjEgMCAtMzUuNSAxNC41dC0xNC41IDM1LjV2MTAwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXpNMzUwIDgwMGg4MDBxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTEwMHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtODAwIHEtMjEgMCAtMzUuNSAxNC41dC0xNC41IDM1LjV2MTAwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXpNNTAgNTAwaDEwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtMTAwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC0xMDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djEwMHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjV6TTM1MCA1MDBoODAwcTIxIDAgMzUuNSAtMTQuNXQxNC41IC0zNS41di0xMDAgcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC04MDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djEwMHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjV6TTUwIDIwMGgxMDBxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTEwMHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtMTAwcS0yMSAwIC0zNS41IDE0LjV0LTE0LjUgMzUuNXYxMDBxMCAyMSAxNC41IDM1LjV0MzUuNSAxNC41ek0zNTAgMjAwaDgwMCBxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTEwMHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtODAwcS0yMSAwIC0zNS41IDE0LjV0LTE0LjUgMzUuNXYxMDBxMCAyMSAxNC41IDM1LjV0MzUuNSAxNC41eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUwNTc7IiBkPSJNNDAwIDBoLTEwMHYxMTAwaDEwMHYtMTEwMHpNNTUwIDExMDBoMTAwcTIxIDAgMzUuNSAtMTQuNXQxNC41IC0zNS41di0xMDBxMCAtMjEgLTE0LjUgLTM1LjV0LTM1LjUgLTE0LjVoLTEwMHEtMjEgMCAtMzUuNSAxNC41dC0xNC41IDM1LjV2MTAwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXpNNTUwIDgwMGg1MDBxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTEwMHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtNTAwIHEtMjEgMCAtMzUuNSAxNC41dC0xNC41IDM1LjV2MTAwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXpNMjY3IDU1MGwtMTY3IC0xMjV2NzVoLTIwMHYxMDBoMjAwdjc1ek01NTAgNTAwaDMwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtMTAwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC0zMDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djEwMHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjV6TTU1MCAyMDBoNjAwIHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtMTAwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC02MDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djEwMHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjV6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTA1ODsiIGQ9Ik01MCAxMTAwaDEwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtMTAwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC0xMDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djEwMHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjV6TTkwMCAwaC0xMDB2MTEwMGgxMDB2LTExMDB6TTUwIDgwMGg1MDBxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTEwMHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtNTAwIHEtMjEgMCAtMzUuNSAxNC41dC0xNC41IDM1LjV2MTAwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXpNMTEwMCA2MDBoMjAwdi0xMDBoLTIwMHYtNzVsLTE2NyAxMjVsMTY3IDEyNXYtNzV6TTUwIDUwMGgzMDBxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTEwMHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtMzAwcS0yMSAwIC0zNS41IDE0LjV0LTE0LjUgMzUuNXYxMDBxMCAyMSAxNC41IDM1LjV0MzUuNSAxNC41ek01MCAyMDBoNjAwIHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtMTAwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC02MDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djEwMHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjV6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTA1OTsiIGQ9Ik03NSAxMDAwaDc1MHEzMSAwIDUzIC0yMnQyMiAtNTN2LTY1MHEwIC0zMSAtMjIgLTUzdC01MyAtMjJoLTc1MHEtMzEgMCAtNTMgMjJ0LTIyIDUzdjY1MHEwIDMxIDIyIDUzdDUzIDIyek0xMjAwIDMwMGwtMzAwIDMwMGwzMDAgMzAwdi02MDB6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTA2MDsiIGQ9Ik00NCAxMTAwaDExMTJxMTggMCAzMSAtMTN0MTMgLTMxdi0xMDEycTAgLTE4IC0xMyAtMzF0LTMxIC0xM2gtMTExMnEtMTggMCAtMzEgMTN0LTEzIDMxdjEwMTJxMCAxOCAxMyAzMXQzMSAxM3pNMTAwIDEwMDB2LTczN2wyNDcgMTgybDI5OCAtMTMxbC03NCAxNTZsMjkzIDMxOGwyMzYgLTI4OHY1MDBoLTEwMDB6TTM0MiA4ODRxNTYgMCA5NSAtMzl0MzkgLTk0LjV0LTM5IC05NXQtOTUgLTM5LjV0LTk1IDM5LjV0LTM5IDk1dDM5IDk0LjUgdDk1IDM5eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUwNjI7IiBkPSJNNjQ4IDExNjlxMTE3IDAgMjE2IC02MHQxNTYuNSAtMTYxdDU3LjUgLTIxOHEwIC0xMTUgLTcwIC0yNThxLTY5IC0xMDkgLTE1OCAtMjI1LjV0LTE0MyAtMTc5LjVsLTU0IC02MnEtOSA4IC0yNS41IDI0LjV0LTYzLjUgNjcuNXQtOTEgMTAzdC05OC41IDEyOHQtOTUuNSAxNDhxLTYwIDEzMiAtNjAgMjQ5cTAgODggMzQgMTY5LjV0OTEuNSAxNDJ0MTM3IDk2LjV0MTY2LjUgMzZ6TTY1Mi41IDk3NHEtOTEuNSAwIC0xNTYuNSAtNjUgdC02NSAtMTU3dDY1IC0xNTYuNXQxNTYuNSAtNjQuNXQxNTYuNSA2NC41dDY1IDE1Ni41dC02NSAxNTd0LTE1Ni41IDY1eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUwNjM7IiBkPSJNNjAwIDExNzdxMTE3IDAgMjI0IC00NS41dDE4NC41IC0xMjN0MTIzIC0xODQuNXQ0NS41IC0yMjR0LTQ1LjUgLTIyNHQtMTIzIC0xODQuNXQtMTg0LjUgLTEyM3QtMjI0IC00NS41dC0yMjQgNDUuNXQtMTg0LjUgMTIzdC0xMjMgMTg0LjV0LTQ1LjUgMjI0dDQ1LjUgMjI0dDEyMyAxODQuNXQxODQuNSAxMjN0MjI0IDQ1LjV6TTYwMCAxNzN2ODU0cS0xMTYgMCAtMjE0LjUgLTU3dC0xNTUuNSAtMTU1LjV0LTU3IC0yMTQuNXQ1NyAtMjE0LjUgdDE1NS41IC0xNTUuNXQyMTQuNSAtNTd6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTA2NDsiIGQ9Ik01NTQgMTI5NXEyMSAtNzIgNTcuNSAtMTQzLjV0NzYgLTEzMHQ4MyAtMTE4dDgyLjUgLTExN3Q3MCAtMTE2dDQ5LjUgLTEyNnQxOC41IC0xMzYuNXEwIC03MSAtMjUuNSAtMTM1dC02OC41IC0xMTF0LTk5IC04MnQtMTE4LjUgLTU0dC0xMjUuNSAtMjNxLTg0IDUgLTE2MS41IDM0dC0xMzkuNSA3OC41dC05OSAxMjV0LTM3IDE2NC41cTAgNjkgMTggMTM2LjV0NDkuNSAxMjYuNXQ2OS41IDExNi41dDgxLjUgMTE3LjV0ODMuNSAxMTkgdDc2LjUgMTMxdDU4LjUgMTQzek0zNDQgNzEwcS0yMyAtMzMgLTQzLjUgLTcwLjV0LTQwLjUgLTEwMi41dC0xNyAtMTIzcTEgLTM3IDE0LjUgLTY5LjV0MzAgLTUydDQxIC0zN3QzOC41IC0yNC41dDMzIC0xNXEyMSAtNyAzMiAtMXQxMyAyMmw2IDM0cTIgMTAgLTIuNSAyMnQtMTMuNSAxOXEtNSA0IC0xNCAxMnQtMjkuNSA0MC41dC0zMi41IDczLjVxLTI2IDg5IDYgMjcxcTIgMTEgLTYgMTFxLTggMSAtMTUgLTEweiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUwNjU7IiBkPSJNMTAwMCAxMDEzbDEwOCAxMTVxMiAxIDUgMnQxMyAydDIwLjUgLTF0MjUgLTkuNXQyOC41IC0yMS41cTIyIC0yMiAyNyAtNDN0MCAtMzJsLTYgLTEwbC0xMDggLTExNXpNMzUwIDExMDBoNDAwcTUwIDAgMTA1IC0xM2wtMTg3IC0xODdoLTM2OHEtNDEgMCAtNzAuNSAtMjkuNXQtMjkuNSAtNzAuNXYtNTAwcTAgLTQxIDI5LjUgLTcwLjV0NzAuNSAtMjkuNWg1MDBxNDEgMCA3MC41IDI5LjV0MjkuNSA3MC41djE4MmwyMDAgMjAwdi0zMzIgcTAgLTE2NSAtOTMuNSAtMjU3LjV0LTI1Ni41IC05Mi41aC00MDBxLTE2NSAwIC0yNTcuNSA5Mi41dC05Mi41IDI1Ny41djQwMHEwIDE2NSA5Mi41IDI1Ny41dDI1Ny41IDkyLjV6TTEwMDkgODAzbC0zNjIgLTM2MmwtMTYxIC01MGw1NSAxNzBsMzU1IDM1NXoiIC8%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDY5OyIgZD0iTTI1MCAxMTAwaDEwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtNDM4bDQ2NCA0NTNxMTUgMTQgMjUuNSAxMHQxMC41IC0yNXYtMTAwMHEwIC0yMSAtMTAuNSAtMjV0LTI1LjUgMTBsLTQ2NCA0NTN2LTQzOHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtMTAwcS0yMSAwIC0zNS41IDE0LjV0LTE0LjUgMzUuNXYxMDAwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDcwOyIgZD0iTTUwIDExMDBoMTAwcTIxIDAgMzUuNSAtMTQuNXQxNC41IC0zNS41di00MzhsNDY0IDQ1M3ExNSAxNCAyNS41IDEwdDEwLjUgLTI1di00MzhsNDY0IDQ1M3ExNSAxNCAyNS41IDEwdDEwLjUgLTI1di0xMDAwcTAgLTIxIC0xMC41IC0yNXQtMjUuNSAxMGwtNDY0IDQ1M3YtNDM4cTAgLTIxIC0xMC41IC0yNXQtMjUuNSAxMGwtNDY0IDQ1M3YtNDM4cTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC0xMDBxLTIxIDAgLTM1LjUgMTQuNSB0LTE0LjUgMzUuNXYxMDAwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDcxOyIgZD0iTTEyMDAgMTA1MHYtMTAwMHEwIC0yMSAtMTAuNSAtMjV0LTI1LjUgMTBsLTQ2NCA0NTN2LTQzOHEwIC0yMSAtMTAuNSAtMjV0LTI1LjUgMTBsLTQ5MiA0ODBxLTE1IDE0IC0xNSAzNXQxNSAzNWw0OTIgNDgwcTE1IDE0IDI1LjUgMTB0MTAuNSAtMjV2LTQzOGw0NjQgNDUzcTE1IDE0IDI1LjUgMTB0MTAuNSAtMjV6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTA3MjsiIGQ9Ik0yNDMgMTA3NGw4MTQgLTQ5OHExOCAtMTEgMTggLTI2dC0xOCAtMjZsLTgxNCAtNDk4cS0xOCAtMTEgLTMwLjUgLTR0LTEyLjUgMjh2MTAwMHEwIDIxIDEyLjUgMjh0MzAuNSAtNHoiIC8%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDc5OyIgZD0iTTg4NSA5MDBsLTM1MiAtMzUzbDM1MiAtMzUzbC0xOTcgLTE5OGwtNTUyIDU1Mmw1NTIgNTUweiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUwODA7IiBkPSJNMTA2NCA1NDdsLTU1MSAtNTUxbC0xOTggMTk4bDM1MyAzNTNsLTM1MyAzNTNsMTk4IDE5OHoiIC8%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDgzOyIgZD0iTTYwMCAxMTc3cTExNyAwIDIyNCAtNDUuNXQxODQuNSAtMTIzdDEyMyAtMTg0LjV0NDUuNSAtMjI0dC00NS41IC0yMjR0LTEyMyAtMTg0LjV0LTE4NC41IC0xMjN0LTIyNCAtNDUuNXQtMjI0IDQ1LjV0LTE4NC41IDEyM3QtMTIzIDE4NC41dC00NS41IDIyNHQ0NS41IDIyNHQxMjMgMTg0LjV0MTg0LjUgMTIzdDIyNCA0NS41ek03NDEuNSA5MTNxLTEyLjUgMCAtMjEuNSAtOWwtMTIwIC0xMjBsLTEyMCAxMjBxLTkgOSAtMjEuNSA5IHQtMjEuNSAtOWwtMTQxIC0xNDFxLTkgLTkgLTkgLTIxLjV0OSAtMjEuNWwxMjAgLTEyMGwtMTIwIC0xMjBxLTkgLTkgLTkgLTIxLjV0OSAtMjEuNWwxNDEgLTE0MXE5IC05IDIxLjUgLTl0MjEuNSA5bDEyMCAxMjBsMTIwIC0xMjBxOSAtOSAyMS41IC05dDIxLjUgOWwxNDEgMTQxcTkgOSA5IDIxLjV0LTkgMjEuNWwtMTIwIDEyMGwxMjAgMTIwcTkgOSA5IDIxLjV0LTkgMjEuNWwtMTQxIDE0MXEtOSA5IC0yMS41IDl6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTA4NDsiIGQ9Ik02MDAgMTE3N3ExMTcgMCAyMjQgLTQ1LjV0MTg0LjUgLTEyM3QxMjMgLTE4NC41dDQ1LjUgLTIyNHQtNDUuNSAtMjI0dC0xMjMgLTE4NC41dC0xODQuNSAtMTIzdC0yMjQgLTQ1LjV0LTIyNCA0NS41dC0xODQuNSAxMjN0LTEyMyAxODQuNXQtNDUuNSAyMjR0NDUuNSAyMjR0MTIzIDE4NC41dDE4NC41IDEyM3QyMjQgNDUuNXpNNTQ2IDYyM2wtODQgODVxLTcgNyAtMTcuNSA3dC0xOC41IC03bC0xMzkgLTEzOXEtNyAtOCAtNyAtMTh0NyAtMTggbDI0MiAtMjQxcTcgLTggMTcuNSAtOHQxNy41IDhsMzc1IDM3NXE3IDcgNyAxNy41dC03IDE4LjVsLTEzOSAxMzlxLTcgNyAtMTcuNSA3dC0xNy41IC03eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUwODU7IiBkPSJNNjAwIDExNzdxMTE3IDAgMjI0IC00NS41dDE4NC41IC0xMjN0MTIzIC0xODQuNXQ0NS41IC0yMjR0LTQ1LjUgLTIyNHQtMTIzIC0xODQuNXQtMTg0LjUgLTEyM3QtMjI0IC00NS41dC0yMjQgNDUuNXQtMTg0LjUgMTIzdC0xMjMgMTg0LjV0LTQ1LjUgMjI0dDQ1LjUgMjI0dDEyMyAxODQuNXQxODQuNSAxMjN0MjI0IDQ1LjV6TTU4OCA5NDFxLTI5IDAgLTU5IC01LjV0LTYzIC0yMC41dC01OCAtMzguNXQtNDEuNSAtNjN0LTE2LjUgLTg5LjUgcTAgLTI1IDIwIC0yNWgxMzFxMzAgLTUgMzUgMTFxNiAyMCAyMC41IDI4dDQ1LjUgOHEyMCAwIDMxLjUgLTEwLjV0MTEuNSAtMjguNXEwIC0yMyAtNyAtMzR0LTI2IC0xOHEtMSAwIC0xMy41IC00dC0xOS41IC03LjV0LTIwIC0xMC41dC0yMiAtMTd0LTE4LjUgLTI0dC0xNS41IC0zNXQtOCAtNDZxLTEgLTggNS41IC0xNi41dDIwLjUgLTguNWgxNzNxNyAwIDIyIDh0MzUgMjh0MzcuNSA0OHQyOS41IDc0dDEyIDEwMHEwIDQ3IC0xNyA4MyB0LTQyLjUgNTd0LTU5LjUgMzQuNXQtNjQgMTh0LTU5IDQuNXpNNjc1IDQwMGgtMTUwcS0xMCAwIC0xNy41IC03LjV0LTcuNSAtMTcuNXYtMTUwcTAgLTEwIDcuNSAtMTcuNXQxNy41IC03LjVoMTUwcTEwIDAgMTcuNSA3LjV0Ny41IDE3LjV2MTUwcTAgMTAgLTcuNSAxNy41dC0xNy41IDcuNXoiIC8%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%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%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDk2OyIgZD0iTTg1MCAxMjAwaDMwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtMzAwcTAgLTIxIC0xMC41IC0yNXQtMjQuNSAxMGwtOTQgOTRsLTI0OSAtMjQ5cS04IC03IC0xOCAtN3QtMTggN2wtMTA2IDEwNnEtNyA4IC03IDE4dDcgMThsMjQ5IDI0OWwtOTQgOTRxLTE0IDE0IC0xMCAyNC41dDI1IDEwLjV6TTM1MCAwaC0zMDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djMwMHEwIDIxIDEwLjUgMjV0MjQuNSAtMTBsOTQgLTk0bDI0OSAyNDkgcTggNyAxOCA3dDE4IC03bDEwNiAtMTA2cTcgLTggNyAtMTh0LTcgLTE4bC0yNDkgLTI0OWw5NCAtOTRxMTQgLTE0IDEwIC0yNC41dC0yNSAtMTAuNXoiIC8%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%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%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%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMTE4OyIgZD0iTTIwMCA4MDBsLTIwMCAtNDAwdjYwMGgyMDBxMCA0MSAyOS41IDcwLjV0NzAuNSAyOS41aDMwMHE0MiAwIDcxIC0yOS41dDI5IC03MC41aDUwMHYtMjAwaC0xMDAwek0xNTAwIDcwMGwtMzAwIC03MDBoLTEyMDBsMzAwIDcwMGgxMjAweiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUxMTk7IiBkPSJNNjM1IDExODRsMjMwIC0yNDlxMTQgLTE0IDEwIC0yNC41dC0yNSAtMTAuNWgtMTUwdi02MDFoMTUwcTIxIDAgMjUgLTEwLjV0LTEwIC0yNC41bC0yMzAgLTI0OXEtMTQgLTE1IC0zNSAtMTV0LTM1IDE1bC0yMzAgMjQ5cS0xNCAxNCAtMTAgMjQuNXQyNSAxMC41aDE1MHY2MDFoLTE1MHEtMjEgMCAtMjUgMTAuNXQxMCAyNC41bDIzMCAyNDlxMTQgMTUgMzUgMTV0MzUgLTE1eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUxMjA7IiBkPSJNOTM2IDg2NGwyNDkgLTIyOXExNCAtMTUgMTQgLTM1LjV0LTE0IC0zNS41bC0yNDkgLTIyOXEtMTUgLTE1IC0yNS41IC0xMC41dC0xMC41IDI0LjV2MTUxaC02MDB2LTE1MXEwIC0yMCAtMTAuNSAtMjQuNXQtMjUuNSAxMC41bC0yNDkgMjI5cS0xNCAxNSAtMTQgMzUuNXQxNCAzNS41bDI0OSAyMjlxMTUgMTUgMjUuNSAxMC41dDEwLjUgLTI1LjV2LTE0OWg2MDB2MTQ5cTAgMjEgMTAuNSAyNS41dDI1LjUgLTEwLjV6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTEyMTsiIGQ9Ik0xMTY5IDQwMGwtMTcyIDczMnEtNSAyMyAtMjMgNDUuNXQtMzggMjIuNWgtNjcycS0yMCAwIC0zOCAtMjB0LTIzIC00MWwtMTcyIC03MzloMTEzOHpNMTEwMCAzMDBoLTEwMDBxLTQxIDAgLTcwLjUgLTI5LjV0LTI5LjUgLTcwLjV2LTEwMHEwIC00MSAyOS41IC03MC41dDcwLjUgLTI5LjVoMTAwMHE0MSAwIDcwLjUgMjkuNXQyOS41IDcwLjV2MTAwcTAgNDEgLTI5LjUgNzAuNXQtNzAuNSAyOS41ek04MDAgMTAwdjEwMGgxMDB2LTEwMGgtMTAwIHpNMTAwMCAxMDB2MTAwaDEwMHYtMTAwaC0xMDB6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTEyMjsiIGQ9Ik0xMTUwIDExMDBxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTg1MHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNXQtMzUuNSAxNC41dC0xNC41IDM1LjV2ODUwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXpNMTAwMCAyMDBsLTY3NSAyMDBoLTM4bDQ3IC0yNzZxMyAtMTYgLTUuNSAtMjB0LTI5LjUgLTRoLTdoLTg0cS0yMCAwIC0zNC41IDE0dC0xOC41IDM1cS01NSAzMzcgLTU1IDM1MXYyNTB2NnEwIDE2IDEgMjMuNXQ2LjUgMTQgdDE3LjUgNi41aDIwMGw2NzUgMjUwdi04NTB6TTAgNzUwdi0yNTBxLTQgMCAtMTEgMC41dC0yNCA2dC0zMCAxNXQtMjQgMzB0LTExIDQ4LjV2NTBxMCAyNiAxMC41IDQ2dDI1IDMwdDI5IDE2dDI1LjUgN3oiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMTIzOyIgZD0iTTU1MyAxMjAwaDk0cTIwIDAgMjkgLTEwLjV0MyAtMjkuNWwtMTggLTM3cTgzIC0xOSAxNDQgLTgyLjV0NzYgLTE0MC41bDYzIC0zMjdsMTE4IC0xNzNoMTdxMTkgMCAzMyAtMTQuNXQxNCAtMzV0LTEzIC00MC41dC0zMSAtMjdxLTggLTQgLTIzIC05LjV0LTY1IC0xOS41dC0xMDMgLTI1dC0xMzIuNSAtMjB0LTE1OC41IC05cS01NyAwIC0xMTUgNXQtMTA0IDEydC04OC41IDE1LjV0LTczLjUgMTcuNXQtNTQuNSAxNnQtMzUuNSAxMmwtMTEgNCBxLTE4IDggLTMxIDI4dC0xMyA0MC41dDE0IDM1dDMzIDE0LjVoMTdsMTE4IDE3M2w2MyAzMjdxMTUgNzcgNzYgMTQwdDE0NCA4M2wtMTggMzJxLTYgMTkgMy41IDMydDI4LjUgMTN6TTQ5OCAxMTBxNTAgLTYgMTAyIC02cTUzIDAgMTAyIDZxLTEyIC00OSAtMzkuNSAtNzkuNXQtNjIuNSAtMzAuNXQtNjMgMzAuNXQtMzkgNzkuNXoiIC8%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%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%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMTM5OyIgZD0iTTUwMCAxMjAwaDIwMHE0MSAwIDcwLjUgLTI5LjV0MjkuNSAtNzAuNXYtMTAwaDMwMHE0MSAwIDcwLjUgLTI5LjV0MjkuNSAtNzAuNXYtNDAwaC01MDB2MTAwaC0yMDB2LTEwMGgtNTAwdjQwMHEwIDQxIDI5LjUgNzAuNXQ3MC41IDI5LjVoMzAwdjEwMHEwIDQxIDI5LjUgNzAuNXQ3MC41IDI5LjV6TTUwMCAxMTAwdi0xMDBoMjAwdjEwMGgtMjAwek0xMjAwIDQwMHYtMjAwcTAgLTQxIC0yOS41IC03MC41dC03MC41IC0yOS41aC0xMDAwIHEtNDEgMCAtNzAuNSAyOS41dC0yOS41IDcwLjV2MjAwaDEyMDB6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTE0MDsiIGQ9Ik01MCAxMjAwaDMwMHEyMSAwIDI1IC0xMC41dC0xMCAtMjQuNWwtOTQgLTk0bDE5OSAtMTk5cTcgLTggNyAtMTh0LTcgLTE4bC0xMDYgLTEwNnEtOCAtNyAtMTggLTd0LTE4IDdsLTE5OSAxOTlsLTk0IC05NHEtMTQgLTE0IC0yNC41IC0xMHQtMTAuNSAyNXYzMDBxMCAyMSAxNC41IDM1LjV0MzUuNSAxNC41ek04NTAgMTIwMGgzMDBxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTMwMHEwIC0yMSAtMTAuNSAtMjV0LTI0LjUgMTBsLTk0IDk0IGwtMTk5IC0xOTlxLTggLTcgLTE4IC03dC0xOCA3bC0xMDYgMTA2cS03IDggLTcgMTh0NyAxOGwxOTkgMTk5bC05NCA5NHEtMTQgMTQgLTEwIDI0LjV0MjUgMTAuNXpNMzY0IDQ3MGwxMDYgLTEwNnE3IC04IDcgLTE4dC03IC0xOGwtMTk5IC0xOTlsOTQgLTk0cTE0IC0xNCAxMCAtMjQuNXQtMjUgLTEwLjVoLTMwMHEtMjEgMCAtMzUuNSAxNC41dC0xNC41IDM1LjV2MzAwcTAgMjEgMTAuNSAyNXQyNC41IC0xMGw5NCAtOTRsMTk5IDE5OSBxOCA3IDE4IDd0MTggLTd6TTEwNzEgMjcxbDk0IDk0cTE0IDE0IDI0LjUgMTB0MTAuNSAtMjV2LTMwMHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtMzAwcS0yMSAwIC0yNSAxMC41dDEwIDI0LjVsOTQgOTRsLTE5OSAxOTlxLTcgOCAtNyAxOHQ3IDE4bDEwNiAxMDZxOCA3IDE4IDd0MTggLTd6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTE0MTsiIGQ9Ik01OTYgMTE5MnExMjEgMCAyMzEuNSAtNDcuNXQxOTAgLTEyN3QxMjcgLTE5MHQ0Ny41IC0yMzEuNXQtNDcuNSAtMjMxLjV0LTEyNyAtMTkwLjV0LTE5MCAtMTI3dC0yMzEuNSAtNDd0LTIzMS41IDQ3dC0xOTAuNSAxMjd0LTEyNyAxOTAuNXQtNDcgMjMxLjV0NDcgMjMxLjV0MTI3IDE5MHQxOTAuNSAxMjd0MjMxLjUgNDcuNXpNNTk2IDEwMTBxLTExMiAwIC0yMDcuNSAtNTUuNXQtMTUxIC0xNTF0LTU1LjUgLTIwNy41dDU1LjUgLTIwNy41IHQxNTEgLTE1MXQyMDcuNSAtNTUuNXQyMDcuNSA1NS41dDE1MSAxNTF0NTUuNSAyMDcuNXQtNTUuNSAyMDcuNXQtMTUxIDE1MXQtMjA3LjUgNTUuNXpNNDU0LjUgOTA1cTIyLjUgMCAzOC41IC0xNnQxNiAtMzguNXQtMTYgLTM5dC0zOC41IC0xNi41dC0zOC41IDE2LjV0LTE2IDM5dDE2IDM4LjV0MzguNSAxNnpNNzU0LjUgOTA1cTIyLjUgMCAzOC41IC0xNnQxNiAtMzguNXQtMTYgLTM5dC0zOCAtMTYuNXEtMTQgMCAtMjkgMTBsLTU1IC0xNDUgcTE3IC0yMyAxNyAtNTFxMCAtMzYgLTI1LjUgLTYxLjV0LTYxLjUgLTI1LjV0LTYxLjUgMjUuNXQtMjUuNSA2MS41cTAgMzIgMjAuNSA1Ni41dDUxLjUgMjkuNWwxMjIgMTI2bDEgMXEtOSAxNCAtOSAyOHEwIDIzIDE2IDM5dDM4LjUgMTZ6TTM0NS41IDcwOXEyMi41IDAgMzguNSAtMTZ0MTYgLTM4LjV0LTE2IC0zOC41dC0zOC41IC0xNnQtMzguNSAxNnQtMTYgMzguNXQxNiAzOC41dDM4LjUgMTZ6TTg1NC41IDcwOXEyMi41IDAgMzguNSAtMTYgdDE2IC0zOC41dC0xNiAtMzguNXQtMzguNSAtMTZ0LTM4LjUgMTZ0LTE2IDM4LjV0MTYgMzguNXQzOC41IDE2eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUxNDI7IiBkPSJNNTQ2IDE3M2w0NjkgNDcwcTkxIDkxIDk5IDE5MnE3IDk4IC01MiAxNzUuNXQtMTU0IDk0LjVxLTIyIDQgLTQ3IDRxLTM0IDAgLTY2LjUgLTEwdC01Ni41IC0yM3QtNTUuNSAtMzh0LTQ4IC00MS41dC00OC41IC00Ny41cS0zNzYgLTM3NSAtMzkxIC0zOTBxLTMwIC0yNyAtNDUgLTQxLjV0LTM3LjUgLTQxdC0zMiAtNDYuNXQtMTYgLTQ3LjV0LTEuNSAtNTYuNXE5IC02MiA1My41IC05NXQ5OS41IC0zM3E3NCAwIDEyNSA1MWw1NDggNTQ4IHEzNiAzNiAyMCA3NXEtNyAxNiAtMjEuNSAyNnQtMzIuNSAxMHEtMjYgMCAtNTAgLTIzcS0xMyAtMTIgLTM5IC0zOGwtMzQxIC0zMzhxLTE1IC0xNSAtMzUuNSAtMTUuNXQtMzQuNSAxMy41dC0xNCAzNC41dDE0IDM0LjVxMzI3IDMzMyAzNjEgMzY3cTM1IDM1IDY3LjUgNTEuNXQ3OC41IDE2LjVxMTQgMCAyOSAtMXE0NCAtOCA3NC41IC0zNS41dDQzLjUgLTY4LjVxMTQgLTQ3IDIgLTk2LjV0LTQ3IC04NC41cS0xMiAtMTEgLTMyIC0zMiB0LTc5LjUgLTgxdC0xMTQuNSAtMTE1dC0xMjQuNSAtMTIzLjV0LTEyMyAtMTE5LjV0LTk2LjUgLTg5dC01NyAtNDVxLTU2IC0yNyAtMTIwIC0yN3EtNzAgMCAtMTI5IDMydC05MyA4OXEtNDggNzggLTM1IDE3M3Q4MSAxNjNsNTExIDUxMXE3MSA3MiAxMTEgOTZxOTEgNTUgMTk4IDU1cTgwIDAgMTUyIC0zM3E3OCAtMzYgMTI5LjUgLTEwM3Q2Ni41IC0xNTRxMTcgLTkzIC0xMSAtMTgzLjV0LTk0IC0xNTYuNWwtNDgyIC00NzYgcS0xNSAtMTUgLTM2IC0xNnQtMzcgMTR0LTE3LjUgMzR0MTQuNSAzNXoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMTQzOyIgZD0iTTY0OSA5NDlxNDggNjggMTA5LjUgMTA0dDEyMS41IDM4LjV0MTE4LjUgLTIwdDEwMi41IC02NHQ3MSAtMTAwLjV0MjcgLTEyM3EwIC01NyAtMzMuNSAtMTE3LjV0LTk0IC0xMjQuNXQtMTI2LjUgLTEyNy41dC0xNTAgLTE1Mi41dC0xNDYgLTE3NHEtNjIgODUgLTE0NS41IDE3NHQtMTUwIDE1Mi41dC0xMjYuNSAxMjcuNXQtOTMuNSAxMjQuNXQtMzMuNSAxMTcuNXEwIDY0IDI4IDEyM3Q3MyAxMDAuNXQxMDQgNjR0MTE5IDIwIHQxMjAuNSAtMzguNXQxMDQuNSAtMTA0ek04OTYgOTcycS0zMyAwIC02NC41IC0xOXQtNTYuNSAtNDZ0LTQ3LjUgLTUzLjV0LTQzLjUgLTQ1LjV0LTM3LjUgLTE5dC0zNiAxOXQtNDAgNDUuNXQtNDMgNTMuNXQtNTQgNDZ0LTY1LjUgMTlxLTY3IDAgLTEyMi41IC01NS41dC01NS41IC0xMzIuNXEwIC0yMyAxMy41IC01MXQ0NiAtNjV0NTcuNSAtNjN0NzYgLTc1bDIyIC0yMnExNSAtMTQgNDQgLTQ0dDUwLjUgLTUxdDQ2IC00NHQ0MSAtMzV0MjMgLTEyIHQyMy41IDEydDQyLjUgMzZ0NDYgNDR0NTIuNSA1MnQ0NCA0M3E0IDQgMTIgMTNxNDMgNDEgNjMuNSA2MnQ1MiA1NXQ0NiA1NXQyNiA0NnQxMS41IDQ0cTAgNzkgLTUzIDEzMy41dC0xMjAgNTQuNXoiIC8%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%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMTYyOyIgZD0iTTc5MyAxMTgybDkgLTlxOCAtMTAgNSAtMjdxLTMgLTExIC03OSAtMjI1LjV0LTc4IC0yMjEuNWwzMDAgMXEyNCAwIDMyLjUgLTE3LjV0LTUuNSAtMzUuNXEtMSAwIC0xMzMuNSAtMTU1dC0yNjcgLTMxMi41dC0xMzguNSAtMTYyLjVxLTEyIC0xNSAtMjYgLTE1aC05bC05IDhxLTkgMTEgLTQgMzJxMiA5IDQyIDEyMy41dDc5IDIyNC41bDM5IDExMGgtMzAycS0yMyAwIC0zMSAxOXEtMTAgMjEgNiA0MXE3NSA4NiAyMDkuNSAyMzcuNSB0MjI4IDI1N3Q5OC41IDExMS41cTkgMTYgMjUgMTZoOXoiIC8%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%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%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%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%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%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%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMTk5OyIgZD0iTTcwMCAxMDB2MTAwaDQwMGwtMjcwIDMwMGgxNzBsLTI3MCAzMDBoMTcwbC0zMDAgMzMzbC0zMDAgLTMzM2gxNzBsLTI3MCAtMzAwaDE3MGwtMjcwIC0zMDBoNDAwdi0xMDBoLTUwcS0yMSAwIC0zNS41IC0xNC41dC0xNC41IC0zNS41di01MGg0MDB2NTBxMCAyMSAtMTQuNSAzNS41dC0zNS41IDE0LjVoLTUweiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUyMDA7IiBkPSJNNjAwIDExNzlxOTQgMCAxNjcuNSAtNTYuNXQ5OS41IC0xNDUuNXE4OSAtNiAxNTAuNSAtNzEuNXQ2MS41IC0xNTUuNXEwIC02MSAtMjkuNSAtMTEyLjV0LTc5LjUgLTgyLjVxOSAtMjkgOSAtNTVxMCAtNzQgLTUyLjUgLTEyNi41dC0xMjYuNSAtNTIuNXEtNTUgMCAtMTAwIDMwdi0yNTFxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTUwaC0zMDB2NTBxMCAyMSAxNC41IDM1LjV0MzUuNSAxNC41djI1MXEtNDUgLTMwIC0xMDAgLTMwIHEtNzQgMCAtMTI2LjUgNTIuNXQtNTIuNSAxMjYuNXEwIDE4IDQgMzhxLTQ3IDIxIC03NS41IDY1dC0yOC41IDk3cTAgNzQgNTIuNSAxMjYuNXQxMjYuNSA1Mi41cTUgMCAyMyAtMnEwIDIgLTEgMTB0LTEgMTNxMCAxMTYgODEuNSAxOTcuNXQxOTcuNSA4MS41eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUyMDE7IiBkPSJNMTAxMCAxMDEwcTExMSAtMTExIDE1MC41IC0yNjAuNXQwIC0yOTl0LTE1MC41IC0yNjAuNXEtODMgLTgzIC0xOTEuNSAtMTI2LjV0LTIxOC41IC00My41dC0yMTguNSA0My41dC0xOTEuNSAxMjYuNXEtMTExIDExMSAtMTUwLjUgMjYwLjV0MCAyOTl0MTUwLjUgMjYwLjVxODMgODMgMTkxLjUgMTI2LjV0MjE4LjUgNDMuNXQyMTguNSAtNDMuNXQxOTEuNSAtMTI2LjV6TTQ3NiAxMDY1cS00IDAgLTggLTFxLTEyMSAtMzQgLTIwOS41IC0xMjIuNSB0LTEyMi41IC0yMDkuNXEtNCAtMTIgMi41IC0yM3QxOC41IC0xNGwzNiAtOXEzIC0xIDcgLTFxMjMgMCAyOSAyMnEyNyA5NiA5OCAxNjZxNzAgNzEgMTY2IDk4cTExIDMgMTcuNSAxMy41dDMuNSAyMi41bC05IDM1cS0zIDEzIC0xNCAxOXEtNyA0IC0xNSA0ek01MTIgOTIwcS00IDAgLTkgLTJxLTgwIC0yNCAtMTM4LjUgLTgyLjV0LTgyLjUgLTEzOC41cS00IC0xMyAyIC0yNHQxOSAtMTRsMzQgLTlxNCAtMSA4IC0xcTIyIDAgMjggMjEgcTE4IDU4IDU4LjUgOTguNXQ5Ny41IDU4LjVxMTIgMyAxOCAxMy41dDMgMjEuNWwtOSAzNXEtMyAxMiAtMTQgMTlxLTcgNCAtMTUgNHpNNzE5LjUgNzE5LjVxLTQ5LjUgNDkuNSAtMTE5LjUgNDkuNXQtMTE5LjUgLTQ5LjV0LTQ5LjUgLTExOS41dDQ5LjUgLTExOS41dDExOS41IC00OS41dDExOS41IDQ5LjV0NDkuNSAxMTkuNXQtNDkuNSAxMTkuNXpNODU1IDU1MXEtMjIgMCAtMjggLTIxcS0xOCAtNTggLTU4LjUgLTk4LjV0LTk4LjUgLTU3LjUgcS0xMSAtNCAtMTcgLTE0LjV0LTMgLTIxLjVsOSAtMzVxMyAtMTIgMTQgLTE5cTcgLTQgMTUgLTRxNCAwIDkgMnE4MCAyNCAxMzguNSA4Mi41dDgyLjUgMTM4LjVxNCAxMyAtMi41IDI0dC0xOC41IDE0bC0zNCA5cS00IDEgLTggMXpNMTAwMCA1MTVxLTIzIDAgLTI5IC0yMnEtMjcgLTk2IC05OCAtMTY2cS03MCAtNzEgLTE2NiAtOThxLTExIC0zIC0xNy41IC0xMy41dC0zLjUgLTIyLjVsOSAtMzVxMyAtMTMgMTQgLTE5cTcgLTQgMTUgLTQgcTQgMCA4IDFxMTIxIDM0IDIwOS41IDEyMi41dDEyMi41IDIwOS41cTQgMTIgLTIuNSAyM3QtMTguNSAxNGwtMzYgOXEtMyAxIC03IDF6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTIwMjsiIGQ9Ik03MDAgODAwaDMwMHYtMzgwaC0xODB2MjAwaC0zNDB2LTIwMGgtMzgwdjc1NXEwIDEwIDcuNSAxNy41dDE3LjUgNy41aDU3NXYtNDAwek0xMDAwIDkwMGgtMjAwdjIwMHpNNzAwIDMwMGgxNjJsLTIxMiAtMjEybC0yMTIgMjEyaDE2MnYyMDBoMTAwdi0yMDB6TTUyMCAwaC0zOTVxLTEwIDAgLTE3LjUgNy41dC03LjUgMTcuNXYzOTV6TTEwMDAgMjIwdi0xOTVxMCAtMTAgLTcuNSAtMTcuNXQtMTcuNSAtNy41aC0xOTV6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTIwMzsiIGQ9Ik03MDAgODAwaDMwMHYtNTIwbC0zNTAgMzUwbC01NTAgLTU1MHYxMDk1cTAgMTAgNy41IDE3LjV0MTcuNSA3LjVoNTc1di00MDB6TTEwMDAgOTAwaC0yMDB2MjAwek04NjIgMjAwaC0xNjJ2LTIwMGgtMTAwdjIwMGgtMTYybDIxMiAyMTJ6TTQ4MCAwaC0zNTVxLTEwIDAgLTE3LjUgNy41dC03LjUgMTcuNXY1NWgzODB2LTgwek0xMDAwIDgwdi01NXEwIC0xMCAtNy41IC0xNy41dC0xNy41IC03LjVoLTE1NXY4MGgxODB6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTIwNDsiIGQ9Ik0xMTYyIDgwMGgtMTYydi0yMDBoMTAwbDEwMCAtMTAwaC0zMDB2MzAwaC0xNjJsMjEyIDIxMnpNMjAwIDgwMGgyMDBxMjcgMCA0MCAtMnQyOS41IC0xMC41dDIzLjUgLTMwdDcgLTU3LjVoMzAwdi0xMDBoLTYwMGwtMjAwIC0zNTB2NDUwaDEwMHEwIDM2IDcgNTcuNXQyMy41IDMwdDI5LjUgMTAuNXQ0MCAyek04MDAgNDAwaDI0MGwtMjQwIC00MDBoLTgwMGwzMDAgNTAwaDUwMHYtMTAweiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUyMDU7IiBkPSJNNjUwIDExMDBoMTAwcTIxIDAgMzUuNSAtMTQuNXQxNC41IC0zNS41di01MGg1MHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtMTAwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC0zMDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djEwMHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjVoNTB2NTBxMCAyMSAxNC41IDM1LjV0MzUuNSAxNC41ek0xMDAwIDg1MHYxNTBxNDEgMCA3MC41IC0yOS41dDI5LjUgLTcwLjV2LTgwMCBxMCAtNDEgLTI5LjUgLTcwLjV0LTcwLjUgLTI5LjVoLTYwMHEtMSAwIC0yMCA0bDI0NiAyNDZsLTMyNiAzMjZ2MzI0cTAgNDEgMjkuNSA3MC41dDcwLjUgMjkuNXYtMTUwcTAgLTYyIDQ0IC0xMDZ0MTA2IC00NGgzMDBxNjIgMCAxMDYgNDR0NDQgMTA2ek00MTIgMjUwbC0yMTIgLTIxMnYxNjJoLTIwMHYxMDBoMjAwdjE2MnoiIC8%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjIxOyIgZD0iTTQ4MCAxMTY1bDY4MiAtNjgzcTMxIC0zMSAzMSAtNzUuNXQtMzEgLTc1LjVsLTEzMSAtMTMxaC00ODFsLTUxNyA1MThxLTMyIDMxIC0zMiA3NS41dDMyIDc1LjVsMjk1IDI5NnEzMSAzMSA3NS41IDMxdDc2LjUgLTMxek0xMDggNzk0bDM0MiAtMzQybDMwMyAzMDRsLTM0MSAzNDF6TTI1MCAxMDBoODAwcTIxIDAgMzUuNSAtMTQuNXQxNC41IC0zNS41di01MGgtOTAwdjUwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXoiIC8%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjM1OyIgZD0iTTU1MCAxMTAwcTYyIDAgMTA2IC00NHQ0NCAtMTA2dC00NCAtMTA2dC0xMDYgLTQ0dC0xMDYgNDR0LTQ0IDEwNnQ0NCAxMDZ0MTA2IDQ0ek01NTAgNzAwcTYyIDAgMTA2IC00NHQ0NCAtMTA2dC00NCAtMTA2dC0xMDYgLTQ0dC0xMDYgNDR0LTQ0IDEwNnQ0NCAxMDZ0MTA2IDQ0ek01NTAgMzAwcTYyIDAgMTA2IC00NHQ0NCAtMTA2dC00NCAtMTA2dC0xMDYgLTQ0dC0xMDYgNDR0LTQ0IDEwNnQ0NCAxMDZ0MTA2IDQ0eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUyMzY7IiBkPSJNMTI1IDExMDBoOTUwcTEwIDAgMTcuNSAtNy41dDcuNSAtMTcuNXYtMTUwcTAgLTEwIC03LjUgLTE3LjV0LTE3LjUgLTcuNWgtOTUwcS0xMCAwIC0xNy41IDcuNXQtNy41IDE3LjV2MTUwcTAgMTAgNy41IDE3LjV0MTcuNSA3LjV6TTEyNSA3MDBoOTUwcTEwIDAgMTcuNSAtNy41dDcuNSAtMTcuNXYtMTUwcTAgLTEwIC03LjUgLTE3LjV0LTE3LjUgLTcuNWgtOTUwcS0xMCAwIC0xNy41IDcuNXQtNy41IDE3LjV2MTUwcTAgMTAgNy41IDE3LjUgdDE3LjUgNy41ek0xMjUgMzAwaDk1MHExMCAwIDE3LjUgLTcuNXQ3LjUgLTE3LjV2LTE1MHEwIC0xMCAtNy41IC0xNy41dC0xNy41IC03LjVoLTk1MHEtMTAgMCAtMTcuNSA3LjV0LTcuNSAxNy41djE1MHEwIDEwIDcuNSAxNy41dDE3LjUgNy41eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUyMzc7IiBkPSJNMzUwIDEyMDBoNTAwcTE2MiAwIDI1NiAtOTMuNXQ5NCAtMjU2LjV2LTUwMHEwIC0xNjUgLTkzLjUgLTI1Ny41dC0yNTYuNSAtOTIuNWgtNTAwcS0xNjUgMCAtMjU3LjUgOTIuNXQtOTIuNSAyNTcuNXY1MDBxMCAxNjUgOTIuNSAyNTcuNXQyNTcuNSA5Mi41ek05MDAgMTAwMGgtNjAwcS00MSAwIC03MC41IC0yOS41dC0yOS41IC03MC41di02MDBxMCAtNDEgMjkuNSAtNzAuNXQ3MC41IC0yOS41aDYwMHE0MSAwIDcwLjUgMjkuNSB0MjkuNSA3MC41djYwMHEwIDQxIC0yOS41IDcwLjV0LTcwLjUgMjkuNXpNMzUwIDkwMGg1MDBxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTMwMHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtNTAwcS0yMSAwIC0zNS41IDE0LjV0LTE0LjUgMzUuNXYzMDBxMCAyMSAxNC41IDM1LjV0MzUuNSAxNC41ek00MDAgODAwdi0yMDBoNDAwdjIwMGgtNDAweiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUyMzg7IiBkPSJNMTUwIDExMDBoMTAwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXQtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtNTB2LTIwMGg1MHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXQtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtNTB2LTIwMGg1MHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXQtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtNTB2LTIwMGg1MHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXQtMTQuNSAtMzUuNSB0LTM1LjUgLTE0LjVoLTEwMDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41dDE0LjUgMzUuNXQzNS41IDE0LjVoNTB2MjAwaC01MHEtMjEgMCAtMzUuNSAxNC41dC0xNC41IDM1LjV0MTQuNSAzNS41dDM1LjUgMTQuNWg1MHYyMDBoLTUwcS0yMSAwIC0zNS41IDE0LjV0LTE0LjUgMzUuNXQxNC41IDM1LjV0MzUuNSAxNC41aDUwdjIwMGgtNTBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41dDE0LjUgMzUuNXQzNS41IDE0LjV6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTIzOTsiIGQ9Ik02NTAgMTE4N3E4NyAtNjcgMTE4LjUgLTE1NnQwIC0xNzh0LTExOC41IC0xNTVxLTg3IDY2IC0xMTguNSAxNTV0MCAxNzh0MTE4LjUgMTU2ek0zMDAgODAwcTEyNCAwIDIxMiAtODh0ODggLTIxMnEtMTI0IDAgLTIxMiA4OHQtODggMjEyek0xMDAwIDgwMHEwIC0xMjQgLTg4IC0yMTJ0LTIxMiAtODhxMCAxMjQgODggMjEydDIxMiA4OHpNMzAwIDUwMHExMjQgMCAyMTIgLTg4dDg4IC0yMTJxLTEyNCAwIC0yMTIgODh0LTg4IDIxMnogTTEwMDAgNTAwcTAgLTEyNCAtODggLTIxMnQtMjEyIC04OHEwIDEyNCA4OCAyMTJ0MjEyIDg4ek03MDAgMTk5di0xNDRxMCAtMjEgLTE0LjUgLTM1LjV0LTM1LjUgLTE0LjV0LTM1LjUgMTQuNXQtMTQuNSAzNS41djE0MnE0MCAtNCA0MyAtNHExNyAwIDU3IDZ6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTI0MDsiIGQ9Ik03NDUgODc4bDY5IDE5cTI1IDYgNDUgLTEybDI5OCAtMjk1cTExIC0xMSAxNSAtMjYuNXQtMiAtMzAuNXEtNSAtMTQgLTE4IC0yMy41dC0yOCAtOS41aC04cTEgMCAxIC0xM3EwIC0yOSAtMiAtNTZ0LTguNSAtNjJ0LTIwIC02M3QtMzMgLTUzdC01MSAtMzl0LTcyLjUgLTE0aC0xNDZxLTE4NCAwIC0xODQgMjg4cTAgMjQgMTAgNDdxLTIwIDQgLTYyIDR0LTYzIC00cTExIC0yNCAxMSAtNDdxMCAtMjg4IC0xODQgLTI4OGgtMTQyIHEtNDggMCAtODQuNSAyMXQtNTYgNTF0LTMyIDcxLjV0LTE2IDc1dC0zLjUgNjguNXEwIDEzIDIgMTNoLTdxLTE1IDAgLTI3LjUgOS41dC0xOC41IDIzLjVxLTYgMTUgLTIgMzAuNXQxNSAyNS41bDI5OCAyOTZxMjAgMTggNDYgMTFsNzYgLTE5cTIwIC01IDMwLjUgLTIyLjV0NS41IC0zNy41dC0yMi41IC0zMXQtMzcuNSAtNWwtNTEgMTJsLTE4MiAtMTkzaDg5MWwtMTgyIDE5M2wtNDQgLTEycS0yMCAtNSAtMzcuNSA2dC0yMi41IDMxdDYgMzcuNSB0MzEgMjIuNXoiIC8%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjQ2OyIgZD0iTTUwIDEwMDBoNDAwcTIxIDAgMzUuNSAtMTQuNXQxNC41IC0zNS41di0zNTBoMTAwdjE1MHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjVoNDAwcTIxIDAgMzUuNSAtMTQuNXQxNC41IC0zNS41di0xNTBoMTAwdi0xMDBoLTEwMHYtMTUwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC00MDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djE1MGgtMTAwdi0zNTBxMCAtMjEgLTE0LjUgLTM1LjV0LTM1LjUgLTE0LjVoLTQwMCBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djgwMHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjV6TTcwMCA3MDB2LTMwMGgzMDB2MzAwaC0zMDB6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTI0NzsiIGQ9Ik0xMDAgMGgtMTAwdjEyMDBoMTAwdi0xMjAwek0yNTAgMTEwMGg0MDBxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTQwMHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtNDAwcS0yMSAwIC0zNS41IDE0LjV0LTE0LjUgMzUuNXY0MDBxMCAyMSAxNC41IDM1LjV0MzUuNSAxNC41ek0zMDAgMTAwMHYtMzAwaDMwMHYzMDBoLTMwMHpNMjUwIDUwMGg5MDBxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTQwMCBxMCAtMjEgLTE0LjUgLTM1LjV0LTM1LjUgLTE0LjVoLTkwMHEtMjEgMCAtMzUuNSAxNC41dC0xNC41IDM1LjV2NDAwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXoiIC8%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjUwOyIgZD0iTTg2NSA1NjVsLTQ5NCAtNDk0cS0yMyAtMjMgLTQxIC0yM3EtMTQgMCAtMjIgMTMuNXQtOCAzOC41djEwMDBxMCAyNSA4IDM4LjV0MjIgMTMuNXExOCAwIDQxIC0yM2w0OTQgLTQ5NHExNCAtMTQgMTQgLTM1dC0xNCAtMzV6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTI1MTsiIGQ9Ik0zMzUgNjM1bDQ5NCA0OTRxMjkgMjkgNTAgMjAuNXQyMSAtNDkuNXYtMTAwMHEwIC00MSAtMjEgLTQ5LjV0LTUwIDIwLjVsLTQ5NCA0OTRxLTE0IDE0IC0xNCAzNXQxNCAzNXoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjUyOyIgZD0iTTEwMCA5MDBoMTAwMHE0MSAwIDQ5LjUgLTIxdC0yMC41IC01MGwtNDk0IC00OTRxLTE0IC0xNCAtMzUgLTE0dC0zNSAxNGwtNDk0IDQ5NHEtMjkgMjkgLTIwLjUgNTB0NDkuNSAyMXoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjUzOyIgZD0iTTYzNSA4NjVsNDk0IC00OTRxMjkgLTI5IDIwLjUgLTUwdC00OS41IC0yMWgtMTAwMHEtNDEgMCAtNDkuNSAyMXQyMC41IDUwbDQ5NCA0OTRxMTQgMTQgMzUgMTR0MzUgLTE0eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUyNTQ7IiBkPSJNNzAwIDc0MXYtMTgybC02OTIgLTMyM3YyMjFsNDEzIDE5M2wtNDEzIDE5M3YyMjF6TTEyMDAgMGgtODAwdjIwMGg4MDB2LTIwMHoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjU1OyIgZD0iTTEyMDAgOTAwaC0yMDB2LTEwMGgyMDB2LTEwMGgtMzAwdjMwMGgyMDB2MTAwaC0yMDB2MTAwaDMwMHYtMzAwek0wIDcwMGg1MHEwIDIxIDQgMzd0OS41IDI2LjV0MTggMTcuNXQyMiAxMXQyOC41IDUuNXQzMSAydDM3IDAuNWgxMDB2LTU1MHEwIC0yMiAtMjUgLTM0LjV0LTUwIC0xMy41bC0yNSAtMnYtMTAwaDQwMHYxMDBxLTQgMCAtMTEgMC41dC0yNCAzdC0zMCA3dC0yNCAxNXQtMTEgMjQuNXY1NTBoMTAwcTI1IDAgMzcgLTAuNXQzMSAtMiB0MjguNSAtNS41dDIyIC0xMXQxOCAtMTcuNXQ5LjUgLTI2LjV0NCAtMzdoNTB2MzAwaC04MDB2LTMwMHoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjU2OyIgZD0iTTgwMCA3MDBoLTUwcTAgMjEgLTQgMzd0LTkuNSAyNi41dC0xOCAxNy41dC0yMiAxMXQtMjguNSA1LjV0LTMxIDJ0LTM3IDAuNWgtMTAwdi01NTBxMCAtMjIgMjUgLTM0LjV0NTAgLTE0LjVsMjUgLTF2LTEwMGgtNDAwdjEwMHE0IDAgMTEgMC41dDI0IDN0MzAgN3QyNCAxNXQxMSAyNC41djU1MGgtMTAwcS0yNSAwIC0zNyAtMC41dC0zMSAtMnQtMjguNSAtNS41dC0yMiAtMTF0LTE4IC0xNy41dC05LjUgLTI2LjV0LTQgLTM3aC01MHYzMDAgaDgwMHYtMzAwek0xMTAwIDIwMGgtMjAwdi0xMDBoMjAwdi0xMDBoLTMwMHYzMDBoMjAwdjEwMGgtMjAwdjEwMGgzMDB2LTMwMHoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjU3OyIgZD0iTTcwMSAxMDk4aDE2MHExNiAwIDIxIC0xMXQtNyAtMjNsLTQ2NCAtNDY0bDQ2NCAtNDY0cTEyIC0xMiA3IC0yM3QtMjEgLTExaC0xNjBxLTEzIDAgLTIzIDlsLTQ3MSA0NzFxLTcgOCAtNyAxOHQ3IDE4bDQ3MSA0NzFxMTAgOSAyMyA5eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUyNTg7IiBkPSJNMzM5IDEwOThoMTYwcTEzIDAgMjMgLTlsNDcxIC00NzFxNyAtOCA3IC0xOHQtNyAtMThsLTQ3MSAtNDcxcS0xMCAtOSAtMjMgLTloLTE2MHEtMTYgMCAtMjEgMTF0NyAyM2w0NjQgNDY0bC00NjQgNDY0cS0xMiAxMiAtNyAyM3QyMSAxMXoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjU5OyIgZD0iTTEwODcgODgycTExIC01IDExIC0yMXYtMTYwcTAgLTEzIC05IC0yM2wtNDcxIC00NzFxLTggLTcgLTE4IC03dC0xOCA3bC00NzEgNDcxcS05IDEwIC05IDIzdjE2MHEwIDE2IDExIDIxdDIzIC03bDQ2NCAtNDY0bDQ2NCA0NjRxMTIgMTIgMjMgN3oiIC8%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%2BCjwvZGVmcz48L3N2Zz4g%29%20format%28%27svg%27%29%7D%2Eglyphicon%7Bposition%3Arelative%3Btop%3A1px%3Bdisplay%3Ainline%2Dblock%3Bfont%2Dfamily%3A%27Glyphicons%20Halflings%27%3Bfont%2Dstyle%3Anormal%3Bfont%2Dweight%3A400%3Bline%2Dheight%3A1%3B%2Dwebkit%2Dfont%2Dsmoothing%3Aantialiased%3B%2Dmoz%2Dosx%2Dfont%2Dsmoothing%3Agrayscale%7D%2Eglyphicon%2Dasterisk%3Abefore%7Bcontent%3A%22%5C2a%22%7D%2Eglyphicon%2Dplus%3Abefore%7Bcontent%3A%22%5C2b%22%7D%2Eglyphicon%2Deur%3Abefore%2C%2Eglyphicon%2Deuro%3Abefore%7Bcontent%3A%22%5C20ac%22%7D%2Eglyphicon%2Dminus%3Abefore%7Bcontent%3A%22%5C2212%22%7D%2Eglyphicon%2Dcloud%3Abefore%7Bcontent%3A%22%5C2601%22%7D%2Eglyphicon%2Denvelope%3Abefore%7Bcontent%3A%22%5C2709%22%7D%2Eglyphicon%2Dpencil%3Abefore%7Bcontent%3A%22%5C270f%22%7D%2Eglyphicon%2Dglass%3Abefore%7Bcontent%3A%22%5Ce001%22%7D%2Eglyphicon%2Dmusic%3Abefore%7Bcontent%3A%22%5Ce002%22%7D%2Eglyphicon%2Dsearch%3Abefore%7Bcontent%3A%22%5Ce003%22%7D%2Eglyphicon%2Dheart%3Abefore%7Bcontent%3A%22%5Ce005%22%7D%2Eglyphicon%2Dstar%3Abefore%7Bcontent%3A%22%5Ce006%22%7D%2Eglyphicon%2Dstar%2Dempty%3Abefore%7Bcontent%3A%22%5Ce007%22%7D%2Eglyphicon%2Duser%3Abefore%7Bcontent%3A%22%5Ce008%22%7D%2Eglyphicon%2Dfilm%3Abefore%7Bcontent%3A%22%5Ce009%22%7D%2Eglyphicon%2Dth%2Dlarge%3Abefore%7Bcontent%3A%22%5Ce010%22%7D%2Eglyphicon%2Dth%3Abefore%7Bcontent%3A%22%5Ce011%22%7D%2Eglyphicon%2Dth%2Dlist%3Abefore%7Bcontent%3A%22%5Ce012%22%7D%2Eglyphicon%2Dok%3Abefore%7Bcontent%3A%22%5Ce013%22%7D%2Eglyphicon%2Dremove%3Abefore%7Bcontent%3A%22%5Ce014%22%7D%2Eglyphicon%2Dzoom%2Din%3Abefore%7Bcontent%3A%22%5Ce015%22%7D%2Eglyphicon%2Dzoom%2Dout%3Abefore%7Bcontent%3A%22%5Ce016%22%7D%2Eglyphicon%2Doff%3Abefore%7Bcontent%3A%22%5Ce017%22%7D%2Eglyphicon%2Dsignal%3Abefore%7Bcontent%3A%22%5Ce018%22%7D%2Eglyphicon%2Dcog%3Abefore%7Bcontent%3A%22%5Ce019%22%7D%2Eglyphicon%2Dtrash%3Abefore%7Bcontent%3A%22%5Ce020%22%7D%2Eglyphicon%2Dhome%3Abefore%7Bcontent%3A%22%5Ce021%22%7D%2Eglyphicon%2Dfile%3Abefore%7Bcontent%3A%22%5Ce022%22%7D%2Eglyphicon%2Dtime%3Abefore%7Bcontent%3A%22%5Ce023%22%7D%2Eglyphicon%2Droad%3Abefore%7Bcontent%3A%22%5Ce024%22%7D%2Eglyphicon%2Ddownload%2Dalt%3Abefore%7Bcontent%3A%22%5Ce025%22%7D%2Eglyphicon%2Ddownload%3Abefore%7Bcontent%3A%22%5Ce026%22%7D%2Eglyphicon%2Dupload%3Abefore%7Bcontent%3A%22%5Ce027%22%7D%2Eglyphicon%2Dinbox%3Abefore%7Bcontent%3A%22%5Ce028%22%7D%2Eglyphicon%2Dplay%2Dcircle%3Abefore%7Bcontent%3A%22%5Ce029%22%7D%2Eglyphicon%2Drepeat%3Abefore%7Bcontent%3A%22%5Ce030%22%7D%2Eglyphicon%2Drefresh%3Abefore%7Bcontent%3A%22%5Ce031%22%7D%2Eglyphicon%2Dlist%2Dalt%3Abefore%7Bcontent%3A%22%5Ce032%22%7D%2Eglyphicon%2Dlock%3Abefore%7Bcontent%3A%22%5Ce033%22%7D%2Eglyphicon%2Dflag%3Abefore%7Bcontent%3A%22%5Ce034%22%7D%2Eglyphicon%2Dheadphones%3Abefore%7Bcontent%3A%22%5Ce035%22%7D%2Eglyphicon%2Dvolume%2Doff%3Abefore%7Bcontent%3A%22%5Ce036%22%7D%2Eglyphicon%2Dvolume%2Ddown%3Abefore%7Bcontent%3A%22%5Ce037%22%7D%2Eglyphicon%2Dvolume%2Dup%3Abefore%7Bcontent%3A%22%5Ce038%22%7D%2Eglyphicon%2Dqrcode%3Abefore%7Bcontent%3A%22%5Ce039%22%7D%2Eglyphicon%2Dbarcode%3Abefore%7Bcontent%3A%22%5Ce040%22%7D%2Eglyphicon%2Dtag%3Abefore%7Bcontent%3A%22%5Ce041%22%7D%2Eglyphicon%2Dtags%3Abefore%7Bcontent%3A%22%5Ce042%22%7D%2Eglyphicon%2Dbook%3Abefore%7Bcontent%3A%22%5Ce043%22%7D%2Eglyphicon%2Dbookmark%3Abefore%7Bcontent%3A%22%5Ce044%22%7D%2Eglyphicon%2Dprint%3Abefore%7Bcontent%3A%22%5Ce045%22%7D%2Eglyphicon%2Dcamera%3Abefore%7Bcontent%3A%22%5Ce046%22%7D%2Eglyphicon%2Dfont%3Abefore%7Bcontent%3A%22%5Ce047%22%7D%2Eglyphicon%2Dbold%3Abefore%7Bcontent%3A%22%5Ce048%22%7D%2Eglyphicon%2Ditalic%3Abefore%7Bcontent%3A%22%5Ce049%22%7D%2Eglyphicon%2Dtext%2Dheight%3Abefore%7Bcontent%3A%22%5Ce050%22%7D%2Eglyphicon%2Dtext%2Dwidth%3Abefore%7Bcontent%3A%22%5Ce051%22%7D%2Eglyphicon%2Dalign%2Dleft%3Abefore%7Bcontent%3A%22%5Ce052%22%7D%2Eglyphicon%2Dalign%2Dcenter%3Abefore%7Bcontent%3A%22%5Ce053%22%7D%2Eglyphicon%2Dalign%2Dright%3Abefore%7Bcontent%3A%22%5Ce054%22%7D%2Eglyphicon%2Dalign%2Djustify%3Abefore%7Bcontent%3A%22%5Ce055%22%7D%2Eglyphicon%2Dlist%3Abefore%7Bcontent%3A%22%5Ce056%22%7D%2Eglyphicon%2Dindent%2Dleft%3Abefore%7Bcontent%3A%22%5Ce057%22%7D%2Eglyphicon%2Dindent%2Dright%3Abefore%7Bcontent%3A%22%5Ce058%22%7D%2Eglyphicon%2Dfacetime%2Dvideo%3Abefore%7Bcontent%3A%22%5Ce059%22%7D%2Eglyphicon%2Dpicture%3Abefore%7Bcontent%3A%22%5Ce060%22%7D%2Eglyphicon%2Dmap%2Dmarker%3Abefore%7Bcontent%3A%22%5Ce062%22%7D%2Eglyphicon%2Dadjust%3Abefore%7Bcontent%3A%22%5Ce063%22%7D%2Eglyphicon%2Dtint%3Abefore%7Bcontent%3A%22%5Ce064%22%7D%2Eglyphicon%2Dedit%3Abefore%7Bcontent%3A%22%5Ce065%22%7D%2Eglyphicon%2Dshare%3Abefore%7Bcontent%3A%22%5Ce066%22%7D%2Eglyphicon%2Dcheck%3Abefore%7Bcontent%3A%22%5Ce067%22%7D%2Eglyphicon%2Dmove%3Abefore%7Bcontent%3A%22%5Ce068%22%7D%2Eglyphicon%2Dstep%2Dbackward%3Abefore%7Bcontent%3A%22%5Ce069%22%7D%2Eglyphicon%2Dfast%2Dbackward%3Abefore%7Bcontent%3A%22%5Ce070%22%7D%2Eglyphicon%2Dbackward%3Abefore%7Bcontent%3A%22%5Ce071%22%7D%2Eglyphicon%2Dplay%3Abefore%7Bcontent%3A%22%5Ce072%22%7D%2Eglyphicon%2Dpause%3Abefore%7Bcontent%3A%22%5Ce073%22%7D%2Eglyphicon%2Dstop%3Abefore%7Bcontent%3A%22%5Ce074%22%7D%2Eglyphicon%2Dforward%3Abefore%7Bcontent%3A%22%5Ce075%22%7D%2Eglyphicon%2Dfast%2Dforward%3Abefore%7Bcontent%3A%22%5Ce076%22%7D%2Eglyphicon%2Dstep%2Dforward%3Abefore%7Bcontent%3A%22%5Ce077%22%7D%2Eglyphicon%2Deject%3Abefore%7Bcontent%3A%22%5Ce078%22%7D%2Eglyphicon%2Dchevron%2Dleft%3Abefore%7Bcontent%3A%22%5Ce079%22%7D%2Eglyphicon%2Dchevron%2Dright%3Abefore%7Bcontent%3A%22%5Ce080%22%7D%2Eglyphicon%2Dplus%2Dsign%3Abefore%7Bcontent%3A%22%5Ce081%22%7D%2Eglyphicon%2Dminus%2Dsign%3Abefore%7Bcontent%3A%22%5Ce082%22%7D%2Eglyphicon%2Dremove%2Dsign%3Abefore%7Bcontent%3A%22%5Ce083%22%7D%2Eglyphicon%2Dok%2Dsign%3Abefore%7Bcontent%3A%22%5Ce084%22%7D%2Eglyphicon%2Dquestion%2Dsign%3Abefore%7Bcontent%3A%22%5Ce085%22%7D%2Eglyphicon%2Dinfo%2Dsign%3Abefore%7Bcontent%3A%22%5Ce086%22%7D%2Eglyphicon%2Dscreenshot%3Abefore%7Bcontent%3A%22%5Ce087%22%7D%2Eglyphicon%2Dremove%2Dcircle%3Abefore%7Bcontent%3A%22%5Ce088%22%7D%2Eglyphicon%2Dok%2Dcircle%3Abefore%7Bcontent%3A%22%5Ce089%22%7D%2Eglyphicon%2Dban%2Dcircle%3Abefore%7Bcontent%3A%22%5Ce090%22%7D%2Eglyphicon%2Darrow%2Dleft%3Abefore%7Bcontent%3A%22%5Ce091%22%7D%2Eglyphicon%2Darrow%2Dright%3Abefore%7Bcontent%3A%22%5Ce092%22%7D%2Eglyphicon%2Darrow%2Dup%3Abefore%7Bcontent%3A%22%5Ce093%22%7D%2Eglyphicon%2Darrow%2Ddown%3Abefore%7Bcontent%3A%22%5Ce094%22%7D%2Eglyphicon%2Dshare%2Dalt%3Abefore%7Bcontent%3A%22%5Ce095%22%7D%2Eglyphicon%2Dresize%2Dfull%3Abefore%7Bcontent%3A%22%5Ce096%22%7D%2Eglyphicon%2Dresize%2Dsmall%3Abefore%7Bcontent%3A%22%5Ce097%22%7D%2Eglyphicon%2Dexclamation%2Dsign%3Abefore%7Bcontent%3A%22%5Ce101%22%7D%2Eglyphicon%2Dgift%3Abefore%7Bcontent%3A%22%5Ce102%22%7D%2Eglyphicon%2Dleaf%3Abefore%7Bcontent%3A%22%5Ce103%22%7D%2Eglyphicon%2Dfire%3Abefore%7Bcontent%3A%22%5Ce104%22%7D%2Eglyphicon%2Deye%2Dopen%3Abefore%7Bcontent%3A%22%5Ce105%22%7D%2Eglyphicon%2Deye%2Dclose%3Abefore%7Bcontent%3A%22%5Ce106%22%7D%2Eglyphicon%2Dwarning%2Dsign%3Abefore%7Bcontent%3A%22%5Ce107%22%7D%2Eglyphicon%2Dplane%3Abefore%7Bcontent%3A%22%5Ce108%22%7D%2Eglyphicon%2Dcalendar%3Abefore%7Bcontent%3A%22%5Ce109%22%7D%2Eglyphicon%2Drandom%3Abefore%7Bcontent%3A%22%5Ce110%22%7D%2Eglyphicon%2Dcomment%3Abefore%7Bcontent%3A%22%5Ce111%22%7D%2Eglyphicon%2Dmagnet%3Abefore%7Bcontent%3A%22%5Ce112%22%7D%2Eglyphicon%2Dchevron%2Dup%3Abefore%7Bcontent%3A%22%5Ce113%22%7D%2Eglyphicon%2Dchevron%2Ddown%3Abefore%7Bcontent%3A%22%5Ce114%22%7D%2Eglyphicon%2Dretweet%3Abefore%7Bcontent%3A%22%5Ce115%22%7D%2Eglyphicon%2Dshopping%2Dcart%3Abefore%7Bcontent%3A%22%5Ce116%22%7D%2Eglyphicon%2Dfolder%2Dclose%3Abefore%7Bcontent%3A%22%5Ce117%22%7D%2Eglyphicon%2Dfolder%2Dopen%3Abefore%7Bcontent%3A%22%5Ce118%22%7D%2Eglyphicon%2Dresize%2Dvertical%3Abefore%7Bcontent%3A%22%5Ce119%22%7D%2Eglyphicon%2Dresize%2Dhorizontal%3Abefore%7Bcontent%3A%22%5Ce120%22%7D%2Eglyphicon%2Dhdd%3Abefore%7Bcontent%3A%22%5Ce121%22%7D%2Eglyphicon%2Dbullhorn%3Abefore%7Bcontent%3A%22%5Ce122%22%7D%2Eglyphicon%2Dbell%3Abefore%7Bcontent%3A%22%5Ce123%22%7D%2Eglyphicon%2Dcertificate%3Abefore%7Bcontent%3A%22%5Ce124%22%7D%2Eglyphicon%2Dthumbs%2Dup%3Abefore%7Bcontent%3A%22%5Ce125%22%7D%2Eglyphicon%2Dthumbs%2Ddown%3Abefore%7Bcontent%3A%22%5Ce126%22%7D%2Eglyphicon%2Dhand%2Dright%3Abefore%7Bcontent%3A%22%5Ce127%22%7D%2Eglyphicon%2Dhand%2Dleft%3Abefore%7Bcontent%3A%22%5Ce128%22%7D%2Eglyphicon%2Dhand%2Dup%3Abefore%7Bcontent%3A%22%5Ce129%22%7D%2Eglyphicon%2Dhand%2Ddown%3Abefore%7Bcontent%3A%22%5Ce130%22%7D%2Eglyphicon%2Dcircle%2Darrow%2Dright%3Abefore%7Bcontent%3A%22%5Ce131%22%7D%2Eglyphicon%2Dcircle%2Darrow%2Dleft%3Abefore%7Bcontent%3A%22%5Ce132%22%7D%2Eglyphicon%2Dcircle%2Darrow%2Dup%3Abefore%7Bcontent%3A%22%5Ce133%22%7D%2Eglyphicon%2Dcircle%2Darrow%2Ddown%3Abefore%7Bcontent%3A%22%5Ce134%22%7D%2Eglyphicon%2Dglobe%3Abefore%7Bcontent%3A%22%5Ce135%22%7D%2Eglyphicon%2Dwrench%3Abefore%7Bcontent%3A%22%5Ce136%22%7D%2Eglyphicon%2Dtasks%3Abefore%7Bcontent%3A%22%5Ce137%22%7D%2Eglyphicon%2Dfilter%3Abefore%7Bcontent%3A%22%5Ce138%22%7D%2Eglyphicon%2Dbriefcase%3Abefore%7Bcontent%3A%22%5Ce139%22%7D%2Eglyphicon%2Dfullscreen%3Abefore%7Bcontent%3A%22%5Ce140%22%7D%2Eglyphicon%2Ddashboard%3Abefore%7Bcontent%3A%22%5Ce141%22%7D%2Eglyphicon%2Dpaperclip%3Abefore%7Bcontent%3A%22%5Ce142%22%7D%2Eglyphicon%2Dheart%2Dempty%3Abefore%7Bcontent%3A%22%5Ce143%22%7D%2Eglyphicon%2Dlink%3Abefore%7Bcontent%3A%22%5Ce144%22%7D%2Eglyphicon%2Dphone%3Abefore%7Bcontent%3A%22%5Ce145%22%7D%2Eglyphicon%2Dpushpin%3Abefore%7Bcontent%3A%22%5Ce146%22%7D%2Eglyphicon%2Dusd%3Abefore%7Bcontent%3A%22%5Ce148%22%7D%2Eglyphicon%2Dgbp%3Abefore%7Bcontent%3A%22%5Ce149%22%7D%2Eglyphicon%2Dsort%3Abefore%7Bcontent%3A%22%5Ce150%22%7D%2Eglyphicon%2Dsort%2Dby%2Dalphabet%3Abefore%7Bcontent%3A%22%5Ce151%22%7D%2Eglyphicon%2Dsort%2Dby%2Dalphabet%2Dalt%3Abefore%7Bcontent%3A%22%5Ce152%22%7D%2Eglyphicon%2Dsort%2Dby%2Dorder%3Abefore%7Bcontent%3A%22%5Ce153%22%7D%2Eglyphicon%2Dsort%2Dby%2Dorder%2Dalt%3Abefore%7Bcontent%3A%22%5Ce154%22%7D%2Eglyphicon%2Dsort%2Dby%2Dattributes%3Abefore%7Bcontent%3A%22%5Ce155%22%7D%2Eglyphicon%2Dsort%2Dby%2Dattributes%2Dalt%3Abefore%7Bcontent%3A%22%5Ce156%22%7D%2Eglyphicon%2Dunchecked%3Abefore%7Bcontent%3A%22%5Ce157%22%7D%2Eglyphicon%2Dexpand%3Abefore%7Bcontent%3A%22%5Ce158%22%7D%2Eglyphicon%2Dcollapse%2Ddown%3Abefore%7Bcontent%3A%22%5Ce159%22%7D%2Eglyphicon%2Dcollapse%2Dup%3Abefore%7Bcontent%3A%22%5Ce160%22%7D%2Eglyphicon%2Dlog%2Din%3Abefore%7Bcontent%3A%22%5Ce161%22%7D%2Eglyphicon%2Dflash%3Abefore%7Bcontent%3A%22%5Ce162%22%7D%2Eglyphicon%2Dlog%2Dout%3Abefore%7Bcontent%3A%22%5Ce163%22%7D%2Eglyphicon%2Dnew%2Dwindow%3Abefore%7Bcontent%3A%22%5Ce164%22%7D%2Eglyphicon%2Drecord%3Abefore%7Bcontent%3A%22%5Ce165%22%7D%2Eglyphicon%2Dsave%3Abefore%7Bcontent%3A%22%5Ce166%22%7D%2Eglyphicon%2Dopen%3Abefore%7Bcontent%3A%22%5Ce167%22%7D%2Eglyphicon%2Dsaved%3Abefore%7Bcontent%3A%22%5Ce168%22%7D%2Eglyphicon%2Dimport%3Abefore%7Bcontent%3A%22%5Ce169%22%7D%2Eglyphicon%2Dexport%3Abefore%7Bcontent%3A%22%5Ce170%22%7D%2Eglyphicon%2Dsend%3Abefore%7Bcontent%3A%22%5Ce171%22%7D%2Eglyphicon%2Dfloppy%2Ddisk%3Abefore%7Bcontent%3A%22%5Ce172%22%7D%2Eglyphicon%2Dfloppy%2Dsaved%3Abefore%7Bcontent%3A%22%5Ce173%22%7D%2Eglyphicon%2Dfloppy%2Dremove%3Abefore%7Bcontent%3A%22%5Ce174%22%7D%2Eglyphicon%2Dfloppy%2Dsave%3Abefore%7Bcontent%3A%22%5Ce175%22%7D%2Eglyphicon%2Dfloppy%2Dopen%3Abefore%7Bcontent%3A%22%5Ce176%22%7D%2Eglyphicon%2Dcredit%2Dcard%3Abefore%7Bcontent%3A%22%5Ce177%22%7D%2Eglyphicon%2Dtransfer%3Abefore%7Bcontent%3A%22%5Ce178%22%7D%2Eglyphicon%2Dcutlery%3Abefore%7Bcontent%3A%22%5Ce179%22%7D%2Eglyphicon%2Dheader%3Abefore%7Bcontent%3A%22%5Ce180%22%7D%2Eglyphicon%2Dcompressed%3Abefore%7Bcontent%3A%22%5Ce181%22%7D%2Eglyphicon%2Dearphone%3Abefore%7Bcontent%3A%22%5Ce182%22%7D%2Eglyphicon%2Dphone%2Dalt%3Abefore%7Bcontent%3A%22%5Ce183%22%7D%2Eglyphicon%2Dtower%3Abefore%7Bcontent%3A%22%5Ce184%22%7D%2Eglyphicon%2Dstats%3Abefore%7Bcontent%3A%22%5Ce185%22%7D%2Eglyphicon%2Dsd%2Dvideo%3Abefore%7Bcontent%3A%22%5Ce186%22%7D%2Eglyphicon%2Dhd%2Dvideo%3Abefore%7Bcontent%3A%22%5Ce187%22%7D%2Eglyphicon%2Dsubtitles%3Abefore%7Bcontent%3A%22%5Ce188%22%7D%2Eglyphicon%2Dsound%2Dstereo%3Abefore%7Bcontent%3A%22%5Ce189%22%7D%2Eglyphicon%2Dsound%2Ddolby%3Abefore%7Bcontent%3A%22%5Ce190%22%7D%2Eglyphicon%2Dsound%2D5%2D1%3Abefore%7Bcontent%3A%22%5Ce191%22%7D%2Eglyphicon%2Dsound%2D6%2D1%3Abefore%7Bcontent%3A%22%5Ce192%22%7D%2Eglyphicon%2Dsound%2D7%2D1%3Abefore%7Bcontent%3A%22%5Ce193%22%7D%2Eglyphicon%2Dcopyright%2Dmark%3Abefore%7Bcontent%3A%22%5Ce194%22%7D%2Eglyphicon%2Dregistration%2Dmark%3Abefore%7Bcontent%3A%22%5Ce195%22%7D%2Eglyphicon%2Dcloud%2Ddownload%3Abefore%7Bcontent%3A%22%5Ce197%22%7D%2Eglyphicon%2Dcloud%2Dupload%3Abefore%7Bcontent%3A%22%5Ce198%22%7D%2Eglyphicon%2Dtree%2Dconifer%3Abefore%7Bcontent%3A%22%5Ce199%22%7D%2Eglyphicon%2Dtree%2Ddeciduous%3Abefore%7Bcontent%3A%22%5Ce200%22%7D%2Eglyphicon%2Dcd%3Abefore%7Bcontent%3A%22%5Ce201%22%7D%2Eglyphicon%2Dsave%2Dfile%3Abefore%7Bcontent%3A%22%5Ce202%22%7D%2Eglyphicon%2Dopen%2Dfile%3Abefore%7Bcontent%3A%22%5Ce203%22%7D%2Eglyphicon%2Dlevel%2Dup%3Abefore%7Bcontent%3A%22%5Ce204%22%7D%2Eglyphicon%2Dcopy%3Abefore%7Bcontent%3A%22%5Ce205%22%7D%2Eglyphicon%2Dpaste%3Abefore%7Bcontent%3A%22%5Ce206%22%7D%2Eglyphicon%2Dalert%3Abefore%7Bcontent%3A%22%5Ce209%22%7D%2Eglyphicon%2Dequalizer%3Abefore%7Bcontent%3A%22%5Ce210%22%7D%2Eglyphicon%2Dking%3Abefore%7Bcontent%3A%22%5Ce211%22%7D%2Eglyphicon%2Dqueen%3Abefore%7Bcontent%3A%22%5Ce212%22%7D%2Eglyphicon%2Dpawn%3Abefore%7Bcontent%3A%22%5Ce213%22%7D%2Eglyphicon%2Dbishop%3Abefore%7Bcontent%3A%22%5Ce214%22%7D%2Eglyphicon%2Dknight%3Abefore%7Bcontent%3A%22%5Ce215%22%7D%2Eglyphicon%2Dbaby%2Dformula%3Abefore%7Bcontent%3A%22%5Ce216%22%7D%2Eglyphicon%2Dtent%3Abefore%7Bcontent%3A%22%5C26fa%22%7D%2Eglyphicon%2Dblackboard%3Abefore%7Bcontent%3A%22%5Ce218%22%7D%2Eglyphicon%2Dbed%3Abefore%7Bcontent%3A%22%5Ce219%22%7D%2Eglyphicon%2Dapple%3Abefore%7Bcontent%3A%22%5Cf8ff%22%7D%2Eglyphicon%2Derase%3Abefore%7Bcontent%3A%22%5Ce221%22%7D%2Eglyphicon%2Dhourglass%3Abefore%7Bcontent%3A%22%5C231b%22%7D%2Eglyphicon%2Dlamp%3Abefore%7Bcontent%3A%22%5Ce223%22%7D%2Eglyphicon%2Dduplicate%3Abefore%7Bcontent%3A%22%5Ce224%22%7D%2Eglyphicon%2Dpiggy%2Dbank%3Abefore%7Bcontent%3A%22%5Ce225%22%7D%2Eglyphicon%2Dscissors%3Abefore%7Bcontent%3A%22%5Ce226%22%7D%2Eglyphicon%2Dbitcoin%3Abefore%7Bcontent%3A%22%5Ce227%22%7D%2Eglyphicon%2Dbtc%3Abefore%7Bcontent%3A%22%5Ce227%22%7D%2Eglyphicon%2Dxbt%3Abefore%7Bcontent%3A%22%5Ce227%22%7D%2Eglyphicon%2Dyen%3Abefore%7Bcontent%3A%22%5C00a5%22%7D%2Eglyphicon%2Djpy%3Abefore%7Bcontent%3A%22%5C00a5%22%7D%2Eglyphicon%2Druble%3Abefore%7Bcontent%3A%22%5C20bd%22%7D%2Eglyphicon%2Drub%3Abefore%7Bcontent%3A%22%5C20bd%22%7D%2Eglyphicon%2Dscale%3Abefore%7Bcontent%3A%22%5Ce230%22%7D%2Eglyphicon%2Dice%2Dlolly%3Abefore%7Bcontent%3A%22%5Ce231%22%7D%2Eglyphicon%2Dice%2Dlolly%2Dtasted%3Abefore%7Bcontent%3A%22%5Ce232%22%7D%2Eglyphicon%2Deducation%3Abefore%7Bcontent%3A%22%5Ce233%22%7D%2Eglyphicon%2Doption%2Dhorizontal%3Abefore%7Bcontent%3A%22%5Ce234%22%7D%2Eglyphicon%2Doption%2Dvertical%3Abefore%7Bcontent%3A%22%5Ce235%22%7D%2Eglyphicon%2Dmenu%2Dhamburger%3Abefore%7Bcontent%3A%22%5Ce236%22%7D%2Eglyphicon%2Dmodal%2Dwindow%3Abefore%7Bcontent%3A%22%5Ce237%22%7D%2Eglyphicon%2Doil%3Abefore%7Bcontent%3A%22%5Ce238%22%7D%2Eglyphicon%2Dgrain%3Abefore%7Bcontent%3A%22%5Ce239%22%7D%2Eglyphicon%2Dsunglasses%3Abefore%7Bcontent%3A%22%5Ce240%22%7D%2Eglyphicon%2Dtext%2Dsize%3Abefore%7Bcontent%3A%22%5Ce241%22%7D%2Eglyphicon%2Dtext%2Dcolor%3Abefore%7Bcontent%3A%22%5Ce242%22%7D%2Eglyphicon%2Dtext%2Dbackground%3Abefore%7Bcontent%3A%22%5Ce243%22%7D%2Eglyphicon%2Dobject%2Dalign%2Dtop%3Abefore%7Bcontent%3A%22%5Ce244%22%7D%2Eglyphicon%2Dobject%2Dalign%2Dbottom%3Abefore%7Bcontent%3A%22%5Ce245%22%7D%2Eglyphicon%2Dobject%2Dalign%2Dhorizontal%3Abefore%7Bcontent%3A%22%5Ce246%22%7D%2Eglyphicon%2Dobject%2Dalign%2Dleft%3Abefore%7Bcontent%3A%22%5Ce247%22%7D%2Eglyphicon%2Dobject%2Dalign%2Dvertical%3Abefore%7Bcontent%3A%22%5Ce248%22%7D%2Eglyphicon%2Dobject%2Dalign%2Dright%3Abefore%7Bcontent%3A%22%5Ce249%22%7D%2Eglyphicon%2Dtriangle%2Dright%3Abefore%7Bcontent%3A%22%5Ce250%22%7D%2Eglyphicon%2Dtriangle%2Dleft%3Abefore%7Bcontent%3A%22%5Ce251%22%7D%2Eglyphicon%2Dtriangle%2Dbottom%3Abefore%7Bcontent%3A%22%5Ce252%22%7D%2Eglyphicon%2Dtriangle%2Dtop%3Abefore%7Bcontent%3A%22%5Ce253%22%7D%2Eglyphicon%2Dconsole%3Abefore%7Bcontent%3A%22%5Ce254%22%7D%2Eglyphicon%2Dsuperscript%3Abefore%7Bcontent%3A%22%5Ce255%22%7D%2Eglyphicon%2Dsubscript%3Abefore%7Bcontent%3A%22%5Ce256%22%7D%2Eglyphicon%2Dmenu%2Dleft%3Abefore%7Bcontent%3A%22%5Ce257%22%7D%2Eglyphicon%2Dmenu%2Dright%3Abefore%7Bcontent%3A%22%5Ce258%22%7D%2Eglyphicon%2Dmenu%2Ddown%3Abefore%7Bcontent%3A%22%5Ce259%22%7D%2Eglyphicon%2Dmenu%2Dup%3Abefore%7Bcontent%3A%22%5Ce260%22%7D%2A%7B%2Dwebkit%2Dbox%2Dsizing%3Aborder%2Dbox%3B%2Dmoz%2Dbox%2Dsizing%3Aborder%2Dbox%3Bbox%2Dsizing%3Aborder%2Dbox%7D%3Aafter%2C%3Abefore%7B%2Dwebkit%2Dbox%2Dsizing%3Aborder%2Dbox%3B%2Dmoz%2Dbox%2Dsizing%3Aborder%2Dbox%3Bbox%2Dsizing%3Aborder%2Dbox%7Dhtml%7Bfont%2Dsize%3A10px%3B%2Dwebkit%2Dtap%2Dhighlight%2Dcolor%3Argba%280%2C0%2C0%2C0%29%7Dbody%7Bfont%2Dfamily%3A%22Helvetica%20Neue%22%2CHelvetica%2CArial%2Csans%2Dserif%3Bfont%2Dsize%3A14px%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23333%3Bbackground%2Dcolor%3A%23fff%7Dbutton%2Cinput%2Cselect%2Ctextarea%7Bfont%2Dfamily%3Ainherit%3Bfont%2Dsize%3Ainherit%3Bline%2Dheight%3Ainherit%7Da%7Bcolor%3A%23337ab7%3Btext%2Ddecoration%3Anone%7Da%3Afocus%2Ca%3Ahover%7Bcolor%3A%2323527c%3Btext%2Ddecoration%3Aunderline%7Da%3Afocus%7Boutline%3Athin%20dotted%3Boutline%3A5px%20auto%20%2Dwebkit%2Dfocus%2Dring%2Dcolor%3Boutline%2Doffset%3A%2D2px%7Dfigure%7Bmargin%3A0%7Dimg%7Bvertical%2Dalign%3Amiddle%7D%2Ecarousel%2Dinner%3E%2Eitem%3Ea%3Eimg%2C%2Ecarousel%2Dinner%3E%2Eitem%3Eimg%2C%2Eimg%2Dresponsive%2C%2Ethumbnail%20a%3Eimg%2C%2Ethumbnail%3Eimg%7Bdisplay%3Ablock%3Bmax%2Dwidth%3A100%25%3Bheight%3Aauto%7D%2Eimg%2Drounded%7Bborder%2Dradius%3A6px%7D%2Eimg%2Dthumbnail%7Bdisplay%3Ainline%2Dblock%3Bmax%2Dwidth%3A100%25%3Bheight%3Aauto%3Bpadding%3A4px%3Bline%2Dheight%3A1%2E42857143%3Bbackground%2Dcolor%3A%23fff%3Bborder%3A1px%20solid%20%23ddd%3Bborder%2Dradius%3A4px%3B%2Dwebkit%2Dtransition%3Aall%20%2E2s%20ease%2Din%2Dout%3B%2Do%2Dtransition%3Aall%20%2E2s%20ease%2Din%2Dout%3Btransition%3Aall%20%2E2s%20ease%2Din%2Dout%7D%2Eimg%2Dcircle%7Bborder%2Dradius%3A50%25%7Dhr%7Bmargin%2Dtop%3A20px%3Bmargin%2Dbottom%3A20px%3Bborder%3A0%3Bborder%2Dtop%3A1px%20solid%20%23eee%7D%2Esr%2Donly%7Bposition%3Aabsolute%3Bwidth%3A1px%3Bheight%3A1px%3Bpadding%3A0%3Bmargin%3A%2D1px%3Boverflow%3Ahidden%3Bclip%3Arect%280%2C0%2C0%2C0%29%3Bborder%3A0%7D%2Esr%2Donly%2Dfocusable%3Aactive%2C%2Esr%2Donly%2Dfocusable%3Afocus%7Bposition%3Astatic%3Bwidth%3Aauto%3Bheight%3Aauto%3Bmargin%3A0%3Boverflow%3Avisible%3Bclip%3Aauto%7D%5Brole%3Dbutton%5D%7Bcursor%3Apointer%7D%2Eh1%2C%2Eh2%2C%2Eh3%2C%2Eh4%2C%2Eh5%2C%2Eh6%2Ch1%2Ch2%2Ch3%2Ch4%2Ch5%2Ch6%7Bfont%2Dfamily%3Ainherit%3Bfont%2Dweight%3A500%3Bline%2Dheight%3A1%2E1%3Bcolor%3Ainherit%7D%2Eh1%20%2Esmall%2C%2Eh1%20small%2C%2Eh2%20%2Esmall%2C%2Eh2%20small%2C%2Eh3%20%2Esmall%2C%2Eh3%20small%2C%2Eh4%20%2Esmall%2C%2Eh4%20small%2C%2Eh5%20%2Esmall%2C%2Eh5%20small%2C%2Eh6%20%2Esmall%2C%2Eh6%20small%2Ch1%20%2Esmall%2Ch1%20small%2Ch2%20%2Esmall%2Ch2%20small%2Ch3%20%2Esmall%2Ch3%20small%2Ch4%20%2Esmall%2Ch4%20small%2Ch5%20%2Esmall%2Ch5%20small%2Ch6%20%2Esmall%2Ch6%20small%7Bfont%2Dweight%3A400%3Bline%2Dheight%3A1%3Bcolor%3A%23777%7D%2Eh1%2C%2Eh2%2C%2Eh3%2Ch1%2Ch2%2Ch3%7Bmargin%2Dtop%3A20px%3Bmargin%2Dbottom%3A10px%7D%2Eh1%20%2Esmall%2C%2Eh1%20small%2C%2Eh2%20%2Esmall%2C%2Eh2%20small%2C%2Eh3%20%2Esmall%2C%2Eh3%20small%2Ch1%20%2Esmall%2Ch1%20small%2Ch2%20%2Esmall%2Ch2%20small%2Ch3%20%2Esmall%2Ch3%20small%7Bfont%2Dsize%3A65%25%7D%2Eh4%2C%2Eh5%2C%2Eh6%2Ch4%2Ch5%2Ch6%7Bmargin%2Dtop%3A10px%3Bmargin%2Dbottom%3A10px%7D%2Eh4%20%2Esmall%2C%2Eh4%20small%2C%2Eh5%20%2Esmall%2C%2Eh5%20small%2C%2Eh6%20%2Esmall%2C%2Eh6%20small%2Ch4%20%2Esmall%2Ch4%20small%2Ch5%20%2Esmall%2Ch5%20small%2Ch6%20%2Esmall%2Ch6%20small%7Bfont%2Dsize%3A75%25%7D%2Eh1%2Ch1%7Bfont%2Dsize%3A36px%7D%2Eh2%2Ch2%7Bfont%2Dsize%3A30px%7D%2Eh3%2Ch3%7Bfont%2Dsize%3A24px%7D%2Eh4%2Ch4%7Bfont%2Dsize%3A18px%7D%2Eh5%2Ch5%7Bfont%2Dsize%3A14px%7D%2Eh6%2Ch6%7Bfont%2Dsize%3A12px%7Dp%7Bmargin%3A0%200%2010px%7D%2Elead%7Bmargin%2Dbottom%3A20px%3Bfont%2Dsize%3A16px%3Bfont%2Dweight%3A300%3Bline%2Dheight%3A1%2E4%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Elead%7Bfont%2Dsize%3A21px%7D%7D%2Esmall%2Csmall%7Bfont%2Dsize%3A85%25%7D%2Emark%2Cmark%7Bpadding%3A%2E2em%3Bbackground%2Dcolor%3A%23fcf8e3%7D%2Etext%2Dleft%7Btext%2Dalign%3Aleft%7D%2Etext%2Dright%7Btext%2Dalign%3Aright%7D%2Etext%2Dcenter%7Btext%2Dalign%3Acenter%7D%2Etext%2Djustify%7Btext%2Dalign%3Ajustify%7D%2Etext%2Dnowrap%7Bwhite%2Dspace%3Anowrap%7D%2Etext%2Dlowercase%7Btext%2Dtransform%3Alowercase%7D%2Etext%2Duppercase%7Btext%2Dtransform%3Auppercase%7D%2Etext%2Dcapitalize%7Btext%2Dtransform%3Acapitalize%7D%2Etext%2Dmuted%7Bcolor%3A%23777%7D%2Etext%2Dprimary%7Bcolor%3A%23337ab7%7Da%2Etext%2Dprimary%3Afocus%2Ca%2Etext%2Dprimary%3Ahover%7Bcolor%3A%23286090%7D%2Etext%2Dsuccess%7Bcolor%3A%233c763d%7Da%2Etext%2Dsuccess%3Afocus%2Ca%2Etext%2Dsuccess%3Ahover%7Bcolor%3A%232b542c%7D%2Etext%2Dinfo%7Bcolor%3A%2331708f%7Da%2Etext%2Dinfo%3Afocus%2Ca%2Etext%2Dinfo%3Ahover%7Bcolor%3A%23245269%7D%2Etext%2Dwarning%7Bcolor%3A%238a6d3b%7Da%2Etext%2Dwarning%3Afocus%2Ca%2Etext%2Dwarning%3Ahover%7Bcolor%3A%2366512c%7D%2Etext%2Ddanger%7Bcolor%3A%23a94442%7Da%2Etext%2Ddanger%3Afocus%2Ca%2Etext%2Ddanger%3Ahover%7Bcolor%3A%23843534%7D%2Ebg%2Dprimary%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23337ab7%7Da%2Ebg%2Dprimary%3Afocus%2Ca%2Ebg%2Dprimary%3Ahover%7Bbackground%2Dcolor%3A%23286090%7D%2Ebg%2Dsuccess%7Bbackground%2Dcolor%3A%23dff0d8%7Da%2Ebg%2Dsuccess%3Afocus%2Ca%2Ebg%2Dsuccess%3Ahover%7Bbackground%2Dcolor%3A%23c1e2b3%7D%2Ebg%2Dinfo%7Bbackground%2Dcolor%3A%23d9edf7%7Da%2Ebg%2Dinfo%3Afocus%2Ca%2Ebg%2Dinfo%3Ahover%7Bbackground%2Dcolor%3A%23afd9ee%7D%2Ebg%2Dwarning%7Bbackground%2Dcolor%3A%23fcf8e3%7Da%2Ebg%2Dwarning%3Afocus%2Ca%2Ebg%2Dwarning%3Ahover%7Bbackground%2Dcolor%3A%23f7ecb5%7D%2Ebg%2Ddanger%7Bbackground%2Dcolor%3A%23f2dede%7Da%2Ebg%2Ddanger%3Afocus%2Ca%2Ebg%2Ddanger%3Ahover%7Bbackground%2Dcolor%3A%23e4b9b9%7D%2Epage%2Dheader%7Bpadding%2Dbottom%3A9px%3Bmargin%3A40px%200%2020px%3Bborder%2Dbottom%3A1px%20solid%20%23eee%7Dol%2Cul%7Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A10px%7Dol%20ol%2Col%20ul%2Cul%20ol%2Cul%20ul%7Bmargin%2Dbottom%3A0%7D%2Elist%2Dunstyled%7Bpadding%2Dleft%3A0%3Blist%2Dstyle%3Anone%7D%2Elist%2Dinline%7Bpadding%2Dleft%3A0%3Bmargin%2Dleft%3A%2D5px%3Blist%2Dstyle%3Anone%7D%2Elist%2Dinline%3Eli%7Bdisplay%3Ainline%2Dblock%3Bpadding%2Dright%3A5px%3Bpadding%2Dleft%3A5px%7Ddl%7Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A20px%7Ddd%2Cdt%7Bline%2Dheight%3A1%2E42857143%7Ddt%7Bfont%2Dweight%3A700%7Ddd%7Bmargin%2Dleft%3A0%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Edl%2Dhorizontal%20dt%7Bfloat%3Aleft%3Bwidth%3A160px%3Boverflow%3Ahidden%3Bclear%3Aleft%3Btext%2Dalign%3Aright%3Btext%2Doverflow%3Aellipsis%3Bwhite%2Dspace%3Anowrap%7D%2Edl%2Dhorizontal%20dd%7Bmargin%2Dleft%3A180px%7D%7Dabbr%5Bdata%2Doriginal%2Dtitle%5D%2Cabbr%5Btitle%5D%7Bcursor%3Ahelp%3Bborder%2Dbottom%3A1px%20dotted%20%23777%7D%2Einitialism%7Bfont%2Dsize%3A90%25%3Btext%2Dtransform%3Auppercase%7Dblockquote%7Bpadding%3A10px%2020px%3Bmargin%3A0%200%2020px%3Bfont%2Dsize%3A17%2E5px%3Bborder%2Dleft%3A5px%20solid%20%23eee%7Dblockquote%20ol%3Alast%2Dchild%2Cblockquote%20p%3Alast%2Dchild%2Cblockquote%20ul%3Alast%2Dchild%7Bmargin%2Dbottom%3A0%7Dblockquote%20%2Esmall%2Cblockquote%20footer%2Cblockquote%20small%7Bdisplay%3Ablock%3Bfont%2Dsize%3A80%25%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23777%7Dblockquote%20%2Esmall%3Abefore%2Cblockquote%20footer%3Abefore%2Cblockquote%20small%3Abefore%7Bcontent%3A%27%5C2014%20%5C00A0%27%7D%2Eblockquote%2Dreverse%2Cblockquote%2Epull%2Dright%7Bpadding%2Dright%3A15px%3Bpadding%2Dleft%3A0%3Btext%2Dalign%3Aright%3Bborder%2Dright%3A5px%20solid%20%23eee%3Bborder%2Dleft%3A0%7D%2Eblockquote%2Dreverse%20%2Esmall%3Abefore%2C%2Eblockquote%2Dreverse%20footer%3Abefore%2C%2Eblockquote%2Dreverse%20small%3Abefore%2Cblockquote%2Epull%2Dright%20%2Esmall%3Abefore%2Cblockquote%2Epull%2Dright%20footer%3Abefore%2Cblockquote%2Epull%2Dright%20small%3Abefore%7Bcontent%3A%27%27%7D%2Eblockquote%2Dreverse%20%2Esmall%3Aafter%2C%2Eblockquote%2Dreverse%20footer%3Aafter%2C%2Eblockquote%2Dreverse%20small%3Aafter%2Cblockquote%2Epull%2Dright%20%2Esmall%3Aafter%2Cblockquote%2Epull%2Dright%20footer%3Aafter%2Cblockquote%2Epull%2Dright%20small%3Aafter%7Bcontent%3A%27%5C00A0%20%5C2014%27%7Daddress%7Bmargin%2Dbottom%3A20px%3Bfont%2Dstyle%3Anormal%3Bline%2Dheight%3A1%2E42857143%7Dcode%2Ckbd%2Cpre%2Csamp%7Bfont%2Dfamily%3Amonospace%7Dcode%7Bpadding%3A2px%204px%3Bfont%2Dsize%3A90%25%3Bcolor%3A%23c7254e%3Bbackground%2Dcolor%3A%23f9f2f4%3Bborder%2Dradius%3A4px%7Dkbd%7Bpadding%3A2px%204px%3Bfont%2Dsize%3A90%25%3Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23333%3Bborder%2Dradius%3A3px%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%20%2D1px%200%20rgba%280%2C0%2C0%2C%2E25%29%3Bbox%2Dshadow%3Ainset%200%20%2D1px%200%20rgba%280%2C0%2C0%2C%2E25%29%7Dkbd%20kbd%7Bpadding%3A0%3Bfont%2Dsize%3A100%25%3Bfont%2Dweight%3A700%3B%2Dwebkit%2Dbox%2Dshadow%3Anone%3Bbox%2Dshadow%3Anone%7Dpre%7Bdisplay%3Ablock%3Bpadding%3A9%2E5px%3Bmargin%3A0%200%2010px%3Bfont%2Dsize%3A13px%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23333%3Bword%2Dbreak%3Abreak%2Dall%3Bword%2Dwrap%3Abreak%2Dword%3Bbackground%2Dcolor%3A%23f5f5f5%3Bborder%3A1px%20solid%20%23ccc%3Bborder%2Dradius%3A4px%7Dpre%20code%7Bpadding%3A0%3Bfont%2Dsize%3Ainherit%3Bcolor%3Ainherit%3Bwhite%2Dspace%3Apre%2Dwrap%3Bbackground%2Dcolor%3Atransparent%3Bborder%2Dradius%3A0%7D%2Epre%2Dscrollable%7Bmax%2Dheight%3A340px%3Boverflow%2Dy%3Ascroll%7D%2Econtainer%7Bpadding%2Dright%3A15px%3Bpadding%2Dleft%3A15px%3Bmargin%2Dright%3Aauto%3Bmargin%2Dleft%3Aauto%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Econtainer%7Bwidth%3A750px%7D%7D%40media%20%28min%2Dwidth%3A992px%29%7B%2Econtainer%7Bwidth%3A970px%7D%7D%40media%20%28min%2Dwidth%3A1200px%29%7B%2Econtainer%7Bwidth%3A1170px%7D%7D%2Econtainer%2Dfluid%7Bpadding%2Dright%3A15px%3Bpadding%2Dleft%3A15px%3Bmargin%2Dright%3Aauto%3Bmargin%2Dleft%3Aauto%7D%2Erow%7Bmargin%2Dright%3A%2D15px%3Bmargin%2Dleft%3A%2D15px%7D%2Ecol%2Dlg%2D1%2C%2Ecol%2Dlg%2D10%2C%2Ecol%2Dlg%2D11%2C%2Ecol%2Dlg%2D12%2C%2Ecol%2Dlg%2D2%2C%2Ecol%2Dlg%2D3%2C%2Ecol%2Dlg%2D4%2C%2Ecol%2Dlg%2D5%2C%2Ecol%2Dlg%2D6%2C%2Ecol%2Dlg%2D7%2C%2Ecol%2Dlg%2D8%2C%2Ecol%2Dlg%2D9%2C%2Ecol%2Dmd%2D1%2C%2Ecol%2Dmd%2D10%2C%2Ecol%2Dmd%2D11%2C%2Ecol%2Dmd%2D12%2C%2Ecol%2Dmd%2D2%2C%2Ecol%2Dmd%2D3%2C%2Ecol%2Dmd%2D4%2C%2Ecol%2Dmd%2D5%2C%2Ecol%2Dmd%2D6%2C%2Ecol%2Dmd%2D7%2C%2Ecol%2Dmd%2D8%2C%2Ecol%2Dmd%2D9%2C%2Ecol%2Dsm%2D1%2C%2Ecol%2Dsm%2D10%2C%2Ecol%2Dsm%2D11%2C%2Ecol%2Dsm%2D12%2C%2Ecol%2Dsm%2D2%2C%2Ecol%2Dsm%2D3%2C%2Ecol%2Dsm%2D4%2C%2Ecol%2Dsm%2D5%2C%2Ecol%2Dsm%2D6%2C%2Ecol%2Dsm%2D7%2C%2Ecol%2Dsm%2D8%2C%2Ecol%2Dsm%2D9%2C%2Ecol%2Dxs%2D1%2C%2Ecol%2Dxs%2D10%2C%2Ecol%2Dxs%2D11%2C%2Ecol%2Dxs%2D12%2C%2Ecol%2Dxs%2D2%2C%2Ecol%2Dxs%2D3%2C%2Ecol%2Dxs%2D4%2C%2Ecol%2Dxs%2D5%2C%2Ecol%2Dxs%2D6%2C%2Ecol%2Dxs%2D7%2C%2Ecol%2Dxs%2D8%2C%2Ecol%2Dxs%2D9%7Bposition%3Arelative%3Bmin%2Dheight%3A1px%3Bpadding%2Dright%3A15px%3Bpadding%2Dleft%3A15px%7D%2Ecol%2Dxs%2D1%2C%2Ecol%2Dxs%2D10%2C%2Ecol%2Dxs%2D11%2C%2Ecol%2Dxs%2D12%2C%2Ecol%2Dxs%2D2%2C%2Ecol%2Dxs%2D3%2C%2Ecol%2Dxs%2D4%2C%2Ecol%2Dxs%2D5%2C%2Ecol%2Dxs%2D6%2C%2Ecol%2Dxs%2D7%2C%2Ecol%2Dxs%2D8%2C%2Ecol%2Dxs%2D9%7Bfloat%3Aleft%7D%2Ecol%2Dxs%2D12%7Bwidth%3A100%25%7D%2Ecol%2Dxs%2D11%7Bwidth%3A91%2E66666667%25%7D%2Ecol%2Dxs%2D10%7Bwidth%3A83%2E33333333%25%7D%2Ecol%2Dxs%2D9%7Bwidth%3A75%25%7D%2Ecol%2Dxs%2D8%7Bwidth%3A66%2E66666667%25%7D%2Ecol%2Dxs%2D7%7Bwidth%3A58%2E33333333%25%7D%2Ecol%2Dxs%2D6%7Bwidth%3A50%25%7D%2Ecol%2Dxs%2D5%7Bwidth%3A41%2E66666667%25%7D%2Ecol%2Dxs%2D4%7Bwidth%3A33%2E33333333%25%7D%2Ecol%2Dxs%2D3%7Bwidth%3A25%25%7D%2Ecol%2Dxs%2D2%7Bwidth%3A16%2E66666667%25%7D%2Ecol%2Dxs%2D1%7Bwidth%3A8%2E33333333%25%7D%2Ecol%2Dxs%2Dpull%2D12%7Bright%3A100%25%7D%2Ecol%2Dxs%2Dpull%2D11%7Bright%3A91%2E66666667%25%7D%2Ecol%2Dxs%2Dpull%2D10%7Bright%3A83%2E33333333%25%7D%2Ecol%2Dxs%2Dpull%2D9%7Bright%3A75%25%7D%2Ecol%2Dxs%2Dpull%2D8%7Bright%3A66%2E66666667%25%7D%2Ecol%2Dxs%2Dpull%2D7%7Bright%3A58%2E33333333%25%7D%2Ecol%2Dxs%2Dpull%2D6%7Bright%3A50%25%7D%2Ecol%2Dxs%2Dpull%2D5%7Bright%3A41%2E66666667%25%7D%2Ecol%2Dxs%2Dpull%2D4%7Bright%3A33%2E33333333%25%7D%2Ecol%2Dxs%2Dpull%2D3%7Bright%3A25%25%7D%2Ecol%2Dxs%2Dpull%2D2%7Bright%3A16%2E66666667%25%7D%2Ecol%2Dxs%2Dpull%2D1%7Bright%3A8%2E33333333%25%7D%2Ecol%2Dxs%2Dpull%2D0%7Bright%3Aauto%7D%2Ecol%2Dxs%2Dpush%2D12%7Bleft%3A100%25%7D%2Ecol%2Dxs%2Dpush%2D11%7Bleft%3A91%2E66666667%25%7D%2Ecol%2Dxs%2Dpush%2D10%7Bleft%3A83%2E33333333%25%7D%2Ecol%2Dxs%2Dpush%2D9%7Bleft%3A75%25%7D%2Ecol%2Dxs%2Dpush%2D8%7Bleft%3A66%2E66666667%25%7D%2Ecol%2Dxs%2Dpush%2D7%7Bleft%3A58%2E33333333%25%7D%2Ecol%2Dxs%2Dpush%2D6%7Bleft%3A50%25%7D%2Ecol%2Dxs%2Dpush%2D5%7Bleft%3A41%2E66666667%25%7D%2Ecol%2Dxs%2Dpush%2D4%7Bleft%3A33%2E33333333%25%7D%2Ecol%2Dxs%2Dpush%2D3%7Bleft%3A25%25%7D%2Ecol%2Dxs%2Dpush%2D2%7Bleft%3A16%2E66666667%25%7D%2Ecol%2Dxs%2Dpush%2D1%7Bleft%3A8%2E33333333%25%7D%2Ecol%2Dxs%2Dpush%2D0%7Bleft%3Aauto%7D%2Ecol%2Dxs%2Doffset%2D12%7Bmargin%2Dleft%3A100%25%7D%2Ecol%2Dxs%2Doffset%2D11%7Bmargin%2Dleft%3A91%2E66666667%25%7D%2Ecol%2Dxs%2Doffset%2D10%7Bmargin%2Dleft%3A83%2E33333333%25%7D%2Ecol%2Dxs%2Doffset%2D9%7Bmargin%2Dleft%3A75%25%7D%2Ecol%2Dxs%2Doffset%2D8%7Bmargin%2Dleft%3A66%2E66666667%25%7D%2Ecol%2Dxs%2Doffset%2D7%7Bmargin%2Dleft%3A58%2E33333333%25%7D%2Ecol%2Dxs%2Doffset%2D6%7Bmargin%2Dleft%3A50%25%7D%2Ecol%2Dxs%2Doffset%2D5%7Bmargin%2Dleft%3A41%2E66666667%25%7D%2Ecol%2Dxs%2Doffset%2D4%7Bmargin%2Dleft%3A33%2E33333333%25%7D%2Ecol%2Dxs%2Doffset%2D3%7Bmargin%2Dleft%3A25%25%7D%2Ecol%2Dxs%2Doffset%2D2%7Bmargin%2Dleft%3A16%2E66666667%25%7D%2Ecol%2Dxs%2Doffset%2D1%7Bmargin%2Dleft%3A8%2E33333333%25%7D%2Ecol%2Dxs%2Doffset%2D0%7Bmargin%2Dleft%3A0%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Ecol%2Dsm%2D1%2C%2Ecol%2Dsm%2D10%2C%2Ecol%2Dsm%2D11%2C%2Ecol%2Dsm%2D12%2C%2Ecol%2Dsm%2D2%2C%2Ecol%2Dsm%2D3%2C%2Ecol%2Dsm%2D4%2C%2Ecol%2Dsm%2D5%2C%2Ecol%2Dsm%2D6%2C%2Ecol%2Dsm%2D7%2C%2Ecol%2Dsm%2D8%2C%2Ecol%2Dsm%2D9%7Bfloat%3Aleft%7D%2Ecol%2Dsm%2D12%7Bwidth%3A100%25%7D%2Ecol%2Dsm%2D11%7Bwidth%3A91%2E66666667%25%7D%2Ecol%2Dsm%2D10%7Bwidth%3A83%2E33333333%25%7D%2Ecol%2Dsm%2D9%7Bwidth%3A75%25%7D%2Ecol%2Dsm%2D8%7Bwidth%3A66%2E66666667%25%7D%2Ecol%2Dsm%2D7%7Bwidth%3A58%2E33333333%25%7D%2Ecol%2Dsm%2D6%7Bwidth%3A50%25%7D%2Ecol%2Dsm%2D5%7Bwidth%3A41%2E66666667%25%7D%2Ecol%2Dsm%2D4%7Bwidth%3A33%2E33333333%25%7D%2Ecol%2Dsm%2D3%7Bwidth%3A25%25%7D%2Ecol%2Dsm%2D2%7Bwidth%3A16%2E66666667%25%7D%2Ecol%2Dsm%2D1%7Bwidth%3A8%2E33333333%25%7D%2Ecol%2Dsm%2Dpull%2D12%7Bright%3A100%25%7D%2Ecol%2Dsm%2Dpull%2D11%7Bright%3A91%2E66666667%25%7D%2Ecol%2Dsm%2Dpull%2D10%7Bright%3A83%2E33333333%25%7D%2Ecol%2Dsm%2Dpull%2D9%7Bright%3A75%25%7D%2Ecol%2Dsm%2Dpull%2D8%7Bright%3A66%2E66666667%25%7D%2Ecol%2Dsm%2Dpull%2D7%7Bright%3A58%2E33333333%25%7D%2Ecol%2Dsm%2Dpull%2D6%7Bright%3A50%25%7D%2Ecol%2Dsm%2Dpull%2D5%7Bright%3A41%2E66666667%25%7D%2Ecol%2Dsm%2Dpull%2D4%7Bright%3A33%2E33333333%25%7D%2Ecol%2Dsm%2Dpull%2D3%7Bright%3A25%25%7D%2Ecol%2Dsm%2Dpull%2D2%7Bright%3A16%2E66666667%25%7D%2Ecol%2Dsm%2Dpull%2D1%7Bright%3A8%2E33333333%25%7D%2Ecol%2Dsm%2Dpull%2D0%7Bright%3Aauto%7D%2Ecol%2Dsm%2Dpush%2D12%7Bleft%3A100%25%7D%2Ecol%2Dsm%2Dpush%2D11%7Bleft%3A91%2E66666667%25%7D%2Ecol%2Dsm%2Dpush%2D10%7Bleft%3A83%2E33333333%25%7D%2Ecol%2Dsm%2Dpush%2D9%7Bleft%3A75%25%7D%2Ecol%2Dsm%2Dpush%2D8%7Bleft%3A66%2E66666667%25%7D%2Ecol%2Dsm%2Dpush%2D7%7Bleft%3A58%2E33333333%25%7D%2Ecol%2Dsm%2Dpush%2D6%7Bleft%3A50%25%7D%2Ecol%2Dsm%2Dpush%2D5%7Bleft%3A41%2E66666667%25%7D%2Ecol%2Dsm%2Dpush%2D4%7Bleft%3A33%2E33333333%25%7D%2Ecol%2Dsm%2Dpush%2D3%7Bleft%3A25%25%7D%2Ecol%2Dsm%2Dpush%2D2%7Bleft%3A16%2E66666667%25%7D%2Ecol%2Dsm%2Dpush%2D1%7Bleft%3A8%2E33333333%25%7D%2Ecol%2Dsm%2Dpush%2D0%7Bleft%3Aauto%7D%2Ecol%2Dsm%2Doffset%2D12%7Bmargin%2Dleft%3A100%25%7D%2Ecol%2Dsm%2Doffset%2D11%7Bmargin%2Dleft%3A91%2E66666667%25%7D%2Ecol%2Dsm%2Doffset%2D10%7Bmargin%2Dleft%3A83%2E33333333%25%7D%2Ecol%2Dsm%2Doffset%2D9%7Bmargin%2Dleft%3A75%25%7D%2Ecol%2Dsm%2Doffset%2D8%7Bmargin%2Dleft%3A66%2E66666667%25%7D%2Ecol%2Dsm%2Doffset%2D7%7Bmargin%2Dleft%3A58%2E33333333%25%7D%2Ecol%2Dsm%2Doffset%2D6%7Bmargin%2Dleft%3A50%25%7D%2Ecol%2Dsm%2Doffset%2D5%7Bmargin%2Dleft%3A41%2E66666667%25%7D%2Ecol%2Dsm%2Doffset%2D4%7Bmargin%2Dleft%3A33%2E33333333%25%7D%2Ecol%2Dsm%2Doffset%2D3%7Bmargin%2Dleft%3A25%25%7D%2Ecol%2Dsm%2Doffset%2D2%7Bmargin%2Dleft%3A16%2E66666667%25%7D%2Ecol%2Dsm%2Doffset%2D1%7Bmargin%2Dleft%3A8%2E33333333%25%7D%2Ecol%2Dsm%2Doffset%2D0%7Bmargin%2Dleft%3A0%7D%7D%40media%20%28min%2Dwidth%3A992px%29%7B%2Ecol%2Dmd%2D1%2C%2Ecol%2Dmd%2D10%2C%2Ecol%2Dmd%2D11%2C%2Ecol%2Dmd%2D12%2C%2Ecol%2Dmd%2D2%2C%2Ecol%2Dmd%2D3%2C%2Ecol%2Dmd%2D4%2C%2Ecol%2Dmd%2D5%2C%2Ecol%2Dmd%2D6%2C%2Ecol%2Dmd%2D7%2C%2Ecol%2Dmd%2D8%2C%2Ecol%2Dmd%2D9%7Bfloat%3Aleft%7D%2Ecol%2Dmd%2D12%7Bwidth%3A100%25%7D%2Ecol%2Dmd%2D11%7Bwidth%3A91%2E66666667%25%7D%2Ecol%2Dmd%2D10%7Bwidth%3A83%2E33333333%25%7D%2Ecol%2Dmd%2D9%7Bwidth%3A75%25%7D%2Ecol%2Dmd%2D8%7Bwidth%3A66%2E66666667%25%7D%2Ecol%2Dmd%2D7%7Bwidth%3A58%2E33333333%25%7D%2Ecol%2Dmd%2D6%7Bwidth%3A50%25%7D%2Ecol%2Dmd%2D5%7Bwidth%3A41%2E66666667%25%7D%2Ecol%2Dmd%2D4%7Bwidth%3A33%2E33333333%25%7D%2Ecol%2Dmd%2D3%7Bwidth%3A25%25%7D%2Ecol%2Dmd%2D2%7Bwidth%3A16%2E66666667%25%7D%2Ecol%2Dmd%2D1%7Bwidth%3A8%2E33333333%25%7D%2Ecol%2Dmd%2Dpull%2D12%7Bright%3A100%25%7D%2Ecol%2Dmd%2Dpull%2D11%7Bright%3A91%2E66666667%25%7D%2Ecol%2Dmd%2Dpull%2D10%7Bright%3A83%2E33333333%25%7D%2Ecol%2Dmd%2Dpull%2D9%7Bright%3A75%25%7D%2Ecol%2Dmd%2Dpull%2D8%7Bright%3A66%2E66666667%25%7D%2Ecol%2Dmd%2Dpull%2D7%7Bright%3A58%2E33333333%25%7D%2Ecol%2Dmd%2Dpull%2D6%7Bright%3A50%25%7D%2Ecol%2Dmd%2Dpull%2D5%7Bright%3A41%2E66666667%25%7D%2Ecol%2Dmd%2Dpull%2D4%7Bright%3A33%2E33333333%25%7D%2Ecol%2Dmd%2Dpull%2D3%7Bright%3A25%25%7D%2Ecol%2Dmd%2Dpull%2D2%7Bright%3A16%2E66666667%25%7D%2Ecol%2Dmd%2Dpull%2D1%7Bright%3A8%2E33333333%25%7D%2Ecol%2Dmd%2Dpull%2D0%7Bright%3Aauto%7D%2Ecol%2Dmd%2Dpush%2D12%7Bleft%3A100%25%7D%2Ecol%2Dmd%2Dpush%2D11%7Bleft%3A91%2E66666667%25%7D%2Ecol%2Dmd%2Dpush%2D10%7Bleft%3A83%2E33333333%25%7D%2Ecol%2Dmd%2Dpush%2D9%7Bleft%3A75%25%7D%2Ecol%2Dmd%2Dpush%2D8%7Bleft%3A66%2E66666667%25%7D%2Ecol%2Dmd%2Dpush%2D7%7Bleft%3A58%2E33333333%25%7D%2Ecol%2Dmd%2Dpush%2D6%7Bleft%3A50%25%7D%2Ecol%2Dmd%2Dpush%2D5%7Bleft%3A41%2E66666667%25%7D%2Ecol%2Dmd%2Dpush%2D4%7Bleft%3A33%2E33333333%25%7D%2Ecol%2Dmd%2Dpush%2D3%7Bleft%3A25%25%7D%2Ecol%2Dmd%2Dpush%2D2%7Bleft%3A16%2E66666667%25%7D%2Ecol%2Dmd%2Dpush%2D1%7Bleft%3A8%2E33333333%25%7D%2Ecol%2Dmd%2Dpush%2D0%7Bleft%3Aauto%7D%2Ecol%2Dmd%2Doffset%2D12%7Bmargin%2Dleft%3A100%25%7D%2Ecol%2Dmd%2Doffset%2D11%7Bmargin%2Dleft%3A91%2E66666667%25%7D%2Ecol%2Dmd%2Doffset%2D10%7Bmargin%2Dleft%3A83%2E33333333%25%7D%2Ecol%2Dmd%2Doffset%2D9%7Bmargin%2Dleft%3A75%25%7D%2Ecol%2Dmd%2Doffset%2D8%7Bmargin%2Dleft%3A66%2E66666667%25%7D%2Ecol%2Dmd%2Doffset%2D7%7Bmargin%2Dleft%3A58%2E33333333%25%7D%2Ecol%2Dmd%2Doffset%2D6%7Bmargin%2Dleft%3A50%25%7D%2Ecol%2Dmd%2Doffset%2D5%7Bmargin%2Dleft%3A41%2E66666667%25%7D%2Ecol%2Dmd%2Doffset%2D4%7Bmargin%2Dleft%3A33%2E33333333%25%7D%2Ecol%2Dmd%2Doffset%2D3%7Bmargin%2Dleft%3A25%25%7D%2Ecol%2Dmd%2Doffset%2D2%7Bmargin%2Dleft%3A16%2E66666667%25%7D%2Ecol%2Dmd%2Doffset%2D1%7Bmargin%2Dleft%3A8%2E33333333%25%7D%2Ecol%2Dmd%2Doffset%2D0%7Bmargin%2Dleft%3A0%7D%7D%40media%20%28min%2Dwidth%3A1200px%29%7B%2Ecol%2Dlg%2D1%2C%2Ecol%2Dlg%2D10%2C%2Ecol%2Dlg%2D11%2C%2Ecol%2Dlg%2D12%2C%2Ecol%2Dlg%2D2%2C%2Ecol%2Dlg%2D3%2C%2Ecol%2Dlg%2D4%2C%2Ecol%2Dlg%2D5%2C%2Ecol%2Dlg%2D6%2C%2Ecol%2Dlg%2D7%2C%2Ecol%2Dlg%2D8%2C%2Ecol%2Dlg%2D9%7Bfloat%3Aleft%7D%2Ecol%2Dlg%2D12%7Bwidth%3A100%25%7D%2Ecol%2Dlg%2D11%7Bwidth%3A91%2E66666667%25%7D%2Ecol%2Dlg%2D10%7Bwidth%3A83%2E33333333%25%7D%2Ecol%2Dlg%2D9%7Bwidth%3A75%25%7D%2Ecol%2Dlg%2D8%7Bwidth%3A66%2E66666667%25%7D%2Ecol%2Dlg%2D7%7Bwidth%3A58%2E33333333%25%7D%2Ecol%2Dlg%2D6%7Bwidth%3A50%25%7D%2Ecol%2Dlg%2D5%7Bwidth%3A41%2E66666667%25%7D%2Ecol%2Dlg%2D4%7Bwidth%3A33%2E33333333%25%7D%2Ecol%2Dlg%2D3%7Bwidth%3A25%25%7D%2Ecol%2Dlg%2D2%7Bwidth%3A16%2E66666667%25%7D%2Ecol%2Dlg%2D1%7Bwidth%3A8%2E33333333%25%7D%2Ecol%2Dlg%2Dpull%2D12%7Bright%3A100%25%7D%2Ecol%2Dlg%2Dpull%2D11%7Bright%3A91%2E66666667%25%7D%2Ecol%2Dlg%2Dpull%2D10%7Bright%3A83%2E33333333%25%7D%2Ecol%2Dlg%2Dpull%2D9%7Bright%3A75%25%7D%2Ecol%2Dlg%2Dpull%2D8%7Bright%3A66%2E66666667%25%7D%2Ecol%2Dlg%2Dpull%2D7%7Bright%3A58%2E33333333%25%7D%2Ecol%2Dlg%2Dpull%2D6%7Bright%3A50%25%7D%2Ecol%2Dlg%2Dpull%2D5%7Bright%3A41%2E66666667%25%7D%2Ecol%2Dlg%2Dpull%2D4%7Bright%3A33%2E33333333%25%7D%2Ecol%2Dlg%2Dpull%2D3%7Bright%3A25%25%7D%2Ecol%2Dlg%2Dpull%2D2%7Bright%3A16%2E66666667%25%7D%2Ecol%2Dlg%2Dpull%2D1%7Bright%3A8%2E33333333%25%7D%2Ecol%2Dlg%2Dpull%2D0%7Bright%3Aauto%7D%2Ecol%2Dlg%2Dpush%2D12%7Bleft%3A100%25%7D%2Ecol%2Dlg%2Dpush%2D11%7Bleft%3A91%2E66666667%25%7D%2Ecol%2Dlg%2Dpush%2D10%7Bleft%3A83%2E33333333%25%7D%2Ecol%2Dlg%2Dpush%2D9%7Bleft%3A75%25%7D%2Ecol%2Dlg%2Dpush%2D8%7Bleft%3A66%2E66666667%25%7D%2Ecol%2Dlg%2Dpush%2D7%7Bleft%3A58%2E33333333%25%7D%2Ecol%2Dlg%2Dpush%2D6%7Bleft%3A50%25%7D%2Ecol%2Dlg%2Dpush%2D5%7Bleft%3A41%2E66666667%25%7D%2Ecol%2Dlg%2Dpush%2D4%7Bleft%3A33%2E33333333%25%7D%2Ecol%2Dlg%2Dpush%2D3%7Bleft%3A25%25%7D%2Ecol%2Dlg%2Dpush%2D2%7Bleft%3A16%2E66666667%25%7D%2Ecol%2Dlg%2Dpush%2D1%7Bleft%3A8%2E33333333%25%7D%2Ecol%2Dlg%2Dpush%2D0%7Bleft%3Aauto%7D%2Ecol%2Dlg%2Doffset%2D12%7Bmargin%2Dleft%3A100%25%7D%2Ecol%2Dlg%2Doffset%2D11%7Bmargin%2Dleft%3A91%2E66666667%25%7D%2Ecol%2Dlg%2Doffset%2D10%7Bmargin%2Dleft%3A83%2E33333333%25%7D%2Ecol%2Dlg%2Doffset%2D9%7Bmargin%2Dleft%3A75%25%7D%2Ecol%2Dlg%2Doffset%2D8%7Bmargin%2Dleft%3A66%2E66666667%25%7D%2Ecol%2Dlg%2Doffset%2D7%7Bmargin%2Dleft%3A58%2E33333333%25%7D%2Ecol%2Dlg%2Doffset%2D6%7Bmargin%2Dleft%3A50%25%7D%2Ecol%2Dlg%2Doffset%2D5%7Bmargin%2Dleft%3A41%2E66666667%25%7D%2Ecol%2Dlg%2Doffset%2D4%7Bmargin%2Dleft%3A33%2E33333333%25%7D%2Ecol%2Dlg%2Doffset%2D3%7Bmargin%2Dleft%3A25%25%7D%2Ecol%2Dlg%2Doffset%2D2%7Bmargin%2Dleft%3A16%2E66666667%25%7D%2Ecol%2Dlg%2Doffset%2D1%7Bmargin%2Dleft%3A8%2E33333333%25%7D%2Ecol%2Dlg%2Doffset%2D0%7Bmargin%2Dleft%3A0%7D%7Dtable%7Bbackground%2Dcolor%3Atransparent%7Dcaption%7Bpadding%2Dtop%3A8px%3Bpadding%2Dbottom%3A8px%3Bcolor%3A%23777%3Btext%2Dalign%3Aleft%7Dth%7B%7D%2Etable%7Bwidth%3A100%25%3Bmax%2Dwidth%3A100%25%3Bmargin%2Dbottom%3A20px%7D%2Etable%3Etbody%3Etr%3Etd%2C%2Etable%3Etbody%3Etr%3Eth%2C%2Etable%3Etfoot%3Etr%3Etd%2C%2Etable%3Etfoot%3Etr%3Eth%2C%2Etable%3Ethead%3Etr%3Etd%2C%2Etable%3Ethead%3Etr%3Eth%7Bpadding%3A8px%3Bline%2Dheight%3A1%2E42857143%3Bvertical%2Dalign%3Atop%3Bborder%2Dtop%3A1px%20solid%20%23ddd%7D%2Etable%3Ethead%3Etr%3Eth%7Bvertical%2Dalign%3Abottom%3Bborder%2Dbottom%3A2px%20solid%20%23ddd%7D%2Etable%3Ecaption%2Bthead%3Etr%3Afirst%2Dchild%3Etd%2C%2Etable%3Ecaption%2Bthead%3Etr%3Afirst%2Dchild%3Eth%2C%2Etable%3Ecolgroup%2Bthead%3Etr%3Afirst%2Dchild%3Etd%2C%2Etable%3Ecolgroup%2Bthead%3Etr%3Afirst%2Dchild%3Eth%2C%2Etable%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%3Etd%2C%2Etable%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%3Eth%7Bborder%2Dtop%3A0%7D%2Etable%3Etbody%2Btbody%7Bborder%2Dtop%3A2px%20solid%20%23ddd%7D%2Etable%20%2Etable%7Bbackground%2Dcolor%3A%23fff%7D%2Etable%2Dcondensed%3Etbody%3Etr%3Etd%2C%2Etable%2Dcondensed%3Etbody%3Etr%3Eth%2C%2Etable%2Dcondensed%3Etfoot%3Etr%3Etd%2C%2Etable%2Dcondensed%3Etfoot%3Etr%3Eth%2C%2Etable%2Dcondensed%3Ethead%3Etr%3Etd%2C%2Etable%2Dcondensed%3Ethead%3Etr%3Eth%7Bpadding%3A5px%7D%2Etable%2Dbordered%7Bborder%3A1px%20solid%20%23ddd%7D%2Etable%2Dbordered%3Etbody%3Etr%3Etd%2C%2Etable%2Dbordered%3Etbody%3Etr%3Eth%2C%2Etable%2Dbordered%3Etfoot%3Etr%3Etd%2C%2Etable%2Dbordered%3Etfoot%3Etr%3Eth%2C%2Etable%2Dbordered%3Ethead%3Etr%3Etd%2C%2Etable%2Dbordered%3Ethead%3Etr%3Eth%7Bborder%3A1px%20solid%20%23ddd%7D%2Etable%2Dbordered%3Ethead%3Etr%3Etd%2C%2Etable%2Dbordered%3Ethead%3Etr%3Eth%7Bborder%2Dbottom%2Dwidth%3A2px%7D%2Etable%2Dstriped%3Etbody%3Etr%3Anth%2Dof%2Dtype%28odd%29%7Bbackground%2Dcolor%3A%23f9f9f9%7D%2Etable%2Dhover%3Etbody%3Etr%3Ahover%7Bbackground%2Dcolor%3A%23f5f5f5%7Dtable%20col%5Bclass%2A%3Dcol%2D%5D%7Bposition%3Astatic%3Bdisplay%3Atable%2Dcolumn%3Bfloat%3Anone%7Dtable%20td%5Bclass%2A%3Dcol%2D%5D%2Ctable%20th%5Bclass%2A%3Dcol%2D%5D%7Bposition%3Astatic%3Bdisplay%3Atable%2Dcell%3Bfloat%3Anone%7D%2Etable%3Etbody%3Etr%2Eactive%3Etd%2C%2Etable%3Etbody%3Etr%2Eactive%3Eth%2C%2Etable%3Etbody%3Etr%3Etd%2Eactive%2C%2Etable%3Etbody%3Etr%3Eth%2Eactive%2C%2Etable%3Etfoot%3Etr%2Eactive%3Etd%2C%2Etable%3Etfoot%3Etr%2Eactive%3Eth%2C%2Etable%3Etfoot%3Etr%3Etd%2Eactive%2C%2Etable%3Etfoot%3Etr%3Eth%2Eactive%2C%2Etable%3Ethead%3Etr%2Eactive%3Etd%2C%2Etable%3Ethead%3Etr%2Eactive%3Eth%2C%2Etable%3Ethead%3Etr%3Etd%2Eactive%2C%2Etable%3Ethead%3Etr%3Eth%2Eactive%7Bbackground%2Dcolor%3A%23f5f5f5%7D%2Etable%2Dhover%3Etbody%3Etr%2Eactive%3Ahover%3Etd%2C%2Etable%2Dhover%3Etbody%3Etr%2Eactive%3Ahover%3Eth%2C%2Etable%2Dhover%3Etbody%3Etr%3Ahover%3E%2Eactive%2C%2Etable%2Dhover%3Etbody%3Etr%3Etd%2Eactive%3Ahover%2C%2Etable%2Dhover%3Etbody%3Etr%3Eth%2Eactive%3Ahover%7Bbackground%2Dcolor%3A%23e8e8e8%7D%2Etable%3Etbody%3Etr%2Esuccess%3Etd%2C%2Etable%3Etbody%3Etr%2Esuccess%3Eth%2C%2Etable%3Etbody%3Etr%3Etd%2Esuccess%2C%2Etable%3Etbody%3Etr%3Eth%2Esuccess%2C%2Etable%3Etfoot%3Etr%2Esuccess%3Etd%2C%2Etable%3Etfoot%3Etr%2Esuccess%3Eth%2C%2Etable%3Etfoot%3Etr%3Etd%2Esuccess%2C%2Etable%3Etfoot%3Etr%3Eth%2Esuccess%2C%2Etable%3Ethead%3Etr%2Esuccess%3Etd%2C%2Etable%3Ethead%3Etr%2Esuccess%3Eth%2C%2Etable%3Ethead%3Etr%3Etd%2Esuccess%2C%2Etable%3Ethead%3Etr%3Eth%2Esuccess%7Bbackground%2Dcolor%3A%23dff0d8%7D%2Etable%2Dhover%3Etbody%3Etr%2Esuccess%3Ahover%3Etd%2C%2Etable%2Dhover%3Etbody%3Etr%2Esuccess%3Ahover%3Eth%2C%2Etable%2Dhover%3Etbody%3Etr%3Ahover%3E%2Esuccess%2C%2Etable%2Dhover%3Etbody%3Etr%3Etd%2Esuccess%3Ahover%2C%2Etable%2Dhover%3Etbody%3Etr%3Eth%2Esuccess%3Ahover%7Bbackground%2Dcolor%3A%23d0e9c6%7D%2Etable%3Etbody%3Etr%2Einfo%3Etd%2C%2Etable%3Etbody%3Etr%2Einfo%3Eth%2C%2Etable%3Etbody%3Etr%3Etd%2Einfo%2C%2Etable%3Etbody%3Etr%3Eth%2Einfo%2C%2Etable%3Etfoot%3Etr%2Einfo%3Etd%2C%2Etable%3Etfoot%3Etr%2Einfo%3Eth%2C%2Etable%3Etfoot%3Etr%3Etd%2Einfo%2C%2Etable%3Etfoot%3Etr%3Eth%2Einfo%2C%2Etable%3Ethead%3Etr%2Einfo%3Etd%2C%2Etable%3Ethead%3Etr%2Einfo%3Eth%2C%2Etable%3Ethead%3Etr%3Etd%2Einfo%2C%2Etable%3Ethead%3Etr%3Eth%2Einfo%7Bbackground%2Dcolor%3A%23d9edf7%7D%2Etable%2Dhover%3Etbody%3Etr%2Einfo%3Ahover%3Etd%2C%2Etable%2Dhover%3Etbody%3Etr%2Einfo%3Ahover%3Eth%2C%2Etable%2Dhover%3Etbody%3Etr%3Ahover%3E%2Einfo%2C%2Etable%2Dhover%3Etbody%3Etr%3Etd%2Einfo%3Ahover%2C%2Etable%2Dhover%3Etbody%3Etr%3Eth%2Einfo%3Ahover%7Bbackground%2Dcolor%3A%23c4e3f3%7D%2Etable%3Etbody%3Etr%2Ewarning%3Etd%2C%2Etable%3Etbody%3Etr%2Ewarning%3Eth%2C%2Etable%3Etbody%3Etr%3Etd%2Ewarning%2C%2Etable%3Etbody%3Etr%3Eth%2Ewarning%2C%2Etable%3Etfoot%3Etr%2Ewarning%3Etd%2C%2Etable%3Etfoot%3Etr%2Ewarning%3Eth%2C%2Etable%3Etfoot%3Etr%3Etd%2Ewarning%2C%2Etable%3Etfoot%3Etr%3Eth%2Ewarning%2C%2Etable%3Ethead%3Etr%2Ewarning%3Etd%2C%2Etable%3Ethead%3Etr%2Ewarning%3Eth%2C%2Etable%3Ethead%3Etr%3Etd%2Ewarning%2C%2Etable%3Ethead%3Etr%3Eth%2Ewarning%7Bbackground%2Dcolor%3A%23fcf8e3%7D%2Etable%2Dhover%3Etbody%3Etr%2Ewarning%3Ahover%3Etd%2C%2Etable%2Dhover%3Etbody%3Etr%2Ewarning%3Ahover%3Eth%2C%2Etable%2Dhover%3Etbody%3Etr%3Ahover%3E%2Ewarning%2C%2Etable%2Dhover%3Etbody%3Etr%3Etd%2Ewarning%3Ahover%2C%2Etable%2Dhover%3Etbody%3Etr%3Eth%2Ewarning%3Ahover%7Bbackground%2Dcolor%3A%23faf2cc%7D%2Etable%3Etbody%3Etr%2Edanger%3Etd%2C%2Etable%3Etbody%3Etr%2Edanger%3Eth%2C%2Etable%3Etbody%3Etr%3Etd%2Edanger%2C%2Etable%3Etbody%3Etr%3Eth%2Edanger%2C%2Etable%3Etfoot%3Etr%2Edanger%3Etd%2C%2Etable%3Etfoot%3Etr%2Edanger%3Eth%2C%2Etable%3Etfoot%3Etr%3Etd%2Edanger%2C%2Etable%3Etfoot%3Etr%3Eth%2Edanger%2C%2Etable%3Ethead%3Etr%2Edanger%3Etd%2C%2Etable%3Ethead%3Etr%2Edanger%3Eth%2C%2Etable%3Ethead%3Etr%3Etd%2Edanger%2C%2Etable%3Ethead%3Etr%3Eth%2Edanger%7Bbackground%2Dcolor%3A%23f2dede%7D%2Etable%2Dhover%3Etbody%3Etr%2Edanger%3Ahover%3Etd%2C%2Etable%2Dhover%3Etbody%3Etr%2Edanger%3Ahover%3Eth%2C%2Etable%2Dhover%3Etbody%3Etr%3Ahover%3E%2Edanger%2C%2Etable%2Dhover%3Etbody%3Etr%3Etd%2Edanger%3Ahover%2C%2Etable%2Dhover%3Etbody%3Etr%3Eth%2Edanger%3Ahover%7Bbackground%2Dcolor%3A%23ebcccc%7D%2Etable%2Dresponsive%7Bmin%2Dheight%3A%2E01%25%3Boverflow%2Dx%3Aauto%7D%40media%20screen%20and%20%28max%2Dwidth%3A767px%29%7B%2Etable%2Dresponsive%7Bwidth%3A100%25%3Bmargin%2Dbottom%3A15px%3Boverflow%2Dy%3Ahidden%3B%2Dms%2Doverflow%2Dstyle%3A%2Dms%2Dautohiding%2Dscrollbar%3Bborder%3A1px%20solid%20%23ddd%7D%2Etable%2Dresponsive%3E%2Etable%7Bmargin%2Dbottom%3A0%7D%2Etable%2Dresponsive%3E%2Etable%3Etbody%3Etr%3Etd%2C%2Etable%2Dresponsive%3E%2Etable%3Etbody%3Etr%3Eth%2C%2Etable%2Dresponsive%3E%2Etable%3Etfoot%3Etr%3Etd%2C%2Etable%2Dresponsive%3E%2Etable%3Etfoot%3Etr%3Eth%2C%2Etable%2Dresponsive%3E%2Etable%3Ethead%3Etr%3Etd%2C%2Etable%2Dresponsive%3E%2Etable%3Ethead%3Etr%3Eth%7Bwhite%2Dspace%3Anowrap%7D%2Etable%2Dresponsive%3E%2Etable%2Dbordered%7Bborder%3A0%7D%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Etd%3Afirst%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Eth%3Afirst%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Etd%3Afirst%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Eth%3Afirst%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Etd%3Afirst%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Eth%3Afirst%2Dchild%7Bborder%2Dleft%3A0%7D%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Etd%3Alast%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Eth%3Alast%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Etd%3Alast%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Eth%3Alast%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Etd%3Alast%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Eth%3Alast%2Dchild%7Bborder%2Dright%3A0%7D%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Alast%2Dchild%3Etd%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Alast%2Dchild%3Eth%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Alast%2Dchild%3Etd%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Alast%2Dchild%3Eth%7Bborder%2Dbottom%3A0%7D%7Dfieldset%7Bmin%2Dwidth%3A0%3Bpadding%3A0%3Bmargin%3A0%3Bborder%3A0%7Dlegend%7Bdisplay%3Ablock%3Bwidth%3A100%25%3Bpadding%3A0%3Bmargin%2Dbottom%3A20px%3Bfont%2Dsize%3A21px%3Bline%2Dheight%3Ainherit%3Bcolor%3A%23333%3Bborder%3A0%3Bborder%2Dbottom%3A1px%20solid%20%23e5e5e5%7Dlabel%7Bdisplay%3Ainline%2Dblock%3Bmax%2Dwidth%3A100%25%3Bmargin%2Dbottom%3A5px%3Bfont%2Dweight%3A700%7Dinput%5Btype%3Dsearch%5D%7B%2Dwebkit%2Dbox%2Dsizing%3Aborder%2Dbox%3B%2Dmoz%2Dbox%2Dsizing%3Aborder%2Dbox%3Bbox%2Dsizing%3Aborder%2Dbox%7Dinput%5Btype%3Dcheckbox%5D%2Cinput%5Btype%3Dradio%5D%7Bmargin%3A4px%200%200%3Bmargin%2Dtop%3A1px%5C9%3Bline%2Dheight%3Anormal%7Dinput%5Btype%3Dfile%5D%7Bdisplay%3Ablock%7Dinput%5Btype%3Drange%5D%7Bdisplay%3Ablock%3Bwidth%3A100%25%7Dselect%5Bmultiple%5D%2Cselect%5Bsize%5D%7Bheight%3Aauto%7Dinput%5Btype%3Dfile%5D%3Afocus%2Cinput%5Btype%3Dcheckbox%5D%3Afocus%2Cinput%5Btype%3Dradio%5D%3Afocus%7Boutline%3Athin%20dotted%3Boutline%3A5px%20auto%20%2Dwebkit%2Dfocus%2Dring%2Dcolor%3Boutline%2Doffset%3A%2D2px%7Doutput%7Bdisplay%3Ablock%3Bpadding%2Dtop%3A7px%3Bfont%2Dsize%3A14px%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23555%7D%2Eform%2Dcontrol%7Bdisplay%3Ablock%3Bwidth%3A100%25%3Bheight%3A34px%3Bpadding%3A6px%2012px%3Bfont%2Dsize%3A14px%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23555%3Bbackground%2Dcolor%3A%23fff%3Bbackground%2Dimage%3Anone%3Bborder%3A1px%20solid%20%23ccc%3Bborder%2Dradius%3A4px%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%3B%2Dwebkit%2Dtransition%3Aborder%2Dcolor%20ease%2Din%2Dout%20%2E15s%2C%2Dwebkit%2Dbox%2Dshadow%20ease%2Din%2Dout%20%2E15s%3B%2Do%2Dtransition%3Aborder%2Dcolor%20ease%2Din%2Dout%20%2E15s%2Cbox%2Dshadow%20ease%2Din%2Dout%20%2E15s%3Btransition%3Aborder%2Dcolor%20ease%2Din%2Dout%20%2E15s%2Cbox%2Dshadow%20ease%2Din%2Dout%20%2E15s%7D%2Eform%2Dcontrol%3Afocus%7Bborder%2Dcolor%3A%2366afe9%3Boutline%3A0%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%208px%20rgba%28102%2C175%2C233%2C%2E6%29%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%208px%20rgba%28102%2C175%2C233%2C%2E6%29%7D%2Eform%2Dcontrol%3A%3A%2Dmoz%2Dplaceholder%7Bcolor%3A%23999%3Bopacity%3A1%7D%2Eform%2Dcontrol%3A%2Dms%2Dinput%2Dplaceholder%7Bcolor%3A%23999%7D%2Eform%2Dcontrol%3A%3A%2Dwebkit%2Dinput%2Dplaceholder%7Bcolor%3A%23999%7D%2Eform%2Dcontrol%5Bdisabled%5D%2C%2Eform%2Dcontrol%5Breadonly%5D%2Cfieldset%5Bdisabled%5D%20%2Eform%2Dcontrol%7Bbackground%2Dcolor%3A%23eee%3Bopacity%3A1%7D%2Eform%2Dcontrol%5Bdisabled%5D%2Cfieldset%5Bdisabled%5D%20%2Eform%2Dcontrol%7Bcursor%3Anot%2Dallowed%7Dtextarea%2Eform%2Dcontrol%7Bheight%3Aauto%7Dinput%5Btype%3Dsearch%5D%7B%2Dwebkit%2Dappearance%3Anone%7D%40media%20screen%20and%20%28%2Dwebkit%2Dmin%2Ddevice%2Dpixel%2Dratio%3A0%29%7Binput%5Btype%3Ddate%5D%2Eform%2Dcontrol%2Cinput%5Btype%3Dtime%5D%2Eform%2Dcontrol%2Cinput%5Btype%3Ddatetime%2Dlocal%5D%2Eform%2Dcontrol%2Cinput%5Btype%3Dmonth%5D%2Eform%2Dcontrol%7Bline%2Dheight%3A34px%7D%2Einput%2Dgroup%2Dsm%20input%5Btype%3Ddate%5D%2C%2Einput%2Dgroup%2Dsm%20input%5Btype%3Dtime%5D%2C%2Einput%2Dgroup%2Dsm%20input%5Btype%3Ddatetime%2Dlocal%5D%2C%2Einput%2Dgroup%2Dsm%20input%5Btype%3Dmonth%5D%2Cinput%5Btype%3Ddate%5D%2Einput%2Dsm%2Cinput%5Btype%3Dtime%5D%2Einput%2Dsm%2Cinput%5Btype%3Ddatetime%2Dlocal%5D%2Einput%2Dsm%2Cinput%5Btype%3Dmonth%5D%2Einput%2Dsm%7Bline%2Dheight%3A30px%7D%2Einput%2Dgroup%2Dlg%20input%5Btype%3Ddate%5D%2C%2Einput%2Dgroup%2Dlg%20input%5Btype%3Dtime%5D%2C%2Einput%2Dgroup%2Dlg%20input%5Btype%3Ddatetime%2Dlocal%5D%2C%2Einput%2Dgroup%2Dlg%20input%5Btype%3Dmonth%5D%2Cinput%5Btype%3Ddate%5D%2Einput%2Dlg%2Cinput%5Btype%3Dtime%5D%2Einput%2Dlg%2Cinput%5Btype%3Ddatetime%2Dlocal%5D%2Einput%2Dlg%2Cinput%5Btype%3Dmonth%5D%2Einput%2Dlg%7Bline%2Dheight%3A46px%7D%7D%2Eform%2Dgroup%7Bmargin%2Dbottom%3A15px%7D%2Echeckbox%2C%2Eradio%7Bposition%3Arelative%3Bdisplay%3Ablock%3Bmargin%2Dtop%3A10px%3Bmargin%2Dbottom%3A10px%7D%2Echeckbox%20label%2C%2Eradio%20label%7Bmin%2Dheight%3A20px%3Bpadding%2Dleft%3A20px%3Bmargin%2Dbottom%3A0%3Bfont%2Dweight%3A400%3Bcursor%3Apointer%7D%2Echeckbox%20input%5Btype%3Dcheckbox%5D%2C%2Echeckbox%2Dinline%20input%5Btype%3Dcheckbox%5D%2C%2Eradio%20input%5Btype%3Dradio%5D%2C%2Eradio%2Dinline%20input%5Btype%3Dradio%5D%7Bposition%3Aabsolute%3Bmargin%2Dtop%3A4px%5C9%3Bmargin%2Dleft%3A%2D20px%7D%2Echeckbox%2B%2Echeckbox%2C%2Eradio%2B%2Eradio%7Bmargin%2Dtop%3A%2D5px%7D%2Echeckbox%2Dinline%2C%2Eradio%2Dinline%7Bposition%3Arelative%3Bdisplay%3Ainline%2Dblock%3Bpadding%2Dleft%3A20px%3Bmargin%2Dbottom%3A0%3Bfont%2Dweight%3A400%3Bvertical%2Dalign%3Amiddle%3Bcursor%3Apointer%7D%2Echeckbox%2Dinline%2B%2Echeckbox%2Dinline%2C%2Eradio%2Dinline%2B%2Eradio%2Dinline%7Bmargin%2Dtop%3A0%3Bmargin%2Dleft%3A10px%7Dfieldset%5Bdisabled%5D%20input%5Btype%3Dcheckbox%5D%2Cfieldset%5Bdisabled%5D%20input%5Btype%3Dradio%5D%2Cinput%5Btype%3Dcheckbox%5D%2Edisabled%2Cinput%5Btype%3Dcheckbox%5D%5Bdisabled%5D%2Cinput%5Btype%3Dradio%5D%2Edisabled%2Cinput%5Btype%3Dradio%5D%5Bdisabled%5D%7Bcursor%3Anot%2Dallowed%7D%2Echeckbox%2Dinline%2Edisabled%2C%2Eradio%2Dinline%2Edisabled%2Cfieldset%5Bdisabled%5D%20%2Echeckbox%2Dinline%2Cfieldset%5Bdisabled%5D%20%2Eradio%2Dinline%7Bcursor%3Anot%2Dallowed%7D%2Echeckbox%2Edisabled%20label%2C%2Eradio%2Edisabled%20label%2Cfieldset%5Bdisabled%5D%20%2Echeckbox%20label%2Cfieldset%5Bdisabled%5D%20%2Eradio%20label%7Bcursor%3Anot%2Dallowed%7D%2Eform%2Dcontrol%2Dstatic%7Bmin%2Dheight%3A34px%3Bpadding%2Dtop%3A7px%3Bpadding%2Dbottom%3A7px%3Bmargin%2Dbottom%3A0%7D%2Eform%2Dcontrol%2Dstatic%2Einput%2Dlg%2C%2Eform%2Dcontrol%2Dstatic%2Einput%2Dsm%7Bpadding%2Dright%3A0%3Bpadding%2Dleft%3A0%7D%2Einput%2Dsm%7Bheight%3A30px%3Bpadding%3A5px%2010px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E5%3Bborder%2Dradius%3A3px%7Dselect%2Einput%2Dsm%7Bheight%3A30px%3Bline%2Dheight%3A30px%7Dselect%5Bmultiple%5D%2Einput%2Dsm%2Ctextarea%2Einput%2Dsm%7Bheight%3Aauto%7D%2Eform%2Dgroup%2Dsm%20%2Eform%2Dcontrol%7Bheight%3A30px%3Bpadding%3A5px%2010px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E5%3Bborder%2Dradius%3A3px%7D%2Eform%2Dgroup%2Dsm%20select%2Eform%2Dcontrol%7Bheight%3A30px%3Bline%2Dheight%3A30px%7D%2Eform%2Dgroup%2Dsm%20select%5Bmultiple%5D%2Eform%2Dcontrol%2C%2Eform%2Dgroup%2Dsm%20textarea%2Eform%2Dcontrol%7Bheight%3Aauto%7D%2Eform%2Dgroup%2Dsm%20%2Eform%2Dcontrol%2Dstatic%7Bheight%3A30px%3Bmin%2Dheight%3A32px%3Bpadding%3A6px%2010px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E5%7D%2Einput%2Dlg%7Bheight%3A46px%3Bpadding%3A10px%2016px%3Bfont%2Dsize%3A18px%3Bline%2Dheight%3A1%2E3333333%3Bborder%2Dradius%3A6px%7Dselect%2Einput%2Dlg%7Bheight%3A46px%3Bline%2Dheight%3A46px%7Dselect%5Bmultiple%5D%2Einput%2Dlg%2Ctextarea%2Einput%2Dlg%7Bheight%3Aauto%7D%2Eform%2Dgroup%2Dlg%20%2Eform%2Dcontrol%7Bheight%3A46px%3Bpadding%3A10px%2016px%3Bfont%2Dsize%3A18px%3Bline%2Dheight%3A1%2E3333333%3Bborder%2Dradius%3A6px%7D%2Eform%2Dgroup%2Dlg%20select%2Eform%2Dcontrol%7Bheight%3A46px%3Bline%2Dheight%3A46px%7D%2Eform%2Dgroup%2Dlg%20select%5Bmultiple%5D%2Eform%2Dcontrol%2C%2Eform%2Dgroup%2Dlg%20textarea%2Eform%2Dcontrol%7Bheight%3Aauto%7D%2Eform%2Dgroup%2Dlg%20%2Eform%2Dcontrol%2Dstatic%7Bheight%3A46px%3Bmin%2Dheight%3A38px%3Bpadding%3A11px%2016px%3Bfont%2Dsize%3A18px%3Bline%2Dheight%3A1%2E3333333%7D%2Ehas%2Dfeedback%7Bposition%3Arelative%7D%2Ehas%2Dfeedback%20%2Eform%2Dcontrol%7Bpadding%2Dright%3A42%2E5px%7D%2Eform%2Dcontrol%2Dfeedback%7Bposition%3Aabsolute%3Btop%3A0%3Bright%3A0%3Bz%2Dindex%3A2%3Bdisplay%3Ablock%3Bwidth%3A34px%3Bheight%3A34px%3Bline%2Dheight%3A34px%3Btext%2Dalign%3Acenter%3Bpointer%2Devents%3Anone%7D%2Eform%2Dgroup%2Dlg%20%2Eform%2Dcontrol%2B%2Eform%2Dcontrol%2Dfeedback%2C%2Einput%2Dgroup%2Dlg%2B%2Eform%2Dcontrol%2Dfeedback%2C%2Einput%2Dlg%2B%2Eform%2Dcontrol%2Dfeedback%7Bwidth%3A46px%3Bheight%3A46px%3Bline%2Dheight%3A46px%7D%2Eform%2Dgroup%2Dsm%20%2Eform%2Dcontrol%2B%2Eform%2Dcontrol%2Dfeedback%2C%2Einput%2Dgroup%2Dsm%2B%2Eform%2Dcontrol%2Dfeedback%2C%2Einput%2Dsm%2B%2Eform%2Dcontrol%2Dfeedback%7Bwidth%3A30px%3Bheight%3A30px%3Bline%2Dheight%3A30px%7D%2Ehas%2Dsuccess%20%2Echeckbox%2C%2Ehas%2Dsuccess%20%2Echeckbox%2Dinline%2C%2Ehas%2Dsuccess%20%2Econtrol%2Dlabel%2C%2Ehas%2Dsuccess%20%2Ehelp%2Dblock%2C%2Ehas%2Dsuccess%20%2Eradio%2C%2Ehas%2Dsuccess%20%2Eradio%2Dinline%2C%2Ehas%2Dsuccess%2Echeckbox%20label%2C%2Ehas%2Dsuccess%2Echeckbox%2Dinline%20label%2C%2Ehas%2Dsuccess%2Eradio%20label%2C%2Ehas%2Dsuccess%2Eradio%2Dinline%20label%7Bcolor%3A%233c763d%7D%2Ehas%2Dsuccess%20%2Eform%2Dcontrol%7Bborder%2Dcolor%3A%233c763d%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%7D%2Ehas%2Dsuccess%20%2Eform%2Dcontrol%3Afocus%7Bborder%2Dcolor%3A%232b542c%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%206px%20%2367b168%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%206px%20%2367b168%7D%2Ehas%2Dsuccess%20%2Einput%2Dgroup%2Daddon%7Bcolor%3A%233c763d%3Bbackground%2Dcolor%3A%23dff0d8%3Bborder%2Dcolor%3A%233c763d%7D%2Ehas%2Dsuccess%20%2Eform%2Dcontrol%2Dfeedback%7Bcolor%3A%233c763d%7D%2Ehas%2Dwarning%20%2Echeckbox%2C%2Ehas%2Dwarning%20%2Echeckbox%2Dinline%2C%2Ehas%2Dwarning%20%2Econtrol%2Dlabel%2C%2Ehas%2Dwarning%20%2Ehelp%2Dblock%2C%2Ehas%2Dwarning%20%2Eradio%2C%2Ehas%2Dwarning%20%2Eradio%2Dinline%2C%2Ehas%2Dwarning%2Echeckbox%20label%2C%2Ehas%2Dwarning%2Echeckbox%2Dinline%20label%2C%2Ehas%2Dwarning%2Eradio%20label%2C%2Ehas%2Dwarning%2Eradio%2Dinline%20label%7Bcolor%3A%238a6d3b%7D%2Ehas%2Dwarning%20%2Eform%2Dcontrol%7Bborder%2Dcolor%3A%238a6d3b%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%7D%2Ehas%2Dwarning%20%2Eform%2Dcontrol%3Afocus%7Bborder%2Dcolor%3A%2366512c%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%206px%20%23c0a16b%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%206px%20%23c0a16b%7D%2Ehas%2Dwarning%20%2Einput%2Dgroup%2Daddon%7Bcolor%3A%238a6d3b%3Bbackground%2Dcolor%3A%23fcf8e3%3Bborder%2Dcolor%3A%238a6d3b%7D%2Ehas%2Dwarning%20%2Eform%2Dcontrol%2Dfeedback%7Bcolor%3A%238a6d3b%7D%2Ehas%2Derror%20%2Echeckbox%2C%2Ehas%2Derror%20%2Echeckbox%2Dinline%2C%2Ehas%2Derror%20%2Econtrol%2Dlabel%2C%2Ehas%2Derror%20%2Ehelp%2Dblock%2C%2Ehas%2Derror%20%2Eradio%2C%2Ehas%2Derror%20%2Eradio%2Dinline%2C%2Ehas%2Derror%2Echeckbox%20label%2C%2Ehas%2Derror%2Echeckbox%2Dinline%20label%2C%2Ehas%2Derror%2Eradio%20label%2C%2Ehas%2Derror%2Eradio%2Dinline%20label%7Bcolor%3A%23a94442%7D%2Ehas%2Derror%20%2Eform%2Dcontrol%7Bborder%2Dcolor%3A%23a94442%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%7D%2Ehas%2Derror%20%2Eform%2Dcontrol%3Afocus%7Bborder%2Dcolor%3A%23843534%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%206px%20%23ce8483%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%206px%20%23ce8483%7D%2Ehas%2Derror%20%2Einput%2Dgroup%2Daddon%7Bcolor%3A%23a94442%3Bbackground%2Dcolor%3A%23f2dede%3Bborder%2Dcolor%3A%23a94442%7D%2Ehas%2Derror%20%2Eform%2Dcontrol%2Dfeedback%7Bcolor%3A%23a94442%7D%2Ehas%2Dfeedback%20label%7E%2Eform%2Dcontrol%2Dfeedback%7Btop%3A25px%7D%2Ehas%2Dfeedback%20label%2Esr%2Donly%7E%2Eform%2Dcontrol%2Dfeedback%7Btop%3A0%7D%2Ehelp%2Dblock%7Bdisplay%3Ablock%3Bmargin%2Dtop%3A5px%3Bmargin%2Dbottom%3A10px%3Bcolor%3A%23737373%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Eform%2Dinline%20%2Eform%2Dgroup%7Bdisplay%3Ainline%2Dblock%3Bmargin%2Dbottom%3A0%3Bvertical%2Dalign%3Amiddle%7D%2Eform%2Dinline%20%2Eform%2Dcontrol%7Bdisplay%3Ainline%2Dblock%3Bwidth%3Aauto%3Bvertical%2Dalign%3Amiddle%7D%2Eform%2Dinline%20%2Eform%2Dcontrol%2Dstatic%7Bdisplay%3Ainline%2Dblock%7D%2Eform%2Dinline%20%2Einput%2Dgroup%7Bdisplay%3Ainline%2Dtable%3Bvertical%2Dalign%3Amiddle%7D%2Eform%2Dinline%20%2Einput%2Dgroup%20%2Eform%2Dcontrol%2C%2Eform%2Dinline%20%2Einput%2Dgroup%20%2Einput%2Dgroup%2Daddon%2C%2Eform%2Dinline%20%2Einput%2Dgroup%20%2Einput%2Dgroup%2Dbtn%7Bwidth%3Aauto%7D%2Eform%2Dinline%20%2Einput%2Dgroup%3E%2Eform%2Dcontrol%7Bwidth%3A100%25%7D%2Eform%2Dinline%20%2Econtrol%2Dlabel%7Bmargin%2Dbottom%3A0%3Bvertical%2Dalign%3Amiddle%7D%2Eform%2Dinline%20%2Echeckbox%2C%2Eform%2Dinline%20%2Eradio%7Bdisplay%3Ainline%2Dblock%3Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A0%3Bvertical%2Dalign%3Amiddle%7D%2Eform%2Dinline%20%2Echeckbox%20label%2C%2Eform%2Dinline%20%2Eradio%20label%7Bpadding%2Dleft%3A0%7D%2Eform%2Dinline%20%2Echeckbox%20input%5Btype%3Dcheckbox%5D%2C%2Eform%2Dinline%20%2Eradio%20input%5Btype%3Dradio%5D%7Bposition%3Arelative%3Bmargin%2Dleft%3A0%7D%2Eform%2Dinline%20%2Ehas%2Dfeedback%20%2Eform%2Dcontrol%2Dfeedback%7Btop%3A0%7D%7D%2Eform%2Dhorizontal%20%2Echeckbox%2C%2Eform%2Dhorizontal%20%2Echeckbox%2Dinline%2C%2Eform%2Dhorizontal%20%2Eradio%2C%2Eform%2Dhorizontal%20%2Eradio%2Dinline%7Bpadding%2Dtop%3A7px%3Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A0%7D%2Eform%2Dhorizontal%20%2Echeckbox%2C%2Eform%2Dhorizontal%20%2Eradio%7Bmin%2Dheight%3A27px%7D%2Eform%2Dhorizontal%20%2Eform%2Dgroup%7Bmargin%2Dright%3A%2D15px%3Bmargin%2Dleft%3A%2D15px%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Eform%2Dhorizontal%20%2Econtrol%2Dlabel%7Bpadding%2Dtop%3A7px%3Bmargin%2Dbottom%3A0%3Btext%2Dalign%3Aright%7D%7D%2Eform%2Dhorizontal%20%2Ehas%2Dfeedback%20%2Eform%2Dcontrol%2Dfeedback%7Bright%3A15px%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Eform%2Dhorizontal%20%2Eform%2Dgroup%2Dlg%20%2Econtrol%2Dlabel%7Bpadding%2Dtop%3A14%2E33px%3Bfont%2Dsize%3A18px%7D%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Eform%2Dhorizontal%20%2Eform%2Dgroup%2Dsm%20%2Econtrol%2Dlabel%7Bpadding%2Dtop%3A6px%3Bfont%2Dsize%3A12px%7D%7D%2Ebtn%7Bdisplay%3Ainline%2Dblock%3Bpadding%3A6px%2012px%3Bmargin%2Dbottom%3A0%3Bfont%2Dsize%3A14px%3Bfont%2Dweight%3A400%3Bline%2Dheight%3A1%2E42857143%3Btext%2Dalign%3Acenter%3Bwhite%2Dspace%3Anowrap%3Bvertical%2Dalign%3Amiddle%3B%2Dms%2Dtouch%2Daction%3Amanipulation%3Btouch%2Daction%3Amanipulation%3Bcursor%3Apointer%3B%2Dwebkit%2Duser%2Dselect%3Anone%3B%2Dmoz%2Duser%2Dselect%3Anone%3B%2Dms%2Duser%2Dselect%3Anone%3Buser%2Dselect%3Anone%3Bbackground%2Dimage%3Anone%3Bborder%3A1px%20solid%20transparent%3Bborder%2Dradius%3A4px%7D%2Ebtn%2Eactive%2Efocus%2C%2Ebtn%2Eactive%3Afocus%2C%2Ebtn%2Efocus%2C%2Ebtn%3Aactive%2Efocus%2C%2Ebtn%3Aactive%3Afocus%2C%2Ebtn%3Afocus%7Boutline%3Athin%20dotted%3Boutline%3A5px%20auto%20%2Dwebkit%2Dfocus%2Dring%2Dcolor%3Boutline%2Doffset%3A%2D2px%7D%2Ebtn%2Efocus%2C%2Ebtn%3Afocus%2C%2Ebtn%3Ahover%7Bcolor%3A%23333%3Btext%2Ddecoration%3Anone%7D%2Ebtn%2Eactive%2C%2Ebtn%3Aactive%7Bbackground%2Dimage%3Anone%3Boutline%3A0%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%203px%205px%20rgba%280%2C0%2C0%2C%2E125%29%3Bbox%2Dshadow%3Ainset%200%203px%205px%20rgba%280%2C0%2C0%2C%2E125%29%7D%2Ebtn%2Edisabled%2C%2Ebtn%5Bdisabled%5D%2Cfieldset%5Bdisabled%5D%20%2Ebtn%7Bcursor%3Anot%2Dallowed%3Bfilter%3Aalpha%28opacity%3D65%29%3B%2Dwebkit%2Dbox%2Dshadow%3Anone%3Bbox%2Dshadow%3Anone%3Bopacity%3A%2E65%7Da%2Ebtn%2Edisabled%2Cfieldset%5Bdisabled%5D%20a%2Ebtn%7Bpointer%2Devents%3Anone%7D%2Ebtn%2Ddefault%7Bcolor%3A%23333%3Bbackground%2Dcolor%3A%23fff%3Bborder%2Dcolor%3A%23ccc%7D%2Ebtn%2Ddefault%2Efocus%2C%2Ebtn%2Ddefault%3Afocus%7Bcolor%3A%23333%3Bbackground%2Dcolor%3A%23e6e6e6%3Bborder%2Dcolor%3A%238c8c8c%7D%2Ebtn%2Ddefault%3Ahover%7Bcolor%3A%23333%3Bbackground%2Dcolor%3A%23e6e6e6%3Bborder%2Dcolor%3A%23adadad%7D%2Ebtn%2Ddefault%2Eactive%2C%2Ebtn%2Ddefault%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddefault%7Bcolor%3A%23333%3Bbackground%2Dcolor%3A%23e6e6e6%3Bborder%2Dcolor%3A%23adadad%7D%2Ebtn%2Ddefault%2Eactive%2Efocus%2C%2Ebtn%2Ddefault%2Eactive%3Afocus%2C%2Ebtn%2Ddefault%2Eactive%3Ahover%2C%2Ebtn%2Ddefault%3Aactive%2Efocus%2C%2Ebtn%2Ddefault%3Aactive%3Afocus%2C%2Ebtn%2Ddefault%3Aactive%3Ahover%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddefault%2Efocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddefault%3Afocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddefault%3Ahover%7Bcolor%3A%23333%3Bbackground%2Dcolor%3A%23d4d4d4%3Bborder%2Dcolor%3A%238c8c8c%7D%2Ebtn%2Ddefault%2Eactive%2C%2Ebtn%2Ddefault%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddefault%7Bbackground%2Dimage%3Anone%7D%2Ebtn%2Ddefault%2Edisabled%2C%2Ebtn%2Ddefault%2Edisabled%2Eactive%2C%2Ebtn%2Ddefault%2Edisabled%2Efocus%2C%2Ebtn%2Ddefault%2Edisabled%3Aactive%2C%2Ebtn%2Ddefault%2Edisabled%3Afocus%2C%2Ebtn%2Ddefault%2Edisabled%3Ahover%2C%2Ebtn%2Ddefault%5Bdisabled%5D%2C%2Ebtn%2Ddefault%5Bdisabled%5D%2Eactive%2C%2Ebtn%2Ddefault%5Bdisabled%5D%2Efocus%2C%2Ebtn%2Ddefault%5Bdisabled%5D%3Aactive%2C%2Ebtn%2Ddefault%5Bdisabled%5D%3Afocus%2C%2Ebtn%2Ddefault%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddefault%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddefault%2Eactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddefault%2Efocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddefault%3Aactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddefault%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddefault%3Ahover%7Bbackground%2Dcolor%3A%23fff%3Bborder%2Dcolor%3A%23ccc%7D%2Ebtn%2Ddefault%20%2Ebadge%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23333%7D%2Ebtn%2Dprimary%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23337ab7%3Bborder%2Dcolor%3A%232e6da4%7D%2Ebtn%2Dprimary%2Efocus%2C%2Ebtn%2Dprimary%3Afocus%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23286090%3Bborder%2Dcolor%3A%23122b40%7D%2Ebtn%2Dprimary%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23286090%3Bborder%2Dcolor%3A%23204d74%7D%2Ebtn%2Dprimary%2Eactive%2C%2Ebtn%2Dprimary%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dprimary%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23286090%3Bborder%2Dcolor%3A%23204d74%7D%2Ebtn%2Dprimary%2Eactive%2Efocus%2C%2Ebtn%2Dprimary%2Eactive%3Afocus%2C%2Ebtn%2Dprimary%2Eactive%3Ahover%2C%2Ebtn%2Dprimary%3Aactive%2Efocus%2C%2Ebtn%2Dprimary%3Aactive%3Afocus%2C%2Ebtn%2Dprimary%3Aactive%3Ahover%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dprimary%2Efocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dprimary%3Afocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dprimary%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23204d74%3Bborder%2Dcolor%3A%23122b40%7D%2Ebtn%2Dprimary%2Eactive%2C%2Ebtn%2Dprimary%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dprimary%7Bbackground%2Dimage%3Anone%7D%2Ebtn%2Dprimary%2Edisabled%2C%2Ebtn%2Dprimary%2Edisabled%2Eactive%2C%2Ebtn%2Dprimary%2Edisabled%2Efocus%2C%2Ebtn%2Dprimary%2Edisabled%3Aactive%2C%2Ebtn%2Dprimary%2Edisabled%3Afocus%2C%2Ebtn%2Dprimary%2Edisabled%3Ahover%2C%2Ebtn%2Dprimary%5Bdisabled%5D%2C%2Ebtn%2Dprimary%5Bdisabled%5D%2Eactive%2C%2Ebtn%2Dprimary%5Bdisabled%5D%2Efocus%2C%2Ebtn%2Dprimary%5Bdisabled%5D%3Aactive%2C%2Ebtn%2Dprimary%5Bdisabled%5D%3Afocus%2C%2Ebtn%2Dprimary%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dprimary%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dprimary%2Eactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dprimary%2Efocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dprimary%3Aactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dprimary%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dprimary%3Ahover%7Bbackground%2Dcolor%3A%23337ab7%3Bborder%2Dcolor%3A%232e6da4%7D%2Ebtn%2Dprimary%20%2Ebadge%7Bcolor%3A%23337ab7%3Bbackground%2Dcolor%3A%23fff%7D%2Ebtn%2Dsuccess%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%235cb85c%3Bborder%2Dcolor%3A%234cae4c%7D%2Ebtn%2Dsuccess%2Efocus%2C%2Ebtn%2Dsuccess%3Afocus%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23449d44%3Bborder%2Dcolor%3A%23255625%7D%2Ebtn%2Dsuccess%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23449d44%3Bborder%2Dcolor%3A%23398439%7D%2Ebtn%2Dsuccess%2Eactive%2C%2Ebtn%2Dsuccess%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dsuccess%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23449d44%3Bborder%2Dcolor%3A%23398439%7D%2Ebtn%2Dsuccess%2Eactive%2Efocus%2C%2Ebtn%2Dsuccess%2Eactive%3Afocus%2C%2Ebtn%2Dsuccess%2Eactive%3Ahover%2C%2Ebtn%2Dsuccess%3Aactive%2Efocus%2C%2Ebtn%2Dsuccess%3Aactive%3Afocus%2C%2Ebtn%2Dsuccess%3Aactive%3Ahover%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dsuccess%2Efocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dsuccess%3Afocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dsuccess%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23398439%3Bborder%2Dcolor%3A%23255625%7D%2Ebtn%2Dsuccess%2Eactive%2C%2Ebtn%2Dsuccess%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dsuccess%7Bbackground%2Dimage%3Anone%7D%2Ebtn%2Dsuccess%2Edisabled%2C%2Ebtn%2Dsuccess%2Edisabled%2Eactive%2C%2Ebtn%2Dsuccess%2Edisabled%2Efocus%2C%2Ebtn%2Dsuccess%2Edisabled%3Aactive%2C%2Ebtn%2Dsuccess%2Edisabled%3Afocus%2C%2Ebtn%2Dsuccess%2Edisabled%3Ahover%2C%2Ebtn%2Dsuccess%5Bdisabled%5D%2C%2Ebtn%2Dsuccess%5Bdisabled%5D%2Eactive%2C%2Ebtn%2Dsuccess%5Bdisabled%5D%2Efocus%2C%2Ebtn%2Dsuccess%5Bdisabled%5D%3Aactive%2C%2Ebtn%2Dsuccess%5Bdisabled%5D%3Afocus%2C%2Ebtn%2Dsuccess%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dsuccess%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dsuccess%2Eactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dsuccess%2Efocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dsuccess%3Aactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dsuccess%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dsuccess%3Ahover%7Bbackground%2Dcolor%3A%235cb85c%3Bborder%2Dcolor%3A%234cae4c%7D%2Ebtn%2Dsuccess%20%2Ebadge%7Bcolor%3A%235cb85c%3Bbackground%2Dcolor%3A%23fff%7D%2Ebtn%2Dinfo%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%235bc0de%3Bborder%2Dcolor%3A%2346b8da%7D%2Ebtn%2Dinfo%2Efocus%2C%2Ebtn%2Dinfo%3Afocus%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%2331b0d5%3Bborder%2Dcolor%3A%231b6d85%7D%2Ebtn%2Dinfo%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%2331b0d5%3Bborder%2Dcolor%3A%23269abc%7D%2Ebtn%2Dinfo%2Eactive%2C%2Ebtn%2Dinfo%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dinfo%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%2331b0d5%3Bborder%2Dcolor%3A%23269abc%7D%2Ebtn%2Dinfo%2Eactive%2Efocus%2C%2Ebtn%2Dinfo%2Eactive%3Afocus%2C%2Ebtn%2Dinfo%2Eactive%3Ahover%2C%2Ebtn%2Dinfo%3Aactive%2Efocus%2C%2Ebtn%2Dinfo%3Aactive%3Afocus%2C%2Ebtn%2Dinfo%3Aactive%3Ahover%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dinfo%2Efocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dinfo%3Afocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dinfo%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23269abc%3Bborder%2Dcolor%3A%231b6d85%7D%2Ebtn%2Dinfo%2Eactive%2C%2Ebtn%2Dinfo%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dinfo%7Bbackground%2Dimage%3Anone%7D%2Ebtn%2Dinfo%2Edisabled%2C%2Ebtn%2Dinfo%2Edisabled%2Eactive%2C%2Ebtn%2Dinfo%2Edisabled%2Efocus%2C%2Ebtn%2Dinfo%2Edisabled%3Aactive%2C%2Ebtn%2Dinfo%2Edisabled%3Afocus%2C%2Ebtn%2Dinfo%2Edisabled%3Ahover%2C%2Ebtn%2Dinfo%5Bdisabled%5D%2C%2Ebtn%2Dinfo%5Bdisabled%5D%2Eactive%2C%2Ebtn%2Dinfo%5Bdisabled%5D%2Efocus%2C%2Ebtn%2Dinfo%5Bdisabled%5D%3Aactive%2C%2Ebtn%2Dinfo%5Bdisabled%5D%3Afocus%2C%2Ebtn%2Dinfo%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dinfo%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dinfo%2Eactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dinfo%2Efocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dinfo%3Aactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dinfo%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dinfo%3Ahover%7Bbackground%2Dcolor%3A%235bc0de%3Bborder%2Dcolor%3A%2346b8da%7D%2Ebtn%2Dinfo%20%2Ebadge%7Bcolor%3A%235bc0de%3Bbackground%2Dcolor%3A%23fff%7D%2Ebtn%2Dwarning%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23f0ad4e%3Bborder%2Dcolor%3A%23eea236%7D%2Ebtn%2Dwarning%2Efocus%2C%2Ebtn%2Dwarning%3Afocus%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23ec971f%3Bborder%2Dcolor%3A%23985f0d%7D%2Ebtn%2Dwarning%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23ec971f%3Bborder%2Dcolor%3A%23d58512%7D%2Ebtn%2Dwarning%2Eactive%2C%2Ebtn%2Dwarning%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dwarning%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23ec971f%3Bborder%2Dcolor%3A%23d58512%7D%2Ebtn%2Dwarning%2Eactive%2Efocus%2C%2Ebtn%2Dwarning%2Eactive%3Afocus%2C%2Ebtn%2Dwarning%2Eactive%3Ahover%2C%2Ebtn%2Dwarning%3Aactive%2Efocus%2C%2Ebtn%2Dwarning%3Aactive%3Afocus%2C%2Ebtn%2Dwarning%3Aactive%3Ahover%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dwarning%2Efocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dwarning%3Afocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dwarning%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23d58512%3Bborder%2Dcolor%3A%23985f0d%7D%2Ebtn%2Dwarning%2Eactive%2C%2Ebtn%2Dwarning%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dwarning%7Bbackground%2Dimage%3Anone%7D%2Ebtn%2Dwarning%2Edisabled%2C%2Ebtn%2Dwarning%2Edisabled%2Eactive%2C%2Ebtn%2Dwarning%2Edisabled%2Efocus%2C%2Ebtn%2Dwarning%2Edisabled%3Aactive%2C%2Ebtn%2Dwarning%2Edisabled%3Afocus%2C%2Ebtn%2Dwarning%2Edisabled%3Ahover%2C%2Ebtn%2Dwarning%5Bdisabled%5D%2C%2Ebtn%2Dwarning%5Bdisabled%5D%2Eactive%2C%2Ebtn%2Dwarning%5Bdisabled%5D%2Efocus%2C%2Ebtn%2Dwarning%5Bdisabled%5D%3Aactive%2C%2Ebtn%2Dwarning%5Bdisabled%5D%3Afocus%2C%2Ebtn%2Dwarning%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dwarning%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dwarning%2Eactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dwarning%2Efocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dwarning%3Aactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dwarning%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dwarning%3Ahover%7Bbackground%2Dcolor%3A%23f0ad4e%3Bborder%2Dcolor%3A%23eea236%7D%2Ebtn%2Dwarning%20%2Ebadge%7Bcolor%3A%23f0ad4e%3Bbackground%2Dcolor%3A%23fff%7D%2Ebtn%2Ddanger%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23d9534f%3Bborder%2Dcolor%3A%23d43f3a%7D%2Ebtn%2Ddanger%2Efocus%2C%2Ebtn%2Ddanger%3Afocus%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23c9302c%3Bborder%2Dcolor%3A%23761c19%7D%2Ebtn%2Ddanger%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23c9302c%3Bborder%2Dcolor%3A%23ac2925%7D%2Ebtn%2Ddanger%2Eactive%2C%2Ebtn%2Ddanger%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddanger%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23c9302c%3Bborder%2Dcolor%3A%23ac2925%7D%2Ebtn%2Ddanger%2Eactive%2Efocus%2C%2Ebtn%2Ddanger%2Eactive%3Afocus%2C%2Ebtn%2Ddanger%2Eactive%3Ahover%2C%2Ebtn%2Ddanger%3Aactive%2Efocus%2C%2Ebtn%2Ddanger%3Aactive%3Afocus%2C%2Ebtn%2Ddanger%3Aactive%3Ahover%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddanger%2Efocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddanger%3Afocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddanger%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23ac2925%3Bborder%2Dcolor%3A%23761c19%7D%2Ebtn%2Ddanger%2Eactive%2C%2Ebtn%2Ddanger%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddanger%7Bbackground%2Dimage%3Anone%7D%2Ebtn%2Ddanger%2Edisabled%2C%2Ebtn%2Ddanger%2Edisabled%2Eactive%2C%2Ebtn%2Ddanger%2Edisabled%2Efocus%2C%2Ebtn%2Ddanger%2Edisabled%3Aactive%2C%2Ebtn%2Ddanger%2Edisabled%3Afocus%2C%2Ebtn%2Ddanger%2Edisabled%3Ahover%2C%2Ebtn%2Ddanger%5Bdisabled%5D%2C%2Ebtn%2Ddanger%5Bdisabled%5D%2Eactive%2C%2Ebtn%2Ddanger%5Bdisabled%5D%2Efocus%2C%2Ebtn%2Ddanger%5Bdisabled%5D%3Aactive%2C%2Ebtn%2Ddanger%5Bdisabled%5D%3Afocus%2C%2Ebtn%2Ddanger%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddanger%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddanger%2Eactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddanger%2Efocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddanger%3Aactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddanger%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddanger%3Ahover%7Bbackground%2Dcolor%3A%23d9534f%3Bborder%2Dcolor%3A%23d43f3a%7D%2Ebtn%2Ddanger%20%2Ebadge%7Bcolor%3A%23d9534f%3Bbackground%2Dcolor%3A%23fff%7D%2Ebtn%2Dlink%7Bfont%2Dweight%3A400%3Bcolor%3A%23337ab7%3Bborder%2Dradius%3A0%7D%2Ebtn%2Dlink%2C%2Ebtn%2Dlink%2Eactive%2C%2Ebtn%2Dlink%3Aactive%2C%2Ebtn%2Dlink%5Bdisabled%5D%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dlink%7Bbackground%2Dcolor%3Atransparent%3B%2Dwebkit%2Dbox%2Dshadow%3Anone%3Bbox%2Dshadow%3Anone%7D%2Ebtn%2Dlink%2C%2Ebtn%2Dlink%3Aactive%2C%2Ebtn%2Dlink%3Afocus%2C%2Ebtn%2Dlink%3Ahover%7Bborder%2Dcolor%3Atransparent%7D%2Ebtn%2Dlink%3Afocus%2C%2Ebtn%2Dlink%3Ahover%7Bcolor%3A%2323527c%3Btext%2Ddecoration%3Aunderline%3Bbackground%2Dcolor%3Atransparent%7D%2Ebtn%2Dlink%5Bdisabled%5D%3Afocus%2C%2Ebtn%2Dlink%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dlink%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dlink%3Ahover%7Bcolor%3A%23777%3Btext%2Ddecoration%3Anone%7D%2Ebtn%2Dgroup%2Dlg%3E%2Ebtn%2C%2Ebtn%2Dlg%7Bpadding%3A10px%2016px%3Bfont%2Dsize%3A18px%3Bline%2Dheight%3A1%2E3333333%3Bborder%2Dradius%3A6px%7D%2Ebtn%2Dgroup%2Dsm%3E%2Ebtn%2C%2Ebtn%2Dsm%7Bpadding%3A5px%2010px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E5%3Bborder%2Dradius%3A3px%7D%2Ebtn%2Dgroup%2Dxs%3E%2Ebtn%2C%2Ebtn%2Dxs%7Bpadding%3A1px%205px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E5%3Bborder%2Dradius%3A3px%7D%2Ebtn%2Dblock%7Bdisplay%3Ablock%3Bwidth%3A100%25%7D%2Ebtn%2Dblock%2B%2Ebtn%2Dblock%7Bmargin%2Dtop%3A5px%7Dinput%5Btype%3Dbutton%5D%2Ebtn%2Dblock%2Cinput%5Btype%3Dreset%5D%2Ebtn%2Dblock%2Cinput%5Btype%3Dsubmit%5D%2Ebtn%2Dblock%7Bwidth%3A100%25%7D%2Efade%7Bopacity%3A0%3B%2Dwebkit%2Dtransition%3Aopacity%20%2E15s%20linear%3B%2Do%2Dtransition%3Aopacity%20%2E15s%20linear%3Btransition%3Aopacity%20%2E15s%20linear%7D%2Efade%2Ein%7Bopacity%3A1%7D%2Ecollapse%7Bdisplay%3Anone%7D%2Ecollapse%2Ein%7Bdisplay%3Ablock%7Dtr%2Ecollapse%2Ein%7Bdisplay%3Atable%2Drow%7Dtbody%2Ecollapse%2Ein%7Bdisplay%3Atable%2Drow%2Dgroup%7D%2Ecollapsing%7Bposition%3Arelative%3Bheight%3A0%3Boverflow%3Ahidden%3B%2Dwebkit%2Dtransition%2Dtiming%2Dfunction%3Aease%3B%2Do%2Dtransition%2Dtiming%2Dfunction%3Aease%3Btransition%2Dtiming%2Dfunction%3Aease%3B%2Dwebkit%2Dtransition%2Dduration%3A%2E35s%3B%2Do%2Dtransition%2Dduration%3A%2E35s%3Btransition%2Dduration%3A%2E35s%3B%2Dwebkit%2Dtransition%2Dproperty%3Aheight%2Cvisibility%3B%2Do%2Dtransition%2Dproperty%3Aheight%2Cvisibility%3Btransition%2Dproperty%3Aheight%2Cvisibility%7D%2Ecaret%7Bdisplay%3Ainline%2Dblock%3Bwidth%3A0%3Bheight%3A0%3Bmargin%2Dleft%3A2px%3Bvertical%2Dalign%3Amiddle%3Bborder%2Dtop%3A4px%20dashed%3Bborder%2Dtop%3A4px%20solid%5C9%3Bborder%2Dright%3A4px%20solid%20transparent%3Bborder%2Dleft%3A4px%20solid%20transparent%7D%2Edropdown%2C%2Edropup%7Bposition%3Arelative%7D%2Edropdown%2Dtoggle%3Afocus%7Boutline%3A0%7D%2Edropdown%2Dmenu%7Bposition%3Aabsolute%3Btop%3A100%25%3Bleft%3A0%3Bz%2Dindex%3A1000%3Bdisplay%3Anone%3Bfloat%3Aleft%3Bmin%2Dwidth%3A160px%3Bpadding%3A5px%200%3Bmargin%3A2px%200%200%3Bfont%2Dsize%3A14px%3Btext%2Dalign%3Aleft%3Blist%2Dstyle%3Anone%3Bbackground%2Dcolor%3A%23fff%3B%2Dwebkit%2Dbackground%2Dclip%3Apadding%2Dbox%3Bbackground%2Dclip%3Apadding%2Dbox%3Bborder%3A1px%20solid%20%23ccc%3Bborder%3A1px%20solid%20rgba%280%2C0%2C0%2C%2E15%29%3Bborder%2Dradius%3A4px%3B%2Dwebkit%2Dbox%2Dshadow%3A0%206px%2012px%20rgba%280%2C0%2C0%2C%2E175%29%3Bbox%2Dshadow%3A0%206px%2012px%20rgba%280%2C0%2C0%2C%2E175%29%7D%2Edropdown%2Dmenu%2Epull%2Dright%7Bright%3A0%3Bleft%3Aauto%7D%2Edropdown%2Dmenu%20%2Edivider%7Bheight%3A1px%3Bmargin%3A9px%200%3Boverflow%3Ahidden%3Bbackground%2Dcolor%3A%23e5e5e5%7D%2Edropdown%2Dmenu%3Eli%3Ea%7Bdisplay%3Ablock%3Bpadding%3A3px%2020px%3Bclear%3Aboth%3Bfont%2Dweight%3A400%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23333%3Bwhite%2Dspace%3Anowrap%7D%2Edropdown%2Dmenu%3Eli%3Ea%3Afocus%2C%2Edropdown%2Dmenu%3Eli%3Ea%3Ahover%7Bcolor%3A%23262626%3Btext%2Ddecoration%3Anone%3Bbackground%2Dcolor%3A%23f5f5f5%7D%2Edropdown%2Dmenu%3E%2Eactive%3Ea%2C%2Edropdown%2Dmenu%3E%2Eactive%3Ea%3Afocus%2C%2Edropdown%2Dmenu%3E%2Eactive%3Ea%3Ahover%7Bcolor%3A%23fff%3Btext%2Ddecoration%3Anone%3Bbackground%2Dcolor%3A%23337ab7%3Boutline%3A0%7D%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%2C%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Afocus%2C%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Ahover%7Bcolor%3A%23777%7D%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Afocus%2C%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Ahover%7Btext%2Ddecoration%3Anone%3Bcursor%3Anot%2Dallowed%3Bbackground%2Dcolor%3Atransparent%3Bbackground%2Dimage%3Anone%3Bfilter%3Aprogid%3ADXImageTransform%2EMicrosoft%2Egradient%28enabled%3Dfalse%29%7D%2Eopen%3E%2Edropdown%2Dmenu%7Bdisplay%3Ablock%7D%2Eopen%3Ea%7Boutline%3A0%7D%2Edropdown%2Dmenu%2Dright%7Bright%3A0%3Bleft%3Aauto%7D%2Edropdown%2Dmenu%2Dleft%7Bright%3Aauto%3Bleft%3A0%7D%2Edropdown%2Dheader%7Bdisplay%3Ablock%3Bpadding%3A3px%2020px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23777%3Bwhite%2Dspace%3Anowrap%7D%2Edropdown%2Dbackdrop%7Bposition%3Afixed%3Btop%3A0%3Bright%3A0%3Bbottom%3A0%3Bleft%3A0%3Bz%2Dindex%3A990%7D%2Epull%2Dright%3E%2Edropdown%2Dmenu%7Bright%3A0%3Bleft%3Aauto%7D%2Edropup%20%2Ecaret%2C%2Enavbar%2Dfixed%2Dbottom%20%2Edropdown%20%2Ecaret%7Bcontent%3A%22%22%3Bborder%2Dtop%3A0%3Bborder%2Dbottom%3A4px%20dashed%3Bborder%2Dbottom%3A4px%20solid%5C9%7D%2Edropup%20%2Edropdown%2Dmenu%2C%2Enavbar%2Dfixed%2Dbottom%20%2Edropdown%20%2Edropdown%2Dmenu%7Btop%3Aauto%3Bbottom%3A100%25%3Bmargin%2Dbottom%3A2px%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dright%20%2Edropdown%2Dmenu%7Bright%3A0%3Bleft%3Aauto%7D%2Enavbar%2Dright%20%2Edropdown%2Dmenu%2Dleft%7Bright%3Aauto%3Bleft%3A0%7D%7D%2Ebtn%2Dgroup%2C%2Ebtn%2Dgroup%2Dvertical%7Bposition%3Arelative%3Bdisplay%3Ainline%2Dblock%3Bvertical%2Dalign%3Amiddle%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2C%2Ebtn%2Dgroup%3E%2Ebtn%7Bposition%3Arelative%3Bfloat%3Aleft%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Eactive%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%3Aactive%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%3Afocus%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%3Ahover%2C%2Ebtn%2Dgroup%3E%2Ebtn%2Eactive%2C%2Ebtn%2Dgroup%3E%2Ebtn%3Aactive%2C%2Ebtn%2Dgroup%3E%2Ebtn%3Afocus%2C%2Ebtn%2Dgroup%3E%2Ebtn%3Ahover%7Bz%2Dindex%3A2%7D%2Ebtn%2Dgroup%20%2Ebtn%2B%2Ebtn%2C%2Ebtn%2Dgroup%20%2Ebtn%2B%2Ebtn%2Dgroup%2C%2Ebtn%2Dgroup%20%2Ebtn%2Dgroup%2B%2Ebtn%2C%2Ebtn%2Dgroup%20%2Ebtn%2Dgroup%2B%2Ebtn%2Dgroup%7Bmargin%2Dleft%3A%2D1px%7D%2Ebtn%2Dtoolbar%7Bmargin%2Dleft%3A%2D5px%7D%2Ebtn%2Dtoolbar%20%2Ebtn%2C%2Ebtn%2Dtoolbar%20%2Ebtn%2Dgroup%2C%2Ebtn%2Dtoolbar%20%2Einput%2Dgroup%7Bfloat%3Aleft%7D%2Ebtn%2Dtoolbar%3E%2Ebtn%2C%2Ebtn%2Dtoolbar%3E%2Ebtn%2Dgroup%2C%2Ebtn%2Dtoolbar%3E%2Einput%2Dgroup%7Bmargin%2Dleft%3A5px%7D%2Ebtn%2Dgroup%3E%2Ebtn%3Anot%28%3Afirst%2Dchild%29%3Anot%28%3Alast%2Dchild%29%3Anot%28%2Edropdown%2Dtoggle%29%7Bborder%2Dradius%3A0%7D%2Ebtn%2Dgroup%3E%2Ebtn%3Afirst%2Dchild%7Bmargin%2Dleft%3A0%7D%2Ebtn%2Dgroup%3E%2Ebtn%3Afirst%2Dchild%3Anot%28%3Alast%2Dchild%29%3Anot%28%2Edropdown%2Dtoggle%29%7Bborder%2Dtop%2Dright%2Dradius%3A0%3Bborder%2Dbottom%2Dright%2Dradius%3A0%7D%2Ebtn%2Dgroup%3E%2Ebtn%3Alast%2Dchild%3Anot%28%3Afirst%2Dchild%29%2C%2Ebtn%2Dgroup%3E%2Edropdown%2Dtoggle%3Anot%28%3Afirst%2Dchild%29%7Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dbottom%2Dleft%2Dradius%3A0%7D%2Ebtn%2Dgroup%3E%2Ebtn%2Dgroup%7Bfloat%3Aleft%7D%2Ebtn%2Dgroup%3E%2Ebtn%2Dgroup%3Anot%28%3Afirst%2Dchild%29%3Anot%28%3Alast%2Dchild%29%3E%2Ebtn%7Bborder%2Dradius%3A0%7D%2Ebtn%2Dgroup%3E%2Ebtn%2Dgroup%3Afirst%2Dchild%3Anot%28%3Alast%2Dchild%29%3E%2Ebtn%3Alast%2Dchild%2C%2Ebtn%2Dgroup%3E%2Ebtn%2Dgroup%3Afirst%2Dchild%3Anot%28%3Alast%2Dchild%29%3E%2Edropdown%2Dtoggle%7Bborder%2Dtop%2Dright%2Dradius%3A0%3Bborder%2Dbottom%2Dright%2Dradius%3A0%7D%2Ebtn%2Dgroup%3E%2Ebtn%2Dgroup%3Alast%2Dchild%3Anot%28%3Afirst%2Dchild%29%3E%2Ebtn%3Afirst%2Dchild%7Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dbottom%2Dleft%2Dradius%3A0%7D%2Ebtn%2Dgroup%20%2Edropdown%2Dtoggle%3Aactive%2C%2Ebtn%2Dgroup%2Eopen%20%2Edropdown%2Dtoggle%7Boutline%3A0%7D%2Ebtn%2Dgroup%3E%2Ebtn%2B%2Edropdown%2Dtoggle%7Bpadding%2Dright%3A8px%3Bpadding%2Dleft%3A8px%7D%2Ebtn%2Dgroup%3E%2Ebtn%2Dlg%2B%2Edropdown%2Dtoggle%7Bpadding%2Dright%3A12px%3Bpadding%2Dleft%3A12px%7D%2Ebtn%2Dgroup%2Eopen%20%2Edropdown%2Dtoggle%7B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%203px%205px%20rgba%280%2C0%2C0%2C%2E125%29%3Bbox%2Dshadow%3Ainset%200%203px%205px%20rgba%280%2C0%2C0%2C%2E125%29%7D%2Ebtn%2Dgroup%2Eopen%20%2Edropdown%2Dtoggle%2Ebtn%2Dlink%7B%2Dwebkit%2Dbox%2Dshadow%3Anone%3Bbox%2Dshadow%3Anone%7D%2Ebtn%20%2Ecaret%7Bmargin%2Dleft%3A0%7D%2Ebtn%2Dlg%20%2Ecaret%7Bborder%2Dwidth%3A5px%205px%200%3Bborder%2Dbottom%2Dwidth%3A0%7D%2Edropup%20%2Ebtn%2Dlg%20%2Ecaret%7Bborder%2Dwidth%3A0%205px%205px%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3E%2Ebtn%7Bdisplay%3Ablock%3Bfloat%3Anone%3Bwidth%3A100%25%3Bmax%2Dwidth%3A100%25%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3E%2Ebtn%7Bfloat%3Anone%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2B%2Ebtn%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2B%2Ebtn%2Dgroup%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%2B%2Ebtn%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%2B%2Ebtn%2Dgroup%7Bmargin%2Dtop%3A%2D1px%3Bmargin%2Dleft%3A0%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%3Anot%28%3Afirst%2Dchild%29%3Anot%28%3Alast%2Dchild%29%7Bborder%2Dradius%3A0%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%3Afirst%2Dchild%3Anot%28%3Alast%2Dchild%29%7Bborder%2Dtop%2Dright%2Dradius%3A4px%3Bborder%2Dbottom%2Dright%2Dradius%3A0%3Bborder%2Dbottom%2Dleft%2Dradius%3A0%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%3Alast%2Dchild%3Anot%28%3Afirst%2Dchild%29%7Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dtop%2Dright%2Dradius%3A0%3Bborder%2Dbottom%2Dleft%2Dradius%3A4px%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3Anot%28%3Afirst%2Dchild%29%3Anot%28%3Alast%2Dchild%29%3E%2Ebtn%7Bborder%2Dradius%3A0%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3Afirst%2Dchild%3Anot%28%3Alast%2Dchild%29%3E%2Ebtn%3Alast%2Dchild%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3Afirst%2Dchild%3Anot%28%3Alast%2Dchild%29%3E%2Edropdown%2Dtoggle%7Bborder%2Dbottom%2Dright%2Dradius%3A0%3Bborder%2Dbottom%2Dleft%2Dradius%3A0%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3Alast%2Dchild%3Anot%28%3Afirst%2Dchild%29%3E%2Ebtn%3Afirst%2Dchild%7Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dtop%2Dright%2Dradius%3A0%7D%2Ebtn%2Dgroup%2Djustified%7Bdisplay%3Atable%3Bwidth%3A100%25%3Btable%2Dlayout%3Afixed%3Bborder%2Dcollapse%3Aseparate%7D%2Ebtn%2Dgroup%2Djustified%3E%2Ebtn%2C%2Ebtn%2Dgroup%2Djustified%3E%2Ebtn%2Dgroup%7Bdisplay%3Atable%2Dcell%3Bfloat%3Anone%3Bwidth%3A1%25%7D%2Ebtn%2Dgroup%2Djustified%3E%2Ebtn%2Dgroup%20%2Ebtn%7Bwidth%3A100%25%7D%2Ebtn%2Dgroup%2Djustified%3E%2Ebtn%2Dgroup%20%2Edropdown%2Dmenu%7Bleft%3Aauto%7D%5Bdata%2Dtoggle%3Dbuttons%5D%3E%2Ebtn%20input%5Btype%3Dcheckbox%5D%2C%5Bdata%2Dtoggle%3Dbuttons%5D%3E%2Ebtn%20input%5Btype%3Dradio%5D%2C%5Bdata%2Dtoggle%3Dbuttons%5D%3E%2Ebtn%2Dgroup%3E%2Ebtn%20input%5Btype%3Dcheckbox%5D%2C%5Bdata%2Dtoggle%3Dbuttons%5D%3E%2Ebtn%2Dgroup%3E%2Ebtn%20input%5Btype%3Dradio%5D%7Bposition%3Aabsolute%3Bclip%3Arect%280%2C0%2C0%2C0%29%3Bpointer%2Devents%3Anone%7D%2Einput%2Dgroup%7Bposition%3Arelative%3Bdisplay%3Atable%3Bborder%2Dcollapse%3Aseparate%7D%2Einput%2Dgroup%5Bclass%2A%3Dcol%2D%5D%7Bfloat%3Anone%3Bpadding%2Dright%3A0%3Bpadding%2Dleft%3A0%7D%2Einput%2Dgroup%20%2Eform%2Dcontrol%7Bposition%3Arelative%3Bz%2Dindex%3A2%3Bfloat%3Aleft%3Bwidth%3A100%25%3Bmargin%2Dbottom%3A0%7D%2Einput%2Dgroup%2Dlg%3E%2Eform%2Dcontrol%2C%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Daddon%2C%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%7Bheight%3A46px%3Bpadding%3A10px%2016px%3Bfont%2Dsize%3A18px%3Bline%2Dheight%3A1%2E3333333%3Bborder%2Dradius%3A6px%7Dselect%2Einput%2Dgroup%2Dlg%3E%2Eform%2Dcontrol%2Cselect%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Daddon%2Cselect%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%7Bheight%3A46px%3Bline%2Dheight%3A46px%7Dselect%5Bmultiple%5D%2Einput%2Dgroup%2Dlg%3E%2Eform%2Dcontrol%2Cselect%5Bmultiple%5D%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Daddon%2Cselect%5Bmultiple%5D%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%2Ctextarea%2Einput%2Dgroup%2Dlg%3E%2Eform%2Dcontrol%2Ctextarea%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Daddon%2Ctextarea%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%7Bheight%3Aauto%7D%2Einput%2Dgroup%2Dsm%3E%2Eform%2Dcontrol%2C%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Daddon%2C%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%7Bheight%3A30px%3Bpadding%3A5px%2010px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E5%3Bborder%2Dradius%3A3px%7Dselect%2Einput%2Dgroup%2Dsm%3E%2Eform%2Dcontrol%2Cselect%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Daddon%2Cselect%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%7Bheight%3A30px%3Bline%2Dheight%3A30px%7Dselect%5Bmultiple%5D%2Einput%2Dgroup%2Dsm%3E%2Eform%2Dcontrol%2Cselect%5Bmultiple%5D%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Daddon%2Cselect%5Bmultiple%5D%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%2Ctextarea%2Einput%2Dgroup%2Dsm%3E%2Eform%2Dcontrol%2Ctextarea%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Daddon%2Ctextarea%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%7Bheight%3Aauto%7D%2Einput%2Dgroup%20%2Eform%2Dcontrol%2C%2Einput%2Dgroup%2Daddon%2C%2Einput%2Dgroup%2Dbtn%7Bdisplay%3Atable%2Dcell%7D%2Einput%2Dgroup%20%2Eform%2Dcontrol%3Anot%28%3Afirst%2Dchild%29%3Anot%28%3Alast%2Dchild%29%2C%2Einput%2Dgroup%2Daddon%3Anot%28%3Afirst%2Dchild%29%3Anot%28%3Alast%2Dchild%29%2C%2Einput%2Dgroup%2Dbtn%3Anot%28%3Afirst%2Dchild%29%3Anot%28%3Alast%2Dchild%29%7Bborder%2Dradius%3A0%7D%2Einput%2Dgroup%2Daddon%2C%2Einput%2Dgroup%2Dbtn%7Bwidth%3A1%25%3Bwhite%2Dspace%3Anowrap%3Bvertical%2Dalign%3Amiddle%7D%2Einput%2Dgroup%2Daddon%7Bpadding%3A6px%2012px%3Bfont%2Dsize%3A14px%3Bfont%2Dweight%3A400%3Bline%2Dheight%3A1%3Bcolor%3A%23555%3Btext%2Dalign%3Acenter%3Bbackground%2Dcolor%3A%23eee%3Bborder%3A1px%20solid%20%23ccc%3Bborder%2Dradius%3A4px%7D%2Einput%2Dgroup%2Daddon%2Einput%2Dsm%7Bpadding%3A5px%2010px%3Bfont%2Dsize%3A12px%3Bborder%2Dradius%3A3px%7D%2Einput%2Dgroup%2Daddon%2Einput%2Dlg%7Bpadding%3A10px%2016px%3Bfont%2Dsize%3A18px%3Bborder%2Dradius%3A6px%7D%2Einput%2Dgroup%2Daddon%20input%5Btype%3Dcheckbox%5D%2C%2Einput%2Dgroup%2Daddon%20input%5Btype%3Dradio%5D%7Bmargin%2Dtop%3A0%7D%2Einput%2Dgroup%20%2Eform%2Dcontrol%3Afirst%2Dchild%2C%2Einput%2Dgroup%2Daddon%3Afirst%2Dchild%2C%2Einput%2Dgroup%2Dbtn%3Afirst%2Dchild%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Afirst%2Dchild%3E%2Ebtn%2Dgroup%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Afirst%2Dchild%3E%2Edropdown%2Dtoggle%2C%2Einput%2Dgroup%2Dbtn%3Alast%2Dchild%3E%2Ebtn%2Dgroup%3Anot%28%3Alast%2Dchild%29%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Alast%2Dchild%3E%2Ebtn%3Anot%28%3Alast%2Dchild%29%3Anot%28%2Edropdown%2Dtoggle%29%7Bborder%2Dtop%2Dright%2Dradius%3A0%3Bborder%2Dbottom%2Dright%2Dradius%3A0%7D%2Einput%2Dgroup%2Daddon%3Afirst%2Dchild%7Bborder%2Dright%3A0%7D%2Einput%2Dgroup%20%2Eform%2Dcontrol%3Alast%2Dchild%2C%2Einput%2Dgroup%2Daddon%3Alast%2Dchild%2C%2Einput%2Dgroup%2Dbtn%3Afirst%2Dchild%3E%2Ebtn%2Dgroup%3Anot%28%3Afirst%2Dchild%29%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Afirst%2Dchild%3E%2Ebtn%3Anot%28%3Afirst%2Dchild%29%2C%2Einput%2Dgroup%2Dbtn%3Alast%2Dchild%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Alast%2Dchild%3E%2Ebtn%2Dgroup%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Alast%2Dchild%3E%2Edropdown%2Dtoggle%7Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dbottom%2Dleft%2Dradius%3A0%7D%2Einput%2Dgroup%2Daddon%3Alast%2Dchild%7Bborder%2Dleft%3A0%7D%2Einput%2Dgroup%2Dbtn%7Bposition%3Arelative%3Bfont%2Dsize%3A0%3Bwhite%2Dspace%3Anowrap%7D%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%7Bposition%3Arelative%7D%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%2B%2Ebtn%7Bmargin%2Dleft%3A%2D1px%7D%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%3Aactive%2C%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%3Afocus%2C%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%3Ahover%7Bz%2Dindex%3A2%7D%2Einput%2Dgroup%2Dbtn%3Afirst%2Dchild%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Afirst%2Dchild%3E%2Ebtn%2Dgroup%7Bmargin%2Dright%3A%2D1px%7D%2Einput%2Dgroup%2Dbtn%3Alast%2Dchild%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Alast%2Dchild%3E%2Ebtn%2Dgroup%7Bz%2Dindex%3A2%3Bmargin%2Dleft%3A%2D1px%7D%2Enav%7Bpadding%2Dleft%3A0%3Bmargin%2Dbottom%3A0%3Blist%2Dstyle%3Anone%7D%2Enav%3Eli%7Bposition%3Arelative%3Bdisplay%3Ablock%7D%2Enav%3Eli%3Ea%7Bposition%3Arelative%3Bdisplay%3Ablock%3Bpadding%3A10px%2015px%7D%2Enav%3Eli%3Ea%3Afocus%2C%2Enav%3Eli%3Ea%3Ahover%7Btext%2Ddecoration%3Anone%3Bbackground%2Dcolor%3A%23eee%7D%2Enav%3Eli%2Edisabled%3Ea%7Bcolor%3A%23777%7D%2Enav%3Eli%2Edisabled%3Ea%3Afocus%2C%2Enav%3Eli%2Edisabled%3Ea%3Ahover%7Bcolor%3A%23777%3Btext%2Ddecoration%3Anone%3Bcursor%3Anot%2Dallowed%3Bbackground%2Dcolor%3Atransparent%7D%2Enav%20%2Eopen%3Ea%2C%2Enav%20%2Eopen%3Ea%3Afocus%2C%2Enav%20%2Eopen%3Ea%3Ahover%7Bbackground%2Dcolor%3A%23eee%3Bborder%2Dcolor%3A%23337ab7%7D%2Enav%20%2Enav%2Ddivider%7Bheight%3A1px%3Bmargin%3A9px%200%3Boverflow%3Ahidden%3Bbackground%2Dcolor%3A%23e5e5e5%7D%2Enav%3Eli%3Ea%3Eimg%7Bmax%2Dwidth%3Anone%7D%2Enav%2Dtabs%7Bborder%2Dbottom%3A1px%20solid%20%23ddd%7D%2Enav%2Dtabs%3Eli%7Bfloat%3Aleft%3Bmargin%2Dbottom%3A%2D1px%7D%2Enav%2Dtabs%3Eli%3Ea%7Bmargin%2Dright%3A2px%3Bline%2Dheight%3A1%2E42857143%3Bborder%3A1px%20solid%20transparent%3Bborder%2Dradius%3A4px%204px%200%200%7D%2Enav%2Dtabs%3Eli%3Ea%3Ahover%7Bborder%2Dcolor%3A%23eee%20%23eee%20%23ddd%7D%2Enav%2Dtabs%3Eli%2Eactive%3Ea%2C%2Enav%2Dtabs%3Eli%2Eactive%3Ea%3Afocus%2C%2Enav%2Dtabs%3Eli%2Eactive%3Ea%3Ahover%7Bcolor%3A%23555%3Bcursor%3Adefault%3Bbackground%2Dcolor%3A%23fff%3Bborder%3A1px%20solid%20%23ddd%3Bborder%2Dbottom%2Dcolor%3Atransparent%7D%2Enav%2Dtabs%2Enav%2Djustified%7Bwidth%3A100%25%3Bborder%2Dbottom%3A0%7D%2Enav%2Dtabs%2Enav%2Djustified%3Eli%7Bfloat%3Anone%7D%2Enav%2Dtabs%2Enav%2Djustified%3Eli%3Ea%7Bmargin%2Dbottom%3A5px%3Btext%2Dalign%3Acenter%7D%2Enav%2Dtabs%2Enav%2Djustified%3E%2Edropdown%20%2Edropdown%2Dmenu%7Btop%3Aauto%3Bleft%3Aauto%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enav%2Dtabs%2Enav%2Djustified%3Eli%7Bdisplay%3Atable%2Dcell%3Bwidth%3A1%25%7D%2Enav%2Dtabs%2Enav%2Djustified%3Eli%3Ea%7Bmargin%2Dbottom%3A0%7D%7D%2Enav%2Dtabs%2Enav%2Djustified%3Eli%3Ea%7Bmargin%2Dright%3A0%3Bborder%2Dradius%3A4px%7D%2Enav%2Dtabs%2Enav%2Djustified%3E%2Eactive%3Ea%2C%2Enav%2Dtabs%2Enav%2Djustified%3E%2Eactive%3Ea%3Afocus%2C%2Enav%2Dtabs%2Enav%2Djustified%3E%2Eactive%3Ea%3Ahover%7Bborder%3A1px%20solid%20%23ddd%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enav%2Dtabs%2Enav%2Djustified%3Eli%3Ea%7Bborder%2Dbottom%3A1px%20solid%20%23ddd%3Bborder%2Dradius%3A4px%204px%200%200%7D%2Enav%2Dtabs%2Enav%2Djustified%3E%2Eactive%3Ea%2C%2Enav%2Dtabs%2Enav%2Djustified%3E%2Eactive%3Ea%3Afocus%2C%2Enav%2Dtabs%2Enav%2Djustified%3E%2Eactive%3Ea%3Ahover%7Bborder%2Dbottom%2Dcolor%3A%23fff%7D%7D%2Enav%2Dpills%3Eli%7Bfloat%3Aleft%7D%2Enav%2Dpills%3Eli%3Ea%7Bborder%2Dradius%3A4px%7D%2Enav%2Dpills%3Eli%2Bli%7Bmargin%2Dleft%3A2px%7D%2Enav%2Dpills%3Eli%2Eactive%3Ea%2C%2Enav%2Dpills%3Eli%2Eactive%3Ea%3Afocus%2C%2Enav%2Dpills%3Eli%2Eactive%3Ea%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23337ab7%7D%2Enav%2Dstacked%3Eli%7Bfloat%3Anone%7D%2Enav%2Dstacked%3Eli%2Bli%7Bmargin%2Dtop%3A2px%3Bmargin%2Dleft%3A0%7D%2Enav%2Djustified%7Bwidth%3A100%25%7D%2Enav%2Djustified%3Eli%7Bfloat%3Anone%7D%2Enav%2Djustified%3Eli%3Ea%7Bmargin%2Dbottom%3A5px%3Btext%2Dalign%3Acenter%7D%2Enav%2Djustified%3E%2Edropdown%20%2Edropdown%2Dmenu%7Btop%3Aauto%3Bleft%3Aauto%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enav%2Djustified%3Eli%7Bdisplay%3Atable%2Dcell%3Bwidth%3A1%25%7D%2Enav%2Djustified%3Eli%3Ea%7Bmargin%2Dbottom%3A0%7D%7D%2Enav%2Dtabs%2Djustified%7Bborder%2Dbottom%3A0%7D%2Enav%2Dtabs%2Djustified%3Eli%3Ea%7Bmargin%2Dright%3A0%3Bborder%2Dradius%3A4px%7D%2Enav%2Dtabs%2Djustified%3E%2Eactive%3Ea%2C%2Enav%2Dtabs%2Djustified%3E%2Eactive%3Ea%3Afocus%2C%2Enav%2Dtabs%2Djustified%3E%2Eactive%3Ea%3Ahover%7Bborder%3A1px%20solid%20%23ddd%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enav%2Dtabs%2Djustified%3Eli%3Ea%7Bborder%2Dbottom%3A1px%20solid%20%23ddd%3Bborder%2Dradius%3A4px%204px%200%200%7D%2Enav%2Dtabs%2Djustified%3E%2Eactive%3Ea%2C%2Enav%2Dtabs%2Djustified%3E%2Eactive%3Ea%3Afocus%2C%2Enav%2Dtabs%2Djustified%3E%2Eactive%3Ea%3Ahover%7Bborder%2Dbottom%2Dcolor%3A%23fff%7D%7D%2Etab%2Dcontent%3E%2Etab%2Dpane%7Bdisplay%3Anone%7D%2Etab%2Dcontent%3E%2Eactive%7Bdisplay%3Ablock%7D%2Enav%2Dtabs%20%2Edropdown%2Dmenu%7Bmargin%2Dtop%3A%2D1px%3Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dtop%2Dright%2Dradius%3A0%7D%2Enavbar%7Bposition%3Arelative%3Bmin%2Dheight%3A50px%3Bmargin%2Dbottom%3A20px%3Bborder%3A1px%20solid%20transparent%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%7Bborder%2Dradius%3A4px%7D%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dheader%7Bfloat%3Aleft%7D%7D%2Enavbar%2Dcollapse%7Bpadding%2Dright%3A15px%3Bpadding%2Dleft%3A15px%3Boverflow%2Dx%3Avisible%3B%2Dwebkit%2Doverflow%2Dscrolling%3Atouch%3Bborder%2Dtop%3A1px%20solid%20transparent%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%200%20rgba%28255%2C255%2C255%2C%2E1%29%3Bbox%2Dshadow%3Ainset%200%201px%200%20rgba%28255%2C255%2C255%2C%2E1%29%7D%2Enavbar%2Dcollapse%2Ein%7Boverflow%2Dy%3Aauto%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dcollapse%7Bwidth%3Aauto%3Bborder%2Dtop%3A0%3B%2Dwebkit%2Dbox%2Dshadow%3Anone%3Bbox%2Dshadow%3Anone%7D%2Enavbar%2Dcollapse%2Ecollapse%7Bdisplay%3Ablock%21important%3Bheight%3Aauto%21important%3Bpadding%2Dbottom%3A0%3Boverflow%3Avisible%21important%7D%2Enavbar%2Dcollapse%2Ein%7Boverflow%2Dy%3Avisible%7D%2Enavbar%2Dfixed%2Dbottom%20%2Enavbar%2Dcollapse%2C%2Enavbar%2Dfixed%2Dtop%20%2Enavbar%2Dcollapse%2C%2Enavbar%2Dstatic%2Dtop%20%2Enavbar%2Dcollapse%7Bpadding%2Dright%3A0%3Bpadding%2Dleft%3A0%7D%7D%2Enavbar%2Dfixed%2Dbottom%20%2Enavbar%2Dcollapse%2C%2Enavbar%2Dfixed%2Dtop%20%2Enavbar%2Dcollapse%7Bmax%2Dheight%3A340px%7D%40media%20%28max%2Ddevice%2Dwidth%3A480px%29%20and%20%28orientation%3Alandscape%29%7B%2Enavbar%2Dfixed%2Dbottom%20%2Enavbar%2Dcollapse%2C%2Enavbar%2Dfixed%2Dtop%20%2Enavbar%2Dcollapse%7Bmax%2Dheight%3A200px%7D%7D%2Econtainer%2Dfluid%3E%2Enavbar%2Dcollapse%2C%2Econtainer%2Dfluid%3E%2Enavbar%2Dheader%2C%2Econtainer%3E%2Enavbar%2Dcollapse%2C%2Econtainer%3E%2Enavbar%2Dheader%7Bmargin%2Dright%3A%2D15px%3Bmargin%2Dleft%3A%2D15px%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Econtainer%2Dfluid%3E%2Enavbar%2Dcollapse%2C%2Econtainer%2Dfluid%3E%2Enavbar%2Dheader%2C%2Econtainer%3E%2Enavbar%2Dcollapse%2C%2Econtainer%3E%2Enavbar%2Dheader%7Bmargin%2Dright%3A0%3Bmargin%2Dleft%3A0%7D%7D%2Enavbar%2Dstatic%2Dtop%7Bz%2Dindex%3A1000%3Bborder%2Dwidth%3A0%200%201px%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dstatic%2Dtop%7Bborder%2Dradius%3A0%7D%7D%2Enavbar%2Dfixed%2Dbottom%2C%2Enavbar%2Dfixed%2Dtop%7Bposition%3Afixed%3Bright%3A0%3Bleft%3A0%3Bz%2Dindex%3A1030%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dfixed%2Dbottom%2C%2Enavbar%2Dfixed%2Dtop%7Bborder%2Dradius%3A0%7D%7D%2Enavbar%2Dfixed%2Dtop%7Btop%3A0%3Bborder%2Dwidth%3A0%200%201px%7D%2Enavbar%2Dfixed%2Dbottom%7Bbottom%3A0%3Bmargin%2Dbottom%3A0%3Bborder%2Dwidth%3A1px%200%200%7D%2Enavbar%2Dbrand%7Bfloat%3Aleft%3Bheight%3A50px%3Bpadding%3A15px%2015px%3Bfont%2Dsize%3A18px%3Bline%2Dheight%3A20px%7D%2Enavbar%2Dbrand%3Afocus%2C%2Enavbar%2Dbrand%3Ahover%7Btext%2Ddecoration%3Anone%7D%2Enavbar%2Dbrand%3Eimg%7Bdisplay%3Ablock%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%3E%2Econtainer%20%2Enavbar%2Dbrand%2C%2Enavbar%3E%2Econtainer%2Dfluid%20%2Enavbar%2Dbrand%7Bmargin%2Dleft%3A%2D15px%7D%7D%2Enavbar%2Dtoggle%7Bposition%3Arelative%3Bfloat%3Aright%3Bpadding%3A9px%2010px%3Bmargin%2Dtop%3A8px%3Bmargin%2Dright%3A15px%3Bmargin%2Dbottom%3A8px%3Bbackground%2Dcolor%3Atransparent%3Bbackground%2Dimage%3Anone%3Bborder%3A1px%20solid%20transparent%3Bborder%2Dradius%3A4px%7D%2Enavbar%2Dtoggle%3Afocus%7Boutline%3A0%7D%2Enavbar%2Dtoggle%20%2Eicon%2Dbar%7Bdisplay%3Ablock%3Bwidth%3A22px%3Bheight%3A2px%3Bborder%2Dradius%3A1px%7D%2Enavbar%2Dtoggle%20%2Eicon%2Dbar%2B%2Eicon%2Dbar%7Bmargin%2Dtop%3A4px%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dtoggle%7Bdisplay%3Anone%7D%7D%2Enavbar%2Dnav%7Bmargin%3A7%2E5px%20%2D15px%7D%2Enavbar%2Dnav%3Eli%3Ea%7Bpadding%2Dtop%3A10px%3Bpadding%2Dbottom%3A10px%3Bline%2Dheight%3A20px%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%7Bposition%3Astatic%3Bfloat%3Anone%3Bwidth%3Aauto%3Bmargin%2Dtop%3A0%3Bbackground%2Dcolor%3Atransparent%3Bborder%3A0%3B%2Dwebkit%2Dbox%2Dshadow%3Anone%3Bbox%2Dshadow%3Anone%7D%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%20%2Edropdown%2Dheader%2C%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%7Bpadding%3A5px%2015px%205px%2025px%7D%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%7Bline%2Dheight%3A20px%7D%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%3Afocus%2C%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%3Ahover%7Bbackground%2Dimage%3Anone%7D%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dnav%7Bfloat%3Aleft%3Bmargin%3A0%7D%2Enavbar%2Dnav%3Eli%7Bfloat%3Aleft%7D%2Enavbar%2Dnav%3Eli%3Ea%7Bpadding%2Dtop%3A15px%3Bpadding%2Dbottom%3A15px%7D%7D%2Enavbar%2Dform%7Bpadding%3A10px%2015px%3Bmargin%2Dtop%3A8px%3Bmargin%2Dright%3A%2D15px%3Bmargin%2Dbottom%3A8px%3Bmargin%2Dleft%3A%2D15px%3Bborder%2Dtop%3A1px%20solid%20transparent%3Bborder%2Dbottom%3A1px%20solid%20transparent%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%200%20rgba%28255%2C255%2C255%2C%2E1%29%2C0%201px%200%20rgba%28255%2C255%2C255%2C%2E1%29%3Bbox%2Dshadow%3Ainset%200%201px%200%20rgba%28255%2C255%2C255%2C%2E1%29%2C0%201px%200%20rgba%28255%2C255%2C255%2C%2E1%29%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dform%20%2Eform%2Dgroup%7Bdisplay%3Ainline%2Dblock%3Bmargin%2Dbottom%3A0%3Bvertical%2Dalign%3Amiddle%7D%2Enavbar%2Dform%20%2Eform%2Dcontrol%7Bdisplay%3Ainline%2Dblock%3Bwidth%3Aauto%3Bvertical%2Dalign%3Amiddle%7D%2Enavbar%2Dform%20%2Eform%2Dcontrol%2Dstatic%7Bdisplay%3Ainline%2Dblock%7D%2Enavbar%2Dform%20%2Einput%2Dgroup%7Bdisplay%3Ainline%2Dtable%3Bvertical%2Dalign%3Amiddle%7D%2Enavbar%2Dform%20%2Einput%2Dgroup%20%2Eform%2Dcontrol%2C%2Enavbar%2Dform%20%2Einput%2Dgroup%20%2Einput%2Dgroup%2Daddon%2C%2Enavbar%2Dform%20%2Einput%2Dgroup%20%2Einput%2Dgroup%2Dbtn%7Bwidth%3Aauto%7D%2Enavbar%2Dform%20%2Einput%2Dgroup%3E%2Eform%2Dcontrol%7Bwidth%3A100%25%7D%2Enavbar%2Dform%20%2Econtrol%2Dlabel%7Bmargin%2Dbottom%3A0%3Bvertical%2Dalign%3Amiddle%7D%2Enavbar%2Dform%20%2Echeckbox%2C%2Enavbar%2Dform%20%2Eradio%7Bdisplay%3Ainline%2Dblock%3Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A0%3Bvertical%2Dalign%3Amiddle%7D%2Enavbar%2Dform%20%2Echeckbox%20label%2C%2Enavbar%2Dform%20%2Eradio%20label%7Bpadding%2Dleft%3A0%7D%2Enavbar%2Dform%20%2Echeckbox%20input%5Btype%3Dcheckbox%5D%2C%2Enavbar%2Dform%20%2Eradio%20input%5Btype%3Dradio%5D%7Bposition%3Arelative%3Bmargin%2Dleft%3A0%7D%2Enavbar%2Dform%20%2Ehas%2Dfeedback%20%2Eform%2Dcontrol%2Dfeedback%7Btop%3A0%7D%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Enavbar%2Dform%20%2Eform%2Dgroup%7Bmargin%2Dbottom%3A5px%7D%2Enavbar%2Dform%20%2Eform%2Dgroup%3Alast%2Dchild%7Bmargin%2Dbottom%3A0%7D%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dform%7Bwidth%3Aauto%3Bpadding%2Dtop%3A0%3Bpadding%2Dbottom%3A0%3Bmargin%2Dright%3A0%3Bmargin%2Dleft%3A0%3Bborder%3A0%3B%2Dwebkit%2Dbox%2Dshadow%3Anone%3Bbox%2Dshadow%3Anone%7D%7D%2Enavbar%2Dnav%3Eli%3E%2Edropdown%2Dmenu%7Bmargin%2Dtop%3A0%3Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dtop%2Dright%2Dradius%3A0%7D%2Enavbar%2Dfixed%2Dbottom%20%2Enavbar%2Dnav%3Eli%3E%2Edropdown%2Dmenu%7Bmargin%2Dbottom%3A0%3Bborder%2Dtop%2Dleft%2Dradius%3A4px%3Bborder%2Dtop%2Dright%2Dradius%3A4px%3Bborder%2Dbottom%2Dright%2Dradius%3A0%3Bborder%2Dbottom%2Dleft%2Dradius%3A0%7D%2Enavbar%2Dbtn%7Bmargin%2Dtop%3A8px%3Bmargin%2Dbottom%3A8px%7D%2Enavbar%2Dbtn%2Ebtn%2Dsm%7Bmargin%2Dtop%3A10px%3Bmargin%2Dbottom%3A10px%7D%2Enavbar%2Dbtn%2Ebtn%2Dxs%7Bmargin%2Dtop%3A14px%3Bmargin%2Dbottom%3A14px%7D%2Enavbar%2Dtext%7Bmargin%2Dtop%3A15px%3Bmargin%2Dbottom%3A15px%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dtext%7Bfloat%3Aleft%3Bmargin%2Dright%3A15px%3Bmargin%2Dleft%3A15px%7D%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dleft%7Bfloat%3Aleft%21important%7D%2Enavbar%2Dright%7Bfloat%3Aright%21important%3Bmargin%2Dright%3A%2D15px%7D%2Enavbar%2Dright%7E%2Enavbar%2Dright%7Bmargin%2Dright%3A0%7D%7D%2Enavbar%2Ddefault%7Bbackground%2Dcolor%3A%23f8f8f8%3Bborder%2Dcolor%3A%23e7e7e7%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dbrand%7Bcolor%3A%23777%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dbrand%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dbrand%3Ahover%7Bcolor%3A%235e5e5e%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dtext%7Bcolor%3A%23777%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3Eli%3Ea%7Bcolor%3A%23777%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3Eli%3Ea%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3Eli%3Ea%3Ahover%7Bcolor%3A%23333%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Eactive%3Ea%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Eactive%3Ea%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Eactive%3Ea%3Ahover%7Bcolor%3A%23555%3Bbackground%2Dcolor%3A%23e7e7e7%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Edisabled%3Ea%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Edisabled%3Ea%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Edisabled%3Ea%3Ahover%7Bcolor%3A%23ccc%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dtoggle%7Bborder%2Dcolor%3A%23ddd%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dtoggle%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dtoggle%3Ahover%7Bbackground%2Dcolor%3A%23ddd%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dtoggle%20%2Eicon%2Dbar%7Bbackground%2Dcolor%3A%23888%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dcollapse%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dform%7Bborder%2Dcolor%3A%23e7e7e7%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Eopen%3Ea%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Eopen%3Ea%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Eopen%3Ea%3Ahover%7Bcolor%3A%23555%3Bbackground%2Dcolor%3A%23e7e7e7%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%7Bcolor%3A%23777%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%3Ahover%7Bcolor%3A%23333%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Eactive%3Ea%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Eactive%3Ea%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Eactive%3Ea%3Ahover%7Bcolor%3A%23555%3Bbackground%2Dcolor%3A%23e7e7e7%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Ahover%7Bcolor%3A%23ccc%3Bbackground%2Dcolor%3Atransparent%7D%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dlink%7Bcolor%3A%23777%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dlink%3Ahover%7Bcolor%3A%23333%7D%2Enavbar%2Ddefault%20%2Ebtn%2Dlink%7Bcolor%3A%23777%7D%2Enavbar%2Ddefault%20%2Ebtn%2Dlink%3Afocus%2C%2Enavbar%2Ddefault%20%2Ebtn%2Dlink%3Ahover%7Bcolor%3A%23333%7D%2Enavbar%2Ddefault%20%2Ebtn%2Dlink%5Bdisabled%5D%3Afocus%2C%2Enavbar%2Ddefault%20%2Ebtn%2Dlink%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Enavbar%2Ddefault%20%2Ebtn%2Dlink%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Enavbar%2Ddefault%20%2Ebtn%2Dlink%3Ahover%7Bcolor%3A%23ccc%7D%2Enavbar%2Dinverse%7Bbackground%2Dcolor%3A%23222%3Bborder%2Dcolor%3A%23080808%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dbrand%7Bcolor%3A%239d9d9d%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dbrand%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dbrand%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dtext%7Bcolor%3A%239d9d9d%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3Eli%3Ea%7Bcolor%3A%239d9d9d%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3Eli%3Ea%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3Eli%3Ea%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Eactive%3Ea%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Eactive%3Ea%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Eactive%3Ea%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23080808%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Edisabled%3Ea%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Edisabled%3Ea%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Edisabled%3Ea%3Ahover%7Bcolor%3A%23444%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dtoggle%7Bborder%2Dcolor%3A%23333%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dtoggle%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dtoggle%3Ahover%7Bbackground%2Dcolor%3A%23333%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dtoggle%20%2Eicon%2Dbar%7Bbackground%2Dcolor%3A%23fff%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dcollapse%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dform%7Bborder%2Dcolor%3A%23101010%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Eopen%3Ea%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Eopen%3Ea%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Eopen%3Ea%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23080808%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Edropdown%2Dheader%7Bborder%2Dcolor%3A%23080808%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%20%2Edivider%7Bbackground%2Dcolor%3A%23080808%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%7Bcolor%3A%239d9d9d%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Eactive%3Ea%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Eactive%3Ea%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Eactive%3Ea%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23080808%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Ahover%7Bcolor%3A%23444%3Bbackground%2Dcolor%3Atransparent%7D%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dlink%7Bcolor%3A%239d9d9d%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dlink%3Ahover%7Bcolor%3A%23fff%7D%2Enavbar%2Dinverse%20%2Ebtn%2Dlink%7Bcolor%3A%239d9d9d%7D%2Enavbar%2Dinverse%20%2Ebtn%2Dlink%3Afocus%2C%2Enavbar%2Dinverse%20%2Ebtn%2Dlink%3Ahover%7Bcolor%3A%23fff%7D%2Enavbar%2Dinverse%20%2Ebtn%2Dlink%5Bdisabled%5D%3Afocus%2C%2Enavbar%2Dinverse%20%2Ebtn%2Dlink%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Enavbar%2Dinverse%20%2Ebtn%2Dlink%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Enavbar%2Dinverse%20%2Ebtn%2Dlink%3Ahover%7Bcolor%3A%23444%7D%2Ebreadcrumb%7Bpadding%3A8px%2015px%3Bmargin%2Dbottom%3A20px%3Blist%2Dstyle%3Anone%3Bbackground%2Dcolor%3A%23f5f5f5%3Bborder%2Dradius%3A4px%7D%2Ebreadcrumb%3Eli%7Bdisplay%3Ainline%2Dblock%7D%2Ebreadcrumb%3Eli%2Bli%3Abefore%7Bpadding%3A0%205px%3Bcolor%3A%23ccc%3Bcontent%3A%22%2F%5C00a0%22%7D%2Ebreadcrumb%3E%2Eactive%7Bcolor%3A%23777%7D%2Epagination%7Bdisplay%3Ainline%2Dblock%3Bpadding%2Dleft%3A0%3Bmargin%3A20px%200%3Bborder%2Dradius%3A4px%7D%2Epagination%3Eli%7Bdisplay%3Ainline%7D%2Epagination%3Eli%3Ea%2C%2Epagination%3Eli%3Espan%7Bposition%3Arelative%3Bfloat%3Aleft%3Bpadding%3A6px%2012px%3Bmargin%2Dleft%3A%2D1px%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23337ab7%3Btext%2Ddecoration%3Anone%3Bbackground%2Dcolor%3A%23fff%3Bborder%3A1px%20solid%20%23ddd%7D%2Epagination%3Eli%3Afirst%2Dchild%3Ea%2C%2Epagination%3Eli%3Afirst%2Dchild%3Espan%7Bmargin%2Dleft%3A0%3Bborder%2Dtop%2Dleft%2Dradius%3A4px%3Bborder%2Dbottom%2Dleft%2Dradius%3A4px%7D%2Epagination%3Eli%3Alast%2Dchild%3Ea%2C%2Epagination%3Eli%3Alast%2Dchild%3Espan%7Bborder%2Dtop%2Dright%2Dradius%3A4px%3Bborder%2Dbottom%2Dright%2Dradius%3A4px%7D%2Epagination%3Eli%3Ea%3Afocus%2C%2Epagination%3Eli%3Ea%3Ahover%2C%2Epagination%3Eli%3Espan%3Afocus%2C%2Epagination%3Eli%3Espan%3Ahover%7Bz%2Dindex%3A3%3Bcolor%3A%2323527c%3Bbackground%2Dcolor%3A%23eee%3Bborder%2Dcolor%3A%23ddd%7D%2Epagination%3E%2Eactive%3Ea%2C%2Epagination%3E%2Eactive%3Ea%3Afocus%2C%2Epagination%3E%2Eactive%3Ea%3Ahover%2C%2Epagination%3E%2Eactive%3Espan%2C%2Epagination%3E%2Eactive%3Espan%3Afocus%2C%2Epagination%3E%2Eactive%3Espan%3Ahover%7Bz%2Dindex%3A2%3Bcolor%3A%23fff%3Bcursor%3Adefault%3Bbackground%2Dcolor%3A%23337ab7%3Bborder%2Dcolor%3A%23337ab7%7D%2Epagination%3E%2Edisabled%3Ea%2C%2Epagination%3E%2Edisabled%3Ea%3Afocus%2C%2Epagination%3E%2Edisabled%3Ea%3Ahover%2C%2Epagination%3E%2Edisabled%3Espan%2C%2Epagination%3E%2Edisabled%3Espan%3Afocus%2C%2Epagination%3E%2Edisabled%3Espan%3Ahover%7Bcolor%3A%23777%3Bcursor%3Anot%2Dallowed%3Bbackground%2Dcolor%3A%23fff%3Bborder%2Dcolor%3A%23ddd%7D%2Epagination%2Dlg%3Eli%3Ea%2C%2Epagination%2Dlg%3Eli%3Espan%7Bpadding%3A10px%2016px%3Bfont%2Dsize%3A18px%3Bline%2Dheight%3A1%2E3333333%7D%2Epagination%2Dlg%3Eli%3Afirst%2Dchild%3Ea%2C%2Epagination%2Dlg%3Eli%3Afirst%2Dchild%3Espan%7Bborder%2Dtop%2Dleft%2Dradius%3A6px%3Bborder%2Dbottom%2Dleft%2Dradius%3A6px%7D%2Epagination%2Dlg%3Eli%3Alast%2Dchild%3Ea%2C%2Epagination%2Dlg%3Eli%3Alast%2Dchild%3Espan%7Bborder%2Dtop%2Dright%2Dradius%3A6px%3Bborder%2Dbottom%2Dright%2Dradius%3A6px%7D%2Epagination%2Dsm%3Eli%3Ea%2C%2Epagination%2Dsm%3Eli%3Espan%7Bpadding%3A5px%2010px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E5%7D%2Epagination%2Dsm%3Eli%3Afirst%2Dchild%3Ea%2C%2Epagination%2Dsm%3Eli%3Afirst%2Dchild%3Espan%7Bborder%2Dtop%2Dleft%2Dradius%3A3px%3Bborder%2Dbottom%2Dleft%2Dradius%3A3px%7D%2Epagination%2Dsm%3Eli%3Alast%2Dchild%3Ea%2C%2Epagination%2Dsm%3Eli%3Alast%2Dchild%3Espan%7Bborder%2Dtop%2Dright%2Dradius%3A3px%3Bborder%2Dbottom%2Dright%2Dradius%3A3px%7D%2Epager%7Bpadding%2Dleft%3A0%3Bmargin%3A20px%200%3Btext%2Dalign%3Acenter%3Blist%2Dstyle%3Anone%7D%2Epager%20li%7Bdisplay%3Ainline%7D%2Epager%20li%3Ea%2C%2Epager%20li%3Espan%7Bdisplay%3Ainline%2Dblock%3Bpadding%3A5px%2014px%3Bbackground%2Dcolor%3A%23fff%3Bborder%3A1px%20solid%20%23ddd%3Bborder%2Dradius%3A15px%7D%2Epager%20li%3Ea%3Afocus%2C%2Epager%20li%3Ea%3Ahover%7Btext%2Ddecoration%3Anone%3Bbackground%2Dcolor%3A%23eee%7D%2Epager%20%2Enext%3Ea%2C%2Epager%20%2Enext%3Espan%7Bfloat%3Aright%7D%2Epager%20%2Eprevious%3Ea%2C%2Epager%20%2Eprevious%3Espan%7Bfloat%3Aleft%7D%2Epager%20%2Edisabled%3Ea%2C%2Epager%20%2Edisabled%3Ea%3Afocus%2C%2Epager%20%2Edisabled%3Ea%3Ahover%2C%2Epager%20%2Edisabled%3Espan%7Bcolor%3A%23777%3Bcursor%3Anot%2Dallowed%3Bbackground%2Dcolor%3A%23fff%7D%2Elabel%7Bdisplay%3Ainline%3Bpadding%3A%2E2em%20%2E6em%20%2E3em%3Bfont%2Dsize%3A75%25%3Bfont%2Dweight%3A700%3Bline%2Dheight%3A1%3Bcolor%3A%23fff%3Btext%2Dalign%3Acenter%3Bwhite%2Dspace%3Anowrap%3Bvertical%2Dalign%3Abaseline%3Bborder%2Dradius%3A%2E25em%7Da%2Elabel%3Afocus%2Ca%2Elabel%3Ahover%7Bcolor%3A%23fff%3Btext%2Ddecoration%3Anone%3Bcursor%3Apointer%7D%2Elabel%3Aempty%7Bdisplay%3Anone%7D%2Ebtn%20%2Elabel%7Bposition%3Arelative%3Btop%3A%2D1px%7D%2Elabel%2Ddefault%7Bbackground%2Dcolor%3A%23777%7D%2Elabel%2Ddefault%5Bhref%5D%3Afocus%2C%2Elabel%2Ddefault%5Bhref%5D%3Ahover%7Bbackground%2Dcolor%3A%235e5e5e%7D%2Elabel%2Dprimary%7Bbackground%2Dcolor%3A%23337ab7%7D%2Elabel%2Dprimary%5Bhref%5D%3Afocus%2C%2Elabel%2Dprimary%5Bhref%5D%3Ahover%7Bbackground%2Dcolor%3A%23286090%7D%2Elabel%2Dsuccess%7Bbackground%2Dcolor%3A%235cb85c%7D%2Elabel%2Dsuccess%5Bhref%5D%3Afocus%2C%2Elabel%2Dsuccess%5Bhref%5D%3Ahover%7Bbackground%2Dcolor%3A%23449d44%7D%2Elabel%2Dinfo%7Bbackground%2Dcolor%3A%235bc0de%7D%2Elabel%2Dinfo%5Bhref%5D%3Afocus%2C%2Elabel%2Dinfo%5Bhref%5D%3Ahover%7Bbackground%2Dcolor%3A%2331b0d5%7D%2Elabel%2Dwarning%7Bbackground%2Dcolor%3A%23f0ad4e%7D%2Elabel%2Dwarning%5Bhref%5D%3Afocus%2C%2Elabel%2Dwarning%5Bhref%5D%3Ahover%7Bbackground%2Dcolor%3A%23ec971f%7D%2Elabel%2Ddanger%7Bbackground%2Dcolor%3A%23d9534f%7D%2Elabel%2Ddanger%5Bhref%5D%3Afocus%2C%2Elabel%2Ddanger%5Bhref%5D%3Ahover%7Bbackground%2Dcolor%3A%23c9302c%7D%2Ebadge%7Bdisplay%3Ainline%2Dblock%3Bmin%2Dwidth%3A10px%3Bpadding%3A3px%207px%3Bfont%2Dsize%3A12px%3Bfont%2Dweight%3A700%3Bline%2Dheight%3A1%3Bcolor%3A%23fff%3Btext%2Dalign%3Acenter%3Bwhite%2Dspace%3Anowrap%3Bvertical%2Dalign%3Amiddle%3Bbackground%2Dcolor%3A%23777%3Bborder%2Dradius%3A10px%7D%2Ebadge%3Aempty%7Bdisplay%3Anone%7D%2Ebtn%20%2Ebadge%7Bposition%3Arelative%3Btop%3A%2D1px%7D%2Ebtn%2Dgroup%2Dxs%3E%2Ebtn%20%2Ebadge%2C%2Ebtn%2Dxs%20%2Ebadge%7Btop%3A0%3Bpadding%3A1px%205px%7Da%2Ebadge%3Afocus%2Ca%2Ebadge%3Ahover%7Bcolor%3A%23fff%3Btext%2Ddecoration%3Anone%3Bcursor%3Apointer%7D%2Elist%2Dgroup%2Ditem%2Eactive%3E%2Ebadge%2C%2Enav%2Dpills%3E%2Eactive%3Ea%3E%2Ebadge%7Bcolor%3A%23337ab7%3Bbackground%2Dcolor%3A%23fff%7D%2Elist%2Dgroup%2Ditem%3E%2Ebadge%7Bfloat%3Aright%7D%2Elist%2Dgroup%2Ditem%3E%2Ebadge%2B%2Ebadge%7Bmargin%2Dright%3A5px%7D%2Enav%2Dpills%3Eli%3Ea%3E%2Ebadge%7Bmargin%2Dleft%3A3px%7D%2Ejumbotron%7Bpadding%2Dtop%3A30px%3Bpadding%2Dbottom%3A30px%3Bmargin%2Dbottom%3A30px%3Bcolor%3Ainherit%3Bbackground%2Dcolor%3A%23eee%7D%2Ejumbotron%20%2Eh1%2C%2Ejumbotron%20h1%7Bcolor%3Ainherit%7D%2Ejumbotron%20p%7Bmargin%2Dbottom%3A15px%3Bfont%2Dsize%3A21px%3Bfont%2Dweight%3A200%7D%2Ejumbotron%3Ehr%7Bborder%2Dtop%2Dcolor%3A%23d5d5d5%7D%2Econtainer%20%2Ejumbotron%2C%2Econtainer%2Dfluid%20%2Ejumbotron%7Bborder%2Dradius%3A6px%7D%2Ejumbotron%20%2Econtainer%7Bmax%2Dwidth%3A100%25%7D%40media%20screen%20and%20%28min%2Dwidth%3A768px%29%7B%2Ejumbotron%7Bpadding%2Dtop%3A48px%3Bpadding%2Dbottom%3A48px%7D%2Econtainer%20%2Ejumbotron%2C%2Econtainer%2Dfluid%20%2Ejumbotron%7Bpadding%2Dright%3A60px%3Bpadding%2Dleft%3A60px%7D%2Ejumbotron%20%2Eh1%2C%2Ejumbotron%20h1%7Bfont%2Dsize%3A63px%7D%7D%2Ethumbnail%7Bdisplay%3Ablock%3Bpadding%3A4px%3Bmargin%2Dbottom%3A20px%3Bline%2Dheight%3A1%2E42857143%3Bbackground%2Dcolor%3A%23fff%3Bborder%3A1px%20solid%20%23ddd%3Bborder%2Dradius%3A4px%3B%2Dwebkit%2Dtransition%3Aborder%20%2E2s%20ease%2Din%2Dout%3B%2Do%2Dtransition%3Aborder%20%2E2s%20ease%2Din%2Dout%3Btransition%3Aborder%20%2E2s%20ease%2Din%2Dout%7D%2Ethumbnail%20a%3Eimg%2C%2Ethumbnail%3Eimg%7Bmargin%2Dright%3Aauto%3Bmargin%2Dleft%3Aauto%7Da%2Ethumbnail%2Eactive%2Ca%2Ethumbnail%3Afocus%2Ca%2Ethumbnail%3Ahover%7Bborder%2Dcolor%3A%23337ab7%7D%2Ethumbnail%20%2Ecaption%7Bpadding%3A9px%3Bcolor%3A%23333%7D%2Ealert%7Bpadding%3A15px%3Bmargin%2Dbottom%3A20px%3Bborder%3A1px%20solid%20transparent%3Bborder%2Dradius%3A4px%7D%2Ealert%20h4%7Bmargin%2Dtop%3A0%3Bcolor%3Ainherit%7D%2Ealert%20%2Ealert%2Dlink%7Bfont%2Dweight%3A700%7D%2Ealert%3Ep%2C%2Ealert%3Eul%7Bmargin%2Dbottom%3A0%7D%2Ealert%3Ep%2Bp%7Bmargin%2Dtop%3A5px%7D%2Ealert%2Ddismissable%2C%2Ealert%2Ddismissible%7Bpadding%2Dright%3A35px%7D%2Ealert%2Ddismissable%20%2Eclose%2C%2Ealert%2Ddismissible%20%2Eclose%7Bposition%3Arelative%3Btop%3A%2D2px%3Bright%3A%2D21px%3Bcolor%3Ainherit%7D%2Ealert%2Dsuccess%7Bcolor%3A%233c763d%3Bbackground%2Dcolor%3A%23dff0d8%3Bborder%2Dcolor%3A%23d6e9c6%7D%2Ealert%2Dsuccess%20hr%7Bborder%2Dtop%2Dcolor%3A%23c9e2b3%7D%2Ealert%2Dsuccess%20%2Ealert%2Dlink%7Bcolor%3A%232b542c%7D%2Ealert%2Dinfo%7Bcolor%3A%2331708f%3Bbackground%2Dcolor%3A%23d9edf7%3Bborder%2Dcolor%3A%23bce8f1%7D%2Ealert%2Dinfo%20hr%7Bborder%2Dtop%2Dcolor%3A%23a6e1ec%7D%2Ealert%2Dinfo%20%2Ealert%2Dlink%7Bcolor%3A%23245269%7D%2Ealert%2Dwarning%7Bcolor%3A%238a6d3b%3Bbackground%2Dcolor%3A%23fcf8e3%3Bborder%2Dcolor%3A%23faebcc%7D%2Ealert%2Dwarning%20hr%7Bborder%2Dtop%2Dcolor%3A%23f7e1b5%7D%2Ealert%2Dwarning%20%2Ealert%2Dlink%7Bcolor%3A%2366512c%7D%2Ealert%2Ddanger%7Bcolor%3A%23a94442%3Bbackground%2Dcolor%3A%23f2dede%3Bborder%2Dcolor%3A%23ebccd1%7D%2Ealert%2Ddanger%20hr%7Bborder%2Dtop%2Dcolor%3A%23e4b9c0%7D%2Ealert%2Ddanger%20%2Ealert%2Dlink%7Bcolor%3A%23843534%7D%40%2Dwebkit%2Dkeyframes%20progress%2Dbar%2Dstripes%7Bfrom%7Bbackground%2Dposition%3A40px%200%7Dto%7Bbackground%2Dposition%3A0%200%7D%7D%40%2Do%2Dkeyframes%20progress%2Dbar%2Dstripes%7Bfrom%7Bbackground%2Dposition%3A40px%200%7Dto%7Bbackground%2Dposition%3A0%200%7D%7D%40keyframes%20progress%2Dbar%2Dstripes%7Bfrom%7Bbackground%2Dposition%3A40px%200%7Dto%7Bbackground%2Dposition%3A0%200%7D%7D%2Eprogress%7Bheight%3A20px%3Bmargin%2Dbottom%3A20px%3Boverflow%3Ahidden%3Bbackground%2Dcolor%3A%23f5f5f5%3Bborder%2Dradius%3A4px%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%202px%20rgba%280%2C0%2C0%2C%2E1%29%3Bbox%2Dshadow%3Ainset%200%201px%202px%20rgba%280%2C0%2C0%2C%2E1%29%7D%2Eprogress%2Dbar%7Bfloat%3Aleft%3Bwidth%3A0%3Bheight%3A100%25%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A20px%3Bcolor%3A%23fff%3Btext%2Dalign%3Acenter%3Bbackground%2Dcolor%3A%23337ab7%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%20%2D1px%200%20rgba%280%2C0%2C0%2C%2E15%29%3Bbox%2Dshadow%3Ainset%200%20%2D1px%200%20rgba%280%2C0%2C0%2C%2E15%29%3B%2Dwebkit%2Dtransition%3Awidth%20%2E6s%20ease%3B%2Do%2Dtransition%3Awidth%20%2E6s%20ease%3Btransition%3Awidth%20%2E6s%20ease%7D%2Eprogress%2Dbar%2Dstriped%2C%2Eprogress%2Dstriped%20%2Eprogress%2Dbar%7Bbackground%2Dimage%3A%2Dwebkit%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3A%2Do%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3Alinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3B%2Dwebkit%2Dbackground%2Dsize%3A40px%2040px%3Bbackground%2Dsize%3A40px%2040px%7D%2Eprogress%2Dbar%2Eactive%2C%2Eprogress%2Eactive%20%2Eprogress%2Dbar%7B%2Dwebkit%2Danimation%3Aprogress%2Dbar%2Dstripes%202s%20linear%20infinite%3B%2Do%2Danimation%3Aprogress%2Dbar%2Dstripes%202s%20linear%20infinite%3Banimation%3Aprogress%2Dbar%2Dstripes%202s%20linear%20infinite%7D%2Eprogress%2Dbar%2Dsuccess%7Bbackground%2Dcolor%3A%235cb85c%7D%2Eprogress%2Dstriped%20%2Eprogress%2Dbar%2Dsuccess%7Bbackground%2Dimage%3A%2Dwebkit%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3A%2Do%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3Alinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%7D%2Eprogress%2Dbar%2Dinfo%7Bbackground%2Dcolor%3A%235bc0de%7D%2Eprogress%2Dstriped%20%2Eprogress%2Dbar%2Dinfo%7Bbackground%2Dimage%3A%2Dwebkit%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3A%2Do%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3Alinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%7D%2Eprogress%2Dbar%2Dwarning%7Bbackground%2Dcolor%3A%23f0ad4e%7D%2Eprogress%2Dstriped%20%2Eprogress%2Dbar%2Dwarning%7Bbackground%2Dimage%3A%2Dwebkit%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3A%2Do%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3Alinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%7D%2Eprogress%2Dbar%2Ddanger%7Bbackground%2Dcolor%3A%23d9534f%7D%2Eprogress%2Dstriped%20%2Eprogress%2Dbar%2Ddanger%7Bbackground%2Dimage%3A%2Dwebkit%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3A%2Do%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3Alinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%7D%2Emedia%7Bmargin%2Dtop%3A15px%7D%2Emedia%3Afirst%2Dchild%7Bmargin%2Dtop%3A0%7D%2Emedia%2C%2Emedia%2Dbody%7Boverflow%3Ahidden%3Bzoom%3A1%7D%2Emedia%2Dbody%7Bwidth%3A10000px%7D%2Emedia%2Dobject%7Bdisplay%3Ablock%7D%2Emedia%2Dobject%2Eimg%2Dthumbnail%7Bmax%2Dwidth%3Anone%7D%2Emedia%2Dright%2C%2Emedia%3E%2Epull%2Dright%7Bpadding%2Dleft%3A10px%7D%2Emedia%2Dleft%2C%2Emedia%3E%2Epull%2Dleft%7Bpadding%2Dright%3A10px%7D%2Emedia%2Dbody%2C%2Emedia%2Dleft%2C%2Emedia%2Dright%7Bdisplay%3Atable%2Dcell%3Bvertical%2Dalign%3Atop%7D%2Emedia%2Dmiddle%7Bvertical%2Dalign%3Amiddle%7D%2Emedia%2Dbottom%7Bvertical%2Dalign%3Abottom%7D%2Emedia%2Dheading%7Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A5px%7D%2Emedia%2Dlist%7Bpadding%2Dleft%3A0%3Blist%2Dstyle%3Anone%7D%2Elist%2Dgroup%7Bpadding%2Dleft%3A0%3Bmargin%2Dbottom%3A20px%7D%2Elist%2Dgroup%2Ditem%7Bposition%3Arelative%3Bdisplay%3Ablock%3Bpadding%3A10px%2015px%3Bmargin%2Dbottom%3A%2D1px%3Bbackground%2Dcolor%3A%23fff%3Bborder%3A1px%20solid%20%23ddd%7D%2Elist%2Dgroup%2Ditem%3Afirst%2Dchild%7Bborder%2Dtop%2Dleft%2Dradius%3A4px%3Bborder%2Dtop%2Dright%2Dradius%3A4px%7D%2Elist%2Dgroup%2Ditem%3Alast%2Dchild%7Bmargin%2Dbottom%3A0%3Bborder%2Dbottom%2Dright%2Dradius%3A4px%3Bborder%2Dbottom%2Dleft%2Dradius%3A4px%7Da%2Elist%2Dgroup%2Ditem%2Cbutton%2Elist%2Dgroup%2Ditem%7Bcolor%3A%23555%7Da%2Elist%2Dgroup%2Ditem%20%2Elist%2Dgroup%2Ditem%2Dheading%2Cbutton%2Elist%2Dgroup%2Ditem%20%2Elist%2Dgroup%2Ditem%2Dheading%7Bcolor%3A%23333%7Da%2Elist%2Dgroup%2Ditem%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%3Ahover%7Bcolor%3A%23555%3Btext%2Ddecoration%3Anone%3Bbackground%2Dcolor%3A%23f5f5f5%7Dbutton%2Elist%2Dgroup%2Ditem%7Bwidth%3A100%25%3Btext%2Dalign%3Aleft%7D%2Elist%2Dgroup%2Ditem%2Edisabled%2C%2Elist%2Dgroup%2Ditem%2Edisabled%3Afocus%2C%2Elist%2Dgroup%2Ditem%2Edisabled%3Ahover%7Bcolor%3A%23777%3Bcursor%3Anot%2Dallowed%3Bbackground%2Dcolor%3A%23eee%7D%2Elist%2Dgroup%2Ditem%2Edisabled%20%2Elist%2Dgroup%2Ditem%2Dheading%2C%2Elist%2Dgroup%2Ditem%2Edisabled%3Afocus%20%2Elist%2Dgroup%2Ditem%2Dheading%2C%2Elist%2Dgroup%2Ditem%2Edisabled%3Ahover%20%2Elist%2Dgroup%2Ditem%2Dheading%7Bcolor%3Ainherit%7D%2Elist%2Dgroup%2Ditem%2Edisabled%20%2Elist%2Dgroup%2Ditem%2Dtext%2C%2Elist%2Dgroup%2Ditem%2Edisabled%3Afocus%20%2Elist%2Dgroup%2Ditem%2Dtext%2C%2Elist%2Dgroup%2Ditem%2Edisabled%3Ahover%20%2Elist%2Dgroup%2Ditem%2Dtext%7Bcolor%3A%23777%7D%2Elist%2Dgroup%2Ditem%2Eactive%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Afocus%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Ahover%7Bz%2Dindex%3A2%3Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23337ab7%3Bborder%2Dcolor%3A%23337ab7%7D%2Elist%2Dgroup%2Ditem%2Eactive%20%2Elist%2Dgroup%2Ditem%2Dheading%2C%2Elist%2Dgroup%2Ditem%2Eactive%20%2Elist%2Dgroup%2Ditem%2Dheading%3E%2Esmall%2C%2Elist%2Dgroup%2Ditem%2Eactive%20%2Elist%2Dgroup%2Ditem%2Dheading%3Esmall%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Afocus%20%2Elist%2Dgroup%2Ditem%2Dheading%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Afocus%20%2Elist%2Dgroup%2Ditem%2Dheading%3E%2Esmall%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Afocus%20%2Elist%2Dgroup%2Ditem%2Dheading%3Esmall%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Ahover%20%2Elist%2Dgroup%2Ditem%2Dheading%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Ahover%20%2Elist%2Dgroup%2Ditem%2Dheading%3E%2Esmall%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Ahover%20%2Elist%2Dgroup%2Ditem%2Dheading%3Esmall%7Bcolor%3Ainherit%7D%2Elist%2Dgroup%2Ditem%2Eactive%20%2Elist%2Dgroup%2Ditem%2Dtext%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Afocus%20%2Elist%2Dgroup%2Ditem%2Dtext%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Ahover%20%2Elist%2Dgroup%2Ditem%2Dtext%7Bcolor%3A%23c7ddef%7D%2Elist%2Dgroup%2Ditem%2Dsuccess%7Bcolor%3A%233c763d%3Bbackground%2Dcolor%3A%23dff0d8%7Da%2Elist%2Dgroup%2Ditem%2Dsuccess%2Cbutton%2Elist%2Dgroup%2Ditem%2Dsuccess%7Bcolor%3A%233c763d%7Da%2Elist%2Dgroup%2Ditem%2Dsuccess%20%2Elist%2Dgroup%2Ditem%2Dheading%2Cbutton%2Elist%2Dgroup%2Ditem%2Dsuccess%20%2Elist%2Dgroup%2Ditem%2Dheading%7Bcolor%3Ainherit%7Da%2Elist%2Dgroup%2Ditem%2Dsuccess%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Dsuccess%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Dsuccess%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Dsuccess%3Ahover%7Bcolor%3A%233c763d%3Bbackground%2Dcolor%3A%23d0e9c6%7Da%2Elist%2Dgroup%2Ditem%2Dsuccess%2Eactive%2Ca%2Elist%2Dgroup%2Ditem%2Dsuccess%2Eactive%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Dsuccess%2Eactive%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Dsuccess%2Eactive%2Cbutton%2Elist%2Dgroup%2Ditem%2Dsuccess%2Eactive%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Dsuccess%2Eactive%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%233c763d%3Bborder%2Dcolor%3A%233c763d%7D%2Elist%2Dgroup%2Ditem%2Dinfo%7Bcolor%3A%2331708f%3Bbackground%2Dcolor%3A%23d9edf7%7Da%2Elist%2Dgroup%2Ditem%2Dinfo%2Cbutton%2Elist%2Dgroup%2Ditem%2Dinfo%7Bcolor%3A%2331708f%7Da%2Elist%2Dgroup%2Ditem%2Dinfo%20%2Elist%2Dgroup%2Ditem%2Dheading%2Cbutton%2Elist%2Dgroup%2Ditem%2Dinfo%20%2Elist%2Dgroup%2Ditem%2Dheading%7Bcolor%3Ainherit%7Da%2Elist%2Dgroup%2Ditem%2Dinfo%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Dinfo%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Dinfo%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Dinfo%3Ahover%7Bcolor%3A%2331708f%3Bbackground%2Dcolor%3A%23c4e3f3%7Da%2Elist%2Dgroup%2Ditem%2Dinfo%2Eactive%2Ca%2Elist%2Dgroup%2Ditem%2Dinfo%2Eactive%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Dinfo%2Eactive%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Dinfo%2Eactive%2Cbutton%2Elist%2Dgroup%2Ditem%2Dinfo%2Eactive%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Dinfo%2Eactive%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%2331708f%3Bborder%2Dcolor%3A%2331708f%7D%2Elist%2Dgroup%2Ditem%2Dwarning%7Bcolor%3A%238a6d3b%3Bbackground%2Dcolor%3A%23fcf8e3%7Da%2Elist%2Dgroup%2Ditem%2Dwarning%2Cbutton%2Elist%2Dgroup%2Ditem%2Dwarning%7Bcolor%3A%238a6d3b%7Da%2Elist%2Dgroup%2Ditem%2Dwarning%20%2Elist%2Dgroup%2Ditem%2Dheading%2Cbutton%2Elist%2Dgroup%2Ditem%2Dwarning%20%2Elist%2Dgroup%2Ditem%2Dheading%7Bcolor%3Ainherit%7Da%2Elist%2Dgroup%2Ditem%2Dwarning%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Dwarning%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Dwarning%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Dwarning%3Ahover%7Bcolor%3A%238a6d3b%3Bbackground%2Dcolor%3A%23faf2cc%7Da%2Elist%2Dgroup%2Ditem%2Dwarning%2Eactive%2Ca%2Elist%2Dgroup%2Ditem%2Dwarning%2Eactive%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Dwarning%2Eactive%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Dwarning%2Eactive%2Cbutton%2Elist%2Dgroup%2Ditem%2Dwarning%2Eactive%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Dwarning%2Eactive%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%238a6d3b%3Bborder%2Dcolor%3A%238a6d3b%7D%2Elist%2Dgroup%2Ditem%2Ddanger%7Bcolor%3A%23a94442%3Bbackground%2Dcolor%3A%23f2dede%7Da%2Elist%2Dgroup%2Ditem%2Ddanger%2Cbutton%2Elist%2Dgroup%2Ditem%2Ddanger%7Bcolor%3A%23a94442%7Da%2Elist%2Dgroup%2Ditem%2Ddanger%20%2Elist%2Dgroup%2Ditem%2Dheading%2Cbutton%2Elist%2Dgroup%2Ditem%2Ddanger%20%2Elist%2Dgroup%2Ditem%2Dheading%7Bcolor%3Ainherit%7Da%2Elist%2Dgroup%2Ditem%2Ddanger%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Ddanger%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Ddanger%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Ddanger%3Ahover%7Bcolor%3A%23a94442%3Bbackground%2Dcolor%3A%23ebcccc%7Da%2Elist%2Dgroup%2Ditem%2Ddanger%2Eactive%2Ca%2Elist%2Dgroup%2Ditem%2Ddanger%2Eactive%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Ddanger%2Eactive%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Ddanger%2Eactive%2Cbutton%2Elist%2Dgroup%2Ditem%2Ddanger%2Eactive%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Ddanger%2Eactive%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23a94442%3Bborder%2Dcolor%3A%23a94442%7D%2Elist%2Dgroup%2Ditem%2Dheading%7Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A5px%7D%2Elist%2Dgroup%2Ditem%2Dtext%7Bmargin%2Dbottom%3A0%3Bline%2Dheight%3A1%2E3%7D%2Epanel%7Bmargin%2Dbottom%3A20px%3Bbackground%2Dcolor%3A%23fff%3Bborder%3A1px%20solid%20transparent%3Bborder%2Dradius%3A4px%3B%2Dwebkit%2Dbox%2Dshadow%3A0%201px%201px%20rgba%280%2C0%2C0%2C%2E05%29%3Bbox%2Dshadow%3A0%201px%201px%20rgba%280%2C0%2C0%2C%2E05%29%7D%2Epanel%2Dbody%7Bpadding%3A15px%7D%2Epanel%2Dheading%7Bpadding%3A10px%2015px%3Bborder%2Dbottom%3A1px%20solid%20transparent%3Bborder%2Dtop%2Dleft%2Dradius%3A3px%3Bborder%2Dtop%2Dright%2Dradius%3A3px%7D%2Epanel%2Dheading%3E%2Edropdown%20%2Edropdown%2Dtoggle%7Bcolor%3Ainherit%7D%2Epanel%2Dtitle%7Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A0%3Bfont%2Dsize%3A16px%3Bcolor%3Ainherit%7D%2Epanel%2Dtitle%3E%2Esmall%2C%2Epanel%2Dtitle%3E%2Esmall%3Ea%2C%2Epanel%2Dtitle%3Ea%2C%2Epanel%2Dtitle%3Esmall%2C%2Epanel%2Dtitle%3Esmall%3Ea%7Bcolor%3Ainherit%7D%2Epanel%2Dfooter%7Bpadding%3A10px%2015px%3Bbackground%2Dcolor%3A%23f5f5f5%3Bborder%2Dtop%3A1px%20solid%20%23ddd%3Bborder%2Dbottom%2Dright%2Dradius%3A3px%3Bborder%2Dbottom%2Dleft%2Dradius%3A3px%7D%2Epanel%3E%2Elist%2Dgroup%2C%2Epanel%3E%2Epanel%2Dcollapse%3E%2Elist%2Dgroup%7Bmargin%2Dbottom%3A0%7D%2Epanel%3E%2Elist%2Dgroup%20%2Elist%2Dgroup%2Ditem%2C%2Epanel%3E%2Epanel%2Dcollapse%3E%2Elist%2Dgroup%20%2Elist%2Dgroup%2Ditem%7Bborder%2Dwidth%3A1px%200%3Bborder%2Dradius%3A0%7D%2Epanel%3E%2Elist%2Dgroup%3Afirst%2Dchild%20%2Elist%2Dgroup%2Ditem%3Afirst%2Dchild%2C%2Epanel%3E%2Epanel%2Dcollapse%3E%2Elist%2Dgroup%3Afirst%2Dchild%20%2Elist%2Dgroup%2Ditem%3Afirst%2Dchild%7Bborder%2Dtop%3A0%3Bborder%2Dtop%2Dleft%2Dradius%3A3px%3Bborder%2Dtop%2Dright%2Dradius%3A3px%7D%2Epanel%3E%2Elist%2Dgroup%3Alast%2Dchild%20%2Elist%2Dgroup%2Ditem%3Alast%2Dchild%2C%2Epanel%3E%2Epanel%2Dcollapse%3E%2Elist%2Dgroup%3Alast%2Dchild%20%2Elist%2Dgroup%2Ditem%3Alast%2Dchild%7Bborder%2Dbottom%3A0%3Bborder%2Dbottom%2Dright%2Dradius%3A3px%3Bborder%2Dbottom%2Dleft%2Dradius%3A3px%7D%2Epanel%3E%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Elist%2Dgroup%20%2Elist%2Dgroup%2Ditem%3Afirst%2Dchild%7Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dtop%2Dright%2Dradius%3A0%7D%2Epanel%2Dheading%2B%2Elist%2Dgroup%20%2Elist%2Dgroup%2Ditem%3Afirst%2Dchild%7Bborder%2Dtop%2Dwidth%3A0%7D%2Elist%2Dgroup%2B%2Epanel%2Dfooter%7Bborder%2Dtop%2Dwidth%3A0%7D%2Epanel%3E%2Epanel%2Dcollapse%3E%2Etable%2C%2Epanel%3E%2Etable%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%7Bmargin%2Dbottom%3A0%7D%2Epanel%3E%2Epanel%2Dcollapse%3E%2Etable%20caption%2C%2Epanel%3E%2Etable%20caption%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%20caption%7Bpadding%2Dright%3A15px%3Bpadding%2Dleft%3A15px%7D%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%7Bborder%2Dtop%2Dleft%2Dradius%3A3px%3Bborder%2Dtop%2Dright%2Dradius%3A3px%7D%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%7Bborder%2Dtop%2Dleft%2Dradius%3A3px%3Bborder%2Dtop%2Dright%2Dradius%3A3px%7D%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Afirst%2Dchild%7Bborder%2Dtop%2Dleft%2Dradius%3A3px%7D%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Alast%2Dchild%7Bborder%2Dtop%2Dright%2Dradius%3A3px%7D%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%7Bborder%2Dbottom%2Dright%2Dradius%3A3px%3Bborder%2Dbottom%2Dleft%2Dradius%3A3px%7D%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%7Bborder%2Dbottom%2Dright%2Dradius%3A3px%3Bborder%2Dbottom%2Dleft%2Dradius%3A3px%7D%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Afirst%2Dchild%7Bborder%2Dbottom%2Dleft%2Dradius%3A3px%7D%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Alast%2Dchild%7Bborder%2Dbottom%2Dright%2Dradius%3A3px%7D%2Epanel%3E%2Epanel%2Dbody%2B%2Etable%2C%2Epanel%3E%2Epanel%2Dbody%2B%2Etable%2Dresponsive%2C%2Epanel%3E%2Etable%2B%2Epanel%2Dbody%2C%2Epanel%3E%2Etable%2Dresponsive%2B%2Epanel%2Dbody%7Bborder%2Dtop%3A1px%20solid%20%23ddd%7D%2Epanel%3E%2Etable%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%2C%2Epanel%3E%2Etable%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%7Bborder%2Dtop%3A0%7D%2Epanel%3E%2Etable%2Dbordered%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%7Bborder%3A0%7D%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Etd%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Eth%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Etd%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Eth%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Ethead%3Etr%3Etd%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Ethead%3Etr%3Eth%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Etd%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Eth%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Etd%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Eth%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Etd%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Eth%3Afirst%2Dchild%7Bborder%2Dleft%3A0%7D%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Etd%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Eth%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Etd%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Eth%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Ethead%3Etr%3Etd%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Ethead%3Etr%3Eth%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Etd%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Eth%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Etd%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Eth%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Etd%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Eth%3Alast%2Dchild%7Bborder%2Dright%3A0%7D%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Afirst%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Afirst%2Dchild%3Eth%2C%2Epanel%3E%2Etable%2Dbordered%3Ethead%3Etr%3Afirst%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dbordered%3Ethead%3Etr%3Afirst%2Dchild%3Eth%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Afirst%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Afirst%2Dchild%3Eth%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Afirst%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Afirst%2Dchild%3Eth%7Bborder%2Dbottom%3A0%7D%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Alast%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Alast%2Dchild%3Eth%2C%2Epanel%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Alast%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Alast%2Dchild%3Eth%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Alast%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Alast%2Dchild%3Eth%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Alast%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Alast%2Dchild%3Eth%7Bborder%2Dbottom%3A0%7D%2Epanel%3E%2Etable%2Dresponsive%7Bmargin%2Dbottom%3A0%3Bborder%3A0%7D%2Epanel%2Dgroup%7Bmargin%2Dbottom%3A20px%7D%2Epanel%2Dgroup%20%2Epanel%7Bmargin%2Dbottom%3A0%3Bborder%2Dradius%3A4px%7D%2Epanel%2Dgroup%20%2Epanel%2B%2Epanel%7Bmargin%2Dtop%3A5px%7D%2Epanel%2Dgroup%20%2Epanel%2Dheading%7Bborder%2Dbottom%3A0%7D%2Epanel%2Dgroup%20%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Elist%2Dgroup%2C%2Epanel%2Dgroup%20%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dtop%3A1px%20solid%20%23ddd%7D%2Epanel%2Dgroup%20%2Epanel%2Dfooter%7Bborder%2Dtop%3A0%7D%2Epanel%2Dgroup%20%2Epanel%2Dfooter%2B%2Epanel%2Dcollapse%20%2Epanel%2Dbody%7Bborder%2Dbottom%3A1px%20solid%20%23ddd%7D%2Epanel%2Ddefault%7Bborder%2Dcolor%3A%23ddd%7D%2Epanel%2Ddefault%3E%2Epanel%2Dheading%7Bcolor%3A%23333%3Bbackground%2Dcolor%3A%23f5f5f5%3Bborder%2Dcolor%3A%23ddd%7D%2Epanel%2Ddefault%3E%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dtop%2Dcolor%3A%23ddd%7D%2Epanel%2Ddefault%3E%2Epanel%2Dheading%20%2Ebadge%7Bcolor%3A%23f5f5f5%3Bbackground%2Dcolor%3A%23333%7D%2Epanel%2Ddefault%3E%2Epanel%2Dfooter%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dbottom%2Dcolor%3A%23ddd%7D%2Epanel%2Dprimary%7Bborder%2Dcolor%3A%23337ab7%7D%2Epanel%2Dprimary%3E%2Epanel%2Dheading%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23337ab7%3Bborder%2Dcolor%3A%23337ab7%7D%2Epanel%2Dprimary%3E%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dtop%2Dcolor%3A%23337ab7%7D%2Epanel%2Dprimary%3E%2Epanel%2Dheading%20%2Ebadge%7Bcolor%3A%23337ab7%3Bbackground%2Dcolor%3A%23fff%7D%2Epanel%2Dprimary%3E%2Epanel%2Dfooter%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dbottom%2Dcolor%3A%23337ab7%7D%2Epanel%2Dsuccess%7Bborder%2Dcolor%3A%23d6e9c6%7D%2Epanel%2Dsuccess%3E%2Epanel%2Dheading%7Bcolor%3A%233c763d%3Bbackground%2Dcolor%3A%23dff0d8%3Bborder%2Dcolor%3A%23d6e9c6%7D%2Epanel%2Dsuccess%3E%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dtop%2Dcolor%3A%23d6e9c6%7D%2Epanel%2Dsuccess%3E%2Epanel%2Dheading%20%2Ebadge%7Bcolor%3A%23dff0d8%3Bbackground%2Dcolor%3A%233c763d%7D%2Epanel%2Dsuccess%3E%2Epanel%2Dfooter%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dbottom%2Dcolor%3A%23d6e9c6%7D%2Epanel%2Dinfo%7Bborder%2Dcolor%3A%23bce8f1%7D%2Epanel%2Dinfo%3E%2Epanel%2Dheading%7Bcolor%3A%2331708f%3Bbackground%2Dcolor%3A%23d9edf7%3Bborder%2Dcolor%3A%23bce8f1%7D%2Epanel%2Dinfo%3E%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dtop%2Dcolor%3A%23bce8f1%7D%2Epanel%2Dinfo%3E%2Epanel%2Dheading%20%2Ebadge%7Bcolor%3A%23d9edf7%3Bbackground%2Dcolor%3A%2331708f%7D%2Epanel%2Dinfo%3E%2Epanel%2Dfooter%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dbottom%2Dcolor%3A%23bce8f1%7D%2Epanel%2Dwarning%7Bborder%2Dcolor%3A%23faebcc%7D%2Epanel%2Dwarning%3E%2Epanel%2Dheading%7Bcolor%3A%238a6d3b%3Bbackground%2Dcolor%3A%23fcf8e3%3Bborder%2Dcolor%3A%23faebcc%7D%2Epanel%2Dwarning%3E%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dtop%2Dcolor%3A%23faebcc%7D%2Epanel%2Dwarning%3E%2Epanel%2Dheading%20%2Ebadge%7Bcolor%3A%23fcf8e3%3Bbackground%2Dcolor%3A%238a6d3b%7D%2Epanel%2Dwarning%3E%2Epanel%2Dfooter%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dbottom%2Dcolor%3A%23faebcc%7D%2Epanel%2Ddanger%7Bborder%2Dcolor%3A%23ebccd1%7D%2Epanel%2Ddanger%3E%2Epanel%2Dheading%7Bcolor%3A%23a94442%3Bbackground%2Dcolor%3A%23f2dede%3Bborder%2Dcolor%3A%23ebccd1%7D%2Epanel%2Ddanger%3E%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dtop%2Dcolor%3A%23ebccd1%7D%2Epanel%2Ddanger%3E%2Epanel%2Dheading%20%2Ebadge%7Bcolor%3A%23f2dede%3Bbackground%2Dcolor%3A%23a94442%7D%2Epanel%2Ddanger%3E%2Epanel%2Dfooter%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dbottom%2Dcolor%3A%23ebccd1%7D%2Eembed%2Dresponsive%7Bposition%3Arelative%3Bdisplay%3Ablock%3Bheight%3A0%3Bpadding%3A0%3Boverflow%3Ahidden%7D%2Eembed%2Dresponsive%20%2Eembed%2Dresponsive%2Ditem%2C%2Eembed%2Dresponsive%20embed%2C%2Eembed%2Dresponsive%20iframe%2C%2Eembed%2Dresponsive%20object%2C%2Eembed%2Dresponsive%20video%7Bposition%3Aabsolute%3Btop%3A0%3Bbottom%3A0%3Bleft%3A0%3Bwidth%3A100%25%3Bheight%3A100%25%3Bborder%3A0%7D%2Eembed%2Dresponsive%2D16by9%7Bpadding%2Dbottom%3A56%2E25%25%7D%2Eembed%2Dresponsive%2D4by3%7Bpadding%2Dbottom%3A75%25%7D%2Ewell%7Bmin%2Dheight%3A20px%3Bpadding%3A19px%3Bmargin%2Dbottom%3A20px%3Bbackground%2Dcolor%3A%23f5f5f5%3Bborder%3A1px%20solid%20%23e3e3e3%3Bborder%2Dradius%3A4px%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E05%29%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E05%29%7D%2Ewell%20blockquote%7Bborder%2Dcolor%3A%23ddd%3Bborder%2Dcolor%3Argba%280%2C0%2C0%2C%2E15%29%7D%2Ewell%2Dlg%7Bpadding%3A24px%3Bborder%2Dradius%3A6px%7D%2Ewell%2Dsm%7Bpadding%3A9px%3Bborder%2Dradius%3A3px%7D%2Eclose%7Bfloat%3Aright%3Bfont%2Dsize%3A21px%3Bfont%2Dweight%3A700%3Bline%2Dheight%3A1%3Bcolor%3A%23000%3Btext%2Dshadow%3A0%201px%200%20%23fff%3Bfilter%3Aalpha%28opacity%3D20%29%3Bopacity%3A%2E2%7D%2Eclose%3Afocus%2C%2Eclose%3Ahover%7Bcolor%3A%23000%3Btext%2Ddecoration%3Anone%3Bcursor%3Apointer%3Bfilter%3Aalpha%28opacity%3D50%29%3Bopacity%3A%2E5%7Dbutton%2Eclose%7B%2Dwebkit%2Dappearance%3Anone%3Bpadding%3A0%3Bcursor%3Apointer%3Bbackground%3A0%200%3Bborder%3A0%7D%2Emodal%2Dopen%7Boverflow%3Ahidden%7D%2Emodal%7Bposition%3Afixed%3Btop%3A0%3Bright%3A0%3Bbottom%3A0%3Bleft%3A0%3Bz%2Dindex%3A1050%3Bdisplay%3Anone%3Boverflow%3Ahidden%3B%2Dwebkit%2Doverflow%2Dscrolling%3Atouch%3Boutline%3A0%7D%2Emodal%2Efade%20%2Emodal%2Ddialog%7B%2Dwebkit%2Dtransition%3A%2Dwebkit%2Dtransform%20%2E3s%20ease%2Dout%3B%2Do%2Dtransition%3A%2Do%2Dtransform%20%2E3s%20ease%2Dout%3Btransition%3Atransform%20%2E3s%20ease%2Dout%3B%2Dwebkit%2Dtransform%3Atranslate%280%2C%2D25%25%29%3B%2Dms%2Dtransform%3Atranslate%280%2C%2D25%25%29%3B%2Do%2Dtransform%3Atranslate%280%2C%2D25%25%29%3Btransform%3Atranslate%280%2C%2D25%25%29%7D%2Emodal%2Ein%20%2Emodal%2Ddialog%7B%2Dwebkit%2Dtransform%3Atranslate%280%2C0%29%3B%2Dms%2Dtransform%3Atranslate%280%2C0%29%3B%2Do%2Dtransform%3Atranslate%280%2C0%29%3Btransform%3Atranslate%280%2C0%29%7D%2Emodal%2Dopen%20%2Emodal%7Boverflow%2Dx%3Ahidden%3Boverflow%2Dy%3Aauto%7D%2Emodal%2Ddialog%7Bposition%3Arelative%3Bwidth%3Aauto%3Bmargin%3A10px%7D%2Emodal%2Dcontent%7Bposition%3Arelative%3Bbackground%2Dcolor%3A%23fff%3B%2Dwebkit%2Dbackground%2Dclip%3Apadding%2Dbox%3Bbackground%2Dclip%3Apadding%2Dbox%3Bborder%3A1px%20solid%20%23999%3Bborder%3A1px%20solid%20rgba%280%2C0%2C0%2C%2E2%29%3Bborder%2Dradius%3A6px%3Boutline%3A0%3B%2Dwebkit%2Dbox%2Dshadow%3A0%203px%209px%20rgba%280%2C0%2C0%2C%2E5%29%3Bbox%2Dshadow%3A0%203px%209px%20rgba%280%2C0%2C0%2C%2E5%29%7D%2Emodal%2Dbackdrop%7Bposition%3Afixed%3Btop%3A0%3Bright%3A0%3Bbottom%3A0%3Bleft%3A0%3Bz%2Dindex%3A1040%3Bbackground%2Dcolor%3A%23000%7D%2Emodal%2Dbackdrop%2Efade%7Bfilter%3Aalpha%28opacity%3D0%29%3Bopacity%3A0%7D%2Emodal%2Dbackdrop%2Ein%7Bfilter%3Aalpha%28opacity%3D50%29%3Bopacity%3A%2E5%7D%2Emodal%2Dheader%7Bmin%2Dheight%3A16%2E43px%3Bpadding%3A15px%3Bborder%2Dbottom%3A1px%20solid%20%23e5e5e5%7D%2Emodal%2Dheader%20%2Eclose%7Bmargin%2Dtop%3A%2D2px%7D%2Emodal%2Dtitle%7Bmargin%3A0%3Bline%2Dheight%3A1%2E42857143%7D%2Emodal%2Dbody%7Bposition%3Arelative%3Bpadding%3A15px%7D%2Emodal%2Dfooter%7Bpadding%3A15px%3Btext%2Dalign%3Aright%3Bborder%2Dtop%3A1px%20solid%20%23e5e5e5%7D%2Emodal%2Dfooter%20%2Ebtn%2B%2Ebtn%7Bmargin%2Dbottom%3A0%3Bmargin%2Dleft%3A5px%7D%2Emodal%2Dfooter%20%2Ebtn%2Dgroup%20%2Ebtn%2B%2Ebtn%7Bmargin%2Dleft%3A%2D1px%7D%2Emodal%2Dfooter%20%2Ebtn%2Dblock%2B%2Ebtn%2Dblock%7Bmargin%2Dleft%3A0%7D%2Emodal%2Dscrollbar%2Dmeasure%7Bposition%3Aabsolute%3Btop%3A%2D9999px%3Bwidth%3A50px%3Bheight%3A50px%3Boverflow%3Ascroll%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Emodal%2Ddialog%7Bwidth%3A600px%3Bmargin%3A30px%20auto%7D%2Emodal%2Dcontent%7B%2Dwebkit%2Dbox%2Dshadow%3A0%205px%2015px%20rgba%280%2C0%2C0%2C%2E5%29%3Bbox%2Dshadow%3A0%205px%2015px%20rgba%280%2C0%2C0%2C%2E5%29%7D%2Emodal%2Dsm%7Bwidth%3A300px%7D%7D%40media%20%28min%2Dwidth%3A992px%29%7B%2Emodal%2Dlg%7Bwidth%3A900px%7D%7D%2Etooltip%7Bposition%3Aabsolute%3Bz%2Dindex%3A1070%3Bdisplay%3Ablock%3Bfont%2Dfamily%3A%22Helvetica%20Neue%22%2CHelvetica%2CArial%2Csans%2Dserif%3Bfont%2Dsize%3A12px%3Bfont%2Dstyle%3Anormal%3Bfont%2Dweight%3A400%3Bline%2Dheight%3A1%2E42857143%3Btext%2Dalign%3Aleft%3Btext%2Dalign%3Astart%3Btext%2Ddecoration%3Anone%3Btext%2Dshadow%3Anone%3Btext%2Dtransform%3Anone%3Bletter%2Dspacing%3Anormal%3Bword%2Dbreak%3Anormal%3Bword%2Dspacing%3Anormal%3Bword%2Dwrap%3Anormal%3Bwhite%2Dspace%3Anormal%3Bfilter%3Aalpha%28opacity%3D0%29%3Bopacity%3A0%3Bline%2Dbreak%3Aauto%7D%2Etooltip%2Ein%7Bfilter%3Aalpha%28opacity%3D90%29%3Bopacity%3A%2E9%7D%2Etooltip%2Etop%7Bpadding%3A5px%200%3Bmargin%2Dtop%3A%2D3px%7D%2Etooltip%2Eright%7Bpadding%3A0%205px%3Bmargin%2Dleft%3A3px%7D%2Etooltip%2Ebottom%7Bpadding%3A5px%200%3Bmargin%2Dtop%3A3px%7D%2Etooltip%2Eleft%7Bpadding%3A0%205px%3Bmargin%2Dleft%3A%2D3px%7D%2Etooltip%2Dinner%7Bmax%2Dwidth%3A200px%3Bpadding%3A3px%208px%3Bcolor%3A%23fff%3Btext%2Dalign%3Acenter%3Bbackground%2Dcolor%3A%23000%3Bborder%2Dradius%3A4px%7D%2Etooltip%2Darrow%7Bposition%3Aabsolute%3Bwidth%3A0%3Bheight%3A0%3Bborder%2Dcolor%3Atransparent%3Bborder%2Dstyle%3Asolid%7D%2Etooltip%2Etop%20%2Etooltip%2Darrow%7Bbottom%3A0%3Bleft%3A50%25%3Bmargin%2Dleft%3A%2D5px%3Bborder%2Dwidth%3A5px%205px%200%3Bborder%2Dtop%2Dcolor%3A%23000%7D%2Etooltip%2Etop%2Dleft%20%2Etooltip%2Darrow%7Bright%3A5px%3Bbottom%3A0%3Bmargin%2Dbottom%3A%2D5px%3Bborder%2Dwidth%3A5px%205px%200%3Bborder%2Dtop%2Dcolor%3A%23000%7D%2Etooltip%2Etop%2Dright%20%2Etooltip%2Darrow%7Bbottom%3A0%3Bleft%3A5px%3Bmargin%2Dbottom%3A%2D5px%3Bborder%2Dwidth%3A5px%205px%200%3Bborder%2Dtop%2Dcolor%3A%23000%7D%2Etooltip%2Eright%20%2Etooltip%2Darrow%7Btop%3A50%25%3Bleft%3A0%3Bmargin%2Dtop%3A%2D5px%3Bborder%2Dwidth%3A5px%205px%205px%200%3Bborder%2Dright%2Dcolor%3A%23000%7D%2Etooltip%2Eleft%20%2Etooltip%2Darrow%7Btop%3A50%25%3Bright%3A0%3Bmargin%2Dtop%3A%2D5px%3Bborder%2Dwidth%3A5px%200%205px%205px%3Bborder%2Dleft%2Dcolor%3A%23000%7D%2Etooltip%2Ebottom%20%2Etooltip%2Darrow%7Btop%3A0%3Bleft%3A50%25%3Bmargin%2Dleft%3A%2D5px%3Bborder%2Dwidth%3A0%205px%205px%3Bborder%2Dbottom%2Dcolor%3A%23000%7D%2Etooltip%2Ebottom%2Dleft%20%2Etooltip%2Darrow%7Btop%3A0%3Bright%3A5px%3Bmargin%2Dtop%3A%2D5px%3Bborder%2Dwidth%3A0%205px%205px%3Bborder%2Dbottom%2Dcolor%3A%23000%7D%2Etooltip%2Ebottom%2Dright%20%2Etooltip%2Darrow%7Btop%3A0%3Bleft%3A5px%3Bmargin%2Dtop%3A%2D5px%3Bborder%2Dwidth%3A0%205px%205px%3Bborder%2Dbottom%2Dcolor%3A%23000%7D%2Epopover%7Bposition%3Aabsolute%3Btop%3A0%3Bleft%3A0%3Bz%2Dindex%3A1060%3Bdisplay%3Anone%3Bmax%2Dwidth%3A276px%3Bpadding%3A1px%3Bfont%2Dfamily%3A%22Helvetica%20Neue%22%2CHelvetica%2CArial%2Csans%2Dserif%3Bfont%2Dsize%3A14px%3Bfont%2Dstyle%3Anormal%3Bfont%2Dweight%3A400%3Bline%2Dheight%3A1%2E42857143%3Btext%2Dalign%3Aleft%3Btext%2Dalign%3Astart%3Btext%2Ddecoration%3Anone%3Btext%2Dshadow%3Anone%3Btext%2Dtransform%3Anone%3Bletter%2Dspacing%3Anormal%3Bword%2Dbreak%3Anormal%3Bword%2Dspacing%3Anormal%3Bword%2Dwrap%3Anormal%3Bwhite%2Dspace%3Anormal%3Bbackground%2Dcolor%3A%23fff%3B%2Dwebkit%2Dbackground%2Dclip%3Apadding%2Dbox%3Bbackground%2Dclip%3Apadding%2Dbox%3Bborder%3A1px%20solid%20%23ccc%3Bborder%3A1px%20solid%20rgba%280%2C0%2C0%2C%2E2%29%3Bborder%2Dradius%3A6px%3B%2Dwebkit%2Dbox%2Dshadow%3A0%205px%2010px%20rgba%280%2C0%2C0%2C%2E2%29%3Bbox%2Dshadow%3A0%205px%2010px%20rgba%280%2C0%2C0%2C%2E2%29%3Bline%2Dbreak%3Aauto%7D%2Epopover%2Etop%7Bmargin%2Dtop%3A%2D10px%7D%2Epopover%2Eright%7Bmargin%2Dleft%3A10px%7D%2Epopover%2Ebottom%7Bmargin%2Dtop%3A10px%7D%2Epopover%2Eleft%7Bmargin%2Dleft%3A%2D10px%7D%2Epopover%2Dtitle%7Bpadding%3A8px%2014px%3Bmargin%3A0%3Bfont%2Dsize%3A14px%3Bbackground%2Dcolor%3A%23f7f7f7%3Bborder%2Dbottom%3A1px%20solid%20%23ebebeb%3Bborder%2Dradius%3A5px%205px%200%200%7D%2Epopover%2Dcontent%7Bpadding%3A9px%2014px%7D%2Epopover%3E%2Earrow%2C%2Epopover%3E%2Earrow%3Aafter%7Bposition%3Aabsolute%3Bdisplay%3Ablock%3Bwidth%3A0%3Bheight%3A0%3Bborder%2Dcolor%3Atransparent%3Bborder%2Dstyle%3Asolid%7D%2Epopover%3E%2Earrow%7Bborder%2Dwidth%3A11px%7D%2Epopover%3E%2Earrow%3Aafter%7Bcontent%3A%22%22%3Bborder%2Dwidth%3A10px%7D%2Epopover%2Etop%3E%2Earrow%7Bbottom%3A%2D11px%3Bleft%3A50%25%3Bmargin%2Dleft%3A%2D11px%3Bborder%2Dtop%2Dcolor%3A%23999%3Bborder%2Dtop%2Dcolor%3Argba%280%2C0%2C0%2C%2E25%29%3Bborder%2Dbottom%2Dwidth%3A0%7D%2Epopover%2Etop%3E%2Earrow%3Aafter%7Bbottom%3A1px%3Bmargin%2Dleft%3A%2D10px%3Bcontent%3A%22%20%22%3Bborder%2Dtop%2Dcolor%3A%23fff%3Bborder%2Dbottom%2Dwidth%3A0%7D%2Epopover%2Eright%3E%2Earrow%7Btop%3A50%25%3Bleft%3A%2D11px%3Bmargin%2Dtop%3A%2D11px%3Bborder%2Dright%2Dcolor%3A%23999%3Bborder%2Dright%2Dcolor%3Argba%280%2C0%2C0%2C%2E25%29%3Bborder%2Dleft%2Dwidth%3A0%7D%2Epopover%2Eright%3E%2Earrow%3Aafter%7Bbottom%3A%2D10px%3Bleft%3A1px%3Bcontent%3A%22%20%22%3Bborder%2Dright%2Dcolor%3A%23fff%3Bborder%2Dleft%2Dwidth%3A0%7D%2Epopover%2Ebottom%3E%2Earrow%7Btop%3A%2D11px%3Bleft%3A50%25%3Bmargin%2Dleft%3A%2D11px%3Bborder%2Dtop%2Dwidth%3A0%3Bborder%2Dbottom%2Dcolor%3A%23999%3Bborder%2Dbottom%2Dcolor%3Argba%280%2C0%2C0%2C%2E25%29%7D%2Epopover%2Ebottom%3E%2Earrow%3Aafter%7Btop%3A1px%3Bmargin%2Dleft%3A%2D10px%3Bcontent%3A%22%20%22%3Bborder%2Dtop%2Dwidth%3A0%3Bborder%2Dbottom%2Dcolor%3A%23fff%7D%2Epopover%2Eleft%3E%2Earrow%7Btop%3A50%25%3Bright%3A%2D11px%3Bmargin%2Dtop%3A%2D11px%3Bborder%2Dright%2Dwidth%3A0%3Bborder%2Dleft%2Dcolor%3A%23999%3Bborder%2Dleft%2Dcolor%3Argba%280%2C0%2C0%2C%2E25%29%7D%2Epopover%2Eleft%3E%2Earrow%3Aafter%7Bright%3A1px%3Bbottom%3A%2D10px%3Bcontent%3A%22%20%22%3Bborder%2Dright%2Dwidth%3A0%3Bborder%2Dleft%2Dcolor%3A%23fff%7D%2Ecarousel%7Bposition%3Arelative%7D%2Ecarousel%2Dinner%7Bposition%3Arelative%3Bwidth%3A100%25%3Boverflow%3Ahidden%7D%2Ecarousel%2Dinner%3E%2Eitem%7Bposition%3Arelative%3Bdisplay%3Anone%3B%2Dwebkit%2Dtransition%3A%2E6s%20ease%2Din%2Dout%20left%3B%2Do%2Dtransition%3A%2E6s%20ease%2Din%2Dout%20left%3Btransition%3A%2E6s%20ease%2Din%2Dout%20left%7D%2Ecarousel%2Dinner%3E%2Eitem%3Ea%3Eimg%2C%2Ecarousel%2Dinner%3E%2Eitem%3Eimg%7Bline%2Dheight%3A1%7D%40media%20all%20and%20%28transform%2D3d%29%2C%28%2Dwebkit%2Dtransform%2D3d%29%7B%2Ecarousel%2Dinner%3E%2Eitem%7B%2Dwebkit%2Dtransition%3A%2Dwebkit%2Dtransform%20%2E6s%20ease%2Din%2Dout%3B%2Do%2Dtransition%3A%2Do%2Dtransform%20%2E6s%20ease%2Din%2Dout%3Btransition%3Atransform%20%2E6s%20ease%2Din%2Dout%3B%2Dwebkit%2Dbackface%2Dvisibility%3Ahidden%3Bbackface%2Dvisibility%3Ahidden%3B%2Dwebkit%2Dperspective%3A1000px%3Bperspective%3A1000px%7D%2Ecarousel%2Dinner%3E%2Eitem%2Eactive%2Eright%2C%2Ecarousel%2Dinner%3E%2Eitem%2Enext%7Bleft%3A0%3B%2Dwebkit%2Dtransform%3Atranslate3d%28100%25%2C0%2C0%29%3Btransform%3Atranslate3d%28100%25%2C0%2C0%29%7D%2Ecarousel%2Dinner%3E%2Eitem%2Eactive%2Eleft%2C%2Ecarousel%2Dinner%3E%2Eitem%2Eprev%7Bleft%3A0%3B%2Dwebkit%2Dtransform%3Atranslate3d%28%2D100%25%2C0%2C0%29%3Btransform%3Atranslate3d%28%2D100%25%2C0%2C0%29%7D%2Ecarousel%2Dinner%3E%2Eitem%2Eactive%2C%2Ecarousel%2Dinner%3E%2Eitem%2Enext%2Eleft%2C%2Ecarousel%2Dinner%3E%2Eitem%2Eprev%2Eright%7Bleft%3A0%3B%2Dwebkit%2Dtransform%3Atranslate3d%280%2C0%2C0%29%3Btransform%3Atranslate3d%280%2C0%2C0%29%7D%7D%2Ecarousel%2Dinner%3E%2Eactive%2C%2Ecarousel%2Dinner%3E%2Enext%2C%2Ecarousel%2Dinner%3E%2Eprev%7Bdisplay%3Ablock%7D%2Ecarousel%2Dinner%3E%2Eactive%7Bleft%3A0%7D%2Ecarousel%2Dinner%3E%2Enext%2C%2Ecarousel%2Dinner%3E%2Eprev%7Bposition%3Aabsolute%3Btop%3A0%3Bwidth%3A100%25%7D%2Ecarousel%2Dinner%3E%2Enext%7Bleft%3A100%25%7D%2Ecarousel%2Dinner%3E%2Eprev%7Bleft%3A%2D100%25%7D%2Ecarousel%2Dinner%3E%2Enext%2Eleft%2C%2Ecarousel%2Dinner%3E%2Eprev%2Eright%7Bleft%3A0%7D%2Ecarousel%2Dinner%3E%2Eactive%2Eleft%7Bleft%3A%2D100%25%7D%2Ecarousel%2Dinner%3E%2Eactive%2Eright%7Bleft%3A100%25%7D%2Ecarousel%2Dcontrol%7Bposition%3Aabsolute%3Btop%3A0%3Bbottom%3A0%3Bleft%3A0%3Bwidth%3A15%25%3Bfont%2Dsize%3A20px%3Bcolor%3A%23fff%3Btext%2Dalign%3Acenter%3Btext%2Dshadow%3A0%201px%202px%20rgba%280%2C0%2C0%2C%2E6%29%3Bfilter%3Aalpha%28opacity%3D50%29%3Bopacity%3A%2E5%7D%2Ecarousel%2Dcontrol%2Eleft%7Bbackground%2Dimage%3A%2Dwebkit%2Dlinear%2Dgradient%28left%2Crgba%280%2C0%2C0%2C%2E5%29%200%2Crgba%280%2C0%2C0%2C%2E0001%29%20100%25%29%3Bbackground%2Dimage%3A%2Do%2Dlinear%2Dgradient%28left%2Crgba%280%2C0%2C0%2C%2E5%29%200%2Crgba%280%2C0%2C0%2C%2E0001%29%20100%25%29%3Bbackground%2Dimage%3A%2Dwebkit%2Dgradient%28linear%2Cleft%20top%2Cright%20top%2Cfrom%28rgba%280%2C0%2C0%2C%2E5%29%29%2Cto%28rgba%280%2C0%2C0%2C%2E0001%29%29%29%3Bbackground%2Dimage%3Alinear%2Dgradient%28to%20right%2Crgba%280%2C0%2C0%2C%2E5%29%200%2Crgba%280%2C0%2C0%2C%2E0001%29%20100%25%29%3Bfilter%3Aprogid%3ADXImageTransform%2EMicrosoft%2Egradient%28startColorstr%3D%27%2380000000%27%2C%20endColorstr%3D%27%2300000000%27%2C%20GradientType%3D1%29%3Bbackground%2Drepeat%3Arepeat%2Dx%7D%2Ecarousel%2Dcontrol%2Eright%7Bright%3A0%3Bleft%3Aauto%3Bbackground%2Dimage%3A%2Dwebkit%2Dlinear%2Dgradient%28left%2Crgba%280%2C0%2C0%2C%2E0001%29%200%2Crgba%280%2C0%2C0%2C%2E5%29%20100%25%29%3Bbackground%2Dimage%3A%2Do%2Dlinear%2Dgradient%28left%2Crgba%280%2C0%2C0%2C%2E0001%29%200%2Crgba%280%2C0%2C0%2C%2E5%29%20100%25%29%3Bbackground%2Dimage%3A%2Dwebkit%2Dgradient%28linear%2Cleft%20top%2Cright%20top%2Cfrom%28rgba%280%2C0%2C0%2C%2E0001%29%29%2Cto%28rgba%280%2C0%2C0%2C%2E5%29%29%29%3Bbackground%2Dimage%3Alinear%2Dgradient%28to%20right%2Crgba%280%2C0%2C0%2C%2E0001%29%200%2Crgba%280%2C0%2C0%2C%2E5%29%20100%25%29%3Bfilter%3Aprogid%3ADXImageTransform%2EMicrosoft%2Egradient%28startColorstr%3D%27%2300000000%27%2C%20endColorstr%3D%27%2380000000%27%2C%20GradientType%3D1%29%3Bbackground%2Drepeat%3Arepeat%2Dx%7D%2Ecarousel%2Dcontrol%3Afocus%2C%2Ecarousel%2Dcontrol%3Ahover%7Bcolor%3A%23fff%3Btext%2Ddecoration%3Anone%3Bfilter%3Aalpha%28opacity%3D90%29%3Boutline%3A0%3Bopacity%3A%2E9%7D%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dleft%2C%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dright%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dnext%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dprev%7Bposition%3Aabsolute%3Btop%3A50%25%3Bz%2Dindex%3A5%3Bdisplay%3Ainline%2Dblock%3Bmargin%2Dtop%3A%2D10px%7D%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dleft%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dprev%7Bleft%3A50%25%3Bmargin%2Dleft%3A%2D10px%7D%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dright%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dnext%7Bright%3A50%25%3Bmargin%2Dright%3A%2D10px%7D%2Ecarousel%2Dcontrol%20%2Eicon%2Dnext%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dprev%7Bwidth%3A20px%3Bheight%3A20px%3Bfont%2Dfamily%3Aserif%3Bline%2Dheight%3A1%7D%2Ecarousel%2Dcontrol%20%2Eicon%2Dprev%3Abefore%7Bcontent%3A%27%5C2039%27%7D%2Ecarousel%2Dcontrol%20%2Eicon%2Dnext%3Abefore%7Bcontent%3A%27%5C203a%27%7D%2Ecarousel%2Dindicators%7Bposition%3Aabsolute%3Bbottom%3A10px%3Bleft%3A50%25%3Bz%2Dindex%3A15%3Bwidth%3A60%25%3Bpadding%2Dleft%3A0%3Bmargin%2Dleft%3A%2D30%25%3Btext%2Dalign%3Acenter%3Blist%2Dstyle%3Anone%7D%2Ecarousel%2Dindicators%20li%7Bdisplay%3Ainline%2Dblock%3Bwidth%3A10px%3Bheight%3A10px%3Bmargin%3A1px%3Btext%2Dindent%3A%2D999px%3Bcursor%3Apointer%3Bbackground%2Dcolor%3A%23000%5C9%3Bbackground%2Dcolor%3Argba%280%2C0%2C0%2C0%29%3Bborder%3A1px%20solid%20%23fff%3Bborder%2Dradius%3A10px%7D%2Ecarousel%2Dindicators%20%2Eactive%7Bwidth%3A12px%3Bheight%3A12px%3Bmargin%3A0%3Bbackground%2Dcolor%3A%23fff%7D%2Ecarousel%2Dcaption%7Bposition%3Aabsolute%3Bright%3A15%25%3Bbottom%3A20px%3Bleft%3A15%25%3Bz%2Dindex%3A10%3Bpadding%2Dtop%3A20px%3Bpadding%2Dbottom%3A20px%3Bcolor%3A%23fff%3Btext%2Dalign%3Acenter%3Btext%2Dshadow%3A0%201px%202px%20rgba%280%2C0%2C0%2C%2E6%29%7D%2Ecarousel%2Dcaption%20%2Ebtn%7Btext%2Dshadow%3Anone%7D%40media%20screen%20and%20%28min%2Dwidth%3A768px%29%7B%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dleft%2C%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dright%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dnext%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dprev%7Bwidth%3A30px%3Bheight%3A30px%3Bmargin%2Dtop%3A%2D15px%3Bfont%2Dsize%3A30px%7D%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dleft%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dprev%7Bmargin%2Dleft%3A%2D15px%7D%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dright%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dnext%7Bmargin%2Dright%3A%2D15px%7D%2Ecarousel%2Dcaption%7Bright%3A20%25%3Bleft%3A20%25%3Bpadding%2Dbottom%3A30px%7D%2Ecarousel%2Dindicators%7Bbottom%3A20px%7D%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3Aafter%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3Abefore%2C%2Ebtn%2Dtoolbar%3Aafter%2C%2Ebtn%2Dtoolbar%3Abefore%2C%2Eclearfix%3Aafter%2C%2Eclearfix%3Abefore%2C%2Econtainer%2Dfluid%3Aafter%2C%2Econtainer%2Dfluid%3Abefore%2C%2Econtainer%3Aafter%2C%2Econtainer%3Abefore%2C%2Edl%2Dhorizontal%20dd%3Aafter%2C%2Edl%2Dhorizontal%20dd%3Abefore%2C%2Eform%2Dhorizontal%20%2Eform%2Dgroup%3Aafter%2C%2Eform%2Dhorizontal%20%2Eform%2Dgroup%3Abefore%2C%2Emodal%2Dfooter%3Aafter%2C%2Emodal%2Dfooter%3Abefore%2C%2Enav%3Aafter%2C%2Enav%3Abefore%2C%2Enavbar%2Dcollapse%3Aafter%2C%2Enavbar%2Dcollapse%3Abefore%2C%2Enavbar%2Dheader%3Aafter%2C%2Enavbar%2Dheader%3Abefore%2C%2Enavbar%3Aafter%2C%2Enavbar%3Abefore%2C%2Epager%3Aafter%2C%2Epager%3Abefore%2C%2Epanel%2Dbody%3Aafter%2C%2Epanel%2Dbody%3Abefore%2C%2Erow%3Aafter%2C%2Erow%3Abefore%7Bdisplay%3Atable%3Bcontent%3A%22%20%22%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3Aafter%2C%2Ebtn%2Dtoolbar%3Aafter%2C%2Eclearfix%3Aafter%2C%2Econtainer%2Dfluid%3Aafter%2C%2Econtainer%3Aafter%2C%2Edl%2Dhorizontal%20dd%3Aafter%2C%2Eform%2Dhorizontal%20%2Eform%2Dgroup%3Aafter%2C%2Emodal%2Dfooter%3Aafter%2C%2Enav%3Aafter%2C%2Enavbar%2Dcollapse%3Aafter%2C%2Enavbar%2Dheader%3Aafter%2C%2Enavbar%3Aafter%2C%2Epager%3Aafter%2C%2Epanel%2Dbody%3Aafter%2C%2Erow%3Aafter%7Bclear%3Aboth%7D%2Ecenter%2Dblock%7Bdisplay%3Ablock%3Bmargin%2Dright%3Aauto%3Bmargin%2Dleft%3Aauto%7D%2Epull%2Dright%7Bfloat%3Aright%21important%7D%2Epull%2Dleft%7Bfloat%3Aleft%21important%7D%2Ehide%7Bdisplay%3Anone%21important%7D%2Eshow%7Bdisplay%3Ablock%21important%7D%2Einvisible%7Bvisibility%3Ahidden%7D%2Etext%2Dhide%7Bfont%3A0%2F0%20a%3Bcolor%3Atransparent%3Btext%2Dshadow%3Anone%3Bbackground%2Dcolor%3Atransparent%3Bborder%3A0%7D%2Ehidden%7Bdisplay%3Anone%21important%7D%2Eaffix%7Bposition%3Afixed%7D%40%2Dms%2Dviewport%7Bwidth%3Adevice%2Dwidth%7D%2Evisible%2Dlg%2C%2Evisible%2Dmd%2C%2Evisible%2Dsm%2C%2Evisible%2Dxs%7Bdisplay%3Anone%21important%7D%2Evisible%2Dlg%2Dblock%2C%2Evisible%2Dlg%2Dinline%2C%2Evisible%2Dlg%2Dinline%2Dblock%2C%2Evisible%2Dmd%2Dblock%2C%2Evisible%2Dmd%2Dinline%2C%2Evisible%2Dmd%2Dinline%2Dblock%2C%2Evisible%2Dsm%2Dblock%2C%2Evisible%2Dsm%2Dinline%2C%2Evisible%2Dsm%2Dinline%2Dblock%2C%2Evisible%2Dxs%2Dblock%2C%2Evisible%2Dxs%2Dinline%2C%2Evisible%2Dxs%2Dinline%2Dblock%7Bdisplay%3Anone%21important%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Evisible%2Dxs%7Bdisplay%3Ablock%21important%7Dtable%2Evisible%2Dxs%7Bdisplay%3Atable%21important%7Dtr%2Evisible%2Dxs%7Bdisplay%3Atable%2Drow%21important%7Dtd%2Evisible%2Dxs%2Cth%2Evisible%2Dxs%7Bdisplay%3Atable%2Dcell%21important%7D%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Evisible%2Dxs%2Dblock%7Bdisplay%3Ablock%21important%7D%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Evisible%2Dxs%2Dinline%7Bdisplay%3Ainline%21important%7D%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Evisible%2Dxs%2Dinline%2Dblock%7Bdisplay%3Ainline%2Dblock%21important%7D%7D%40media%20%28min%2Dwidth%3A768px%29%20and%20%28max%2Dwidth%3A991px%29%7B%2Evisible%2Dsm%7Bdisplay%3Ablock%21important%7Dtable%2Evisible%2Dsm%7Bdisplay%3Atable%21important%7Dtr%2Evisible%2Dsm%7Bdisplay%3Atable%2Drow%21important%7Dtd%2Evisible%2Dsm%2Cth%2Evisible%2Dsm%7Bdisplay%3Atable%2Dcell%21important%7D%7D%40media%20%28min%2Dwidth%3A768px%29%20and%20%28max%2Dwidth%3A991px%29%7B%2Evisible%2Dsm%2Dblock%7Bdisplay%3Ablock%21important%7D%7D%40media%20%28min%2Dwidth%3A768px%29%20and%20%28max%2Dwidth%3A991px%29%7B%2Evisible%2Dsm%2Dinline%7Bdisplay%3Ainline%21important%7D%7D%40media%20%28min%2Dwidth%3A768px%29%20and%20%28max%2Dwidth%3A991px%29%7B%2Evisible%2Dsm%2Dinline%2Dblock%7Bdisplay%3Ainline%2Dblock%21important%7D%7D%40media%20%28min%2Dwidth%3A992px%29%20and%20%28max%2Dwidth%3A1199px%29%7B%2Evisible%2Dmd%7Bdisplay%3Ablock%21important%7Dtable%2Evisible%2Dmd%7Bdisplay%3Atable%21important%7Dtr%2Evisible%2Dmd%7Bdisplay%3Atable%2Drow%21important%7Dtd%2Evisible%2Dmd%2Cth%2Evisible%2Dmd%7Bdisplay%3Atable%2Dcell%21important%7D%7D%40media%20%28min%2Dwidth%3A992px%29%20and%20%28max%2Dwidth%3A1199px%29%7B%2Evisible%2Dmd%2Dblock%7Bdisplay%3Ablock%21important%7D%7D%40media%20%28min%2Dwidth%3A992px%29%20and%20%28max%2Dwidth%3A1199px%29%7B%2Evisible%2Dmd%2Dinline%7Bdisplay%3Ainline%21important%7D%7D%40media%20%28min%2Dwidth%3A992px%29%20and%20%28max%2Dwidth%3A1199px%29%7B%2Evisible%2Dmd%2Dinline%2Dblock%7Bdisplay%3Ainline%2Dblock%21important%7D%7D%40media%20%28min%2Dwidth%3A1200px%29%7B%2Evisible%2Dlg%7Bdisplay%3Ablock%21important%7Dtable%2Evisible%2Dlg%7Bdisplay%3Atable%21important%7Dtr%2Evisible%2Dlg%7Bdisplay%3Atable%2Drow%21important%7Dtd%2Evisible%2Dlg%2Cth%2Evisible%2Dlg%7Bdisplay%3Atable%2Dcell%21important%7D%7D%40media%20%28min%2Dwidth%3A1200px%29%7B%2Evisible%2Dlg%2Dblock%7Bdisplay%3Ablock%21important%7D%7D%40media%20%28min%2Dwidth%3A1200px%29%7B%2Evisible%2Dlg%2Dinline%7Bdisplay%3Ainline%21important%7D%7D%40media%20%28min%2Dwidth%3A1200px%29%7B%2Evisible%2Dlg%2Dinline%2Dblock%7Bdisplay%3Ainline%2Dblock%21important%7D%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Ehidden%2Dxs%7Bdisplay%3Anone%21important%7D%7D%40media%20%28min%2Dwidth%3A768px%29%20and%20%28max%2Dwidth%3A991px%29%7B%2Ehidden%2Dsm%7Bdisplay%3Anone%21important%7D%7D%40media%20%28min%2Dwidth%3A992px%29%20and%20%28max%2Dwidth%3A1199px%29%7B%2Ehidden%2Dmd%7Bdisplay%3Anone%21important%7D%7D%40media%20%28min%2Dwidth%3A1200px%29%7B%2Ehidden%2Dlg%7Bdisplay%3Anone%21important%7D%7D%2Evisible%2Dprint%7Bdisplay%3Anone%21important%7D%40media%20print%7B%2Evisible%2Dprint%7Bdisplay%3Ablock%21important%7Dtable%2Evisible%2Dprint%7Bdisplay%3Atable%21important%7Dtr%2Evisible%2Dprint%7Bdisplay%3Atable%2Drow%21important%7Dtd%2Evisible%2Dprint%2Cth%2Evisible%2Dprint%7Bdisplay%3Atable%2Dcell%21important%7D%7D%2Evisible%2Dprint%2Dblock%7Bdisplay%3Anone%21important%7D%40media%20print%7B%2Evisible%2Dprint%2Dblock%7Bdisplay%3Ablock%21important%7D%7D%2Evisible%2Dprint%2Dinline%7Bdisplay%3Anone%21important%7D%40media%20print%7B%2Evisible%2Dprint%2Dinline%7Bdisplay%3Ainline%21important%7D%7D%2Evisible%2Dprint%2Dinline%2Dblock%7Bdisplay%3Anone%21important%7D%40media%20print%7B%2Evisible%2Dprint%2Dinline%2Dblock%7Bdisplay%3Ainline%2Dblock%21important%7D%7D%40media%20print%7B%2Ehidden%2Dprint%7Bdisplay%3Anone%21important%7D%7D%0A" rel="stylesheet" />
<script src="data:application/x-javascript;base64,/*!
 * Bootstrap v3.3.5 (http://getbootstrap.com)
 * Copyright 2011-2015 Twitter, Inc.
 * Licensed under the MIT license
 */
if("undefined"==typeof jQuery)throw new Error("Bootstrap's JavaScript requires jQuery");+function(a){"use strict";var b=a.fn.jquery.split(" ")[0].split(".");if(b[0]<2&&b[1]<9||1==b[0]&&9==b[1]&&b[2]<1)throw new Error("Bootstrap's JavaScript requires jQuery version 1.9.1 or higher")}(jQuery),+function(a){"use strict";function b(){var a=document.createElement("bootstrap"),b={WebkitTransition:"webkitTransitionEnd",MozTransition:"transitionend",OTransition:"oTransitionEnd otransitionend",transition:"transitionend"};for(var c in b)if(void 0!==a.style[c])return{end:b[c]};return!1}a.fn.emulateTransitionEnd=function(b){var c=!1,d=this;a(this).one("bsTransitionEnd",function(){c=!0});var e=function(){c||a(d).trigger(a.support.transition.end)};return setTimeout(e,b),this},a(function(){a.support.transition=b(),a.support.transition&&(a.event.special.bsTransitionEnd={bindType:a.support.transition.end,delegateType:a.support.transition.end,handle:function(b){return a(b.target).is(this)?b.handleObj.handler.apply(this,arguments):void 0}})})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var c=a(this),e=c.data("bs.alert");e||c.data("bs.alert",e=new d(this)),"string"==typeof b&&e[b].call(c)})}var c='[data-dismiss="alert"]',d=function(b){a(b).on("click",c,this.close)};d.VERSION="3.3.5",d.TRANSITION_DURATION=150,d.prototype.close=function(b){function c(){g.detach().trigger("closed.bs.alert").remove()}var e=a(this),f=e.attr("data-target");f||(f=e.attr("href"),f=f&&f.replace(/.*(?=#[^\s]*$)/,""));var g=a(f);b&&b.preventDefault(),g.length||(g=e.closest(".alert")),g.trigger(b=a.Event("close.bs.alert")),b.isDefaultPrevented()||(g.removeClass("in"),a.support.transition&&g.hasClass("fade")?g.one("bsTransitionEnd",c).emulateTransitionEnd(d.TRANSITION_DURATION):c())};var e=a.fn.alert;a.fn.alert=b,a.fn.alert.Constructor=d,a.fn.alert.noConflict=function(){return a.fn.alert=e,this},a(document).on("click.bs.alert.data-api",c,d.prototype.close)}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.button"),f="object"==typeof b&&b;e||d.data("bs.button",e=new c(this,f)),"toggle"==b?e.toggle():b&&e.setState(b)})}var c=function(b,d){this.$element=a(b),this.options=a.extend({},c.DEFAULTS,d),this.isLoading=!1};c.VERSION="3.3.5",c.DEFAULTS={loadingText:"loading..."},c.prototype.setState=function(b){var c="disabled",d=this.$element,e=d.is("input")?"val":"html",f=d.data();b+="Text",null==f.resetText&&d.data("resetText",d[e]()),setTimeout(a.proxy(function(){d[e](null==f[b]?this.options[b]:f[b]),"loadingText"==b?(this.isLoading=!0,d.addClass(c).attr(c,c)):this.isLoading&&(this.isLoading=!1,d.removeClass(c).removeAttr(c))},this),0)},c.prototype.toggle=function(){var a=!0,b=this.$element.closest('[data-toggle="buttons"]');if(b.length){var c=this.$element.find("input");"radio"==c.prop("type")?(c.prop("checked")&&(a=!1),b.find(".active").removeClass("active"),this.$element.addClass("active")):"checkbox"==c.prop("type")&&(c.prop("checked")!==this.$element.hasClass("active")&&(a=!1),this.$element.toggleClass("active")),c.prop("checked",this.$element.hasClass("active")),a&&c.trigger("change")}else this.$element.attr("aria-pressed",!this.$element.hasClass("active")),this.$element.toggleClass("active")};var d=a.fn.button;a.fn.button=b,a.fn.button.Constructor=c,a.fn.button.noConflict=function(){return a.fn.button=d,this},a(document).on("click.bs.button.data-api",'[data-toggle^="button"]',function(c){var d=a(c.target);d.hasClass("btn")||(d=d.closest(".btn")),b.call(d,"toggle"),a(c.target).is('input[type="radio"]')||a(c.target).is('input[type="checkbox"]')||c.preventDefault()}).on("focus.bs.button.data-api blur.bs.button.data-api",'[data-toggle^="button"]',function(b){a(b.target).closest(".btn").toggleClass("focus",/^focus(in)?$/.test(b.type))})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.carousel"),f=a.extend({},c.DEFAULTS,d.data(),"object"==typeof b&&b),g="string"==typeof b?b:f.slide;e||d.data("bs.carousel",e=new c(this,f)),"number"==typeof b?e.to(b):g?e[g]():f.interval&&e.pause().cycle()})}var c=function(b,c){this.$element=a(b),this.$indicators=this.$element.find(".carousel-indicators"),this.options=c,this.paused=null,this.sliding=null,this.interval=null,this.$active=null,this.$items=null,this.options.keyboard&&this.$element.on("keydown.bs.carousel",a.proxy(this.keydown,this)),"hover"==this.options.pause&&!("ontouchstart"in document.documentElement)&&this.$element.on("mouseenter.bs.carousel",a.proxy(this.pause,this)).on("mouseleave.bs.carousel",a.proxy(this.cycle,this))};c.VERSION="3.3.5",c.TRANSITION_DURATION=600,c.DEFAULTS={interval:5e3,pause:"hover",wrap:!0,keyboard:!0},c.prototype.keydown=function(a){if(!/input|textarea/i.test(a.target.tagName)){switch(a.which){case 37:this.prev();break;case 39:this.next();break;default:return}a.preventDefault()}},c.prototype.cycle=function(b){return b||(this.paused=!1),this.interval&&clearInterval(this.interval),this.options.interval&&!this.paused&&(this.interval=setInterval(a.proxy(this.next,this),this.options.interval)),this},c.prototype.getItemIndex=function(a){return this.$items=a.parent().children(".item"),this.$items.index(a||this.$active)},c.prototype.getItemForDirection=function(a,b){var c=this.getItemIndex(b),d="prev"==a&&0===c||"next"==a&&c==this.$items.length-1;if(d&&!this.options.wrap)return b;var e="prev"==a?-1:1,f=(c+e)%this.$items.length;return this.$items.eq(f)},c.prototype.to=function(a){var b=this,c=this.getItemIndex(this.$active=this.$element.find(".item.active"));return a>this.$items.length-1||0>a?void 0:this.sliding?this.$element.one("slid.bs.carousel",function(){b.to(a)}):c==a?this.pause().cycle():this.slide(a>c?"next":"prev",this.$items.eq(a))},c.prototype.pause=function(b){return b||(this.paused=!0),this.$element.find(".next, .prev").length&&a.support.transition&&(this.$element.trigger(a.support.transition.end),this.cycle(!0)),this.interval=clearInterval(this.interval),this},c.prototype.next=function(){return this.sliding?void 0:this.slide("next")},c.prototype.prev=function(){return this.sliding?void 0:this.slide("prev")},c.prototype.slide=function(b,d){var e=this.$element.find(".item.active"),f=d||this.getItemForDirection(b,e),g=this.interval,h="next"==b?"left":"right",i=this;if(f.hasClass("active"))return this.sliding=!1;var j=f[0],k=a.Event("slide.bs.carousel",{relatedTarget:j,direction:h});if(this.$element.trigger(k),!k.isDefaultPrevented()){if(this.sliding=!0,g&&this.pause(),this.$indicators.length){this.$indicators.find(".active").removeClass("active");var l=a(this.$indicators.children()[this.getItemIndex(f)]);l&&l.addClass("active")}var m=a.Event("slid.bs.carousel",{relatedTarget:j,direction:h});return a.support.transition&&this.$element.hasClass("slide")?(f.addClass(b),f[0].offsetWidth,e.addClass(h),f.addClass(h),e.one("bsTransitionEnd",function(){f.removeClass([b,h].join(" ")).addClass("active"),e.removeClass(["active",h].join(" ")),i.sliding=!1,setTimeout(function(){i.$element.trigger(m)},0)}).emulateTransitionEnd(c.TRANSITION_DURATION)):(e.removeClass("active"),f.addClass("active"),this.sliding=!1,this.$element.trigger(m)),g&&this.cycle(),this}};var d=a.fn.carousel;a.fn.carousel=b,a.fn.carousel.Constructor=c,a.fn.carousel.noConflict=function(){return a.fn.carousel=d,this};var e=function(c){var d,e=a(this),f=a(e.attr("data-target")||(d=e.attr("href"))&&d.replace(/.*(?=#[^\s]+$)/,""));if(f.hasClass("carousel")){var g=a.extend({},f.data(),e.data()),h=e.attr("data-slide-to");h&&(g.interval=!1),b.call(f,g),h&&f.data("bs.carousel").to(h),c.preventDefault()}};a(document).on("click.bs.carousel.data-api","[data-slide]",e).on("click.bs.carousel.data-api","[data-slide-to]",e),a(window).on("load",function(){a('[data-ride="carousel"]').each(function(){var c=a(this);b.call(c,c.data())})})}(jQuery),+function(a){"use strict";function b(b){var c,d=b.attr("data-target")||(c=b.attr("href"))&&c.replace(/.*(?=#[^\s]+$)/,"");return a(d)}function c(b){return this.each(function(){var c=a(this),e=c.data("bs.collapse"),f=a.extend({},d.DEFAULTS,c.data(),"object"==typeof b&&b);!e&&f.toggle&&/show|hide/.test(b)&&(f.toggle=!1),e||c.data("bs.collapse",e=new d(this,f)),"string"==typeof b&&e[b]()})}var d=function(b,c){this.$element=a(b),this.options=a.extend({},d.DEFAULTS,c),this.$trigger=a('[data-toggle="collapse"][href="#'+b.id+'"],[data-toggle="collapse"][data-target="#'+b.id+'"]'),this.transitioning=null,this.options.parent?this.$parent=this.getParent():this.addAriaAndCollapsedClass(this.$element,this.$trigger),this.options.toggle&&this.toggle()};d.VERSION="3.3.5",d.TRANSITION_DURATION=350,d.DEFAULTS={toggle:!0},d.prototype.dimension=function(){var a=this.$element.hasClass("width");return a?"width":"height"},d.prototype.show=function(){if(!this.transitioning&&!this.$element.hasClass("in")){var b,e=this.$parent&&this.$parent.children(".panel").children(".in, .collapsing");if(!(e&&e.length&&(b=e.data("bs.collapse"),b&&b.transitioning))){var f=a.Event("show.bs.collapse");if(this.$element.trigger(f),!f.isDefaultPrevented()){e&&e.length&&(c.call(e,"hide"),b||e.data("bs.collapse",null));var g=this.dimension();this.$element.removeClass("collapse").addClass("collapsing")[g](0).attr("aria-expanded",!0),this.$trigger.removeClass("collapsed").attr("aria-expanded",!0),this.transitioning=1;var h=function(){this.$element.removeClass("collapsing").addClass("collapse in")[g](""),this.transitioning=0,this.$element.trigger("shown.bs.collapse")};if(!a.support.transition)return h.call(this);var i=a.camelCase(["scroll",g].join("-"));this.$element.one("bsTransitionEnd",a.proxy(h,this)).emulateTransitionEnd(d.TRANSITION_DURATION)[g](this.$element[0][i])}}}},d.prototype.hide=function(){if(!this.transitioning&&this.$element.hasClass("in")){var b=a.Event("hide.bs.collapse");if(this.$element.trigger(b),!b.isDefaultPrevented()){var c=this.dimension();this.$element[c](this.$element[c]())[0].offsetHeight,this.$element.addClass("collapsing").removeClass("collapse in").attr("aria-expanded",!1),this.$trigger.addClass("collapsed").attr("aria-expanded",!1),this.transitioning=1;var e=function(){this.transitioning=0,this.$element.removeClass("collapsing").addClass("collapse").trigger("hidden.bs.collapse")};return a.support.transition?void this.$element[c](0).one("bsTransitionEnd",a.proxy(e,this)).emulateTransitionEnd(d.TRANSITION_DURATION):e.call(this)}}},d.prototype.toggle=function(){this[this.$element.hasClass("in")?"hide":"show"]()},d.prototype.getParent=function(){return a(this.options.parent).find('[data-toggle="collapse"][data-parent="'+this.options.parent+'"]').each(a.proxy(function(c,d){var e=a(d);this.addAriaAndCollapsedClass(b(e),e)},this)).end()},d.prototype.addAriaAndCollapsedClass=function(a,b){var c=a.hasClass("in");a.attr("aria-expanded",c),b.toggleClass("collapsed",!c).attr("aria-expanded",c)};var e=a.fn.collapse;a.fn.collapse=c,a.fn.collapse.Constructor=d,a.fn.collapse.noConflict=function(){return a.fn.collapse=e,this},a(document).on("click.bs.collapse.data-api",'[data-toggle="collapse"]',function(d){var e=a(this);e.attr("data-target")||d.preventDefault();var f=b(e),g=f.data("bs.collapse"),h=g?"toggle":e.data();c.call(f,h)})}(jQuery),+function(a){"use strict";function b(b){var c=b.attr("data-target");c||(c=b.attr("href"),c=c&&/#[A-Za-z]/.test(c)&&c.replace(/.*(?=#[^\s]*$)/,""));var d=c&&a(c);return d&&d.length?d:b.parent()}function c(c){c&&3===c.which||(a(e).remove(),a(f).each(function(){var d=a(this),e=b(d),f={relatedTarget:this};e.hasClass("open")&&(c&&"click"==c.type&&/input|textarea/i.test(c.target.tagName)&&a.contains(e[0],c.target)||(e.trigger(c=a.Event("hide.bs.dropdown",f)),c.isDefaultPrevented()||(d.attr("aria-expanded","false"),e.removeClass("open").trigger("hidden.bs.dropdown",f))))}))}function d(b){return this.each(function(){var c=a(this),d=c.data("bs.dropdown");d||c.data("bs.dropdown",d=new g(this)),"string"==typeof b&&d[b].call(c)})}var e=".dropdown-backdrop",f='[data-toggle="dropdown"]',g=function(b){a(b).on("click.bs.dropdown",this.toggle)};g.VERSION="3.3.5",g.prototype.toggle=function(d){var e=a(this);if(!e.is(".disabled, :disabled")){var f=b(e),g=f.hasClass("open");if(c(),!g){"ontouchstart"in document.documentElement&&!f.closest(".navbar-nav").length&&a(document.createElement("div")).addClass("dropdown-backdrop").insertAfter(a(this)).on("click",c);var h={relatedTarget:this};if(f.trigger(d=a.Event("show.bs.dropdown",h)),d.isDefaultPrevented())return;e.trigger("focus").attr("aria-expanded","true"),f.toggleClass("open").trigger("shown.bs.dropdown",h)}return!1}},g.prototype.keydown=function(c){if(/(38|40|27|32)/.test(c.which)&&!/input|textarea/i.test(c.target.tagName)){var d=a(this);if(c.preventDefault(),c.stopPropagation(),!d.is(".disabled, :disabled")){var e=b(d),g=e.hasClass("open");if(!g&&27!=c.which||g&&27==c.which)return 27==c.which&&e.find(f).trigger("focus"),d.trigger("click");var h=" li:not(.disabled):visible a",i=e.find(".dropdown-menu"+h);if(i.length){var j=i.index(c.target);38==c.which&&j>0&&j--,40==c.which&&j<i.length-1&&j++,~j||(j=0),i.eq(j).trigger("focus")}}}};var h=a.fn.dropdown;a.fn.dropdown=d,a.fn.dropdown.Constructor=g,a.fn.dropdown.noConflict=function(){return a.fn.dropdown=h,this},a(document).on("click.bs.dropdown.data-api",c).on("click.bs.dropdown.data-api",".dropdown form",function(a){a.stopPropagation()}).on("click.bs.dropdown.data-api",f,g.prototype.toggle).on("keydown.bs.dropdown.data-api",f,g.prototype.keydown).on("keydown.bs.dropdown.data-api",".dropdown-menu",g.prototype.keydown)}(jQuery),+function(a){"use strict";function b(b,d){return this.each(function(){var e=a(this),f=e.data("bs.modal"),g=a.extend({},c.DEFAULTS,e.data(),"object"==typeof b&&b);f||e.data("bs.modal",f=new c(this,g)),"string"==typeof b?f[b](d):g.show&&f.show(d)})}var c=function(b,c){this.options=c,this.$body=a(document.body),this.$element=a(b),this.$dialog=this.$element.find(".modal-dialog"),this.$backdrop=null,this.isShown=null,this.originalBodyPad=null,this.scrollbarWidth=0,this.ignoreBackdropClick=!1,this.options.remote&&this.$element.find(".modal-content").load(this.options.remote,a.proxy(function(){this.$element.trigger("loaded.bs.modal")},this))};c.VERSION="3.3.5",c.TRANSITION_DURATION=300,c.BACKDROP_TRANSITION_DURATION=150,c.DEFAULTS={backdrop:!0,keyboard:!0,show:!0},c.prototype.toggle=function(a){return this.isShown?this.hide():this.show(a)},c.prototype.show=function(b){var d=this,e=a.Event("show.bs.modal",{relatedTarget:b});this.$element.trigger(e),this.isShown||e.isDefaultPrevented()||(this.isShown=!0,this.checkScrollbar(),this.setScrollbar(),this.$body.addClass("modal-open"),this.escape(),this.resize(),this.$element.on("click.dismiss.bs.modal",'[data-dismiss="modal"]',a.proxy(this.hide,this)),this.$dialog.on("mousedown.dismiss.bs.modal",function(){d.$element.one("mouseup.dismiss.bs.modal",function(b){a(b.target).is(d.$element)&&(d.ignoreBackdropClick=!0)})}),this.backdrop(function(){var e=a.support.transition&&d.$element.hasClass("fade");d.$element.parent().length||d.$element.appendTo(d.$body),d.$element.show().scrollTop(0),d.adjustDialog(),e&&d.$element[0].offsetWidth,d.$element.addClass("in"),d.enforceFocus();var f=a.Event("shown.bs.modal",{relatedTarget:b});e?d.$dialog.one("bsTransitionEnd",function(){d.$element.trigger("focus").trigger(f)}).emulateTransitionEnd(c.TRANSITION_DURATION):d.$element.trigger("focus").trigger(f)}))},c.prototype.hide=function(b){b&&b.preventDefault(),b=a.Event("hide.bs.modal"),this.$element.trigger(b),this.isShown&&!b.isDefaultPrevented()&&(this.isShown=!1,this.escape(),this.resize(),a(document).off("focusin.bs.modal"),this.$element.removeClass("in").off("click.dismiss.bs.modal").off("mouseup.dismiss.bs.modal"),this.$dialog.off("mousedown.dismiss.bs.modal"),a.support.transition&&this.$element.hasClass("fade")?this.$element.one("bsTransitionEnd",a.proxy(this.hideModal,this)).emulateTransitionEnd(c.TRANSITION_DURATION):this.hideModal())},c.prototype.enforceFocus=function(){a(document).off("focusin.bs.modal").on("focusin.bs.modal",a.proxy(function(a){this.$element[0]===a.target||this.$element.has(a.target).length||this.$element.trigger("focus")},this))},c.prototype.escape=function(){this.isShown&&this.options.keyboard?this.$element.on("keydown.dismiss.bs.modal",a.proxy(function(a){27==a.which&&this.hide()},this)):this.isShown||this.$element.off("keydown.dismiss.bs.modal")},c.prototype.resize=function(){this.isShown?a(window).on("resize.bs.modal",a.proxy(this.handleUpdate,this)):a(window).off("resize.bs.modal")},c.prototype.hideModal=function(){var a=this;this.$element.hide(),this.backdrop(function(){a.$body.removeClass("modal-open"),a.resetAdjustments(),a.resetScrollbar(),a.$element.trigger("hidden.bs.modal")})},c.prototype.removeBackdrop=function(){this.$backdrop&&this.$backdrop.remove(),this.$backdrop=null},c.prototype.backdrop=function(b){var d=this,e=this.$element.hasClass("fade")?"fade":"";if(this.isShown&&this.options.backdrop){var f=a.support.transition&&e;if(this.$backdrop=a(document.createElement("div")).addClass("modal-backdrop "+e).appendTo(this.$body),this.$element.on("click.dismiss.bs.modal",a.proxy(function(a){return this.ignoreBackdropClick?void(this.ignoreBackdropClick=!1):void(a.target===a.currentTarget&&("static"==this.options.backdrop?this.$element[0].focus():this.hide()))},this)),f&&this.$backdrop[0].offsetWidth,this.$backdrop.addClass("in"),!b)return;f?this.$backdrop.one("bsTransitionEnd",b).emulateTransitionEnd(c.BACKDROP_TRANSITION_DURATION):b()}else if(!this.isShown&&this.$backdrop){this.$backdrop.removeClass("in");var g=function(){d.removeBackdrop(),b&&b()};a.support.transition&&this.$element.hasClass("fade")?this.$backdrop.one("bsTransitionEnd",g).emulateTransitionEnd(c.BACKDROP_TRANSITION_DURATION):g()}else b&&b()},c.prototype.handleUpdate=function(){this.adjustDialog()},c.prototype.adjustDialog=function(){var a=this.$element[0].scrollHeight>document.documentElement.clientHeight;this.$element.css({paddingLeft:!this.bodyIsOverflowing&&a?this.scrollbarWidth:"",paddingRight:this.bodyIsOverflowing&&!a?this.scrollbarWidth:""})},c.prototype.resetAdjustments=function(){this.$element.css({paddingLeft:"",paddingRight:""})},c.prototype.checkScrollbar=function(){var a=window.innerWidth;if(!a){var b=document.documentElement.getBoundingClientRect();a=b.right-Math.abs(b.left)}this.bodyIsOverflowing=document.body.clientWidth<a,this.scrollbarWidth=this.measureScrollbar()},c.prototype.setScrollbar=function(){var a=parseInt(this.$body.css("padding-right")||0,10);this.originalBodyPad=document.body.style.paddingRight||"",this.bodyIsOverflowing&&this.$body.css("padding-right",a+this.scrollbarWidth)},c.prototype.resetScrollbar=function(){this.$body.css("padding-right",this.originalBodyPad)},c.prototype.measureScrollbar=function(){var a=document.createElement("div");a.className="modal-scrollbar-measure",this.$body.append(a);var b=a.offsetWidth-a.clientWidth;return this.$body[0].removeChild(a),b};var d=a.fn.modal;a.fn.modal=b,a.fn.modal.Constructor=c,a.fn.modal.noConflict=function(){return a.fn.modal=d,this},a(document).on("click.bs.modal.data-api",'[data-toggle="modal"]',function(c){var d=a(this),e=d.attr("href"),f=a(d.attr("data-target")||e&&e.replace(/.*(?=#[^\s]+$)/,"")),g=f.data("bs.modal")?"toggle":a.extend({remote:!/#/.test(e)&&e},f.data(),d.data());d.is("a")&&c.preventDefault(),f.one("show.bs.modal",function(a){a.isDefaultPrevented()||f.one("hidden.bs.modal",function(){d.is(":visible")&&d.trigger("focus")})}),b.call(f,g,this)})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.tooltip"),f="object"==typeof b&&b;(e||!/destroy|hide/.test(b))&&(e||d.data("bs.tooltip",e=new c(this,f)),"string"==typeof b&&e[b]())})}var c=function(a,b){this.type=null,this.options=null,this.enabled=null,this.timeout=null,this.hoverState=null,this.$element=null,this.inState=null,this.init("tooltip",a,b)};c.VERSION="3.3.5",c.TRANSITION_DURATION=150,c.DEFAULTS={animation:!0,placement:"top",selector:!1,template:'<div class="tooltip" role="tooltip"><div class="tooltip-arrow"></div><div class="tooltip-inner"></div></div>',trigger:"hover focus",title:"",delay:0,html:!1,container:!1,viewport:{selector:"body",padding:0}},c.prototype.init=function(b,c,d){if(this.enabled=!0,this.type=b,this.$element=a(c),this.options=this.getOptions(d),this.$viewport=this.options.viewport&&a(a.isFunction(this.options.viewport)?this.options.viewport.call(this,this.$element):this.options.viewport.selector||this.options.viewport),this.inState={click:!1,hover:!1,focus:!1},this.$element[0]instanceof document.constructor&&!this.options.selector)throw new Error("`selector` option must be specified when initializing "+this.type+" on the window.document object!");for(var e=this.options.trigger.split(" "),f=e.length;f--;){var g=e[f];if("click"==g)this.$element.on("click."+this.type,this.options.selector,a.proxy(this.toggle,this));else if("manual"!=g){var h="hover"==g?"mouseenter":"focusin",i="hover"==g?"mouseleave":"focusout";this.$element.on(h+"."+this.type,this.options.selector,a.proxy(this.enter,this)),this.$element.on(i+"."+this.type,this.options.selector,a.proxy(this.leave,this))}}this.options.selector?this._options=a.extend({},this.options,{trigger:"manual",selector:""}):this.fixTitle()},c.prototype.getDefaults=function(){return c.DEFAULTS},c.prototype.getOptions=function(b){return b=a.extend({},this.getDefaults(),this.$element.data(),b),b.delay&&"number"==typeof b.delay&&(b.delay={show:b.delay,hide:b.delay}),b},c.prototype.getDelegateOptions=function(){var b={},c=this.getDefaults();return this._options&&a.each(this._options,function(a,d){c[a]!=d&&(b[a]=d)}),b},c.prototype.enter=function(b){var c=b instanceof this.constructor?b:a(b.currentTarget).data("bs."+this.type);return c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c)),b instanceof a.Event&&(c.inState["focusin"==b.type?"focus":"hover"]=!0),c.tip().hasClass("in")||"in"==c.hoverState?void(c.hoverState="in"):(clearTimeout(c.timeout),c.hoverState="in",c.options.delay&&c.options.delay.show?void(c.timeout=setTimeout(function(){"in"==c.hoverState&&c.show()},c.options.delay.show)):c.show())},c.prototype.isInStateTrue=function(){for(var a in this.inState)if(this.inState[a])return!0;return!1},c.prototype.leave=function(b){var c=b instanceof this.constructor?b:a(b.currentTarget).data("bs."+this.type);return c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c)),b instanceof a.Event&&(c.inState["focusout"==b.type?"focus":"hover"]=!1),c.isInStateTrue()?void 0:(clearTimeout(c.timeout),c.hoverState="out",c.options.delay&&c.options.delay.hide?void(c.timeout=setTimeout(function(){"out"==c.hoverState&&c.hide()},c.options.delay.hide)):c.hide())},c.prototype.show=function(){var b=a.Event("show.bs."+this.type);if(this.hasContent()&&this.enabled){this.$element.trigger(b);var d=a.contains(this.$element[0].ownerDocument.documentElement,this.$element[0]);if(b.isDefaultPrevented()||!d)return;var e=this,f=this.tip(),g=this.getUID(this.type);this.setContent(),f.attr("id",g),this.$element.attr("aria-describedby",g),this.options.animation&&f.addClass("fade");var h="function"==typeof this.options.placement?this.options.placement.call(this,f[0],this.$element[0]):this.options.placement,i=/\s?auto?\s?/i,j=i.test(h);j&&(h=h.replace(i,"")||"top"),f.detach().css({top:0,left:0,display:"block"}).addClass(h).data("bs."+this.type,this),this.options.container?f.appendTo(this.options.container):f.insertAfter(this.$element),this.$element.trigger("inserted.bs."+this.type);var k=this.getPosition(),l=f[0].offsetWidth,m=f[0].offsetHeight;if(j){var n=h,o=this.getPosition(this.$viewport);h="bottom"==h&&k.bottom+m>o.bottom?"top":"top"==h&&k.top-m<o.top?"bottom":"right"==h&&k.right+l>o.width?"left":"left"==h&&k.left-l<o.left?"right":h,f.removeClass(n).addClass(h)}var p=this.getCalculatedOffset(h,k,l,m);this.applyPlacement(p,h);var q=function(){var a=e.hoverState;e.$element.trigger("shown.bs."+e.type),e.hoverState=null,"out"==a&&e.leave(e)};a.support.transition&&this.$tip.hasClass("fade")?f.one("bsTransitionEnd",q).emulateTransitionEnd(c.TRANSITION_DURATION):q()}},c.prototype.applyPlacement=function(b,c){var d=this.tip(),e=d[0].offsetWidth,f=d[0].offsetHeight,g=parseInt(d.css("margin-top"),10),h=parseInt(d.css("margin-left"),10);isNaN(g)&&(g=0),isNaN(h)&&(h=0),b.top+=g,b.left+=h,a.offset.setOffset(d[0],a.extend({using:function(a){d.css({top:Math.round(a.top),left:Math.round(a.left)})}},b),0),d.addClass("in");var i=d[0].offsetWidth,j=d[0].offsetHeight;"top"==c&&j!=f&&(b.top=b.top+f-j);var k=this.getViewportAdjustedDelta(c,b,i,j);k.left?b.left+=k.left:b.top+=k.top;var l=/top|bottom/.test(c),m=l?2*k.left-e+i:2*k.top-f+j,n=l?"offsetWidth":"offsetHeight";d.offset(b),this.replaceArrow(m,d[0][n],l)},c.prototype.replaceArrow=function(a,b,c){this.arrow().css(c?"left":"top",50*(1-a/b)+"%").css(c?"top":"left","")},c.prototype.setContent=function(){var a=this.tip(),b=this.getTitle();a.find(".tooltip-inner")[this.options.html?"html":"text"](b),a.removeClass("fade in top bottom left right")},c.prototype.hide=function(b){function d(){"in"!=e.hoverState&&f.detach(),e.$element.removeAttr("aria-describedby").trigger("hidden.bs."+e.type),b&&b()}var e=this,f=a(this.$tip),g=a.Event("hide.bs."+this.type);return this.$element.trigger(g),g.isDefaultPrevented()?void 0:(f.removeClass("in"),a.support.transition&&f.hasClass("fade")?f.one("bsTransitionEnd",d).emulateTransitionEnd(c.TRANSITION_DURATION):d(),this.hoverState=null,this)},c.prototype.fixTitle=function(){var a=this.$element;(a.attr("title")||"string"!=typeof a.attr("data-original-title"))&&a.attr("data-original-title",a.attr("title")||"").attr("title","")},c.prototype.hasContent=function(){return this.getTitle()},c.prototype.getPosition=function(b){b=b||this.$element;var c=b[0],d="BODY"==c.tagName,e=c.getBoundingClientRect();null==e.width&&(e=a.extend({},e,{width:e.right-e.left,height:e.bottom-e.top}));var f=d?{top:0,left:0}:b.offset(),g={scroll:d?document.documentElement.scrollTop||document.body.scrollTop:b.scrollTop()},h=d?{width:a(window).width(),height:a(window).height()}:null;return a.extend({},e,g,h,f)},c.prototype.getCalculatedOffset=function(a,b,c,d){return"bottom"==a?{top:b.top+b.height,left:b.left+b.width/2-c/2}:"top"==a?{top:b.top-d,left:b.left+b.width/2-c/2}:"left"==a?{top:b.top+b.height/2-d/2,left:b.left-c}:{top:b.top+b.height/2-d/2,left:b.left+b.width}},c.prototype.getViewportAdjustedDelta=function(a,b,c,d){var e={top:0,left:0};if(!this.$viewport)return e;var f=this.options.viewport&&this.options.viewport.padding||0,g=this.getPosition(this.$viewport);if(/right|left/.test(a)){var h=b.top-f-g.scroll,i=b.top+f-g.scroll+d;h<g.top?e.top=g.top-h:i>g.top+g.height&&(e.top=g.top+g.height-i)}else{var j=b.left-f,k=b.left+f+c;j<g.left?e.left=g.left-j:k>g.right&&(e.left=g.left+g.width-k)}return e},c.prototype.getTitle=function(){var a,b=this.$element,c=this.options;return a=b.attr("data-original-title")||("function"==typeof c.title?c.title.call(b[0]):c.title)},c.prototype.getUID=function(a){do a+=~~(1e6*Math.random());while(document.getElementById(a));return a},c.prototype.tip=function(){if(!this.$tip&&(this.$tip=a(this.options.template),1!=this.$tip.length))throw new Error(this.type+" `template` option must consist of exactly 1 top-level element!");return this.$tip},c.prototype.arrow=function(){return this.$arrow=this.$arrow||this.tip().find(".tooltip-arrow")},c.prototype.enable=function(){this.enabled=!0},c.prototype.disable=function(){this.enabled=!1},c.prototype.toggleEnabled=function(){this.enabled=!this.enabled},c.prototype.toggle=function(b){var c=this;b&&(c=a(b.currentTarget).data("bs."+this.type),c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c))),b?(c.inState.click=!c.inState.click,c.isInStateTrue()?c.enter(c):c.leave(c)):c.tip().hasClass("in")?c.leave(c):c.enter(c)},c.prototype.destroy=function(){var a=this;clearTimeout(this.timeout),this.hide(function(){a.$element.off("."+a.type).removeData("bs."+a.type),a.$tip&&a.$tip.detach(),a.$tip=null,a.$arrow=null,a.$viewport=null})};var d=a.fn.tooltip;a.fn.tooltip=b,a.fn.tooltip.Constructor=c,a.fn.tooltip.noConflict=function(){return a.fn.tooltip=d,this}}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.popover"),f="object"==typeof b&&b;(e||!/destroy|hide/.test(b))&&(e||d.data("bs.popover",e=new c(this,f)),"string"==typeof b&&e[b]())})}var c=function(a,b){this.init("popover",a,b)};if(!a.fn.tooltip)throw new Error("Popover requires tooltip.js");c.VERSION="3.3.5",c.DEFAULTS=a.extend({},a.fn.tooltip.Constructor.DEFAULTS,{placement:"right",trigger:"click",content:"",template:'<div class="popover" role="tooltip"><div class="arrow"></div><h3 class="popover-title"></h3><div class="popover-content"></div></div>'}),c.prototype=a.extend({},a.fn.tooltip.Constructor.prototype),c.prototype.constructor=c,c.prototype.getDefaults=function(){return c.DEFAULTS},c.prototype.setContent=function(){var a=this.tip(),b=this.getTitle(),c=this.getContent();a.find(".popover-title")[this.options.html?"html":"text"](b),a.find(".popover-content").children().detach().end()[this.options.html?"string"==typeof c?"html":"append":"text"](c),a.removeClass("fade top bottom left right in"),a.find(".popover-title").html()||a.find(".popover-title").hide()},c.prototype.hasContent=function(){return this.getTitle()||this.getContent()},c.prototype.getContent=function(){var a=this.$element,b=this.options;return a.attr("data-content")||("function"==typeof b.content?b.content.call(a[0]):b.content)},c.prototype.arrow=function(){return this.$arrow=this.$arrow||this.tip().find(".arrow")};var d=a.fn.popover;a.fn.popover=b,a.fn.popover.Constructor=c,a.fn.popover.noConflict=function(){return a.fn.popover=d,this}}(jQuery),+function(a){"use strict";function b(c,d){this.$body=a(document.body),this.$scrollElement=a(a(c).is(document.body)?window:c),this.options=a.extend({},b.DEFAULTS,d),this.selector=(this.options.target||"")+" .nav li > a",this.offsets=[],this.targets=[],this.activeTarget=null,this.scrollHeight=0,this.$scrollElement.on("scroll.bs.scrollspy",a.proxy(this.process,this)),this.refresh(),this.process()}function c(c){return this.each(function(){var d=a(this),e=d.data("bs.scrollspy"),f="object"==typeof c&&c;e||d.data("bs.scrollspy",e=new b(this,f)),"string"==typeof c&&e[c]()})}b.VERSION="3.3.5",b.DEFAULTS={offset:10},b.prototype.getScrollHeight=function(){return this.$scrollElement[0].scrollHeight||Math.max(this.$body[0].scrollHeight,document.documentElement.scrollHeight)},b.prototype.refresh=function(){var b=this,c="offset",d=0;this.offsets=[],this.targets=[],this.scrollHeight=this.getScrollHeight(),a.isWindow(this.$scrollElement[0])||(c="position",d=this.$scrollElement.scrollTop()),this.$body.find(this.selector).map(function(){var b=a(this),e=b.data("target")||b.attr("href"),f=/^#./.test(e)&&a(e);return f&&f.length&&f.is(":visible")&&[[f[c]().top+d,e]]||null}).sort(function(a,b){return a[0]-b[0]}).each(function(){b.offsets.push(this[0]),b.targets.push(this[1])})},b.prototype.process=function(){var a,b=this.$scrollElement.scrollTop()+this.options.offset,c=this.getScrollHeight(),d=this.options.offset+c-this.$scrollElement.height(),e=this.offsets,f=this.targets,g=this.activeTarget;if(this.scrollHeight!=c&&this.refresh(),b>=d)return g!=(a=f[f.length-1])&&this.activate(a);if(g&&b<e[0])return this.activeTarget=null,this.clear();for(a=e.length;a--;)g!=f[a]&&b>=e[a]&&(void 0===e[a+1]||b<e[a+1])&&this.activate(f[a])},b.prototype.activate=function(b){this.activeTarget=b,this.clear();var c=this.selector+'[data-target="'+b+'"],'+this.selector+'[href="'+b+'"]',d=a(c).parents("li").addClass("active");d.parent(".dropdown-menu").length&&(d=d.closest("li.dropdown").addClass("active")),
d.trigger("activate.bs.scrollspy")},b.prototype.clear=function(){a(this.selector).parentsUntil(this.options.target,".active").removeClass("active")};var d=a.fn.scrollspy;a.fn.scrollspy=c,a.fn.scrollspy.Constructor=b,a.fn.scrollspy.noConflict=function(){return a.fn.scrollspy=d,this},a(window).on("load.bs.scrollspy.data-api",function(){a('[data-spy="scroll"]').each(function(){var b=a(this);c.call(b,b.data())})})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.tab");e||d.data("bs.tab",e=new c(this)),"string"==typeof b&&e[b]()})}var c=function(b){this.element=a(b)};c.VERSION="3.3.5",c.TRANSITION_DURATION=150,c.prototype.show=function(){var b=this.element,c=b.closest("ul:not(.dropdown-menu)"),d=b.data("target");if(d||(d=b.attr("href"),d=d&&d.replace(/.*(?=#[^\s]*$)/,"")),!b.parent("li").hasClass("active")){var e=c.find(".active:last a"),f=a.Event("hide.bs.tab",{relatedTarget:b[0]}),g=a.Event("show.bs.tab",{relatedTarget:e[0]});if(e.trigger(f),b.trigger(g),!g.isDefaultPrevented()&&!f.isDefaultPrevented()){var h=a(d);this.activate(b.closest("li"),c),this.activate(h,h.parent(),function(){e.trigger({type:"hidden.bs.tab",relatedTarget:b[0]}),b.trigger({type:"shown.bs.tab",relatedTarget:e[0]})})}}},c.prototype.activate=function(b,d,e){function f(){g.removeClass("active").find("> .dropdown-menu > .active").removeClass("active").end().find('[data-toggle="tab"]').attr("aria-expanded",!1),b.addClass("active").find('[data-toggle="tab"]').attr("aria-expanded",!0),h?(b[0].offsetWidth,b.addClass("in")):b.removeClass("fade"),b.parent(".dropdown-menu").length&&b.closest("li.dropdown").addClass("active").end().find('[data-toggle="tab"]').attr("aria-expanded",!0),e&&e()}var g=d.find("> .active"),h=e&&a.support.transition&&(g.length&&g.hasClass("fade")||!!d.find("> .fade").length);g.length&&h?g.one("bsTransitionEnd",f).emulateTransitionEnd(c.TRANSITION_DURATION):f(),g.removeClass("in")};var d=a.fn.tab;a.fn.tab=b,a.fn.tab.Constructor=c,a.fn.tab.noConflict=function(){return a.fn.tab=d,this};var e=function(c){c.preventDefault(),b.call(a(this),"show")};a(document).on("click.bs.tab.data-api",'[data-toggle="tab"]',e).on("click.bs.tab.data-api",'[data-toggle="pill"]',e)}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.affix"),f="object"==typeof b&&b;e||d.data("bs.affix",e=new c(this,f)),"string"==typeof b&&e[b]()})}var c=function(b,d){this.options=a.extend({},c.DEFAULTS,d),this.$target=a(this.options.target).on("scroll.bs.affix.data-api",a.proxy(this.checkPosition,this)).on("click.bs.affix.data-api",a.proxy(this.checkPositionWithEventLoop,this)),this.$element=a(b),this.affixed=null,this.unpin=null,this.pinnedOffset=null,this.checkPosition()};c.VERSION="3.3.5",c.RESET="affix affix-top affix-bottom",c.DEFAULTS={offset:0,target:window},c.prototype.getState=function(a,b,c,d){var e=this.$target.scrollTop(),f=this.$element.offset(),g=this.$target.height();if(null!=c&&"top"==this.affixed)return c>e?"top":!1;if("bottom"==this.affixed)return null!=c?e+this.unpin<=f.top?!1:"bottom":a-d>=e+g?!1:"bottom";var h=null==this.affixed,i=h?e:f.top,j=h?g:b;return null!=c&&c>=e?"top":null!=d&&i+j>=a-d?"bottom":!1},c.prototype.getPinnedOffset=function(){if(this.pinnedOffset)return this.pinnedOffset;this.$element.removeClass(c.RESET).addClass("affix");var a=this.$target.scrollTop(),b=this.$element.offset();return this.pinnedOffset=b.top-a},c.prototype.checkPositionWithEventLoop=function(){setTimeout(a.proxy(this.checkPosition,this),1)},c.prototype.checkPosition=function(){if(this.$element.is(":visible")){var b=this.$element.height(),d=this.options.offset,e=d.top,f=d.bottom,g=Math.max(a(document).height(),a(document.body).height());"object"!=typeof d&&(f=e=d),"function"==typeof e&&(e=d.top(this.$element)),"function"==typeof f&&(f=d.bottom(this.$element));var h=this.getState(g,b,e,f);if(this.affixed!=h){null!=this.unpin&&this.$element.css("top","");var i="affix"+(h?"-"+h:""),j=a.Event(i+".bs.affix");if(this.$element.trigger(j),j.isDefaultPrevented())return;this.affixed=h,this.unpin="bottom"==h?this.getPinnedOffset():null,this.$element.removeClass(c.RESET).addClass(i).trigger(i.replace("affix","affixed")+".bs.affix")}"bottom"==h&&this.$element.offset({top:g-b-f})}};var d=a.fn.affix;a.fn.affix=b,a.fn.affix.Constructor=c,a.fn.affix.noConflict=function(){return a.fn.affix=d,this},a(window).on("load",function(){a('[data-spy="affix"]').each(function(){var c=a(this),d=c.data();d.offset=d.offset||{},null!=d.offsetBottom&&(d.offset.bottom=d.offsetBottom),null!=d.offsetTop&&(d.offset.top=d.offsetTop),b.call(c,d)})})}(jQuery);"></script>
<script src="data:application/x-javascript;base64,LyoqCiogQHByZXNlcnZlIEhUTUw1IFNoaXYgMy43LjIgfCBAYWZhcmthcyBAamRhbHRvbiBAam9uX25lYWwgQHJlbSB8IE1JVC9HUEwyIExpY2Vuc2VkCiovCi8vIE9ubHkgcnVuIHRoaXMgY29kZSBpbiBJRSA4CmlmICghIXdpbmRvdy5uYXZpZ2F0b3IudXNlckFnZW50Lm1hdGNoKCJNU0lFIDgiKSkgewohZnVuY3Rpb24oYSxiKXtmdW5jdGlvbiBjKGEsYil7dmFyIGM9YS5jcmVhdGVFbGVtZW50KCJwIiksZD1hLmdldEVsZW1lbnRzQnlUYWdOYW1lKCJoZWFkIilbMF18fGEuZG9jdW1lbnRFbGVtZW50O3JldHVybiBjLmlubmVySFRNTD0ieDxzdHlsZT4iK2IrIjwvc3R5bGU+IixkLmluc2VydEJlZm9yZShjLmxhc3RDaGlsZCxkLmZpcnN0Q2hpbGQpfWZ1bmN0aW9uIGQoKXt2YXIgYT10LmVsZW1lbnRzO3JldHVybiJzdHJpbmciPT10eXBlb2YgYT9hLnNwbGl0KCIgIik6YX1mdW5jdGlvbiBlKGEsYil7dmFyIGM9dC5lbGVtZW50czsic3RyaW5nIiE9dHlwZW9mIGMmJihjPWMuam9pbigiICIpKSwic3RyaW5nIiE9dHlwZW9mIGEmJihhPWEuam9pbigiICIpKSx0LmVsZW1lbnRzPWMrIiAiK2EsaihiKX1mdW5jdGlvbiBmKGEpe3ZhciBiPXNbYVtxXV07cmV0dXJuIGJ8fChiPXt9LHIrKyxhW3FdPXIsc1tyXT1iKSxifWZ1bmN0aW9uIGcoYSxjLGQpe2lmKGN8fChjPWIpLGwpcmV0dXJuIGMuY3JlYXRlRWxlbWVudChhKTtkfHwoZD1mKGMpKTt2YXIgZTtyZXR1cm4gZT1kLmNhY2hlW2FdP2QuY2FjaGVbYV0uY2xvbmVOb2RlKCk6cC50ZXN0KGEpPyhkLmNhY2hlW2FdPWQuY3JlYXRlRWxlbShhKSkuY2xvbmVOb2RlKCk6ZC5jcmVhdGVFbGVtKGEpLCFlLmNhbkhhdmVDaGlsZHJlbnx8by50ZXN0KGEpfHxlLnRhZ1Vybj9lOmQuZnJhZy5hcHBlbmRDaGlsZChlKX1mdW5jdGlvbiBoKGEsYyl7aWYoYXx8KGE9YiksbClyZXR1cm4gYS5jcmVhdGVEb2N1bWVudEZyYWdtZW50KCk7Yz1jfHxmKGEpO2Zvcih2YXIgZT1jLmZyYWcuY2xvbmVOb2RlKCksZz0wLGg9ZCgpLGk9aC5sZW5ndGg7aT5nO2crKyllLmNyZWF0ZUVsZW1lbnQoaFtnXSk7cmV0dXJuIGV9ZnVuY3Rpb24gaShhLGIpe2IuY2FjaGV8fChiLmNhY2hlPXt9LGIuY3JlYXRlRWxlbT1hLmNyZWF0ZUVsZW1lbnQsYi5jcmVhdGVGcmFnPWEuY3JlYXRlRG9jdW1lbnRGcmFnbWVudCxiLmZyYWc9Yi5jcmVhdGVGcmFnKCkpLGEuY3JlYXRlRWxlbWVudD1mdW5jdGlvbihjKXtyZXR1cm4gdC5zaGl2TWV0aG9kcz9nKGMsYSxiKTpiLmNyZWF0ZUVsZW0oYyl9LGEuY3JlYXRlRG9jdW1lbnRGcmFnbWVudD1GdW5jdGlvbigiaCxmIiwicmV0dXJuIGZ1bmN0aW9uKCl7dmFyIG49Zi5jbG9uZU5vZGUoKSxjPW4uY3JlYXRlRWxlbWVudDtoLnNoaXZNZXRob2RzJiYoIitkKCkuam9pbigpLnJlcGxhY2UoL1tcd1wtOl0rL2csZnVuY3Rpb24oYSl7cmV0dXJuIGIuY3JlYXRlRWxlbShhKSxiLmZyYWcuY3JlYXRlRWxlbWVudChhKSwnYygiJythKyciKSd9KSsiKTtyZXR1cm4gbn0iKSh0LGIuZnJhZyl9ZnVuY3Rpb24gaihhKXthfHwoYT1iKTt2YXIgZD1mKGEpO3JldHVybiF0LnNoaXZDU1N8fGt8fGQuaGFzQ1NTfHwoZC5oYXNDU1M9ISFjKGEsImFydGljbGUsYXNpZGUsZGlhbG9nLGZpZ2NhcHRpb24sZmlndXJlLGZvb3RlcixoZWFkZXIsaGdyb3VwLG1haW4sbmF2LHNlY3Rpb257ZGlzcGxheTpibG9ja31tYXJre2JhY2tncm91bmQ6I0ZGMDtjb2xvcjojMDAwfXRlbXBsYXRle2Rpc3BsYXk6bm9uZX0iKSksbHx8aShhLGQpLGF9dmFyIGssbCxtPSIzLjcuMiIsbj1hLmh0bWw1fHx7fSxvPS9ePHxeKD86YnV0dG9ufG1hcHxzZWxlY3R8dGV4dGFyZWF8b2JqZWN0fGlmcmFtZXxvcHRpb258b3B0Z3JvdXApJC9pLHA9L14oPzphfGJ8Y29kZXxkaXZ8ZmllbGRzZXR8aDF8aDJ8aDN8aDR8aDV8aDZ8aXxsYWJlbHxsaXxvbHxwfHF8c3BhbnxzdHJvbmd8c3R5bGV8dGFibGV8dGJvZHl8dGR8dGh8dHJ8dWwpJC9pLHE9Il9odG1sNXNoaXYiLHI9MCxzPXt9OyFmdW5jdGlvbigpe3RyeXt2YXIgYT1iLmNyZWF0ZUVsZW1lbnQoImEiKTthLmlubmVySFRNTD0iPHh5ej48L3h5ej4iLGs9ImhpZGRlbiJpbiBhLGw9MT09YS5jaGlsZE5vZGVzLmxlbmd0aHx8ZnVuY3Rpb24oKXtiLmNyZWF0ZUVsZW1lbnQoImEiKTt2YXIgYT1iLmNyZWF0ZURvY3VtZW50RnJhZ21lbnQoKTtyZXR1cm4idW5kZWZpbmVkIj09dHlwZW9mIGEuY2xvbmVOb2RlfHwidW5kZWZpbmVkIj09dHlwZW9mIGEuY3JlYXRlRG9jdW1lbnRGcmFnbWVudHx8InVuZGVmaW5lZCI9PXR5cGVvZiBhLmNyZWF0ZUVsZW1lbnR9KCl9Y2F0Y2goYyl7az0hMCxsPSEwfX0oKTt2YXIgdD17ZWxlbWVudHM6bi5lbGVtZW50c3x8ImFiYnIgYXJ0aWNsZSBhc2lkZSBhdWRpbyBiZGkgY2FudmFzIGRhdGEgZGF0YWxpc3QgZGV0YWlscyBkaWFsb2cgZmlnY2FwdGlvbiBmaWd1cmUgZm9vdGVyIGhlYWRlciBoZ3JvdXAgbWFpbiBtYXJrIG1ldGVyIG5hdiBvdXRwdXQgcGljdHVyZSBwcm9ncmVzcyBzZWN0aW9uIHN1bW1hcnkgdGVtcGxhdGUgdGltZSB2aWRlbyIsdmVyc2lvbjptLHNoaXZDU1M6bi5zaGl2Q1NTIT09ITEsc3VwcG9ydHNVbmtub3duRWxlbWVudHM6bCxzaGl2TWV0aG9kczpuLnNoaXZNZXRob2RzIT09ITEsdHlwZToiZGVmYXVsdCIsc2hpdkRvY3VtZW50OmosY3JlYXRlRWxlbWVudDpnLGNyZWF0ZURvY3VtZW50RnJhZ21lbnQ6aCxhZGRFbGVtZW50czplfTthLmh0bWw1PXQsaihiKX0odGhpcyxkb2N1bWVudCk7Cn07Cg=="></script>
<script src="data:application/x-javascript;base64,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"></script>

<style type="text/css">code{white-space: pre;}</style>
<link href="data:text/css;charset=utf-8,pre%20%2Eoperator%2C%0Apre%20%2Eparen%20%7B%0Acolor%3A%20rgb%28104%2C%20118%2C%20135%29%0A%7D%0Apre%20%2Eliteral%20%7B%0Acolor%3A%20%23990073%0A%7D%0Apre%20%2Enumber%20%7B%0Acolor%3A%20%23099%3B%0A%7D%0Apre%20%2Ecomment%20%7B%0Acolor%3A%20%23998%3B%0Afont%2Dstyle%3A%20italic%0A%7D%0Apre%20%2Ekeyword%20%7B%0Acolor%3A%20%23900%3B%0Afont%2Dweight%3A%20bold%0A%7D%0Apre%20%2Eidentifier%20%7B%0Acolor%3A%20rgb%280%2C%200%2C%200%29%3B%0A%7D%0Apre%20%2Estring%20%7B%0Acolor%3A%20%23d14%3B%0A%7D%0A" rel="stylesheet" type="text/css" />
<script src="data:application/x-javascript;base64,
var hljs=new function(){function m(p){return p.replace(/&/gm,"&amp;").replace(/</gm,"&lt;")}function f(r,q,p){return RegExp(q,"m"+(r.cI?"i":"")+(p?"g":""))}function b(r){for(var p=0;p<r.childNodes.length;p++){var q=r.childNodes[p];if(q.nodeName=="CODE"){return q}if(!(q.nodeType==3&&q.nodeValue.match(/\s+/))){break}}}function h(t,s){var p="";for(var r=0;r<t.childNodes.length;r++){if(t.childNodes[r].nodeType==3){var q=t.childNodes[r].nodeValue;if(s){q=q.replace(/\n/g,"")}p+=q}else{if(t.childNodes[r].nodeName=="BR"){p+="\n"}else{p+=h(t.childNodes[r])}}}if(/MSIE [678]/.test(navigator.userAgent)){p=p.replace(/\r/g,"\n")}return p}function a(s){var r=s.className.split(/\s+/);r=r.concat(s.parentNode.className.split(/\s+/));for(var q=0;q<r.length;q++){var p=r[q].replace(/^language-/,"");if(e[p]){return p}}}function c(q){var p=[];(function(s,t){for(var r=0;r<s.childNodes.length;r++){if(s.childNodes[r].nodeType==3){t+=s.childNodes[r].nodeValue.length}else{if(s.childNodes[r].nodeName=="BR"){t+=1}else{if(s.childNodes[r].nodeType==1){p.push({event:"start",offset:t,node:s.childNodes[r]});t=arguments.callee(s.childNodes[r],t);p.push({event:"stop",offset:t,node:s.childNodes[r]})}}}}return t})(q,0);return p}function k(y,w,x){var q=0;var z="";var s=[];function u(){if(y.length&&w.length){if(y[0].offset!=w[0].offset){return(y[0].offset<w[0].offset)?y:w}else{return w[0].event=="start"?y:w}}else{return y.length?y:w}}function t(D){var A="<"+D.nodeName.toLowerCase();for(var B=0;B<D.attributes.length;B++){var C=D.attributes[B];A+=" "+C.nodeName.toLowerCase();if(C.value!==undefined&&C.value!==false&&C.value!==null){A+='="'+m(C.value)+'"'}}return A+">"}while(y.length||w.length){var v=u().splice(0,1)[0];z+=m(x.substr(q,v.offset-q));q=v.offset;if(v.event=="start"){z+=t(v.node);s.push(v.node)}else{if(v.event=="stop"){var p,r=s.length;do{r--;p=s[r];z+=("</"+p.nodeName.toLowerCase()+">")}while(p!=v.node);s.splice(r,1);while(r<s.length){z+=t(s[r]);r++}}}}return z+m(x.substr(q))}function j(){function q(x,y,v){if(x.compiled){return}var u;var s=[];if(x.k){x.lR=f(y,x.l||hljs.IR,true);for(var w in x.k){if(!x.k.hasOwnProperty(w)){continue}if(x.k[w] instanceof Object){u=x.k[w]}else{u=x.k;w="keyword"}for(var r in u){if(!u.hasOwnProperty(r)){continue}x.k[r]=[w,u[r]];s.push(r)}}}if(!v){if(x.bWK){x.b="\\b("+s.join("|")+")\\s"}x.bR=f(y,x.b?x.b:"\\B|\\b");if(!x.e&&!x.eW){x.e="\\B|\\b"}if(x.e){x.eR=f(y,x.e)}}if(x.i){x.iR=f(y,x.i)}if(x.r===undefined){x.r=1}if(!x.c){x.c=[]}x.compiled=true;for(var t=0;t<x.c.length;t++){if(x.c[t]=="self"){x.c[t]=x}q(x.c[t],y,false)}if(x.starts){q(x.starts,y,false)}}for(var p in e){if(!e.hasOwnProperty(p)){continue}q(e[p].dM,e[p],true)}}function d(B,C){if(!j.called){j();j.called=true}function q(r,M){for(var L=0;L<M.c.length;L++){if((M.c[L].bR.exec(r)||[null])[0]==r){return M.c[L]}}}function v(L,r){if(D[L].e&&D[L].eR.test(r)){return 1}if(D[L].eW){var M=v(L-1,r);return M?M+1:0}return 0}function w(r,L){return L.i&&L.iR.test(r)}function K(N,O){var M=[];for(var L=0;L<N.c.length;L++){M.push(N.c[L].b)}var r=D.length-1;do{if(D[r].e){M.push(D[r].e)}r--}while(D[r+1].eW);if(N.i){M.push(N.i)}return f(O,M.join("|"),true)}function p(M,L){var N=D[D.length-1];if(!N.t){N.t=K(N,E)}N.t.lastIndex=L;var r=N.t.exec(M);return r?[M.substr(L,r.index-L),r[0],false]:[M.substr(L),"",true]}function z(N,r){var L=E.cI?r[0].toLowerCase():r[0];var M=N.k[L];if(M&&M instanceof Array){return M}return false}function F(L,P){L=m(L);if(!P.k){return L}var r="";var O=0;P.lR.lastIndex=0;var M=P.lR.exec(L);while(M){r+=L.substr(O,M.index-O);var N=z(P,M);if(N){x+=N[1];r+='<span class="'+N[0]+'">'+M[0]+"</span>"}else{r+=M[0]}O=P.lR.lastIndex;M=P.lR.exec(L)}return r+L.substr(O,L.length-O)}function J(L,M){if(M.sL&&e[M.sL]){var r=d(M.sL,L);x+=r.keyword_count;return r.value}else{return F(L,M)}}function I(M,r){var L=M.cN?'<span class="'+M.cN+'">':"";if(M.rB){y+=L;M.buffer=""}else{if(M.eB){y+=m(r)+L;M.buffer=""}else{y+=L;M.buffer=r}}D.push(M);A+=M.r}function G(N,M,Q){var R=D[D.length-1];if(Q){y+=J(R.buffer+N,R);return false}var P=q(M,R);if(P){y+=J(R.buffer+N,R);I(P,M);return P.rB}var L=v(D.length-1,M);if(L){var O=R.cN?"</span>":"";if(R.rE){y+=J(R.buffer+N,R)+O}else{if(R.eE){y+=J(R.buffer+N,R)+O+m(M)}else{y+=J(R.buffer+N+M,R)+O}}while(L>1){O=D[D.length-2].cN?"</span>":"";y+=O;L--;D.length--}var r=D[D.length-1];D.length--;D[D.length-1].buffer="";if(r.starts){I(r.starts,"")}return R.rE}if(w(M,R)){throw"Illegal"}}var E=e[B];var D=[E.dM];var A=0;var x=0;var y="";try{var s,u=0;E.dM.buffer="";do{s=p(C,u);var t=G(s[0],s[1],s[2]);u+=s[0].length;if(!t){u+=s[1].length}}while(!s[2]);if(D.length>1){throw"Illegal"}return{r:A,keyword_count:x,value:y}}catch(H){if(H=="Illegal"){return{r:0,keyword_count:0,value:m(C)}}else{throw H}}}function g(t){var p={keyword_count:0,r:0,value:m(t)};var r=p;for(var q in e){if(!e.hasOwnProperty(q)){continue}var s=d(q,t);s.language=q;if(s.keyword_count+s.r>r.keyword_count+r.r){r=s}if(s.keyword_count+s.r>p.keyword_count+p.r){r=p;p=s}}if(r.language){p.second_best=r}return p}function i(r,q,p){if(q){r=r.replace(/^((<[^>]+>|\t)+)/gm,function(t,w,v,u){return w.replace(/\t/g,q)})}if(p){r=r.replace(/\n/g,"<br>")}return r}function n(t,w,r){var x=h(t,r);var v=a(t);var y,s;if(v){y=d(v,x)}else{return}var q=c(t);if(q.length){s=document.createElement("pre");s.innerHTML=y.value;y.value=k(q,c(s),x)}y.value=i(y.value,w,r);var u=t.className;if(!u.match("(\\s|^)(language-)?"+v+"(\\s|$)")){u=u?(u+" "+v):v}if(/MSIE [678]/.test(navigator.userAgent)&&t.tagName=="CODE"&&t.parentNode.tagName=="PRE"){s=t.parentNode;var p=document.createElement("div");p.innerHTML="<pre><code>"+y.value+"</code></pre>";t=p.firstChild.firstChild;p.firstChild.cN=s.cN;s.parentNode.replaceChild(p.firstChild,s)}else{t.innerHTML=y.value}t.className=u;t.result={language:v,kw:y.keyword_count,re:y.r};if(y.second_best){t.second_best={language:y.second_best.language,kw:y.second_best.keyword_count,re:y.second_best.r}}}function o(){if(o.called){return}o.called=true;var r=document.getElementsByTagName("pre");for(var p=0;p<r.length;p++){var q=b(r[p]);if(q){n(q,hljs.tabReplace)}}}function l(){if(window.addEventListener){window.addEventListener("DOMContentLoaded",o,false);window.addEventListener("load",o,false)}else{if(window.attachEvent){window.attachEvent("onload",o)}else{window.onload=o}}}var e={};this.LANGUAGES=e;this.highlight=d;this.highlightAuto=g;this.fixMarkup=i;this.highlightBlock=n;this.initHighlighting=o;this.initHighlightingOnLoad=l;this.IR="[a-zA-Z][a-zA-Z0-9_]*";this.UIR="[a-zA-Z_][a-zA-Z0-9_]*";this.NR="\\b\\d+(\\.\\d+)?";this.CNR="\\b(0[xX][a-fA-F0-9]+|(\\d+(\\.\\d*)?|\\.\\d+)([eE][-+]?\\d+)?)";this.BNR="\\b(0b[01]+)";this.RSR="!|!=|!==|%|%=|&|&&|&=|\\*|\\*=|\\+|\\+=|,|\\.|-|-=|/|/=|:|;|<|<<|<<=|<=|=|==|===|>|>=|>>|>>=|>>>|>>>=|\\?|\\[|\\{|\\(|\\^|\\^=|\\||\\|=|\\|\\||~";this.ER="(?![\\s\\S])";this.BE={b:"\\\\.",r:0};this.ASM={cN:"string",b:"'",e:"'",i:"\\n",c:[this.BE],r:0};this.QSM={cN:"string",b:'"',e:'"',i:"\\n",c:[this.BE],r:0};this.CLCM={cN:"comment",b:"//",e:"$"};this.CBLCLM={cN:"comment",b:"/\\*",e:"\\*/"};this.HCM={cN:"comment",b:"#",e:"$"};this.NM={cN:"number",b:this.NR,r:0};this.CNM={cN:"number",b:this.CNR,r:0};this.BNM={cN:"number",b:this.BNR,r:0};this.inherit=function(r,s){var p={};for(var q in r){p[q]=r[q]}if(s){for(var q in s){p[q]=s[q]}}return p}}();hljs.LANGUAGES.cpp=function(){var a={keyword:{"false":1,"int":1,"float":1,"while":1,"private":1,"char":1,"catch":1,"export":1,virtual:1,operator:2,sizeof:2,dynamic_cast:2,typedef:2,const_cast:2,"const":1,struct:1,"for":1,static_cast:2,union:1,namespace:1,unsigned:1,"long":1,"throw":1,"volatile":2,"static":1,"protected":1,bool:1,template:1,mutable:1,"if":1,"public":1,friend:2,"do":1,"return":1,"goto":1,auto:1,"void":2,"enum":1,"else":1,"break":1,"new":1,extern:1,using:1,"true":1,"class":1,asm:1,"case":1,typeid:1,"short":1,reinterpret_cast:2,"default":1,"double":1,register:1,explicit:1,signed:1,typename:1,"try":1,"this":1,"switch":1,"continue":1,wchar_t:1,inline:1,"delete":1,alignof:1,char16_t:1,char32_t:1,constexpr:1,decltype:1,noexcept:1,nullptr:1,static_assert:1,thread_local:1,restrict:1,_Bool:1,complex:1},built_in:{std:1,string:1,cin:1,cout:1,cerr:1,clog:1,stringstream:1,istringstream:1,ostringstream:1,auto_ptr:1,deque:1,list:1,queue:1,stack:1,vector:1,map:1,set:1,bitset:1,multiset:1,multimap:1,unordered_set:1,unordered_map:1,unordered_multiset:1,unordered_multimap:1,array:1,shared_ptr:1}};return{dM:{k:a,i:"</",c:[hljs.CLCM,hljs.CBLCLM,hljs.QSM,{cN:"string",b:"'\\\\?.",e:"'",i:"."},{cN:"number",b:"\\b(\\d+(\\.\\d*)?|\\.\\d+)(u|U|l|L|ul|UL|f|F)"},hljs.CNM,{cN:"preprocessor",b:"#",e:"$"},{cN:"stl_container",b:"\\b(deque|list|queue|stack|vector|map|set|bitset|multiset|multimap|unordered_map|unordered_set|unordered_multiset|unordered_multimap|array)\\s*<",e:">",k:a,r:10,c:["self"]}]}}}();hljs.LANGUAGES.r={dM:{c:[hljs.HCM,{cN:"number",b:"\\b0[xX][0-9a-fA-F]+[Li]?\\b",e:hljs.IMMEDIATE_RE,r:0},{cN:"number",b:"\\b\\d+(?:[eE][+\\-]?\\d*)?L\\b",e:hljs.IMMEDIATE_RE,r:0},{cN:"number",b:"\\b\\d+\\.(?!\\d)(?:i\\b)?",e:hljs.IMMEDIATE_RE,r:1},{cN:"number",b:"\\b\\d+(?:\\.\\d*)?(?:[eE][+\\-]?\\d*)?i?\\b",e:hljs.IMMEDIATE_RE,r:0},{cN:"number",b:"\\.\\d+(?:[eE][+\\-]?\\d*)?i?\\b",e:hljs.IMMEDIATE_RE,r:1},{cN:"keyword",b:"(?:tryCatch|library|setGeneric|setGroupGeneric)\\b",e:hljs.IMMEDIATE_RE,r:10},{cN:"keyword",b:"\\.\\.\\.",e:hljs.IMMEDIATE_RE,r:10},{cN:"keyword",b:"\\.\\.\\d+(?![\\w.])",e:hljs.IMMEDIATE_RE,r:10},{cN:"keyword",b:"\\b(?:function)",e:hljs.IMMEDIATE_RE,r:2},{cN:"keyword",b:"(?:if|in|break|next|repeat|else|for|return|switch|while|try|stop|warning|require|attach|detach|source|setMethod|setClass)\\b",e:hljs.IMMEDIATE_RE,r:1},{cN:"literal",b:"(?:NA|NA_integer_|NA_real_|NA_character_|NA_complex_)\\b",e:hljs.IMMEDIATE_RE,r:10},{cN:"literal",b:"(?:NULL|TRUE|FALSE|T|F|Inf|NaN)\\b",e:hljs.IMMEDIATE_RE,r:1},{cN:"identifier",b:"[a-zA-Z.][a-zA-Z0-9._]*\\b",e:hljs.IMMEDIATE_RE,r:0},{cN:"operator",b:"<\\-(?!\\s*\\d)",e:hljs.IMMEDIATE_RE,r:2},{cN:"operator",b:"\\->|<\\-",e:hljs.IMMEDIATE_RE,r:1},{cN:"operator",b:"%%|~",e:hljs.IMMEDIATE_RE},{cN:"operator",b:">=|<=|==|!=|\\|\\||&&|=|\\+|\\-|\\*|/|\\^|>|<|!|&|\\||\\$|:",e:hljs.IMMEDIATE_RE,r:0},{cN:"operator",b:"%",e:"%",i:"\\n",r:1},{cN:"identifier",b:"`",e:"`",r:0},{cN:"string",b:'"',e:'"',c:[hljs.BE],r:0},{cN:"string",b:"'",e:"'",c:[hljs.BE],r:0},{cN:"paren",b:"[[({\\])}]",e:hljs.IMMEDIATE_RE,r:0}]}};
hljs.initHighlightingOnLoad();

"></script>
<style type="text/css">
  pre:not([class]) {
    background-color: white;
  }
</style>
<script type="text/javascript">
if (window.hljs && document.readyState && document.readyState === "complete") {
   window.setTimeout(function() {
      hljs.initHighlighting();
   }, 0);
}
</script>



<style type="text/css">
h1 {
  font-size: 34px;
}
h1.title {
  font-size: 38px;
}
h2 {
  font-size: 30px;
}
h3 {
  font-size: 24px;
}
h4 {
  font-size: 18px;
}
h5 {
  font-size: 16px;
}
h6 {
  font-size: 12px;
}
.table th:not([align]) {
  text-align: left;
}
</style>

<link href="data:text/css;charset=utf-8,%23TOC%20%7B%0Aposition%3A%20fixed%3B%0Aleft%3A%200%3B%0Atop%3A%2040px%3B%0Awidth%3A%20200px%3B%0Aheight%3A%20100%25%3B%0Aoverflow%3Aauto%3B%0A%7D%0Abody%20%7B%0Amax%2Dwidth%3A%20800px%3B%0Amargin%3A%20auto%3B%0Amargin%2Dleft%3A210px%3B%0Aline%2Dheight%3A%2020px%3B%0A%7D%0A" rel="stylesheet" type="text/css" />

</head>

<body>

<style type="text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
code {
  color: inherit;
  background-color: rgba(0, 0, 0, 0.04);
}
img {
  max-width:100%;
  height: auto;
}
.tabbed-pane {
  padding-top: 12px;
}
button.code-folding-btn:focus {
  outline: none;
}
</style>


<div class="container-fluid main-container">

<!-- tabsets -->
<script src="data:application/x-javascript;base64,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"></script>
<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});
</script>

<!-- code folding -->






<div class="fluid-row" id="header">



<h1 class="title toc-ignore">SFA extract features Deng et al 2014</h1>
<h4 class="author"><em>Kushal K Dey</em></h4>
<h4 class="date"><em>June 17, 2016</em></h4>

</div>

<div id="TOC">
<ul>
<li><a href="#loading-deng-et-al-2014">Loading Deng et al 2014</a></li>
<li><a href="#load-the-sfa-input-sparse-loadings-sqrt-transformation">Load the SFA input (sparse loadings: sqrt transformation)</a></li>
<li><a href="#factor-annotations">Factor Annotations</a><ul>
<li><a href="#factor-1-annotations">Factor 1 annotations</a></li>
<li><a href="#factor-2-annotations">Factor 2 annotations</a></li>
<li><a href="#factor-3-annotations">Factor 3 annotations</a></li>
<li><a href="#factor-4-annotations">Factor 4 annotations</a></li>
<li><a href="#factor-5-annotations">Factor 5 annotations</a></li>
<li><a href="#factor-6-annotations">Factor 6 annotations</a></li>
<li><a href="#factor-7-annotations">Factor 7 annotations</a></li>
<li><a href="#factor-8-annotations">Factor 8 annotations</a></li>
<li><a href="#factor-9-annotations">Factor 9 annotations</a></li>
<li><a href="#factor-10-annotations">Factor 10 annotations</a></li>
</ul></li>
<li><a href="#load-the-sfa-input-sparse-loadings-voom-transformation">Load the SFA input (sparse loadings: voom transformation)</a></li>
<li><a href="#factor-annotations-1">Factor Annotations</a><ul>
<li><a href="#factor-1-annotations-1">Factor 1 annotations</a></li>
<li><a href="#factor-2-annotations-1">Factor 2 annotations</a></li>
<li><a href="#factor-3-annotations-1">Factor 3 annotations</a></li>
<li><a href="#factor-4-annotations-1">Factor 4 annotations</a></li>
<li><a href="#factor-5-annotations-1">Factor 5 annotations</a></li>
<li><a href="#factor-6-annotations-1">Factor 6 annotations</a></li>
<li><a href="#factor-7-annotations-1">Factor 7 annotations</a></li>
<li><a href="#factor-8-annotations-1">Factor 8 annotations</a></li>
<li><a href="#factor-9-annotations-1">Factor 9 annotations</a></li>
<li><a href="#factor-10-annotations-1">Factor 10 annotations</a></li>
</ul></li>
<li><a href="#load-the-sfa-input-sparse-factors-sqrt-transformation">Load the SFA input (sparse factors: sqrt transformation)</a></li>
<li><a href="#factor-annotations-2">Factor Annotations</a><ul>
<li><a href="#factor-1-annotations-2">Factor 1 annotations</a></li>
<li><a href="#factor-2-annotations-2">Factor 2 annotations</a></li>
<li><a href="#factor-3-annotations-2">Factor 3 annotations</a></li>
<li><a href="#factor-4-annotations-2">Factor 4 annotations</a></li>
<li><a href="#factor-5-annotations-2">Factor 5 annotations</a></li>
<li><a href="#factor-6-annotations-2">Factor 6 annotations</a></li>
<li><a href="#factor-7-annotations-2">Factor 7 annotations</a></li>
<li><a href="#factor-8-annotations-2">Factor 8 annotations</a></li>
<li><a href="#factor-9-annotations-2">Factor 9 annotations</a></li>
<li><a href="#factor-10-annotations-2">Factor 10 annotations</a></li>
</ul></li>
<li><a href="#load-the-sfa-input-sparse-factors-voom-transformation">Load the SFA input (sparse factors: voom transformation)</a></li>
<li><a href="#factor-annotations-3">Factor Annotations</a><ul>
<li><a href="#factor-1-annotations-3">Factor 1 annotations</a></li>
<li><a href="#factor-2-annotations-3">Factor 2 annotations</a></li>
<li><a href="#factor-3-annotations-3">Factor 3 annotations</a></li>
<li><a href="#factor-4-annotations-3">Factor 4 annotations</a></li>
<li><a href="#factor-5-annotations-3">Factor 5 annotations</a></li>
<li><a href="#factor-6-annotations-3">Factor 6 annotations</a></li>
<li><a href="#factor-7-annotations-3">Factor 7 annotations</a></li>
<li><a href="#factor-8-annotations-3">Factor 8 annotations</a></li>
<li><a href="#factor-9-annotations-3">Factor 9 annotations</a></li>
<li><a href="#factor-10-annotations-3">Factor 10 annotations</a></li>
</ul></li>
</ul>
</div>

<pre class="r"><code>library(knitr)
source(&quot;../R/SFA.ExtractTopFeatures.R&quot;)
source(&quot;../R/SFA.TopFeaturesPerFac.R&quot;)</code></pre>
<div id="loading-deng-et-al-2014" class="section level2">
<h2>Loading Deng et al 2014</h2>
<pre class="r"><code>library(devtools)

read.data1 = function() {
  x = tempfile()
  download.file('https://cdn.rawgit.com/kkdey/singleCellRNASeqMouseDeng2014/master/data/Deng2014MouseEsc.rda', destfile=x, quiet=TRUE)
  z = get(load((x)))
  return(z)
}

Deng2014MouseESC &lt;- read.data1()

deng.counts &lt;- Biobase::exprs(Deng2014MouseESC)
deng.meta_data &lt;- Biobase::pData(Deng2014MouseESC)
deng.gene_names &lt;- rownames(deng.counts)</code></pre>
</div>
<div id="load-the-sfa-input-sparse-loadings-sqrt-transformation" class="section level2">
<h2>Load the SFA input (sparse loadings: sqrt transformation)</h2>
<pre class="r"><code>lambda_out &lt;- read.table(&quot;../sfa_outputs/Deng2014PPS/sqrt_deng_counts_lambda.out&quot;)
f_out &lt;- t(read.table(&quot;../sfa_outputs/Deng2014PPS/sqrt_deng_counts_F.out&quot;))

indices_mat &lt;- SFA.ExtractTopFeatures(f_out, top_features = 100,
                      options = &quot;min&quot;,mult.annotate = TRUE)

top_gene_names &lt;- t(apply(indices_mat, 1, function(x) return (deng.gene_names[x])));</code></pre>
</div>
<div id="factor-annotations" class="section level2">
<h2>Factor Annotations</h2>
<div id="factor-1-annotations" class="section level3">
<h3>Factor 1 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[1,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">query</th>
<th align="left">summary</th>
<th align="left">name</th>
<th align="left">X_id</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">H1foo</td>
<td align="left">Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Nucleosomes consist of approximately 146 bp of DNA wrapped around a histone octamer composed of pairs of each of the four core histones (H2A, H2B, H3, and H4). The chromatin fiber is further compacted through the interaction of a linker histone, H1, with the DNA between the nucleosomes to form higher order chromatin structures. The protein encoded is a replication-independent histone that is a member of the histone H1 family. This gene contains introns, unlike most histone genes and the encoded protein is expressed only in oocytes.</td>
<td align="left">H1 histone family, member O, oocyte-specific</td>
<td align="left">171506</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Isyna1</td>
<td align="left">NA</td>
<td align="left">myo-inositol 1-phosphate synthase A1</td>
<td align="left">71780</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Oosp1</td>
<td align="left">NA</td>
<td align="left">oocyte secreted protein 1</td>
<td align="left">170834</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Bpgm</td>
<td align="left">NA</td>
<td align="left">2,3-bisphosphoglycerate mutase</td>
<td align="left">12183</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Txnip</td>
<td align="left">NA</td>
<td align="left">thioredoxin interacting protein</td>
<td align="left">56338</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">BC051665</td>
<td align="left">NA</td>
<td align="left">cDNA sequence BC051665</td>
<td align="left">218275</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Eef2</td>
<td align="left">NA</td>
<td align="left">eukaryotic translation elongation factor 2</td>
<td align="left">13629</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tet3</td>
<td align="left">NA</td>
<td align="left">tet methylcytosine dioxygenase 3</td>
<td align="left">194388</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rtn4</td>
<td align="left">NA</td>
<td align="left">reticulon 4</td>
<td align="left">68585</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Polr1b</td>
<td align="left">NA</td>
<td align="left">polymerase (RNA) I polypeptide B</td>
<td align="left">20017</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Zar1</td>
<td align="left">NA</td>
<td align="left">zygote arrest 1</td>
<td align="left">317755</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tcfcp2l1</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">Fbxo15</td>
<td align="left">NA</td>
<td align="left">F-box protein 15</td>
<td align="left">50764</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Parp1</td>
<td align="left">NA</td>
<td align="left">poly (ADP-ribose) polymerase family, member 1</td>
<td align="left">11545</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pramel5</td>
<td align="left">NA</td>
<td align="left">preferentially expressed antigen in melanoma like 5</td>
<td align="left">384077</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Slc12a7</td>
<td align="left">NA</td>
<td align="left">solute carrier family 12, member 7</td>
<td align="left">20499</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tceb1</td>
<td align="left">NA</td>
<td align="left">transcription elongation factor B (SIII), polypeptide 1</td>
<td align="left">67923</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Smc5</td>
<td align="left">NA</td>
<td align="left">structural maintenance of chromosomes 5</td>
<td align="left">226026</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Npm1</td>
<td align="left">NA</td>
<td align="left">nucleophosmin 1</td>
<td align="left">18148</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Trim43a</td>
<td align="left">NA</td>
<td align="left">tripartite motif-containing 43A</td>
<td align="left">547109</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pemt</td>
<td align="left">NA</td>
<td align="left">phosphatidylethanolamine N-methyltransferase</td>
<td align="left">18618</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pgd</td>
<td align="left">NA</td>
<td align="left">phosphogluconate dehydrogenase</td>
<td align="left">110208</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mcm5</td>
<td align="left">The protein encoded by this gene is a member of the oligameric minichromosome maintenance protein complex. During DNA replication, the complex loads onto chromatin in early G1 and is converted into an active replicative helicase during S phase. It functions to limit DNA synthesis to once per cell cycle. During embryogenesis, the encoded protein is negatively regulated through expression of paired box protein Pax 3. Alternative splicing results in multiple transcript variants.</td>
<td align="left">minichromosome maintenance complex component 5</td>
<td align="left">17218</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">9430015G10Rik</td>
<td align="left">NA</td>
<td align="left">RIKEN cDNA 9430015G10 gene</td>
<td align="left">230996</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pou5f1</td>
<td align="left">The protein encoded by this gene belongs to the POU domain family of transcription factors. POU domain transcription factors bind to a specific octamer DNA motif and regulate cell type-specific differentiation pathways. The encoded protein plays a key role in embryonic development and stem cell pluripotency. Alternative splicing results in multiple transcript variants.</td>
<td align="left">POU domain, class 5, transcription factor 1</td>
<td align="left">18999</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Lsm14b</td>
<td align="left">NA</td>
<td align="left">LSM family member 14B</td>
<td align="left">241846</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ftsj3</td>
<td align="left">NA</td>
<td align="left">FtsJ RNA methyltransferase homolog 3 (E. coli)</td>
<td align="left">56095</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rtel1</td>
<td align="left">NA</td>
<td align="left">regulator of telomere elongation helicase 1</td>
<td align="left">269400</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Nsd1</td>
<td align="left">NA</td>
<td align="left">nuclear receptor-binding SET-domain protein 1</td>
<td align="left">18193</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Hip1</td>
<td align="left">NA</td>
<td align="left">huntingtin interacting protein 1</td>
<td align="left">215114</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gga2</td>
<td align="left">NA</td>
<td align="left">golgi associated, gamma adaptin ear containing, ARF binding protein 2</td>
<td align="left">74105</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Elp3</td>
<td align="left">NA</td>
<td align="left">elongator acetyltransferase complex subunit 3</td>
<td align="left">74195</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm2a</td>
<td align="left">NA</td>
<td align="left">GM2 ganglioside activator protein</td>
<td align="left">14667</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ccdc6</td>
<td align="left">NA</td>
<td align="left">coiled-coil domain containing 6</td>
<td align="left">76551</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Dnajc3</td>
<td align="left">NA</td>
<td align="left">DnaJ heat shock protein family (Hsp40) member C3</td>
<td align="left">100037258</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cpsf1</td>
<td align="left">NA</td>
<td align="left">cleavage and polyadenylation specific factor 1</td>
<td align="left">94230</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Unc50</td>
<td align="left">NA</td>
<td align="left">unc-50 homolog (C. elegans)</td>
<td align="left">67387</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Lrrfip1</td>
<td align="left">NA</td>
<td align="left">leucine rich repeat (in FLII) interacting protein 1</td>
<td align="left">16978</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tet1</td>
<td align="left">NA</td>
<td align="left">tet methylcytosine dioxygenase 1</td>
<td align="left">52463</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">2410004A20Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">Bhmt</td>
<td align="left">NA</td>
<td align="left">betaine-homocysteine methyltransferase</td>
<td align="left">12116</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Mkrn1</td>
<td align="left">NA</td>
<td align="left">makorin, ring finger protein, 1</td>
<td align="left">54484</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm11517</td>
<td align="left">NA</td>
<td align="left">predicted gene 11517</td>
<td align="left">ENSMUSG00000081249</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gm11517</td>
<td align="left">NA</td>
<td align="left">ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene</td>
<td align="left">629750</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">BC053393</td>
<td align="left">NA</td>
<td align="left">cDNA sequence BC053393</td>
<td align="left">407814</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Trp53</td>
<td align="left">This gene encodes tumor protein p53, which responds to diverse cellular stresses to regulate target genes that induce cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. p53 protein is expressed at low level in normal cells and at a high level in a variety of transformed cell lines, where it’s believed to contribute to transformation and malignancy. p53 is a DNA-binding protein containing transcription activation, DNA-binding, and oligomerization domains. It is postulated to bind to a p53-binding site and activate expression of downstream genes that inhibit growth and/or invasion, and thus function as a tumor suppressor. Mice deficient for this gene are developmentally normal but are susceptible to spontaneous tumors. Evidence to date shows that this gene contains one promoter, in contrast to alternative promoters of the human gene, and transcribes a few of splice variants which encode different isoforms, although the biological validity or the full-length nature of some variants has not been determined.</td>
<td align="left">transformation related protein 53</td>
<td align="left">22059</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Celf2</td>
<td align="left">NA</td>
<td align="left">CUGBP, Elav-like family member 2</td>
<td align="left">14007</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Hdgf</td>
<td align="left">NA</td>
<td align="left">hepatoma-derived growth factor</td>
<td align="left">15191</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Insig1</td>
<td align="left">NA</td>
<td align="left">insulin induced gene 1</td>
<td align="left">231070</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ccne1</td>
<td align="left">NA</td>
<td align="left">cyclin E1</td>
<td align="left">12447</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rcc2</td>
<td align="left">NA</td>
<td align="left">regulator of chromosome condensation 2</td>
<td align="left">108911</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Arfip1</td>
<td align="left">NA</td>
<td align="left">ADP-ribosylation factor interacting protein 1</td>
<td align="left">99889</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Adh1</td>
<td align="left">NA</td>
<td align="left">alcohol dehydrogenase 1 (class I)</td>
<td align="left">11522</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Stbd1</td>
<td align="left">NA</td>
<td align="left">starch binding domain 1</td>
<td align="left">52331</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Lcp1</td>
<td align="left">NA</td>
<td align="left">lymphocyte cytosolic protein 1</td>
<td align="left">18826</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Blmh</td>
<td align="left">The encoded protein is a cytoplasmic cysteine peptidase involved in inactivation of bleomycin, a glycopeptide which is a component of combination chemotherapy regimens for cancer. This encoded enzyme is highly conserved, and it contains the signature active site residues of cysteine protease papain superfamily enzymes. It is postulated that this enzyme has protective effects against bleomycin-induced pulmonary fibrosis and bleomycin tumor resistance.</td>
<td align="left">bleomycin hydrolase</td>
<td align="left">104184</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pik3c2a</td>
<td align="left">NA</td>
<td align="left">phosphatidylinositol 3-kinase, C2 domain containing, alpha polypeptide</td>
<td align="left">18704</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Bach1</td>
<td align="left">NA</td>
<td align="left">BTB and CNC homology 1, basic leucine zipper transcription factor 1</td>
<td align="left">12013</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Spic</td>
<td align="left">NA</td>
<td align="left">Spi-C transcription factor (Spi-1/PU.1 related)</td>
<td align="left">20728</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">C86187</td>
<td align="left">NA</td>
<td align="left">expressed sequence C86187</td>
<td align="left">97402</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Calcoco2</td>
<td align="left">NA</td>
<td align="left">calcium binding and coiled-coil domain 2</td>
<td align="left">76815</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Kif16b</td>
<td align="left">NA</td>
<td align="left">kinesin family member 16B</td>
<td align="left">16558</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cryl1</td>
<td align="left">NA</td>
<td align="left">crystallin, lambda 1</td>
<td align="left">68631</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tars2</td>
<td align="left">NA</td>
<td align="left">threonyl-tRNA synthetase 2, mitochondrial (putative)</td>
<td align="left">71807</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Litaf</td>
<td align="left">NA</td>
<td align="left">LPS-induced TN factor</td>
<td align="left">56722</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ubb</td>
<td align="left">This gene encodes ubiquitin, one of the most conserved proteins known. Ubiquitin has a major role in targeting cellular proteins for degradation by the 26S proteosome. It is also involved in the maintenance of chromatin structure, the regulation of gene expression, and the stress response. Ubiquitin is synthesized as a precursor protein consisting of either polyubiquitin chains or a single ubiquitin moiety fused to an unrelated protein. This gene consists of four direct repeats of the ubiquitin coding sequence with no spacer sequence. Consequently, the protein is expressed as a polyubiquitin precursor with a final amino acid after the last repeat. Pseudogenes of this gene are located on chromosomes 3 and 14. Alternative splicing results in multiple transcript variants.</td>
<td align="left">ubiquitin B</td>
<td align="left">22187</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cul5</td>
<td align="left">NA</td>
<td align="left">cullin 5</td>
<td align="left">75717</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cdk5rap3</td>
<td align="left">NA</td>
<td align="left">CDK5 regulatory subunit associated protein 3</td>
<td align="left">80280</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Parp8</td>
<td align="left">NA</td>
<td align="left">poly (ADP-ribose) polymerase family, member 8</td>
<td align="left">52552</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Mcm7</td>
<td align="left">NA</td>
<td align="left">minichromosome maintenance complex component 7</td>
<td align="left">17220</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Usp5</td>
<td align="left">NA</td>
<td align="left">ubiquitin specific peptidase 5 (isopeptidase T)</td>
<td align="left">22225</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tm9sf2</td>
<td align="left">NA</td>
<td align="left">transmembrane 9 superfamily member 2</td>
<td align="left">68059</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Snx5</td>
<td align="left">NA</td>
<td align="left">sorting nexin 5</td>
<td align="left">69178</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Mybl2</td>
<td align="left">NA</td>
<td align="left">myeloblastosis oncogene-like 2</td>
<td align="left">17865</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Etv5</td>
<td align="left">NA</td>
<td align="left">ets variant 5</td>
<td align="left">104156</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Mesdc2</td>
<td align="left">NA</td>
<td align="left">mesoderm development candidate 2</td>
<td align="left">67943</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ninj1</td>
<td align="left">NA</td>
<td align="left">ninjurin 1</td>
<td align="left">18081</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Hsp90ab1</td>
<td align="left">NA</td>
<td align="left">heat shock protein 90 alpha (cytosolic), class B member 1</td>
<td align="left">15516</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Hmga2</td>
<td align="left">NA</td>
<td align="left">high mobility group AT-hook 2</td>
<td align="left">15364</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Spns1</td>
<td align="left">NA</td>
<td align="left">spinster homolog 1</td>
<td align="left">73658</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Id2</td>
<td align="left">NA</td>
<td align="left">inhibitor of DNA binding 2</td>
<td align="left">15902</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pold1</td>
<td align="left">NA</td>
<td align="left">polymerase (DNA directed), delta 1, catalytic subunit</td>
<td align="left">18971</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ulk1</td>
<td align="left">NA</td>
<td align="left">unc-51 like kinase 1</td>
<td align="left">22241</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Map1lc3b</td>
<td align="left">NA</td>
<td align="left">microtubule-associated protein 1 light chain 3 beta</td>
<td align="left">67443</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Sat1</td>
<td align="left">NA</td>
<td align="left">spermidine/spermine N1-acetyl transferase 1</td>
<td align="left">20229</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tmem231</td>
<td align="left">NA</td>
<td align="left">transmembrane protein 231</td>
<td align="left">234740</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mat2a</td>
<td align="left">NA</td>
<td align="left">methionine adenosyltransferase II, alpha</td>
<td align="left">232087</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ddx41</td>
<td align="left">NA</td>
<td align="left">DEAD (Asp-Glu-Ala-Asp) box polypeptide 41</td>
<td align="left">72935</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mfge8</td>
<td align="left">NA</td>
<td align="left">milk fat globule-EGF factor 8 protein</td>
<td align="left">17304</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ap3d1</td>
<td align="left">NA</td>
<td align="left">adaptor-related protein complex 3, delta 1 subunit</td>
<td align="left">11776</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ephb4</td>
<td align="left">NA</td>
<td align="left">Eph receptor B4</td>
<td align="left">13846</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Yaf2</td>
<td align="left">NA</td>
<td align="left">YY1 associated factor 2</td>
<td align="left">67057</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ash1l</td>
<td align="left">NA</td>
<td align="left">ash1 (absent, small, or homeotic)-like (Drosophila)</td>
<td align="left">192195</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Dnaja4</td>
<td align="left">NA</td>
<td align="left">DnaJ heat shock protein family (Hsp40) member A4</td>
<td align="left">58233</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Smagp</td>
<td align="left">NA</td>
<td align="left">small cell adhesion glycoprotein</td>
<td align="left">207818</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ganab</td>
<td align="left">NA</td>
<td align="left">alpha glucosidase 2 alpha neutral subunit</td>
<td align="left">14376</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Spag9</td>
<td align="left">NA</td>
<td align="left">sperm associated antigen 9</td>
<td align="left">70834</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Creg1</td>
<td align="left">NA</td>
<td align="left">cellular repressor of E1A-stimulated genes 1</td>
<td align="left">433375</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Plod1</td>
<td align="left">NA</td>
<td align="left">procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1</td>
<td align="left">18822</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Slc25a5</td>
<td align="left">This gene encodes a transmembrane domain-containing protein that localizes to the mitochondrial inner membrane. The encoded protein facilitates the exchange of ADP from the cytoplasm with ATP from the mitochondria. Pseudogenes for this gene are found on multiple chromosomes.</td>
<td align="left">solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 5</td>
<td align="left">11740</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Poldip2</td>
<td align="left">NA</td>
<td align="left">polymerase (DNA-directed), delta interacting protein 2</td>
<td align="left">67811</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_load_sqrt/gene_names_clus_&quot;,1,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-2-annotations" class="section level3">
<h3>Factor 2 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[2,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">query</th>
<th align="left">X_id</th>
<th align="left">summary</th>
<th align="left">name</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Actb</td>
<td align="left">11461</td>
<td align="left">This gene encodes a member of the actin family of proteins. Actins are highly conserved proteins that are among the most abundant proteins in eukaryotic cells and are involved in cell motility, structure, and integrity. Localization, stability, and translation of the transcribed mRNA are regulated through the binding of multiple factors to its 3’ UTR sequence. Homozygous knockout mice for this gene exhibit embryonic lethality. Numerous pseudogenes of this gene have been identified in the mouse genome.</td>
<td align="left">actin, beta</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Hsp90ab1</td>
<td align="left">15516</td>
<td align="left">NA</td>
<td align="left">heat shock protein 90 alpha (cytosolic), class B member 1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fabp3</td>
<td align="left">14077</td>
<td align="left">NA</td>
<td align="left">fatty acid binding protein 3, muscle and heart</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tcl1</td>
<td align="left">21432</td>
<td align="left">NA</td>
<td align="left">T cell lymphoma breakpoint 1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Crip2</td>
<td align="left">68337</td>
<td align="left">NA</td>
<td align="left">cysteine rich protein 2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Npm1</td>
<td align="left">18148</td>
<td align="left">NA</td>
<td align="left">nucleophosmin 1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">D6Ertd527e</td>
<td align="left">52372</td>
<td align="left">NA</td>
<td align="left">DNA segment, Chr 6, ERATO Doi 527, expressed</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gpbp1</td>
<td align="left">73274</td>
<td align="left">NA</td>
<td align="left">GC-rich promoter binding protein 1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Stip1</td>
<td align="left">20867</td>
<td align="left">NA</td>
<td align="left">stress-induced phosphoprotein 1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Spin1</td>
<td align="left">20729</td>
<td align="left">NA</td>
<td align="left">spindlin 1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm11517</td>
<td align="left">ENSMUSG00000081249</td>
<td align="left">NA</td>
<td align="left">predicted gene 11517</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gm11517</td>
<td align="left">629750</td>
<td align="left">NA</td>
<td align="left">ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Krt18</td>
<td align="left">16668</td>
<td align="left">NA</td>
<td align="left">keratin 18</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Omt2b</td>
<td align="left">382088</td>
<td align="left">NA</td>
<td align="left">oocyte maturation, beta</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Eef2</td>
<td align="left">13629</td>
<td align="left">NA</td>
<td align="left">eukaryotic translation elongation factor 2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Id2</td>
<td align="left">15902</td>
<td align="left">NA</td>
<td align="left">inhibitor of DNA binding 2</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Khdc1b</td>
<td align="left">98582</td>
<td align="left">NA</td>
<td align="left">KH domain containing 1B</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tceb1</td>
<td align="left">67923</td>
<td align="left">NA</td>
<td align="left">transcription elongation factor B (SIII), polypeptide 1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Omt2a</td>
<td align="left">18379</td>
<td align="left">NA</td>
<td align="left">oocyte maturation, alpha</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Psap</td>
<td align="left">19156</td>
<td align="left">This gene encodes a multifunctional glycoprotein that plays a role in the intracellular metabolism of various sphingolipids or secreted into the plasma, milk or cerebrospinal fluid. The encoded protein undergoes proteolytic processing to generate four different polypeptides known as saposin A, B, C or D, that are required for the hydrolysis of certain sphingolipids by lysosomal hydrolases. Alternately, the encoded protein is secreted into body fluids where it exhibits neurotrophic and myelinotrophic activities. A complete lack of the encoded protein is fatal to mice either at the neonatal stage or within the first month due to severe leukodystrophy and sphingolipid accumulation. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar processing to generate the mature saposins.</td>
<td align="left">prosaposin</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Obox6</td>
<td align="left">252830</td>
<td align="left">NA</td>
<td align="left">oocyte specific homeobox 6</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Fbxw24</td>
<td align="left">382106</td>
<td align="left">NA</td>
<td align="left">F-box and WD-40 domain protein 24</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Larp4</td>
<td align="left">207214</td>
<td align="left">NA</td>
<td align="left">La ribonucleoprotein domain family, member 4</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Dppa5a</td>
<td align="left">434423</td>
<td align="left">NA</td>
<td align="left">developmental pluripotency associated 5A</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Uhrf1</td>
<td align="left">18140</td>
<td align="left">NA</td>
<td align="left">ubiquitin-like, containing PHD and RING finger domains, 1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Map1lc3b</td>
<td align="left">67443</td>
<td align="left">NA</td>
<td align="left">microtubule-associated protein 1 light chain 3 beta</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Oas1d</td>
<td align="left">100535</td>
<td align="left">NA</td>
<td align="left">2’-5’ oligoadenylate synthetase 1D</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ubxn1</td>
<td align="left">225896</td>
<td align="left">NA</td>
<td align="left">UBX domain protein 1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Nlrp4f</td>
<td align="left">97895</td>
<td align="left">NA</td>
<td align="left">NLR family, pyrin domain containing 4F</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">C87499</td>
<td align="left">381590</td>
<td align="left">NA</td>
<td align="left">expressed sequence C87499</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rpl8</td>
<td align="left">26961</td>
<td align="left">NA</td>
<td align="left">ribosomal protein L8</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">LOC100502936</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">Oosp1</td>
<td align="left">170834</td>
<td align="left">NA</td>
<td align="left">oocyte secreted protein 1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rps3</td>
<td align="left">27050</td>
<td align="left">NA</td>
<td align="left">ribosomal protein S3</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Oas1c</td>
<td align="left">114643</td>
<td align="left">NA</td>
<td align="left">2’-5’ oligoadenylate synthetase 1C</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Bfsp1</td>
<td align="left">12075</td>
<td align="left">NA</td>
<td align="left">beaded filament structural protein 1, in lens-CP94</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Lrpap1</td>
<td align="left">16976</td>
<td align="left">NA</td>
<td align="left">low density lipoprotein receptor-related protein associated protein 1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Eif4e1b</td>
<td align="left">218268</td>
<td align="left">NA</td>
<td align="left">eukaryotic translation initiation factor 4E family member 1B</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rif1</td>
<td align="left">51869</td>
<td align="left">NA</td>
<td align="left">replication timing regulatory factor 1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Oog3</td>
<td align="left">100012</td>
<td align="left">NA</td>
<td align="left">oogenesin 3</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Siah2</td>
<td align="left">20439</td>
<td align="left">NA</td>
<td align="left">seven in absentia 2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tiparp</td>
<td align="left">99929</td>
<td align="left">NA</td>
<td align="left">TCDD-inducible poly(ADP-ribose) polymerase</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Elavl2</td>
<td align="left">15569</td>
<td align="left">NA</td>
<td align="left">ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B)</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Krt8</td>
<td align="left">16691</td>
<td align="left">NA</td>
<td align="left">keratin 8</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tdgf1</td>
<td align="left">21667</td>
<td align="left">NA</td>
<td align="left">teratocarcinoma-derived growth factor 1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Dab2</td>
<td align="left">13132</td>
<td align="left">NA</td>
<td align="left">disabled 2, mitogen-responsive phosphoprotein</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Lcp1</td>
<td align="left">18826</td>
<td align="left">NA</td>
<td align="left">lymphocyte cytosolic protein 1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Nexn</td>
<td align="left">68810</td>
<td align="left">NA</td>
<td align="left">nexilin</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gli3</td>
<td align="left">14634</td>
<td align="left">NA</td>
<td align="left">GLI-Kruppel family member GLI3</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tomm22</td>
<td align="left">223696</td>
<td align="left">NA</td>
<td align="left">translocase of outer mitochondrial membrane 22 homolog (yeast)</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rpl13a</td>
<td align="left">22121</td>
<td align="left">NA</td>
<td align="left">ribosomal protein L13A</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tspan8</td>
<td align="left">216350</td>
<td align="left">NA</td>
<td align="left">tetraspanin 8</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Parp12</td>
<td align="left">243771</td>
<td align="left">NA</td>
<td align="left">poly (ADP-ribose) polymerase family, member 12</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gm7056</td>
<td align="left">631105</td>
<td align="left">NA</td>
<td align="left">predicted gene 7056</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pramel7</td>
<td align="left">347712</td>
<td align="left">NA</td>
<td align="left">preferentially expressed antigen in melanoma like 7</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cd63</td>
<td align="left">12512</td>
<td align="left">NA</td>
<td align="left">CD63 antigen</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Psat1</td>
<td align="left">107272</td>
<td align="left">NA</td>
<td align="left">phosphoserine aminotransferase 1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Etfb</td>
<td align="left">110826</td>
<td align="left">NA</td>
<td align="left">electron transferring flavoprotein, beta polypeptide</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Accsl</td>
<td align="left">381411</td>
<td align="left">NA</td>
<td align="left">1-aminocyclopropane-1-carboxylate synthase (non-functional)-like</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Wdr74</td>
<td align="left">107071</td>
<td align="left">NA</td>
<td align="left">WD repeat domain 74</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Brdt</td>
<td align="left">114642</td>
<td align="left">The protein encoded by this gene belongs to the BET protein family. BET proteins have two N-terminal bromodomains and one C-terminal extraterminal domain (ET domain). BET proteins regulate chromatin reorganization via binding to acetylated histones. This gene is thought to play a role in the transcriptional regulation of spermatogenesis. Although referred to as testis-specific bromodomain (Brdt) protein, RT-PCR indicates that this gene is expressed in both mouse oocytes and testes. Alternative splicing results in multiple transcript variants encoding different proteins.</td>
<td align="left">bromodomain, testis-specific</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Iqgap1</td>
<td align="left">29875</td>
<td align="left">NA</td>
<td align="left">IQ motif containing GTPase activating protein 1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fbxw15</td>
<td align="left">382105</td>
<td align="left">NA</td>
<td align="left">F-box and WD-40 domain protein 15</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Eif3b</td>
<td align="left">27979</td>
<td align="left">NA</td>
<td align="left">eukaryotic translation initiation factor 3, subunit B</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Btg1</td>
<td align="left">12226</td>
<td align="left">NA</td>
<td align="left">B cell translocation gene 1, anti-proliferative</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Brca2</td>
<td align="left">12190</td>
<td align="left">NA</td>
<td align="left">breast cancer 2, early onset</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Jhdm1d</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">Rlim</td>
<td align="left">19820</td>
<td align="left">NA</td>
<td align="left">ring finger protein, LIM domain interacting</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Slc6a14</td>
<td align="left">56774</td>
<td align="left">NA</td>
<td align="left">solute carrier family 6 (neurotransmitter transporter), member 14</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gldc</td>
<td align="left">104174</td>
<td align="left">NA</td>
<td align="left">glycine decarboxylase</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm4340</td>
<td align="left">100043292</td>
<td align="left">NA</td>
<td align="left">predicted gene 4340</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">F11r</td>
<td align="left">16456</td>
<td align="left">NA</td>
<td align="left">F11 receptor</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Smg7</td>
<td align="left">226517</td>
<td align="left">NA</td>
<td align="left">Smg-7 homolog, nonsense mediated mRNA decay factor (C. elegans)</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tceb3</td>
<td align="left">27224</td>
<td align="left">NA</td>
<td align="left">transcription elongation factor B (SIII), polypeptide 3</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rplp1</td>
<td align="left">56040</td>
<td align="left">NA</td>
<td align="left">ribosomal protein, large, P1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ap2a2</td>
<td align="left">11772</td>
<td align="left">NA</td>
<td align="left">adaptor-related protein complex 2, alpha 2 subunit</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Nobox</td>
<td align="left">18291</td>
<td align="left">NA</td>
<td align="left">NOBOX oogenesis homeobox</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Atrx</td>
<td align="left">22589</td>
<td align="left">NA</td>
<td align="left">alpha thalassemia/mental retardation syndrome X-linked</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cyp2s1</td>
<td align="left">74134</td>
<td align="left">NA</td>
<td align="left">cytochrome P450, family 2, subfamily s, polypeptide 1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pramel6</td>
<td align="left">347711</td>
<td align="left">NA</td>
<td align="left">preferentially expressed antigen in melanoma like 6</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gdap1</td>
<td align="left">14545</td>
<td align="left">NA</td>
<td align="left">ganglioside-induced differentiation-associated-protein 1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Wapal</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">Rtn4</td>
<td align="left">68585</td>
<td align="left">NA</td>
<td align="left">reticulon 4</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Upp1</td>
<td align="left">22271</td>
<td align="left">NA</td>
<td align="left">uridine phosphorylase 1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Zfp57</td>
<td align="left">22715</td>
<td align="left">NA</td>
<td align="left">zinc finger protein 57</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Eprs</td>
<td align="left">107508</td>
<td align="left">NA</td>
<td align="left">glutamyl-prolyl-tRNA synthetase</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Capza2</td>
<td align="left">12343</td>
<td align="left">NA</td>
<td align="left">capping protein (actin filament) muscle Z-line, alpha 2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pabpn1</td>
<td align="left">54196</td>
<td align="left">NA</td>
<td align="left">poly(A) binding protein, nuclear 1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tmprss2</td>
<td align="left">50528</td>
<td align="left">NA</td>
<td align="left">transmembrane protease, serine 2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tcfcp2l1</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">Helq</td>
<td align="left">191578</td>
<td align="left">NA</td>
<td align="left">helicase, POLQ-like</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ckb</td>
<td align="left">12709</td>
<td align="left">NA</td>
<td align="left">creatine kinase, brain</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Lgals1</td>
<td align="left">16852</td>
<td align="left">NA</td>
<td align="left">lectin, galactose binding, soluble 1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Znfx1</td>
<td align="left">98999</td>
<td align="left">NA</td>
<td align="left">zinc finger, NFX1-type containing 1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ddx21</td>
<td align="left">56200</td>
<td align="left">NA</td>
<td align="left">DEAD (Asp-Glu-Ala-Asp) box polypeptide 21</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rpl4</td>
<td align="left">67891</td>
<td align="left">NA</td>
<td align="left">ribosomal protein L4</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Arfgef1</td>
<td align="left">211673</td>
<td align="left">NA</td>
<td align="left">ADP-ribosylation factor guanine nucleotide-exchange factor 1(brefeldin A-inhibited)</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Yif1a</td>
<td align="left">68090</td>
<td align="left">NA</td>
<td align="left">Yip1 interacting factor homolog A (S. cerevisiae)</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Bcat1</td>
<td align="left">12035</td>
<td align="left">NA</td>
<td align="left">branched chain aminotransferase 1, cytosolic</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cul4b</td>
<td align="left">72584</td>
<td align="left">NA</td>
<td align="left">cullin 4B</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Nme2</td>
<td align="left">18103</td>
<td align="left">NA</td>
<td align="left">NME/NM23 nucleoside diphosphate kinase 2</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_load_sqrt/gene_names_clus_&quot;,2,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-3-annotations" class="section level3">
<h3>Factor 3 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[3,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">X_id</th>
<th align="left">name</th>
<th align="left">query</th>
<th align="left">summary</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">56455</td>
<td align="left">dynein light chain LC8-type 1</td>
<td align="left">Dynll1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">30939</td>
<td align="left">pituitary tumor-transforming gene 1</td>
<td align="left">Pttg1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">108989</td>
<td align="left">translocated promoter region, nuclear basket protein</td>
<td align="left">Tpr</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">67923</td>
<td align="left">transcription elongation factor B (SIII), polypeptide 1</td>
<td align="left">Tceb1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">75753</td>
<td align="left">Kruppel-like factor 17</td>
<td align="left">Klf17</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">51788</td>
<td align="left">H2A histone family, member Z</td>
<td align="left">H2afz</td>
<td align="left">Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Nucleosomes consist of approximately 146 bp of DNA wrapped around a histone octamer composed of pairs of each of the four core histones (H2A, H2B, H3, and H4). The chromatin fiber is further compacted through the interaction of a linker histone, H1, with the DNA between the nucleosomes to form higher order chromatin structures. This gene encodes a replication-independent member of the histone H2A family that is distinct from other members of the family. Studies in mice have shown that this particular histone is required for embryonic development and indicate that lack of functional histone H2A leads to embryonic lethality. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20103</td>
<td align="left">ribosomal protein S5</td>
<td align="left">Rps5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">51869</td>
<td align="left">replication timing regulatory factor 1</td>
<td align="left">Rif1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">81898</td>
<td align="left">splicing factor 3b, subunit 1</td>
<td align="left">Sf3b1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">11947</td>
<td align="left">ATP synthase, H+ transporting mitochondrial F1 complex, beta subunit</td>
<td align="left">Atp5b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">27225</td>
<td align="left">DEAD (Asp-Glu-Ala-Asp) box polypeptide 24</td>
<td align="left">Ddx24</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">14609</td>
<td align="left">gap junction protein, alpha 1</td>
<td align="left">Gja1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">99377</td>
<td align="left">sal-like 4 (Drosophila)</td>
<td align="left">Sall4</td>
<td align="left">This gene belongs to the spalt family of zinc finger transcription factors. In mouse, functions for this gene have been described in many embryonic developmental processes, including brain, heart, and limb development. In addition, this gene is an important pluripotency factor that is required for stem cell maintenance. Homozygous mutant mice display embryonic lethality, while conditional knock-out in embryonic germ cells results in failure to establish a robust stem cell population. A pseudogene of this gene is found on chromosome 2. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">276770</td>
<td align="left">eukaryotic translation initiation factor 5A</td>
<td align="left">Eif5a</td>
<td align="left">This gene encodes an elongation initiation factor, which participates in protein synthesis. The encoded protein also plays roles in mRNA metabolism, cell proliferation, and cell cycle control. This protein contains a modified lysine residue called hypusine, which appears to be necessary for its function. Alternatively spliced transcript variants have been described. Related pseudogenes exist on chromosomes 2, 5, and 19.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">67955</td>
<td align="left">SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae)</td>
<td align="left">Sugt1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">207214</td>
<td align="left">La ribonucleoprotein domain family, member 4</td>
<td align="left">Larp4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20044</td>
<td align="left">ribosomal protein S14</td>
<td align="left">Rps14</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">67039</td>
<td align="left">RNA binding motif protein 25</td>
<td align="left">Rbm25</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">22608</td>
<td align="left">Y box protein 1</td>
<td align="left">Ybx1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">106298</td>
<td align="left">RRN3 RNA polymerase I transcription factor homolog (yeast)</td>
<td align="left">Rrn3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">53317</td>
<td align="left">pleiotropic regulator 1</td>
<td align="left">Plrg1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">56194</td>
<td align="left">pre-mRNA processing factor 40A</td>
<td align="left">Prpf40a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">216134</td>
<td align="left">pyridoxal (pyridoxine, vitamin B6) kinase</td>
<td align="left">Pdxk</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">18789</td>
<td align="left">poly (A) polymerase alpha</td>
<td align="left">Papola</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">234023</td>
<td align="left">arginine and glutamate rich 1</td>
<td align="left">Arglu1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">434423</td>
<td align="left">developmental pluripotency associated 5A</td>
<td align="left">Dppa5a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">60532</td>
<td align="left">Wilms tumour 1-associating protein</td>
<td align="left">Wtap</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">51810</td>
<td align="left">heterogeneous nuclear ribonucleoprotein U</td>
<td align="left">Hnrnpu</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">67628</td>
<td align="left">acidic (leucine-rich) nuclear phosphoprotein 32 family, member B</td>
<td align="left">Anp32b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">22680</td>
<td align="left">zinc finger protein 207</td>
<td align="left">Zfp207</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">50764</td>
<td align="left">F-box protein 15</td>
<td align="left">Fbxo15</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">73708</td>
<td align="left">developmental pluripotency-associated 3</td>
<td align="left">Dppa3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">72567</td>
<td align="left">BCL2-associated transcription factor 1</td>
<td align="left">Bclaf1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">50927</td>
<td align="left">nuclear autoantigenic sperm protein (histone-binding)</td>
<td align="left">Nasp</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">547109</td>
<td align="left">tripartite motif-containing 43A</td>
<td align="left">Trim43a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">230596</td>
<td align="left">PRP38 pre-mRNA processing factor 38 (yeast) domain containing A</td>
<td align="left">Prpf38a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Gnb2l1</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">70790</td>
<td align="left">ubiquitin protein ligase E3 component n-recognin 5</td>
<td align="left">Ubr5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">171284</td>
<td align="left">T cell immunoglobulin and mucin domain containing 2</td>
<td align="left">Timd2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">665775</td>
<td align="left">biorientation of chromosomes in cell division 1-like</td>
<td align="left">Bod1l</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">24074</td>
<td align="left">TATA-box binding protein associated factor 7</td>
<td align="left">Taf7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">23994</td>
<td align="left">DAZ associated protein 2</td>
<td align="left">Dazap2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">67763</td>
<td align="left">phosphoribosyl pyrophosphate synthetase-associated protein 1</td>
<td align="left">Prpsap1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">14056</td>
<td align="left">enhancer of zeste 2 polycomb repressive complex 2 subunit</td>
<td align="left">Ezh2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">108143</td>
<td align="left">TATA-box binding protein associated factor 9</td>
<td align="left">Taf9</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">19951</td>
<td align="left">ribosomal protein L32</td>
<td align="left">Rpl32</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">73826</td>
<td align="left">polymerase (DNA-directed), delta interacting protein 3</td>
<td align="left">Poldip3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">22627</td>
<td align="left">tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide</td>
<td align="left">Ywhae</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">15519</td>
<td align="left">heat shock protein 90, alpha (cytosolic), class A member 1</td>
<td align="left">Hsp90aa1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">232341</td>
<td align="left">WNK lysine deficient protein kinase 1</td>
<td align="left">Wnk1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">11946</td>
<td align="left">ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1</td>
<td align="left">Atp5a1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">73274</td>
<td align="left">GC-rich promoter binding protein 1</td>
<td align="left">Gpbp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">67781</td>
<td align="left">interleukin enhancer binding factor 2</td>
<td align="left">Ilf2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">66921</td>
<td align="left">PRP38 pre-mRNA processing factor 38 (yeast) domain containing B</td>
<td align="left">Prpf38b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">75717</td>
<td align="left">cullin 5</td>
<td align="left">Cul5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">102339</td>
<td align="left">component of oligomeric golgi complex 4</td>
<td align="left">Cog4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">208606</td>
<td align="left">arginine/serine-rich coiled-coil 2</td>
<td align="left">Rsrc2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12035</td>
<td align="left">branched chain aminotransferase 1, cytosolic</td>
<td align="left">Bcat1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">212880</td>
<td align="left">DEAD (Asp-Glu-Ala-Asp) box polypeptide 46</td>
<td align="left">Ddx46</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">15516</td>
<td align="left">heat shock protein 90 alpha (cytosolic), class B member 1</td>
<td align="left">Hsp90ab1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">231413</td>
<td align="left">G-rich RNA sequence binding factor 1</td>
<td align="left">Grsf1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">51886</td>
<td align="left">far upstream element (FUSE) binding protein 1</td>
<td align="left">Fubp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">76846</td>
<td align="left">ribosomal protein S9</td>
<td align="left">Rps9</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">26554</td>
<td align="left">cullin 3</td>
<td align="left">Cul3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">321022</td>
<td align="left">carnitine deficiency-associated gene expressed in ventricle 3</td>
<td align="left">Cdv3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">27223</td>
<td align="left">transformation related protein 53 binding protein 1</td>
<td align="left">Trp53bp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">17149</td>
<td align="left">mago homolog, exon junction complex core component</td>
<td align="left">Magoh</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">20728</td>
<td align="left">Spi-C transcription factor (Spi-1/PU.1 related)</td>
<td align="left">Spic</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">13589</td>
<td align="left">microtubule-associated protein, RP/EB family, member 1</td>
<td align="left">Mapre1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">22187</td>
<td align="left">ubiquitin B</td>
<td align="left">Ubb</td>
<td align="left">This gene encodes ubiquitin, one of the most conserved proteins known. Ubiquitin has a major role in targeting cellular proteins for degradation by the 26S proteosome. It is also involved in the maintenance of chromatin structure, the regulation of gene expression, and the stress response. Ubiquitin is synthesized as a precursor protein consisting of either polyubiquitin chains or a single ubiquitin moiety fused to an unrelated protein. This gene consists of four direct repeats of the ubiquitin coding sequence with no spacer sequence. Consequently, the protein is expressed as a polyubiquitin precursor with a final amino acid after the last repeat. Pseudogenes of this gene are located on chromosomes 3 and 14. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">70769</td>
<td align="left">nucleolar and coiled-body phosphoprotein 1</td>
<td align="left">Nolc1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">11837</td>
<td align="left">ribosomal protein, large, P0</td>
<td align="left">Rplp0</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20658</td>
<td align="left">Son DNA binding protein</td>
<td align="left">Son</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">69237</td>
<td align="left">GTP binding protein 4</td>
<td align="left">Gtpbp4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">66126</td>
<td align="left">ELF1 homolog, elongation factor 1</td>
<td align="left">Elof1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">72193</td>
<td align="left">SR-related CTD-associated factor 11</td>
<td align="left">Scaf11</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">240641</td>
<td align="left">kinesin family member 20B</td>
<td align="left">Kif20b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">225363</td>
<td align="left">eukaryotic translation termination factor 1</td>
<td align="left">Etf1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">12660</td>
<td align="left">choline kinase alpha</td>
<td align="left">Chka</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">226982</td>
<td align="left">eukaryotic translation initiation factor 5B</td>
<td align="left">Eif5b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">226591</td>
<td align="left">TIP41, TOR signalling pathway regulator-like (S. cerevisiae)</td>
<td align="left">Tiprl</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">52276</td>
<td align="left">cell division cycle associated 8</td>
<td align="left">Cdca8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">268697</td>
<td align="left">cyclin B1</td>
<td align="left">Ccnb1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">66276</td>
<td align="left">RIKEN cDNA 1810009A15 gene</td>
<td align="left">1810009A15Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">207165</td>
<td align="left">bromodomain PHD finger transcription factor</td>
<td align="left">Bptf</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12211</td>
<td align="left">baculoviral IAP repeat-containing 6</td>
<td align="left">Birc6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">230376</td>
<td align="left">HAUS augmin-like complex, subunit 6</td>
<td align="left">Haus6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">170791</td>
<td align="left">RNA binding motif protein 39</td>
<td align="left">Rbm39</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">54636</td>
<td align="left">WD repeat domain 45</td>
<td align="left">Wdr45</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">70472</td>
<td align="left">ATPase family, AAA domain containing 2</td>
<td align="left">Atad2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">69241</td>
<td align="left">polymerase (RNA) II (DNA directed) polypeptide D</td>
<td align="left">Polr2d</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">97402</td>
<td align="left">expressed sequence C86187</td>
<td align="left">C86187</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">102103</td>
<td align="left">mitochondrial tumor suppressor 1</td>
<td align="left">Mtus1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">22209</td>
<td align="left">ubiquitin-conjugating enzyme E2A</td>
<td align="left">Ube2a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Tubb2c</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">ENSMUSG00000092341</td>
<td align="left">metastasis associated lung adenocarcinoma transcript 1 (non-coding RNA)</td>
<td align="left">Malat1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">72289</td>
<td align="left">metastasis associated lung adenocarcinoma transcript 1 (non-coding RNA)</td>
<td align="left">Malat1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">19045</td>
<td align="left">protein phosphatase 1, catalytic subunit, alpha isoform</td>
<td align="left">Ppp1ca</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">213109</td>
<td align="left">PHD finger protein 3</td>
<td align="left">Phf3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">93762</td>
<td align="left">SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5</td>
<td align="left">Smarca5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">67973</td>
<td align="left">M-phase phosphoprotein 10 (U3 small nucleolar ribonucleoprotein)</td>
<td align="left">Mphosph10</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_load_sqrt/gene_names_clus_&quot;,3,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-4-annotations" class="section level3">
<h3>Factor 4 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[4,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">X_id</th>
<th align="left">query</th>
<th align="left">name</th>
<th align="left">summary</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">171284</td>
<td align="left">Timd2</td>
<td align="left">T cell immunoglobulin and mucin domain containing 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">11461</td>
<td align="left">Actb</td>
<td align="left">actin, beta</td>
<td align="left">This gene encodes a member of the actin family of proteins. Actins are highly conserved proteins that are among the most abundant proteins in eukaryotic cells and are involved in cell motility, structure, and integrity. Localization, stability, and translation of the transcribed mRNA are regulated through the binding of multiple factors to its 3’ UTR sequence. Homozygous knockout mice for this gene exhibit embryonic lethality. Numerous pseudogenes of this gene have been identified in the mouse genome.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">11650</td>
<td align="left">Alppl2</td>
<td align="left">alkaline phosphatase, placental-like 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">18618</td>
<td align="left">Pemt</td>
<td align="left">phosphatidylethanolamine N-methyltransferase</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">15519</td>
<td align="left">Hsp90aa1</td>
<td align="left">heat shock protein 90, alpha (cytosolic), class A member 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">18477</td>
<td align="left">Prdx1</td>
<td align="left">peroxiredoxin 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">102436</td>
<td align="left">Lars2</td>
<td align="left">leucyl-tRNA synthetase, mitochondrial</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">22042</td>
<td align="left">Tfrc</td>
<td align="left">transferrin receptor</td>
<td align="left">This gene encodes a cell surface receptor necessary for cellular iron uptake by the process of receptor-mediated endocytosis. This receptor is required for erythropoiesis and neurologic development. Mice that are deficient in this receptor show impaired erythroid development and abnormal iron homeostasis.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">100038982</td>
<td align="left">Gm1995</td>
<td align="left">REX1, RNA exonuclease 1 homolog pseudogene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">21888</td>
<td align="left">Tle4</td>
<td align="left">transducin-like enhancer of split 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">67923</td>
<td align="left">Tceb1</td>
<td align="left">transcription elongation factor B (SIII), polypeptide 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">14312</td>
<td align="left">Brd2</td>
<td align="left">bromodomain containing 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">52187</td>
<td align="left">Rragd</td>
<td align="left">Ras-related GTP binding D</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">20750</td>
<td align="left">Spp1</td>
<td align="left">secreted phosphoprotein 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">18263</td>
<td align="left">Odc1</td>
<td align="left">ornithine decarboxylase, structural 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12705</td>
<td align="left">Cited1</td>
<td align="left">Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">67443</td>
<td align="left">Map1lc3b</td>
<td align="left">microtubule-associated protein 1 light chain 3 beta</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">70769</td>
<td align="left">Nolc1</td>
<td align="left">nucleolar and coiled-body phosphoprotein 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">333433</td>
<td align="left">Gpd1l</td>
<td align="left">glycerol-3-phosphate dehydrogenase 1-like</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">207214</td>
<td align="left">Larp4</td>
<td align="left">La ribonucleoprotein domain family, member 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">109032</td>
<td align="left">Sp110</td>
<td align="left">Sp110 nuclear body protein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">117198</td>
<td align="left">Ivns1abp</td>
<td align="left">influenza virus NS1A binding protein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ENSMUSG00000094635</td>
<td align="left">Gm7104</td>
<td align="left">predicted gene 7104</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">633093</td>
<td align="left">Gm7104</td>
<td align="left">REX1, RNA exonuclease 1 homolog pseudogene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20512</td>
<td align="left">Slc1a3</td>
<td align="left">solute carrier family 1 (glial high affinity glutamate transporter), member 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12660</td>
<td align="left">Chka</td>
<td align="left">choline kinase alpha</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">230796</td>
<td align="left">Wdtc1</td>
<td align="left">WD and tetratricopeptide repeats 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">22187</td>
<td align="left">Ubb</td>
<td align="left">ubiquitin B</td>
<td align="left">This gene encodes ubiquitin, one of the most conserved proteins known. Ubiquitin has a major role in targeting cellular proteins for degradation by the 26S proteosome. It is also involved in the maintenance of chromatin structure, the regulation of gene expression, and the stress response. Ubiquitin is synthesized as a precursor protein consisting of either polyubiquitin chains or a single ubiquitin moiety fused to an unrelated protein. This gene consists of four direct repeats of the ubiquitin coding sequence with no spacer sequence. Consequently, the protein is expressed as a polyubiquitin precursor with a final amino acid after the last repeat. Pseudogenes of this gene are located on chromosomes 3 and 14. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">60595</td>
<td align="left">Actn4</td>
<td align="left">actinin alpha 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12465</td>
<td align="left">Cct5</td>
<td align="left">chaperonin containing Tcp1, subunit 5 (epsilon)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">17913</td>
<td align="left">Myo1c</td>
<td align="left">myosin IC</td>
<td align="left">This gene encodes a member of the unconventional myosin protein family, which are actin-based molecular motors. The protein is found in the cytoplasm, and one isoform with a unique N-terminus is also found in the nucleus. The protein functions in intracellular vesicle transport to the plasma membrane. The nuclear isoform associates with RNA polymerase I and II and functions in transcription initiation. Multiple transcript variants encoding different isoforms have been found for this gene.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">74781</td>
<td align="left">Wipi2</td>
<td align="left">WD repeat domain, phosphoinositide interacting 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">71819</td>
<td align="left">Kif23</td>
<td align="left">kinesin family member 23</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">14465</td>
<td align="left">Gata6</td>
<td align="left">GATA binding protein 6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">14725</td>
<td align="left">Lrp2</td>
<td align="left">low density lipoprotein receptor-related protein 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12224</td>
<td align="left">Klf5</td>
<td align="left">Kruppel-like factor 5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">18817</td>
<td align="left">Plk1</td>
<td align="left">polo-like kinase 1</td>
<td align="left">The Ser/Thr protein kinase encoded by this gene belongs to the CDC5/Polo subfamily. It is highly expressed during mitosis and may play a role in DNA replication during S phase. This gene is expressed in all embryonic tissues, but restricted to thymus and ovaries in adult tissues. Homozygous knockout mice were embryonic lethal, suggesting that this gene is important for early embryonic development. This gene is thought to be a potential oncogene because it is overexpressed in a variety of tumors and tumor cell lines. Depletion of this protein in cancer cells has been shown to inhibit cell proliferation and suppress oncogenic transformation; hence, it is a target for cancer therapy.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">104479</td>
<td align="left">Ccdc117</td>
<td align="left">coiled-coil domain containing 117</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">234724</td>
<td align="left">Tat</td>
<td align="left">tyrosine aminotransferase</td>
<td align="left">This gene encodes a liver-specific mitochondrial enzyme that catalyzes the conversion of L-tyrosine into p-hydroxyphenylpyruvate. Regulated by glucocorticoid and polypeptide hormones, this gene’s expression is affected by deletion of a regulatory region near the albino locus on chromosome 7. Mutations in this gene cause tyrosinemia type II in humans.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">233724</td>
<td align="left">Tmem41b</td>
<td align="left">transmembrane protein 41B</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">276770</td>
<td align="left">Eif5a</td>
<td align="left">eukaryotic translation initiation factor 5A</td>
<td align="left">This gene encodes an elongation initiation factor, which participates in protein synthesis. The encoded protein also plays roles in mRNA metabolism, cell proliferation, and cell cycle control. This protein contains a modified lysine residue called hypusine, which appears to be necessary for its function. Alternatively spliced transcript variants have been described. Related pseudogenes exist on chromosomes 2, 5, and 19.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">11772</td>
<td align="left">Ap2a2</td>
<td align="left">adaptor-related protein complex 2, alpha 2 subunit</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">16691</td>
<td align="left">Krt8</td>
<td align="left">keratin 8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">107995</td>
<td align="left">Cdc20</td>
<td align="left">cell division cycle 20</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20531</td>
<td align="left">Slc34a2</td>
<td align="left">solute carrier family 34 (sodium phosphate), member 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">14824</td>
<td align="left">Grn</td>
<td align="left">granulin</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">19024</td>
<td align="left">Ppfibp2</td>
<td align="left">PTPRF interacting protein, binding protein 2 (liprin beta 2)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">347712</td>
<td align="left">Pramel7</td>
<td align="left">preferentially expressed antigen in melanoma like 7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">22271</td>
<td align="left">Upp1</td>
<td align="left">uridine phosphorylase 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">78891</td>
<td align="left">Scyl1</td>
<td align="left">SCY1-like 1 (S. cerevisiae)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20068</td>
<td align="left">Rps17</td>
<td align="left">ribosomal protein S17</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Mtap4</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">13030</td>
<td align="left">Ctsb</td>
<td align="left">cathepsin B</td>
<td align="left">This gene encodes a member of the peptidase C1 family and preproprotein that is proteolytically processed to generate multiple protein products. These products include the cathepsin B light and heavy chains, which can dimerize to generate the double chain form of the enzyme. This enzyme is a lysosomal cysteine protease with both endopeptidase and exopeptidase activity that may play a role in protein turnover. Homozygous knockout mice for this gene exhibit reduced pancreatic damage following induced pancreatitis and reduced hepatocyte apoptosis in a model of liver injury. Pseudogenes of this gene have been identified in the genome.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">76815</td>
<td align="left">Calcoco2</td>
<td align="left">calcium binding and coiled-coil domain 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">12385</td>
<td align="left">Ctnna1</td>
<td align="left">catenin (cadherin associated protein), alpha 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">27979</td>
<td align="left">Eif3b</td>
<td align="left">eukaryotic translation initiation factor 3, subunit B</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">230709</td>
<td align="left">Zmpste24</td>
<td align="left">zinc metallopeptidase, STE24</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">15452</td>
<td align="left">Hprt</td>
<td align="left">hypoxanthine guanine phosphoribosyl transferase</td>
<td align="left">The protein encoded by this gene is a transferase, which catalyzes conversion of hypoxanthine to inosine monophosphate and guanine to guanosine monophosphate via transfer of the 5-phosphoribosyl group from 5-phosphoribosyl 1-pyrophosphate. This enzyme plays a central role in the generation of purine nucleotides through the purine salvage pathway.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">13132</td>
<td align="left">Dab2</td>
<td align="left">disabled 2, mitogen-responsive phosphoprotein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">74204</td>
<td align="left">Xpo6</td>
<td align="left">exportin 6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">14670</td>
<td align="left">Gnl1</td>
<td align="left">guanine nucleotide binding protein-like 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">76846</td>
<td align="left">Rps9</td>
<td align="left">ribosomal protein S9</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">14228</td>
<td align="left">Fkbp4</td>
<td align="left">FK506 binding protein 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12785</td>
<td align="left">Cnbp</td>
<td align="left">cellular nucleic acid binding protein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">224912</td>
<td align="left">Crb3</td>
<td align="left">crumbs family member 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">19156</td>
<td align="left">Psap</td>
<td align="left">prosaposin</td>
<td align="left">This gene encodes a multifunctional glycoprotein that plays a role in the intracellular metabolism of various sphingolipids or secreted into the plasma, milk or cerebrospinal fluid. The encoded protein undergoes proteolytic processing to generate four different polypeptides known as saposin A, B, C or D, that are required for the hydrolysis of certain sphingolipids by lysosomal hydrolases. Alternately, the encoded protein is secreted into body fluids where it exhibits neurotrophic and myelinotrophic activities. A complete lack of the encoded protein is fatal to mice either at the neonatal stage or within the first month due to severe leukodystrophy and sphingolipid accumulation. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar processing to generate the mature saposins.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">320938</td>
<td align="left">Tnpo3</td>
<td align="left">transportin 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ENSMUSG00000081249</td>
<td align="left">Gm11517</td>
<td align="left">predicted gene 11517</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">629750</td>
<td align="left">Gm11517</td>
<td align="left">ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">110954</td>
<td align="left">Rpl10</td>
<td align="left">ribosomal protein L10</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20586</td>
<td align="left">Smarca4</td>
<td align="left">SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">13660</td>
<td align="left">Ehd1</td>
<td align="left">EH-domain containing 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20833</td>
<td align="left">Ssrp1</td>
<td align="left">structure specific recognition protein 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">26965</td>
<td align="left">Cul1</td>
<td align="left">cullin 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">74134</td>
<td align="left">Cyp2s1</td>
<td align="left">cytochrome P450, family 2, subfamily s, polypeptide 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">18140</td>
<td align="left">Uhrf1</td>
<td align="left">ubiquitin-like, containing PHD and RING finger domains, 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">67338</td>
<td align="left">Rffl</td>
<td align="left">ring finger and FYVE like domain containing protein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">23989</td>
<td align="left">Med24</td>
<td align="left">mediator complex subunit 24</td>
<td align="left">This gene encodes a component of the mediator complex (also known as TRAP, SMCC, DRIP, or ARC), a transcriptional coactivator complex thought to be required for the expression of almost all genes. The mediator complex is recruited by transcriptional activators or nuclear receptors to induce gene expression, possibly by interacting with RNA polymerase II and promoting the formation of a transcriptional pre-initiation complex. The product of this gene may form a submodule of the mediator complex that magnifies the effects of activators on the general transcription machinery. Alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">19663</td>
<td align="left">Rbpms</td>
<td align="left">RNA binding protein gene with multiple splicing</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">666060</td>
<td align="left">Frmpd1</td>
<td align="left">FERM and PDZ domain containing 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">14566</td>
<td align="left">Gdf9</td>
<td align="left">growth differentiation factor 9</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">23879</td>
<td align="left">Fxr2</td>
<td align="left">fragile X mental retardation, autosomal homolog 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">54397</td>
<td align="left">Ppt2</td>
<td align="left">palmitoyl-protein thioesterase 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">14726</td>
<td align="left">Pdpn</td>
<td align="left">podoplanin</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">223775</td>
<td align="left">Pim3</td>
<td align="left">proviral integration site 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">71780</td>
<td align="left">Isyna1</td>
<td align="left">myo-inositol 1-phosphate synthase A1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">17748</td>
<td align="left">Mt1</td>
<td align="left">metallothionein 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">13669</td>
<td align="left">Eif3a</td>
<td align="left">eukaryotic translation initiation factor 3, subunit A</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">72560</td>
<td align="left">Naalad2</td>
<td align="left">N-acetylated alpha-linked acidic dipeptidase 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">214048</td>
<td align="left">Larp1b</td>
<td align="left">La ribonucleoprotein domain family, member 1B</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">13033</td>
<td align="left">Ctsd</td>
<td align="left">cathepsin D</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">18102</td>
<td align="left">Nme1</td>
<td align="left">NME/NM23 nucleoside diphosphate kinase 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">15903</td>
<td align="left">Id3</td>
<td align="left">inhibitor of DNA binding 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">55949</td>
<td align="left">Eef1b2</td>
<td align="left">eukaryotic translation elongation factor 1 beta 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">51869</td>
<td align="left">Rif1</td>
<td align="left">replication timing regulatory factor 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">228983</td>
<td align="left">Osbpl2</td>
<td align="left">oxysterol binding protein-like 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">12447</td>
<td align="left">Ccne1</td>
<td align="left">cyclin E1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">237542</td>
<td align="left">Osbpl8</td>
<td align="left">oxysterol binding protein-like 8</td>
<td align="left">This gene encodes a member of the oxysterol-binding protein (Osbp) family, a group of intracellular lipid receptors. Like most members, the encoded protein contains an N-terminal pleckstrin homology domain and a highly conserved C-terminal Osbp-like sterol-binding domain. Two transcript variants encoding different isoforms have been found for this gene.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ENSMUSG00000092341</td>
<td align="left">Malat1</td>
<td align="left">metastasis associated lung adenocarcinoma transcript 1 (non-coding RNA)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">72289</td>
<td align="left">Malat1</td>
<td align="left">metastasis associated lung adenocarcinoma transcript 1 (non-coding RNA)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">71973</td>
<td align="left">Rbpms2</td>
<td align="left">RNA binding protein with multiple splicing 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">97031</td>
<td align="left">Tprn</td>
<td align="left">taperin</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">66925</td>
<td align="left">Sdhd</td>
<td align="left">succinate dehydrogenase complex, subunit D, integral membrane protein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_load_sqrt/gene_names_clus_&quot;,4,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-5-annotations" class="section level3">
<h3>Factor 5 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[5,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">name</th>
<th align="left">X_id</th>
<th align="left">query</th>
<th align="left">summary</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">eukaryotic translation elongation factor 1 alpha 1</td>
<td align="left">13627</td>
<td align="left">Eef1a1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ribosomal protein L4</td>
<td align="left">67891</td>
<td align="left">Rpl4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">chaperonin containing Tcp1, subunit 5 (epsilon)</td>
<td align="left">12465</td>
<td align="left">Cct5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">fructose bisphosphatase 2</td>
<td align="left">14120</td>
<td align="left">Fbp2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 5</td>
<td align="left">11740</td>
<td align="left">Slc25a5</td>
<td align="left">This gene encodes a transmembrane domain-containing protein that localizes to the mitochondrial inner membrane. The encoded protein facilitates the exchange of ADP from the cytoplasm with ATP from the mitochondria. Pseudogenes for this gene are found on multiple chromosomes.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">proteasome (prosome, macropain) subunit, alpha type 7</td>
<td align="left">26444</td>
<td align="left">Psma7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1</td>
<td align="left">11946</td>
<td align="left">Atp5a1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">eukaryotic translation elongation factor 1 gamma</td>
<td align="left">67160</td>
<td align="left">Eef1g</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NME/NM23 nucleoside diphosphate kinase 1</td>
<td align="left">18102</td>
<td align="left">Nme1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Tcfcp2l1</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">creatine kinase, brain</td>
<td align="left">12709</td>
<td align="left">Ckb</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">chaperonin containing Tcp1, subunit 7 (eta)</td>
<td align="left">12468</td>
<td align="left">Cct7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">heat shock protein 90 alpha (cytosolic), class B member 1</td>
<td align="left">15516</td>
<td align="left">Hsp90ab1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">actin, beta</td>
<td align="left">11461</td>
<td align="left">Actb</td>
<td align="left">This gene encodes a member of the actin family of proteins. Actins are highly conserved proteins that are among the most abundant proteins in eukaryotic cells and are involved in cell motility, structure, and integrity. Localization, stability, and translation of the transcribed mRNA are regulated through the binding of multiple factors to its 3’ UTR sequence. Homozygous knockout mice for this gene exhibit embryonic lethality. Numerous pseudogenes of this gene have been identified in the mouse genome.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">proteasome (prosome, macropain) 26S subunit, ATPase 3</td>
<td align="left">19182</td>
<td align="left">Psmc3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">peroxiredoxin 6</td>
<td align="left">11758</td>
<td align="left">Prdx6</td>
<td align="left">This gene encodes a member of the peroxiredoxin family of peroxidases. The encoded protein is a bifunctional enzyme that has glutathione peroxidase and phospholipase activities. This protein is an antioxidant that reduces peroxidized membrane phospholipids and plays an important role in phospholipid homeostasis based on its ability to generate lysophospholipid substrate for the remodeling pathway of phospholipid synthesis. Mice lacking this gene are sensitive to oxidant stress, have altered lung phospholipid metabolism and susceptible to skin tumorigenesis. Alternate splicing of this gene results in multiple transcript variants. A pseudogene of this gene is found on chromosome 4.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">protease (prosome, macropain) 26S subunit, ATPase 5</td>
<td align="left">19184</td>
<td align="left">Psmc5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">creatine kinase, mitochondrial 1, ubiquitous</td>
<td align="left">12716</td>
<td align="left">Ckmt1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">eukaryotic translation elongation factor 2</td>
<td align="left">13629</td>
<td align="left">Eef2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">fatty acid binding protein 3, muscle and heart</td>
<td align="left">14077</td>
<td align="left">Fabp3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">malate dehydrogenase 2, NAD (mitochondrial)</td>
<td align="left">17448</td>
<td align="left">Mdh2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">proteasome (prosome, macropain) subunit, beta type 6</td>
<td align="left">19175</td>
<td align="left">Psmb6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">electron transferring flavoprotein, beta polypeptide</td>
<td align="left">110826</td>
<td align="left">Etfb</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">developmental pluripotency associated 5A</td>
<td align="left">434423</td>
<td align="left">Dppa5a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4</td>
<td align="left">11739</td>
<td align="left">Slc25a4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">calcium binding and coiled-coil domain 2</td>
<td align="left">76815</td>
<td align="left">Calcoco2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit</td>
<td align="left">28080</td>
<td align="left">Atp5o</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein)</td>
<td align="left">66656</td>
<td align="left">Eef1d</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ubiquinol-cytochrome c reductase core protein 1</td>
<td align="left">22273</td>
<td align="left">Uqcrc1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">adenylate kinase 4</td>
<td align="left">11639</td>
<td align="left">Ak4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Gnb2l1</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">proteasome (prosome, macropain) subunit, alpha type 6</td>
<td align="left">26443</td>
<td align="left">Psma6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1</td>
<td align="left">11949</td>
<td align="left">Atp5c1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">succinate-CoA ligase, GDP-forming, alpha subunit</td>
<td align="left">56451</td>
<td align="left">Suclg1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">eukaryotic translation initiation factor 3, subunit D</td>
<td align="left">55944</td>
<td align="left">Eif3d</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B</td>
<td align="left">53817</td>
<td align="left">Ddx39b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">proteasome (prosome, macropain) 26S subunit, ATPase, 6</td>
<td align="left">67089</td>
<td align="left">Psmc6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">proteasome maturation protein</td>
<td align="left">66537</td>
<td align="left">Pomp</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">beta-transducin repeat containing protein</td>
<td align="left">12234</td>
<td align="left">Btrc</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">cytochrome c oxidase subunit IV isoform 1</td>
<td align="left">12857</td>
<td align="left">Cox4i1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NADH dehydrogenase (ubiquinone) Fe-S protein 7</td>
<td align="left">75406</td>
<td align="left">Ndufs7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">chaperonin containing Tcp1, subunit 2 (beta)</td>
<td align="left">12461</td>
<td align="left">Cct2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">proteasome (prosome, macropain) subunit, beta type 2</td>
<td align="left">26445</td>
<td align="left">Psmb2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">mitochondrial ribosomal protein L17</td>
<td align="left">27397</td>
<td align="left">Mrpl17</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">RAB18, member RAS oncogene family</td>
<td align="left">19330</td>
<td align="left">Rab18</td>
<td align="left">This gene encodes a member of the Ras-related small GTPases, which regulate membrane trafficking in organelles and transport vesicles. This protein is expressed predominantly in lipid droplets, organelles that store neutral lipids, and is proposed to play a role in lipolysis and lipogenesis. In humans mutations in this gene are associated with Warburg micro syndrome type 3. A pseudogene of this gene is located on chromosome X. Alternative splicing results in multiple transcript variants encoding different isoforms.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Kruppel-like factor 17</td>
<td align="left">75753</td>
<td align="left">Klf17</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">proteasome (prosome, macropain) 26S subunit, ATPase 2</td>
<td align="left">19181</td>
<td align="left">Psmc2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ribosomal protein L7</td>
<td align="left">19989</td>
<td align="left">Rpl7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">leucine aminopeptidase 3</td>
<td align="left">66988</td>
<td align="left">Lap3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">proteasome (prosome, macropain) 26S subunit, ATPase, 4</td>
<td align="left">23996</td>
<td align="left">Psmc4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Janus kinase 2</td>
<td align="left">16452</td>
<td align="left">Jak2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ubiquinol-cytochrome c reductase, complex III subunit X</td>
<td align="left">66152</td>
<td align="left">Uqcr10</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">eukaryotic translation initiation factor 5A</td>
<td align="left">276770</td>
<td align="left">Eif5a</td>
<td align="left">This gene encodes an elongation initiation factor, which participates in protein synthesis. The encoded protein also plays roles in mRNA metabolism, cell proliferation, and cell cycle control. This protein contains a modified lysine residue called hypusine, which appears to be necessary for its function. Alternatively spliced transcript variants have been described. Related pseudogenes exist on chromosomes 2, 5, and 19.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">nucleolin</td>
<td align="left">17975</td>
<td align="left">Ncl</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">isocitrate dehydrogenase 1 (NADP+), soluble</td>
<td align="left">15926</td>
<td align="left">Idh1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">tripartite motif-containing 61</td>
<td align="left">260296</td>
<td align="left">Trim61</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">RIKEN cDNA 2210409E12 gene</td>
<td align="left">ENSMUSG00000081766</td>
<td align="left">2210409E12Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">transcription elongation factor B (SIII), polypeptide 2 pseudogene</td>
<td align="left">72381</td>
<td align="left">2210409E12Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">chaperonin containing Tcp1, subunit 6a (zeta)</td>
<td align="left">12466</td>
<td align="left">Cct6a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">chaperonin containing Tcp1, subunit 6a (zeta)</td>
<td align="left">ENSMUSG00000029447</td>
<td align="left">Cct6a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">WD repeat domain 61</td>
<td align="left">66317</td>
<td align="left">Wdr61</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ribosomal protein L8</td>
<td align="left">26961</td>
<td align="left">Rpl8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">peroxiredoxin 1</td>
<td align="left">18477</td>
<td align="left">Prdx1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">prothymosin alpha</td>
<td align="left">19231</td>
<td align="left">Ptma</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">proteasome (prosome, macropain) subunit, alpha type 2</td>
<td align="left">19166</td>
<td align="left">Psma2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">poly (ADP-ribose) polymerase family, member 1</td>
<td align="left">11545</td>
<td align="left">Parp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ribosomal protein S3</td>
<td align="left">27050</td>
<td align="left">Rps3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">proteasome (prosome, macropain) subunit, alpha type 1</td>
<td align="left">26440</td>
<td align="left">Psma1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">poly (ADP-ribose) polymerase family, member 12</td>
<td align="left">243771</td>
<td align="left">Parp12</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ribosomal protein S5</td>
<td align="left">20103</td>
<td align="left">Rps5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">sorting nexin 2</td>
<td align="left">67804</td>
<td align="left">Snx2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">gamma-aminobutyric acid (GABA) A receptor-associated protein-like 2</td>
<td align="left">93739</td>
<td align="left">Gabarapl2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">protein phosphatase 2, regulatory subunit A, alpha</td>
<td align="left">51792</td>
<td align="left">Ppp2r1a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">angio-associated migratory protein</td>
<td align="left">227290</td>
<td align="left">Aamp</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">proteasome (prosome, macropain) subunit, beta type 1</td>
<td align="left">19170</td>
<td align="left">Psmb1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ash2 (absent, small, or homeotic)-like (Drosophila)</td>
<td align="left">23808</td>
<td align="left">Ash2l</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">fatty acid binding protein 5, epidermal</td>
<td align="left">16592</td>
<td align="left">Fabp5</td>
<td align="left">The protein encoded by this gene is part of the fatty acid binding protein family (FABP). FABPs are a family of small, highly conserved, cytoplasmic proteins that bind long-chain fatty acids and other hydrophobic ligands and participate in fatty acid uptake, transport, and metabolism. In humans this gene has been associated with psoriasis and type 2 diabetes. In mouse deficiency of this gene in combination with a deficiency in Fabp4 confers protection against atherosclerosis, diet-induced obesity, insulin resistance and experimental autoimmune encephalomyelitis (the mouse model for multiple sclerosis). Alternative splicing results in multiple transcript variants that encode different protein isoforms. The mouse genome contains many pseudogenes similar to this locus.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">glutathione peroxidase 1</td>
<td align="left">14775</td>
<td align="left">Gpx1</td>
<td align="left">This gene product belongs to the family of glutathione peroxidase, which functions in the detoxification of hydrogen peroxide. It contains a selenocysteine (Sec) residue at its active site. The selenocysteine is encoded by the UGA codon, which normally signals translation termination. The 3’ UTR of Sec-containing genes have a common stem-loop structure, the sec insertion sequence (SECIS), which is necessary for the recognition of UGA as a Sec codon rather than as a stop signal.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">COP9 signalosome subunit 5</td>
<td align="left">26754</td>
<td align="left">Cops5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NSFL1 (p97) cofactor (p47)</td>
<td align="left">386649</td>
<td align="left">Nsfl1c</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">spermidine/spermine N1-acetyl transferase 1</td>
<td align="left">20229</td>
<td align="left">Sat1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">mitochondrial ribosomal protein L28</td>
<td align="left">68611</td>
<td align="left">Mrpl28</td>
<td align="left">Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ferritin light polypeptide 1</td>
<td align="left">14325</td>
<td align="left">Ftl1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">expressed sequence AU015228</td>
<td align="left">ENSMUSG00000074804</td>
<td align="left">AU015228</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">expressed sequence AU015228</td>
<td align="left">99169</td>
<td align="left">AU015228</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ganglioside-induced differentiation-associated-protein 1</td>
<td align="left">14545</td>
<td align="left">Gdap1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">eukaryotic translation elongation factor 1 beta 2</td>
<td align="left">55949</td>
<td align="left">Eef1b2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ribosomal protein L14</td>
<td align="left">67115</td>
<td align="left">Rpl14</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">transformation related protein 53</td>
<td align="left">22059</td>
<td align="left">Trp53</td>
<td align="left">This gene encodes tumor protein p53, which responds to diverse cellular stresses to regulate target genes that induce cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. p53 protein is expressed at low level in normal cells and at a high level in a variety of transformed cell lines, where it’s believed to contribute to transformation and malignancy. p53 is a DNA-binding protein containing transcription activation, DNA-binding, and oligomerization domains. It is postulated to bind to a p53-binding site and activate expression of downstream genes that inhibit growth and/or invasion, and thus function as a tumor suppressor. Mice deficient for this gene are developmentally normal but are susceptible to spontaneous tumors. Evidence to date shows that this gene contains one promoter, in contrast to alternative promoters of the human gene, and transcribes a few of splice variants which encode different isoforms, although the biological validity or the full-length nature of some variants has not been determined.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">predicted pseudogene 4850</td>
<td align="left">ENSMUSG00000100205</td>
<td align="left">Gm4850</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">THO complex 4 pseudogene</td>
<td align="left">226957</td>
<td align="left">Gm4850</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F</td>
<td align="left">11957</td>
<td align="left">Atp5j</td>
<td align="left">The protein encoded by this gene is a component of mitochondrial adenosine triphosphate synthase, which catalyzes the conversion of ATP from ADP. Mitochondrial adenosine triphosphate synthase consists of extrinsic and intrinsic membrane domains that are joined by a stalk. The protein encoded by this gene is a subunit of the stalk domain. A bi-directional promoter that drives expression of this gene has been has been identified. Pseudogenes of this gene are found on chromosomes 14 and 17. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">translin</td>
<td align="left">22099</td>
<td align="left">Tsn</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">voltage-dependent anion channel 1</td>
<td align="left">22333</td>
<td align="left">Vdac1</td>
<td align="left">This gene encodes a voltage-dependent anion channel protein that is a major component of the outer mitochondrial membrane. The encoded protein facilitates the exchange of metabolites and ions across the outer mitochondrial membrane and may regulate mitochondrial functions. This protein also forms channels in the plasma membrane and may be involved in transmembrane electron transport. Multiple pseudogenes of this gene are found on chromosomes 1, 2, 3, 6, 8, 9, and X.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">acyl-Coenzyme A dehydrogenase, long-chain</td>
<td align="left">11363</td>
<td align="left">Acadl</td>
<td align="left">This gene encodes a homotetrameric mitochondrial flavoprotein and is a member of the acyl-CoA dehydrogenase family. Members of this family catalyze the first step of fatty acid beta-oxidation, forming a C2-C3 trans-double bond in a FAD-dependent reaction. As beta-oxidation cycles through its four steps, each member of the acyl-CoA dehydrogenase family works at an optimum fatty acid chain-length. This enzyme has its optimum length between C12- and C16-acylCoA. In mice, deficiency of this gene can cause sudden death, cardiomyopathy as well as fasting and cold intolerance.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">threonyl-tRNA synthetase</td>
<td align="left">110960</td>
<td align="left">Tars</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">sorting nexin 1</td>
<td align="left">56440</td>
<td align="left">Snx1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">mitochondrial carrier 2</td>
<td align="left">56428</td>
<td align="left">Mtch2</td>
<td align="left">This gene encodes a member of the SLC25 family of nuclear-encoded transporters that are localized in the inner mitochondrial membrane. Members of this superfamily are involved in many metabolic pathways and cell functions. Genome-wide association studies in human have identified single-nucleotide polymorphisms in several loci associated with obesity. This gene is one such locus, which is highly expressed in white adipose tissue and adipocytes, and thought to play a regulatory role in adipocyte differentiation and biology. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. A recent study showed this gene to be an authentic stop codon readthrough target, and that its mRNA can give rise to an additional C-terminally extended isoform by use of an alternative in-frame translation termination codon.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">protease (prosome, macropain) 26S subunit, ATPase 1</td>
<td align="left">19179</td>
<td align="left">Psmc1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">proteasome (prosome, macropain) subunit, beta type 3</td>
<td align="left">26446</td>
<td align="left">Psmb3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NADH dehydrogenase (ubiquinone) flavoprotein 1</td>
<td align="left">17995</td>
<td align="left">Ndufv1</td>
<td align="left">This gene encodes a subunit of the NADH-ubiquinone oxidoreductase (complex I) enzyme, which is a large, multimeric protein. It is the first enzyme complex in the mitochondrial electron transport chain and catalyzes the transfer of electrons from NADH to the electron acceptor ubiquinone. The proton gradient created by electron transfer drives the conversion of ADP to ATP. This gene is a core subunit and is conserved in prokaryotes and eukaryotes. The human ortholog of this protein has been characterized. It has consensus motifs for NADH, flavin mononucleotide, and iron-sulfur binding sites and participates in the oxidation of NADH as part of the dehydrogenase module of complex I. In humans, deficiencies in complex I are associated with myopathies, encephalomyopathies, and neurodegenerative disorders.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">cysteine rich protein 2</td>
<td align="left">68337</td>
<td align="left">Crip2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">caspase 6</td>
<td align="left">12368</td>
<td align="left">Casp6</td>
<td align="left">This gene encodes a member of the cysteine proteases that plays important roles in regulating apoptosis and neurodegeneration. The encoded protein is involved in the transmission of pain and axonal degeneration. Genetic deletion of this gene in mice results in the delay of axon pruning and protects from axon degeneration.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">chaperonin containing Tcp1, subunit 8 (theta)</td>
<td align="left">12469</td>
<td align="left">Cct8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_load_sqrt/gene_names_clus_&quot;,5,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-6-annotations" class="section level3">
<h3>Factor 6 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[6,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">name</th>
<th align="left">summary</th>
<th align="left">X_id</th>
<th align="left">query</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">actin, beta</td>
<td align="left">This gene encodes a member of the actin family of proteins. Actins are highly conserved proteins that are among the most abundant proteins in eukaryotic cells and are involved in cell motility, structure, and integrity. Localization, stability, and translation of the transcribed mRNA are regulated through the binding of multiple factors to its 3’ UTR sequence. Homozygous knockout mice for this gene exhibit embryonic lethality. Numerous pseudogenes of this gene have been identified in the mouse genome.</td>
<td align="left">11461</td>
<td align="left">Actb</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">translocated promoter region, nuclear basket protein</td>
<td align="left">NA</td>
<td align="left">108989</td>
<td align="left">Tpr</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">H47</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">cold shock domain containing E1, RNA binding</td>
<td align="left">NA</td>
<td align="left">229663</td>
<td align="left">Csde1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">eukaryotic translation initiation factor 4, gamma 2</td>
<td align="left">Translation initiation is mediated by specific recognition of the cap structure by eukaryotic translation initiation factor 4F (eIF4F), which is a cap binding protein complex that consists of three subunits: eIF4A, eIF4E and eIF4G. The protein encoded by this gene shares similarity with the C-terminal region of eIF4G, that contains the binding sites for eIF4A and eIF3; eIF4G in addition, contains a binding site for eIF4E at the N-terminus. Unlike eIF4G which supports cap-dependent and independent translation, this gene product functions as a general repressor of translation by forming translationally inactive complexes. Transgene expression of the apolipoprotein B mRNA-editing enzyme (APOBEC-1) causes extensive editing of this mRNA, which could contribute to the potent oncogenesis induced by overexpression of APOBEC-1. In vitro and in vivo studies in human indicate that translation of this mRNA initiates exclusively at a non-AUG (GUG) codon. This also appears to be true for mouse. Two alternatively spliced transcript variants that encode different isoforms have been found for this gene.</td>
<td align="left">13690</td>
<td align="left">Eif4g2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">BCL2-associated transcription factor 1</td>
<td align="left">NA</td>
<td align="left">72567</td>
<td align="left">Bclaf1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">heterogeneous nuclear ribonucleoprotein U</td>
<td align="left">NA</td>
<td align="left">51810</td>
<td align="left">Hnrnpu</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">heat shock protein 5</td>
<td align="left">NA</td>
<td align="left">14828</td>
<td align="left">Hspa5</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">prolyl 4-hydroxylase, beta polypeptide</td>
<td align="left">NA</td>
<td align="left">18453</td>
<td align="left">P4hb</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">developmental pluripotency-associated 3</td>
<td align="left">NA</td>
<td align="left">73708</td>
<td align="left">Dppa3</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">polymerase (DNA-directed), delta interacting protein 3</td>
<td align="left">NA</td>
<td align="left">73826</td>
<td align="left">Poldip3</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">splicing factor 3b, subunit 1</td>
<td align="left">NA</td>
<td align="left">81898</td>
<td align="left">Sf3b1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">proline-rich coiled-coil 2C</td>
<td align="left">NA</td>
<td align="left">226562</td>
<td align="left">Prrc2c</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">H3 histone, family 3B</td>
<td align="left">Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Two molecules of each of the four core histones (H2A, H2B, H3, and H4) form an octamer, around which approximately 146 bp of DNA is wrapped in repeating units, called nucleosomes. The linker histone, H1, interacts with linker DNA between nucleosomes and functions in the compaction of chromatin into higher order structures. This gene contains introns and its mRNA is polyadenylated, unlike most histone genes. The protein encoded by this gene is a replication-independent histone that is a member of the histone H3 family.</td>
<td align="left">15081</td>
<td align="left">H3f3b</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">heat shock protein 90, alpha (cytosolic), class A member 1</td>
<td align="left">NA</td>
<td align="left">15519</td>
<td align="left">Hsp90aa1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">eukaryotic translation elongation factor 1 alpha 1</td>
<td align="left">NA</td>
<td align="left">13627</td>
<td align="left">Eef1a1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">chaperonin containing Tcp1, subunit 6a (zeta)</td>
<td align="left">NA</td>
<td align="left">12466</td>
<td align="left">Cct6a</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">chaperonin containing Tcp1, subunit 6a (zeta)</td>
<td align="left">NA</td>
<td align="left">ENSMUSG00000029447</td>
<td align="left">Cct6a</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">senataxin</td>
<td align="left">NA</td>
<td align="left">269254</td>
<td align="left">Setx</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">TATA-box binding protein associated factor 7</td>
<td align="left">NA</td>
<td align="left">24074</td>
<td align="left">Taf7</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">glutamate-ammonia ligase (glutamine synthetase)</td>
<td align="left">NA</td>
<td align="left">14645</td>
<td align="left">Glul</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">GC-rich promoter binding protein 1</td>
<td align="left">NA</td>
<td align="left">73274</td>
<td align="left">Gpbp1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">MAX gene associated</td>
<td align="left">NA</td>
<td align="left">29808</td>
<td align="left">Mga</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">topoisomerase (DNA) II alpha</td>
<td align="left">NA</td>
<td align="left">21973</td>
<td align="left">Top2a</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ubiquitin C</td>
<td align="left">NA</td>
<td align="left">22190</td>
<td align="left">Ubc</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">biorientation of chromosomes in cell division 1-like</td>
<td align="left">NA</td>
<td align="left">665775</td>
<td align="left">Bod1l</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">syndecan 4</td>
<td align="left">NA</td>
<td align="left">20971</td>
<td align="left">Sdc4</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">cullin 3</td>
<td align="left">NA</td>
<td align="left">26554</td>
<td align="left">Cul3</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NOP16 nucleolar protein</td>
<td align="left">NA</td>
<td align="left">28126</td>
<td align="left">Nop16</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">nucleolin</td>
<td align="left">NA</td>
<td align="left">17975</td>
<td align="left">Ncl</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">transient receptor potential cation channel, subfamily M, member 7</td>
<td align="left">NA</td>
<td align="left">58800</td>
<td align="left">Trpm7</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RNA binding motif protein 8a</td>
<td align="left">NA</td>
<td align="left">60365</td>
<td align="left">Rbm8a</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">geminin</td>
<td align="left">NA</td>
<td align="left">57441</td>
<td align="left">Gmnn</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RRN3 RNA polymerase I transcription factor homolog (yeast)</td>
<td align="left">NA</td>
<td align="left">106298</td>
<td align="left">Rrn3</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">hyaluronan mediated motility receptor (RHAMM)</td>
<td align="left">NA</td>
<td align="left">15366</td>
<td align="left">Hmmr</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">cathepsin B</td>
<td align="left">This gene encodes a member of the peptidase C1 family and preproprotein that is proteolytically processed to generate multiple protein products. These products include the cathepsin B light and heavy chains, which can dimerize to generate the double chain form of the enzyme. This enzyme is a lysosomal cysteine protease with both endopeptidase and exopeptidase activity that may play a role in protein turnover. Homozygous knockout mice for this gene exhibit reduced pancreatic damage following induced pancreatitis and reduced hepatocyte apoptosis in a model of liver injury. Pseudogenes of this gene have been identified in the genome.</td>
<td align="left">13030</td>
<td align="left">Ctsb</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ferritin light polypeptide 1</td>
<td align="left">NA</td>
<td align="left">14325</td>
<td align="left">Ftl1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">replication timing regulatory factor 1</td>
<td align="left">NA</td>
<td align="left">51869</td>
<td align="left">Rif1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">transcription elongation factor B (SIII), polypeptide 3</td>
<td align="left">NA</td>
<td align="left">27224</td>
<td align="left">Tceb3</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">zinc finger, HIT type 3</td>
<td align="left">NA</td>
<td align="left">448850</td>
<td align="left">Znhit3</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ELOVL family member 6, elongation of long chain fatty acids (yeast)</td>
<td align="left">NA</td>
<td align="left">170439</td>
<td align="left">Elovl6</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">MAD2L1 binding protein</td>
<td align="left">NA</td>
<td align="left">66591</td>
<td align="left">Mad2l1bp</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">heat shock protein 90 alpha (cytosolic), class B member 1</td>
<td align="left">NA</td>
<td align="left">15516</td>
<td align="left">Hsp90ab1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">structural maintenance of chromosomes 4</td>
<td align="left">NA</td>
<td align="left">70099</td>
<td align="left">Smc4</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">lysine (K)-specific demethylase 5B</td>
<td align="left">NA</td>
<td align="left">75605</td>
<td align="left">Kdm5b</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RAN binding protein 2</td>
<td align="left">NA</td>
<td align="left">19386</td>
<td align="left">Ranbp2</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">secreted phosphoprotein 1</td>
<td align="left">NA</td>
<td align="left">20750</td>
<td align="left">Spp1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RNA binding motif protein 25</td>
<td align="left">NA</td>
<td align="left">67039</td>
<td align="left">Rbm25</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">predicted gene 11517</td>
<td align="left">NA</td>
<td align="left">ENSMUSG00000081249</td>
<td align="left">Gm11517</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene</td>
<td align="left">NA</td>
<td align="left">629750</td>
<td align="left">Gm11517</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">basic leucine zipper and W2 domains 1</td>
<td align="left">NA</td>
<td align="left">66882</td>
<td align="left">Bzw1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">arginine/serine-rich coiled-coil 2</td>
<td align="left">NA</td>
<td align="left">208606</td>
<td align="left">Rsrc2</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">antigen identified by monoclonal antibody Ki 67</td>
<td align="left">NA</td>
<td align="left">17345</td>
<td align="left">Mki67</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">transportin 3</td>
<td align="left">NA</td>
<td align="left">320938</td>
<td align="left">Tnpo3</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">pre-mRNA processing factor 40A</td>
<td align="left">NA</td>
<td align="left">56194</td>
<td align="left">Prpf40a</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RAD21 cohesin complex component</td>
<td align="left">NA</td>
<td align="left">19357</td>
<td align="left">Rad21</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">kinesin family member 2C</td>
<td align="left">NA</td>
<td align="left">73804</td>
<td align="left">Kif2c</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">serine hydroxymethyltransferase 1 (soluble)</td>
<td align="left">NA</td>
<td align="left">20425</td>
<td align="left">Shmt1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">RIKEN cDNA 2810474O19 gene</td>
<td align="left">NA</td>
<td align="left">67246</td>
<td align="left">2810474O19Rik</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">poly (ADP-ribose) polymerase family, member 1</td>
<td align="left">NA</td>
<td align="left">11545</td>
<td align="left">Parp1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">secreted acidic cysteine rich glycoprotein</td>
<td align="left">NA</td>
<td align="left">20692</td>
<td align="left">Sparc</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">asparagine synthetase</td>
<td align="left">NA</td>
<td align="left">27053</td>
<td align="left">Asns</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">arginine and glutamate rich 1</td>
<td align="left">NA</td>
<td align="left">234023</td>
<td align="left">Arglu1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">proteasome (prosome, macropain) 26S subunit, ATPase, 6</td>
<td align="left">NA</td>
<td align="left">67089</td>
<td align="left">Psmc6</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Sfi1 homolog, spindle assembly associated (yeast)</td>
<td align="left">NA</td>
<td align="left">78887</td>
<td align="left">Sfi1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">solute carrier family 34 (sodium phosphate), member 2</td>
<td align="left">NA</td>
<td align="left">20531</td>
<td align="left">Slc34a2</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">katanin p60 (ATPase-containing) subunit A1</td>
<td align="left">NA</td>
<td align="left">23924</td>
<td align="left">Katna1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">TIP41, TOR signalling pathway regulator-like (S. cerevisiae)</td>
<td align="left">NA</td>
<td align="left">226591</td>
<td align="left">Tiprl</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">dyskeratosis congenita 1, dyskerin</td>
<td align="left">NA</td>
<td align="left">245474</td>
<td align="left">Dkc1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">thyroid hormone receptor interactor 12</td>
<td align="left">NA</td>
<td align="left">14897</td>
<td align="left">Trip12</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">cyclin-dependent kinase 4</td>
<td align="left">NA</td>
<td align="left">12567</td>
<td align="left">Cdk4</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">TOX high mobility group box family member 4</td>
<td align="left">NA</td>
<td align="left">268741</td>
<td align="left">Tox4</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">strawberry notch homolog 1 (Drosophila)</td>
<td align="left">NA</td>
<td align="left">243272</td>
<td align="left">Sbno1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">high-mobility group nucleosome binding domain 5</td>
<td align="left">NA</td>
<td align="left">50887</td>
<td align="left">Hmgn5</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">transformer 2 beta homolog (Drosophila)</td>
<td align="left">NA</td>
<td align="left">20462</td>
<td align="left">Tra2b</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">SMEK homolog 1, suppressor of mek1 (Dictyostelium)</td>
<td align="left">NA</td>
<td align="left">68734</td>
<td align="left">Smek1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">dynein light chain LC8-type 1</td>
<td align="left">NA</td>
<td align="left">56455</td>
<td align="left">Dynll1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ferric-chelate reductase 1</td>
<td align="left">NA</td>
<td align="left">20321</td>
<td align="left">Frrs1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">WD repeat domain 26</td>
<td align="left">NA</td>
<td align="left">226757</td>
<td align="left">Wdr26</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">adenylate kinase 4</td>
<td align="left">NA</td>
<td align="left">11639</td>
<td align="left">Ak4</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">chaperonin containing Tcp1, subunit 4 (delta)</td>
<td align="left">NA</td>
<td align="left">12464</td>
<td align="left">Cct4</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">retinoblastoma binding protein 6</td>
<td align="left">NA</td>
<td align="left">19647</td>
<td align="left">Rbbp6</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">tetratricopeptide repeat domain 1</td>
<td align="left">NA</td>
<td align="left">66827</td>
<td align="left">Ttc1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked</td>
<td align="left">NA</td>
<td align="left">13205</td>
<td align="left">Ddx3x</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">epithelial cell adhesion molecule</td>
<td align="left">NA</td>
<td align="left">17075</td>
<td align="left">Epcam</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">heterogeneous nuclear ribonucleoprotein K</td>
<td align="left">The protein encoded by this gene is a component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complex, and is a poly-cytosine binding protein (PCBP). It is found in multiple subcellular compartments including the nucleus, cytoplasm and mitochondria. This gene product is thought to interact with RNA, DNA, and protein, and is involved in multiple cellular processes, including transcription, chromatin remodeling, DNA damage response, signal transduction, mRNA splicing, export, and translation. Multiple transcript variants and protein isoforms exist, with some isoforms containing a unique C-terminus. There are four pseudogenes of this gene, found on chromosomes 2, 3, 7 and 13.</td>
<td align="left">15387</td>
<td align="left">Hnrnpk</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">smu-1 suppressor of mec-8 and unc-52 homolog (C. elegans)</td>
<td align="left">NA</td>
<td align="left">74255</td>
<td align="left">Smu1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">proteasome (prosome, macropain) 26S subunit, non-ATPase, 2</td>
<td align="left">NA</td>
<td align="left">21762</td>
<td align="left">Psmd2</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">TATA-box binding protein associated factor, RNA polymerase I, D</td>
<td align="left">NA</td>
<td align="left">75316</td>
<td align="left">Taf1d</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">poly(A) binding protein, nuclear 1</td>
<td align="left">NA</td>
<td align="left">54196</td>
<td align="left">Pabpn1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">GTP binding protein 4</td>
<td align="left">NA</td>
<td align="left">69237</td>
<td align="left">Gtpbp4</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ubiquitin protein ligase E3 component n-recognin 5</td>
<td align="left">NA</td>
<td align="left">70790</td>
<td align="left">Ubr5</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">cleavage and polyadenylation specific factor 6</td>
<td align="left">NA</td>
<td align="left">432508</td>
<td align="left">Cpsf6</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">proteasome (prosome, macropain) subunit, alpha type 4</td>
<td align="left">NA</td>
<td align="left">26441</td>
<td align="left">Psma4</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">eukaryotic translation initiation factor 1</td>
<td align="left">NA</td>
<td align="left">20918</td>
<td align="left">Eif1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">pyruvate dehyrogenase phosphatase catalytic subunit 2</td>
<td align="left">NA</td>
<td align="left">382051</td>
<td align="left">Pdp2</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">protein disulfide isomerase associated 3</td>
<td align="left">NA</td>
<td align="left">14827</td>
<td align="left">Pdia3</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ribosomal protein S5</td>
<td align="left">NA</td>
<td align="left">20103</td>
<td align="left">Rps5</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">structural maintenance of chromosomes 3</td>
<td align="left">NA</td>
<td align="left">13006</td>
<td align="left">Smc3</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">CGG triplet repeat binding protein 1</td>
<td align="left">NA</td>
<td align="left">106143</td>
<td align="left">Cggbp1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">serine/arginine-rich splicing factor 5</td>
<td align="left">The protein encoded by this gene is a member of the serine/arginine (SR)-rich family of pre-mRNA splicing factors, which constitute part of the spliceosome. Each of these factors contains an RNA recognition motif (RRM) for binding RNA and an RS domain for binding other proteins. The RS domain is rich in serine and arginine residues and facilitates interaction between different SR splicing factors. In addition to being critical for mRNA splicing, the SR proteins have also been shown to be involved in mRNA export from the nucleus and in translation. Three transcript variants encoding the same protein have been found for this gene.</td>
<td align="left">20384</td>
<td align="left">Srsf5</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Son DNA binding protein</td>
<td align="left">NA</td>
<td align="left">20658</td>
<td align="left">Son</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_load_sqrt/gene_names_clus_&quot;,6,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-7-annotations" class="section level3">
<h3>Factor 7 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[7,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">query</th>
<th align="left">name</th>
<th align="left">summary</th>
<th align="left">X_id</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Eif5a</td>
<td align="left">eukaryotic translation initiation factor 5A</td>
<td align="left">This gene encodes an elongation initiation factor, which participates in protein synthesis. The encoded protein also plays roles in mRNA metabolism, cell proliferation, and cell cycle control. This protein contains a modified lysine residue called hypusine, which appears to be necessary for its function. Alternatively spliced transcript variants have been described. Related pseudogenes exist on chromosomes 2, 5, and 19.</td>
<td align="left">276770</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Sord</td>
<td align="left">sorbitol dehydrogenase</td>
<td align="left">NA</td>
<td align="left">20322</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rrm2</td>
<td align="left">ribonucleotide reductase M2</td>
<td align="left">NA</td>
<td align="left">20135</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">G3bp2</td>
<td align="left">GTPase activating protein (SH3 domain) binding protein 2</td>
<td align="left">NA</td>
<td align="left">23881</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Crip2</td>
<td align="left">cysteine rich protein 2</td>
<td align="left">NA</td>
<td align="left">68337</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Hsp90ab1</td>
<td align="left">heat shock protein 90 alpha (cytosolic), class B member 1</td>
<td align="left">NA</td>
<td align="left">15516</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Hprt</td>
<td align="left">hypoxanthine guanine phosphoribosyl transferase</td>
<td align="left">The protein encoded by this gene is a transferase, which catalyzes conversion of hypoxanthine to inosine monophosphate and guanine to guanosine monophosphate via transfer of the 5-phosphoribosyl group from 5-phosphoribosyl 1-pyrophosphate. This enzyme plays a central role in the generation of purine nucleotides through the purine salvage pathway.</td>
<td align="left">15452</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Dab2</td>
<td align="left">disabled 2, mitogen-responsive phosphoprotein</td>
<td align="left">NA</td>
<td align="left">13132</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rragd</td>
<td align="left">Ras-related GTP binding D</td>
<td align="left">NA</td>
<td align="left">52187</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rbm47</td>
<td align="left">RNA binding motif protein 47</td>
<td align="left">NA</td>
<td align="left">245945</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Hsp90aa1</td>
<td align="left">heat shock protein 90, alpha (cytosolic), class A member 1</td>
<td align="left">NA</td>
<td align="left">15519</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Dppa3</td>
<td align="left">developmental pluripotency-associated 3</td>
<td align="left">NA</td>
<td align="left">73708</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Actn4</td>
<td align="left">actinin alpha 4</td>
<td align="left">NA</td>
<td align="left">60595</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tbc1d15</td>
<td align="left">TBC1 domain family, member 15</td>
<td align="left">NA</td>
<td align="left">66687</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tpd52</td>
<td align="left">tumor protein D52</td>
<td align="left">NA</td>
<td align="left">21985</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Mt1</td>
<td align="left">metallothionein 1</td>
<td align="left">NA</td>
<td align="left">17748</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gsto1</td>
<td align="left">glutathione S-transferase omega 1</td>
<td align="left">This gene encodes a member of the omega class of glutathione S-transferase (GST) proteins. GSTs are involved in the metabolism of xenobiotics and carcinogens. There is evidence that the encoded protein is involved in the biotransformation of arsenic.</td>
<td align="left">14873</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ddb1</td>
<td align="left">damage specific DNA binding protein 1</td>
<td align="left">NA</td>
<td align="left">13194</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Psat1</td>
<td align="left">phosphoserine aminotransferase 1</td>
<td align="left">NA</td>
<td align="left">107272</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Calcoco2</td>
<td align="left">calcium binding and coiled-coil domain 2</td>
<td align="left">NA</td>
<td align="left">76815</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pdha1</td>
<td align="left">pyruvate dehydrogenase E1 alpha 1</td>
<td align="left">NA</td>
<td align="left">18597</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Lrpap1</td>
<td align="left">low density lipoprotein receptor-related protein associated protein 1</td>
<td align="left">NA</td>
<td align="left">16976</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Calm1</td>
<td align="left">calmodulin 1</td>
<td align="left">This gene encodes a member of the EF-hand calcium-binding protein family. The encoded protein acts as a calcium sensor and is involved in relaying signals to calcium-sensitive proteins, enzymes and ion channels. The protein-calcium complex binds target proteins to regulate several cellular processes, including smooth muscle contraction, inflammation, apoptosis and the immune response. Mutations in the human gene are associated with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome 14. Alternative splicing results in multiple transcript variants encoding different isoforms.</td>
<td align="left">12313</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Srpk1</td>
<td align="left">serine/arginine-rich protein specific kinase 1</td>
<td align="left">NA</td>
<td align="left">20815</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Arhgap1</td>
<td align="left">Rho GTPase activating protein 1</td>
<td align="left">NA</td>
<td align="left">228359</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Alppl2</td>
<td align="left">alkaline phosphatase, placental-like 2</td>
<td align="left">NA</td>
<td align="left">11650</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Prps1</td>
<td align="left">phosphoribosyl pyrophosphate synthetase 1</td>
<td align="left">NA</td>
<td align="left">19139</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Paip1</td>
<td align="left">polyadenylate binding protein-interacting protein 1</td>
<td align="left">NA</td>
<td align="left">218693</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Timd2</td>
<td align="left">T cell immunoglobulin and mucin domain containing 2</td>
<td align="left">NA</td>
<td align="left">171284</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Spna2</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">Cited1</td>
<td align="left">Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1</td>
<td align="left">NA</td>
<td align="left">12705</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">LOC100502936</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">Ppfibp2</td>
<td align="left">PTPRF interacting protein, binding protein 2 (liprin beta 2)</td>
<td align="left">NA</td>
<td align="left">19024</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Kif23</td>
<td align="left">kinesin family member 23</td>
<td align="left">NA</td>
<td align="left">71819</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Slbp</td>
<td align="left">stem-loop binding protein</td>
<td align="left">NA</td>
<td align="left">20492</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cnnm4</td>
<td align="left">cyclin M4</td>
<td align="left">NA</td>
<td align="left">94220</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mphosph6</td>
<td align="left">M phase phosphoprotein 6</td>
<td align="left">NA</td>
<td align="left">68533</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pdxk</td>
<td align="left">pyridoxal (pyridoxine, vitamin B6) kinase</td>
<td align="left">NA</td>
<td align="left">216134</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cnbp</td>
<td align="left">cellular nucleic acid binding protein</td>
<td align="left">NA</td>
<td align="left">12785</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tdgf1</td>
<td align="left">teratocarcinoma-derived growth factor 1</td>
<td align="left">NA</td>
<td align="left">21667</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Dazap2</td>
<td align="left">DAZ associated protein 2</td>
<td align="left">NA</td>
<td align="left">23994</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Wtap</td>
<td align="left">Wilms tumour 1-associating protein</td>
<td align="left">NA</td>
<td align="left">60532</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Dnajc8</td>
<td align="left">DnaJ heat shock protein family (Hsp40) member C8</td>
<td align="left">NA</td>
<td align="left">68598</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Stk24</td>
<td align="left">serine/threonine kinase 24</td>
<td align="left">NA</td>
<td align="left">223255</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gpd1l</td>
<td align="left">glycerol-3-phosphate dehydrogenase 1-like</td>
<td align="left">NA</td>
<td align="left">333433</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Fbxo15</td>
<td align="left">F-box protein 15</td>
<td align="left">NA</td>
<td align="left">50764</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ash2l</td>
<td align="left">ash2 (absent, small, or homeotic)-like (Drosophila)</td>
<td align="left">NA</td>
<td align="left">23808</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Prdx3</td>
<td align="left">peroxiredoxin 3</td>
<td align="left">NA</td>
<td align="left">11757</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Trim43a</td>
<td align="left">tripartite motif-containing 43A</td>
<td align="left">NA</td>
<td align="left">547109</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ccndbp1</td>
<td align="left">cyclin D-type binding-protein 1</td>
<td align="left">NA</td>
<td align="left">17151</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Kdm2b</td>
<td align="left">lysine (K)-specific demethylase 2B</td>
<td align="left">The protein encoded by this gene is a H3K36-specific histone demethylase, which contains an N-terminal jumonji C domain, a CxxC zinc finger domain, a plant homeodomain finger, an F-box, and eight leucine-rich repeats. Amongst its demonstrated functions, this protein plays roles in the suppression of premature cellular senescence, leukemia maintenance and development, maintenance of mouse embryonic stem cell pluripotency, and induced pluripotent stem cell generation. Mice homozygous for a targeted deletion of the zinc finger domain display embryonic lethality with development ceasing at approximately 7 to 8 days post coitum, demonstrating an essential role in early development. A pseudogene of this gene is found on chromosome 4. Alternative splicing results in multiple transcript variants.</td>
<td align="left">30841</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ccnb1</td>
<td align="left">cyclin B1</td>
<td align="left">NA</td>
<td align="left">268697</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Crxos1</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">Fam63a</td>
<td align="left">family with sequence similarity 63, member A</td>
<td align="left">NA</td>
<td align="left">75007</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Larp4</td>
<td align="left">La ribonucleoprotein domain family, member 4</td>
<td align="left">NA</td>
<td align="left">207214</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Nae1</td>
<td align="left">NEDD8 activating enzyme E1 subunit 1</td>
<td align="left">NA</td>
<td align="left">234664</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Epb4.1l5</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">Mta3</td>
<td align="left">metastasis associated 3</td>
<td align="left">NA</td>
<td align="left">116871</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Myo1c</td>
<td align="left">myosin IC</td>
<td align="left">This gene encodes a member of the unconventional myosin protein family, which are actin-based molecular motors. The protein is found in the cytoplasm, and one isoform with a unique N-terminus is also found in the nucleus. The protein functions in intracellular vesicle transport to the plasma membrane. The nuclear isoform associates with RNA polymerase I and II and functions in transcription initiation. Multiple transcript variants encoding different isoforms have been found for this gene.</td>
<td align="left">17913</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Mapk6</td>
<td align="left">mitogen-activated protein kinase 6</td>
<td align="left">NA</td>
<td align="left">50772</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Plin2</td>
<td align="left">perilipin 2</td>
<td align="left">NA</td>
<td align="left">11520</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ywhae</td>
<td align="left">tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide</td>
<td align="left">NA</td>
<td align="left">22627</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Dusp14</td>
<td align="left">dual specificity phosphatase 14</td>
<td align="left">NA</td>
<td align="left">56405</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Anxa7</td>
<td align="left">annexin A7</td>
<td align="left">NA</td>
<td align="left">11750</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Set</td>
<td align="left">SET nuclear oncogene</td>
<td align="left">NA</td>
<td align="left">56086</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pold3</td>
<td align="left">polymerase (DNA-directed), delta 3, accessory subunit</td>
<td align="left">NA</td>
<td align="left">67967</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ptges</td>
<td align="left">prostaglandin E synthase</td>
<td align="left">NA</td>
<td align="left">64292</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cgn</td>
<td align="left">cingulin</td>
<td align="left">NA</td>
<td align="left">70737</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">1500003O03Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">Jarid2</td>
<td align="left">jumonji, AT rich interactive domain 2</td>
<td align="left">NA</td>
<td align="left">16468</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rnpep</td>
<td align="left">arginyl aminopeptidase (aminopeptidase B)</td>
<td align="left">NA</td>
<td align="left">215615</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cfl2</td>
<td align="left">cofilin 2, muscle</td>
<td align="left">NA</td>
<td align="left">12632</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Sidt2</td>
<td align="left">SID1 transmembrane family, member 2</td>
<td align="left">NA</td>
<td align="left">214597</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pdhb</td>
<td align="left">pyruvate dehydrogenase (lipoamide) beta</td>
<td align="left">NA</td>
<td align="left">68263</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mapre1</td>
<td align="left">microtubule-associated protein, RP/EB family, member 1</td>
<td align="left">NA</td>
<td align="left">13589</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ube2q2</td>
<td align="left">ubiquitin-conjugating enzyme E2Q family member 2</td>
<td align="left">NA</td>
<td align="left">109161</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Lypla1</td>
<td align="left">lysophospholipase 1</td>
<td align="left">NA</td>
<td align="left">18777</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Zfp207</td>
<td align="left">zinc finger protein 207</td>
<td align="left">NA</td>
<td align="left">22680</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gdap2</td>
<td align="left">ganglioside-induced differentiation-associated-protein 2</td>
<td align="left">NA</td>
<td align="left">14547</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Mylpf</td>
<td align="left">myosin light chain, phosphorylatable, fast skeletal muscle</td>
<td align="left">NA</td>
<td align="left">17907</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tmem59</td>
<td align="left">transmembrane protein 59</td>
<td align="left">NA</td>
<td align="left">56374</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Lin28a</td>
<td align="left">lin-28 homolog A (C. elegans)</td>
<td align="left">NA</td>
<td align="left">83557</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ptma</td>
<td align="left">prothymosin alpha</td>
<td align="left">NA</td>
<td align="left">19231</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ncoa4</td>
<td align="left">nuclear receptor coactivator 4</td>
<td align="left">NA</td>
<td align="left">27057</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cenpn</td>
<td align="left">centromere protein N</td>
<td align="left">NA</td>
<td align="left">72155</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Bcas2</td>
<td align="left">breast carcinoma amplified sequence 2</td>
<td align="left">NA</td>
<td align="left">68183</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fgf4</td>
<td align="left">fibroblast growth factor 4</td>
<td align="left">NA</td>
<td align="left">14175</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ubb</td>
<td align="left">ubiquitin B</td>
<td align="left">This gene encodes ubiquitin, one of the most conserved proteins known. Ubiquitin has a major role in targeting cellular proteins for degradation by the 26S proteosome. It is also involved in the maintenance of chromatin structure, the regulation of gene expression, and the stress response. Ubiquitin is synthesized as a precursor protein consisting of either polyubiquitin chains or a single ubiquitin moiety fused to an unrelated protein. This gene consists of four direct repeats of the ubiquitin coding sequence with no spacer sequence. Consequently, the protein is expressed as a polyubiquitin precursor with a final amino acid after the last repeat. Pseudogenes of this gene are located on chromosomes 3 and 14. Alternative splicing results in multiple transcript variants.</td>
<td align="left">22187</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gabarapl2</td>
<td align="left">gamma-aminobutyric acid (GABA) A receptor-associated protein-like 2</td>
<td align="left">NA</td>
<td align="left">93739</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Vps26a</td>
<td align="left">VPS26 retromer complex component A</td>
<td align="left">NA</td>
<td align="left">30930</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Spin1</td>
<td align="left">spindlin 1</td>
<td align="left">NA</td>
<td align="left">20729</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ugcg</td>
<td align="left">UDP-glucose ceramide glucosyltransferase</td>
<td align="left">NA</td>
<td align="left">22234</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Nup37</td>
<td align="left">nucleoporin 37</td>
<td align="left">NA</td>
<td align="left">69736</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rab8a</td>
<td align="left">RAB8A, member RAS oncogene family</td>
<td align="left">NA</td>
<td align="left">17274</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mier3</td>
<td align="left">MIER family member 3</td>
<td align="left">NA</td>
<td align="left">218613</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cth</td>
<td align="left">cystathionase (cystathionine gamma-lyase)</td>
<td align="left">NA</td>
<td align="left">107869</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mbtd1</td>
<td align="left">mbt domain containing 1</td>
<td align="left">NA</td>
<td align="left">103537</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ube2d3</td>
<td align="left">ubiquitin-conjugating enzyme E2D 3</td>
<td align="left">NA</td>
<td align="left">66105</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Snx18</td>
<td align="left">sorting nexin 18</td>
<td align="left">NA</td>
<td align="left">170625</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Usp15</td>
<td align="left">ubiquitin specific peptidase 15</td>
<td align="left">The protein encoded by this gene is a member of the large ubiquitin specific protease (Usp) family of proteins. These proteins are known to cleave ubiquitin, and contain a conserved cysteine residue (Cys box) and two conserved histidine residues (His box) that are thought to form part of the active site of the protease. This protein has been shown to cleave both the ubiquitin-proline and the ubiquitin-methionine bonds in vitro. This protein is thought to regulate many cellular processes through its deubiquitination activity, including the transforming growth factor beta (TGF-beta) pathway. Cardiac-specific overexpression of the human ortholog of this gene in mice causes enlargement of the heart that is more pronounced in the atrium than in the ventricle. This gene has two pseudogenes on chromosome 14. Alternative splicing results in multiple transcript variants that encode multiple protein isoforms.</td>
<td align="left">14479</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_load_sqrt/gene_names_clus_&quot;,7,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-8-annotations" class="section level3">
<h3>Factor 8 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[8,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">X_id</th>
<th align="left">name</th>
<th align="left">query</th>
<th align="left">notfound</th>
<th align="left">summary</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">ENSMUSG00000081249</td>
<td align="left">predicted gene 11517</td>
<td align="left">Gm11517</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">629750</td>
<td align="left">ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene</td>
<td align="left">Gm11517</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">50764</td>
<td align="left">F-box protein 15</td>
<td align="left">Fbxo15</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">252830</td>
<td align="left">oocyte specific homeobox 6</td>
<td align="left">Obox6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">666747</td>
<td align="left">tripartite motif-containing 43B</td>
<td align="left">Trim43b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">216134</td>
<td align="left">pyridoxal (pyridoxine, vitamin B6) kinase</td>
<td align="left">Pdxk</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">LOC100502936</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">547109</td>
<td align="left">tripartite motif-containing 43A</td>
<td align="left">Trim43a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">22715</td>
<td align="left">zinc finger protein 57</td>
<td align="left">Zfp57</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">666731</td>
<td align="left">tripartite motif-containing 43C</td>
<td align="left">Trim43c</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">68133</td>
<td align="left">glycine cleavage system protein H (aminomethyl carrier)</td>
<td align="left">Gcsh</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">23918</td>
<td align="left">inosine 5’-phosphate dehydrogenase 2</td>
<td align="left">Impdh2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20729</td>
<td align="left">spindlin 1</td>
<td align="left">Spin1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">109032</td>
<td align="left">Sp110 nuclear body protein</td>
<td align="left">Sp110</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">12705</td>
<td align="left">Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1</td>
<td align="left">Cited1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">21432</td>
<td align="left">T cell lymphoma breakpoint 1</td>
<td align="left">Tcl1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">100535</td>
<td align="left">2’-5’ oligoadenylate synthetase 1D</td>
<td align="left">Oas1d</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">16691</td>
<td align="left">keratin 8</td>
<td align="left">Krt8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">105418</td>
<td align="left">RIKEN cDNA E330034G19 gene</td>
<td align="left">E330034G19Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">22042</td>
<td align="left">transferrin receptor</td>
<td align="left">Tfrc</td>
<td align="left">NA</td>
<td align="left">This gene encodes a cell surface receptor necessary for cellular iron uptake by the process of receptor-mediated endocytosis. This receptor is required for erythropoiesis and neurologic development. Mice that are deficient in this receptor show impaired erythroid development and abnormal iron homeostasis.</td>
</tr>
<tr class="odd">
<td align="left">66065</td>
<td align="left">hydroxysteroid (17-beta) dehydrogenase 14</td>
<td align="left">Hsd17b14</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">382106</td>
<td align="left">F-box and WD-40 domain protein 24</td>
<td align="left">Fbxw24</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20670</td>
<td align="left">SRY (sex determining region Y)-box 15</td>
<td align="left">Sox15</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">20496</td>
<td align="left">solute carrier family 12, member 2</td>
<td align="left">Slc12a2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">52372</td>
<td align="left">DNA segment, Chr 6, ERATO Doi 527, expressed</td>
<td align="left">D6Ertd527e</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">21991</td>
<td align="left">triosephosphate isomerase 1</td>
<td align="left">Tpi1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">11750</td>
<td align="left">annexin A7</td>
<td align="left">Anxa7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">66734</td>
<td align="left">microtubule-associated protein 1 light chain 3 alpha</td>
<td align="left">Map1lc3a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">12447</td>
<td align="left">cyclin E1</td>
<td align="left">Ccne1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">13813</td>
<td align="left">eomesodermin</td>
<td align="left">Eomes</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">104174</td>
<td align="left">glycine decarboxylase</td>
<td align="left">Gldc</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">11732</td>
<td align="left">progressive ankylosis</td>
<td align="left">Ank</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">12660</td>
<td align="left">choline kinase alpha</td>
<td align="left">Chka</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12049</td>
<td align="left">Bcl2-like 10</td>
<td align="left">Bcl2l10</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">107272</td>
<td align="left">phosphoserine aminotransferase 1</td>
<td align="left">Psat1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">232217</td>
<td align="left">RIKEN cDNA 4933427D06 gene</td>
<td align="left">4933427D06Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">13731</td>
<td align="left">epithelial membrane protein 2</td>
<td align="left">Emp2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">217666</td>
<td align="left">L-2-hydroxyglutarate dehydrogenase</td>
<td align="left">L2hgdh</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">232679</td>
<td align="left">zinc finger, C3HC type 1</td>
<td align="left">Zc3hc1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">218268</td>
<td align="left">eukaryotic translation initiation factor 4E family member 1B</td>
<td align="left">Eif4e1b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">22037</td>
<td align="left">tumor rejection antigen P1A</td>
<td align="left">Trap1a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">14187</td>
<td align="left">aldo-keto reductase family 1, member B8</td>
<td align="left">Akr1b8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">98582</td>
<td align="left">KH domain containing 1B</td>
<td align="left">Khdc1b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">18263</td>
<td align="left">ornithine decarboxylase, structural 1</td>
<td align="left">Odc1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">60532</td>
<td align="left">Wilms tumour 1-associating protein</td>
<td align="left">Wtap</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">11650</td>
<td align="left">alkaline phosphatase, placental-like 2</td>
<td align="left">Alppl2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">22388</td>
<td align="left">WD repeat domain 1</td>
<td align="left">Wdr1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">171284</td>
<td align="left">T cell immunoglobulin and mucin domain containing 2</td>
<td align="left">Timd2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">75901</td>
<td align="left">decapping mRNA 1A</td>
<td align="left">Dcp1a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">70572</td>
<td align="left">importin 5</td>
<td align="left">Ipo5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Nt5c3l</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">13017</td>
<td align="left">C-terminal binding protein 2</td>
<td align="left">Ctbp2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">231699</td>
<td align="left">2’-5’ oligoadenylate synthetase 1E</td>
<td align="left">Oas1e</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">241627</td>
<td align="left">WD repeat domain 76</td>
<td align="left">Wdr76</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">50790</td>
<td align="left">acyl-CoA synthetase long-chain family member 4</td>
<td align="left">Acsl4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">347712</td>
<td align="left">preferentially expressed antigen in melanoma like 7</td>
<td align="left">Pramel7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">70349</td>
<td align="left">coatomer protein complex, subunit beta 1</td>
<td align="left">Copb1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">218613</td>
<td align="left">MIER family member 3</td>
<td align="left">Mier3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">53893</td>
<td align="left">nudix (nucleoside diphosphate linked moiety X)-type motif 5</td>
<td align="left">Nudt5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">232087</td>
<td align="left">methionine adenosyltransferase II, alpha</td>
<td align="left">Mat2a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">52588</td>
<td align="left">tetraspanin 14</td>
<td align="left">Tspan14</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">108705</td>
<td align="left">pituitary tumor-transforming 1 interacting protein</td>
<td align="left">Pttg1ip</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">72114</td>
<td align="left">zinc finger, BED type containing 3</td>
<td align="left">Zbed3</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the zinc finger protein superfamily. This protein may regulate the Wnt/beta-catenin signaling pathway. This protein may be involved in insulin resistance and type 2 diabetes in humans. Alternative splicing results in multiple transcript variants.</td>
</tr>
<tr class="even">
<td align="left">19156</td>
<td align="left">prosaposin</td>
<td align="left">Psap</td>
<td align="left">NA</td>
<td align="left">This gene encodes a multifunctional glycoprotein that plays a role in the intracellular metabolism of various sphingolipids or secreted into the plasma, milk or cerebrospinal fluid. The encoded protein undergoes proteolytic processing to generate four different polypeptides known as saposin A, B, C or D, that are required for the hydrolysis of certain sphingolipids by lysosomal hydrolases. Alternately, the encoded protein is secreted into body fluids where it exhibits neurotrophic and myelinotrophic activities. A complete lack of the encoded protein is fatal to mice either at the neonatal stage or within the first month due to severe leukodystrophy and sphingolipid accumulation. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar processing to generate the mature saposins.</td>
</tr>
<tr class="odd">
<td align="left">18195</td>
<td align="left">N-ethylmaleimide sensitive fusion protein</td>
<td align="left">Nsf</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">15452</td>
<td align="left">hypoxanthine guanine phosphoribosyl transferase</td>
<td align="left">Hprt</td>
<td align="left">NA</td>
<td align="left">The protein encoded by this gene is a transferase, which catalyzes conversion of hypoxanthine to inosine monophosphate and guanine to guanosine monophosphate via transfer of the 5-phosphoribosyl group from 5-phosphoribosyl 1-pyrophosphate. This enzyme plays a central role in the generation of purine nucleotides through the purine salvage pathway.</td>
</tr>
<tr class="odd">
<td align="left">21873</td>
<td align="left">tight junction protein 2</td>
<td align="left">Tjp2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">68533</td>
<td align="left">M phase phosphoprotein 6</td>
<td align="left">Mphosph6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20262</td>
<td align="left">stathmin-like 3</td>
<td align="left">Stmn3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">23807</td>
<td align="left">ariadne RBR E3 ubiquitin protein ligase 2</td>
<td align="left">Arih2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">17436</td>
<td align="left">malic enzyme 1, NADP(+)-dependent, cytosolic</td>
<td align="left">Me1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">17886</td>
<td align="left">myosin, heavy polypeptide 9, non-muscle</td>
<td align="left">Myh9</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">16978</td>
<td align="left">leucine rich repeat (in FLII) interacting protein 1</td>
<td align="left">Lrrfip1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">226777</td>
<td align="left">RIKEN cDNA C130074G19 gene</td>
<td align="left">C130074G19Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">381590</td>
<td align="left">expressed sequence C87499</td>
<td align="left">C87499</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">56351</td>
<td align="left">prostaglandin E synthase 3 (cytosolic)</td>
<td align="left">Ptges3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">333433</td>
<td align="left">glycerol-3-phosphate dehydrogenase 1-like</td>
<td align="left">Gpd1l</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">27357</td>
<td align="left">glycogenin</td>
<td align="left">Gyg</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">71310</td>
<td align="left">TBC1 domain family, member 9</td>
<td align="left">Tbc1d9</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">73708</td>
<td align="left">developmental pluripotency-associated 3</td>
<td align="left">Dppa3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">231327</td>
<td align="left">phosphoribosyl pyrophosphate amidotransferase</td>
<td align="left">Ppat</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">407814</td>
<td align="left">cDNA sequence BC053393</td>
<td align="left">BC053393</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">71853</td>
<td align="left">protein disulfide isomerase associated 6</td>
<td align="left">Pdia6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">213773</td>
<td align="left">transducin (beta)-like 3</td>
<td align="left">Tbl3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">319448</td>
<td align="left">fibronectin type III domain containing 3A</td>
<td align="left">Fndc3a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">110213</td>
<td align="left">transmembrane BAX inhibitor motif containing 6</td>
<td align="left">Tmbim6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">11522</td>
<td align="left">alcohol dehydrogenase 1 (class I)</td>
<td align="left">Adh1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">56454</td>
<td align="left">aldehyde dehydrogenase 18 family, member A1</td>
<td align="left">Aldh18a1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">207214</td>
<td align="left">La ribonucleoprotein domain family, member 4</td>
<td align="left">Larp4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">18826</td>
<td align="left">lymphocyte cytosolic protein 1</td>
<td align="left">Lcp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">211347</td>
<td align="left">pantothenate kinase 3</td>
<td align="left">Pank3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">11465</td>
<td align="left">actin, gamma, cytoplasmic 1</td>
<td align="left">Actg1</td>
<td align="left">NA</td>
<td align="left">Actins are highly conserved proteins that are involved in various types of cell motility and maintenance of the cytoskeleton. In vertebrates, three main groups of actin isoforms, alpha, beta, and gamma, have been identified. The alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. The beta and gamma actins co-exist in most cell types as components of the cytoskeleton, and as mediators of internal cell motility. Actin, gamma 1, encoded by this gene, is a cytoplasmic actin found in non-muscle cells. Alternative splicing results in multiple transcript variants.</td>
</tr>
<tr class="odd">
<td align="left">16529</td>
<td align="left">potassium channel, subfamily K, member 5</td>
<td align="left">Kcnk5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">102991</td>
<td align="left">expressed sequence AU022751</td>
<td align="left">AU022751</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">71340</td>
<td align="left">RIO kinase 1 (yeast)</td>
<td align="left">Riok1</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the RIO family of atypical serine protein kinases. A similar protein in humans is a component of the protein arginine methyltransferase 5 complex that specifically recruits the RNA-binding protein nucleolin as a methylation substrate.</td>
</tr>
<tr class="even">
<td align="left">217154</td>
<td align="left">SH3 and cysteine rich domain 2</td>
<td align="left">Stac2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">244745</td>
<td align="left">dpy-19-like 1 (C. elegans)</td>
<td align="left">Dpy19l1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">13427</td>
<td align="left">dynein cytoplasmic 1 intermediate chain 2</td>
<td align="left">Dync1i2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">13205</td>
<td align="left">DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked</td>
<td align="left">Ddx3x</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">270166</td>
<td align="left">caseinolytic mitochondrial matrix peptidase chaperone subunit</td>
<td align="left">Clpx</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">107652</td>
<td align="left">UDP-N-acetylglucosamine pyrophosphorylase 1</td>
<td align="left">Uap1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_load_sqrt/gene_names_clus_&quot;,8,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-9-annotations" class="section level3">
<h3>Factor 9 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[9,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">X_id</th>
<th align="left">name</th>
<th align="left">query</th>
<th align="left">summary</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">171506</td>
<td align="left">H1 histone family, member O, oocyte-specific</td>
<td align="left">H1foo</td>
<td align="left">Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Nucleosomes consist of approximately 146 bp of DNA wrapped around a histone octamer composed of pairs of each of the four core histones (H2A, H2B, H3, and H4). The chromatin fiber is further compacted through the interaction of a linker histone, H1, with the DNA between the nucleosomes to form higher order chromatin structures. The protein encoded is a replication-independent histone that is a member of the histone H1 family. This gene contains introns, unlike most histone genes and the encoded protein is expressed only in oocytes.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">170834</td>
<td align="left">oocyte secreted protein 1</td>
<td align="left">Oosp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">207818</td>
<td align="left">small cell adhesion glycoprotein</td>
<td align="left">Smagp</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">66868</td>
<td align="left">major facilitator superfamily domain containing 1</td>
<td align="left">Mfsd1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">12236</td>
<td align="left">BUB1B, mitotic checkpoint serine/threonine kinase</td>
<td align="left">Bub1b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">68059</td>
<td align="left">transmembrane 9 superfamily member 2</td>
<td align="left">Tm9sf2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">16709</td>
<td align="left">kinectin 1</td>
<td align="left">Ktn1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">66447</td>
<td align="left">microsomal glutathione S-transferase 3</td>
<td align="left">Mgst3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">22223</td>
<td align="left">ubiquitin carboxy-terminal hydrolase L1</td>
<td align="left">Uchl1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">286940</td>
<td align="left">filamin, beta</td>
<td align="left">Flnb</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">12183</td>
<td align="left">2,3-bisphosphoglycerate mutase</td>
<td align="left">Bpgm</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">68801</td>
<td align="left">ELOVL family member 5, elongation of long chain fatty acids (yeast)</td>
<td align="left">Elovl5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">317755</td>
<td align="left">zygote arrest 1</td>
<td align="left">Zar1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">71780</td>
<td align="left">myo-inositol 1-phosphate synthase A1</td>
<td align="left">Isyna1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">15516</td>
<td align="left">heat shock protein 90 alpha (cytosolic), class B member 1</td>
<td align="left">Hsp90ab1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">67968</td>
<td align="left">oocyte expressed protein</td>
<td align="left">Ooep</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">26961</td>
<td align="left">ribosomal protein L8</td>
<td align="left">Rpl8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ENSMUSG00000092341</td>
<td align="left">metastasis associated lung adenocarcinoma transcript 1 (non-coding RNA)</td>
<td align="left">Malat1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">72289</td>
<td align="left">metastasis associated lung adenocarcinoma transcript 1 (non-coding RNA)</td>
<td align="left">Malat1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">207214</td>
<td align="left">La ribonucleoprotein domain family, member 4</td>
<td align="left">Larp4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">LOC100502936</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">434204</td>
<td align="left">WAS protein homolog associated with actin, golgi membranes and microtubules</td>
<td align="left">Whamm</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">24084</td>
<td align="left">tektin 2</td>
<td align="left">Tekt2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">56030</td>
<td align="left">transmembrane protein 131</td>
<td align="left">Tmem131</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">241846</td>
<td align="left">LSM family member 14B</td>
<td align="left">Lsm14b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">110074</td>
<td align="left">deoxyuridine triphosphatase</td>
<td align="left">Dut</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">75339</td>
<td align="left">M-phase phosphoprotein 8</td>
<td align="left">Mphosph8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">319765</td>
<td align="left">insulin-like growth factor 2 mRNA binding protein 2</td>
<td align="left">Igf2bp2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">21849</td>
<td align="left">tripartite motif-containing 28</td>
<td align="left">Trim28</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">54609</td>
<td align="left">ubiquilin 2</td>
<td align="left">Ubqln2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">11461</td>
<td align="left">actin, beta</td>
<td align="left">Actb</td>
<td align="left">This gene encodes a member of the actin family of proteins. Actins are highly conserved proteins that are among the most abundant proteins in eukaryotic cells and are involved in cell motility, structure, and integrity. Localization, stability, and translation of the transcribed mRNA are regulated through the binding of multiple factors to its 3’ UTR sequence. Homozygous knockout mice for this gene exhibit embryonic lethality. Numerous pseudogenes of this gene have been identified in the mouse genome.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">21807</td>
<td align="left">TSC22 domain family, member 1</td>
<td align="left">Tsc22d1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">11650</td>
<td align="left">alkaline phosphatase, placental-like 2</td>
<td align="left">Alppl2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">67804</td>
<td align="left">sorting nexin 2</td>
<td align="left">Snx2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">19231</td>
<td align="left">prothymosin alpha</td>
<td align="left">Ptma</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12317</td>
<td align="left">calreticulin</td>
<td align="left">Calr</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">50887</td>
<td align="left">high-mobility group nucleosome binding domain 5</td>
<td align="left">Hmgn5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">AI848100</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">12116</td>
<td align="left">betaine-homocysteine methyltransferase</td>
<td align="left">Bhmt</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">18753</td>
<td align="left">protein kinase C, delta</td>
<td align="left">Prkcd</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">54208</td>
<td align="left">ADP-ribosylation factor-like 6 interacting protein 1</td>
<td align="left">Arl6ip1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12488</td>
<td align="left">CD2-associated protein</td>
<td align="left">Cd2ap</td>
<td align="left">This gene encodes a scaffolding molecule that regulates the actin cytoskeleton. The protein directly interacts with filamentous actin and a variety of cell membrane proteins through multiple actin binding sites, SH3 domains, and a proline-rich region containing binding sites for SH3 domains. The cytoplasmic protein localizes to membrane ruffles, lipid rafts, and the leading edges of cells. It is implicated in dynamic actin remodeling and membrane trafficking that occurs during receptor endocytosis and cytokinesis. The mouse genome contains at least two pseudogenes located on chromosomes 9 and 17.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">12550</td>
<td align="left">cadherin 1</td>
<td align="left">Cdh1</td>
<td align="left">This gene encodes E-cadherin, a calcium-dependent cell adhesion molecule that functions in the establishment and maintenance of epithelial cell morphology during embryongenesis and adulthood. The encoded preproprotein undergoes proteolytic processing to generate a mature protein. Targeted mutations disrupting binding of calcium to the encoded protein in mice cause death in utero due to failed blastocyst and trophectoderm formation. This gene is located adjacent to a related cadherin gene on chromosome 8.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">268567</td>
<td align="left">transmembrane protein 229B</td>
<td align="left">Tmem229b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">66913</td>
<td align="left">KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2</td>
<td align="left">Kdelr2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">56338</td>
<td align="left">thioredoxin interacting protein</td>
<td align="left">Txnip</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20185</td>
<td align="left">nuclear receptor co-repressor 1</td>
<td align="left">Ncor1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">76846</td>
<td align="left">ribosomal protein S9</td>
<td align="left">Rps9</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">333433</td>
<td align="left">glycerol-3-phosphate dehydrogenase 1-like</td>
<td align="left">Gpd1l</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">18140</td>
<td align="left">ubiquitin-like, containing PHD and RING finger domains, 1</td>
<td align="left">Uhrf1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">22121</td>
<td align="left">ribosomal protein L13A</td>
<td align="left">Rpl13a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Spnb2</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">ENSMUSG00000081249</td>
<td align="left">predicted gene 11517</td>
<td align="left">Gm11517</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">629750</td>
<td align="left">ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene</td>
<td align="left">Gm11517</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">30058</td>
<td align="left">translocase of inner mitochondrial membrane 8A1</td>
<td align="left">Timm8a1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">22027</td>
<td align="left">heat shock protein 90, beta (Grp94), member 1</td>
<td align="left">Hsp90b1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">18081</td>
<td align="left">ninjurin 1</td>
<td align="left">Ninj1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">207785</td>
<td align="left">cysteine-serine-rich nuclear protein 2</td>
<td align="left">Csrnp2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">18379</td>
<td align="left">oocyte maturation, alpha</td>
<td align="left">Omt2a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">382088</td>
<td align="left">oocyte maturation, beta</td>
<td align="left">Omt2b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">80517</td>
<td align="left">HERPUD family member 2</td>
<td align="left">Herpud2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">70427</td>
<td align="left">MIER family member 2</td>
<td align="left">Mier2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">77579</td>
<td align="left">myosin, heavy polypeptide 10, non-muscle</td>
<td align="left">Myh10</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">26940</td>
<td align="left">ECSIT signalling integrator</td>
<td align="left">Ecsit</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20354</td>
<td align="left">sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D</td>
<td align="left">Sema4d</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">194388</td>
<td align="left">tet methylcytosine dioxygenase 3</td>
<td align="left">Tet3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">67623</td>
<td align="left">transmembrane 7 superfamily member 3</td>
<td align="left">Tm7sf3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">547109</td>
<td align="left">tripartite motif-containing 43A</td>
<td align="left">Trim43a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">217708</td>
<td align="left">lin-52 homolog (C. elegans)</td>
<td align="left">Lin52</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">1700019E19Rik</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">11740</td>
<td align="left">solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 5</td>
<td align="left">Slc25a5</td>
<td align="left">This gene encodes a transmembrane domain-containing protein that localizes to the mitochondrial inner membrane. The encoded protein facilitates the exchange of ADP from the cytoplasm with ATP from the mitochondria. Pseudogenes for this gene are found on multiple chromosomes.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">13684</td>
<td align="left">eukaryotic translation initiation factor 4E</td>
<td align="left">Eif4e</td>
<td align="left">This gene encodes a component of the eukaryotic translation initiation factor 4F complex, which recognizes the 7-methylguanosine cap structure at the 5’ end of messenger RNAs. The encoded protein aids in translation initiation by recruiting ribosomes to the 5’-cap structure. Association of this protein with the 4F complex is the rate-limiting step in translation initiation. This gene acts as a proto-oncogene, and its expression and activation is associated with transformation and tumorigenesis. It has also been associated with autism spectrum disorders. Consistently, knockout of this gene results in increased translation of neuroligins, postsynaptic proteins linked to autism spectrum disorders. Pseudogenes of this gene are found on other chromosomes. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">94244</td>
<td align="left">FK506 binding protein 6</td>
<td align="left">Fkbp6</td>
<td align="left">This gene is a member of the FK506-binding protein (Fkbp) family. The encoded protein plays a role in male-specific fertility and homologous pairing of chromosomes during meiosis. The protein may also be involved in LINE1 transposon silencing and binding to Hsp90 as a co-chaperone. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">217995</td>
<td align="left">HEAT repeat containing 1</td>
<td align="left">Heatr1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">17448</td>
<td align="left">malate dehydrogenase 2, NAD (mitochondrial)</td>
<td align="left">Mdh2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">67834</td>
<td align="left">isocitrate dehydrogenase 3 (NAD+) alpha</td>
<td align="left">Idh3a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">68137</td>
<td align="left">KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1</td>
<td align="left">Kdelr1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">19684</td>
<td align="left">radixin</td>
<td align="left">Rdx</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Gnb2l1</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">56392</td>
<td align="left">soc-2 (suppressor of clear) homolog (C. elegans)</td>
<td align="left">Shoc2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">28040</td>
<td align="left">DNA segment, Chr 6, Wayne State University 163, expressed</td>
<td align="left">D6Wsu163e</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">76273</td>
<td align="left">Nedd4 family interacting protein 2</td>
<td align="left">Ndfip2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20750</td>
<td align="left">secreted phosphoprotein 1</td>
<td align="left">Spp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">59052</td>
<td align="left">methyltransferase like 9</td>
<td align="left">Mettl9</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">54214</td>
<td align="left">golgi autoantigen, golgin subfamily a, 4</td>
<td align="left">Golga4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">14667</td>
<td align="left">GM2 ganglioside activator protein</td>
<td align="left">Gm2a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">18453</td>
<td align="left">prolyl 4-hydroxylase, beta polypeptide</td>
<td align="left">P4hb</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">2410004A20Rik</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">70584</td>
<td align="left">p21 protein (Cdc42/Rac)-activated kinase 4</td>
<td align="left">Pak4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">20501</td>
<td align="left">solute carrier family 16 (monocarboxylic acid transporters), member 1</td>
<td align="left">Slc16a1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">226519</td>
<td align="left">laminin, gamma 1</td>
<td align="left">Lamc1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">68520</td>
<td align="left">zinc finger, FYVE domain containing 21</td>
<td align="left">Zfyve21</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">68631</td>
<td align="left">crystallin, lambda 1</td>
<td align="left">Cryl1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">18618</td>
<td align="left">phosphatidylethanolamine N-methyltransferase</td>
<td align="left">Pemt</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">73708</td>
<td align="left">developmental pluripotency-associated 3</td>
<td align="left">Dppa3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">225326</td>
<td align="left">phosphoinositide-3-kinase, class 3</td>
<td align="left">Pik3c3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">14107</td>
<td align="left">FAT atypical cadherin 1</td>
<td align="left">Fat1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">68895</td>
<td align="left">RAS-like, family 11, member A</td>
<td align="left">Rasl11a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">347712</td>
<td align="left">preferentially expressed antigen in melanoma like 7</td>
<td align="left">Pramel7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">11804</td>
<td align="left">amyloid beta (A4) precursor-like protein 2</td>
<td align="left">Aplp2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">70354</td>
<td align="left">SECIS binding protein 2-like</td>
<td align="left">Secisbp2l</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">71449</td>
<td align="left">methyltransferase like 13</td>
<td align="left">Mettl13</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_load_sqrt/gene_names_clus_&quot;,9,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-10-annotations" class="section level3">
<h3>Factor 10 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[10,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">X_id</th>
<th align="left">name</th>
<th align="left">query</th>
<th align="left">summary</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">171284</td>
<td align="left">T cell immunoglobulin and mucin domain containing 2</td>
<td align="left">Timd2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">11650</td>
<td align="left">alkaline phosphatase, placental-like 2</td>
<td align="left">Alppl2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">18618</td>
<td align="left">phosphatidylethanolamine N-methyltransferase</td>
<td align="left">Pemt</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">60532</td>
<td align="left">Wilms tumour 1-associating protein</td>
<td align="left">Wtap</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">19025</td>
<td align="left">cathepsin A</td>
<td align="left">Ctsa</td>
<td align="left">This gene encodes a glycoprotein with deamidase, esterase and carboxypeptidase activities. The encoded protein associates with and provides a protective function to the lysosomal enzymes beta-galactosidase and neuraminidase. Deficiency of the related gene in humans results in galactosialidosis. The proprotein is processed into two shorter chains. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">22042</td>
<td align="left">transferrin receptor</td>
<td align="left">Tfrc</td>
<td align="left">This gene encodes a cell surface receptor necessary for cellular iron uptake by the process of receptor-mediated endocytosis. This receptor is required for erythropoiesis and neurologic development. Mice that are deficient in this receptor show impaired erythroid development and abnormal iron homeostasis.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">27050</td>
<td align="left">ribosomal protein S3</td>
<td align="left">Rps3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">67923</td>
<td align="left">transcription elongation factor B (SIII), polypeptide 1</td>
<td align="left">Tceb1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Gnb2l1</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">16978</td>
<td align="left">leucine rich repeat (in FLII) interacting protein 1</td>
<td align="left">Lrrfip1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">19042</td>
<td align="left">protein phosphatase 1A, magnesium dependent, alpha isoform</td>
<td align="left">Ppm1a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">16691</td>
<td align="left">keratin 8</td>
<td align="left">Krt8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20044</td>
<td align="left">ribosomal protein S14</td>
<td align="left">Rps14</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">17748</td>
<td align="left">metallothionein 1</td>
<td align="left">Mt1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Sc4mol</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">16668</td>
<td align="left">keratin 18</td>
<td align="left">Krt18</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">230709</td>
<td align="left">zinc metallopeptidase, STE24</td>
<td align="left">Zmpste24</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">15902</td>
<td align="left">inhibitor of DNA binding 2</td>
<td align="left">Id2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">232679</td>
<td align="left">zinc finger, C3HC type 1</td>
<td align="left">Zc3hc1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">16004</td>
<td align="left">insulin-like growth factor 2 receptor</td>
<td align="left">Igf2r</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">22361</td>
<td align="left">vanin 1</td>
<td align="left">Vnn1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">72194</td>
<td align="left">F-box and leucine-rich repeat protein 20</td>
<td align="left">Fbxl20</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">14137</td>
<td align="left">farnesyl diphosphate farnesyl transferase 1</td>
<td align="left">Fdft1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">22234</td>
<td align="left">UDP-glucose ceramide glucosyltransferase</td>
<td align="left">Ugcg</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">233724</td>
<td align="left">transmembrane protein 41B</td>
<td align="left">Tmem41b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">26961</td>
<td align="left">ribosomal protein L8</td>
<td align="left">Rpl8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">11461</td>
<td align="left">actin, beta</td>
<td align="left">Actb</td>
<td align="left">This gene encodes a member of the actin family of proteins. Actins are highly conserved proteins that are among the most abundant proteins in eukaryotic cells and are involved in cell motility, structure, and integrity. Localization, stability, and translation of the transcribed mRNA are regulated through the binding of multiple factors to its 3’ UTR sequence. Homozygous knockout mice for this gene exhibit embryonic lethality. Numerous pseudogenes of this gene have been identified in the mouse genome.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">207214</td>
<td align="left">La ribonucleoprotein domain family, member 4</td>
<td align="left">Larp4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">72157</td>
<td align="left">phosphoglucomutase 2</td>
<td align="left">Pgm2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">107272</td>
<td align="left">phosphoserine aminotransferase 1</td>
<td align="left">Psat1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ENSMUSG00000075611</td>
<td align="left">predicted gene 11545</td>
<td align="left">Gm11545</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">217122</td>
<td align="left">predicted gene 11545</td>
<td align="left">Gm11545</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">268756</td>
<td align="left">gulonolactone (L-) oxidase</td>
<td align="left">Gulo</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">14913</td>
<td align="left">guanylate cyclase activator 1a (retina)</td>
<td align="left">Guca1a</td>
<td align="left">This gene encodes a calcium-binding photoreceptor protein. The encoded protein may be involved in modulation of guanylyl cyclase activity, and in turn, the mammalian cone phototransduction cascade. Disruption of this gene results in the retinal degeneration associated with cone dystrophy.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">19951</td>
<td align="left">ribosomal protein L32</td>
<td align="left">Rpl32</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">20103</td>
<td align="left">ribosomal protein S5</td>
<td align="left">Rps5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">19989</td>
<td align="left">ribosomal protein L7</td>
<td align="left">Rpl7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">LOC100502936</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">333433</td>
<td align="left">glycerol-3-phosphate dehydrogenase 1-like</td>
<td align="left">Gpd1l</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">67115</td>
<td align="left">ribosomal protein L14</td>
<td align="left">Rpl14</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">13032</td>
<td align="left">cathepsin C</td>
<td align="left">Ctsc</td>
<td align="left">This gene encodes a member of the peptidase C1 (papain) family of cysteine proteases. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate multiple protein products. These products include the dipeptidyl peptidase 1 light, heavy, and exclusion domain chains, which together comprise one subunit of the homotetrameric enzyme. This enzyme has amino dipeptidase activity and may play a role in the activation of granzymes during inflammation. Homozygous knockout mice for this gene exhibit impaired granzyme activation and enhanced survival in a sepsis model.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">59020</td>
<td align="left">PDZ domain containing 1</td>
<td align="left">Pdzk1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">93692</td>
<td align="left">glutaredoxin</td>
<td align="left">Glrx</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">56442</td>
<td align="left">serine incorporator 1</td>
<td align="left">Serinc1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">18073</td>
<td align="left">nidogen 1</td>
<td align="left">Nid1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">21873</td>
<td align="left">tight junction protein 2</td>
<td align="left">Tjp2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">54397</td>
<td align="left">palmitoyl-protein thioesterase 2</td>
<td align="left">Ppt2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">13132</td>
<td align="left">disabled 2, mitogen-responsive phosphoprotein</td>
<td align="left">Dab2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">52187</td>
<td align="left">Ras-related GTP binding D</td>
<td align="left">Rragd</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">14860</td>
<td align="left">glutathione S-transferase, alpha 4</td>
<td align="left">Gsta4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">15452</td>
<td align="left">hypoxanthine guanine phosphoribosyl transferase</td>
<td align="left">Hprt</td>
<td align="left">The protein encoded by this gene is a transferase, which catalyzes conversion of hypoxanthine to inosine monophosphate and guanine to guanosine monophosphate via transfer of the 5-phosphoribosyl group from 5-phosphoribosyl 1-pyrophosphate. This enzyme plays a central role in the generation of purine nucleotides through the purine salvage pathway.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">71409</td>
<td align="left">formin-like 2</td>
<td align="left">Fmnl2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">18826</td>
<td align="left">lymphocyte cytosolic protein 1</td>
<td align="left">Lcp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">14462</td>
<td align="left">GATA binding protein 3</td>
<td align="left">Gata3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">73167</td>
<td align="left">Rho GTPase activating protein 8</td>
<td align="left">Arhgap8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">14187</td>
<td align="left">aldo-keto reductase family 1, member B8</td>
<td align="left">Akr1b8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">23849</td>
<td align="left">Kruppel-like factor 6</td>
<td align="left">Klf6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">14252</td>
<td align="left">flotillin 2</td>
<td align="left">Flot2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">75717</td>
<td align="left">cullin 5</td>
<td align="left">Cul5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">29876</td>
<td align="left">chloride intracellular channel 4 (mitochondrial)</td>
<td align="left">Clic4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">13033</td>
<td align="left">cathepsin D</td>
<td align="left">Ctsd</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">56529</td>
<td align="left">SEC11 homolog A, signal peptidase complex subunit</td>
<td align="left">Sec11a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">110196</td>
<td align="left">farnesyl diphosphate synthetase</td>
<td align="left">Fdps</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">14827</td>
<td align="left">protein disulfide isomerase associated 3</td>
<td align="left">Pdia3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">77579</td>
<td align="left">myosin, heavy polypeptide 10, non-muscle</td>
<td align="left">Myh10</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">11749</td>
<td align="left">annexin A6</td>
<td align="left">Anxa6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">14824</td>
<td align="left">granulin</td>
<td align="left">Grn</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12035</td>
<td align="left">branched chain aminotransferase 1, cytosolic</td>
<td align="left">Bcat1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">26965</td>
<td align="left">cullin 1</td>
<td align="left">Cul1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">231580</td>
<td align="left">cyclin G associated kinase</td>
<td align="left">Gak</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">212531</td>
<td align="left">SH3 domain binding glutamic acid-rich protein like 2</td>
<td align="left">Sh3bgrl2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12330</td>
<td align="left">calnexin</td>
<td align="left">Canx</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">73708</td>
<td align="left">developmental pluripotency-associated 3</td>
<td align="left">Dppa3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">216350</td>
<td align="left">tetraspanin 8</td>
<td align="left">Tspan8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">21667</td>
<td align="left">teratocarcinoma-derived growth factor 1</td>
<td align="left">Tdgf1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">75753</td>
<td align="left">Kruppel-like factor 17</td>
<td align="left">Klf17</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">22601</td>
<td align="left">yes-associated protein 1</td>
<td align="left">Yap1</td>
<td align="left">This gene encodes a protein which binds to the SH3 domain of the Yes proto-oncogene product, a tyrosine kinase. This protein contains a WW domain, consisting of four conserved aromatic amino acids including two tryptophan residues. This conserved WW domain is found in various structural, regulatory and signaling molecules in various species, and may play a role in protein-protein interaction. Following cellular damage, phosphorylation of this encoded protein may suppress apoptosis. This protein may be involved in malignant transformation in cancer. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">20322</td>
<td align="left">sorbitol dehydrogenase</td>
<td align="left">Sord</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">234740</td>
<td align="left">transmembrane protein 231</td>
<td align="left">Tmem231</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">244668</td>
<td align="left">signal-induced proliferation-associated 1 like 2</td>
<td align="left">Sipa1l2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ENSMUSG00000057534</td>
<td align="left">predicted gene 15698</td>
<td align="left">Gm15698</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">217066</td>
<td align="left">transcription elongation factor B (SIII), polypeptide 2 pseudogene</td>
<td align="left">Gm15698</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">16644</td>
<td align="left">kininogen 1</td>
<td align="left">Kng1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12036</td>
<td align="left">branched chain aminotransferase 2, mitochondrial</td>
<td align="left">Bcat2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20848</td>
<td align="left">signal transducer and activator of transcription 3</td>
<td align="left">Stat3</td>
<td align="left">The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. This protein is activated through phosphorylation in response to various cytokines and growth factors including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2. This protein mediates the expression of a variety of genes in response to cell stimuli, and thus plays a key role in many cellular processes such as cell growth and apoptosis. The small GTPase Rac1 has been shown to bind and regulate the activity of this protein. PIAS3 protein is a specific inhibitor of this protein. Alternative splicing results in multiple transcript variants encoding distinct isoforms.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">19934</td>
<td align="left">ribosomal protein L22</td>
<td align="left">Rpl22</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">68479</td>
<td align="left">PHD finger protein 5A</td>
<td align="left">Phf5a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">244416</td>
<td align="left">protein phosphatase 1, regulatory (inhibitor) subunit 3B</td>
<td align="left">Ppp1r3b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">207304</td>
<td align="left">HECT domain containing 1</td>
<td align="left">Hectd1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">9530008L14Rik</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">19329</td>
<td align="left">RAB17, member RAS oncogene family</td>
<td align="left">Rab17</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12534</td>
<td align="left">cyclin-dependent kinase 1</td>
<td align="left">Cdk1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">13665</td>
<td align="left">eukaryotic translation initiation factor 2, subunit 1 alpha</td>
<td align="left">Eif2s1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">26941</td>
<td align="left">solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1</td>
<td align="left">Slc9a3r1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">13684</td>
<td align="left">eukaryotic translation initiation factor 4E</td>
<td align="left">Eif4e</td>
<td align="left">This gene encodes a component of the eukaryotic translation initiation factor 4F complex, which recognizes the 7-methylguanosine cap structure at the 5’ end of messenger RNAs. The encoded protein aids in translation initiation by recruiting ribosomes to the 5’-cap structure. Association of this protein with the 4F complex is the rate-limiting step in translation initiation. This gene acts as a proto-oncogene, and its expression and activation is associated with transformation and tumorigenesis. It has also been associated with autism spectrum disorders. Consistently, knockout of this gene results in increased translation of neuroligins, postsynaptic proteins linked to autism spectrum disorders. Pseudogenes of this gene are found on other chromosomes. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">52468</td>
<td align="left">CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2</td>
<td align="left">Ctdsp2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">67945</td>
<td align="left">ribosomal protein L41</td>
<td align="left">Rpl41</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12709</td>
<td align="left">creatine kinase, brain</td>
<td align="left">Ckb</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">52530</td>
<td align="left">NHP2 ribonucleoprotein</td>
<td align="left">Nhp2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">56307</td>
<td align="left">methionine aminopeptidase 2</td>
<td align="left">Metap2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">22271</td>
<td align="left">uridine phosphorylase 1</td>
<td align="left">Upp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">66446</td>
<td align="left">exosome component 7</td>
<td align="left">Exosc7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_load_sqrt/gene_names_clus_&quot;,10,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
</div>
<div id="load-the-sfa-input-sparse-loadings-voom-transformation" class="section level2">
<h2>Load the SFA input (sparse loadings: voom transformation)</h2>
<pre class="r"><code>lambda_out &lt;- read.table(&quot;../sfa_outputs/Deng2014PPS/voom_deng_counts_lambda.out&quot;)
f_out &lt;- t(read.table(&quot;../sfa_outputs/Deng2014PPS/voom_deng_counts_F.out&quot;))

indices_mat &lt;- SFA.ExtractTopFeatures(f_out, top_features = 100,
                      options = &quot;min&quot;,mult.annotate = TRUE)

top_gene_names &lt;- t(apply(indices_mat, 1, function(x) return (deng.gene_names[x])));</code></pre>
</div>
<div id="factor-annotations-1" class="section level2">
<h2>Factor Annotations</h2>
<div id="factor-1-annotations-1" class="section level3">
<h3>Factor 1 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[1,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">query</th>
<th align="left">name</th>
<th align="left">X_id</th>
<th align="left">summary</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Frmd4b</td>
<td align="left">FERM domain containing 4B</td>
<td align="left">232288</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Acer1</td>
<td align="left">alkaline ceramidase 1</td>
<td align="left">171168</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mypn</td>
<td align="left">myopalladin</td>
<td align="left">68802</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Frmpd1</td>
<td align="left">FERM and PDZ domain containing 1</td>
<td align="left">666060</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Adap2</td>
<td align="left">ArfGAP with dual PH domains 2</td>
<td align="left">216991</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Abca3</td>
<td align="left">ATP-binding cassette, sub-family A (ABC1), member 3</td>
<td align="left">27410</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cdc42ep5</td>
<td align="left">CDC42 effector protein (Rho GTPase binding) 5</td>
<td align="left">58804</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Sept8</td>
<td align="left">septin 8</td>
<td align="left">20362</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cnnm4</td>
<td align="left">cyclin M4</td>
<td align="left">94220</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rapgefl1</td>
<td align="left">Rap guanine nucleotide exchange factor (GEF)-like 1</td>
<td align="left">268480</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rasgrp4</td>
<td align="left">RAS guanyl releasing protein 4</td>
<td align="left">233046</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Atg4d</td>
<td align="left">autophagy related 4D, cysteine peptidase</td>
<td align="left">235040</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Stac2</td>
<td align="left">SH3 and cysteine rich domain 2</td>
<td align="left">217154</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">2310040G24Rik</td>
<td align="left">RIKEN cDNA 2310040G24 gene</td>
<td align="left">ENSMUSG00000101655</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">2310040G24Rik</td>
<td align="left">RIKEN cDNA 2310040G24 gene</td>
<td align="left">381792</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Wdr91</td>
<td align="left">WD repeat domain 91</td>
<td align="left">101240</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gga1</td>
<td align="left">golgi associated, gamma adaptin ear containing, ARF binding protein 1</td>
<td align="left">106039</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cish</td>
<td align="left">cytokine inducible SH2-containing protein</td>
<td align="left">12700</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cdc25b</td>
<td align="left">cell division cycle 25B</td>
<td align="left">12531</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Afmid</td>
<td align="left">arylformamidase</td>
<td align="left">71562</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Prune2</td>
<td align="left">prune homolog 2 (Drosophila)</td>
<td align="left">353211</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Abat</td>
<td align="left">4-aminobutyrate aminotransferase</td>
<td align="left">268860</td>
<td align="left">The encoded gene product is responsible for catabolism of gamma-aminobutyric acid (GABA), a mostly inhibitory neurotransmitter in the central nervous system, into succinic semialdehyde. Deficiency of this encoded protein includes psychomotor retardation, hypotonia, hyperreflexia, lethargy, refractory seizures, and EEG abnormalities. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tcl1</td>
<td align="left">T cell lymphoma breakpoint 1</td>
<td align="left">21432</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Clcn3</td>
<td align="left">chloride channel, voltage-sensitive 3</td>
<td align="left">12725</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Dok1</td>
<td align="left">docking protein 1</td>
<td align="left">13448</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Vill</td>
<td align="left">villin-like</td>
<td align="left">22351</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Dbt</td>
<td align="left">dihydrolipoamide branched chain transacylase E2</td>
<td align="left">13171</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Med12l</td>
<td align="left">mediator complex subunit 12-like</td>
<td align="left">329650</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Erbb2</td>
<td align="left">erb-b2 receptor tyrosine kinase 2</td>
<td align="left">13866</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tom1l2</td>
<td align="left">target of myb1-like 2 (chicken)</td>
<td align="left">216810</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gpr161</td>
<td align="left">G protein-coupled receptor 161</td>
<td align="left">240888</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Neo1</td>
<td align="left">neogenin</td>
<td align="left">18007</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Shroom3</td>
<td align="left">shroom family member 3</td>
<td align="left">27428</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Nit1</td>
<td align="left">nitrilase 1</td>
<td align="left">27045</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Flii</td>
<td align="left">flightless I actin binding protein</td>
<td align="left">14248</td>
<td align="left">This gene encodes a protein with gelsolin-like repeats and an N-terminal leucine-rich repeat domain. The protein is similar to a Drosophila protein involved in early embryogenesis and the structural organization of indirect flight muscle. This protein may act as an actin-remodelling protein as well as a transcriptional coactivator. Homozygous knockout mice show embryonic lethality. This protein may act to regulate wound repair. Alternative splicing results in multiple transcript variants encoding different isoforms.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Frmd8</td>
<td align="left">FERM domain containing 8</td>
<td align="left">67457</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">BC021767</td>
<td align="left">cDNA sequence BC021767</td>
<td align="left">ENSMUSG00000085006</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">BC021767</td>
<td align="left">cingulin pseudogene</td>
<td align="left">545551</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ell3</td>
<td align="left">elongation factor RNA polymerase II-like 3</td>
<td align="left">269344</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Smtn</td>
<td align="left">smoothelin</td>
<td align="left">29856</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Strada</td>
<td align="left">STE20-related kinase adaptor alpha</td>
<td align="left">72149</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ppcdc</td>
<td align="left">phosphopantothenoylcysteine decarboxylase</td>
<td align="left">66812</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pik3r6</td>
<td align="left">phosphoinositide-3-kinase, regulatory subunit 6</td>
<td align="left">104709</td>
<td align="left">Phosphoinositide 3-kinase gamma is a lipid kinase that produces the lipid second messenger phosphatidylinositol 3,4,5-trisphosphate. The kinase is composed of a catalytic subunit and one of several regulatory subunits, and is chiefly activated by G protein-coupled receptors. This gene encodes a regulatory subunit, and is distantly related to the phosphoinositide-3-kinase, regulatory subunit 5 gene which is located adjacent to this gene on chromosome 11. The protein binds to both the catalytic subunit and to G beta-gamma, and mediates activation of the kinase subunit downstream of G protein-coupled receptors. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Zfp395</td>
<td align="left">zinc finger protein 395</td>
<td align="left">380912</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cybasc3</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">Gpr137b-ps</td>
<td align="left">G protein-coupled receptor 137B, pseudogene</td>
<td align="left">ENSMUSG00000097715</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gpr137b-ps</td>
<td align="left">G protein-coupled receptor 137B, pseudogene</td>
<td align="left">664862</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Zmiz2</td>
<td align="left">zinc finger, MIZ-type containing 2</td>
<td align="left">52915</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pigz</td>
<td align="left">phosphatidylinositol glycan anchor biosynthesis, class Z</td>
<td align="left">239827</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Klc4</td>
<td align="left">kinesin light chain 4</td>
<td align="left">74764</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Myh10</td>
<td align="left">myosin, heavy polypeptide 10, non-muscle</td>
<td align="left">77579</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pemt</td>
<td align="left">phosphatidylethanolamine N-methyltransferase</td>
<td align="left">18618</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Sh3gl3</td>
<td align="left">SH3-domain GRB2-like 3</td>
<td align="left">ENSMUSG00000030638</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Sh3gl3</td>
<td align="left">SH3-domain GRB2-like 3</td>
<td align="left">20408</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cgn</td>
<td align="left">cingulin</td>
<td align="left">70737</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">D17H6S56E-3</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">Arhgef26</td>
<td align="left">Rho guanine nucleotide exchange factor (GEF) 26</td>
<td align="left">622434</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Obfc2a</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">Vgll4</td>
<td align="left">vestigial like family member 4</td>
<td align="left">232334</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">2310001A20Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">Lats2</td>
<td align="left">large tumor suppressor 2</td>
<td align="left">50523</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cyp2s1</td>
<td align="left">cytochrome P450, family 2, subfamily s, polypeptide 1</td>
<td align="left">74134</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Zfp949</td>
<td align="left">zinc finger protein 949</td>
<td align="left">71640</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Vps13d</td>
<td align="left">vacuolar protein sorting 13D</td>
<td align="left">230895</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tmem45a</td>
<td align="left">transmembrane protein 45a</td>
<td align="left">56277</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Kctd9</td>
<td align="left">potassium channel tetramerisation domain containing 9</td>
<td align="left">105440</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gpr137b</td>
<td align="left">G protein-coupled receptor 137B</td>
<td align="left">83924</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Zfp777</td>
<td align="left">zinc finger protein 777</td>
<td align="left">72306</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cpeb3</td>
<td align="left">cytoplasmic polyadenylation element binding protein 3</td>
<td align="left">208922</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Anxa9</td>
<td align="left">annexin A9</td>
<td align="left">71790</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Smpd1</td>
<td align="left">sphingomyelin phosphodiesterase 1, acid lysosomal</td>
<td align="left">20597</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Il6st</td>
<td align="left">interleukin 6 signal transducer</td>
<td align="left">16195</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gata4</td>
<td align="left">GATA binding protein 4</td>
<td align="left">14463</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Nt5c3l</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">Tie1</td>
<td align="left">tyrosine kinase with immunoglobulin-like and EGF-like domains 1</td>
<td align="left">21846</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Iqgap3</td>
<td align="left">IQ motif containing GTPase activating protein 3</td>
<td align="left">404710</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gata1</td>
<td align="left">GATA binding protein 1</td>
<td align="left">14460</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">4933406J08Rik</td>
<td align="left">RIKEN cDNA 4933406J08 gene</td>
<td align="left">74401</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Creb3</td>
<td align="left">cAMP responsive element binding protein 3</td>
<td align="left">12913</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">St7l</td>
<td align="left">suppression of tumorigenicity 7-like</td>
<td align="left">229681</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Aldh6a1</td>
<td align="left">aldehyde dehydrogenase family 6, subfamily A1</td>
<td align="left">104776</td>
<td align="left">This gene encodes a member of the aldehyde dehydrogenase protein family. The encoded enzyme is a mitochondrial methylmalonate semialdehyde dehydrogenase that plays a role in the valine and pyrimidine catabolic pathways. This enzyme catalyzes the irreversible oxidative decarboxylation of malonate and methylmalonate semialdehydes to acetyl- and propionyl-CoA. Mutations in the human gene result in Methylmalonate Semialdehyde Dehydrogenase Deficiency, characterized by elevated beta-alanine, 3-hydroxypropionic acid, and both isomers of 3-amino and 3-hydroxyisobutyric acids in urine organic acids. Alternate splicing results in multiple transcript variants encoding different isoforms.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ftsjd2</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">Slc5a11</td>
<td align="left">solute carrier family 5 (sodium/glucose cotransporter), member 11</td>
<td align="left">233836</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ddx58</td>
<td align="left">DEAD (Asp-Glu-Ala-Asp) box polypeptide 58</td>
<td align="left">230073</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pgrmc1</td>
<td align="left">progesterone receptor membrane component 1</td>
<td align="left">53328</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Osbpl7</td>
<td align="left">oxysterol binding protein-like 7</td>
<td align="left">71240</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ctsd</td>
<td align="left">cathepsin D</td>
<td align="left">13033</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Osbpl6</td>
<td align="left">oxysterol binding protein-like 6</td>
<td align="left">99031</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ethe1</td>
<td align="left">ethylmalonic encephalopathy 1</td>
<td align="left">66071</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tsc22d4</td>
<td align="left">TSC22 domain family, member 4</td>
<td align="left">78829</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Dkk1</td>
<td align="left">dickkopf WNT signaling pathway inhibitor 1</td>
<td align="left">13380</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Lpcat4</td>
<td align="left">lysophosphatidylcholine acyltransferase 4</td>
<td align="left">99010</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rmnd5a</td>
<td align="left">required for meiotic nuclear division 5 homolog A</td>
<td align="left">68477</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ttc7b</td>
<td align="left">tetratricopeptide repeat domain 7B</td>
<td align="left">104718</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Dhcr7</td>
<td align="left">7-dehydrocholesterol reductase</td>
<td align="left">13360</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Prkcz</td>
<td align="left">protein kinase C, zeta</td>
<td align="left">18762</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gas2l3</td>
<td align="left">growth arrest-specific 2 like 3</td>
<td align="left">237436</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Chmp7</td>
<td align="left">charged multivesicular body protein 7</td>
<td align="left">105513</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Frs2</td>
<td align="left">fibroblast growth factor receptor substrate 2</td>
<td align="left">327826</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Lpgat1</td>
<td align="left">lysophosphatidylglycerol acyltransferase 1</td>
<td align="left">226856</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Slc20a1</td>
<td align="left">solute carrier family 20, member 1</td>
<td align="left">20515</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Atg9a</td>
<td align="left">autophagy related 9A</td>
<td align="left">245860</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rgn</td>
<td align="left">regucalcin</td>
<td align="left">19733</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tuft1</td>
<td align="left">tuftelin 1</td>
<td align="left">22156</td>
<td align="left">Tuftelin is an acidic protein that is thought to play a role in dental enamel mineralization and is implicated in caries susceptibility. It is also thought to be involved with adaptation to hypoxia, mesenchymal stem cell function, and neurotrophin nerve growth factor mediated neuronal differentiation.</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_load_voom/gene_names_clus_&quot;,1,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-2-annotations-1" class="section level3">
<h3>Factor 2 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[2,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">query</th>
<th align="left">X_id</th>
<th align="left">name</th>
<th align="left">summary</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Gm7056</td>
<td align="left">631105</td>
<td align="left">predicted gene 7056</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Aimp1</td>
<td align="left">13722</td>
<td align="left">aminoacyl tRNA synthetase complex-interacting multifunctional protein 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ndufs6</td>
<td align="left">407785</td>
<td align="left">NADH dehydrogenase (ubiquinone) Fe-S protein 6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Wdr61</td>
<td align="left">66317</td>
<td align="left">WD repeat domain 61</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Jazf1</td>
<td align="left">231986</td>
<td align="left">JAZF zinc finger 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Btg4</td>
<td align="left">56057</td>
<td align="left">B cell translocation gene 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tcl1b1</td>
<td align="left">27379</td>
<td align="left">T cell leukemia/lymphoma 1B, 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Suclg1</td>
<td align="left">56451</td>
<td align="left">succinate-CoA ligase, GDP-forming, alpha subunit</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fbp2</td>
<td align="left">14120</td>
<td align="left">fructose bisphosphatase 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Nlrp9b</td>
<td align="left">243874</td>
<td align="left">NLR family, pyrin domain containing 9B</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Oosp1</td>
<td align="left">170834</td>
<td align="left">oocyte secreted protein 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Creb3l4</td>
<td align="left">78284</td>
<td align="left">cAMP responsive element binding protein 3-like 4</td>
<td align="left">This gene encodes a CREB (cyclic AMP-responsive element-binding) protein with a transmembrane domain which localizes it to the ER membrane. The encoded protein may play a role in adiposity and male germ cell development. Homozygous knockout mice for this gene show increased adipogenesis, elevated testicular germ cell apoptosis and defects in spermatogenesis. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Bmp2k</td>
<td align="left">140780</td>
<td align="left">BMP2 inducible kinase</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Creg1</td>
<td align="left">433375</td>
<td align="left">cellular repressor of E1A-stimulated genes 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Etfb</td>
<td align="left">110826</td>
<td align="left">electron transferring flavoprotein, beta polypeptide</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Sebox</td>
<td align="left">18292</td>
<td align="left">SEBOX homeobox</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Nell1</td>
<td align="left">338352</td>
<td align="left">NEL-like 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Mro</td>
<td align="left">71263</td>
<td align="left">maestro</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Duoxa2</td>
<td align="left">66811</td>
<td align="left">dual oxidase maturation factor 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gm97</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">Mrps18a</td>
<td align="left">68565</td>
<td align="left">mitochondrial ribosomal protein S18A</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Psmg3</td>
<td align="left">66506</td>
<td align="left">proteasome (prosome, macropain) assembly chaperone 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">C86187</td>
<td align="left">97402</td>
<td align="left">expressed sequence C86187</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Fam46b</td>
<td align="left">100342</td>
<td align="left">family with sequence similarity 46, member B</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Plxna4</td>
<td align="left">243743</td>
<td align="left">plexin A4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Lmo1</td>
<td align="left">109594</td>
<td align="left">LIM domain only 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Wee2</td>
<td align="left">381759</td>
<td align="left">WEE1 homolog 2 (S. pombe)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Siah2</td>
<td align="left">20439</td>
<td align="left">seven in absentia 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tcl1b5</td>
<td align="left">27382</td>
<td align="left">T cell leukemia/lymphoma 1B, 5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ndufa12</td>
<td align="left">66414</td>
<td align="left">NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Grm2</td>
<td align="left">108068</td>
<td align="left">glutamate receptor, metabotropic 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Omt2b</td>
<td align="left">382088</td>
<td align="left">oocyte maturation, beta</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tcl1b4</td>
<td align="left">27380</td>
<td align="left">T cell leukemia/lymphoma 1B, 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gm1965</td>
<td align="left">ENSMUSG00000090254</td>
<td align="left">predicted gene 1965</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm1965</td>
<td align="left">434065</td>
<td align="left">predicted gene 1965</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">D6Ertd474e</td>
<td align="left">ENSMUSG00000072679</td>
<td align="left">DNA segment, Chr 6, ERATO Doi 474, expressed</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">D6Ertd474e</td>
<td align="left">52285</td>
<td align="left">DNA segment, Chr 6, ERATO Doi 474, expressed</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Egfr</td>
<td align="left">13649</td>
<td align="left">epidermal growth factor receptor</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Th</td>
<td align="left">21823</td>
<td align="left">tyrosine hydroxylase</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">D6Ertd527e</td>
<td align="left">52372</td>
<td align="left">DNA segment, Chr 6, ERATO Doi 527, expressed</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Nlrp9c</td>
<td align="left">330490</td>
<td align="left">NLR family, pyrin domain containing 9C</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Dnahc9</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">Gm1564</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">Dgkb</td>
<td align="left">217480</td>
<td align="left">diacylglycerol kinase, beta</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Afap1</td>
<td align="left">70292</td>
<td align="left">actin filament associated protein 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ict1</td>
<td align="left">68572</td>
<td align="left">immature colon carcinoma transcript 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tcfap2e</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">Mfap2</td>
<td align="left">17150</td>
<td align="left">microfibrillar-associated protein 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Epha3</td>
<td align="left">13837</td>
<td align="left">Eph receptor A3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Mesp2</td>
<td align="left">17293</td>
<td align="left">mesoderm posterior 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">2610034M16Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">Ndufa5</td>
<td align="left">68202</td>
<td align="left">NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tcl1b3</td>
<td align="left">27378</td>
<td align="left">T cell leukemia/lymphoma 1B, 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ndufb7</td>
<td align="left">66916</td>
<td align="left">NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rundc3b</td>
<td align="left">242819</td>
<td align="left">RUN domain containing 3B</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Bmp5</td>
<td align="left">12160</td>
<td align="left">bone morphogenetic protein 5</td>
<td align="left">This gene encodes a member of the transforming growth factor beta superfamily of regulatory proteins that plays an important role in the process of bone and cartilage development. The encoded preproprotein undergoes proteolytic processing to generate a disulfide linked homodimeric glycoprotein. Mice lacking the encoded protein exhibit a short ear phenotype, which is characterized by reduced size of external ear, altered size and shape of the sternum, and other skeletal and soft-tissue abnormalities.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">0610040J01Rik</td>
<td align="left">76261</td>
<td align="left">RIKEN cDNA 0610040J01 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Krt84</td>
<td align="left">16680</td>
<td align="left">keratin 84</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm428</td>
<td align="left">242502</td>
<td align="left">predicted gene 428</td>
<td align="left">This gene belongs to a family of related genes tandemly arranged in two clusters on chromosome 4. This family, which appears to be mouse-specific and composed of multiple highly similar members, is supported by limited transcript data. Members of the family maintain an intact open reading frame although the encoded protein has no known function. This gene is supported by alignment of transcripts.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Med8</td>
<td align="left">80509</td>
<td align="left">mediator complex subunit 8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Arl2bp</td>
<td align="left">107566</td>
<td align="left">ADP-ribosylation factor-like 2 binding protein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tdgf1</td>
<td align="left">21667</td>
<td align="left">teratocarcinoma-derived growth factor 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gda</td>
<td align="left">14544</td>
<td align="left">guanine deaminase</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Sh3bgrl</td>
<td align="left">56726</td>
<td align="left">SH3-binding domain glutamic acid-rich protein like</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Parvb</td>
<td align="left">170736</td>
<td align="left">parvin, beta</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Psmc3</td>
<td align="left">19182</td>
<td align="left">proteasome (prosome, macropain) 26S subunit, ATPase 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Krtcap2</td>
<td align="left">66059</td>
<td align="left">keratinocyte associated protein 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">7420426K07Rik</td>
<td align="left">546157</td>
<td align="left">RIKEN cDNA 7420426K07 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gulo</td>
<td align="left">268756</td>
<td align="left">gulonolactone (L-) oxidase</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Fam49a</td>
<td align="left">76820</td>
<td align="left">family with sequence similarity 49, member A</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rapgef5</td>
<td align="left">217944</td>
<td align="left">Rap guanine nucleotide exchange factor (GEF) 5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tcl1b2</td>
<td align="left">27381</td>
<td align="left">T cell leukemia/lymphoma 1B, 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gabra3</td>
<td align="left">14396</td>
<td align="left">gamma-aminobutyric acid (GABA) A receptor, subunit alpha 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cope</td>
<td align="left">59042</td>
<td align="left">coatomer protein complex, subunit epsilon</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Apoc1</td>
<td align="left">11812</td>
<td align="left">apolipoprotein C-I</td>
<td align="left">This gene encodes a precursor plasma protein that is cleaved to yield a signal peptide and two alternatively processed mature peptides. The encoded protein, which is a component of chylomicrons, very low density lipoproteins and high density lipoproteins, transports lipids from the intestines to other locations in the body. This protein binds to free fatty acids preventing their uptake by cells. This protein is a cofactor for lecithin cholesterol acyltransferase, an enzyme that catalyzes the conversion of free cholesterol to cholesteryl esters. The encoded protein inhibits the activity of the cholesteryl ester transfer protein which promotes the exchange of neutral lipids between lipoproteins. In humans this gene is associated with risk of coronary artery disease and age-associated memory impairment. Mice lacking this gene demonstrate impaired memory. This gene is clustered with three other apolipoprotein genes on chromosome 7. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Wdr69</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">Timm13</td>
<td align="left">30055</td>
<td align="left">translocase of inner mitochondrial membrane 13</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cox16</td>
<td align="left">66272</td>
<td align="left">cytochrome c oxidase assembly protein 16</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Apobec3</td>
<td align="left">80287</td>
<td align="left">apolipoprotein B mRNA editing enzyme, catalytic polypeptide 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Psme1</td>
<td align="left">19186</td>
<td align="left">proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mrpl39</td>
<td align="left">27393</td>
<td align="left">mitochondrial ribosomal protein L39</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pde3b</td>
<td align="left">18576</td>
<td align="left">phosphodiesterase 3B, cGMP-inhibited</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fhod3</td>
<td align="left">225288</td>
<td align="left">formin homology 2 domain containing 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Antxr2</td>
<td align="left">71914</td>
<td align="left">anthrax toxin receptor 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cntn4</td>
<td align="left">269784</td>
<td align="left">contactin 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Fa2h</td>
<td align="left">338521</td>
<td align="left">fatty acid 2-hydroxylase</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rph3a</td>
<td align="left">19894</td>
<td align="left">rabphilin 3A</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ica1</td>
<td align="left">15893</td>
<td align="left">islet cell autoantigen 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tshz2</td>
<td align="left">228911</td>
<td align="left">teashirt zinc finger family member 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rfpl4b</td>
<td align="left">215919</td>
<td align="left">ret finger protein-like 4B</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Slain1</td>
<td align="left">105439</td>
<td align="left">SLAIN motif family, member 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">AA415398</td>
<td align="left">433752</td>
<td align="left">expressed sequence AA415398</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Efcab6</td>
<td align="left">77627</td>
<td align="left">EF-hand calcium binding domain 6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Plce1</td>
<td align="left">74055</td>
<td align="left">phospholipase C, epsilon 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Obox5</td>
<td align="left">252829</td>
<td align="left">oocyte specific homeobox 5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Plxnc1</td>
<td align="left">54712</td>
<td align="left">plexin C1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Adcy5</td>
<td align="left">224129</td>
<td align="left">adenylate cyclase 5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Bloc1s1</td>
<td align="left">14533</td>
<td align="left">biogenesis of lysosomal organelles complex-1, subunit 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fbxo43</td>
<td align="left">78803</td>
<td align="left">F-box protein 43</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Prox1</td>
<td align="left">19130</td>
<td align="left">prospero homeobox 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Oog3</td>
<td align="left">100012</td>
<td align="left">oogenesin 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Sgms2</td>
<td align="left">74442</td>
<td align="left">sphingomyelin synthase 2</td>
<td align="left">Sphingomyelin, a major component of cell and Golgi membranes, is made by the transfer of phosphocholine from phosphatidylcholine onto ceramide, with diacylglycerol as a side product. The protein encoded by this gene is an enzyme that catalyzes this reaction primarily at the cell membrane. The synthesis is reversible, and this enzyme can catalyze the reaction in either direction. The encoded protein is required for cell growth.</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_load_voom/gene_names_clus_&quot;,2,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-3-annotations-1" class="section level3">
<h3>Factor 3 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[3,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">query</th>
<th align="left">X_id</th>
<th align="left">name</th>
<th align="left">notfound</th>
<th align="left">summary</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Fbp2</td>
<td align="left">14120</td>
<td align="left">fructose bisphosphatase 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Socs7</td>
<td align="left">192157</td>
<td align="left">suppressor of cytokine signaling 7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ckmt1</td>
<td align="left">12716</td>
<td align="left">creatine kinase, mitochondrial 1, ubiquitous</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cdx2</td>
<td align="left">12591</td>
<td align="left">caudal type homeobox 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ptges</td>
<td align="left">64292</td>
<td align="left">prostaglandin E synthase</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Phc2</td>
<td align="left">54383</td>
<td align="left">polyhomeotic-like 2 (Drosophila)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Slc10a3</td>
<td align="left">214601</td>
<td align="left">solute carrier family 10 (sodium/bile acid cotransporter family), member 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pnrc1</td>
<td align="left">108767</td>
<td align="left">proline-rich nuclear receptor coactivator 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Chic1</td>
<td align="left">12212</td>
<td align="left">cysteine-rich hydrophobic domain 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Zfp82</td>
<td align="left">330502</td>
<td align="left">zinc finger protein 82</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Chml</td>
<td align="left">12663</td>
<td align="left">choroideremia-like</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Jazf1</td>
<td align="left">231986</td>
<td align="left">JAZF zinc finger 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gpt2</td>
<td align="left">108682</td>
<td align="left">glutamic pyruvate transaminase (alanine aminotransferase) 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gtdc1</td>
<td align="left">227835</td>
<td align="left">glycosyltransferase-like domain containing 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tmem164</td>
<td align="left">209497</td>
<td align="left">transmembrane protein 164</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ptpn9</td>
<td align="left">56294</td>
<td align="left">protein tyrosine phosphatase, non-receptor type 9</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Bbs2</td>
<td align="left">67378</td>
<td align="left">Bardet-Biedl syndrome 2 (human)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Zfp952</td>
<td align="left">240067</td>
<td align="left">zinc finger protein 952</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Reep2</td>
<td align="left">225362</td>
<td align="left">receptor accessory protein 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Spire1</td>
<td align="left">68166</td>
<td align="left">spire homolog 1 (Drosophila)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Wdr85</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Mpzl1</td>
<td align="left">68481</td>
<td align="left">myelin protein zero-like 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Abtb2</td>
<td align="left">99382</td>
<td align="left">ankyrin repeat and BTB (POZ) domain containing 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cttnbp2nl</td>
<td align="left">80281</td>
<td align="left">CTTNBP2 N-terminal like</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Epas1</td>
<td align="left">13819</td>
<td align="left">endothelial PAS domain protein 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Zfp113</td>
<td align="left">56314</td>
<td align="left">zinc finger protein 113</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tk2</td>
<td align="left">57813</td>
<td align="left">thymidine kinase 2, mitochondrial</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ston2</td>
<td align="left">108800</td>
<td align="left">stonin 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tob2</td>
<td align="left">57259</td>
<td align="left">transducer of ERBB2, 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pdpr</td>
<td align="left">319518</td>
<td align="left">pyruvate dehydrogenase phosphatase regulatory subunit</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm8801</td>
<td align="left">ENSMUSG00000092284</td>
<td align="left">predicted gene 8801</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gm8801</td>
<td align="left">667766</td>
<td align="left">protein phosphatase 1, regulatory subunit 10 pseudogene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mapkbp1</td>
<td align="left">26390</td>
<td align="left">mitogen-activated protein kinase binding protein 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">E2f2</td>
<td align="left">242705</td>
<td align="left">E2F transcription factor 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Spag1</td>
<td align="left">26942</td>
<td align="left">sperm associated antigen 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Nsun4</td>
<td align="left">72181</td>
<td align="left">NOL1/NOP2/Sun domain family, member 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Sdc4</td>
<td align="left">20971</td>
<td align="left">syndecan 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Steap3</td>
<td align="left">68428</td>
<td align="left">STEAP family member 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Btbd2</td>
<td align="left">208198</td>
<td align="left">BTB (POZ) domain containing 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Zfp770</td>
<td align="left">228491</td>
<td align="left">zinc finger protein 770</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Zbtb37</td>
<td align="left">240869</td>
<td align="left">zinc finger and BTB domain containing 37</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Jak2</td>
<td align="left">16452</td>
<td align="left">Janus kinase 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cpeb4</td>
<td align="left">67579</td>
<td align="left">cytoplasmic polyadenylation element binding protein 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Depdc5</td>
<td align="left">277854</td>
<td align="left">DEP domain containing 5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Trmt12</td>
<td align="left">68260</td>
<td align="left">tRNA methyltranferase 12</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Fam136a</td>
<td align="left">66488</td>
<td align="left">family with sequence similarity 136, member A</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Zbtb24</td>
<td align="left">268294</td>
<td align="left">zinc finger and BTB domain containing 24</td>
<td align="left">NA</td>
<td align="left">This gene encodes a protein containing eight C2H2-type zinc fingers and a BTB domain. Expression of this gene is induced by bone morphogenetic protein-2 signaling. Mutation of the related gene in humans causes immunodeficiency-centromeric instability-facial anomalies syndrome-2. Alternative splicing results in multiple transcript variants.</td>
</tr>
<tr class="even">
<td align="left">Cldn4</td>
<td align="left">12740</td>
<td align="left">claudin 4</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets, and also play critical roles in maintaining cell polarity and signal transductions. The protein encoded by this gene is a high-affinity receptor for clostridium perfringens enterotoxin (CPE) produced by the bacterium Clostridium perfringens, and the interaction with CPE results in increased membrane permeability by forming small pores in plasma membrane. This protein augments alveolar epithelial barrier function and is induced in acute lung injury. It is highly expressed in pancreatic and ovarian cancers.</td>
</tr>
<tr class="odd">
<td align="left">Tulp3</td>
<td align="left">22158</td>
<td align="left">tubby-like protein 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Clock</td>
<td align="left">12753</td>
<td align="left">circadian locomotor output cycles kaput</td>
<td align="left">NA</td>
<td align="left">The protein encoded by this gene plays a central role in the regulation of circadian rhythms. The protein encodes a transcription factor of the basic helix-loop-helix (bHLH) family and contains DNA binding histone acetyltransferase activity. The encoded protein forms a heterodimer with Arntl (Bmal1) that binds E-box enhancer elements upstream of Period (Per1, Per2, Per3) and Cryptochrome (Cry1, Cry2) genes and activates transcription of these genes. Per and Cry proteins heterodimerize and repress their own transcription by interacting in a feedback loop with Clock/Arntl complexes. Polymorphisms in this gene may be associated with behavioral changes, obesity, and metabolic syndrome. Two transcripts encoding the same protein have been found for this gene.</td>
</tr>
<tr class="odd">
<td align="left">Sertad2</td>
<td align="left">58172</td>
<td align="left">SERTA domain containing 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tulp4</td>
<td align="left">68842</td>
<td align="left">tubby like protein 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Zfp142</td>
<td align="left">77264</td>
<td align="left">zinc finger protein 142</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Fut11</td>
<td align="left">73068</td>
<td align="left">fucosyltransferase 11</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Elf3</td>
<td align="left">13710</td>
<td align="left">E74-like factor 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Elf1</td>
<td align="left">13709</td>
<td align="left">E74-like factor 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">C230052I12Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Hif3a</td>
<td align="left">53417</td>
<td align="left">hypoxia inducible factor 3, alpha subunit</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Usp49</td>
<td align="left">224836</td>
<td align="left">ubiquitin specific peptidase 49</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Csf3r</td>
<td align="left">12986</td>
<td align="left">colony stimulating factor 3 receptor (granulocyte)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">6430548M08Rik</td>
<td align="left">234797</td>
<td align="left">RIKEN cDNA 6430548M08 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Vil1</td>
<td align="left">22349</td>
<td align="left">villin 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Stxbp5</td>
<td align="left">78808</td>
<td align="left">syntaxin binding protein 5 (tomosyn)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Dnajc18</td>
<td align="left">76594</td>
<td align="left">DnaJ heat shock protein family (Hsp40) member C18</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Orc1</td>
<td align="left">18392</td>
<td align="left">origin recognition complex, subunit 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tiam2</td>
<td align="left">24001</td>
<td align="left">T cell lymphoma invasion and metastasis 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Otud3</td>
<td align="left">73162</td>
<td align="left">OTU domain containing 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">AA415398</td>
<td align="left">433752</td>
<td align="left">expressed sequence AA415398</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm13023</td>
<td align="left">194227</td>
<td align="left">predicted gene 13023</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Itpr1</td>
<td align="left">16438</td>
<td align="left">inositol 1,4,5-trisphosphate receptor 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cntln</td>
<td align="left">338349</td>
<td align="left">centlein, centrosomal protein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">C87977</td>
<td align="left">97187</td>
<td align="left">expressed sequence C87977</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Efr3b</td>
<td align="left">668212</td>
<td align="left">EFR3 homolog B</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">C2cd3</td>
<td align="left">277939</td>
<td align="left">C2 calcium-dependent domain containing 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mpp5</td>
<td align="left">56217</td>
<td align="left">membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Afap1</td>
<td align="left">70292</td>
<td align="left">actin filament associated protein 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm5134</td>
<td align="left">333669</td>
<td align="left">predicted gene 5134</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cdyl</td>
<td align="left">12593</td>
<td align="left">chromodomain protein, Y chromosome-like</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">1700030J22Rik</td>
<td align="left">69528</td>
<td align="left">RIKEN cDNA 1700030J22 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tfdp2</td>
<td align="left">211586</td>
<td align="left">transcription factor Dp 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pacs1</td>
<td align="left">107975</td>
<td align="left">phosphofurin acidic cluster sorting protein 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rhpn2</td>
<td align="left">52428</td>
<td align="left">rhophilin, Rho GTPase binding protein 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gjb3</td>
<td align="left">14620</td>
<td align="left">gap junction protein, beta 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">2210408I21Rik</td>
<td align="left">72371</td>
<td align="left">RIKEN cDNA 2210408I21 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Slc26a2</td>
<td align="left">13521</td>
<td align="left">solute carrier family 26 (sulfate transporter), member 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">2810403A07Rik</td>
<td align="left">74200</td>
<td align="left">RIKEN cDNA 2810403A07 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Sec16b</td>
<td align="left">89867</td>
<td align="left">SEC16 homolog B (S. cerevisiae)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ankrd44</td>
<td align="left">329154</td>
<td align="left">ankyrin repeat domain 44</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">D430042O09Rik</td>
<td align="left">233865</td>
<td align="left">RIKEN cDNA D430042O09 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gm2a</td>
<td align="left">14667</td>
<td align="left">GM2 ganglioside activator protein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Got1l1</td>
<td align="left">76615</td>
<td align="left">glutamic-oxaloacetic transaminase 1-like 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tiparp</td>
<td align="left">99929</td>
<td align="left">TCDD-inducible poly(ADP-ribose) polymerase</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Sema4b</td>
<td align="left">20352</td>
<td align="left">sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gm505</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Spon1</td>
<td align="left">233744</td>
<td align="left">spondin 1, (f-spondin) extracellular matrix protein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Zc3h7b</td>
<td align="left">20286</td>
<td align="left">zinc finger CCCH type containing 7B</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tcfap2e</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Nme4</td>
<td align="left">56520</td>
<td align="left">NME/NM23 nucleoside diphosphate kinase 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ftsjd1</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Sh2d3c</td>
<td align="left">27387</td>
<td align="left">SH2 domain containing 3C</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rcan3</td>
<td align="left">53902</td>
<td align="left">regulator of calcineurin 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_load_voom/gene_names_clus_&quot;,3,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-4-annotations-1" class="section level3">
<h3>Factor 4 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[4,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">X_id</th>
<th align="left">name</th>
<th align="left">query</th>
<th align="left">summary</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">18022</td>
<td align="left">nuclear factor, erythroid derived 2</td>
<td align="left">Nfe2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12159</td>
<td align="left">bone morphogenetic protein 4</td>
<td align="left">Bmp4</td>
<td align="left">This gene encodes a member of the transforming growth factor beta superfamily of regulatory proteins that plays an important role in the process of bone and cartilage development. The encoded preproprotein undergoes proteolytic processing to generate a disulfide linked homodimeric glycoprotein. Mice lacking the encoded protein die in utero. Transgenic mice overexpressing the encoded protein in a neuron-specific manner exhibit a phenotype resembling the rare hereditary connective tissue disease, fibrodysplasia ossificans progressiva. Alternative splicing results in multiple transcript variants. A pseudogene of this gene has been defined on the X chromosome.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">22044</td>
<td align="left">thyrotropin releasing hormone</td>
<td align="left">Trh</td>
<td align="left">This gene encodes a member of the thyrotropin-releasing hormone family. Cleavage of the encoded proprotein releases mature thyrotropin-releasing hormone, which is a tripeptide hypothalamic regulatory hormone. The mouse proprotein contains five thyrotropin-releasing hormone tripeptides. Thyrotropin-releasing hormone is involved in the regulation and release of thyroid-stimulating hormone, as well as prolactin. Disruption of this gene results in hypothyroidism, elevated thyroid-stimulating hormone levels, and hyperglycemia.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">69903</td>
<td align="left">Ras interacting protein 1</td>
<td align="left">Rasip1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">57781</td>
<td align="left">CD200 receptor 1</td>
<td align="left">Cd200r1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">83456</td>
<td align="left">Moloney leukemia virus 10-like 1</td>
<td align="left">Mov10l1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">232201</td>
<td align="left">Rho GTPase activating protein 25</td>
<td align="left">Arhgap25</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">22646</td>
<td align="left">zinc finger protein 105</td>
<td align="left">Zfp105</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">11932</td>
<td align="left">ATPase, Na+/K+ transporting, beta 2 polypeptide</td>
<td align="left">Atp1b2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">70951</td>
<td align="left">spermatogenesis associated 1</td>
<td align="left">Spata1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">12404</td>
<td align="left">cerebellin 1 precursor protein</td>
<td align="left">Cbln1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">106052</td>
<td align="left">F-box protein 4</td>
<td align="left">Fbxo4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">22127</td>
<td align="left">testis specific X-linked gene</td>
<td align="left">Tsx</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">68519</td>
<td align="left">echinoderm microtubule associated protein like 1</td>
<td align="left">Eml1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">18029</td>
<td align="left">nuclear factor I/C</td>
<td align="left">Nfic</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">433904</td>
<td align="left">OCIA domain containing 2</td>
<td align="left">Ociad2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">279653</td>
<td align="left">protocadherin 19</td>
<td align="left">Pcdh19</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">19124</td>
<td align="left">protein C receptor, endothelial</td>
<td align="left">Procr</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">14734</td>
<td align="left">glypican 3</td>
<td align="left">Gpc3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">27052</td>
<td align="left">acyloxyacyl hydrolase</td>
<td align="left">Aoah</td>
<td align="left">This genes encodes an enzyme that catalyzes the hydrolysis of acyloxylacyl-linked fatty acyl chains from bacterial lipopolysaccharides. The encoded protein modulates host inflammatory response to gram-negative bacteria. The proprotein is further cleaved into a large and small chain that interact in a heterodimer. Alternative splicing results in multiple transcript variants for this gene.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">18671</td>
<td align="left">ATP-binding cassette, sub-family B (MDR/TAP), member 1A</td>
<td align="left">Abcb1a</td>
<td align="left">The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance as well as antigen presentation. This gene encodes a p-glycoprotein which actively transports a variety of hydrophobic amphipathic drugs and plays a major role in the blood-brain barrier permeability of certain drugs.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">4921530L18Rik</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">69101</td>
<td align="left">YdjC homolog (bacterial)</td>
<td align="left">Ydjc</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">321019</td>
<td align="left">G protein-coupled receptor 183</td>
<td align="left">Gpr183</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Spnb1</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">70021</td>
<td align="left">5’-nucleotidase domain containing 2</td>
<td align="left">Nt5dc2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">94212</td>
<td align="left">phosphoprotein associated with glycosphingolipid microdomains 1</td>
<td align="left">Pag1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Gm1568</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">58206</td>
<td align="left">zinc finger and BTB domain containing 32</td>
<td align="left">Zbtb32</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">100048658</td>
<td align="left">DEAD (Asp-Glu-Ala-Asp) box polypeptide 43</td>
<td align="left">Ddx43</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">14555</td>
<td align="left">glycerol-3-phosphate dehydrogenase 1 (soluble)</td>
<td align="left">Gpd1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12780</td>
<td align="left">ATP-binding cassette, sub-family C (CFTR/MRP), member 2</td>
<td align="left">Abcc2</td>
<td align="left">The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein functions in the canalicular surface of the hepatocyte and in biliary transport, and appears to contribute to drug resistance in mammalian cells. Several different mutations in the human gene have been observed in patients with Dubin-Johnson syndrome (DJS), an autosomal recessive disorder characterized by conjugated hyperbilirubinemia. Alternative splice variants have been observed for this gene; however, they have not been fully described.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">97484</td>
<td align="left">component of oligomeric golgi complex 8</td>
<td align="left">Cog8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">80861</td>
<td align="left">DEXH (Asp-Glu-X-His) box polypeptide 58</td>
<td align="left">Dhx58</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">106795</td>
<td align="left">transcription factor 19</td>
<td align="left">Tcf19</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">17921</td>
<td align="left">myosin VIIA</td>
<td align="left">Myo7a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ENSMUSG00000099681</td>
<td align="left">RIKEN cDNA 1700052K11 gene</td>
<td align="left">1700052K11Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">73431</td>
<td align="left">RIKEN cDNA 1700052K11 gene</td>
<td align="left">1700052K11Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">320508</td>
<td align="left">cache domain containing 1</td>
<td align="left">Cachd1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">56532</td>
<td align="left">receptor-interacting serine-threonine kinase 3</td>
<td align="left">Ripk3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">74409</td>
<td align="left">hyaluronoglucosaminidase 6</td>
<td align="left">Hyal6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">268297</td>
<td align="left">sex comb on midleg-like 4 (Drosophila)</td>
<td align="left">Scml4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">242466</td>
<td align="left">zinc finger protein 462</td>
<td align="left">Zfp462</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">109232</td>
<td align="left">saccharopine dehydrogenase (putative)</td>
<td align="left">Sccpdh</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">74315</td>
<td align="left">ring finger protein 145</td>
<td align="left">Rnf145</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">18988</td>
<td align="left">POU domain, class 2, transcription factor 3</td>
<td align="left">Pou2f3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">67149</td>
<td align="left">Na+/K+ transporting ATPase interacting 1</td>
<td align="left">Nkain1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12374</td>
<td align="left">calcium-sensing receptor</td>
<td align="left">Casr</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">215001</td>
<td align="left">WAP, FS, Ig, KU, and NTR-containing protein 1</td>
<td align="left">Wfikkn1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">14221</td>
<td align="left">four jointed box 1 (Drosophila)</td>
<td align="left">Fjx1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">16195</td>
<td align="left">interleukin 6 signal transducer</td>
<td align="left">Il6st</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">212114</td>
<td align="left">NHL repeat containing 3</td>
<td align="left">Nhlrc3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">217364</td>
<td align="left">endo-beta-N-acetylglucosaminidase</td>
<td align="left">Engase</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">70419</td>
<td align="left">RIKEN cDNA 2810408A11 gene</td>
<td align="left">2810408A11Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">235461</td>
<td align="left">family with sequence similarity 63, member B</td>
<td align="left">Fam63b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">13426</td>
<td align="left">dynein cytoplasmic 1 intermediate chain 1</td>
<td align="left">Dync1i1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Fam40b</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">328417</td>
<td align="left">poly (ADP-ribose) polymerase family, member 4</td>
<td align="left">Parp4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">21841</td>
<td align="left">cytotoxic granule-associated RNA binding protein 1</td>
<td align="left">Tia1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Mterfd3</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">112407</td>
<td align="left">egl-9 family hypoxia-inducible factor 3</td>
<td align="left">Egln3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">65257</td>
<td align="left">ankyrin repeat and SOCS box-containing 3</td>
<td align="left">Asb3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">11676</td>
<td align="left">aldolase C, fructose-bisphosphate</td>
<td align="left">Aldoc</td>
<td align="left">This gene encodes a member of the aldolase family of enzymes that is mainly expressed in neuronal tissues. The encoded protein is an enzyme of the glycolysis pathway, and catalyzes the conversion of fructose-1,6-bisphosphate to glyceraldehyde-3-phosphate and dihydroxyacetone phosphate. Alternate splicing of this gene results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">9130017N09Rik</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">14066</td>
<td align="left">coagulation factor III</td>
<td align="left">F3</td>
<td align="left">This gene encodes a membrane-bound glycoprotein that forms the primary physiological initiator of the blood coagulation process following vascular damage. The encoded protein binds to coagulation factor VIIa and the ensuing complex catalyzes the proteolytic activation of coagulation factors IX and X. Mice lacking encoded protein die in utero resulting from massive hemorrhaging in both extraembryonic and embryonic vessels. A severe deficiency of the encoded protein in mice results in impaired uterine homeostasis, shorter life spans due to spontaneous fatal hemorrhages and cardiac fibrosis.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">68328</td>
<td align="left">RAB13, member RAS oncogene family</td>
<td align="left">Rab13</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">217370</td>
<td align="left">cDNA sequence BC017643</td>
<td align="left">BC017643</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">80904</td>
<td align="left">deltex 3, E3 ubiquitin ligase</td>
<td align="left">Dtx3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">76813</td>
<td align="left">armadillo repeat containing 6</td>
<td align="left">Armc6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">72421</td>
<td align="left">tetratricopeptide repeat domain 30B</td>
<td align="left">Ttc30b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">68039</td>
<td align="left">neuromedin B</td>
<td align="left">Nmb</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">233879</td>
<td align="left">aspartate beta-hydroxylase domain containing 1</td>
<td align="left">Asphd1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">76483</td>
<td align="left">lipase maturation factor 1</td>
<td align="left">Lmf1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">26561</td>
<td align="left">matrix metallopeptidase 23</td>
<td align="left">Mmp23</td>
<td align="left">This gene encodes a member of the matrix metalloproteinase family of extracellular matrix-degrading enzymes that are involved in tissue remodeling, wound repair, progression of atherosclerosis and tumor invasion. The encoded protein contains an N-terminal cysteine array and a novel immunoglobulin-fold domain at the C-terminus. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar processing.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">219181</td>
<td align="left">A kinase (PRKA) anchor protein 11</td>
<td align="left">Akap11</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">217138</td>
<td align="left">proline rich 15-like</td>
<td align="left">Prr15l</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">26357</td>
<td align="left">ATP-binding cassette, sub-family G (WHITE), member 2</td>
<td align="left">Abcg2</td>
<td align="left">The membrane-associated protein encoded by this gene is included in the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the White subfamily. Alternatively referred to as a breast cancer resistance protein, the human protein functions as a xenobiotic transporter which may play a major role in multi-drug resistance. This protein likely serves as a cellular defense mechanism in response to mitoxantrone and anthracycline exposure.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ENSMUSG00000097080</td>
<td align="left">RIKEN cDNA 1700086O06 gene</td>
<td align="left">1700086O06Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">73516</td>
<td align="left">RIKEN cDNA 1700086O06 gene</td>
<td align="left">1700086O06Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">66887</td>
<td align="left">lon peptidase 2, peroxisomal</td>
<td align="left">Lonp2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">93843</td>
<td align="left">pregnancy upregulated non-ubiquitously expressed CaM kinase</td>
<td align="left">Pnck</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">17164</td>
<td align="left">MAP kinase-activated protein kinase 2</td>
<td align="left">Mapkapk2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">217203</td>
<td align="left">transmembrane protein 106A</td>
<td align="left">Tmem106a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">80384</td>
<td align="left">testis expressed gene 21</td>
<td align="left">Tex21</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">235627</td>
<td align="left">neurobeachin-like 2</td>
<td align="left">Nbeal2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">72634</td>
<td align="left">tudor and KH domain containing protein</td>
<td align="left">Tdrkh</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">69024</td>
<td align="left">sorting nexin 15</td>
<td align="left">Snx15</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">209630</td>
<td align="left">FERM domain containing 4A</td>
<td align="left">Frmd4a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ENSMUSG00000097248</td>
<td align="left">predicted gene 2694</td>
<td align="left">Gm2694</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">100040294</td>
<td align="left">predicted gene 2694</td>
<td align="left">Gm2694</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">14696</td>
<td align="left">guanine nucleotide binding protein (G protein), beta 4</td>
<td align="left">Gnb4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">626995</td>
<td align="left">predicted gene 13128</td>
<td align="left">Gm13128</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">75599</td>
<td align="left">protocadherin 1</td>
<td align="left">Pcdh1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">329251</td>
<td align="left">protein phosphatase 1, regulatory (inhibitor) subunit 12B</td>
<td align="left">Ppp1r12b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">239435</td>
<td align="left">alanine and arginine rich domain containing protein</td>
<td align="left">Aard</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">208884</td>
<td align="left">zinc finger, DHHC domain containing 9</td>
<td align="left">Zdhhc9</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">56631</td>
<td align="left">tripartite motif-containing 17</td>
<td align="left">Trim17</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12295</td>
<td align="left">calcium channel, voltage-dependent, beta 1 subunit</td>
<td align="left">Cacnb1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20613</td>
<td align="left">snail family zinc finger 1</td>
<td align="left">Snai1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">116873</td>
<td align="left">stromal interaction molecule 2</td>
<td align="left">Stim2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ENSMUSG00000086894</td>
<td align="left">predicted gene 15708</td>
<td align="left">Gm15708</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">100504231</td>
<td align="left">predicted gene 15708</td>
<td align="left">Gm15708</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">21410</td>
<td align="left">HNF1 homeobox B</td>
<td align="left">Hnf1b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">79456</td>
<td align="left">RecQ protein-like 4</td>
<td align="left">Recql4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_load_voom/gene_names_clus_&quot;,4,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-5-annotations-1" class="section level3">
<h3>Factor 5 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[5,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">query</th>
<th align="left">name</th>
<th align="left">X_id</th>
<th align="left">summary</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">BC051665</td>
<td align="left">cDNA sequence BC051665</td>
<td align="left">218275</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tat</td>
<td align="left">tyrosine aminotransferase</td>
<td align="left">234724</td>
<td align="left">This gene encodes a liver-specific mitochondrial enzyme that catalyzes the conversion of L-tyrosine into p-hydroxyphenylpyruvate. Regulated by glucocorticoid and polypeptide hormones, this gene’s expression is affected by deletion of a regulatory region near the albino locus on chromosome 7. Mutations in this gene cause tyrosinemia type II in humans.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Efna1</td>
<td align="left">ephrin A1</td>
<td align="left">13636</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Abhd14b</td>
<td align="left">abhydrolase domain containing 14b</td>
<td align="left">76491</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Plac1</td>
<td align="left">placental specific protein 1</td>
<td align="left">56096</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pdzk1ip1</td>
<td align="left">PDZK1 interacting protein 1</td>
<td align="left">67182</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Glipr1</td>
<td align="left">GLI pathogenesis-related 1 (glioma)</td>
<td align="left">73690</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Snap91</td>
<td align="left">synaptosomal-associated protein 91</td>
<td align="left">20616</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Vgll3</td>
<td align="left">vestigial like family member 3</td>
<td align="left">73569</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rassf4</td>
<td align="left">Ras association (RalGDS/AF-6) domain family member 4</td>
<td align="left">213391</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm3776</td>
<td align="left">predicted gene 3776</td>
<td align="left">100042295</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">S100a16</td>
<td align="left">S100 calcium binding protein A16</td>
<td align="left">67860</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Entpd1</td>
<td align="left">ectonucleoside triphosphate diphosphohydrolase 1</td>
<td align="left">12495</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tbx15</td>
<td align="left">T-box 15</td>
<td align="left">21384</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">1700001L19Rik</td>
<td align="left">RIKEN cDNA 1700001L19 gene</td>
<td align="left">69315</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Blnk</td>
<td align="left">B cell linker</td>
<td align="left">17060</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cyba</td>
<td align="left">cytochrome b-245, alpha polypeptide</td>
<td align="left">13057</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">3110003A17Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">Gsta1</td>
<td align="left">glutathione S-transferase, alpha 1 (Ya)</td>
<td align="left">14857</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cdx1</td>
<td align="left">caudal type homeobox 1</td>
<td align="left">12590</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cebpa</td>
<td align="left">CCAAT/enhancer binding protein (C/EBP), alpha</td>
<td align="left">12606</td>
<td align="left">This intronless gene encodes a transcription factor that contains a basic leucine zipper (bZIP) domain and recognizes the CCAAT motif in the promoters of target genes. The encoded protein functions in homodimers and also heterodimers with CCAAT/enhancer-binding proteins beta and gamma. Activity of this protein can modulate the expression of genes involved in cell cycle regulation as well as in body weight homeostasis. The use of alternative in-frame non-AUG (CUG) and AUG start codons results in several protein isoforms with different lengths. Differential translation initiation is mediated by an out-of-frame, upstream open reading frame which is located between the CUG and the first AUG start codons.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Myl9</td>
<td align="left">myosin, light polypeptide 9, regulatory</td>
<td align="left">98932</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Car4</td>
<td align="left">carbonic anhydrase 4</td>
<td align="left">12351</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Adck5</td>
<td align="left">aarF domain containing kinase 5</td>
<td align="left">268822</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rnf144b</td>
<td align="left">ring finger protein 144B</td>
<td align="left">218215</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Slc6a14</td>
<td align="left">solute carrier family 6 (neurotransmitter transporter), member 14</td>
<td align="left">56774</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rbms1</td>
<td align="left">RNA binding motif, single stranded interacting protein 1</td>
<td align="left">56878</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">S100a14</td>
<td align="left">S100 calcium binding protein A14</td>
<td align="left">66166</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gpsm3</td>
<td align="left">G-protein signalling modulator 3 (AGS3-like, C. elegans)</td>
<td align="left">106512</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Acpp</td>
<td align="left">acid phosphatase, prostate</td>
<td align="left">56318</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cldn3</td>
<td align="left">claudin 3</td>
<td align="left">12739</td>
<td align="left">This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets, and also play critical roles in maintaining cell polarity and signal transductions. The protein encoded by this gene is a low-affinity receptor for clostridium perfringens enterotoxin (CPE) produced by the bacterium Clostridium perfringens, and the interaction with CPE results in increased membrane permeability by forming small pores in plasma membrane. This protein is highly overexpressed in uterine carcinosarcoma. This protein is also predominantly present in brain endothelial cells, where it plays a specific role in the establishment and maintenance of blood brain barrier tight junction morphology.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Dbndd2</td>
<td align="left">dysbindin (dystrobrevin binding protein 1) domain containing 2</td>
<td align="left">52840</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Arhgef5</td>
<td align="left">Rho guanine nucleotide exchange factor (GEF) 5</td>
<td align="left">54324</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tmem109</td>
<td align="left">transmembrane protein 109</td>
<td align="left">68539</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Efnb1</td>
<td align="left">ephrin B1</td>
<td align="left">13641</td>
<td align="left">This gene encodes a membrane protein that acts as a ligand for Eph family receptors. Signalling occurs bidirectionally in both the cell containing the receptor and the cell expressing this protein. Activity of this protein is important in neuronal axon growth and other developmental processes.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Grhl1</td>
<td align="left">grainyhead-like 1 (Drosophila)</td>
<td align="left">195733</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tspan1</td>
<td align="left">tetraspanin 1</td>
<td align="left">66805</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pla2g5</td>
<td align="left">phospholipase A2, group V</td>
<td align="left">18784</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ngfrap1</td>
<td align="left">nerve growth factor receptor (TNFRSF16) associated protein 1</td>
<td align="left">12070</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ctsll3</td>
<td align="left">cathepsin L-like 3</td>
<td align="left">70202</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ankzf1</td>
<td align="left">ankyrin repeat and zinc finger domain containing 1</td>
<td align="left">52231</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Osbpl5</td>
<td align="left">oxysterol binding protein-like 5</td>
<td align="left">79196</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Acad11</td>
<td align="left">acyl-Coenzyme A dehydrogenase family, member 11</td>
<td align="left">102632</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Slc39a2</td>
<td align="left">solute carrier family 39 (zinc transporter), member 2</td>
<td align="left">214922</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cmklr1</td>
<td align="left">chemokine-like receptor 1</td>
<td align="left">14747</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Isx</td>
<td align="left">intestine specific homeobox</td>
<td align="left">71597</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">2510009E07Rik</td>
<td align="left">RIKEN cDNA 2510009E07 gene</td>
<td align="left">72190</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Aldh3b2</td>
<td align="left">aldehyde dehydrogenase 3 family, member B2</td>
<td align="left">621603</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Trpv5</td>
<td align="left">transient receptor potential cation channel, subfamily V, member 5</td>
<td align="left">194352</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">St6galnac2</td>
<td align="left">ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2</td>
<td align="left">20446</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pcbp4</td>
<td align="left">poly(rC) binding protein 4</td>
<td align="left">59092</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Dmrta2</td>
<td align="left">doublesex and mab-3 related transcription factor like family A2</td>
<td align="left">242620</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Sept12</td>
<td align="left">septin 12</td>
<td align="left">71089</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ldlrap1</td>
<td align="left">low density lipoprotein receptor adaptor protein 1</td>
<td align="left">100017</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tmem54</td>
<td align="left">transmembrane protein 54</td>
<td align="left">66260</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tmem106a</td>
<td align="left">transmembrane protein 106A</td>
<td align="left">217203</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cd82</td>
<td align="left">CD82 antigen</td>
<td align="left">12521</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Myo1e</td>
<td align="left">myosin IE</td>
<td align="left">71602</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">5730559C18Rik</td>
<td align="left">RIKEN cDNA 5730559C18 gene</td>
<td align="left">67313</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gpr20</td>
<td align="left">G protein-coupled receptor 20</td>
<td align="left">239530</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Bhmt</td>
<td align="left">betaine-homocysteine methyltransferase</td>
<td align="left">12116</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ovol1</td>
<td align="left">ovo like zinc finger 1</td>
<td align="left">18426</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cald1</td>
<td align="left">caldesmon 1</td>
<td align="left">109624</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pold1</td>
<td align="left">polymerase (DNA directed), delta 1, catalytic subunit</td>
<td align="left">18971</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pon2</td>
<td align="left">paraoxonase 2</td>
<td align="left">330260</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pecam1</td>
<td align="left">platelet/endothelial cell adhesion molecule 1</td>
<td align="left">18613</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cd22</td>
<td align="left">CD22 antigen</td>
<td align="left">12483</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">1190002H23Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">Rec8</td>
<td align="left">REC8 meiotic recombination protein</td>
<td align="left">56739</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Glrx</td>
<td align="left">glutaredoxin</td>
<td align="left">93692</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Bcdin3d</td>
<td align="left">BCDIN3 domain containing</td>
<td align="left">75284</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">S1pr5</td>
<td align="left">sphingosine-1-phosphate receptor 5</td>
<td align="left">94226</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Slc25a24</td>
<td align="left">solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 24</td>
<td align="left">229731</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ppl</td>
<td align="left">periplakin</td>
<td align="left">19041</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">2310044G17Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">Tpcn2</td>
<td align="left">two pore segment channel 2</td>
<td align="left">233979</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Dmkn</td>
<td align="left">dermokine</td>
<td align="left">73712</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">D4Bwg0951e</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">Mdfic</td>
<td align="left">MyoD family inhibitor domain containing</td>
<td align="left">16543</td>
<td align="left">This gene product is a member of a family of proteins characterized by a specific cysteine-rich C-terminal domain, which is involved in transcriptional regulation of viral genome expression. Alternative translation initiation from an upstream non-AUG (GUG), and an in-frame, downstream AUG codon, results in the production of two isoforms, which in human have been shown to have different subcellular localization.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Grb10</td>
<td align="left">growth factor receptor bound protein 10</td>
<td align="left">14783</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gsta2</td>
<td align="left">glutathione S-transferase, alpha 2 (Yc2)</td>
<td align="left">14858</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Slc19a3</td>
<td align="left">solute carrier family 19, member 3</td>
<td align="left">80721</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ankrd37</td>
<td align="left">ankyrin repeat domain 37</td>
<td align="left">654824</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Slc22a4</td>
<td align="left">solute carrier family 22 (organic cation transporter), member 4</td>
<td align="left">30805</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gstm5</td>
<td align="left">glutathione S-transferase, mu 5</td>
<td align="left">14866</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Snhg11</td>
<td align="left">small nucleolar RNA host gene 11</td>
<td align="left">319317</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">S100a6</td>
<td align="left">S100 calcium binding protein A6 (calcyclin)</td>
<td align="left">20200</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Nanog</td>
<td align="left">Nanog homeobox</td>
<td align="left">71950</td>
<td align="left">The protein encoded by this gene is a DNA binding homeobox transcription factor involved in embryonic stem (ES) cell proliferation, renewal, and pluripotency. The encoded protein can block ES cell differentiation and can also autorepress its own expression in differentiating cells. Several transcript variants encoding different isoforms have been found for this gene.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">A4galt</td>
<td align="left">alpha 1,4-galactosyltransferase</td>
<td align="left">239559</td>
<td align="left">The protein encoded by this gene catalyzes the transfer of galactose to lactosylceramide to form globotriaosylceramide, which has been identified as the P(k) antigen of the P blood group system. The encoded protein, which is a type II membrane protein found in the Golgi, is also required for the synthesis of the bacterial verotoxins receptor. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ak3</td>
<td align="left">adenylate kinase 3</td>
<td align="left">56248</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tmem37</td>
<td align="left">transmembrane protein 37</td>
<td align="left">170706</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gata2</td>
<td align="left">GATA binding protein 2</td>
<td align="left">14461</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Lactb</td>
<td align="left">lactamase, beta</td>
<td align="left">80907</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Sema5a</td>
<td align="left">sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A</td>
<td align="left">20356</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tmem189</td>
<td align="left">transmembrane protein 189</td>
<td align="left">407243</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Wnt7b</td>
<td align="left">wingless-type MMTV integration site family, member 7B</td>
<td align="left">22422</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Slc43a2</td>
<td align="left">solute carrier family 43, member 2</td>
<td align="left">215113</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Eno3</td>
<td align="left">enolase 3, beta muscle</td>
<td align="left">13808</td>
<td align="left">This gene encodes one of the three enolase isoenzymes found in vertebrates. Enolase is a dimeric enzyme that converts 2-phosphoglycerate to phosphoenolpyruvate as part of the glycolytic pathway. This isozyme is found in skeletal muscle where it is involved in muscle development and regeneration. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Trim38</td>
<td align="left">tripartite motif-containing 38</td>
<td align="left">214158</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Hs3st1</td>
<td align="left">heparan sulfate (glucosamine) 3-O-sulfotransferase 1</td>
<td align="left">15476</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_load_voom/gene_names_clus_&quot;,5,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-6-annotations-1" class="section level3">
<h3>Factor 6 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[6,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">name</th>
<th align="left">X_id</th>
<th align="left">query</th>
<th align="left">summary</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">thioesterase superfamily member 4</td>
<td align="left">75778</td>
<td align="left">Them4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">2’-5’ oligoadenylate synthetase 1A</td>
<td align="left">246730</td>
<td align="left">Oas1a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Kruppel-like factor 3 (basic)</td>
<td align="left">16599</td>
<td align="left">Klf3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">histone deacetylase 3</td>
<td align="left">15183</td>
<td align="left">Hdac3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">brain-specific angiogenesis inhibitor 1-associated protein 2</td>
<td align="left">108100</td>
<td align="left">Baiap2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">2’-5’ oligoadenylate synthetase 1G</td>
<td align="left">23960</td>
<td align="left">Oas1g</td>
<td align="left">This gene encodes a member of the oligoadenylate synthetase family of proteins. This gene and several other family members are present in a gene cluster on chromosome 5. These proteins are believed to function in antiviral immunity through binding to viral dsRNA and subsequent synthesis of 2’-5’-oligoadenylates. The expression of this gene has been shown to be induced by interferon. Alternative splicing of this gene results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">mitogen-activated protein kinase kinase kinase kinase 4</td>
<td align="left">26921</td>
<td align="left">Map4k4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">L-threonine dehydrogenase</td>
<td align="left">58865</td>
<td align="left">Tdh</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">acireductone dioxygenase 1</td>
<td align="left">104923</td>
<td align="left">Adi1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">CDC42 effector protein (Rho GTPase binding) 3</td>
<td align="left">260409</td>
<td align="left">Cdc42ep3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">phorbol-12-myristate-13-acetate-induced protein 1</td>
<td align="left">58801</td>
<td align="left">Pmaip1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">transmembrane protein with EGF-like and two follistatin-like domains 1</td>
<td align="left">230157</td>
<td align="left">Tmeff1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">protein tyrosine phosphatase, non-receptor type 6</td>
<td align="left">15170</td>
<td align="left">Ptpn6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">HUS1 checkpoint clamp component</td>
<td align="left">15574</td>
<td align="left">Hus1</td>
<td align="left">This gene encodes a component of a cell cycle checkpoint complex that causes cell cycle arrest in response to bulky DNA lesions and DNA replication blockage. Together with the proteins Rad9 and Rad1, the encoded protein forms a heterotrimeric complex known as the 9-1-1 complex. Mice lacking the encoded protein develop spontaneous chromosomal abnormalities resulting in embryonic lethality. Alternative splicing of this gene results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">IMP1 inner mitochondrial membrane peptidase-like (S. cerevisiae)</td>
<td align="left">66541</td>
<td align="left">Immp1l</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">cyclin-dependent kinase 19</td>
<td align="left">78334</td>
<td align="left">Cdk19</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">PWWP domain containing 2A</td>
<td align="left">70802</td>
<td align="left">Pwwp2a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">guanosine monophosphate reductase 2</td>
<td align="left">105446</td>
<td align="left">Gmpr2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">serine hydroxymethyltransferase 2 (mitochondrial)</td>
<td align="left">108037</td>
<td align="left">Shmt2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">deleted in liver cancer 1</td>
<td align="left">50768</td>
<td align="left">Dlc1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">RIKEN cDNA 2610318N02 gene</td>
<td align="left">70458</td>
<td align="left">2610318N02Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">mannosidase, alpha, class 2C, member 1</td>
<td align="left">73744</td>
<td align="left">Man2c1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">son of sevenless homolog 2 (Drosophila)</td>
<td align="left">20663</td>
<td align="left">Sos2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">cysteine-rich hydrophobic domain 2</td>
<td align="left">74277</td>
<td align="left">Chic2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">zinc finger protein 637</td>
<td align="left">232337</td>
<td align="left">Zfp637</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">family with sequence similarity 126, member A</td>
<td align="left">84652</td>
<td align="left">Fam126a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ribonuclease/angiogenin inhibitor 1</td>
<td align="left">107702</td>
<td align="left">Rnh1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">mitochondrial antiviral signaling protein</td>
<td align="left">228607</td>
<td align="left">Mavs</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">drosha, ribonuclease type III</td>
<td align="left">14000</td>
<td align="left">Drosha</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RIKEN cDNA 1700025G04 gene</td>
<td align="left">69399</td>
<td align="left">1700025G04Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">thioredoxin-related transmembrane protein 3</td>
<td align="left">67988</td>
<td align="left">Tmx3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">transmembrane protein 19</td>
<td align="left">67226</td>
<td align="left">Tmem19</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Bet1 golgi vesicular membrane trafficking protein</td>
<td align="left">12068</td>
<td align="left">Bet1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">regulatory factor X, 2 (influences HLA class II expression)</td>
<td align="left">19725</td>
<td align="left">Rfx2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">kinesin family member C2</td>
<td align="left">16581</td>
<td align="left">Kifc2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ELOVL family member 5, elongation of long chain fatty acids (yeast)</td>
<td align="left">68801</td>
<td align="left">Elovl5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">cyclin G1</td>
<td align="left">12450</td>
<td align="left">Ccng1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RIKEN cDNA 5430416N02 gene</td>
<td align="left">ENSMUSG00000097772</td>
<td align="left">5430416N02Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">RIKEN cDNA 5430416N02 gene</td>
<td align="left">100503199</td>
<td align="left">5430416N02Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">mevalonate kinase</td>
<td align="left">17855</td>
<td align="left">Mvk</td>
<td align="left">This gene encodes mevalonate kinase, a key enzyme involved in the biosynthesis of cholesterol and non-sterol isoprenes. The complete lack of encoded protein is lethal to mouse embryos. Mice lacking one allele of this gene exhibit increased levels of mevalonate in spleen, heart and kidney, as well as increased levels of serum immunoglobulins A and D. Alternative splicing results in multiple transcript variants encoding different isoforms.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">adenosine deaminase, tRNA-specific 2</td>
<td align="left">66757</td>
<td align="left">Adat2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">pleckstrin homology like domain, family A, member 1</td>
<td align="left">21664</td>
<td align="left">Phlda1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">N(alpha)-acetyltransferase 30, NatC catalytic subunit</td>
<td align="left">70646</td>
<td align="left">Naa30</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">c-abl oncogene 1, non-receptor tyrosine kinase</td>
<td align="left">11350</td>
<td align="left">Abl1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">family with sequence similarity 83, member D</td>
<td align="left">71878</td>
<td align="left">Fam83d</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">phospholipid scramblase 1</td>
<td align="left">22038</td>
<td align="left">Plscr1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">tRNA methyltransferase 11</td>
<td align="left">73681</td>
<td align="left">Trmt11</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">leucine zipper and CTNNBIP1 domain containing</td>
<td align="left">69151</td>
<td align="left">Lzic</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">biliverdin reductase B (flavin reductase (NADPH))</td>
<td align="left">233016</td>
<td align="left">Blvrb</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ras suppressor protein 1</td>
<td align="left">20163</td>
<td align="left">Rsu1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">intraflagellar transport 46</td>
<td align="left">76568</td>
<td align="left">Ift46</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Gm2382</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">WD repeat domain 6</td>
<td align="left">83669</td>
<td align="left">Wdr6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">mitogen-activated protein kinase 14</td>
<td align="left">26416</td>
<td align="left">Mapk14</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">TBC1 domain family, member 1</td>
<td align="left">57915</td>
<td align="left">Tbc1d1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Ppap2a</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">coenzyme Q6 monooxygenase</td>
<td align="left">217707</td>
<td align="left">Coq6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">p21 protein (Cdc42/Rac)-activated kinase 4</td>
<td align="left">70584</td>
<td align="left">Pak4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">MAF1 homolog, negative regulator of RNA polymerase III</td>
<td align="left">68877</td>
<td align="left">Maf1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">succinate dehydrogenase complex assembly factor 2</td>
<td align="left">66072</td>
<td align="left">Sdhaf2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ubiquitin specific peptidase 42</td>
<td align="left">76800</td>
<td align="left">Usp42</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">DEP domain containing MTOR-interacting protein</td>
<td align="left">97998</td>
<td align="left">Deptor</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">protein S (alpha)</td>
<td align="left">19128</td>
<td align="left">Pros1</td>
<td align="left">This gene encodes a vitamin K-dependent protein with key roles in multiple biological processes including coagulation, apoptosis and vasculogenesis. The encoded protein undergoes proteolytic processing to generate a mature protein which is secreted into the plasma. Mice lacking the encoded protein die in utero from a fulminant coagulopathy and associated hemorrhages.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">tripartite motif family-like 2</td>
<td align="left">622117</td>
<td align="left">Triml2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, beta</td>
<td align="left">18036</td>
<td align="left">Nfkbib</td>
<td align="left">This gene encodes an inhibitor of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB). The encoded protein prevents NF-kappaB-mediated transcription activation by sequestering it in the cytosol. In response to signals that induce NF-kappaB, such as cytokines and growth factors, the encoded protein undergoes phosphorylation, triggering its rapid ubiquitination and proteasomal degradation. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">retinitis pigmentosa GTPase regulator interacting protein 1</td>
<td align="left">77945</td>
<td align="left">Rpgrip1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">gap junction protein, beta 3</td>
<td align="left">14620</td>
<td align="left">Gjb3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">APAF1 interacting protein</td>
<td align="left">56369</td>
<td align="left">Apip</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">acetoacetyl-CoA synthetase</td>
<td align="left">78894</td>
<td align="left">Aacs</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">six transmembrane epithelial antigen of the prostate 1</td>
<td align="left">70358</td>
<td align="left">Steap1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">esterase D/formylglutathione hydrolase</td>
<td align="left">13885</td>
<td align="left">Esd</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">5, 10-methenyltetrahydrofolate synthetase</td>
<td align="left">107885</td>
<td align="left">Mthfs</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">isoamyl acetate-hydrolyzing esterase 1 homolog</td>
<td align="left">67732</td>
<td align="left">Iah1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">hydroxysteroid (17-beta) dehydrogenase 4</td>
<td align="left">15488</td>
<td align="left">Hsd17b4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">protein O-glucosyltransferase 1</td>
<td align="left">224143</td>
<td align="left">Poglut1</td>
<td align="left">This gene encodes a protein that can catalyze transfer of either UDP-glucose or UDP-xylose to epidermal growth factor (EGF) repeats, such as those found in Notch. Loss of this gene product results in embryonic lethality. Embryos have neural plate defects, heart defects, and truncations of their posterior axis. Alternate splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">major facilitator superfamily domain containing 8</td>
<td align="left">72175</td>
<td align="left">Mfsd8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">serine/arginine-rich splicing factor 4</td>
<td align="left">57317</td>
<td align="left">Srsf4</td>
<td align="left">The protein encoded by this gene is a member of the serine/arginine (SR)-rich family of pre-mRNA splicing factors, which constitute part of the spliceosome. Each of these factors contains an RNA recognition motif (RRM) for binding RNA and an RS domain for binding other proteins. The RS domain is rich in serine and arginine residues and facilitates interaction between different SR splicing factors. In addition to being critical for mRNA splicing, the SR proteins have also been shown to be involved in mRNA export from the nucleus and in translation.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">nudE neurodevelopment protein 1 like 1</td>
<td align="left">83431</td>
<td align="left">Ndel1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">minichromosome maintenance 8 homologous recombination repair factor</td>
<td align="left">66634</td>
<td align="left">Mcm8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">protein phosphatase 2, regulatory subunit B, gamma</td>
<td align="left">269643</td>
<td align="left">Ppp2r2c</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">WD repeat containing, antisense to Trp53</td>
<td align="left">216853</td>
<td align="left">Wrap53</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">2,4-dienoyl CoA reductase 1, mitochondrial</td>
<td align="left">67460</td>
<td align="left">Decr1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Hrsp12</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">general transcription factor II E, polypeptide 1 (alpha subunit)</td>
<td align="left">74197</td>
<td align="left">Gtf2e1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">cytochrome c oxidase assembly protein 18</td>
<td align="left">231430</td>
<td align="left">Cox18</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">protein disulfide isomerase associated 5</td>
<td align="left">72599</td>
<td align="left">Pdia5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">SHANK-associated RH domain interacting protein</td>
<td align="left">106025</td>
<td align="left">Sharpin</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">nucleobindin 2</td>
<td align="left">53322</td>
<td align="left">Nucb2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">2310003C23Rik</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Klraq1</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">eukaryotic translation initiation factor 2, subunit 3, structural gene Y-linked</td>
<td align="left">26908</td>
<td align="left">Eif2s3y</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">coiled-coil domain containing 163</td>
<td align="left">68394</td>
<td align="left">Ccdc163</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fanconi anemia, complementation group B</td>
<td align="left">237211</td>
<td align="left">Fancb</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Werner helicase interacting protein 1</td>
<td align="left">78903</td>
<td align="left">Wrnip1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">twinfilin actin binding protein 2</td>
<td align="left">23999</td>
<td align="left">Twf2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">polymerase (RNA) III (DNA directed) polypeptide D</td>
<td align="left">67065</td>
<td align="left">Polr3d</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rho GTPase activating protein 42</td>
<td align="left">71544</td>
<td align="left">Arhgap42</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">cDNA sequence BC055324</td>
<td align="left">381306</td>
<td align="left">BC055324</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">BEN domain containing 7</td>
<td align="left">209645</td>
<td align="left">Bend7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">DIS3 homolog, exosome endoribonuclease and 3’-5’ exoribonuclease</td>
<td align="left">72662</td>
<td align="left">Dis3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">RAB, member RAS oncogene family-like 3</td>
<td align="left">67657</td>
<td align="left">Rabl3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_load_voom/gene_names_clus_&quot;,6,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-7-annotations-1" class="section level3">
<h3>Factor 7 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[7,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">name</th>
<th align="left">X_id</th>
<th align="left">query</th>
<th align="left">summary</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">zinc finger protein 180</td>
<td align="left">210135</td>
<td align="left">Zfp180</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ninein-like</td>
<td align="left">78177</td>
<td align="left">Ninl</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">zinc finger protein 646</td>
<td align="left">233905</td>
<td align="left">Zfp646</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">endo/exonuclease (5’-3’), endonuclease G-like</td>
<td align="left">208194</td>
<td align="left">Exog</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">unc-45 myosin chaperone A</td>
<td align="left">101869</td>
<td align="left">Unc45a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Sec1 family domain containing 2</td>
<td align="left">212986</td>
<td align="left">Scfd2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NADPH dependent diflavin oxidoreductase 1</td>
<td align="left">78797</td>
<td align="left">Ndor1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">centromere protein I</td>
<td align="left">102920</td>
<td align="left">Cenpi</td>
<td align="left">This gene encodes a protein that may be constitutively associated with centromeres and might be involved in recruiting centromere protein A to the centromere for kinetochore assembly. A similar gene in human is involved in the response of gonadal tissues to follicle-stimulating hormone. Alternatively spliced transcript variants have been identified.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Fam203a</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">target of myb1-like 2 (chicken)</td>
<td align="left">216810</td>
<td align="left">Tom1l2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">microtubule associated serine/threonine kinase 3</td>
<td align="left">546071</td>
<td align="left">Mast3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">vav 2 oncogene</td>
<td align="left">22325</td>
<td align="left">Vav2</td>
<td align="left">This gene encodes a member of the Vav family of Rho guanine nucleotide exchange factors. Vav family proteins are involved in the development and activation of lymphocytes, and the encoded protein may also be involved in angiogenesis. Disruption of this gene in mice is associated with heart, artery, and kidney defects, as well as tachycardia and hypertension. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">RAN binding protein 10</td>
<td align="left">74334</td>
<td align="left">Ranbp10</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">VPS29 retromer complex component</td>
<td align="left">56433</td>
<td align="left">Vps29</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Kruppel-like factor 11</td>
<td align="left">194655</td>
<td align="left">Klf11</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">CCAAT/enhancer binding protein (C/EBP), gamma</td>
<td align="left">12611</td>
<td align="left">Cebpg</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Trp53rk</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">leucine rich repeat containing 14</td>
<td align="left">223664</td>
<td align="left">Lrrc14</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">aminopeptidase-like 1</td>
<td align="left">228961</td>
<td align="left">Npepl1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">zinc finger with KRAB and SCAN domains 14</td>
<td align="left">67235</td>
<td align="left">Zkscan14</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">adenylate cyclase 9</td>
<td align="left">11515</td>
<td align="left">Adcy9</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">solute carrier family 39 (metal ion transporter), member 13</td>
<td align="left">68427</td>
<td align="left">Slc39a13</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">tRNA phosphotransferase 1</td>
<td align="left">107328</td>
<td align="left">Trpt1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">cytochrome c oxidase subunit VIIb</td>
<td align="left">66142</td>
<td align="left">Cox7b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Solh</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">kelch-like 15</td>
<td align="left">236904</td>
<td align="left">Klhl15</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">large tumor suppressor</td>
<td align="left">16798</td>
<td align="left">Lats1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">zinc finger and BTB domain containing 2</td>
<td align="left">381990</td>
<td align="left">Zbtb2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">predicted gene 13251</td>
<td align="left">433791</td>
<td align="left">Gm13251</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">cytosolic thiouridylase subunit 1</td>
<td align="left">233189</td>
<td align="left">Ctu1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">WD repeat domain 72</td>
<td align="left">546144</td>
<td align="left">Wdr72</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">missing oocyte, meiosis regulator, homolog (Drosophila)</td>
<td align="left">252875</td>
<td align="left">Mios</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">kelch repeat and BTB (POZ) domain containing 4</td>
<td align="left">67136</td>
<td align="left">Kbtbd4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RIKEN cDNA 2810021J22 gene</td>
<td align="left">69944</td>
<td align="left">2810021J22Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">testis-specific kinase 2</td>
<td align="left">230661</td>
<td align="left">Tesk2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">1110018G07Rik</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">tribbles pseudokinase 1</td>
<td align="left">211770</td>
<td align="left">Trib1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">leucine rich repeat containing 47</td>
<td align="left">72946</td>
<td align="left">Lrrc47</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">sepiapterin reductase</td>
<td align="left">20751</td>
<td align="left">Spr</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">acyl-CoA thioesterase 11</td>
<td align="left">329910</td>
<td align="left">Acot11</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">RAB6A GEF compex partner 1</td>
<td align="left">242406</td>
<td align="left">Rgp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">cysteine rich protein 61</td>
<td align="left">16007</td>
<td align="left">Cyr61</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">family with sequence similarity 160, member B2</td>
<td align="left">239170</td>
<td align="left">Fam160b2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">phospholipase C, delta 3</td>
<td align="left">72469</td>
<td align="left">Plcd3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">START domain containing 3</td>
<td align="left">59045</td>
<td align="left">Stard3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">GRAM domain containing 4</td>
<td align="left">223752</td>
<td align="left">Gramd4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">golgi associated PDZ and coiled-coil motif containing</td>
<td align="left">94221</td>
<td align="left">Gopc</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">epithelial splicing regulatory protein 2</td>
<td align="left">77411</td>
<td align="left">Esrp2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">translocase of inner mitochondrial membrane 8B</td>
<td align="left">30057</td>
<td align="left">Timm8b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">2610301G19Rik</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">guanine nucleotide binding protein (G protein), beta 1</td>
<td align="left">14688</td>
<td align="left">Gnb1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">mindbomb E3 ubiquitin protein ligase 1</td>
<td align="left">225164</td>
<td align="left">Mib1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">salvador family WW domain containing 1</td>
<td align="left">64010</td>
<td align="left">Sav1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">DNA topoisomerase 1, mitochondrial</td>
<td align="left">72960</td>
<td align="left">Top1mt</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Rod1</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">RNA binding motif protein 41</td>
<td align="left">237073</td>
<td align="left">Rbm41</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">RIKEN cDNA 0610030E20 gene</td>
<td align="left">68364</td>
<td align="left">0610030E20Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian)</td>
<td align="left">17135</td>
<td align="left">Mafk</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">glutamine fructose-6-phosphate transaminase 2</td>
<td align="left">14584</td>
<td align="left">Gfpt2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">poliovirus receptor</td>
<td align="left">52118</td>
<td align="left">Pvr</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">uveal autoantigen with coiled-coil domains and ankyrin repeats</td>
<td align="left">72565</td>
<td align="left">Uaca</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">DDB1 and CUL4 associated factor 5</td>
<td align="left">320808</td>
<td align="left">Dcaf5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ligase IV, DNA, ATP-dependent</td>
<td align="left">319583</td>
<td align="left">Lig4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">zinc finger protein 653</td>
<td align="left">319601</td>
<td align="left">Zfp653</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">nuclear receptor subfamily 2, group C, member 2</td>
<td align="left">22026</td>
<td align="left">Nr2c2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">adenosine deaminase, RNA-specific</td>
<td align="left">56417</td>
<td align="left">Adar</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ataxin 7</td>
<td align="left">246103</td>
<td align="left">Atxn7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RIKEN cDNA 2700094K13 gene</td>
<td align="left">72657</td>
<td align="left">2700094K13Rik</td>
<td align="left">This gene encodes a nucleolar protein, which belongs to the SelWTH family. It functions as an oxidoreductase, and has been shown to protect neurons against UVB-induced damage by inhibiting apoptotic cell death pathways, promote mitochondrial biogenesis and mitochondrial function, and suppress cellular senescence through genome maintenance and redox regulation. This protein is a selenoprotein, containing the rare amino acid selenocysteine (Sec) at its active site. Sec is encoded by the UGA codon, which normally signals translation termination. The 3’ UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. Alternatively spliced transcript variants have been found for this gene.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">tet methylcytosine dioxygenase 2</td>
<td align="left">214133</td>
<td align="left">Tet2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">tubulin tyrosine ligase-like family, member 4</td>
<td align="left">67534</td>
<td align="left">Ttll4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">stromal interaction molecule 1</td>
<td align="left">20866</td>
<td align="left">Stim1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">BC046331</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">spermatogenesis associated 7</td>
<td align="left">104871</td>
<td align="left">Spata7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">coiled-coil domain containing 155</td>
<td align="left">384619</td>
<td align="left">Ccdc155</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">tumor necrosis factor (ligand) superfamily, member 13b</td>
<td align="left">24099</td>
<td align="left">Tnfsf13b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">2-oxoglutarate and iron-dependent oxygenase domain containing 2</td>
<td align="left">66627</td>
<td align="left">Ogfod2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">nodal modulator 1</td>
<td align="left">211548</td>
<td align="left">Nomo1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">corneodesmosin</td>
<td align="left">386463</td>
<td align="left">Cdsn</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">topoisomerase (DNA) III alpha</td>
<td align="left">21975</td>
<td align="left">Top3a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">solute carrier family 16 (monocarboxylic acid transporters), member 5</td>
<td align="left">217316</td>
<td align="left">Slc16a5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">torsin A interacting protein 2</td>
<td align="left">240832</td>
<td align="left">Tor1aip2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">PWWP domain containing 2B</td>
<td align="left">101631</td>
<td align="left">Pwwp2b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">protein tyrosine phosphatase, non-receptor type 21</td>
<td align="left">24000</td>
<td align="left">Ptpn21</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RIKEN cDNA 1810037I17 gene</td>
<td align="left">67704</td>
<td align="left">1810037I17Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">mortality factor 4 like 2</td>
<td align="left">56397</td>
<td align="left">Morf4l2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3</td>
<td align="left">26433</td>
<td align="left">Plod3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ubiquitin specific peptidase 54</td>
<td align="left">78787</td>
<td align="left">Usp54</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">reticulon 2 (Z-band associated protein)</td>
<td align="left">20167</td>
<td align="left">Rtn2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">zinc finger protein 775</td>
<td align="left">243372</td>
<td align="left">Zfp775</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">fibroblast growth factor binding protein 1</td>
<td align="left">14181</td>
<td align="left">Fgfbp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">xylulokinase homolog (H. influenzae)</td>
<td align="left">102448</td>
<td align="left">Xylb</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Tcfeb</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">sorting nexin 8</td>
<td align="left">231834</td>
<td align="left">Snx8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">copine I</td>
<td align="left">266692</td>
<td align="left">Cpne1</td>
<td align="left">This gene encodes a protein that contains two N-terminal type II C2 domains and an integrin A domain-like sequence in the C-terminus. Its activity is also upregulated in mouse embryos. This gene and the gene for RNA binding motif protein 12 overlap at map location 2 H2. Two alternatively spliced variants that encode the same isoform have been identified for this gene.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">kinesin light chain 4</td>
<td align="left">74764</td>
<td align="left">Klc4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">zinc finger protein 644</td>
<td align="left">52397</td>
<td align="left">Zfp644</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">SUMO/sentrin specific peptidase 5</td>
<td align="left">320213</td>
<td align="left">Senp5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ubinuclein 1</td>
<td align="left">170644</td>
<td align="left">Ubn1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">WD repeat domain 53</td>
<td align="left">68980</td>
<td align="left">Wdr53</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">transmembrane protein 87B</td>
<td align="left">72477</td>
<td align="left">Tmem87b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_load_voom/gene_names_clus_&quot;,7,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-8-annotations-1" class="section level3">
<h3>Factor 8 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[8,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">query</th>
<th align="left">name</th>
<th align="left">X_id</th>
<th align="left">notfound</th>
<th align="left">summary</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Obox6</td>
<td align="left">oocyte specific homeobox 6</td>
<td align="left">252830</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Anxa2</td>
<td align="left">annexin A2</td>
<td align="left">12306</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Dppa1</td>
<td align="left">developmental pluripotency associated 1</td>
<td align="left">347708</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gm11517</td>
<td align="left">predicted gene 11517</td>
<td align="left">ENSMUSG00000081249</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm11517</td>
<td align="left">ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene</td>
<td align="left">629750</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Slc15a2</td>
<td align="left">solute carrier family 15 (H+/peptide transporter), member 2</td>
<td align="left">57738</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ano9</td>
<td align="left">anoctamin 9</td>
<td align="left">71345</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Adh1</td>
<td align="left">alcohol dehydrogenase 1 (class I)</td>
<td align="left">11522</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Anxa6</td>
<td align="left">annexin A6</td>
<td align="left">11749</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Capg</td>
<td align="left">capping protein (actin filament), gelsolin-like</td>
<td align="left">12332</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Stmn3</td>
<td align="left">stathmin-like 3</td>
<td align="left">20262</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Bex6</td>
<td align="left">brain expressed family member 6</td>
<td align="left">328660</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">BC053393</td>
<td align="left">cDNA sequence BC053393</td>
<td align="left">407814</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Dsp</td>
<td align="left">desmoplakin</td>
<td align="left">109620</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rab39</td>
<td align="left">RAB39, member RAS oncogene family</td>
<td align="left">270160</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Lcp1</td>
<td align="left">lymphocyte cytosolic protein 1</td>
<td align="left">18826</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">5730469M10Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Zc3hc1</td>
<td align="left">zinc finger, C3HC type 1</td>
<td align="left">232679</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Sh3bgrl2</td>
<td align="left">SH3 domain binding glutamic acid-rich protein like 2</td>
<td align="left">212531</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cthrc1</td>
<td align="left">collagen triple helix repeat containing 1</td>
<td align="left">68588</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Agmat</td>
<td align="left">agmatine ureohydrolase (agmatinase)</td>
<td align="left">75986</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tfrc</td>
<td align="left">transferrin receptor</td>
<td align="left">22042</td>
<td align="left">NA</td>
<td align="left">This gene encodes a cell surface receptor necessary for cellular iron uptake by the process of receptor-mediated endocytosis. This receptor is required for erythropoiesis and neurologic development. Mice that are deficient in this receptor show impaired erythroid development and abnormal iron homeostasis.</td>
</tr>
<tr class="odd">
<td align="left">Krt8</td>
<td align="left">keratin 8</td>
<td align="left">16691</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cited1</td>
<td align="left">Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1</td>
<td align="left">12705</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gsta4</td>
<td align="left">glutathione S-transferase, alpha 4</td>
<td align="left">14860</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Id2</td>
<td align="left">inhibitor of DNA binding 2</td>
<td align="left">15902</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ccdc42</td>
<td align="left">coiled-coil domain containing 42</td>
<td align="left">276920</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tmsb4x</td>
<td align="left">thymosin, beta 4, X chromosome</td>
<td align="left">19241</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ubtfl1</td>
<td align="left">upstream binding transcription factor, RNA polymerase I-like 1</td>
<td align="left">546118</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ficd</td>
<td align="left">FIC domain containing</td>
<td align="left">231630</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Enpep</td>
<td align="left">glutamyl aminopeptidase</td>
<td align="left">13809</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gng2</td>
<td align="left">guanine nucleotide binding protein (G protein), gamma 2</td>
<td align="left">14702</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Icam1</td>
<td align="left">intercellular adhesion molecule 1</td>
<td align="left">15894</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">0610005C13Rik</td>
<td align="left">RIKEN cDNA 0610005C13 gene</td>
<td align="left">71661</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Hsd17b14</td>
<td align="left">hydroxysteroid (17-beta) dehydrogenase 14</td>
<td align="left">66065</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Sft2d2</td>
<td align="left">SFT2 domain containing 2</td>
<td align="left">108735</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ovol2</td>
<td align="left">ovo like zinc finger 2</td>
<td align="left">107586</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Zyx</td>
<td align="left">zyxin</td>
<td align="left">22793</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm11544</td>
<td align="left">predicted gene 11544</td>
<td align="left">ENSMUSG00000081586</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gm11544</td>
<td align="left">predicted gene 11544</td>
<td align="left">432591</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ank</td>
<td align="left">progressive ankylosis</td>
<td align="left">11732</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Sipa1l2</td>
<td align="left">signal-induced proliferation-associated 1 like 2</td>
<td align="left">244668</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fxyd6</td>
<td align="left">FXYD domain-containing ion transport regulator 6</td>
<td align="left">59095</td>
<td align="left">NA</td>
<td align="left">This reference sequence was derived from multiple replicate ESTs and validated by similar human genomic sequence. This gene encodes a member of a family of small membrane proteins that share a 35-amino acid signature sequence domain, beginning with the sequence PFXYD and containing 7 invariant and 6 highly conserved amino acids. The approved human gene nomenclature for the family is FXYD-domain containing ion transport regulator. Transmembrane topology has been established for two family members (FXYD1 and FXYD2), with the N-terminus extracellular and the C-terminus on the cytoplasmic side of the membrane. FXYD2, also known as the gamma subunit of the Na,K-ATPase, regulates the properties of that enzyme. FXYD1 (phospholemman), FXYD2 (gamma), FXYD3 (MAT-8), FXYD4 (CHIF), and FXYD5 (RIC) have been shown to induce channel activity in experimental expression systems. This gene product, Fxyd6, is novel and has not been characterized as a protein. [RefSeq curation by Kathleen J. Sweadner, Ph.D., <a href="mailto:sweadner@helix.mgh.harvard.edu">sweadner@helix.mgh.harvard.edu</a>., Jul 2006].</td>
</tr>
<tr class="even">
<td align="left">Tmem56</td>
<td align="left">transmembrane protein 56</td>
<td align="left">99887</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cst7</td>
<td align="left">cystatin F (leukocystatin)</td>
<td align="left">13011</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Fmnl2</td>
<td align="left">formin-like 2</td>
<td align="left">71409</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tmem9</td>
<td align="left">transmembrane protein 9</td>
<td align="left">66241</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Top2b</td>
<td align="left">topoisomerase (DNA) II beta</td>
<td align="left">21974</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Lrrfip1</td>
<td align="left">leucine rich repeat (in FLII) interacting protein 1</td>
<td align="left">16978</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rasl11a</td>
<td align="left">RAS-like, family 11, member A</td>
<td align="left">68895</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pgm2</td>
<td align="left">phosphoglucomutase 2</td>
<td align="left">72157</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rusc1</td>
<td align="left">RUN and SH3 domain containing 1</td>
<td align="left">72296</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Hcrt</td>
<td align="left">hypocretin</td>
<td align="left">15171</td>
<td align="left">NA</td>
<td align="left">This gene encodes a hypothalamic neuropeptide precursor protein that gives rise to two mature neuropeptides, orexin A and orexin B, by proteolytic processing. Orexin A and orexin B, which bind to orphan G-protein coupled receptors Hcrtr1 and Hcrtr2, function in the regulation of sleep and arousal. This neuropeptide arrangement may also play a role in feeding behavior, metabolism, and homeostasis.</td>
</tr>
<tr class="even">
<td align="left">Tmprss2</td>
<td align="left">transmembrane protease, serine 2</td>
<td align="left">50528</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Klrg2</td>
<td align="left">killer cell lectin-like receptor subfamily G, member 2</td>
<td align="left">74253</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">D4Bwg0951e</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Zfp820</td>
<td align="left">zinc finger protein 820</td>
<td align="left">75424</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Glrx</td>
<td align="left">glutaredoxin</td>
<td align="left">93692</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Atxn7l3</td>
<td align="left">ataxin 7-like 3</td>
<td align="left">217218</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Serping1</td>
<td align="left">serine (or cysteine) peptidase inhibitor, clade G, member 1</td>
<td align="left">12258</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ooep</td>
<td align="left">oocyte expressed protein</td>
<td align="left">67968</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">B4galt5</td>
<td align="left">UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5</td>
<td align="left">56336</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Eomes</td>
<td align="left">eomesodermin</td>
<td align="left">13813</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ankrd10</td>
<td align="left">ankyrin repeat domain 10</td>
<td align="left">102334</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tbc1d9</td>
<td align="left">TBC1 domain family, member 9</td>
<td align="left">71310</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pdzk1</td>
<td align="left">PDZ domain containing 1</td>
<td align="left">59020</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Csrnp2</td>
<td align="left">cysteine-serine-rich nuclear protein 2</td>
<td align="left">207785</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tcirg1</td>
<td align="left">T cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 protein A3</td>
<td align="left">27060</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ppt2</td>
<td align="left">palmitoyl-protein thioesterase 2</td>
<td align="left">54397</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Mdh1</td>
<td align="left">malate dehydrogenase 1, NAD (soluble)</td>
<td align="left">17449</td>
<td align="left">NA</td>
<td align="left">This gene encodes an enzyme that catalyzes the NAD/NADH-dependent, reversible oxidation of malate to oxaloacetate in many metabolic pathways, including the citric acid cycle. Two main isozymes are known to exist in eukaryotic cells: one is found in the mitochondrial matrix and the other in the cytoplasm. This gene encodes the cytosolic isozyme, which plays a key role in the malate-aspartate shuttle that allows malate to pass through the mitochondrial membrane to be transformed into oxaloacetate for further cellular processes. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is localized in the peroxisomes. A pseudogene has been identified on chromosomes 12.</td>
</tr>
<tr class="odd">
<td align="left">Capns1</td>
<td align="left">calpain, small subunit 1</td>
<td align="left">12336</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">L2hgdh</td>
<td align="left">L-2-hydroxyglutarate dehydrogenase</td>
<td align="left">217666</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Dsc2</td>
<td align="left">desmocollin 2</td>
<td align="left">13506</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the desmocollin protein subfamily. Desmocollins are cadherin-like transmembrane glycoproteins that are major components of the desmosome. Desmosomes are cell-cell junctions that help resist shearing forces and are found in high concentrations in cells subject to mechanical stress. Alternative splicing results in multiple transcript variants.</td>
</tr>
<tr class="even">
<td align="left">Ppp1r3b</td>
<td align="left">protein phosphatase 1, regulatory (inhibitor) subunit 3B</td>
<td align="left">244416</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Slc44a4</td>
<td align="left">solute carrier family 44, member 4</td>
<td align="left">70129</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Prkag2</td>
<td align="left">protein kinase, AMP-activated, gamma 2 non-catalytic subunit</td>
<td align="left">108099</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fam57b</td>
<td align="left">family with sequence similarity 57, member B</td>
<td align="left">68952</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cbr2</td>
<td align="left">carbonyl reductase 2</td>
<td align="left">12409</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Trim7</td>
<td align="left">tripartite motif-containing 7</td>
<td align="left">94089</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">2700023E23Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rgs11</td>
<td align="left">regulator of G-protein signaling 11</td>
<td align="left">50782</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Bambi</td>
<td align="left">BMP and activin membrane-bound inhibitor</td>
<td align="left">68010</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">AU018829</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Myo1e</td>
<td align="left">myosin IE</td>
<td align="left">71602</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm13718</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Acot2</td>
<td align="left">acyl-CoA thioesterase 2</td>
<td align="left">171210</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Dnajb9</td>
<td align="left">DnaJ heat shock protein family (Hsp40) member B9</td>
<td align="left">27362</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Nudt5</td>
<td align="left">nudix (nucleoside diphosphate linked moiety X)-type motif 5</td>
<td align="left">53893</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Bhmt2</td>
<td align="left">betaine-homocysteine methyltransferase 2</td>
<td align="left">64918</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Spnb3</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mbp</td>
<td align="left">myelin basic protein</td>
<td align="left">17196</td>
<td align="left">NA</td>
<td align="left">The protein encoded by the classic Mbp gene is a major constituent of the myelin sheath of oligodendrocytes and Schwann cells in the nervous system. However, Mbp-related transcripts are also present in the bone marrow and the immune system. These mRNAs arise from the long Mbp gene (otherwise called ‘Golli-Mbp’) that contains 3 additional exons located upstream of the classic Mbp exons. Alternative splicing from the Golli and the Mbp transcription start sites gives rise to 2 sets of Mbp-related transcripts and gene products. The Golli mRNAs contain 3 exons unique to Golli-Mbp, spliced in-frame to 1 or more Mbp exons. They encode hybrid proteins that have N-terminal Golli aa sequence linked to Mbp aa sequence. The second family of transcripts contain only Mbp exons and produce the well characterized myelin basic proteins. This complex gene structure is conserved among species suggesting that the Mbp transcription unit is an integral part of the Golli transcription unit and that this arrangement is important for the function and/or regulation of these genes. Mutation of the Mbp gene is associated with the ‘shiverer’ and ‘myelin deficient’ phenotypes in mouse.</td>
</tr>
<tr class="even">
<td align="left">Sdcbp</td>
<td align="left">syndecan binding protein</td>
<td align="left">53378</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cgnl1</td>
<td align="left">cingulin-like 1</td>
<td align="left">68178</td>
<td align="left">NA</td>
<td align="left">This gene encodes a protein localized to the tight junctions and adherens junctions in vertebrate epithelial cells. The encoded protein regulates the activity of Rho family GTPases during junction assembly and at confluence. At the adherens junctions, the encoded protein is part of a protein complex that links E-cadherin to the microtubule cytoskeleton. Alternative splicing of this gene results in multiple transcript variants.</td>
</tr>
<tr class="even">
<td align="left">Wnk2</td>
<td align="left">WNK lysine deficient protein kinase 2</td>
<td align="left">75607</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Hand1</td>
<td align="left">heart and neural crest derivatives expressed transcript 1</td>
<td align="left">15110</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Chmp2b</td>
<td align="left">charged multivesicular body protein 2B</td>
<td align="left">68942</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tnfsf13b</td>
<td align="left">tumor necrosis factor (ligand) superfamily, member 13b</td>
<td align="left">24099</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Mpp7</td>
<td align="left">membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7)</td>
<td align="left">75739</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fam154a</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Trib3</td>
<td align="left">tribbles pseudokinase 3</td>
<td align="left">228775</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Krt18</td>
<td align="left">keratin 18</td>
<td align="left">16668</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rnf128</td>
<td align="left">ring finger protein 128</td>
<td align="left">66889</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_load_voom/gene_names_clus_&quot;,8,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-9-annotations-1" class="section level3">
<h3>Factor 9 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[9,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">X_id</th>
<th align="left">summary</th>
<th align="left">query</th>
<th align="left">name</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">54419</td>
<td align="left">This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets, and also play critical roles in maintaining cell polarity and signal transductions. The protein encoded by this gene is essential for blastocyst formation in preimplantation mouse embryos, and is invloved in and is crucial for the formation and maintenance of the epidermal permeability barrier. This gene is adjacent to another family member Cldn9 on chromosome 17.</td>
<td align="left">Cldn6</td>
<td align="left">claudin 6</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">329828</td>
<td align="left">NA</td>
<td align="left">AI464131</td>
<td align="left">expressed sequence AI464131</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">67912</td>
<td align="left">NA</td>
<td align="left">1600012H06Rik</td>
<td align="left">RIKEN cDNA 1600012H06 gene</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">H47</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">231717</td>
<td align="left">NA</td>
<td align="left">Fam109a</td>
<td align="left">family with sequence similarity 109, member A</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">19655</td>
<td align="left">NA</td>
<td align="left">Rbmx</td>
<td align="left">RNA binding motif protein, X chromosome</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">13052</td>
<td align="left">This gene encodes a protein that is part of the Cortical Thymocyte marker in Xenopus (CTX) subfamily within the immunoglobulin superfamily. Members of this subfamily, predominantly expressed on the surface of endothelial and epithelial cells, help establish cell polarity and provide a barrier function, regulating migration of immune cells. This protein, first identified as the receptor for adenovirus subgroup C and coxsakieviruses group B, is developmentally regulated and plays an important role in cardiac development. Alternative splicing results in multiple transcript variants that encode different protein isoforms.</td>
<td align="left">Cxadr</td>
<td align="left">coxsackie virus and adenovirus receptor</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">269356</td>
<td align="left">NA</td>
<td align="left">Slc4a11</td>
<td align="left">solute carrier family 4, sodium bicarbonate transporter-like, member 11</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">11605</td>
<td align="left">NA</td>
<td align="left">Gla</td>
<td align="left">galactosidase, alpha</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">117160</td>
<td align="left">NA</td>
<td align="left">Ttyh2</td>
<td align="left">tweety family member 2</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">320435</td>
<td align="left">NA</td>
<td align="left">Rinl</td>
<td align="left">Ras and Rab interactor-like</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">66269</td>
<td align="left">NA</td>
<td align="left">Tmed6</td>
<td align="left">transmembrane emp24 protein transport domain containing 6</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">68366</td>
<td align="left">NA</td>
<td align="left">Tmem129</td>
<td align="left">transmembrane protein 129</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">192166</td>
<td align="left">NA</td>
<td align="left">Sardh</td>
<td align="left">sarcosine dehydrogenase</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">347712</td>
<td align="left">NA</td>
<td align="left">Pramel7</td>
<td align="left">preferentially expressed antigen in melanoma like 7</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">56312</td>
<td align="left">NA</td>
<td align="left">Nupr1</td>
<td align="left">nuclear protein transcription regulator 1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">56522</td>
<td align="left">NA</td>
<td align="left">Papolb</td>
<td align="left">poly (A) polymerase beta (testis specific)</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">114585</td>
<td align="left">NA</td>
<td align="left">D17H6S53E</td>
<td align="left">DNA segment, Chr 17, human D6S53E</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">73167</td>
<td align="left">NA</td>
<td align="left">Arhgap8</td>
<td align="left">Rho GTPase activating protein 8</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">228852</td>
<td align="left">NA</td>
<td align="left">Ppp1r16b</td>
<td align="left">protein phosphatase 1, regulatory (inhibitor) subunit 16B</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">74091</td>
<td align="left">NA</td>
<td align="left">Npl</td>
<td align="left">N-acetylneuraminate pyruvate lyase</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">78802</td>
<td align="left">NA</td>
<td align="left">Ttc30a1</td>
<td align="left">tetratricopeptide repeat domain 30A1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">73062</td>
<td align="left">NA</td>
<td align="left">Ppp1r16a</td>
<td align="left">protein phosphatase 1, regulatory (inhibitor) subunit 16A</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">13039</td>
<td align="left">This gene encodes a member of the peptidase C1 (papain) family of cysteine proteases. The encoded preproprotein is proteolytically processed to generate multiple protein products. These products include the activation peptide and the cathepsin L1 heavy and light chains. The mature enzyme appears to be important in embryonic development through its processing of histone H3 and may play a role in disease progression in a model of kidney disease. Homozygous knockout mice for this gene exhibit hair loss, skin thickening, bone and heart defects, and enhanced susceptibility to bacterial infection. A pseudogene of this gene has been identified in the genome.</td>
<td align="left">Ctsl</td>
<td align="left">cathepsin L</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">14275</td>
<td align="left">NA</td>
<td align="left">Folr1</td>
<td align="left">folate receptor 1 (adult)</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">80721</td>
<td align="left">NA</td>
<td align="left">Slc19a3</td>
<td align="left">solute carrier family 19, member 3</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">378425</td>
<td align="left">NA</td>
<td align="left">Nlrp12</td>
<td align="left">NLR family, pyrin domain containing 12</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12265</td>
<td align="left">This gene encodes a member of the NOD-like receptor protein family. This protein acts as a transcriptional coactivator and component of the enhanceosome complex to stimulate transcription of MHC class II genes in the adaptive immune response. This protein may also regulate the transcription of MHC class I genes. Mutations in the human gene have been linked to a rare immunodeficiency, bare lymphocyte syndrome, and homozygous knockout mice exhibit many features of this disease. Alternative splicing results in multiple transcript variants encoding different isoforms.</td>
<td align="left">Ciita</td>
<td align="left">class II transactivator</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">17748</td>
<td align="left">NA</td>
<td align="left">Mt1</td>
<td align="left">metallothionein 1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">27279</td>
<td align="left">NA</td>
<td align="left">Tnfrsf12a</td>
<td align="left">tumor necrosis factor receptor superfamily, member 12a</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">56702</td>
<td align="left">Histones are basic nuclear proteins responsible for nucleosome structure of the chromosomal fiber in eukaryotes. Two molecules of each of the four core histones (H2A, H2B, H3, and H4) form an octamer, around which approximately 146 bp of DNA is wrapped in repeating units, called nucleosomes. The linker histone, H1, interacts with linker DNA between nucleosomes and functions in the compaction of chromatin into higher order structures. This gene is intronless and encodes a replication-dependent histone that is a member of the histone H1 family. Transcripts from this gene lack polyA tails but instead contain a palindromic termination element.</td>
<td align="left">Hist1h1b</td>
<td align="left">histone cluster 1, H1b</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">278679</td>
<td align="left">NA</td>
<td align="left">Apol7b</td>
<td align="left">apolipoprotein L 7b</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">666348</td>
<td align="left">NA</td>
<td align="left">Apol7e</td>
<td align="left">apolipoprotein L 7e</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">278679</td>
<td align="left">NA</td>
<td align="left">Apol7b</td>
<td align="left">apolipoprotein L 7b</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">LOC100503167</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">15356</td>
<td align="left">NA</td>
<td align="left">Hmgcl</td>
<td align="left">3-hydroxy-3-methylglutaryl-Coenzyme A lyase</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">22346</td>
<td align="left">NA</td>
<td align="left">Vhl</td>
<td align="left">von Hippel-Lindau tumor suppressor</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">381686</td>
<td align="left">NA</td>
<td align="left">Kpna7</td>
<td align="left">karyopherin alpha 7 (importin alpha 8)</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">102058</td>
<td align="left">NA</td>
<td align="left">Exoc8</td>
<td align="left">exocyst complex component 8</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Stk30</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">83395</td>
<td align="left">NA</td>
<td align="left">Sp6</td>
<td align="left">trans-acting transcription factor 6</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">381591</td>
<td align="left">NA</td>
<td align="left">L1td1</td>
<td align="left">LINE-1 type transposase domain containing 1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">217664</td>
<td align="left">NA</td>
<td align="left">Mgat2</td>
<td align="left">mannoside acetylglucosaminyltransferase 2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">70317</td>
<td align="left">NA</td>
<td align="left">Arl16</td>
<td align="left">ADP-ribosylation factor-like 16</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">18762</td>
<td align="left">NA</td>
<td align="left">Prkcz</td>
<td align="left">protein kinase C, zeta</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">76041</td>
<td align="left">NA</td>
<td align="left">Ccdc125</td>
<td align="left">coiled-coil domain containing 125</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">50530</td>
<td align="left">NA</td>
<td align="left">Mfap5</td>
<td align="left">microfibrillar associated protein 5</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Mettl11a</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">72699</td>
<td align="left">NA</td>
<td align="left">Lime1</td>
<td align="left">Lck interacting transmembrane adaptor 1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">17131</td>
<td align="left">NA</td>
<td align="left">Smad7</td>
<td align="left">SMAD family member 7</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">28126</td>
<td align="left">NA</td>
<td align="left">Nop16</td>
<td align="left">NOP16 nucleolar protein</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">73680</td>
<td align="left">NA</td>
<td align="left">Zbtb8a</td>
<td align="left">zinc finger and BTB domain containing 8a</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">13479</td>
<td align="left">NA</td>
<td align="left">Dpep1</td>
<td align="left">dipeptidase 1 (renal)</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">71522</td>
<td align="left">NA</td>
<td align="left">Ggt6</td>
<td align="left">gamma-glutamyltransferase 6</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">170439</td>
<td align="left">NA</td>
<td align="left">Elovl6</td>
<td align="left">ELOVL family member 6, elongation of long chain fatty acids (yeast)</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">69769</td>
<td align="left">NA</td>
<td align="left">Tnfaip8l2</td>
<td align="left">tumor necrosis factor, alpha-induced protein 8-like 2</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">29862</td>
<td align="left">NA</td>
<td align="left">Ninj2</td>
<td align="left">ninjurin 2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">4922505G16Rik</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Crxos1</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">246104</td>
<td align="left">NA</td>
<td align="left">Rhbdl3</td>
<td align="left">rhomboid, veinlet-like 3 (Drosophila)</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">72599</td>
<td align="left">NA</td>
<td align="left">Pdia5</td>
<td align="left">protein disulfide isomerase associated 5</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">19053</td>
<td align="left">NA</td>
<td align="left">Ppp2cb</td>
<td align="left">protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">666731</td>
<td align="left">NA</td>
<td align="left">Trim43c</td>
<td align="left">tripartite motif-containing 43C</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">666747</td>
<td align="left">NA</td>
<td align="left">Trim43b</td>
<td align="left">tripartite motif-containing 43B</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">1700023L04Rik</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">216350</td>
<td align="left">NA</td>
<td align="left">Tspan8</td>
<td align="left">tetraspanin 8</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20431</td>
<td align="left">NA</td>
<td align="left">Pmel</td>
<td align="left">premelanosome protein</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">80291</td>
<td align="left">NA</td>
<td align="left">Rilpl2</td>
<td align="left">Rab interacting lysosomal protein-like 2</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">70465</td>
<td align="left">NA</td>
<td align="left">Wdr77</td>
<td align="left">WD repeat domain 77</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12370</td>
<td align="left">This gene is part of a family of caspases, aspartate-specific cysteine proteases well studied for their involvement in immune and apoptosis signaling. This protein, an initiator of apoptotic cell death, is activated by death-inducing tumor necrosis family receptors and targets downstream effectors. In mouse deficiency of this gene can cause embryonic lethality. This protein may have a role in embryogenesis. Alternative splicing results in multiple transcript variants that encode different protein isoforms.</td>
<td align="left">Casp8</td>
<td align="left">caspase 8</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">104943</td>
<td align="left">NA</td>
<td align="left">Fam110c</td>
<td align="left">family with sequence similarity 110, member C</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">210146</td>
<td align="left">NA</td>
<td align="left">Irgq</td>
<td align="left">immunity-related GTPase family, Q</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">12492</td>
<td align="left">This gene encodes a CD36-like type III transmembrane glycoprotein that localizes to the lysosomal membrane. Mice lacking the encoded protein exhibit an increased postnatal mortality caused by an obstruction of the ureteropelvic junction, deafness, peripheral demyelinating neuropathy and tubular proteinuria.</td>
<td align="left">Scarb2</td>
<td align="left">scavenger receptor class B, member 2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">66333</td>
<td align="left">NA</td>
<td align="left">Aqp11</td>
<td align="left">aquaporin 11</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">237940</td>
<td align="left">NA</td>
<td align="left">Aoc2</td>
<td align="left">amine oxidase, copper containing 2 (retina-specific)</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">16467</td>
<td align="left">NA</td>
<td align="left">Atcay</td>
<td align="left">ataxia, cerebellar, Cayman type</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">72512</td>
<td align="left">NA</td>
<td align="left">Tmem173</td>
<td align="left">transmembrane protein 173</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">20167</td>
<td align="left">NA</td>
<td align="left">Rtn2</td>
<td align="left">reticulon 2 (Z-band associated protein)</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">11448</td>
<td align="left">This gene encodes the epsilon subunit of the muscle-derived nicotinic acetylcholine receptor, a pentameric neurotransmitter receptor and member of the ligand-gated ion channel superfamily. The acetylcholine receptor changes subunit composition shortly after birth when the epsilon subunit replaces the gamma subunit seen in embryonic receptors. In mice, deficiency of this gene can lead to a decline in the number of nicotinic acetylcholine receptors at neuromuscular junctions and causes progressive muscle weakness, atrophy and premature death. Mutations in this gene serve as a pathophysiological model for human congenital myasthenia. Several alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known.</td>
<td align="left">Chrne</td>
<td align="left">cholinergic receptor, nicotinic, epsilon polypeptide</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">77781</td>
<td align="left">NA</td>
<td align="left">Epm2aip1</td>
<td align="left">EPM2A (laforin) interacting protein 1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">347711</td>
<td align="left">NA</td>
<td align="left">Pramel6</td>
<td align="left">preferentially expressed antigen in melanoma like 6</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12417</td>
<td align="left">NA</td>
<td align="left">Cbx3</td>
<td align="left">chromobox 3</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">56322</td>
<td align="left">NA</td>
<td align="left">Timm22</td>
<td align="left">translocase of inner mitochondrial membrane 22</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">213121</td>
<td align="left">NA</td>
<td align="left">Ankrd35</td>
<td align="left">ankyrin repeat domain 35</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">16646</td>
<td align="left">NA</td>
<td align="left">Kpna1</td>
<td align="left">karyopherin (importin) alpha 1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">237211</td>
<td align="left">NA</td>
<td align="left">Fancb</td>
<td align="left">Fanconi anemia, complementation group B</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">107733</td>
<td align="left">NA</td>
<td align="left">Mrpl41</td>
<td align="left">mitochondrial ribosomal protein L41</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">71924</td>
<td align="left">NA</td>
<td align="left">Tube1</td>
<td align="left">epsilon-tubulin 1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">13838</td>
<td align="left">NA</td>
<td align="left">Epha4</td>
<td align="left">Eph receptor A4</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">17527</td>
<td align="left">NA</td>
<td align="left">Mpv17</td>
<td align="left">MpV17 mitochondrial inner membrane protein</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">230757</td>
<td align="left">NA</td>
<td align="left">5730409E04Rik</td>
<td align="left">RIKEN cDNA 5730409E04Rik gene</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">386655</td>
<td align="left">NA</td>
<td align="left">Eid2</td>
<td align="left">EP300 interacting inhibitor of differentiation 2</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">547109</td>
<td align="left">NA</td>
<td align="left">Trim43a</td>
<td align="left">tripartite motif-containing 43A</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">66054</td>
<td align="left">NA</td>
<td align="left">Cndp2</td>
<td align="left">CNDP dipeptidase 2 (metallopeptidase M20 family)</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ENSMUSG00000085241</td>
<td align="left">NA</td>
<td align="left">Snhg3</td>
<td align="left">small nucleolar RNA host gene 3</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">399101</td>
<td align="left">NA</td>
<td align="left">Snhg3</td>
<td align="left">small nucleolar RNA host gene 3</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">19200</td>
<td align="left">NA</td>
<td align="left">Pstpip1</td>
<td align="left">proline-serine-threonine phosphatase-interacting protein 1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ENSMUSG00000085114</td>
<td align="left">NA</td>
<td align="left">1600025M17Rik</td>
<td align="left">RIKEN cDNA 1600025M17 gene</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">72030</td>
<td align="left">NA</td>
<td align="left">1600025M17Rik</td>
<td align="left">RIKEN cDNA 1600025M17 gene</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">244198</td>
<td align="left">NA</td>
<td align="left">Olfml1</td>
<td align="left">olfactomedin-like 1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Gm14511</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">380709</td>
<td align="left">NA</td>
<td align="left">Spata22</td>
<td align="left">spermatogenesis associated 22</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">117592</td>
<td align="left">NA</td>
<td align="left">B3galt6</td>
<td align="left">UDP-Gal:betaGal beta 1,3-galactosyltransferase, polypeptide 6</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_load_voom/gene_names_clus_&quot;,9,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-10-annotations-1" class="section level3">
<h3>Factor 10 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[10,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">X_id</th>
<th align="left">name</th>
<th align="left">query</th>
<th align="left">summary</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">23945</td>
<td align="left">monoglyceride lipase</td>
<td align="left">Mgll</td>
<td align="left">This gene encodes a monoglyceride lipase, which catalyzes the hydrolysis of monoglycerides into fatty acids and glycerol. This enzyme is also thought to hydrolyze the endocannabinoid 2-arachidonoylglycerol. Alternatively spliced transcript variants have been described.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">19411</td>
<td align="left">retinoic acid receptor, gamma</td>
<td align="left">Rarg</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">56857</td>
<td align="left">solute carrier family 37 (glycerol-3-phosphate transporter), member 2</td>
<td align="left">Slc37a2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">83672</td>
<td align="left">synaptotagmin-like 3</td>
<td align="left">Sytl3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">74691</td>
<td align="left">tudor domain containing 9</td>
<td align="left">Tdrd9</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Pet112l</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">100340</td>
<td align="left">sphingomyelin phosphodiesterase, acid-like 3B</td>
<td align="left">Smpdl3b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">13511</td>
<td align="left">desmoglein 2</td>
<td align="left">Dsg2</td>
<td align="left">This gene encodes a member of the cadherin family of proteins that forms an integral transmembrane component of desmosomes, the multiprotein complexes involved in cell adhesion, organization of the cytoskeleton, cell sorting and cell signaling. The encoded preproprotein undergoes proteolytic processing to generate a mature, functional protein. Mice lacking the encoded protein die in utero. Mutant mice lacking a part of the extracellular adhesive domain of the encoded protein develop cardiac fibrosis and dilation. This gene is located in a cluster of desmosomal cadherin genes on chromosome 18.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">99887</td>
<td align="left">transmembrane protein 56</td>
<td align="left">Tmem56</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">106861</td>
<td align="left">abhydrolase domain containing 3</td>
<td align="left">Abhd3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">68262</td>
<td align="left">1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)</td>
<td align="left">Agpat4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">277973</td>
<td align="left">solute carrier family 9 (sodium/hydrogen exchanger), member 5</td>
<td align="left">Slc9a5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">72026</td>
<td align="left">tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase</td>
<td align="left">Trmu</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">13643</td>
<td align="left">ephrin B3</td>
<td align="left">Efnb3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">108653</td>
<td align="left">ribosomal modification protein rimK-like family member B</td>
<td align="left">Rimklb</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">24099</td>
<td align="left">tumor necrosis factor (ligand) superfamily, member 13b</td>
<td align="left">Tnfsf13b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">13711</td>
<td align="left">E74-like factor 5</td>
<td align="left">Elf5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">224250</td>
<td align="left">claudin domain containing 1</td>
<td align="left">Cldnd1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">19260</td>
<td align="left">protein tyrosine phosphatase, non-receptor type 22 (lymphoid)</td>
<td align="left">Ptpn22</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Mll1</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">69106</td>
<td align="left">stomatin-like 1</td>
<td align="left">Stoml1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">22654</td>
<td align="left">zinc finger protein 13</td>
<td align="left">Zfp13</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">15275</td>
<td align="left">hexokinase 1</td>
<td align="left">Hk1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">56296</td>
<td align="left">DMRT-like family B with proline-rich C-terminal, 1</td>
<td align="left">Dmrtb1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ENSMUSG00000101609</td>
<td align="left">KCNQ1 overlapping transcript 1</td>
<td align="left">Kcnq1ot1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">63830</td>
<td align="left">KCNQ1 overlapping transcript 1</td>
<td align="left">Kcnq1ot1</td>
<td align="left">The distal end of mouse chromosome 7 contains two clusters of epigenetically-regulated genes that are expressed from only one chromosome in a parent-of-origin manner. Each cluster, or imprinted domain, is regulated by a functionally independent imprinting control region (ICR). The telomeric imprinted domain is regulated by an ICR located in an intron of Kcnq1, and contains at least eight genes that are expressed exclusively or preferentially from the maternally-inherited allele. The DNA of the ICR is specifically methylated on the maternally-inherited chromosome, and unmethylated on the paternally-inherited chromosome. The ICR contains the promoter of the Kcnq1ot1 gene that is exclusively expressed from the paternal allele. The Kcnq1ot1 transcript is the antisense to the Kcnq1 gene and is a unspliced long non-coding RNA. It interacts with chromatin and regulates transcription of multiple target genes through epigenetic modifications.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">13121</td>
<td align="left">cytochrome P450, family 51</td>
<td align="left">Cyp51</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12972</td>
<td align="left">crystallin, zeta</td>
<td align="left">Cryz</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">68588</td>
<td align="left">collagen triple helix repeat containing 1</td>
<td align="left">Cthrc1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">69354</td>
<td align="left">solute carrier family 38, member 4</td>
<td align="left">Slc38a4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">4930500J02Rik</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">12447</td>
<td align="left">cyclin E1</td>
<td align="left">Ccne1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">15378</td>
<td align="left">hepatic nuclear factor 4, alpha</td>
<td align="left">Hnf4a</td>
<td align="left">The protein encoded by this gene is a transcription factor involved in the development of the pancreas, liver, kidney, and intestines. The encoded protein also functions to maintain glucose homeostasis. Several transcript variants encoding different isoforms have been found for this gene.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">230582</td>
<td align="left">cytochrome b5 reductase-like</td>
<td align="left">Cyb5rl</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">224617</td>
<td align="left">TBC1 domain family, member 24</td>
<td align="left">Tbc1d24</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">381693</td>
<td align="left">WD40 repeat domain 95</td>
<td align="left">Wdr95</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">78781</td>
<td align="left">zinc finger CCCH type, antiviral 1</td>
<td align="left">Zc3hav1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">66734</td>
<td align="left">microtubule-associated protein 1 light chain 3 alpha</td>
<td align="left">Map1lc3a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">170758</td>
<td align="left">RAS-related C3 botulinum substrate 3</td>
<td align="left">Rac3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">19335</td>
<td align="left">RAB23, member RAS oncogene family</td>
<td align="left">Rab23</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">67279</td>
<td align="left">mediator complex subunit 31</td>
<td align="left">Med31</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">26900</td>
<td align="left">DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked</td>
<td align="left">Ddx3y</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">224912</td>
<td align="left">crumbs family member 3</td>
<td align="left">Crb3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">234309</td>
<td align="left">carbonyl reductase 4</td>
<td align="left">Cbr4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">170716</td>
<td align="left">cytochrome P450, family 4, subfamily f, polypeptide 13</td>
<td align="left">Cyp4f13</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12967</td>
<td align="left">crystallin, gamma D</td>
<td align="left">Crygd</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">269614</td>
<td align="left">pantothenate kinase 4</td>
<td align="left">Pank4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">331063</td>
<td align="left">gasdermin C2</td>
<td align="left">Gsdmc2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">11833</td>
<td align="left">aquaporin 8</td>
<td align="left">Aqp8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">71723</td>
<td align="left">DEAH (Asp-Glu-Ala-His) box polypeptide 34</td>
<td align="left">Dhx34</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">15932</td>
<td align="left">iduronidase, alpha-L-</td>
<td align="left">Idua</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">66271</td>
<td align="left">transmembrane protein 126A</td>
<td align="left">Tmem126a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">21974</td>
<td align="left">topoisomerase (DNA) II beta</td>
<td align="left">Top2b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">20531</td>
<td align="left">solute carrier family 34 (sodium phosphate), member 2</td>
<td align="left">Slc34a2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">14622</td>
<td align="left">gap junction protein, beta 5</td>
<td align="left">Gjb5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">170643</td>
<td align="left">kin of IRRE like (Drosophila)</td>
<td align="left">Kirrel</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">76467</td>
<td align="left">methionine sulfoxide reductase B2</td>
<td align="left">Msrb2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">107747</td>
<td align="left">aldehyde dehydrogenase 1 family, member L1</td>
<td align="left">Aldh1l1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">385643</td>
<td align="left">kininogen 2</td>
<td align="left">Kng2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">353282</td>
<td align="left">Scm-like with four mbt domains 2</td>
<td align="left">Sfmbt2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">74114</td>
<td align="left">carnitine O-octanoyltransferase</td>
<td align="left">Crot</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">66090</td>
<td align="left">yippee-like 3 (Drosophila)</td>
<td align="left">Ypel3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">12332</td>
<td align="left">capping protein (actin filament), gelsolin-like</td>
<td align="left">Capg</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">17988</td>
<td align="left">N-myc downstream regulated gene 1</td>
<td align="left">Ndrg1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">17060</td>
<td align="left">B cell linker</td>
<td align="left">Blnk</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">170625</td>
<td align="left">sorting nexin 18</td>
<td align="left">Snx18</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">72296</td>
<td align="left">RUN and SH3 domain containing 1</td>
<td align="left">Rusc1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">72560</td>
<td align="left">N-acetylated alpha-linked acidic dipeptidase 2</td>
<td align="left">Naalad2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">328660</td>
<td align="left">brain expressed family member 6</td>
<td align="left">Bex6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">72739</td>
<td align="left">zinc finger with KRAB and SCAN domains 3</td>
<td align="left">Zkscan3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">22228</td>
<td align="left">uncoupling protein 2 (mitochondrial, proton carrier)</td>
<td align="left">Ucp2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">234686</td>
<td align="left">formin homology 2 domain containing 1</td>
<td align="left">Fhod1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">2200002K05Rik</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">75939</td>
<td align="left">RIKEN cDNA 4930579G24 gene</td>
<td align="left">4930579G24Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">73181</td>
<td align="left">nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4</td>
<td align="left">Nfatc4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12751</td>
<td align="left">tripeptidyl peptidase I</td>
<td align="left">Tpp1</td>
<td align="left">This gene encodes a lysosomal serine protease that cleaves N-terminal tripeptides from protein substrates. The encoded preproprotein undergoes autocatalytic processing to generate a mature enzyme. Mice lacking the encoded protein exhibit a progressive neurodegeneration and a greatly shortened lifespan. At the cellular level, mice lacking the encoded protein exhibit accumulation of autofluorescent lipopigments. Mutations in the human ortholog of this gene cause classical late-infantile neuronal ceroid lipofuscinosis.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">68867</td>
<td align="left">ring finger protein 122</td>
<td align="left">Rnf122</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">170459</td>
<td align="left">StAR-related lipid transfer (START) domain containing 4</td>
<td align="left">Stard4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">215951</td>
<td align="left">lactation elevated 1</td>
<td align="left">Lace1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">14137</td>
<td align="left">farnesyl diphosphate farnesyl transferase 1</td>
<td align="left">Fdft1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">77706</td>
<td align="left">ATP-binding cassette, sub-family B (MDR/TAP), member 5</td>
<td align="left">Abcb5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">14148</td>
<td align="left">ferredoxin 1</td>
<td align="left">Fdx1</td>
<td align="left">Ferrodoxins are iron-sulfur proteins that facilitate monooxygenase reactions catalyzed by P450 enzymes. The protein encoded by this gene is present in the mitochondrial matrix and transfers electrons from ferredoxin reductase to steroidogenic mitochondrial cytochrome P450 proteins. Alternative splicing results in multiple transcript variants encoding different isoforms.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">11749</td>
<td align="left">annexin A6</td>
<td align="left">Anxa6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">14865</td>
<td align="left">glutathione S-transferase, mu 4</td>
<td align="left">Gstm4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">69572</td>
<td align="left">major facilitator superfamily domain containing 3</td>
<td align="left">Mfsd3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">338350</td>
<td align="left">acyl-Coenzyme A dehydrogenase family, member 12</td>
<td align="left">Acad12</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">113868</td>
<td align="left">acetyl-Coenzyme A acyltransferase 1A</td>
<td align="left">Acaa1a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">17423</td>
<td align="left">N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2</td>
<td align="left">Ndst2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">109820</td>
<td align="left">progastricsin (pepsinogen C)</td>
<td align="left">Pgc</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">208084</td>
<td align="left">PIF1 5’-to-3’ DNA helicase</td>
<td align="left">Pif1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">268822</td>
<td align="left">aarF domain containing kinase 5</td>
<td align="left">Adck5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">408065</td>
<td align="left">zinc finger protein 456</td>
<td align="left">Zfp456</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">17427</td>
<td align="left">meiosis-specific nuclear structural protein 1</td>
<td align="left">Mns1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">21961</td>
<td align="left">tensin 1</td>
<td align="left">Tns1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">217705</td>
<td align="left">family with sequence similarity 161, member B</td>
<td align="left">Fam161b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">52830</td>
<td align="left">proline-rich nuclear receptor coactivator 2</td>
<td align="left">Pnrc2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20674</td>
<td align="left">SRY (sex determining region Y)-box 2</td>
<td align="left">Sox2</td>
<td align="left">This intronless gene encodes a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. The product of this gene is required for stem-cell maintenance in the central nervous system, and also regulates gene expression in the stomach. Mutations in a similar gene in human have been associated with optic nerve hypoplasia and with syndromic microphthalmia, a severe form of structural eye malformation. This gene lies within an intron of another gene called SOX2 overlapping transcript (Sox2ot).</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">17829</td>
<td align="left">mucin 1, transmembrane</td>
<td align="left">Muc1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">77592</td>
<td align="left">RIKEN cDNA 4931406H21 gene</td>
<td align="left">4931406H21Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">74548</td>
<td align="left">gasdermin C4</td>
<td align="left">Gsdmc4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">19285</td>
<td align="left">polymerase I and transcript release factor</td>
<td align="left">Ptrf</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_load_voom/gene_names_clus_&quot;,10,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
</div>
<div id="load-the-sfa-input-sparse-factors-sqrt-transformation" class="section level2">
<h2>Load the SFA input (sparse factors: sqrt transformation)</h2>
<pre class="r"><code>lambda_out &lt;- read.table(&quot;../sfa_outputs/Deng2014PPS/sqrt_deng_counts_transpose_lambda.out&quot;)
f_out &lt;- read.table(&quot;../sfa_outputs/Deng2014PPS/sqrt_deng_counts_transpose_F.out&quot;)

indices_mat &lt;- SFA.ExtractTopFeatures(lambda_out, top_features = 100, options = &quot;min&quot;,mult.annotate = TRUE)


top_gene_names &lt;- t(apply(indices_mat, 1, function(x) return (deng.gene_names[x])));</code></pre>
</div>
<div id="factor-annotations-2" class="section level2">
<h2>Factor Annotations</h2>
<div id="factor-1-annotations-2" class="section level3">
<h3>Factor 1 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[1,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">name</th>
<th align="left">X_id</th>
<th align="left">query</th>
<th align="left">summary</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">peroxiredoxin 1</td>
<td align="left">18477</td>
<td align="left">Prdx1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">sorting nexin 2</td>
<td align="left">67804</td>
<td align="left">Snx2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">syndecan 4</td>
<td align="left">20971</td>
<td align="left">Sdc4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">actin, beta</td>
<td align="left">11461</td>
<td align="left">Actb</td>
<td align="left">This gene encodes a member of the actin family of proteins. Actins are highly conserved proteins that are among the most abundant proteins in eukaryotic cells and are involved in cell motility, structure, and integrity. Localization, stability, and translation of the transcribed mRNA are regulated through the binding of multiple factors to its 3’ UTR sequence. Homozygous knockout mice for this gene exhibit embryonic lethality. Numerous pseudogenes of this gene have been identified in the mouse genome.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">glutaredoxin</td>
<td align="left">93692</td>
<td align="left">Glrx</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">oocyte specific homeobox 6</td>
<td align="left">252830</td>
<td align="left">Obox6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">predicted gene 11517</td>
<td align="left">ENSMUSG00000081249</td>
<td align="left">Gm11517</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene</td>
<td align="left">629750</td>
<td align="left">Gm11517</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">prostaglandin reductase 1</td>
<td align="left">67103</td>
<td align="left">Ptgr1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">uridine phosphorylase 1</td>
<td align="left">22271</td>
<td align="left">Upp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">preferentially expressed antigen in melanoma like 5</td>
<td align="left">384077</td>
<td align="left">Pramel5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">teratocarcinoma-derived growth factor 1</td>
<td align="left">21667</td>
<td align="left">Tdgf1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ubiquitin-like, containing PHD and RING finger domains, 1</td>
<td align="left">18140</td>
<td align="left">Uhrf1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">hepatoma-derived growth factor</td>
<td align="left">15191</td>
<td align="left">Hdgf</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">cyclin E1</td>
<td align="left">12447</td>
<td align="left">Ccne1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 5</td>
<td align="left">11740</td>
<td align="left">Slc25a5</td>
<td align="left">This gene encodes a transmembrane domain-containing protein that localizes to the mitochondrial inner membrane. The encoded protein facilitates the exchange of ADP from the cytoplasm with ATP from the mitochondria. Pseudogenes for this gene are found on multiple chromosomes.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide</td>
<td align="left">22631</td>
<td align="left">Ywhaz</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">eukaryotic translation elongation factor 1 alpha 1</td>
<td align="left">13627</td>
<td align="left">Eef1a1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">aldolase A, fructose-bisphosphate</td>
<td align="left">11674</td>
<td align="left">Aldoa</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">fructose bisphosphatase 2</td>
<td align="left">14120</td>
<td align="left">Fbp2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">H2A histone family, member Y</td>
<td align="left">26914</td>
<td align="left">H2afy</td>
<td align="left">Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Nucleosomes consist of approximately 146 bp of DNA wrapped around a histone octamer composed of pairs of each of the four core histones (H2A, H2B, H3, and H4). The chromatin fiber is further compacted through the interaction of a linker histone, H1, with the DNA between the nucleosomes to form higher order chromatin structures. This gene encodes a replication-independent histone that is a member of the histone H2A family. It replaces conventional H2A histones in a subset of nucleosomes where it represses transcription and participates in stable X chromosome inactivation. Alternative splicing results in multiple transcript variants encoding different isoforms.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">electron transferring flavoprotein, beta polypeptide</td>
<td align="left">110826</td>
<td align="left">Etfb</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">cathepsin C</td>
<td align="left">13032</td>
<td align="left">Ctsc</td>
<td align="left">This gene encodes a member of the peptidase C1 (papain) family of cysteine proteases. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate multiple protein products. These products include the dipeptidyl peptidase 1 light, heavy, and exclusion domain chains, which together comprise one subunit of the homotetrameric enzyme. This enzyme has amino dipeptidase activity and may play a role in the activation of granzymes during inflammation. Homozygous knockout mice for this gene exhibit impaired granzyme activation and enhanced survival in a sepsis model.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Pkm2</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">stress-induced phosphoprotein 1</td>
<td align="left">20867</td>
<td align="left">Stip1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1</td>
<td align="left">11946</td>
<td align="left">Atp5a1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">F-box protein 15</td>
<td align="left">50764</td>
<td align="left">Fbxo15</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">proliferation-associated 2G4</td>
<td align="left">18813</td>
<td align="left">Pa2g4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">succinate-CoA ligase, GDP-forming, alpha subunit</td>
<td align="left">56451</td>
<td align="left">Suclg1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">hematological and neurological expressed 1-like</td>
<td align="left">52009</td>
<td align="left">Hn1l</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">cullin 5</td>
<td align="left">75717</td>
<td align="left">Cul5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">glutathione S-transferase, alpha 4</td>
<td align="left">14860</td>
<td align="left">Gsta4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C3 (subunit 9)</td>
<td align="left">228033</td>
<td align="left">Atp5g3</td>
<td align="left">The protein encoded by this gene is a subunit of mitochondrial membrane ATP synthase, the enzyme that catalyzes ATP synthesis during oxidative phosphorylation. This gene encodes subunit 9, which is present in multiple copies in the transmembrane part of the ATP synthase complex. Phenotype and gene expression profiles suggest correlations between this gene and alcoholism- and obesity-related phenotypes. Alternative splicing results in multiple transcript variants and protein isoforms.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">enoyl Coenzyme A hydratase, short chain, 1, mitochondrial</td>
<td align="left">93747</td>
<td align="left">Echs1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">expressed sequence AA467197</td>
<td align="left">433470</td>
<td align="left">AA467197</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">peroxiredoxin 2</td>
<td align="left">21672</td>
<td align="left">Prdx2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">disabled 2, mitogen-responsive phosphoprotein</td>
<td align="left">13132</td>
<td align="left">Dab2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RB1-inducible coiled-coil 1</td>
<td align="left">12421</td>
<td align="left">Rb1cc1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">son of sevenless homolog 1 (Drosophila)</td>
<td align="left">20662</td>
<td align="left">Sos1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">myo-inositol 1-phosphate synthase A1</td>
<td align="left">71780</td>
<td align="left">Isyna1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">aldehyde dehydrogenase 9, subfamily A1</td>
<td align="left">56752</td>
<td align="left">Aldh9a1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ring finger protein 216</td>
<td align="left">108086</td>
<td align="left">Rnf216</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">choline kinase alpha</td>
<td align="left">12660</td>
<td align="left">Chka</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ankyrin repeat domain 10</td>
<td align="left">102334</td>
<td align="left">Ankrd10</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">heat shock protein 90 alpha (cytosolic), class B member 1</td>
<td align="left">15516</td>
<td align="left">Hsp90ab1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">nudix (nucleoside diphosphate linked moiety X)-type motif 5</td>
<td align="left">53893</td>
<td align="left">Nudt5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">WD repeat domain 45</td>
<td align="left">54636</td>
<td align="left">Wdr45</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">SET nuclear oncogene</td>
<td align="left">56086</td>
<td align="left">Set</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">secreted acidic cysteine rich glycoprotein</td>
<td align="left">20692</td>
<td align="left">Sparc</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RIKEN cDNA C130026I21 gene</td>
<td align="left">620078</td>
<td align="left">C130026I21Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Sp110 nuclear body protein</td>
<td align="left">109032</td>
<td align="left">Sp110</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">gap junction protein, beta 3</td>
<td align="left">14620</td>
<td align="left">Gjb3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1</td>
<td align="left">11949</td>
<td align="left">Atp5c1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">S-phase kinase-associated protein 1A</td>
<td align="left">21402</td>
<td align="left">Skp1a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">developmental pluripotency-associated 3</td>
<td align="left">73708</td>
<td align="left">Dppa3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NADH dehydrogenase (ubiquinone) 1 beta subcomplex 8</td>
<td align="left">67264</td>
<td align="left">Ndufb8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">transmembrane BAX inhibitor motif containing 6</td>
<td align="left">110213</td>
<td align="left">Tmbim6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">T cell immunoglobulin and mucin domain containing 2</td>
<td align="left">171284</td>
<td align="left">Timd2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">aquaporin 8</td>
<td align="left">11833</td>
<td align="left">Aqp8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide</td>
<td align="left">22627</td>
<td align="left">Ywhae</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">A kinase (PRKA) anchor protein (gravin) 12</td>
<td align="left">83397</td>
<td align="left">Akap12</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">COMM domain containing 3</td>
<td align="left">12238</td>
<td align="left">Commd3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">cellular nucleic acid binding protein</td>
<td align="left">12785</td>
<td align="left">Cnbp</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">alcohol dehydrogenase 5 (class III), chi polypeptide</td>
<td align="left">11532</td>
<td align="left">Adh5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">titin</td>
<td align="left">22138</td>
<td align="left">Ttn</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">suppressor of cytokine signaling 3</td>
<td align="left">12702</td>
<td align="left">Socs3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">high-mobility group nucleosome binding domain 5</td>
<td align="left">50887</td>
<td align="left">Hmgn5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ferritin light polypeptide 1</td>
<td align="left">14325</td>
<td align="left">Ftl1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">F-box protein 3</td>
<td align="left">57443</td>
<td align="left">Fbxo3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NHP2 ribonucleoprotein</td>
<td align="left">52530</td>
<td align="left">Nhp2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">collagen, type IV, alpha 1</td>
<td align="left">12826</td>
<td align="left">Col4a1</td>
<td align="left">This gene encodes the alpha-1 subunit of the type IV collagens, an essential component of basement membranes. The encoded protein forms a triple helical heterotrimer comprised of two alpha-1 and one alpha-2 subunits that assembles into a type IV collagen network. This gene is located adjacent to the gene encoding alpha-2 subunit. Mice lacking both the alpha-1 and alpha-2 subunits of collagen IV die in utero due to structural deficiencies in the basement membranes and certain mutations in this gene cause perinatal cerebral hemorrhage and porencephaly. Alternative splicing of this gene results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">snurportin 1</td>
<td align="left">66069</td>
<td align="left">Snupn</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">nucleophosmin 1</td>
<td align="left">18148</td>
<td align="left">Npm1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">tripartite motif-containing 43B</td>
<td align="left">666747</td>
<td align="left">Trim43b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">succinate dehydrogenase complex, subunit D, integral membrane protein</td>
<td align="left">66925</td>
<td align="left">Sdhd</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">tubulin, beta 5 class I</td>
<td align="left">22154</td>
<td align="left">Tubb5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ELOVL family member 7, elongation of long chain fatty acids (yeast)</td>
<td align="left">74559</td>
<td align="left">Elovl7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">rogdi homolog</td>
<td align="left">66049</td>
<td align="left">Rogdi</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">malic enzyme 1, NADP(+)-dependent, cytosolic</td>
<td align="left">17436</td>
<td align="left">Me1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">acyl-CoA synthetase long-chain family member 4</td>
<td align="left">50790</td>
<td align="left">Acsl4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">hydroxyacyl-Coenzyme A dehydrogenase</td>
<td align="left">15107</td>
<td align="left">Hadh</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">golgi membrane protein 1</td>
<td align="left">105348</td>
<td align="left">Golm1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">TBC1 domain family, member 9</td>
<td align="left">71310</td>
<td align="left">Tbc1d9</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">aconitase 1</td>
<td align="left">11428</td>
<td align="left">Aco1</td>
<td align="left">This gene encodes a member of the aconitase/IPM isomerase protein family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Depending on iron levels in the cytosol, the encoded protein can function as either an aconitase enzyme or as an mRNA binding protein. When cellular iron levels are high, the encoded protein functions as an aconitase, an essential enzyme in the TCA cycle that catalyzes the conversion of citrate to isocitrate. When cellular iron levels are low, the encoded protein regulates iron uptake and utilization by binding to iron-responsive elements in the untranslated regions of mRNAs for genes involved in iron metabolism. Disruption of this gene is associated with pulmonary hypertension and polycythemia.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">N-acylsphingosine amidohydrolase 1</td>
<td align="left">11886</td>
<td align="left">Asah1</td>
<td align="left">This gene encodes acid ceramidase, an enzyme that plays a central role in ceramide metabolism. The encoded protein undergoes proteolytic processing to generate a heterodimeric enzyme comprised of alpha and beta subunits that catalyzes the hydrolysis of sphingolipid ceramide into sphingosine and free fatty acid. The homozygous disruption of this gene leads to embryonic lethality in mice whereas the heterozygous animals exhibit a progressive lipid storage disease phenotype.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">alkaline phosphatase, placental-like 2</td>
<td align="left">11650</td>
<td align="left">Alppl2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">adenine phosphoribosyl transferase</td>
<td align="left">11821</td>
<td align="left">Aprt</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">isocitrate dehydrogenase 3 (NAD+) alpha</td>
<td align="left">67834</td>
<td align="left">Idh3a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">serine (or cysteine) peptidase inhibitor, clade B, member 6a</td>
<td align="left">20719</td>
<td align="left">Serpinb6a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">guanylate cyclase activator 1a (retina)</td>
<td align="left">14913</td>
<td align="left">Guca1a</td>
<td align="left">This gene encodes a calcium-binding photoreceptor protein. The encoded protein may be involved in modulation of guanylyl cyclase activity, and in turn, the mammalian cone phototransduction cascade. Disruption of this gene results in the retinal degeneration associated with cone dystrophy.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">yippee-like 2 (Drosophila)</td>
<td align="left">77864</td>
<td align="left">Ypel2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">guanine nucleotide binding protein (G protein), beta 1</td>
<td align="left">14688</td>
<td align="left">Gnb1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">voltage-dependent anion channel 1</td>
<td align="left">22333</td>
<td align="left">Vdac1</td>
<td align="left">This gene encodes a voltage-dependent anion channel protein that is a major component of the outer mitochondrial membrane. The encoded protein facilitates the exchange of metabolites and ions across the outer mitochondrial membrane and may regulate mitochondrial functions. This protein also forms channels in the plasma membrane and may be involved in transmembrane electron transport. Multiple pseudogenes of this gene are found on chromosomes 1, 2, 3, 6, 8, 9, and X.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">A930001N09Rik</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">actin, gamma, cytoplasmic 1</td>
<td align="left">11465</td>
<td align="left">Actg1</td>
<td align="left">Actins are highly conserved proteins that are involved in various types of cell motility and maintenance of the cytoskeleton. In vertebrates, three main groups of actin isoforms, alpha, beta, and gamma, have been identified. The alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. The beta and gamma actins co-exist in most cell types as components of the cytoskeleton, and as mediators of internal cell motility. Actin, gamma 1, encoded by this gene, is a cytoplasmic actin found in non-muscle cells. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">SH3 domain binding glutamic acid-rich protein-like 3</td>
<td align="left">73723</td>
<td align="left">Sh3bgrl3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">translocase of outer mitochondrial membrane 5 homolog (yeast)</td>
<td align="left">68512</td>
<td align="left">Tomm5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ring finger protein 7</td>
<td align="left">19823</td>
<td align="left">Rnf7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ADP-ribosylation factor-like 6 interacting protein 1</td>
<td align="left">54208</td>
<td align="left">Arl6ip1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">lysophosphatidylcholine acyltransferase 3</td>
<td align="left">14792</td>
<td align="left">Lpcat3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">proteasome (prosome, macropain) subunit, alpha type 1</td>
<td align="left">26440</td>
<td align="left">Psma1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_fac_sqrt/gene_names_clus_&quot;,1,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-2-annotations-2" class="section level3">
<h3>Factor 2 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[2,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">summary</th>
<th align="left">query</th>
<th align="left">X_id</th>
<th align="left">name</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">This gene encodes a member of the actin family of proteins. Actins are highly conserved proteins that are among the most abundant proteins in eukaryotic cells and are involved in cell motility, structure, and integrity. Localization, stability, and translation of the transcribed mRNA are regulated through the binding of multiple factors to its 3’ UTR sequence. Homozygous knockout mice for this gene exhibit embryonic lethality. Numerous pseudogenes of this gene have been identified in the mouse genome.</td>
<td align="left">Actb</td>
<td align="left">11461</td>
<td align="left">actin, beta</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">The protein encoded by this gene is a member of the Rho guanine nucleotide dissociation inhibitor (GDI) family. This gene is expressed at high levels in hematopoietic cells. This protein is cytosolic, and dissociation of Rho from this protein is required for membrane association and activation of Rho by Guanine Nucleotide Exchange Factors (GEFs). C-terminal truncations of this gene product have been reported to promote metastasis. Multiple transcript variants and protein isoforms exist.</td>
<td align="left">Arhgdib</td>
<td align="left">11857</td>
<td align="left">Rho, GDP dissociation inhibitor (GDI) beta</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">LOC100502936</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Car2</td>
<td align="left">12349</td>
<td align="left">carbonic anhydrase 2</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Dppa3</td>
<td align="left">73708</td>
<td align="left">developmental pluripotency-associated 3</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Mt1</td>
<td align="left">17748</td>
<td align="left">metallothionein 1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Tubb5</td>
<td align="left">22154</td>
<td align="left">tubulin, beta 5 class I</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Rac2</td>
<td align="left">19354</td>
<td align="left">RAS-related C3 botulinum substrate 2</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Accsl</td>
<td align="left">381411</td>
<td align="left">1-aminocyclopropane-1-carboxylate synthase (non-functional)-like</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">This gene encodes a member of the zinc finger protein superfamily. This protein may regulate the Wnt/beta-catenin signaling pathway. This protein may be involved in insulin resistance and type 2 diabetes in humans. Alternative splicing results in multiple transcript variants.</td>
<td align="left">Zbed3</td>
<td align="left">72114</td>
<td align="left">zinc finger, BED type containing 3</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Bmp15</td>
<td align="left">12155</td>
<td align="left">bone morphogenetic protein 15</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Bcl2l10</td>
<td align="left">12049</td>
<td align="left">Bcl2-like 10</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Nlrp14</td>
<td align="left">76858</td>
<td align="left">NLR family, pyrin domain containing 14</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Dusp14</td>
<td align="left">56405</td>
<td align="left">dual specificity phosphatase 14</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Cd34</td>
<td align="left">12490</td>
<td align="left">CD34 antigen</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Srgn</td>
<td align="left">19073</td>
<td align="left">serglycin</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">This gene encodes a member of the WD repeat coronin family. The encoded protein may bind actin and interact with microtubules. Alternative splicing results in multiple transcript variants.</td>
<td align="left">Coro1a</td>
<td align="left">12721</td>
<td align="left">coronin, actin binding protein 1A</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Tubb3</td>
<td align="left">22152</td>
<td align="left">tubulin, beta 3 class III</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Eltd1</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Cd53</td>
<td align="left">12508</td>
<td align="left">CD53 antigen</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Tmsb4x</td>
<td align="left">19241</td>
<td align="left">thymosin, beta 4, X chromosome</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Oas1d</td>
<td align="left">100535</td>
<td align="left">2’-5’ oligoadenylate synthetase 1D</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Cd93</td>
<td align="left">17064</td>
<td align="left">CD93 antigen</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">This gene encodes a precursor protein that is member of the FXYD family of transmembrane glycoproteins. Like most members of the FXYD family, the encoded protein is a subunit of the sodium-potassium adenosine triphosphatase pump. FXYD family members have tissue-specific expression and differentially regulate the activity of this pump. The protein encoded by this gene also plays a role in cell adhesion and motility. The orthologous human protein inhibits epithelial cadherin, a calcium-dependent adhesion protein and is associated with cancer (promotes metastasis). Alternative splicing of this mouse gene results in multiple transcript variants.</td>
<td align="left">Fxyd5</td>
<td align="left">18301</td>
<td align="left">FXYD domain-containing ion transport regulator 5</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Lgals9</td>
<td align="left">16859</td>
<td align="left">lectin, galactose binding, soluble 9</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Rgs18</td>
<td align="left">64214</td>
<td align="left">regulator of G-protein signaling 18</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Gdpd1</td>
<td align="left">66569</td>
<td align="left">glycerophosphodiester phosphodiesterase domain containing 1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Myo5b</td>
<td align="left">17919</td>
<td align="left">myosin VB</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Zfp57</td>
<td align="left">22715</td>
<td align="left">zinc finger protein 57</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Gdf9</td>
<td align="left">14566</td>
<td align="left">growth differentiation factor 9</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Pak1ip1</td>
<td align="left">68083</td>
<td align="left">PAK1 interacting protein 1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Crip2</td>
<td align="left">68337</td>
<td align="left">cysteine rich protein 2</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">AU022751</td>
<td align="left">102991</td>
<td align="left">expressed sequence AU022751</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Mef2c</td>
<td align="left">17260</td>
<td align="left">myocyte enhancer factor 2C</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Samsn1</td>
<td align="left">67742</td>
<td align="left">SAM domain, SH3 domain and nuclear localization signals, 1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Rpl32</td>
<td align="left">19951</td>
<td align="left">ribosomal protein L32</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Ddx3x</td>
<td align="left">13205</td>
<td align="left">DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Stmn1</td>
<td align="left">16765</td>
<td align="left">stathmin 1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Mbnl1</td>
<td align="left">56758</td>
<td align="left">muscleblind-like 1 (Drosophila)</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Mbnl3</td>
<td align="left">171170</td>
<td align="left">muscleblind-like 3 (Drosophila)</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Rbbp7</td>
<td align="left">245688</td>
<td align="left">retinoblastoma binding protein 7</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Zfand2a</td>
<td align="left">100494</td>
<td align="left">zinc finger, AN1-type domain 2A</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Klf17</td>
<td align="left">75753</td>
<td align="left">Kruppel-like factor 17</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Cfl2</td>
<td align="left">12632</td>
<td align="left">cofilin 2, muscle</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Nasp</td>
<td align="left">50927</td>
<td align="left">nuclear autoantigenic sperm protein (histone-binding)</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Fam46c</td>
<td align="left">74645</td>
<td align="left">family with sequence similarity 46, member C</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Eef1a1</td>
<td align="left">13627</td>
<td align="left">eukaryotic translation elongation factor 1 alpha 1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Ctla2a</td>
<td align="left">13024</td>
<td align="left">cytotoxic T lymphocyte-associated protein 2 alpha</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Il12a</td>
<td align="left">16159</td>
<td align="left">interleukin 12a</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Gm11545</td>
<td align="left">ENSMUSG00000075611</td>
<td align="left">predicted gene 11545</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Gm11545</td>
<td align="left">217122</td>
<td align="left">predicted gene 11545</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Zfp296</td>
<td align="left">63872</td>
<td align="left">zinc finger protein 296</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">2810417H13Rik</td>
<td align="left">68026</td>
<td align="left">RIKEN cDNA 2810417H13 gene</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">AI662270</td>
<td align="left">ENSMUSG00000087107</td>
<td align="left">expressed sequence AI662270</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">AI662270</td>
<td align="left">100043636</td>
<td align="left">expressed sequence AI662270</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Alox5ap</td>
<td align="left">11690</td>
<td align="left">arachidonate 5-lipoxygenase activating protein</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">C87499</td>
<td align="left">381590</td>
<td align="left">expressed sequence C87499</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Rnf114</td>
<td align="left">81018</td>
<td align="left">ring finger protein 114</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Gm15698</td>
<td align="left">ENSMUSG00000057534</td>
<td align="left">predicted gene 15698</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Gm15698</td>
<td align="left">217066</td>
<td align="left">transcription elongation factor B (SIII), polypeptide 2 pseudogene</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Csrnp2</td>
<td align="left">207785</td>
<td align="left">cysteine-serine-rich nuclear protein 2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Anxa7</td>
<td align="left">11750</td>
<td align="left">annexin A7</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Tagln2</td>
<td align="left">21346</td>
<td align="left">transgelin 2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Calcrl</td>
<td align="left">54598</td>
<td align="left">calcitonin receptor-like</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Strn</td>
<td align="left">268980</td>
<td align="left">striatin, calmodulin binding protein</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Ptpn21</td>
<td align="left">24000</td>
<td align="left">protein tyrosine phosphatase, non-receptor type 21</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Bfsp1</td>
<td align="left">12075</td>
<td align="left">beaded filament structural protein 1, in lens-CP94</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Zfp266</td>
<td align="left">77519</td>
<td align="left">zinc finger protein 266</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Sun1</td>
<td align="left">77053</td>
<td align="left">Sad1 and UNC84 domain containing 1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Wtap</td>
<td align="left">60532</td>
<td align="left">Wilms tumour 1-associating protein</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Btg4</td>
<td align="left">56057</td>
<td align="left">B cell translocation gene 4</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">This gene encodes a member of the RIO family of atypical serine protein kinases. A similar protein in humans is a component of the protein arginine methyltransferase 5 complex that specifically recruits the RNA-binding protein nucleolin as a methylation substrate.</td>
<td align="left">Riok1</td>
<td align="left">71340</td>
<td align="left">RIO kinase 1 (yeast)</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Gmfg</td>
<td align="left">63986</td>
<td align="left">glia maturation factor, gamma</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Cd81</td>
<td align="left">12520</td>
<td align="left">CD81 antigen</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Kcnq1ot1</td>
<td align="left">ENSMUSG00000101609</td>
<td align="left">KCNQ1 overlapping transcript 1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">The distal end of mouse chromosome 7 contains two clusters of epigenetically-regulated genes that are expressed from only one chromosome in a parent-of-origin manner. Each cluster, or imprinted domain, is regulated by a functionally independent imprinting control region (ICR). The telomeric imprinted domain is regulated by an ICR located in an intron of Kcnq1, and contains at least eight genes that are expressed exclusively or preferentially from the maternally-inherited allele. The DNA of the ICR is specifically methylated on the maternally-inherited chromosome, and unmethylated on the paternally-inherited chromosome. The ICR contains the promoter of the Kcnq1ot1 gene that is exclusively expressed from the paternal allele. The Kcnq1ot1 transcript is the antisense to the Kcnq1 gene and is a unspliced long non-coding RNA. It interacts with chromatin and regulates transcription of multiple target genes through epigenetic modifications.</td>
<td align="left">Kcnq1ot1</td>
<td align="left">63830</td>
<td align="left">KCNQ1 overlapping transcript 1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Wdr47</td>
<td align="left">99512</td>
<td align="left">WD repeat domain 47</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">In eukaryotic cells, most proteins in the cytosol and nucleus are degraded via the ubiquitin-proteasome pathway. The 26S proteasome is a self-compartmentalizing protease comprised of approximately 31 different subunits. It contains a barrel-shaped proteolytic core complex (the 20S proteasome), capped at one or both ends by 19S regulatory complexes, which recognize ubiquitinated proteins. Protein degradation by proteasomes is the source of most antigenic peptides presented on MHC class I molecules. This gene encodes a non-ATPase subunit of the 26S proteasome.</td>
<td align="left">Psmd1</td>
<td align="left">70247</td>
<td align="left">proteasome (prosome, macropain) 26S subunit, non-ATPase, 1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Pard3</td>
<td align="left">93742</td>
<td align="left">par-3 family cell polarity regulator</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Fbp2</td>
<td align="left">14120</td>
<td align="left">fructose bisphosphatase 2</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Nfya</td>
<td align="left">18044</td>
<td align="left">nuclear transcription factor-Y alpha</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Me1</td>
<td align="left">17436</td>
<td align="left">malic enzyme 1, NADP(+)-dependent, cytosolic</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">D6Ertd527e</td>
<td align="left">52372</td>
<td align="left">DNA segment, Chr 6, ERATO Doi 527, expressed</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Trip12</td>
<td align="left">14897</td>
<td align="left">thyroid hormone receptor interactor 12</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Fbxw15</td>
<td align="left">382105</td>
<td align="left">F-box and WD-40 domain protein 15</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Spin1</td>
<td align="left">20729</td>
<td align="left">spindlin 1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Fundc2</td>
<td align="left">67391</td>
<td align="left">FUN14 domain containing 2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Ucp2</td>
<td align="left">22228</td>
<td align="left">uncoupling protein 2 (mitochondrial, proton carrier)</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Ifitm2</td>
<td align="left">80876</td>
<td align="left">interferon induced transmembrane protein 2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">This gene encodes a transmembrane protein that is a common subunit of several interleukin receptor complexes. These receptors are comprised of alpha and beta subunits in addition to this gamma subunit. Signalling through this pathway in important in immune cell differentiation and function. Alternative splicing results in multiple transcript variants.</td>
<td align="left">Il2rg</td>
<td align="left">16186</td>
<td align="left">interleukin 2 receptor, gamma chain</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Mrpl44</td>
<td align="left">69163</td>
<td align="left">mitochondrial ribosomal protein L44</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Ifi203</td>
<td align="left">15950</td>
<td align="left">interferon activated gene 203</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Obfc2a</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Aurka</td>
<td align="left">20878</td>
<td align="left">aurora kinase A</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Cd69</td>
<td align="left">12515</td>
<td align="left">CD69 antigen</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Ipo5</td>
<td align="left">70572</td>
<td align="left">importin 5</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Smap2</td>
<td align="left">69780</td>
<td align="left">small ArfGAP 2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Tia1</td>
<td align="left">21841</td>
<td align="left">cytotoxic granule-associated RNA binding protein 1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Nucleosomes consist of approximately 146 bp of DNA wrapped around a histone octamer composed of pairs of each of the four core histones (H2A, H2B, H3, and H4). The chromatin fiber is further compacted through the interaction of a linker histone, H1, with the DNA between the nucleosomes to form higher order chromatin structures. The protein encoded is a replication-independent histone that is a member of the histone H1 family. This gene contains introns, unlike most histone genes and the encoded protein is expressed only in oocytes.</td>
<td align="left">H1foo</td>
<td align="left">171506</td>
<td align="left">H1 histone family, member O, oocyte-specific</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Cdk16</td>
<td align="left">18555</td>
<td align="left">cyclin-dependent kinase 16</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Fam111a</td>
<td align="left">107373</td>
<td align="left">family with sequence similarity 111, member A</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Tuba1b</td>
<td align="left">22143</td>
<td align="left">tubulin, alpha 1B</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Vim</td>
<td align="left">22352</td>
<td align="left">vimentin</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Emp3</td>
<td align="left">13732</td>
<td align="left">epithelial membrane protein 3</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_fac_sqrt/gene_names_clus_&quot;,2,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-3-annotations-2" class="section level3">
<h3>Factor 3 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[3,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">X_id</th>
<th align="left">name</th>
<th align="left">query</th>
<th align="left">notfound</th>
<th align="left">summary</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">99929</td>
<td align="left">TCDD-inducible poly(ADP-ribose) polymerase</td>
<td align="left">Tiparp</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">LOC100502936</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">71805</td>
<td align="left">nucleoporin 93</td>
<td align="left">Nup93</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12151</td>
<td align="left">Bmi1 polycomb ring finger oncogene</td>
<td align="left">Bmi1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">81018</td>
<td align="left">ring finger protein 114</td>
<td align="left">Rnf114</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">18475</td>
<td align="left">platelet-activating factor acetylhydrolase, isoform 1b, subunit 2</td>
<td align="left">Pafah1b2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">70701</td>
<td align="left">NIPA-like domain containing 1</td>
<td align="left">Nipal1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">71954</td>
<td align="left">suppressor of defective silencing 3 homolog (S. cerevisiae)</td>
<td align="left">Suds3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">72462</td>
<td align="left">ribosomal RNA processing 1 homolog B (S. cerevisiae)</td>
<td align="left">Rrp1b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">330409</td>
<td align="left">cat eye syndrome chromosome region, candidate 2</td>
<td align="left">Cecr2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Ube2d2</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">56338</td>
<td align="left">thioredoxin interacting protein</td>
<td align="left">Txnip</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">71562</td>
<td align="left">arylformamidase</td>
<td align="left">Afmid</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">58230</td>
<td align="left">ring finger protein 8</td>
<td align="left">Rnf8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">71340</td>
<td align="left">RIO kinase 1 (yeast)</td>
<td align="left">Riok1</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the RIO family of atypical serine protein kinases. A similar protein in humans is a component of the protein arginine methyltransferase 5 complex that specifically recruits the RNA-binding protein nucleolin as a methylation substrate.</td>
</tr>
<tr class="even">
<td align="left">100535</td>
<td align="left">2’-5’ oligoadenylate synthetase 1D</td>
<td align="left">Oas1d</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">23994</td>
<td align="left">DAZ associated protein 2</td>
<td align="left">Dazap2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">235134</td>
<td align="left">nuclear factor related to kappa B binding protein</td>
<td align="left">Nfrkb</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">22712</td>
<td align="left">zinc finger protein 54</td>
<td align="left">Zfp54</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">27225</td>
<td align="left">DEAD (Asp-Glu-Ala-Asp) box polypeptide 24</td>
<td align="left">Ddx24</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20662</td>
<td align="left">son of sevenless homolog 1 (Drosophila)</td>
<td align="left">Sos1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">80912</td>
<td align="left">pumilio RNA-binding family member 1</td>
<td align="left">Pum1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">68350</td>
<td align="left">mitochondrial ubiquitin ligase activator of NFKB 1</td>
<td align="left">Mul1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">27406</td>
<td align="left">ATP-binding cassette, sub-family F (GCN20), member 3</td>
<td align="left">Abcf3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">233900</td>
<td align="left">ring finger protein 40</td>
<td align="left">Rnf40</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">27223</td>
<td align="left">transformation related protein 53 binding protein 1</td>
<td align="left">Trp53bp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">72018</td>
<td align="left">FUN14 domain containing 1</td>
<td align="left">Fundc1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">71890</td>
<td align="left">MAD2 mitotic arrest deficient-like 2</td>
<td align="left">Mad2l2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Rab1</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">666806</td>
<td align="left">predicted gene 8300</td>
<td align="left">Gm8300</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">55944</td>
<td align="left">eukaryotic translation initiation factor 3, subunit D</td>
<td align="left">Eif3d</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">75425</td>
<td align="left">TELO2 interacting protein 1</td>
<td align="left">Tti1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">67922</td>
<td align="left">family with sequence similarity 32, member A</td>
<td align="left">Fam32a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">229542</td>
<td align="left">GATA zinc finger domain containing 2B</td>
<td align="left">Gatad2b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">213895</td>
<td align="left">BMS1, ribosome biogenesis factor</td>
<td align="left">Bms1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">225288</td>
<td align="left">formin homology 2 domain containing 3</td>
<td align="left">Fhod3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">71968</td>
<td align="left">WD repeat domain 73</td>
<td align="left">Wdr73</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">20815</td>
<td align="left">serine/arginine-rich protein specific kinase 1</td>
<td align="left">Srpk1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">22256</td>
<td align="left">uracil DNA glycosylase</td>
<td align="left">Ung</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">67936</td>
<td align="left">WD repeat domain 55</td>
<td align="left">Wdr55</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">22152</td>
<td align="left">tubulin, beta 3 class III</td>
<td align="left">Tubb3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">76809</td>
<td align="left">Bri3 binding protein</td>
<td align="left">Bri3bp</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">435337</td>
<td align="left">predicted gene 5662</td>
<td align="left">Gm5662</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">230810</td>
<td align="left">solute carrier family 30 (zinc transporter), member 2</td>
<td align="left">Slc30a2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">16452</td>
<td align="left">Janus kinase 2</td>
<td align="left">Jak2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Ccdc101</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">16650</td>
<td align="left">karyopherin (importin) alpha 6</td>
<td align="left">Kpna6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">217995</td>
<td align="left">HEAT repeat containing 1</td>
<td align="left">Heatr1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">54723</td>
<td align="left">tuftelin interacting protein 11</td>
<td align="left">Tfip11</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">232853</td>
<td align="left">zinc finger protein 954</td>
<td align="left">Zfp954</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">12049</td>
<td align="left">Bcl2-like 10</td>
<td align="left">Bcl2l10</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">16211</td>
<td align="left">karyopherin (importin) beta 1</td>
<td align="left">Kpnb1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">26433</td>
<td align="left">procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3</td>
<td align="left">Plod3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">229543</td>
<td align="left">integrator complex subunit 3</td>
<td align="left">Ints3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20933</td>
<td align="left">mediator complex subunit 22</td>
<td align="left">Med22</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">69125</td>
<td align="left">CCR4-NOT transcription complex, subunit 8</td>
<td align="left">Cnot8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ENSMUSG00000100205</td>
<td align="left">predicted pseudogene 4850</td>
<td align="left">Gm4850</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">226957</td>
<td align="left">THO complex 4 pseudogene</td>
<td align="left">Gm4850</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">233802</td>
<td align="left">THUMP domain containing 1</td>
<td align="left">Thumpd1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">243616</td>
<td align="left">solute carrier family 6 (neurotransmitter transporter, GABA), member 11</td>
<td align="left">Slc6a11</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">53325</td>
<td align="left">BTG3 associated nuclear protein</td>
<td align="left">Banp</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">223691</td>
<td align="left">eukaryotic translation initiation factor 3, subunit L</td>
<td align="left">Eif3l</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">80981</td>
<td align="left">ADP-ribosylation factor-like 4D</td>
<td align="left">Arl4d</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">216151</td>
<td align="left">polymerase (RNA) mitochondrial (DNA directed)</td>
<td align="left">Polrmt</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">217558</td>
<td align="left">G2/M-phase specific E3 ubiquitin ligase</td>
<td align="left">G2e3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">54366</td>
<td align="left">catenin (cadherin associated protein), alpha-like 1</td>
<td align="left">Ctnnal1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">545662</td>
<td align="left">RIKEN cDNA B020004J07 gene</td>
<td align="left">B020004J07Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">18628</td>
<td align="left">period circadian clock 3</td>
<td align="left">Per3</td>
<td align="left">NA</td>
<td align="left">This gene is a member of the Period family of genes and is expressed in a circadian pattern in the suprachiasmatic nucleus, the primary circadian pacemaker in the mammalian brain. Genes in this family encode components of the circadian rhythms of locomotor activity, metabolism, and behavior. This gene is upregulated by Clock/Arntl heterodimers but then represses this upregulation in a feedback loop using Per/Cry heterodimers to interact with Clock/Arntl. Polymorphisms in this gene have been linked to sleep disorders. Multiple transcript variants encoding different isoforms have been found for this gene.</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Fam54a</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">73674</td>
<td align="left">WD repeat domain 75</td>
<td align="left">Wdr75</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">56354</td>
<td align="left">DnaJ heat shock protein family (Hsp40) member C7</td>
<td align="left">Dnajc7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">77041</td>
<td align="left">arylsulfatase K</td>
<td align="left">Arsk</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">67973</td>
<td align="left">M-phase phosphoprotein 10 (U3 small nucleolar ribonucleoprotein)</td>
<td align="left">Mphosph10</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">56057</td>
<td align="left">B cell translocation gene 4</td>
<td align="left">Btg4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">69076</td>
<td align="left">TP53 regulated inhibitor of apoptosis 1</td>
<td align="left">Triap1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">246791</td>
<td align="left">oocyte specific homeobox 3</td>
<td align="left">Obox3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">57354</td>
<td align="left">Crm, cramped-like (Drosophila)</td>
<td align="left">Cramp1l</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">54128</td>
<td align="left">phosphomannomutase 2</td>
<td align="left">Pmm2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">67299</td>
<td align="left">dedicator of cytokinesis 7</td>
<td align="left">Dock7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">114606</td>
<td align="left">transducin-like enhancer of split 6</td>
<td align="left">Tle6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20641</td>
<td align="left">small nuclear ribonucleoprotein D1</td>
<td align="left">Snrpd1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">66689</td>
<td align="left">kelch-like 28</td>
<td align="left">Klhl28</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">276852</td>
<td align="left">DNA segment, Chr 11, Wayne State University 47, expressed</td>
<td align="left">D11Wsu47e</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">268980</td>
<td align="left">striatin, calmodulin binding protein</td>
<td align="left">Strn</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">277666</td>
<td align="left">predicted gene 13078</td>
<td align="left">Gm13078</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">544881</td>
<td align="left">expressed sequence BB287469</td>
<td align="left">BB287469</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">14164</td>
<td align="left">fibroblast growth factor 1</td>
<td align="left">Fgf1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">74155</td>
<td align="left">ERBB receptor feedback inhibitor 1</td>
<td align="left">Errfi1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Myst2</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">11933</td>
<td align="left">ATPase, Na+/K+ transporting, beta 3 polypeptide</td>
<td align="left">Atp1b3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">52397</td>
<td align="left">zinc finger protein 644</td>
<td align="left">Zfp644</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">100043292</td>
<td align="left">predicted gene 4340</td>
<td align="left">Gm4340</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">15519</td>
<td align="left">heat shock protein 90, alpha (cytosolic), class A member 1</td>
<td align="left">Hsp90aa1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">381590</td>
<td align="left">expressed sequence C87499</td>
<td align="left">C87499</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">224171</td>
<td align="left">RIKEN cDNA C330027C09 gene</td>
<td align="left">C330027C09Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">71919</td>
<td align="left">RNA polymerase II associated protein 3</td>
<td align="left">Rpap3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">228361</td>
<td align="left">autophagy/beclin 1 regulator 1</td>
<td align="left">Ambra1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">212880</td>
<td align="left">DEAD (Asp-Glu-Ala-Asp) box polypeptide 46</td>
<td align="left">Ddx46</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">22036</td>
<td align="left">TRAF-interacting protein</td>
<td align="left">Traip</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">72306</td>
<td align="left">zinc finger protein 777</td>
<td align="left">Zfp777</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">14020</td>
<td align="left">ecotropic viral integration site 5</td>
<td align="left">Evi5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_fac_sqrt/gene_names_clus_&quot;,3,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-4-annotations-2" class="section level3">
<h3>Factor 4 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[4,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">name</th>
<th align="left">summary</th>
<th align="left">X_id</th>
<th align="left">query</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">actin, beta</td>
<td align="left">This gene encodes a member of the actin family of proteins. Actins are highly conserved proteins that are among the most abundant proteins in eukaryotic cells and are involved in cell motility, structure, and integrity. Localization, stability, and translation of the transcribed mRNA are regulated through the binding of multiple factors to its 3’ UTR sequence. Homozygous knockout mice for this gene exhibit embryonic lethality. Numerous pseudogenes of this gene have been identified in the mouse genome.</td>
<td align="left">11461</td>
<td align="left">Actb</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">zinc finger, BED type containing 3</td>
<td align="left">This gene encodes a member of the zinc finger protein superfamily. This protein may regulate the Wnt/beta-catenin signaling pathway. This protein may be involved in insulin resistance and type 2 diabetes in humans. Alternative splicing results in multiple transcript variants.</td>
<td align="left">72114</td>
<td align="left">Zbed3</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">GM2 ganglioside activator protein</td>
<td align="left">NA</td>
<td align="left">14667</td>
<td align="left">Gm2a</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">expressed sequence C86187</td>
<td align="left">NA</td>
<td align="left">97402</td>
<td align="left">C86187</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">fatty acid binding protein 3, muscle and heart</td>
<td align="left">NA</td>
<td align="left">14077</td>
<td align="left">Fabp3</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">B cell translocation gene 4</td>
<td align="left">NA</td>
<td align="left">56057</td>
<td align="left">Btg4</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">prosaposin</td>
<td align="left">This gene encodes a multifunctional glycoprotein that plays a role in the intracellular metabolism of various sphingolipids or secreted into the plasma, milk or cerebrospinal fluid. The encoded protein undergoes proteolytic processing to generate four different polypeptides known as saposin A, B, C or D, that are required for the hydrolysis of certain sphingolipids by lysosomal hydrolases. Alternately, the encoded protein is secreted into body fluids where it exhibits neurotrophic and myelinotrophic activities. A complete lack of the encoded protein is fatal to mice either at the neonatal stage or within the first month due to severe leukodystrophy and sphingolipid accumulation. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar processing to generate the mature saposins.</td>
<td align="left">19156</td>
<td align="left">Psap</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">oogenesin 3</td>
<td align="left">NA</td>
<td align="left">100012</td>
<td align="left">Oog3</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">aldo-keto reductase family 1, member B8</td>
<td align="left">NA</td>
<td align="left">14187</td>
<td align="left">Akr1b8</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">keratin 18</td>
<td align="left">NA</td>
<td align="left">16668</td>
<td align="left">Krt18</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">developmental pluripotency associated 5A</td>
<td align="left">NA</td>
<td align="left">434423</td>
<td align="left">Dppa5a</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">heat shock protein 8</td>
<td align="left">NA</td>
<td align="left">15481</td>
<td align="left">Hspa8</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">calcium binding and coiled-coil domain 2</td>
<td align="left">NA</td>
<td align="left">76815</td>
<td align="left">Calcoco2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">expressed sequence AU022751</td>
<td align="left">NA</td>
<td align="left">102991</td>
<td align="left">AU022751</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">poly (ADP-ribose) polymerase family, member 12</td>
<td align="left">NA</td>
<td align="left">243771</td>
<td align="left">Parp12</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">malate dehydrogenase 2, NAD (mitochondrial)</td>
<td align="left">NA</td>
<td align="left">17448</td>
<td align="left">Mdh2</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ribosomal protein L8</td>
<td align="left">NA</td>
<td align="left">26961</td>
<td align="left">Rpl8</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">syndecan 4</td>
<td align="left">NA</td>
<td align="left">20971</td>
<td align="left">Sdc4</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">cysteine rich protein 2</td>
<td align="left">NA</td>
<td align="left">68337</td>
<td align="left">Crip2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">CD63 antigen</td>
<td align="left">NA</td>
<td align="left">12512</td>
<td align="left">Cd63</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">seven in absentia 2</td>
<td align="left">NA</td>
<td align="left">20439</td>
<td align="left">Siah2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">sorbitol dehydrogenase</td>
<td align="left">NA</td>
<td align="left">20322</td>
<td align="left">Sord</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">inhibitor of DNA binding 2</td>
<td align="left">NA</td>
<td align="left">15902</td>
<td align="left">Id2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">E74-like factor 3</td>
<td align="left">NA</td>
<td align="left">13710</td>
<td align="left">Elf3</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">heat shock protein 90 alpha (cytosolic), class B member 1</td>
<td align="left">NA</td>
<td align="left">15516</td>
<td align="left">Hsp90ab1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">actin, gamma, cytoplasmic 1</td>
<td align="left">Actins are highly conserved proteins that are involved in various types of cell motility and maintenance of the cytoskeleton. In vertebrates, three main groups of actin isoforms, alpha, beta, and gamma, have been identified. The alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. The beta and gamma actins co-exist in most cell types as components of the cytoskeleton, and as mediators of internal cell motility. Actin, gamma 1, encoded by this gene, is a cytoplasmic actin found in non-muscle cells. Alternative splicing results in multiple transcript variants.</td>
<td align="left">11465</td>
<td align="left">Actg1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">tripartite motif-containing 61</td>
<td align="left">NA</td>
<td align="left">260296</td>
<td align="left">Trim61</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">keratin 8</td>
<td align="left">NA</td>
<td align="left">16691</td>
<td align="left">Krt8</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">cDNA sequence BC053393</td>
<td align="left">NA</td>
<td align="left">407814</td>
<td align="left">BC053393</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">lactate dehydrogenase B</td>
<td align="left">This gene encodes the B subunit of lactate dehydrogenase enzyme, which catalyzes the interconversion of pyruvate and lactate with concomitant interconversion of NADH and NAD+ in a post-glycolysis process. Alternatively spliced transcript variants have also been found for this gene. Recent studies have shown that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is localized in the peroxisomes. Pseudogenes have been identified on chromosomes 1 and 19.</td>
<td align="left">16832</td>
<td align="left">Ldhb</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">gamma-aminobutyric acid (GABA) A receptor-associated protein-like 2</td>
<td align="left">NA</td>
<td align="left">93739</td>
<td align="left">Gabarapl2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Kruppel-like factor 17</td>
<td align="left">NA</td>
<td align="left">75753</td>
<td align="left">Klf17</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ribosomal protein S3</td>
<td align="left">NA</td>
<td align="left">27050</td>
<td align="left">Rps3</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">prothymosin alpha</td>
<td align="left">NA</td>
<td align="left">19231</td>
<td align="left">Ptma</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ribosomal protein S14</td>
<td align="left">NA</td>
<td align="left">20044</td>
<td align="left">Rps14</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">cystatin B</td>
<td align="left">NA</td>
<td align="left">13014</td>
<td align="left">Cstb</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">spindlin 1</td>
<td align="left">NA</td>
<td align="left">20729</td>
<td align="left">Spin1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ribosomal protein L7</td>
<td align="left">NA</td>
<td align="left">19989</td>
<td align="left">Rpl7</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">predicted gene 13023</td>
<td align="left">NA</td>
<td align="left">194227</td>
<td align="left">Gm13023</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">kelch-like 8</td>
<td align="left">NA</td>
<td align="left">246293</td>
<td align="left">Klhl8</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NME/NM23 nucleoside diphosphate kinase 1</td>
<td align="left">NA</td>
<td align="left">18102</td>
<td align="left">Nme1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">oocyte maturation, alpha</td>
<td align="left">NA</td>
<td align="left">18379</td>
<td align="left">Omt2a</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">transgelin 2</td>
<td align="left">NA</td>
<td align="left">21346</td>
<td align="left">Tagln2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">oocyte maturation, beta</td>
<td align="left">NA</td>
<td align="left">382088</td>
<td align="left">Omt2b</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">prostaglandin E synthase</td>
<td align="left">NA</td>
<td align="left">64292</td>
<td align="left">Ptges</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">methionine adenosyltransferase II, beta</td>
<td align="left">NA</td>
<td align="left">108645</td>
<td align="left">Mat2b</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">family with sequence similarity 96, member A</td>
<td align="left">NA</td>
<td align="left">68250</td>
<td align="left">Fam96a</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">low density lipoprotein receptor-related protein associated protein 1</td>
<td align="left">NA</td>
<td align="left">16976</td>
<td align="left">Lrpap1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">CNDP dipeptidase 2 (metallopeptidase M20 family)</td>
<td align="left">NA</td>
<td align="left">66054</td>
<td align="left">Cndp2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ribosomal protein L4</td>
<td align="left">NA</td>
<td align="left">67891</td>
<td align="left">Rpl4</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">coiled-coil domain containing 6</td>
<td align="left">NA</td>
<td align="left">76551</td>
<td align="left">Ccdc6</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">cytochrome c oxidase subunit IV isoform 1</td>
<td align="left">NA</td>
<td align="left">12857</td>
<td align="left">Cox4i1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">tetraspanin 8</td>
<td align="left">NA</td>
<td align="left">216350</td>
<td align="left">Tspan8</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ret finger protein-like 4</td>
<td align="left">NA</td>
<td align="left">192658</td>
<td align="left">Rfpl4</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">sorting nexin 1</td>
<td align="left">NA</td>
<td align="left">56440</td>
<td align="left">Snx1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">metallothionein 1</td>
<td align="left">NA</td>
<td align="left">17748</td>
<td align="left">Mt1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">eukaryotic translation elongation factor 1 alpha 1</td>
<td align="left">NA</td>
<td align="left">13627</td>
<td align="left">Eef1a1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">sprouty homolog 4 (Drosophila)</td>
<td align="left">NA</td>
<td align="left">24066</td>
<td align="left">Spry4</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">myosin, heavy polypeptide 10, non-muscle</td>
<td align="left">NA</td>
<td align="left">77579</td>
<td align="left">Myh10</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">polycystic kidney disease 2-like 2</td>
<td align="left">NA</td>
<td align="left">53871</td>
<td align="left">Pkd2l2</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Rps4y2</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">eukaryotic translation elongation factor 2</td>
<td align="left">NA</td>
<td align="left">13629</td>
<td align="left">Eef2</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">oocyte secreted protein 1</td>
<td align="left">NA</td>
<td align="left">170834</td>
<td align="left">Oosp1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">phospholipase D1</td>
<td align="left">NA</td>
<td align="left">18805</td>
<td align="left">Pld1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">creatine kinase, brain</td>
<td align="left">NA</td>
<td align="left">12709</td>
<td align="left">Ckb</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">tropomyosin 1, alpha</td>
<td align="left">NA</td>
<td align="left">22003</td>
<td align="left">Tpm1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">bone morphogenetic protein 15</td>
<td align="left">NA</td>
<td align="left">12155</td>
<td align="left">Bmp15</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">low density lipoprotein receptor-related protein 2</td>
<td align="left">NA</td>
<td align="left">14725</td>
<td align="left">Lrp2</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">M phase phosphoprotein 6</td>
<td align="left">NA</td>
<td align="left">68533</td>
<td align="left">Mphosph6</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Bcl2-like 10</td>
<td align="left">NA</td>
<td align="left">12049</td>
<td align="left">Bcl2l10</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">disabled 2, mitogen-responsive phosphoprotein</td>
<td align="left">NA</td>
<td align="left">13132</td>
<td align="left">Dab2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">CD9 antigen</td>
<td align="left">NA</td>
<td align="left">12527</td>
<td align="left">Cd9</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">claudin 4</td>
<td align="left">This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets, and also play critical roles in maintaining cell polarity and signal transductions. The protein encoded by this gene is a high-affinity receptor for clostridium perfringens enterotoxin (CPE) produced by the bacterium Clostridium perfringens, and the interaction with CPE results in increased membrane permeability by forming small pores in plasma membrane. This protein augments alveolar epithelial barrier function and is induced in acute lung injury. It is highly expressed in pancreatic and ovarian cancers.</td>
<td align="left">12740</td>
<td align="left">Cldn4</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">solute carrier family 6 (neurotransmitter transporter, creatine), member 8</td>
<td align="left">NA</td>
<td align="left">102857</td>
<td align="left">Slc6a8</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">kelch repeat and BTB (POZ) domain containing 8</td>
<td align="left">NA</td>
<td align="left">243574</td>
<td align="left">Kbtbd8</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RIKEN cDNA 2210409E12 gene</td>
<td align="left">NA</td>
<td align="left">ENSMUSG00000081766</td>
<td align="left">2210409E12Rik</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">transcription elongation factor B (SIII), polypeptide 2 pseudogene</td>
<td align="left">NA</td>
<td align="left">72381</td>
<td align="left">2210409E12Rik</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">DNA segment, Chr 6, ERATO Doi 527, expressed</td>
<td align="left">NA</td>
<td align="left">52372</td>
<td align="left">D6Ertd527e</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">epsin 2</td>
<td align="left">NA</td>
<td align="left">13855</td>
<td align="left">Epn2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RIKEN cDNA 4933427D06 gene</td>
<td align="left">NA</td>
<td align="left">232217</td>
<td align="left">4933427D06Rik</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NLR family, pyrin domain containing 4F</td>
<td align="left">NA</td>
<td align="left">97895</td>
<td align="left">Nlrp4f</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">v-abl Abelson murine leukemia viral oncogene 2 (arg, Abelson-related gene)</td>
<td align="left">NA</td>
<td align="left">11352</td>
<td align="left">Abl2</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">eukaryotic translation elongation factor 1 gamma</td>
<td align="left">NA</td>
<td align="left">67160</td>
<td align="left">Eef1g</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4</td>
<td align="left">NA</td>
<td align="left">11739</td>
<td align="left">Slc25a4</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">heat shock protein 90, alpha (cytosolic), class A member 1</td>
<td align="left">NA</td>
<td align="left">15519</td>
<td align="left">Hsp90aa1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Gm97</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">cullin 1</td>
<td align="left">NA</td>
<td align="left">26965</td>
<td align="left">Cul1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">T cell leukemia/lymphoma 1B, 1</td>
<td align="left">NA</td>
<td align="left">27379</td>
<td align="left">Tcl1b1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">developmental pluripotency associated 1</td>
<td align="left">NA</td>
<td align="left">347708</td>
<td align="left">Dppa1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 5</td>
<td align="left">This gene encodes a transmembrane domain-containing protein that localizes to the mitochondrial inner membrane. The encoded protein facilitates the exchange of ADP from the cytoplasm with ATP from the mitochondria. Pseudogenes for this gene are found on multiple chromosomes.</td>
<td align="left">11740</td>
<td align="left">Slc25a5</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">enoyl Coenzyme A hydratase domain containing 2</td>
<td align="left">NA</td>
<td align="left">52430</td>
<td align="left">Echdc2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">LOC100502936</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">tet methylcytosine dioxygenase 3</td>
<td align="left">NA</td>
<td align="left">194388</td>
<td align="left">Tet3</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">epithelial cell adhesion molecule</td>
<td align="left">NA</td>
<td align="left">17075</td>
<td align="left">Epcam</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">oogenesin 1</td>
<td align="left">NA</td>
<td align="left">193322</td>
<td align="left">Oog1</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">alcohol dehydrogenase 1 (class I)</td>
<td align="left">NA</td>
<td align="left">11522</td>
<td align="left">Adh1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">actin related protein 2/3 complex, subunit 5</td>
<td align="left">NA</td>
<td align="left">67771</td>
<td align="left">Arpc5</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NLR family, pyrin domain containing 4A</td>
<td align="left">NA</td>
<td align="left">243880</td>
<td align="left">Nlrp4a</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Janus kinase 2</td>
<td align="left">NA</td>
<td align="left">16452</td>
<td align="left">Jak2</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">lectin, galactose binding, soluble 1</td>
<td align="left">NA</td>
<td align="left">16852</td>
<td align="left">Lgals1</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">sorting nexin 2</td>
<td align="left">NA</td>
<td align="left">67804</td>
<td align="left">Snx2</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_fac_sqrt/gene_names_clus_&quot;,4,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-5-annotations-2" class="section level3">
<h3>Factor 5 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[5,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">X_id</th>
<th align="left">name</th>
<th align="left">query</th>
<th align="left">notfound</th>
<th align="left">summary</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">ENSMUSG00000081586</td>
<td align="left">predicted gene 11544</td>
<td align="left">Gm11544</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">432591</td>
<td align="left">predicted gene 11544</td>
<td align="left">Gm11544</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">LOC100502936</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">66591</td>
<td align="left">MAD2L1 binding protein</td>
<td align="left">Mad2l1bp</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">12049</td>
<td align="left">Bcl2-like 10</td>
<td align="left">Bcl2l10</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">277666</td>
<td align="left">predicted gene 13078</td>
<td align="left">Gm13078</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">54196</td>
<td align="left">poly(A) binding protein, nuclear 1</td>
<td align="left">Pabpn1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">20531</td>
<td align="left">solute carrier family 34 (sodium phosphate), member 2</td>
<td align="left">Slc34a2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">170734</td>
<td align="left">zinc finger and SCAN domain containing 5B</td>
<td align="left">Zscan5b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">106021</td>
<td align="left">topoisomerase I binding, arginine/serine-rich</td>
<td align="left">Topors</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">H47</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">105418</td>
<td align="left">RIKEN cDNA E330034G19 gene</td>
<td align="left">E330034G19Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">246791</td>
<td align="left">oocyte specific homeobox 3</td>
<td align="left">Obox3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">27224</td>
<td align="left">transcription elongation factor B (SIII), polypeptide 3</td>
<td align="left">Tceb3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20728</td>
<td align="left">Spi-C transcription factor (Spi-1/PU.1 related)</td>
<td align="left">Spic</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">236537</td>
<td align="left">zinc finger protein 352</td>
<td align="left">Zfp352</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ENSMUSG00000074804</td>
<td align="left">expressed sequence AU015228</td>
<td align="left">AU015228</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">99169</td>
<td align="left">expressed sequence AU015228</td>
<td align="left">AU015228</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Dub1a</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">252830</td>
<td align="left">oocyte specific homeobox 6</td>
<td align="left">Obox6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">70369</td>
<td align="left">BCL2-associated athanogene 5</td>
<td align="left">Bag5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">69020</td>
<td align="left">zinc finger protein 707</td>
<td align="left">Zfp707</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ENSMUSG00000100205</td>
<td align="left">predicted pseudogene 4850</td>
<td align="left">Gm4850</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">226957</td>
<td align="left">THO complex 4 pseudogene</td>
<td align="left">Gm4850</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ENSMUSG00000081249</td>
<td align="left">predicted gene 11517</td>
<td align="left">Gm11517</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">629750</td>
<td align="left">ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene</td>
<td align="left">Gm11517</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">26554</td>
<td align="left">cullin 3</td>
<td align="left">Cul3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">666806</td>
<td align="left">predicted gene 8300</td>
<td align="left">Gm8300</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">73274</td>
<td align="left">GC-rich promoter binding protein 1</td>
<td align="left">Gpbp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">545662</td>
<td align="left">RIKEN cDNA B020004J07 gene</td>
<td align="left">B020004J07Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">435337</td>
<td align="left">predicted gene 5662</td>
<td align="left">Gm5662</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">15257</td>
<td align="left">homeodomain interacting protein kinase 1</td>
<td align="left">Hipk1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">51869</td>
<td align="left">replication timing regulatory factor 1</td>
<td align="left">Rif1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">19139</td>
<td align="left">phosphoribosyl pyrophosphate synthetase 1</td>
<td align="left">Prps1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">52521</td>
<td align="left">zinc finger protein 622</td>
<td align="left">Zfp622</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">29864</td>
<td align="left">ring finger protein 11</td>
<td align="left">Rnf11</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">100073351</td>
<td align="left">Yy2 transcription factor</td>
<td align="left">Yy2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Usp17l5</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">73708</td>
<td align="left">developmental pluripotency-associated 3</td>
<td align="left">Dppa3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">19647</td>
<td align="left">retinoblastoma binding protein 6</td>
<td align="left">Rbbp6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">243272</td>
<td align="left">strawberry notch homolog 1 (Drosophila)</td>
<td align="left">Sbno1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">100038982</td>
<td align="left">REX1, RNA exonuclease 1 homolog pseudogene</td>
<td align="left">Gm1995</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">106298</td>
<td align="left">RRN3 RNA polymerase I transcription factor homolog (yeast)</td>
<td align="left">Rrn3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">52372</td>
<td align="left">DNA segment, Chr 6, ERATO Doi 527, expressed</td>
<td align="left">D6Ertd527e</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">217194</td>
<td align="left">kelch-like 11</td>
<td align="left">Klhl11</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">668359</td>
<td align="left">predicted gene 9125</td>
<td align="left">Gm9125</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">56715</td>
<td align="left">RAB guanine nucleotide exchange factor (GEF) 1</td>
<td align="left">Rabgef1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">78887</td>
<td align="left">Sfi1 homolog, spindle assembly associated (yeast)</td>
<td align="left">Sfi1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">100039042</td>
<td align="left">predicted gene 2016</td>
<td align="left">Gm2016</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">27275</td>
<td align="left">nuclear fragile X mental retardation protein interacting protein 1</td>
<td align="left">Nufip1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">108989</td>
<td align="left">translocated promoter region, nuclear basket protein</td>
<td align="left">Tpr</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">19820</td>
<td align="left">ring finger protein, LIM domain interacting</td>
<td align="left">Rlim</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">99890</td>
<td align="left">protein arginine N-methyltransferase 6</td>
<td align="left">Prmt6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">217664</td>
<td align="left">mannoside acetylglucosaminyltransferase 2</td>
<td align="left">Mgat2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">70611</td>
<td align="left">F-box protein 33</td>
<td align="left">Fbxo33</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">27362</td>
<td align="left">DnaJ heat shock protein family (Hsp40) member B9</td>
<td align="left">Dnajb9</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">229663</td>
<td align="left">cold shock domain containing E1, RNA binding</td>
<td align="left">Csde1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">22712</td>
<td align="left">zinc finger protein 54</td>
<td align="left">Zfp54</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">448850</td>
<td align="left">zinc finger, HIT type 3</td>
<td align="left">Znhit3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">213541</td>
<td align="left">YTH domain family 2</td>
<td align="left">Ythdf2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">56399</td>
<td align="left">A kinase (PRKA) anchor protein 8</td>
<td align="left">Akap8</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the A-kinase anchoring protein (AKAP) family. These proteins are characterized by their ability to bind to the R subunit of protein kinase A (PKA) and anchor the protein at different subcellular locations. This protein has been shown to regulate apoptosis and to be involved in palatogenesis. Knockdown of this gene has been associated with altered histone modifications and reduced expression of developmental genes in mouse embryonic stem cells. Alternative splicing results in multiple transcript variants.</td>
</tr>
<tr class="even">
<td align="left">116940</td>
<td align="left">trimethylguanosine synthase 1</td>
<td align="left">Tgs1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">104681</td>
<td align="left">solute carrier family 16 (monocarboxylic acid transporters), member 6</td>
<td align="left">Slc16a6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">232853</td>
<td align="left">zinc finger protein 954</td>
<td align="left">Zfp954</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">211347</td>
<td align="left">pantothenate kinase 3</td>
<td align="left">Pank3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">93759</td>
<td align="left">sirtuin 1</td>
<td align="left">Sirt1</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the sirtuin family of proteins, characterized by their deacetylase activity and proposed role in longevity. The encoded protein regulates gene expression in a wide range of cell and tissue types through its NAD+-dependent deacetylation of histones, transcription factors and transcriptional coactivators. Brain-specific overexpression of this gene has been shown to result in increased median lifespan. Viability of homozygous knockout mice for this gene varies with strain background. Homozygous knockout mice of strains that do not exhibit embryonic lethality are sterile and have a reduced lifespan. Alternative splicing results in multiple transcript variants.</td>
</tr>
<tr class="odd">
<td align="left">ENSMUSG00000071217</td>
<td align="left">predicted pseudogene 2022</td>
<td align="left">Gm2022</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">100039052</td>
<td align="left">predicted pseudogene 2022</td>
<td align="left">Gm2022</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">12702</td>
<td align="left">suppressor of cytokine signaling 3</td>
<td align="left">Socs3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">30946</td>
<td align="left">activator of basal transcription 1</td>
<td align="left">Abt1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">544881</td>
<td align="left">expressed sequence BB287469</td>
<td align="left">BB287469</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12447</td>
<td align="left">cyclin E1</td>
<td align="left">Ccne1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">17872</td>
<td align="left">protein phosphatase 1, regulatory (inhibitor) subunit 15A</td>
<td align="left">Ppp1r15a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">214048</td>
<td align="left">La ribonucleoprotein domain family, member 1B</td>
<td align="left">Larp1b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">12428</td>
<td align="left">cyclin A2</td>
<td align="left">Ccna2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">104836</td>
<td align="left">Casitas B-lineage lymphoma-like 1</td>
<td align="left">Cbll1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">75605</td>
<td align="left">lysine (K)-specific demethylase 5B</td>
<td align="left">Kdm5b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">382106</td>
<td align="left">F-box and WD-40 domain protein 24</td>
<td align="left">Fbxw24</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">24074</td>
<td align="left">TATA-box binding protein associated factor 7</td>
<td align="left">Taf7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">98582</td>
<td align="left">KH domain containing 1B</td>
<td align="left">Khdc1b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">22042</td>
<td align="left">transferrin receptor</td>
<td align="left">Tfrc</td>
<td align="left">NA</td>
<td align="left">This gene encodes a cell surface receptor necessary for cellular iron uptake by the process of receptor-mediated endocytosis. This receptor is required for erythropoiesis and neurologic development. Mice that are deficient in this receptor show impaired erythroid development and abnormal iron homeostasis.</td>
</tr>
<tr class="even">
<td align="left">207213</td>
<td align="left">TD and POZ domain containing 1</td>
<td align="left">Tdpoz1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">228913</td>
<td align="left">zinc finger protein 217</td>
<td align="left">Zfp217</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">21432</td>
<td align="left">T cell lymphoma breakpoint 1</td>
<td align="left">Tcl1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">13030</td>
<td align="left">cathepsin B</td>
<td align="left">Ctsb</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the peptidase C1 family and preproprotein that is proteolytically processed to generate multiple protein products. These products include the cathepsin B light and heavy chains, which can dimerize to generate the double chain form of the enzyme. This enzyme is a lysosomal cysteine protease with both endopeptidase and exopeptidase activity that may play a role in protein turnover. Homozygous knockout mice for this gene exhibit reduced pancreatic damage following induced pancreatitis and reduced hepatocyte apoptosis in a model of liver injury. Pseudogenes of this gene have been identified in the genome.</td>
</tr>
<tr class="even">
<td align="left">23942</td>
<td align="left">metastasis-associated gene family, member 2</td>
<td align="left">Mta2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">13663</td>
<td align="left">etoposide induced 2.4 mRNA</td>
<td align="left">Ei24</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Tmem92-ps</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">77041</td>
<td align="left">arylsulfatase K</td>
<td align="left">Arsk</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">666747</td>
<td align="left">tripartite motif-containing 43B</td>
<td align="left">Trim43b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">100535</td>
<td align="left">2’-5’ oligoadenylate synthetase 1D</td>
<td align="left">Oas1d</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Crxos1</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">12421</td>
<td align="left">RB1-inducible coiled-coil 1</td>
<td align="left">Rb1cc1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">67027</td>
<td align="left">makorin, ring finger protein, 2</td>
<td align="left">Mkrn2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">81898</td>
<td align="left">splicing factor 3b, subunit 1</td>
<td align="left">Sf3b1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">110809</td>
<td align="left">serine/arginine-rich splicing factor 1</td>
<td align="left">Srsf1</td>
<td align="left">NA</td>
<td align="left">The protein encoded by this gene is a member of the serine/arginine (SR)-rich family of pre-mRNA splicing factors, which constitute part of the spliceosome. Each of these factors contains an RNA recognition motif (RRM) for binding RNA and an RS domain for binding other proteins. The RS domain is rich in serine and arginine residues and facilitates interaction between different SR splicing factors. In addition to being critical for mRNA splicing, the SR proteins have also been shown to be involved in mRNA export from the nucleus and in translation. Two transcript variants encoding different isoforms have been found for this gene.</td>
</tr>
<tr class="odd">
<td align="left">244061</td>
<td align="left">Smad nuclear interacting protein 1 pseudogene</td>
<td align="left">Gm4971</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">55942</td>
<td align="left">SERTA domain containing 1</td>
<td align="left">Sertad1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">72404</td>
<td align="left">WD repeat domain 44</td>
<td align="left">Wdr44</td>
<td align="left">NA</td>
<td align="left">This gene encodes a protein containing multiple WD repeats. The encoded protein may play a role in vesicle trafficking. Alternate splicing results in multiple transcript variants.</td>
</tr>
<tr class="even">
<td align="left">19877</td>
<td align="left">Rho-associated coiled-coil containing protein kinase 1</td>
<td align="left">Rock1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">14131</td>
<td align="left">Fc receptor, IgG, low affinity III</td>
<td align="left">Fcgr3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">217558</td>
<td align="left">G2/M-phase specific E3 ubiquitin ligase</td>
<td align="left">G2e3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">235048</td>
<td align="left">zinc finger protein 599</td>
<td align="left">Zfp599</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">211948</td>
<td align="left">phosphodiesterase 12</td>
<td align="left">Pde12</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">170834</td>
<td align="left">oocyte secreted protein 1</td>
<td align="left">Oosp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_fac_sqrt/gene_names_clus_&quot;,5,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-6-annotations-2" class="section level3">
<h3>Factor 6 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[6,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">name</th>
<th align="left">X_id</th>
<th align="left">query</th>
<th align="left">notfound</th>
<th align="left">summary</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">preferentially expressed antigen in melanoma like 7</td>
<td align="left">347712</td>
<td align="left">Pramel7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ethanolamine kinase 1</td>
<td align="left">75320</td>
<td align="left">Etnk1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1</td>
<td align="left">11946</td>
<td align="left">Atp5a1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">2’-5’ oligoadenylate synthetase 1D</td>
<td align="left">100535</td>
<td align="left">Oas1d</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">predicted gene 5039</td>
<td align="left">ENSMUSG00000093847</td>
<td align="left">Gm5039</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">eukaryotic translation initiation factor 1A pseudogene</td>
<td align="left">266459</td>
<td align="left">Gm5039</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Gm13718</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">regulator of G-protein signaling 2</td>
<td align="left">19735</td>
<td align="left">Rgs2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">MIS18 binding protein 1</td>
<td align="left">217653</td>
<td align="left">Mis18bp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">tetratricopeptide repeat domain 4</td>
<td align="left">72354</td>
<td align="left">Ttc4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ceroid-lipofuscinosis, neuronal 8</td>
<td align="left">26889</td>
<td align="left">Cln8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ret finger protein-like 4B</td>
<td align="left">215919</td>
<td align="left">Rfpl4b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">F-box and WD-40 domain protein 15</td>
<td align="left">382105</td>
<td align="left">Fbxw15</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Kruppel-like factor 17</td>
<td align="left">75753</td>
<td align="left">Klf17</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">cyclin M2</td>
<td align="left">94219</td>
<td align="left">Cnnm2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">kelch-like 22</td>
<td align="left">224023</td>
<td align="left">Klhl22</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">anti-silencing function 1B histone chaperone</td>
<td align="left">66929</td>
<td align="left">Asf1b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">expressed sequence AI464131</td>
<td align="left">329828</td>
<td align="left">AI464131</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Myst4</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">pitrilysin metallepetidase 1</td>
<td align="left">69617</td>
<td align="left">Pitrm1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">protein phosphatase 1, regulatory (inhibitor) subunit 8</td>
<td align="left">100336</td>
<td align="left">Ppp1r8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">expressed sequence BB287469</td>
<td align="left">544881</td>
<td align="left">BB287469</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">F-box and WD-40 domain protein 24</td>
<td align="left">382106</td>
<td align="left">Fbxw24</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ubiquitin specific peptidase 4 (proto-oncogene)</td>
<td align="left">22258</td>
<td align="left">Usp4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">major vault protein</td>
<td align="left">78388</td>
<td align="left">Mvp</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Wapal</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">leucine-rich repeats and calponin homology (CH) domain containing 1</td>
<td align="left">380916</td>
<td align="left">Lrch1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">thioredoxin interacting protein</td>
<td align="left">56338</td>
<td align="left">Txnip</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">predicted pseudogene 2022</td>
<td align="left">ENSMUSG00000071217</td>
<td align="left">Gm2022</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">predicted pseudogene 2022</td>
<td align="left">100039052</td>
<td align="left">Gm2022</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Ube2d2</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">solute carrier family 34 (sodium phosphate), member 2</td>
<td align="left">20531</td>
<td align="left">Slc34a2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">LOC100502936</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">dual specificity phosphatase 22</td>
<td align="left">105352</td>
<td align="left">Dusp22</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ubiquitin specific peptidase 15</td>
<td align="left">14479</td>
<td align="left">Usp15</td>
<td align="left">NA</td>
<td align="left">The protein encoded by this gene is a member of the large ubiquitin specific protease (Usp) family of proteins. These proteins are known to cleave ubiquitin, and contain a conserved cysteine residue (Cys box) and two conserved histidine residues (His box) that are thought to form part of the active site of the protease. This protein has been shown to cleave both the ubiquitin-proline and the ubiquitin-methionine bonds in vitro. This protein is thought to regulate many cellular processes through its deubiquitination activity, including the transforming growth factor beta (TGF-beta) pathway. Cardiac-specific overexpression of the human ortholog of this gene in mice causes enlargement of the heart that is more pronounced in the atrium than in the ventricle. This gene has two pseudogenes on chromosome 14. Alternative splicing results in multiple transcript variants that encode multiple protein isoforms.</td>
</tr>
<tr class="even">
<td align="left">speckle-type POZ protein</td>
<td align="left">20747</td>
<td align="left">Spop</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">CLP1, cleavage and polyadenylation factor I subunit</td>
<td align="left">98985</td>
<td align="left">Clp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">CGG triplet repeat binding protein 1</td>
<td align="left">106143</td>
<td align="left">Cggbp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">predicted gene 5662</td>
<td align="left">435337</td>
<td align="left">Gm5662</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">predicted gene 4340</td>
<td align="left">100043292</td>
<td align="left">Gm4340</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ELL associated factor 1</td>
<td align="left">74427</td>
<td align="left">Eaf1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">H2A histone family, member Z</td>
<td align="left">51788</td>
<td align="left">H2afz</td>
<td align="left">NA</td>
<td align="left">Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Nucleosomes consist of approximately 146 bp of DNA wrapped around a histone octamer composed of pairs of each of the four core histones (H2A, H2B, H3, and H4). The chromatin fiber is further compacted through the interaction of a linker histone, H1, with the DNA between the nucleosomes to form higher order chromatin structures. This gene encodes a replication-independent member of the histone H2A family that is distinct from other members of the family. Studies in mice have shown that this particular histone is required for embryonic development and indicate that lack of functional histone H2A leads to embryonic lethality. Alternative splicing results in multiple transcript variants.</td>
</tr>
<tr class="odd">
<td align="left">LPS-induced TN factor</td>
<td align="left">56722</td>
<td align="left">Litaf</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">retinoid X receptor alpha</td>
<td align="left">20181</td>
<td align="left">Rxra</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">zinc finger protein 57</td>
<td align="left">22715</td>
<td align="left">Zfp57</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">DNA-damage-inducible transcript 4-like</td>
<td align="left">73284</td>
<td align="left">Ddit4l</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Tmem92-ps</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rab geranylgeranyl transferase, b subunit</td>
<td align="left">19352</td>
<td align="left">Rabggtb</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">KH domain containing 1B</td>
<td align="left">98582</td>
<td align="left">Khdc1b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">synovial sarcoma translocation, Chromosome 18</td>
<td align="left">268996</td>
<td align="left">Ss18</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">predicted gene 2016</td>
<td align="left">100039042</td>
<td align="left">Gm2016</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">splA/ryanodine receptor domain and SOCS box containing 4</td>
<td align="left">211949</td>
<td align="left">Spsb4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">spindlin 1</td>
<td align="left">20729</td>
<td align="left">Spin1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">sphingomyelin phosphodiesterase 1, acid lysosomal</td>
<td align="left">20597</td>
<td align="left">Smpd1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">coenzyme Q3 methyltransferase</td>
<td align="left">230027</td>
<td align="left">Coq3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">N-ethylmaleimide sensitive fusion protein</td>
<td align="left">18195</td>
<td align="left">Nsf</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">glutamate-cysteine ligase, catalytic subunit</td>
<td align="left">14629</td>
<td align="left">Gclc</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">casein kinase 1, gamma 1</td>
<td align="left">214897</td>
<td align="left">Csnk1g1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">predicted gene 8300</td>
<td align="left">666806</td>
<td align="left">Gm8300</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RIO kinase 1 (yeast)</td>
<td align="left">71340</td>
<td align="left">Riok1</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the RIO family of atypical serine protein kinases. A similar protein in humans is a component of the protein arginine methyltransferase 5 complex that specifically recruits the RNA-binding protein nucleolin as a methylation substrate.</td>
</tr>
<tr class="odd">
<td align="left">polymerase (RNA) III (DNA directed) polypeptide G</td>
<td align="left">67486</td>
<td align="left">Polr3g</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">MKL/myocardin-like 2</td>
<td align="left">239719</td>
<td align="left">Mkl2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">solute carrier family 22, member 23</td>
<td align="left">73102</td>
<td align="left">Slc22a23</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">CDC-like kinase 2</td>
<td align="left">12748</td>
<td align="left">Clk2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Zfp259</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">zinc finger, BED type containing 3</td>
<td align="left">72114</td>
<td align="left">Zbed3</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the zinc finger protein superfamily. This protein may regulate the Wnt/beta-catenin signaling pathway. This protein may be involved in insulin resistance and type 2 diabetes in humans. Alternative splicing results in multiple transcript variants.</td>
</tr>
<tr class="odd">
<td align="left">Bmi1 polycomb ring finger oncogene</td>
<td align="left">12151</td>
<td align="left">Bmi1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">anthrax toxin receptor 1</td>
<td align="left">69538</td>
<td align="left">Antxr1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">RAB6A GEF compex partner 1</td>
<td align="left">242406</td>
<td align="left">Rgp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">F-box and WD-40 domain protein 18</td>
<td align="left">546161</td>
<td align="left">Fbxw18</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">eukaryotic translation initiation factor 1B</td>
<td align="left">68969</td>
<td align="left">Eif1b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RIKEN cDNA 6430548M08 gene</td>
<td align="left">234797</td>
<td align="left">6430548M08Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">T cell lymphoma invasion and metastasis 1</td>
<td align="left">21844</td>
<td align="left">Tiam1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">nuclear transcription factor-Y alpha</td>
<td align="left">18044</td>
<td align="left">Nfya</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">centrosomal protein 97</td>
<td align="left">74201</td>
<td align="left">Cep97</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ubiquitin protein ligase E3 component n-recognin 7 (putative)</td>
<td align="left">66622</td>
<td align="left">Ubr7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">cAMP-regulated phosphoprotein 19</td>
<td align="left">59046</td>
<td align="left">Arpp19</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">CCR4-NOT transcription complex, subunit 6-like</td>
<td align="left">231464</td>
<td align="left">Cnot6l</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">multiple coagulation factor deficiency 2</td>
<td align="left">193813</td>
<td align="left">Mcfd2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rac GTPase-activating protein 1</td>
<td align="left">26934</td>
<td align="left">Racgap1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">caseinolytic mitochondrial matrix peptidase chaperone subunit</td>
<td align="left">270166</td>
<td align="left">Clpx</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">WD repeat domain 44</td>
<td align="left">72404</td>
<td align="left">Wdr44</td>
<td align="left">NA</td>
<td align="left">This gene encodes a protein containing multiple WD repeats. The encoded protein may play a role in vesicle trafficking. Alternate splicing results in multiple transcript variants.</td>
</tr>
<tr class="odd">
<td align="left">1-aminocyclopropane-1-carboxylate synthase (non-functional)-like</td>
<td align="left">381411</td>
<td align="left">Accsl</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">phosphoserine aminotransferase 1</td>
<td align="left">107272</td>
<td align="left">Psat1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">nuclear receptor coactivator 3</td>
<td align="left">17979</td>
<td align="left">Ncoa3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">DnaJ heat shock protein family (Hsp40) member B14</td>
<td align="left">70604</td>
<td align="left">Dnajb14</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">malectin</td>
<td align="left">109154</td>
<td align="left">Mlec</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">IQ motif containing GTPase activating protein 3</td>
<td align="left">404710</td>
<td align="left">Iqgap3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">translocase of inner mitochondrial membrane 17a</td>
<td align="left">21854</td>
<td align="left">Timm17a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Lins</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">diacylglycerol kinase, epsilon</td>
<td align="left">56077</td>
<td align="left">Dgke</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RAB GTPase activating protein 1-like</td>
<td align="left">29809</td>
<td align="left">Rabgap1l</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">cytochrome P450, family 2, subfamily s, polypeptide 1</td>
<td align="left">74134</td>
<td align="left">Cyp2s1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">peroxisomal membrane protein 4</td>
<td align="left">59038</td>
<td align="left">Pxmp4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">prospero homeobox 1</td>
<td align="left">19130</td>
<td align="left">Prox1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">pituitary tumor-transforming gene 1</td>
<td align="left">30939</td>
<td align="left">Pttg1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NEL-like 1</td>
<td align="left">338352</td>
<td align="left">Nell1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">coxsackie virus and adenovirus receptor</td>
<td align="left">13052</td>
<td align="left">Cxadr</td>
<td align="left">NA</td>
<td align="left">This gene encodes a protein that is part of the Cortical Thymocyte marker in Xenopus (CTX) subfamily within the immunoglobulin superfamily. Members of this subfamily, predominantly expressed on the surface of endothelial and epithelial cells, help establish cell polarity and provide a barrier function, regulating migration of immune cells. This protein, first identified as the receptor for adenovirus subgroup C and coxsakieviruses group B, is developmentally regulated and plays an important role in cardiac development. Alternative splicing results in multiple transcript variants that encode different protein isoforms.</td>
</tr>
<tr class="odd">
<td align="left">activating transcription factor 7 interacting protein 2</td>
<td align="left">75329</td>
<td align="left">Atf7ip2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">PAP associated domain containing 5</td>
<td align="left">214627</td>
<td align="left">Papd5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">formin 1</td>
<td align="left">14260</td>
<td align="left">Fmn1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">predicted gene 9125</td>
<td align="left">668359</td>
<td align="left">Gm9125</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_fac_sqrt/gene_names_clus_&quot;,6,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-7-annotations-2" class="section level3">
<h3>Factor 7 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[7,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">summary</th>
<th align="left">query</th>
<th align="left">name</th>
<th align="left">X_id</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">This gene encodes a member of the actin family of proteins. Actins are highly conserved proteins that are among the most abundant proteins in eukaryotic cells and are involved in cell motility, structure, and integrity. Localization, stability, and translation of the transcribed mRNA are regulated through the binding of multiple factors to its 3’ UTR sequence. Homozygous knockout mice for this gene exhibit embryonic lethality. Numerous pseudogenes of this gene have been identified in the mouse genome.</td>
<td align="left">Actb</td>
<td align="left">actin, beta</td>
<td align="left">11461</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Hsp90ab1</td>
<td align="left">heat shock protein 90 alpha (cytosolic), class B member 1</td>
<td align="left">15516</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Hsp90aa1</td>
<td align="left">heat shock protein 90, alpha (cytosolic), class A member 1</td>
<td align="left">15519</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Hspa8</td>
<td align="left">heat shock protein 8</td>
<td align="left">15481</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Rpl8</td>
<td align="left">ribosomal protein L8</td>
<td align="left">26961</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Rps3</td>
<td align="left">ribosomal protein S3</td>
<td align="left">27050</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Rpl13a</td>
<td align="left">ribosomal protein L13A</td>
<td align="left">22121</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Calcoco2</td>
<td align="left">calcium binding and coiled-coil domain 2</td>
<td align="left">76815</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Rps14</td>
<td align="left">ribosomal protein S14</td>
<td align="left">20044</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Isyna1</td>
<td align="left">myo-inositol 1-phosphate synthase A1</td>
<td align="left">71780</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Rps11</td>
<td align="left">ribosomal protein S11</td>
<td align="left">27207</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Rpl7</td>
<td align="left">ribosomal protein L7</td>
<td align="left">19989</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Eef1a1</td>
<td align="left">eukaryotic translation elongation factor 1 alpha 1</td>
<td align="left">13627</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Ptma</td>
<td align="left">prothymosin alpha</td>
<td align="left">19231</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Rpl4</td>
<td align="left">ribosomal protein L4</td>
<td align="left">67891</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">This gene encodes an elongation initiation factor, which participates in protein synthesis. The encoded protein also plays roles in mRNA metabolism, cell proliferation, and cell cycle control. This protein contains a modified lysine residue called hypusine, which appears to be necessary for its function. Alternatively spliced transcript variants have been described. Related pseudogenes exist on chromosomes 2, 5, and 19.</td>
<td align="left">Eif5a</td>
<td align="left">eukaryotic translation initiation factor 5A</td>
<td align="left">276770</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Map1lc3b</td>
<td align="left">microtubule-associated protein 1 light chain 3 beta</td>
<td align="left">67443</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Cnbp</td>
<td align="left">cellular nucleic acid binding protein</td>
<td align="left">12785</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Crip2</td>
<td align="left">cysteine rich protein 2</td>
<td align="left">68337</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Dppa5a</td>
<td align="left">developmental pluripotency associated 5A</td>
<td align="left">434423</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">This gene encodes a transmembrane domain-containing protein that localizes to the mitochondrial inner membrane. The encoded protein facilitates the exchange of ADP from the cytoplasm with ATP from the mitochondria. Pseudogenes for this gene are found on multiple chromosomes.</td>
<td align="left">Slc25a5</td>
<td align="left">solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 5</td>
<td align="left">11740</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Wtap</td>
<td align="left">Wilms tumour 1-associating protein</td>
<td align="left">60532</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Tceb1</td>
<td align="left">transcription elongation factor B (SIII), polypeptide 1</td>
<td align="left">67923</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Sord</td>
<td align="left">sorbitol dehydrogenase</td>
<td align="left">20322</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Mt1</td>
<td align="left">metallothionein 1</td>
<td align="left">17748</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Mdh2</td>
<td align="left">malate dehydrogenase 2, NAD (mitochondrial)</td>
<td align="left">17448</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Gm2a</td>
<td align="left">GM2 ganglioside activator protein</td>
<td align="left">14667</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Npm1</td>
<td align="left">nucleophosmin 1</td>
<td align="left">18148</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Crxos1</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Gabarapl2</td>
<td align="left">gamma-aminobutyric acid (GABA) A receptor-associated protein-like 2</td>
<td align="left">93739</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Dppa3</td>
<td align="left">developmental pluripotency-associated 3</td>
<td align="left">73708</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Rplp0</td>
<td align="left">ribosomal protein, large, P0</td>
<td align="left">11837</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Fabp3</td>
<td align="left">fatty acid binding protein 3, muscle and heart</td>
<td align="left">14077</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Nme1</td>
<td align="left">NME/NM23 nucleoside diphosphate kinase 1</td>
<td align="left">18102</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Eef2</td>
<td align="left">eukaryotic translation elongation factor 2</td>
<td align="left">13629</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Rps9</td>
<td align="left">ribosomal protein S9</td>
<td align="left">76846</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Lrpap1</td>
<td align="left">low density lipoprotein receptor-related protein associated protein 1</td>
<td align="left">16976</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Cd9</td>
<td align="left">CD9 antigen</td>
<td align="left">12527</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Ptges3</td>
<td align="left">prostaglandin E synthase 3 (cytosolic)</td>
<td align="left">56351</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Cct7</td>
<td align="left">chaperonin containing Tcp1, subunit 7 (eta)</td>
<td align="left">12468</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">The protein encoded by this gene is a transferase, which catalyzes conversion of hypoxanthine to inosine monophosphate and guanine to guanosine monophosphate via transfer of the 5-phosphoribosyl group from 5-phosphoribosyl 1-pyrophosphate. This enzyme plays a central role in the generation of purine nucleotides through the purine salvage pathway.</td>
<td align="left">Hprt</td>
<td align="left">hypoxanthine guanine phosphoribosyl transferase</td>
<td align="left">15452</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Nme2</td>
<td align="left">NME/NM23 nucleoside diphosphate kinase 2</td>
<td align="left">18103</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Psma6</td>
<td align="left">proteasome (prosome, macropain) subunit, alpha type 6</td>
<td align="left">26443</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Rps5</td>
<td align="left">ribosomal protein S5</td>
<td align="left">20103</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Eif2s2</td>
<td align="left">eukaryotic translation initiation factor 2, subunit 2 (beta)</td>
<td align="left">67204</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Pa2g4</td>
<td align="left">proliferation-associated 2G4</td>
<td align="left">18813</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Ndufa9</td>
<td align="left">NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9</td>
<td align="left">66108</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Sfn</td>
<td align="left">stratifin</td>
<td align="left">55948</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Gnb2l1</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Stip1</td>
<td align="left">stress-induced phosphoprotein 1</td>
<td align="left">20867</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Eef1g</td>
<td align="left">eukaryotic translation elongation factor 1 gamma</td>
<td align="left">67160</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Rpl14</td>
<td align="left">ribosomal protein L14</td>
<td align="left">67115</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Ptges</td>
<td align="left">prostaglandin E synthase</td>
<td align="left">64292</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">The protein encoded by this gene is a member of the DnaJ family, whose members act as cochaperones of heat shock protein 70. Heat shock proteins facilitate protein folding, trafficking, prevention of aggregation, and proteolytic degradation. Members of this family are characterized by a highly conserved N-terminal J domain, a glycine/phenylalanine-rich region, four CxxCxGxG zinc finger repeats, and a C-terminal substrate-binding domain. The J domain mediates the interaction with heat shock protein 70 to recruit substrates and regulate ATP hydrolysis activity. Mice deficient for this gene display reduced levels of activation‐induced deaminase, an enzyme that deaminates deoxycytidine at the immunoglobulin genes during immune responses. In addition, mice lacking this gene exhibit severe defects in spermatogenesis. Several pseudogenes of this gene are found on other chromosomes. Alternative splicing results in multiple transcript variants.</td>
<td align="left">Dnaja1</td>
<td align="left">DnaJ heat shock protein family (Hsp40) member A1</td>
<td align="left">15502</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Cstb</td>
<td align="left">cystatin B</td>
<td align="left">13014</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Cd63</td>
<td align="left">CD63 antigen</td>
<td align="left">12512</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Rplp2</td>
<td align="left">ribosomal protein, large P2</td>
<td align="left">67186</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Eef1b2</td>
<td align="left">eukaryotic translation elongation factor 1 beta 2</td>
<td align="left">55949</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Ftl1</td>
<td align="left">ferritin light polypeptide 1</td>
<td align="left">14325</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Eif3i</td>
<td align="left">eukaryotic translation initiation factor 3, subunit I</td>
<td align="left">54709</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Cox4i1</td>
<td align="left">cytochrome c oxidase subunit IV isoform 1</td>
<td align="left">12857</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Cct8</td>
<td align="left">chaperonin containing Tcp1, subunit 8 (theta)</td>
<td align="left">12469</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 40S subunit. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome.</td>
<td align="left">Rps20</td>
<td align="left">ribosomal protein S20</td>
<td align="left">67427</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Actins are highly conserved proteins that are involved in various types of cell motility and maintenance of the cytoskeleton. In vertebrates, three main groups of actin isoforms, alpha, beta, and gamma, have been identified. The alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. The beta and gamma actins co-exist in most cell types as components of the cytoskeleton, and as mediators of internal cell motility. Actin, gamma 1, encoded by this gene, is a cytoplasmic actin found in non-muscle cells. Alternative splicing results in multiple transcript variants.</td>
<td align="left">Actg1</td>
<td align="left">actin, gamma, cytoplasmic 1</td>
<td align="left">11465</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Ncl</td>
<td align="left">nucleolin</td>
<td align="left">17975</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Psmc4</td>
<td align="left">proteasome (prosome, macropain) 26S subunit, ATPase, 4</td>
<td align="left">23996</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Snx1</td>
<td align="left">sorting nexin 1</td>
<td align="left">56440</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">2210409E12Rik</td>
<td align="left">RIKEN cDNA 2210409E12 gene</td>
<td align="left">ENSMUSG00000081766</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">2210409E12Rik</td>
<td align="left">transcription elongation factor B (SIII), polypeptide 2 pseudogene</td>
<td align="left">72381</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Actn4</td>
<td align="left">actinin alpha 4</td>
<td align="left">60595</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Rplp1</td>
<td align="left">ribosomal protein, large, P1</td>
<td align="left">56040</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">The protein encoded by this gene is a component of mitochondrial adenosine triphosphate synthase, which catalyzes the conversion of ATP from ADP. Mitochondrial adenosine triphosphate synthase consists of extrinsic and intrinsic membrane domains that are joined by a stalk. The protein encoded by this gene is a subunit of the stalk domain. A bi-directional promoter that drives expression of this gene has been has been identified. Pseudogenes of this gene are found on chromosomes 14 and 17. Alternative splicing results in multiple transcript variants.</td>
<td align="left">Atp5j</td>
<td align="left">ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F</td>
<td align="left">11957</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Rbm47</td>
<td align="left">RNA binding motif protein 47</td>
<td align="left">245945</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Slc25a3</td>
<td align="left">solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 3</td>
<td align="left">18674</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Gm1995</td>
<td align="left">REX1, RNA exonuclease 1 homolog pseudogene</td>
<td align="left">100038982</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Eef1d</td>
<td align="left">eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein)</td>
<td align="left">66656</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Set</td>
<td align="left">SET nuclear oncogene</td>
<td align="left">56086</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Dab2</td>
<td align="left">disabled 2, mitogen-responsive phosphoprotein</td>
<td align="left">13132</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">This gene encodes a member of the glutathione peroxidase protein family. Glutathione peroxidase catalyzes the reduction of hydrogen peroxide, organic hydroperoxide, and lipid peroxides by reduced glutathione and functions in the protection of cells against oxidative damage. Plasma glutathione peroxidase has been shown to be a selenium-containing enzyme and the UGA codon is translated into a selenocysteine. A similar protein in rat has been identified as a moonlighting protein based on its ability to serve dual functions as a peroxidase as well as a structural protein in mature spermatozoa. Disruption of this gene in spermatocytes is associated with male infertility. Alternative splicing results in multiple transcript variants. Two pseudogenes of this gene have been defined on chromosomes 10 and 17.</td>
<td align="left">Gpx4</td>
<td align="left">glutathione peroxidase 4</td>
<td align="left">625249</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Rpl22</td>
<td align="left">ribosomal protein L22</td>
<td align="left">19934</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Npc2</td>
<td align="left">Niemann-Pick type C2</td>
<td align="left">67963</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Eif3l</td>
<td align="left">eukaryotic translation initiation factor 3, subunit L</td>
<td align="left">223691</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Ran</td>
<td align="left">RAN, member RAS oncogene family</td>
<td align="left">19384</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Echdc2</td>
<td align="left">enoyl Coenzyme A hydratase domain containing 2</td>
<td align="left">52430</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Cdc42</td>
<td align="left">cell division cycle 42</td>
<td align="left">12540</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Ckb</td>
<td align="left">creatine kinase, brain</td>
<td align="left">12709</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Bcat1</td>
<td align="left">branched chain aminotransferase 1, cytosolic</td>
<td align="left">12035</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Mtf2</td>
<td align="left">metal response element binding transcription factor 2</td>
<td align="left">17765</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Translation initiation is mediated by specific recognition of the cap structure by eukaryotic translation initiation factor 4F (eIF4F), which is a cap binding protein complex that consists of three subunits: eIF4A, eIF4E and eIF4G. The protein encoded by this gene shares similarity with the C-terminal region of eIF4G, that contains the binding sites for eIF4A and eIF3; eIF4G in addition, contains a binding site for eIF4E at the N-terminus. Unlike eIF4G which supports cap-dependent and independent translation, this gene product functions as a general repressor of translation by forming translationally inactive complexes. Transgene expression of the apolipoprotein B mRNA-editing enzyme (APOBEC-1) causes extensive editing of this mRNA, which could contribute to the potent oncogenesis induced by overexpression of APOBEC-1. In vitro and in vivo studies in human indicate that translation of this mRNA initiates exclusively at a non-AUG (GUG) codon. This also appears to be true for mouse. Two alternatively spliced transcript variants that encode different isoforms have been found for this gene.</td>
<td align="left">Eif4g2</td>
<td align="left">eukaryotic translation initiation factor 4, gamma 2</td>
<td align="left">13690</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Eif4a1</td>
<td align="left">eukaryotic translation initiation factor 4A1</td>
<td align="left">13681</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Hnrnpa2b1</td>
<td align="left">heterogeneous nuclear ribonucleoprotein A2/B1</td>
<td align="left">53379</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">This gene encodes a key enzyme of the nonoxidative pentose phosphate pathway that provides ribose-5-phosphate for nucleic acid synthesis and nicotinamide adenine dinucleotide phosphate (NADPH) for lipid biosynthesis. The encoded protein is important for maintaining structure and function of mitochondria. Studies in knockout mice identify that deficiency of this gene product is a cause of sperm dysmotility and male infertility. Deficiency of this protein has also been identified as a cause of hepatocarcinogenesis in mice. Two related pseudogenes have been identified on chromosome 10.</td>
<td align="left">Taldo1</td>
<td align="left">transaldolase 1</td>
<td align="left">21351</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">6720456B07Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Cndp2</td>
<td align="left">CNDP dipeptidase 2 (metallopeptidase M20 family)</td>
<td align="left">66054</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Rrm2</td>
<td align="left">ribonucleotide reductase M2</td>
<td align="left">20135</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Nhp2</td>
<td align="left">NHP2 ribonucleoprotein</td>
<td align="left">52530</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Renbp</td>
<td align="left">renin binding protein</td>
<td align="left">19703</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Gm11517</td>
<td align="left">predicted gene 11517</td>
<td align="left">ENSMUSG00000081249</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Gm11517</td>
<td align="left">ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene</td>
<td align="left">629750</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Tcfcp2l1</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Cct5</td>
<td align="left">chaperonin containing Tcp1, subunit 5 (epsilon)</td>
<td align="left">12465</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Hdgf</td>
<td align="left">hepatoma-derived growth factor</td>
<td align="left">15191</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_fac_sqrt/gene_names_clus_&quot;,7,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-8-annotations-2" class="section level3">
<h3>Factor 8 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[8,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">query</th>
<th align="left">X_id</th>
<th align="left">name</th>
<th align="left">summary</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Upp1</td>
<td align="left">22271</td>
<td align="left">uridine phosphorylase 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tdgf1</td>
<td align="left">21667</td>
<td align="left">teratocarcinoma-derived growth factor 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm2a</td>
<td align="left">14667</td>
<td align="left">GM2 ganglioside activator protein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Actb</td>
<td align="left">11461</td>
<td align="left">actin, beta</td>
<td align="left">This gene encodes a member of the actin family of proteins. Actins are highly conserved proteins that are among the most abundant proteins in eukaryotic cells and are involved in cell motility, structure, and integrity. Localization, stability, and translation of the transcribed mRNA are regulated through the binding of multiple factors to its 3’ UTR sequence. Homozygous knockout mice for this gene exhibit embryonic lethality. Numerous pseudogenes of this gene have been identified in the mouse genome.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tat</td>
<td align="left">234724</td>
<td align="left">tyrosine aminotransferase</td>
<td align="left">This gene encodes a liver-specific mitochondrial enzyme that catalyzes the conversion of L-tyrosine into p-hydroxyphenylpyruvate. Regulated by glucocorticoid and polypeptide hormones, this gene’s expression is affected by deletion of a regulatory region near the albino locus on chromosome 7. Mutations in this gene cause tyrosinemia type II in humans.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tet1</td>
<td align="left">52463</td>
<td align="left">tet methylcytosine dioxygenase 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ctsb</td>
<td align="left">13030</td>
<td align="left">cathepsin B</td>
<td align="left">This gene encodes a member of the peptidase C1 family and preproprotein that is proteolytically processed to generate multiple protein products. These products include the cathepsin B light and heavy chains, which can dimerize to generate the double chain form of the enzyme. This enzyme is a lysosomal cysteine protease with both endopeptidase and exopeptidase activity that may play a role in protein turnover. Homozygous knockout mice for this gene exhibit reduced pancreatic damage following induced pancreatitis and reduced hepatocyte apoptosis in a model of liver injury. Pseudogenes of this gene have been identified in the genome.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cldn4</td>
<td align="left">12740</td>
<td align="left">claudin 4</td>
<td align="left">This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets, and also play critical roles in maintaining cell polarity and signal transductions. The protein encoded by this gene is a high-affinity receptor for clostridium perfringens enterotoxin (CPE) produced by the bacterium Clostridium perfringens, and the interaction with CPE results in increased membrane permeability by forming small pores in plasma membrane. This protein augments alveolar epithelial barrier function and is induced in acute lung injury. It is highly expressed in pancreatic and ovarian cancers.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Spp1</td>
<td align="left">20750</td>
<td align="left">secreted phosphoprotein 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Dab2</td>
<td align="left">13132</td>
<td align="left">disabled 2, mitogen-responsive phosphoprotein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Col4a1</td>
<td align="left">12826</td>
<td align="left">collagen, type IV, alpha 1</td>
<td align="left">This gene encodes the alpha-1 subunit of the type IV collagens, an essential component of basement membranes. The encoded protein forms a triple helical heterotrimer comprised of two alpha-1 and one alpha-2 subunits that assembles into a type IV collagen network. This gene is located adjacent to the gene encoding alpha-2 subunit. Mice lacking both the alpha-1 and alpha-2 subunits of collagen IV die in utero due to structural deficiencies in the basement membranes and certain mutations in this gene cause perinatal cerebral hemorrhage and porencephaly. Alternative splicing of this gene results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Fn1</td>
<td align="left">14268</td>
<td align="left">fibronectin 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Aqp8</td>
<td align="left">11833</td>
<td align="left">aquaporin 8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Slc46a1</td>
<td align="left">52466</td>
<td align="left">solute carrier family 46, member 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Actn4</td>
<td align="left">60595</td>
<td align="left">actinin alpha 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Akap12</td>
<td align="left">83397</td>
<td align="left">A kinase (PRKA) anchor protein (gravin) 12</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">4930583H14Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">Pdgfra</td>
<td align="left">18595</td>
<td align="left">platelet derived growth factor receptor, alpha polypeptide</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Amotl2</td>
<td align="left">56332</td>
<td align="left">angiomotin-like 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Aco1</td>
<td align="left">11428</td>
<td align="left">aconitase 1</td>
<td align="left">This gene encodes a member of the aconitase/IPM isomerase protein family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Depending on iron levels in the cytosol, the encoded protein can function as either an aconitase enzyme or as an mRNA binding protein. When cellular iron levels are high, the encoded protein functions as an aconitase, an essential enzyme in the TCA cycle that catalyzes the conversion of citrate to isocitrate. When cellular iron levels are low, the encoded protein regulates iron uptake and utilization by binding to iron-responsive elements in the untranslated regions of mRNAs for genes involved in iron metabolism. Disruption of this gene is associated with pulmonary hypertension and polycythemia.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rnf130</td>
<td align="left">59044</td>
<td align="left">ring finger protein 130</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Sparc</td>
<td align="left">20692</td>
<td align="left">secreted acidic cysteine rich glycoprotein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fam101b</td>
<td align="left">76566</td>
<td align="left">family with sequence similarity 101, member B</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Glrx</td>
<td align="left">93692</td>
<td align="left">glutaredoxin</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ap2a2</td>
<td align="left">11772</td>
<td align="left">adaptor-related protein complex 2, alpha 2 subunit</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Smpd1</td>
<td align="left">20597</td>
<td align="left">sphingomyelin phosphodiesterase 1, acid lysosomal</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cyp2s1</td>
<td align="left">74134</td>
<td align="left">cytochrome P450, family 2, subfamily s, polypeptide 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Col4a2</td>
<td align="left">12827</td>
<td align="left">collagen, type IV, alpha 2</td>
<td align="left">This gene encodes the alpha-2 subunit of the type IV collagens, an essential component of basement membranes. The encoded protein forms a triple helical heterotrimer comprised of alpha-1 and alpha-2 subunits that assembles into a type IV collagen network. Canstatin, a peptide derived fom the C-terminus of the collagen chain, is a matrikine that has been shown to inhibit angiogenesis. Homozygous knockout mice for this gene exhibit impaired basement membrane integrity and embryonic lethality. This gene shares a bi-directional promoter with a related gene on chromosome 8.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">BC051665</td>
<td align="left">218275</td>
<td align="left">cDNA sequence BC051665</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ly6g6e</td>
<td align="left">70274</td>
<td align="left">lymphocyte antigen 6 complex, locus G6E</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Slc1a3</td>
<td align="left">20512</td>
<td align="left">solute carrier family 1 (glial high affinity glutamate transporter), member 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ephx2</td>
<td align="left">13850</td>
<td align="left">epoxide hydrolase 2, cytoplasmic</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Glud1</td>
<td align="left">14661</td>
<td align="left">glutamate dehydrogenase 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gata3</td>
<td align="left">14462</td>
<td align="left">GATA binding protein 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ckb</td>
<td align="left">12709</td>
<td align="left">creatine kinase, brain</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Idh3a</td>
<td align="left">67834</td>
<td align="left">isocitrate dehydrogenase 3 (NAD+) alpha</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tmem62</td>
<td align="left">96957</td>
<td align="left">transmembrane protein 62</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Crip2</td>
<td align="left">68337</td>
<td align="left">cysteine rich protein 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Slc24a5</td>
<td align="left">317750</td>
<td align="left">solute carrier family 24, member 5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Fabp3</td>
<td align="left">14077</td>
<td align="left">fatty acid binding protein 3, muscle and heart</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Serpinh1</td>
<td align="left">12406</td>
<td align="left">serine (or cysteine) peptidase inhibitor, clade H, member 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">E130012A19Rik</td>
<td align="left">103551</td>
<td align="left">RIKEN cDNA E130012A19 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rragd</td>
<td align="left">52187</td>
<td align="left">Ras-related GTP binding D</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Smpdl3a</td>
<td align="left">57319</td>
<td align="left">sphingomyelin phosphodiesterase, acid-like 3A</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Actg1</td>
<td align="left">11465</td>
<td align="left">actin, gamma, cytoplasmic 1</td>
<td align="left">Actins are highly conserved proteins that are involved in various types of cell motility and maintenance of the cytoskeleton. In vertebrates, three main groups of actin isoforms, alpha, beta, and gamma, have been identified. The alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. The beta and gamma actins co-exist in most cell types as components of the cytoskeleton, and as mediators of internal cell motility. Actin, gamma 1, encoded by this gene, is a cytoplasmic actin found in non-muscle cells. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Mt1</td>
<td align="left">17748</td>
<td align="left">metallothionein 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fbp2</td>
<td align="left">14120</td>
<td align="left">fructose bisphosphatase 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cldn7</td>
<td align="left">53624</td>
<td align="left">claudin 7</td>
<td align="left">This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets, and also play critical roles in maintaining cell polarity and signal transductions. This gene is expressed constitutively in the mammary epithelium throughout development, and might be involved in vesicle trafficking to the basolateral membrane. It is essential for NaCl homeostasis in distal nephrons. The knockout mice lacking this gene showed severe salt wasting, chronic dehydration, and growth retardation, and died within 12 days after birth. Alternatively spliced transcript variants have been found for this gene.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Poglut1</td>
<td align="left">224143</td>
<td align="left">protein O-glucosyltransferase 1</td>
<td align="left">This gene encodes a protein that can catalyze transfer of either UDP-glucose or UDP-xylose to epidermal growth factor (EGF) repeats, such as those found in Notch. Loss of this gene product results in embryonic lethality. Embryos have neural plate defects, heart defects, and truncations of their posterior axis. Alternate splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ncl</td>
<td align="left">17975</td>
<td align="left">nucleolin</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Plod2</td>
<td align="left">26432</td>
<td align="left">procollagen lysine, 2-oxoglutarate 5-dioxygenase 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Zc3hc1</td>
<td align="left">232679</td>
<td align="left">zinc finger, C3HC type 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Asns</td>
<td align="left">27053</td>
<td align="left">asparagine synthetase</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cln8</td>
<td align="left">26889</td>
<td align="left">ceroid-lipofuscinosis, neuronal 8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mtf2</td>
<td align="left">17765</td>
<td align="left">metal response element binding transcription factor 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Sord</td>
<td align="left">20322</td>
<td align="left">sorbitol dehydrogenase</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pyy</td>
<td align="left">217212</td>
<td align="left">peptide YY</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gjb5</td>
<td align="left">14622</td>
<td align="left">gap junction protein, beta 5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Slc39a2</td>
<td align="left">214922</td>
<td align="left">solute carrier family 39 (zinc transporter), member 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ube2l6</td>
<td align="left">56791</td>
<td align="left">ubiquitin-conjugating enzyme E2L 6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Zc3hav1</td>
<td align="left">78781</td>
<td align="left">zinc finger CCCH type, antiviral 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Lrpap1</td>
<td align="left">16976</td>
<td align="left">low density lipoprotein receptor-related protein associated protein 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Stip1</td>
<td align="left">20867</td>
<td align="left">stress-induced phosphoprotein 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Klf4</td>
<td align="left">16600</td>
<td align="left">Kruppel-like factor 4 (gut)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mt2</td>
<td align="left">17750</td>
<td align="left">metallothionein 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">C77370</td>
<td align="left">245555</td>
<td align="left">expressed sequence C77370</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gnai2</td>
<td align="left">14678</td>
<td align="left">guanine nucleotide binding protein (G protein), alpha inhibiting 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ak7</td>
<td align="left">78801</td>
<td align="left">adenylate kinase 7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gcnt1</td>
<td align="left">14537</td>
<td align="left">glucosaminyl (N-acetyl) transferase 1, core 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Fam25c</td>
<td align="left">69134</td>
<td align="left">family with sequence similarity 25, member C</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ccbl2</td>
<td align="left">229905</td>
<td align="left">cysteine conjugate-beta lyase 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Jam2</td>
<td align="left">67374</td>
<td align="left">junction adhesion molecule 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cdx2</td>
<td align="left">12591</td>
<td align="left">caudal type homeobox 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Agtrap</td>
<td align="left">11610</td>
<td align="left">angiotensin II, type I receptor-associated protein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Prkci</td>
<td align="left">18759</td>
<td align="left">protein kinase C, iota</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Fancm</td>
<td align="left">104806</td>
<td align="left">Fanconi anemia, complementation group M</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Eef2</td>
<td align="left">13629</td>
<td align="left">eukaryotic translation elongation factor 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Trp53</td>
<td align="left">22059</td>
<td align="left">transformation related protein 53</td>
<td align="left">This gene encodes tumor protein p53, which responds to diverse cellular stresses to regulate target genes that induce cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. p53 protein is expressed at low level in normal cells and at a high level in a variety of transformed cell lines, where it’s believed to contribute to transformation and malignancy. p53 is a DNA-binding protein containing transcription activation, DNA-binding, and oligomerization domains. It is postulated to bind to a p53-binding site and activate expression of downstream genes that inhibit growth and/or invasion, and thus function as a tumor suppressor. Mice deficient for this gene are developmentally normal but are susceptible to spontaneous tumors. Evidence to date shows that this gene contains one promoter, in contrast to alternative promoters of the human gene, and transcribes a few of splice variants which encode different isoforms, although the biological validity or the full-length nature of some variants has not been determined.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rnd3</td>
<td align="left">74194</td>
<td align="left">Rho family GTPase 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pgm1</td>
<td align="left">66681</td>
<td align="left">phosphoglucomutase 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Setx</td>
<td align="left">269254</td>
<td align="left">senataxin</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">0610010O12Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">Mfge8</td>
<td align="left">17304</td>
<td align="left">milk fat globule-EGF factor 8 protein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Aldh9a1</td>
<td align="left">56752</td>
<td align="left">aldehyde dehydrogenase 9, subfamily A1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm4926</td>
<td align="left">ENSMUSG00000086909</td>
<td align="left">predicted gene 4926</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gm4926</td>
<td align="left">237749</td>
<td align="left">T-cell immunoglobulin and mucin domain containing 2 pseudogene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ppfibp2</td>
<td align="left">19024</td>
<td align="left">PTPRF interacting protein, binding protein 2 (liprin beta 2)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Myh10</td>
<td align="left">77579</td>
<td align="left">myosin, heavy polypeptide 10, non-muscle</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Hspa8</td>
<td align="left">15481</td>
<td align="left">heat shock protein 8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ass1</td>
<td align="left">11898</td>
<td align="left">argininosuccinate synthetase 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Wdr1</td>
<td align="left">22388</td>
<td align="left">WD repeat domain 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Slc6a14</td>
<td align="left">56774</td>
<td align="left">solute carrier family 6 (neurotransmitter transporter), member 14</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Snx1</td>
<td align="left">56440</td>
<td align="left">sorting nexin 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pvrl1</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">Akr1b8</td>
<td align="left">14187</td>
<td align="left">aldo-keto reductase family 1, member B8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Mesdc2</td>
<td align="left">67943</td>
<td align="left">mesoderm development candidate 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mtch2</td>
<td align="left">56428</td>
<td align="left">mitochondrial carrier 2</td>
<td align="left">This gene encodes a member of the SLC25 family of nuclear-encoded transporters that are localized in the inner mitochondrial membrane. Members of this superfamily are involved in many metabolic pathways and cell functions. Genome-wide association studies in human have identified single-nucleotide polymorphisms in several loci associated with obesity. This gene is one such locus, which is highly expressed in white adipose tissue and adipocytes, and thought to play a regulatory role in adipocyte differentiation and biology. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. A recent study showed this gene to be an authentic stop codon readthrough target, and that its mRNA can give rise to an additional C-terminally extended isoform by use of an alternative in-frame translation termination codon.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Wrap53</td>
<td align="left">216853</td>
<td align="left">WD repeat containing, antisense to Trp53</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Timd2</td>
<td align="left">171284</td>
<td align="left">T cell immunoglobulin and mucin domain containing 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pdzd3</td>
<td align="left">170761</td>
<td align="left">PDZ domain containing 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mylpf</td>
<td align="left">17907</td>
<td align="left">myosin light chain, phosphorylatable, fast skeletal muscle</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_fac_sqrt/gene_names_clus_&quot;,8,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-9-annotations-2" class="section level3">
<h3>Factor 9 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[9,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">query</th>
<th align="left">name</th>
<th align="left">X_id</th>
<th align="left">summary</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Sat1</td>
<td align="left">spermidine/spermine N1-acetyl transferase 1</td>
<td align="left">20229</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">1700013H16Rik</td>
<td align="left">RIKEN cDNA 1700013H16 gene</td>
<td align="left">75514</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Slc25a5</td>
<td align="left">solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 5</td>
<td align="left">11740</td>
<td align="left">This gene encodes a transmembrane domain-containing protein that localizes to the mitochondrial inner membrane. The encoded protein facilitates the exchange of ADP from the cytoplasm with ATP from the mitochondria. Pseudogenes for this gene are found on multiple chromosomes.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Jazf1</td>
<td align="left">JAZF zinc finger 1</td>
<td align="left">231986</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Zfp655</td>
<td align="left">zinc finger protein 655</td>
<td align="left">72611</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pard3</td>
<td align="left">par-3 family cell polarity regulator</td>
<td align="left">93742</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Usp12</td>
<td align="left">ubiquitin specific peptidase 12</td>
<td align="left">22217</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Serinc1</td>
<td align="left">serine incorporator 1</td>
<td align="left">56442</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Calm1</td>
<td align="left">calmodulin 1</td>
<td align="left">12313</td>
<td align="left">This gene encodes a member of the EF-hand calcium-binding protein family. The encoded protein acts as a calcium sensor and is involved in relaying signals to calcium-sensitive proteins, enzymes and ion channels. The protein-calcium complex binds target proteins to regulate several cellular processes, including smooth muscle contraction, inflammation, apoptosis and the immune response. Mutations in the human gene are associated with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome 14. Alternative splicing results in multiple transcript variants encoding different isoforms.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Map4k5</td>
<td align="left">mitogen-activated protein kinase kinase kinase kinase 5</td>
<td align="left">399510</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Hmgn5</td>
<td align="left">high-mobility group nucleosome binding domain 5</td>
<td align="left">50887</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Eef1d</td>
<td align="left">eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein)</td>
<td align="left">66656</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ovol2</td>
<td align="left">ovo like zinc finger 2</td>
<td align="left">107586</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Dnajb2</td>
<td align="left">DnaJ heat shock protein family (Hsp40) member B2</td>
<td align="left">56812</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pcnt</td>
<td align="left">pericentrin (kendrin)</td>
<td align="left">18541</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Hmgb3</td>
<td align="left">high mobility group box 3</td>
<td align="left">15354</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm5635</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">Actg1</td>
<td align="left">actin, gamma, cytoplasmic 1</td>
<td align="left">11465</td>
<td align="left">Actins are highly conserved proteins that are involved in various types of cell motility and maintenance of the cytoskeleton. In vertebrates, three main groups of actin isoforms, alpha, beta, and gamma, have been identified. The alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. The beta and gamma actins co-exist in most cell types as components of the cytoskeleton, and as mediators of internal cell motility. Actin, gamma 1, encoded by this gene, is a cytoplasmic actin found in non-muscle cells. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rlim</td>
<td align="left">ring finger protein, LIM domain interacting</td>
<td align="left">19820</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Oog1</td>
<td align="left">oogenesin 1</td>
<td align="left">193322</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Eif2c2</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">G6pdx</td>
<td align="left">glucose-6-phosphate dehydrogenase X-linked</td>
<td align="left">14381</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ddx39</td>
<td align="left">DEAD (Asp-Glu-Ala-Asp) box polypeptide 39</td>
<td align="left">68278</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ypel5</td>
<td align="left">yippee-like 5 (Drosophila)</td>
<td align="left">383295</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">1600012H06Rik</td>
<td align="left">RIKEN cDNA 1600012H06 gene</td>
<td align="left">67912</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Dusp11</td>
<td align="left">dual specificity phosphatase 11 (RNA/RNP complex 1-interacting)</td>
<td align="left">72102</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tax1bp1</td>
<td align="left">Tax1 (human T cell leukemia virus type I) binding protein 1</td>
<td align="left">52440</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Exosc7</td>
<td align="left">exosome component 7</td>
<td align="left">66446</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">1700019M22Rik</td>
<td align="left">RIKEN cDNA 1700019M22 gene</td>
<td align="left">ENSMUSG00000059695</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">1700019M22Rik</td>
<td align="left">NFX-like protein</td>
<td align="left">69423</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ube2a</td>
<td align="left">ubiquitin-conjugating enzyme E2A</td>
<td align="left">22209</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Nup54</td>
<td align="left">nucleoporin 54</td>
<td align="left">269113</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ddx52</td>
<td align="left">DEAD (Asp-Glu-Ala-Asp) box polypeptide 52</td>
<td align="left">78394</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Bcor</td>
<td align="left">BCL6 interacting corepressor</td>
<td align="left">71458</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ston2</td>
<td align="left">stonin 2</td>
<td align="left">108800</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pgam5</td>
<td align="left">phosphoglycerate mutase family member 5</td>
<td align="left">72542</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Got1</td>
<td align="left">glutamic-oxaloacetic transaminase 1, soluble</td>
<td align="left">14718</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Fank1</td>
<td align="left">fibronectin type 3 and ankyrin repeat domains 1</td>
<td align="left">66930</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Timd2</td>
<td align="left">T cell immunoglobulin and mucin domain containing 2</td>
<td align="left">171284</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cdca4</td>
<td align="left">cell division cycle associated 4</td>
<td align="left">71963</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">6720463M24Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">Hprt</td>
<td align="left">hypoxanthine guanine phosphoribosyl transferase</td>
<td align="left">15452</td>
<td align="left">The protein encoded by this gene is a transferase, which catalyzes conversion of hypoxanthine to inosine monophosphate and guanine to guanosine monophosphate via transfer of the 5-phosphoribosyl group from 5-phosphoribosyl 1-pyrophosphate. This enzyme plays a central role in the generation of purine nucleotides through the purine salvage pathway.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Dkc1</td>
<td align="left">dyskeratosis congenita 1, dyskerin</td>
<td align="left">245474</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ecsit</td>
<td align="left">ECSIT signalling integrator</td>
<td align="left">26940</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Zbtb24</td>
<td align="left">zinc finger and BTB domain containing 24</td>
<td align="left">268294</td>
<td align="left">This gene encodes a protein containing eight C2H2-type zinc fingers and a BTB domain. Expression of this gene is induced by bone morphogenetic protein-2 signaling. Mutation of the related gene in humans causes immunodeficiency-centromeric instability-facial anomalies syndrome-2. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">9130011E15Rik</td>
<td align="left">RIKEN cDNA 9130011E15 gene</td>
<td align="left">71617</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm2016</td>
<td align="left">predicted gene 2016</td>
<td align="left">100039042</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">AU015228</td>
<td align="left">expressed sequence AU015228</td>
<td align="left">ENSMUSG00000074804</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">AU015228</td>
<td align="left">expressed sequence AU015228</td>
<td align="left">99169</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Csnk1d</td>
<td align="left">casein kinase 1, delta</td>
<td align="left">104318</td>
<td align="left">This gene encodes a member of the casein kinase I (CKI) family of serine/threonine protein kinases. A highly similar human protein regulates an array of cellular processes by influencing the Wnt and hedgehog signaling pathways. The encoded protein may also be involved in the regulation of apoptosis, circadian rhythm, microtubule dynamics, chromosome segregation, and p53-mediated effects on growth. Alternatively spliced transcript variants encoding different isoforms have been described.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Sun1</td>
<td align="left">Sad1 and UNC84 domain containing 1</td>
<td align="left">77053</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Dtnb</td>
<td align="left">dystrobrevin, beta</td>
<td align="left">13528</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Meg3</td>
<td align="left">maternally expressed 3</td>
<td align="left">ENSMUSG00000021268</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Meg3</td>
<td align="left">maternally expressed 3</td>
<td align="left">17263</td>
<td align="left">This gene is paternally-imprinted and thus expressed predominantly from the maternal allele. It generates alternatively-spliced long non protein-coding RNAs that overlap with the microRNAs Mir770 and Mir1906-1. Transcripts from this gene function as negative regulators of growth and may be down-regulated in tumor cells. This gene is expressed in a reciprocal pattern from the nearby Dlk1 (delta-like 1 homolog) gene, which is paternally-expressed. Deletion of this locus disrupts imprinting in this genomic region and results in perinatal morbidity.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Plekhm3</td>
<td align="left">pleckstrin homology domain containing, family M, member 3</td>
<td align="left">241075</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Herc2</td>
<td align="left">HECT and RLD domain containing E3 ubiquitin protein ligase 2</td>
<td align="left">15204</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ogn</td>
<td align="left">osteoglycin</td>
<td align="left">18295</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Numb</td>
<td align="left">numb homolog (Drosophila)</td>
<td align="left">18222</td>
<td align="left">This gene encodes a conserved protein that is distributed asymmetrically during cell division in the developing embryo. The encoded protein participates in cell fate decisions by interacting with the Notch receptor. Loss of function of this gene results in severe defects in neural development and loss of viability. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">2610029G23Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">L2hgdh</td>
<td align="left">L-2-hydroxyglutarate dehydrogenase</td>
<td align="left">217666</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm5662</td>
<td align="left">predicted gene 5662</td>
<td align="left">435337</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Calu</td>
<td align="left">calumenin</td>
<td align="left">12321</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Zfp828</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">Unc119b</td>
<td align="left">unc-119 lipid binding chaperone B</td>
<td align="left">106840</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Zfp957</td>
<td align="left">zinc finger protein 957</td>
<td align="left">105590</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Plekhh1</td>
<td align="left">pleckstrin homology domain containing, family H (with MyTH4 domain) member 1</td>
<td align="left">211945</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Zfp352</td>
<td align="left">zinc finger protein 352</td>
<td align="left">236537</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rasl11a</td>
<td align="left">RAS-like, family 11, member A</td>
<td align="left">68895</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">B4galnt4</td>
<td align="left">beta-1,4-N-acetyl-galactosaminyl transferase 4</td>
<td align="left">330671</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ftsjd2</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">Zfp451</td>
<td align="left">zinc finger protein 451</td>
<td align="left">98403</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tmed8</td>
<td align="left">transmembrane emp24 domain containing 8</td>
<td align="left">382620</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fzd7</td>
<td align="left">frizzled class receptor 7</td>
<td align="left">14369</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Sip1</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">1700021F05Rik</td>
<td align="left">RIKEN cDNA 1700021F05 gene</td>
<td align="left">67851</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tead4</td>
<td align="left">TEA domain family member 4</td>
<td align="left">21679</td>
<td align="left">This gene product is a member of the transcriptional enhancer factor (TEF) family of transcription factors, which contain the TEA/ATTS DNA-binding domain. It is preferentially expressed in the skeletal muscle, and binds to the M-CAT regulatory element found in promoters of muscle-specific genes to direct their gene expression. This factor may play a role in the embryonic development of skeletal muscle. Alternatively spliced transcripts encoding distinct isoforms, which are translated through the use of a non-AUG (AUU) initiation codon, have been described for this gene.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Plk3</td>
<td align="left">polo-like kinase 3</td>
<td align="left">12795</td>
<td align="left">This gene encodes a member of the highly conserved polo-like kinase family of serine/threonine kinases. Members of this family are characterized by an amino-terminal catalytic domain and a carboxy-terminal bipartite polo box domain that functions as a substrate-binding motif and a cellular localization signal. Polo-like kinases have primarily been implicated in cell cycle regulation. In mouse, this protein that has been reported to localize to the nucleolus during interphase but is undetectable during mitosis, following nucleolus dissociation during prophase. The protein relocalizes to the nucleolus just prior to cytokinesis and peak levels are detected during G1 of interphase. This gene has been implicated in regulation of entry into S phase, with RNAi-induced depletion resulting in failure to re-enter the cell cycle. Mice deficient for this gene exhibit increased weight and tumor development at advanced age. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pim1</td>
<td align="left">proviral integration site 1</td>
<td align="left">18712</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tada1</td>
<td align="left">transcriptional adaptor 1</td>
<td align="left">27878</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Wdr74</td>
<td align="left">WD repeat domain 74</td>
<td align="left">107071</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Olfr881</td>
<td align="left">olfactory receptor 881</td>
<td align="left">258413</td>
<td align="left">Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pot1a</td>
<td align="left">protection of telomeres 1A</td>
<td align="left">101185</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mettl11a</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">Senp1</td>
<td align="left">SUMO1/sentrin specific peptidase 1</td>
<td align="left">223870</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tmem50b</td>
<td align="left">transmembrane protein 50B</td>
<td align="left">77975</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Dnajc15</td>
<td align="left">DnaJ heat shock protein family (Hsp40) member C15</td>
<td align="left">66148</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rnf113a2</td>
<td align="left">ring finger protein 113A2</td>
<td align="left">66381</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Zfp777</td>
<td align="left">zinc finger protein 777</td>
<td align="left">72306</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Zfp251</td>
<td align="left">zinc finger protein 251</td>
<td align="left">71591</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Atp1a3</td>
<td align="left">ATPase, Na+/K+ transporting, alpha 3 polypeptide</td>
<td align="left">232975</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm8300</td>
<td align="left">predicted gene 8300</td>
<td align="left">666806</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gm13078</td>
<td align="left">predicted gene 13078</td>
<td align="left">277666</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Usp17l5</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">Lpin2</td>
<td align="left">lipin 2</td>
<td align="left">64898</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tmem87b</td>
<td align="left">transmembrane protein 87B</td>
<td align="left">72477</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Sp5</td>
<td align="left">trans-acting transcription factor 5</td>
<td align="left">64406</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Atrx</td>
<td align="left">alpha thalassemia/mental retardation syndrome X-linked</td>
<td align="left">22589</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Kcnip3</td>
<td align="left">Kv channel interacting protein 3, calsenilin</td>
<td align="left">56461</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Vmn2r1</td>
<td align="left">vomeronasal 2, receptor 1</td>
<td align="left">56544</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Mixl1</td>
<td align="left">Mix1 homeobox-like 1 (Xenopus laevis)</td>
<td align="left">27217</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ssh3</td>
<td align="left">slingshot homolog 3 (Drosophila)</td>
<td align="left">245857</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">BC031353</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">Sycp2</td>
<td align="left">synaptonemal complex protein 2</td>
<td align="left">320558</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_fac_sqrt/gene_names_clus_&quot;,9,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-10-annotations-2" class="section level3">
<h3>Factor 10 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[10,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">query</th>
<th align="left">name</th>
<th align="left">X_id</th>
<th align="left">notfound</th>
<th align="left">summary</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Trim61</td>
<td align="left">tripartite motif-containing 61</td>
<td align="left">260296</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Spin1</td>
<td align="left">spindlin 1</td>
<td align="left">20729</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Omt2b</td>
<td align="left">oocyte maturation, beta</td>
<td align="left">382088</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ccdc6</td>
<td align="left">coiled-coil domain containing 6</td>
<td align="left">76551</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pkd2l2</td>
<td align="left">polycystic kidney disease 2-like 2</td>
<td align="left">53871</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Bmp15</td>
<td align="left">bone morphogenetic protein 15</td>
<td align="left">12155</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Bcl2l10</td>
<td align="left">Bcl2-like 10</td>
<td align="left">12049</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">D6Ertd527e</td>
<td align="left">DNA segment, Chr 6, ERATO Doi 527, expressed</td>
<td align="left">52372</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Omt2a</td>
<td align="left">oocyte maturation, alpha</td>
<td align="left">18379</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tcl1b1</td>
<td align="left">T cell leukemia/lymphoma 1B, 1</td>
<td align="left">27379</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Btg4</td>
<td align="left">B cell translocation gene 4</td>
<td align="left">56057</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">LOC100502936</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Nlrp4a</td>
<td align="left">NLR family, pyrin domain containing 4A</td>
<td align="left">243880</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Khdc1b</td>
<td align="left">KH domain containing 1B</td>
<td align="left">98582</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">E330034G19Rik</td>
<td align="left">RIKEN cDNA E330034G19 gene</td>
<td align="left">105418</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Psmd1</td>
<td align="left">proteasome (prosome, macropain) 26S subunit, non-ATPase, 1</td>
<td align="left">70247</td>
<td align="left">NA</td>
<td align="left">In eukaryotic cells, most proteins in the cytosol and nucleus are degraded via the ubiquitin-proteasome pathway. The 26S proteasome is a self-compartmentalizing protease comprised of approximately 31 different subunits. It contains a barrel-shaped proteolytic core complex (the 20S proteasome), capped at one or both ends by 19S regulatory complexes, which recognize ubiquitinated proteins. Protein degradation by proteasomes is the source of most antigenic peptides presented on MHC class I molecules. This gene encodes a non-ATPase subunit of the 26S proteasome.</td>
</tr>
<tr class="odd">
<td align="left">Pum1</td>
<td align="left">pumilio RNA-binding family member 1</td>
<td align="left">80912</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Fbxw24</td>
<td align="left">F-box and WD-40 domain protein 24</td>
<td align="left">382106</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Eif5a</td>
<td align="left">eukaryotic translation initiation factor 5A</td>
<td align="left">276770</td>
<td align="left">NA</td>
<td align="left">This gene encodes an elongation initiation factor, which participates in protein synthesis. The encoded protein also plays roles in mRNA metabolism, cell proliferation, and cell cycle control. This protein contains a modified lysine residue called hypusine, which appears to be necessary for its function. Alternatively spliced transcript variants have been described. Related pseudogenes exist on chromosomes 2, 5, and 19.</td>
</tr>
<tr class="even">
<td align="left">Rpl4</td>
<td align="left">ribosomal protein L4</td>
<td align="left">67891</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Dazl</td>
<td align="left">deleted in azoospermia-like</td>
<td align="left">13164</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the depleted in azoospermia-like (DAZL) protein family. Members of this family contain an RNA recognition motif, interact with poly A binding proteins, and may be involved in the initiation of translation. The encoded protein is expressed in the cytoplasm of pluripotent stem cells, and in both male and female germ cells, where it is essential for gametogenesis. Disruption of this gene is associated with infertility. Alternative splicing results in multiple transcript variants.</td>
</tr>
<tr class="even">
<td align="left">Obox5</td>
<td align="left">oocyte specific homeobox 5</td>
<td align="left">252829</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Klf17</td>
<td align="left">Kruppel-like factor 17</td>
<td align="left">75753</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tgfb2</td>
<td align="left">transforming growth factor, beta 2</td>
<td align="left">21808</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Sdhd</td>
<td align="left">succinate dehydrogenase complex, subunit D, integral membrane protein</td>
<td align="left">66925</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Eif4e1b</td>
<td align="left">eukaryotic translation initiation factor 4E family member 1B</td>
<td align="left">218268</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rhpn2</td>
<td align="left">rhophilin, Rho GTPase binding protein 2</td>
<td align="left">52428</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cbx5</td>
<td align="left">chromobox 5</td>
<td align="left">12419</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Papd7</td>
<td align="left">PAP associated domain containing 7</td>
<td align="left">210106</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Paip1</td>
<td align="left">polyadenylate binding protein-interacting protein 1</td>
<td align="left">218693</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Dusp14</td>
<td align="left">dual specificity phosphatase 14</td>
<td align="left">56405</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cstf1</td>
<td align="left">cleavage stimulation factor, 3’ pre-RNA, subunit 1</td>
<td align="left">67337</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tcl1</td>
<td align="left">T cell lymphoma breakpoint 1</td>
<td align="left">21432</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Birc5</td>
<td align="left">baculoviral IAP repeat-containing 5</td>
<td align="left">11799</td>
<td align="left">NA</td>
<td align="left">This gene is a member of the inhibitor of apoptosis (IAP) gene family, which encode negative regulatory proteins that prevent apoptotic cell death. IAP family members usually contain multiple baculovirus IAP repeat (BIR) domains, but this gene encodes proteins with only a single BIR domain. The encoded proteins also lack a C-terminus RING finger domain. In humans, gene expression is high during fetal development and in most tumors yet low in adult tissues. Antisense transcripts have been identified in human that regulate this gene’s expression. At least three transcript variants encoding distinct isoforms have been found for this gene, although at least one of these transcript variants is a nonsense-mediated decay (NMD) candidate.</td>
</tr>
<tr class="odd">
<td align="left">Mllt3</td>
<td align="left">myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3</td>
<td align="left">70122</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Oosp1</td>
<td align="left">oocyte secreted protein 1</td>
<td align="left">170834</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mbtd1</td>
<td align="left">mbt domain containing 1</td>
<td align="left">103537</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Agpat4</td>
<td align="left">1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)</td>
<td align="left">68262</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Eif4e3</td>
<td align="left">eukaryotic translation initiation factor 4E member 3</td>
<td align="left">66892</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Calr</td>
<td align="left">calreticulin</td>
<td align="left">12317</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Trim75</td>
<td align="left">tripartite motif-containing 75</td>
<td align="left">333307</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gnb2l1</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gdf9</td>
<td align="left">growth differentiation factor 9</td>
<td align="left">14566</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rps5</td>
<td align="left">ribosomal protein S5</td>
<td align="left">20103</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tnfsf13b</td>
<td align="left">tumor necrosis factor (ligand) superfamily, member 13b</td>
<td align="left">24099</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ghitm</td>
<td align="left">growth hormone inducible transmembrane protein</td>
<td align="left">66092</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Eef1a1</td>
<td align="left">eukaryotic translation elongation factor 1 alpha 1</td>
<td align="left">13627</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rsu1</td>
<td align="left">Ras suppressor protein 1</td>
<td align="left">20163</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pttg1</td>
<td align="left">pituitary tumor-transforming gene 1</td>
<td align="left">30939</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Uchl1</td>
<td align="left">ubiquitin carboxy-terminal hydrolase L1</td>
<td align="left">22223</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gli3</td>
<td align="left">GLI-Kruppel family member GLI3</td>
<td align="left">14634</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gnb1</td>
<td align="left">guanine nucleotide binding protein (G protein), beta 1</td>
<td align="left">14688</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Wee2</td>
<td align="left">WEE1 homolog 2 (S. pombe)</td>
<td align="left">381759</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Accsl</td>
<td align="left">1-aminocyclopropane-1-carboxylate synthase (non-functional)-like</td>
<td align="left">381411</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Trim60</td>
<td align="left">tripartite motif-containing 60</td>
<td align="left">234329</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Creb3l4</td>
<td align="left">cAMP responsive element binding protein 3-like 4</td>
<td align="left">78284</td>
<td align="left">NA</td>
<td align="left">This gene encodes a CREB (cyclic AMP-responsive element-binding) protein with a transmembrane domain which localizes it to the ER membrane. The encoded protein may play a role in adiposity and male germ cell development. Homozygous knockout mice for this gene show increased adipogenesis, elevated testicular germ cell apoptosis and defects in spermatogenesis. Alternative splicing results in multiple transcript variants.</td>
</tr>
<tr class="odd">
<td align="left">Oog3</td>
<td align="left">oogenesin 3</td>
<td align="left">100012</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Fbxw28</td>
<td align="left">F-box and WD-40 domain protein 28</td>
<td align="left">668758</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Sin3a</td>
<td align="left">transcriptional regulator, SIN3A (yeast)</td>
<td align="left">20466</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Arid1a</td>
<td align="left">AT rich interactive domain 1A (SWI-like)</td>
<td align="left">93760</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Npm1</td>
<td align="left">nucleophosmin 1</td>
<td align="left">18148</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Aurka</td>
<td align="left">aurora kinase A</td>
<td align="left">20878</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Trub2</td>
<td align="left">TruB pseudouridine (psi) synthase family member 2</td>
<td align="left">227682</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Nlrp14</td>
<td align="left">NLR family, pyrin domain containing 14</td>
<td align="left">76858</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">C87977</td>
<td align="left">expressed sequence C87977</td>
<td align="left">97187</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gm7056</td>
<td align="left">predicted gene 7056</td>
<td align="left">631105</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pla2g4c</td>
<td align="left">phospholipase A2, group IVC (cytosolic, calcium-independent)</td>
<td align="left">232889</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tti1</td>
<td align="left">TELO2 interacting protein 1</td>
<td align="left">75425</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Use1</td>
<td align="left">unconventional SNARE in the ER 1 homolog (S. cerevisiae)</td>
<td align="left">67023</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Calm2</td>
<td align="left">calmodulin 2</td>
<td align="left">12314</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ddx10</td>
<td align="left">DEAD (Asp-Glu-Ala-Asp) box polypeptide 10</td>
<td align="left">77591</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Oas1e</td>
<td align="left">2’-5’ oligoadenylate synthetase 1E</td>
<td align="left">231699</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Wdr73</td>
<td align="left">WD repeat domain 73</td>
<td align="left">71968</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Mtmr14</td>
<td align="left">myotubularin related protein 14</td>
<td align="left">97287</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cox10</td>
<td align="left">cytochrome c oxidase assembly protein 10</td>
<td align="left">70383</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Yap1</td>
<td align="left">yes-associated protein 1</td>
<td align="left">22601</td>
<td align="left">NA</td>
<td align="left">This gene encodes a protein which binds to the SH3 domain of the Yes proto-oncogene product, a tyrosine kinase. This protein contains a WW domain, consisting of four conserved aromatic amino acids including two tryptophan residues. This conserved WW domain is found in various structural, regulatory and signaling molecules in various species, and may play a role in protein-protein interaction. Following cellular damage, phosphorylation of this encoded protein may suppress apoptosis. This protein may be involved in malignant transformation in cancer. Alternative splicing results in multiple transcript variants.</td>
</tr>
<tr class="odd">
<td align="left">Chsy1</td>
<td align="left">chondroitin sulfate synthase 1</td>
<td align="left">269941</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Dbf4</td>
<td align="left">DBF4 zinc finger</td>
<td align="left">27214</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rgs2</td>
<td align="left">regulator of G-protein signaling 2</td>
<td align="left">19735</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ier3ip1</td>
<td align="left">immediate early response 3 interacting protein 1</td>
<td align="left">66191</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fmn2</td>
<td align="left">formin 2</td>
<td align="left">54418</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Sars</td>
<td align="left">seryl-aminoacyl-tRNA synthetase</td>
<td align="left">20226</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Arglu1</td>
<td align="left">arginine and glutamate rich 1</td>
<td align="left">234023</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tcl1b5</td>
<td align="left">T cell leukemia/lymphoma 1B, 5</td>
<td align="left">27382</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mea1</td>
<td align="left">male enhanced antigen 1</td>
<td align="left">17256</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Prpf31</td>
<td align="left">pre-mRNA processing factor 31</td>
<td align="left">68988</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Plekhg1</td>
<td align="left">pleckstrin homology domain containing, family G (with RhoGef domain) member 1</td>
<td align="left">213783</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Nlrp5</td>
<td align="left">NLR family, pyrin domain containing 5</td>
<td align="left">23968</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the NACHT, leucine-rich repeat, and pyrin domain containing family. Members of this family have a pyrin domain at the N-terminus, a central NACHT domain, and a C-terminal leucine-rich repeat domain. This gene encodes a maternal-effect factor that is essential for early embryonic development in the mouse. Homozygous null mutant females are sterile, and embryos die following the first cleavage. This gene is required for endoplasmic reticulum redistribution and calcium homeostasis in oocytes. In addition, ovulated oocytes mutant for this gene have abnormal mitochondrial localization and increased mitochondrial activity, which results in mitochondrial damage and early embryonic lethality. Pseudogenes of this gene have been found on chromosomes 7 and 12. Alternative splicing results in multiple transcript variants.</td>
</tr>
<tr class="odd">
<td align="left">Nif3l1</td>
<td align="left">Ngg1 interacting factor 3-like 1 (S. pombe)</td>
<td align="left">65102</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">2900010J23Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mdm4</td>
<td align="left">transformed mouse 3T3 cell double minute 4</td>
<td align="left">17248</td>
<td align="left">NA</td>
<td align="left">This gene encodes a protein that has been shown to negatively regulate the activity of the tumor suppressor protein p53. Homozygous knockout mice exhibit embryonic lethality as a result of p53-dependent apoptosis and cell cycle arrest. Amplification of this gene or overexpression of the encoded protein has been linked to a range of human cancers. A pseudogene has been identified on the X chromosome. Alternative splicing of this gene results in multiple transcript variants.</td>
</tr>
<tr class="even">
<td align="left">Ncor1</td>
<td align="left">nuclear receptor co-repressor 1</td>
<td align="left">20185</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pdxk</td>
<td align="left">pyridoxal (pyridoxine, vitamin B6) kinase</td>
<td align="left">216134</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cnot6l</td>
<td align="left">CCR4-NOT transcription complex, subunit 6-like</td>
<td align="left">231464</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tcl1b3</td>
<td align="left">T cell leukemia/lymphoma 1B, 3</td>
<td align="left">27378</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">P4ha3</td>
<td align="left">procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha polypeptide III</td>
<td align="left">320452</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Slc6a11</td>
<td align="left">solute carrier family 6 (neurotransmitter transporter, GABA), member 11</td>
<td align="left">243616</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Abhd14a</td>
<td align="left">abhydrolase domain containing 14A</td>
<td align="left">68644</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm1965</td>
<td align="left">predicted gene 1965</td>
<td align="left">ENSMUSG00000090254</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gm1965</td>
<td align="left">predicted gene 1965</td>
<td align="left">434065</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Abcf2</td>
<td align="left">ATP-binding cassette, sub-family F (GCN20), member 2</td>
<td align="left">27407</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_fac_sqrt/gene_names_clus_&quot;,10,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
</div>
<div id="load-the-sfa-input-sparse-factors-voom-transformation" class="section level2">
<h2>Load the SFA input (sparse factors: voom transformation)</h2>
<pre class="r"><code>lambda_out &lt;- read.table(&quot;../sfa_outputs/Deng2014PPS/voom_deng_counts_transpose_lambda.out&quot;)
f_out &lt;- read.table(&quot;../sfa_outputs/Deng2014PPS/voom_deng_counts_transpose_F.out&quot;)

indices_mat &lt;- SFA.ExtractTopFeatures(lambda_out, top_features = 100, options = &quot;min&quot;,mult.annotate = TRUE)


top_gene_names &lt;- t(apply(indices_mat, 1, function(x) return (deng.gene_names[x])));</code></pre>
</div>
<div id="factor-annotations-3" class="section level2">
<h2>Factor Annotations</h2>
<div id="factor-1-annotations-3" class="section level3">
<h3>Factor 1 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[1,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">name</th>
<th align="left">X_id</th>
<th align="left">query</th>
<th align="left">notfound</th>
<th align="left">summary</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">SMAD family member 3</td>
<td align="left">17127</td>
<td align="left">Smad3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">methylenetetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase</td>
<td align="left">17768</td>
<td align="left">Mthfd2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">protein phosphatase 2, regulatory subunit A, beta</td>
<td align="left">73699</td>
<td align="left">Ppp2r1b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">centrobin, centrosomal BRCA2 interacting protein</td>
<td align="left">216846</td>
<td align="left">Cntrob</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">AU RNA binding protein/enoyl-coenzyme A hydratase</td>
<td align="left">11992</td>
<td align="left">Auh</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">decapping mRNA 1A</td>
<td align="left">75901</td>
<td align="left">Dcp1a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">TSC22 domain family, member 1</td>
<td align="left">21807</td>
<td align="left">Tsc22d1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RNA polymerase II associated protein 2</td>
<td align="left">231571</td>
<td align="left">Rpap2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">coiled-coil domain containing 138</td>
<td align="left">76138</td>
<td align="left">Ccdc138</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">mitogen-activated protein kinase 8 interacting protein 3</td>
<td align="left">30957</td>
<td align="left">Mapk8ip3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">calcium binding and coiled coil domain 1</td>
<td align="left">67488</td>
<td align="left">Calcoco1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">tetraspanin 14</td>
<td align="left">52588</td>
<td align="left">Tspan14</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">peroxisomal trans-2-enoyl-CoA reductase</td>
<td align="left">111175</td>
<td align="left">Pecr</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">mature T cell proliferation 1</td>
<td align="left">17763</td>
<td align="left">Mtcp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">eukaryotic elongation factor-2 kinase</td>
<td align="left">13631</td>
<td align="left">Eef2k</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">glucose-6-phosphate dehydrogenase X-linked</td>
<td align="left">14381</td>
<td align="left">G6pdx</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">choline/ethanolaminephosphotransferase 1</td>
<td align="left">99712</td>
<td align="left">Cept1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">family with sequence similarity 117, member B</td>
<td align="left">72750</td>
<td align="left">Fam117b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">GDNF-inducible zinc finger protein 1</td>
<td align="left">74533</td>
<td align="left">Gzf1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">peroxisomal biogenesis factor 1</td>
<td align="left">71382</td>
<td align="left">Pex1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">mitogen-activated protein kinase 1 interacting protein 1</td>
<td align="left">69546</td>
<td align="left">Mapk1ip1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">chimerin 1</td>
<td align="left">108699</td>
<td align="left">Chn1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">bladder cancer associated protein</td>
<td align="left">53619</td>
<td align="left">Blcap</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">tetratricopeptide repeat domain 37</td>
<td align="left">218343</td>
<td align="left">Ttc37</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">5’-nucleotidase, cytosolic II</td>
<td align="left">76952</td>
<td align="left">Nt5c2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">adrenocortical dysplasia</td>
<td align="left">497652</td>
<td align="left">Acd</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">uronyl-2-sulfotransferase</td>
<td align="left">338362</td>
<td align="left">Ust</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">sorting nexin 12</td>
<td align="left">55988</td>
<td align="left">Snx12</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Epb4.1l4a</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Narg2</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">disco interacting protein 2 homolog C</td>
<td align="left">208440</td>
<td align="left">Dip2c</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rho GTPase activating protein 42</td>
<td align="left">71544</td>
<td align="left">Arhgap42</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Wdr20a</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">fucosyltransferase 8</td>
<td align="left">53618</td>
<td align="left">Fut8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ankyrin repeat and SOCS box-containing 8</td>
<td align="left">78541</td>
<td align="left">Asb8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">C030046I01Rik</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">phosphodiesterase 1B, Ca2+-calmodulin dependent</td>
<td align="left">18574</td>
<td align="left">Pde1b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">centromere protein J</td>
<td align="left">219103</td>
<td align="left">Cenpj</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Ccdc41</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">CDK5 and Abl enzyme substrate 2</td>
<td align="left">252966</td>
<td align="left">Cables2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">dual specificity phosphatase 1</td>
<td align="left">19252</td>
<td align="left">Dusp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">spindlin 1</td>
<td align="left">20729</td>
<td align="left">Spin1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">RIO kinase 1 (yeast)</td>
<td align="left">71340</td>
<td align="left">Riok1</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the RIO family of atypical serine protein kinases. A similar protein in humans is a component of the protein arginine methyltransferase 5 complex that specifically recruits the RNA-binding protein nucleolin as a methylation substrate.</td>
</tr>
<tr class="even">
<td align="left">solute carrier family 30 (zinc transporter), member 3</td>
<td align="left">22784</td>
<td align="left">Slc30a3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">mediator complex subunit 26</td>
<td align="left">70625</td>
<td align="left">Med26</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">tumor necrosis factor, alpha-induced protein 8</td>
<td align="left">106869</td>
<td align="left">Tnfaip8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">FIP1 like 1 (S. cerevisiae)</td>
<td align="left">66899</td>
<td align="left">Fip1l1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">solute carrier family 4 (anion exchanger), member 8</td>
<td align="left">59033</td>
<td align="left">Slc4a8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">muskelin 1, intracellular mediator containing kelch motifs</td>
<td align="left">27418</td>
<td align="left">Mkln1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">MIER family member 2</td>
<td align="left">70427</td>
<td align="left">Mier2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">1110028C15Rik</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">nuclear factor I/B</td>
<td align="left">18028</td>
<td align="left">Nfib</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">family with sequence similarity 126, member A</td>
<td align="left">84652</td>
<td align="left">Fam126a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">aspartate-beta-hydroxylase</td>
<td align="left">65973</td>
<td align="left">Asph</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ankyrin repeat domain 49</td>
<td align="left">56503</td>
<td align="left">Ankrd49</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">molybdenum cofactor sulfurase</td>
<td align="left">68591</td>
<td align="left">Mocos</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">methylphosphate capping enzyme</td>
<td align="left">231803</td>
<td align="left">Mepce</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">StAR-related lipid transfer (START) domain containing 5</td>
<td align="left">170460</td>
<td align="left">Stard5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">UPF3 regulator of nonsense transcripts homolog A (yeast)</td>
<td align="left">67031</td>
<td align="left">Upf3a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">MKL/myocardin-like 2</td>
<td align="left">239719</td>
<td align="left">Mkl2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">carcinoembryonic antigen-related cell adhesion molecule 20</td>
<td align="left">71601</td>
<td align="left">Ceacam20</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">cAMP responsive element binding protein 3-like 4</td>
<td align="left">78284</td>
<td align="left">Creb3l4</td>
<td align="left">NA</td>
<td align="left">This gene encodes a CREB (cyclic AMP-responsive element-binding) protein with a transmembrane domain which localizes it to the ER membrane. The encoded protein may play a role in adiposity and male germ cell development. Homozygous knockout mice for this gene show increased adipogenesis, elevated testicular germ cell apoptosis and defects in spermatogenesis. Alternative splicing results in multiple transcript variants.</td>
</tr>
<tr class="odd">
<td align="left">Josephin domain containing 1</td>
<td align="left">74158</td>
<td align="left">Josd1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ankyrin repeat, SAM and basic leucine zipper domain containing 1</td>
<td align="left">74068</td>
<td align="left">Asz1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">syntaxin 5A</td>
<td align="left">56389</td>
<td align="left">Stx5a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">mesoderm specific transcript</td>
<td align="left">17294</td>
<td align="left">Mest</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">fibronectin leucine rich transmembrane protein 3</td>
<td align="left">71436</td>
<td align="left">Flrt3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">eukaryotic translation initiation factor 1B</td>
<td align="left">68969</td>
<td align="left">Eif1b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">F-box and WD-40 domain protein 5</td>
<td align="left">30839</td>
<td align="left">Fbxw5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">coiled-coil domain containing 14</td>
<td align="left">239839</td>
<td align="left">Ccdc14</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">meiotic nuclear divisions 1</td>
<td align="left">76915</td>
<td align="left">Mnd1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">v-rel reticuloendotheliosis viral oncogene homolog A (avian)</td>
<td align="left">19697</td>
<td align="left">Rela</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rpgrip1-like</td>
<td align="left">244585</td>
<td align="left">Rpgrip1l</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ubiquitin specific peptidase 30</td>
<td align="left">100756</td>
<td align="left">Usp30</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">MORN repeat containing 4</td>
<td align="left">226123</td>
<td align="left">Morn4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Tsga14</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">integrin alpha FG-GAP repeat containing 1</td>
<td align="left">71927</td>
<td align="left">Itfg1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">mitogen-activated protein kinase kinase kinase 1</td>
<td align="left">26401</td>
<td align="left">Map3k1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">guanine nucleotide binding protein (G protein), gamma 3</td>
<td align="left">14704</td>
<td align="left">Gng3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">folliculin</td>
<td align="left">216805</td>
<td align="left">Flcn</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">polycystic kidney disease 2-like 2</td>
<td align="left">53871</td>
<td align="left">Pkd2l2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">transforming, acidic coiled-coil containing protein 2</td>
<td align="left">57752</td>
<td align="left">Tacc2</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the transforming, acidic coiled-coil (TACC) family of proteins. Members of this family are centrosomal proteins that interact with microtubules and tubulin. TACC proteins are thought to be involved in centrosome/mitotic spindle dynamics and gene regulation. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms.</td>
</tr>
<tr class="odd">
<td align="left">carnosine dipeptidase 1 (metallopeptidase M20 family)</td>
<td align="left">338403</td>
<td align="left">Cndp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NUF2, NDC80 kinetochore complex component</td>
<td align="left">66977</td>
<td align="left">Nuf2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">anoctamin 10</td>
<td align="left">102566</td>
<td align="left">Ano10</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the anoctamin family, which in mammals is comprised of 10 members. Anoctamin proteins are proposed to have eight transmembrane domains with both termini facing the cytoplasm and a C-terminal domain of unknown function. While some members have been characterized as calcium-activated chloride channels, this protein is reported to inhibit anion conductance. Alternative splicing results in multiple transcript variants that encode different protein isoforms.</td>
</tr>
<tr class="even">
<td align="left">inositol 1,3,4-triphosphate 5/6 kinase</td>
<td align="left">217837</td>
<td align="left">Itpk1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">serine (or cysteine) peptidase inhibitor, clade B, member 1c</td>
<td align="left">380839</td>
<td align="left">Serpinb1c</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">centrosomal protein 70</td>
<td align="left">68121</td>
<td align="left">Cep70</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">mediator complex subunit 22</td>
<td align="left">20933</td>
<td align="left">Med22</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">solute carrier family 35, member B4</td>
<td align="left">58246</td>
<td align="left">Slc35b4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">tudor domain containing 3</td>
<td align="left">219249</td>
<td align="left">Tdrd3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Tcfe3</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">angiopoietin-like 2</td>
<td align="left">26360</td>
<td align="left">Angptl2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">solute carrier family 30 (zinc transporter), member 2</td>
<td align="left">230810</td>
<td align="left">Slc30a2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Zfp295</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">oocyte secreted protein 1</td>
<td align="left">170834</td>
<td align="left">Oosp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">phospholipase C, gamma 2</td>
<td align="left">234779</td>
<td align="left">Plcg2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">predicted gene 3143</td>
<td align="left">ENSMUSG00000105153</td>
<td align="left">Gm3143</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">predicted gene 3143</td>
<td align="left">100041108</td>
<td align="left">Gm3143</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">predicted gene 10857</td>
<td align="left">ENSMUSG00000102887</td>
<td align="left">Gm10857</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">predicted gene 10857</td>
<td align="left">100038358</td>
<td align="left">Gm10857</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">human immunodeficiency virus type I enhancer binding protein 1</td>
<td align="left">110521</td>
<td align="left">Hivep1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_fac_voom/gene_names_clus_&quot;,1,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-2-annotations-3" class="section level3">
<h3>Factor 2 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[2,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">name</th>
<th align="left">query</th>
<th align="left">X_id</th>
<th align="left">summary</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">gap junction protein, beta 5</td>
<td align="left">Gjb5</td>
<td align="left">14622</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">secreted phosphoprotein 1</td>
<td align="left">Spp1</td>
<td align="left">20750</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">solute carrier family 38, member 4</td>
<td align="left">Slc38a4</td>
<td align="left">69354</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">desmoglein 2</td>
<td align="left">Dsg2</td>
<td align="left">13511</td>
<td align="left">This gene encodes a member of the cadherin family of proteins that forms an integral transmembrane component of desmosomes, the multiprotein complexes involved in cell adhesion, organization of the cytoskeleton, cell sorting and cell signaling. The encoded preproprotein undergoes proteolytic processing to generate a mature, functional protein. Mice lacking the encoded protein die in utero. Mutant mice lacking a part of the extracellular adhesive domain of the encoded protein develop cardiac fibrosis and dilation. This gene is located in a cluster of desmosomal cadherin genes on chromosome 18.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">cDNA sequence BC053393</td>
<td align="left">BC053393</td>
<td align="left">407814</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Mll1</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Epb4.1l1</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">retinol saturase (all trans retinol 13,14 reductase)</td>
<td align="left">Retsat</td>
<td align="left">67442</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">capping protein (actin filament), gelsolin-like</td>
<td align="left">Capg</td>
<td align="left">12332</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">1600029D21Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">tripeptidyl peptidase I</td>
<td align="left">Tpp1</td>
<td align="left">12751</td>
<td align="left">This gene encodes a lysosomal serine protease that cleaves N-terminal tripeptides from protein substrates. The encoded preproprotein undergoes autocatalytic processing to generate a mature enzyme. Mice lacking the encoded protein exhibit a progressive neurodegeneration and a greatly shortened lifespan. At the cellular level, mice lacking the encoded protein exhibit accumulation of autofluorescent lipopigments. Mutations in the human ortholog of this gene cause classical late-infantile neuronal ceroid lipofuscinosis.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">solute carrier family 37 (glycerol-3-phosphate transporter), member 2</td>
<td align="left">Slc37a2</td>
<td align="left">56857</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NYN domain and retroviral integrase containing</td>
<td align="left">Nynrin</td>
<td align="left">277154</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ras homolog family member C</td>
<td align="left">Rhoc</td>
<td align="left">11853</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">proline-rich nuclear receptor coactivator 2</td>
<td align="left">Pnrc2</td>
<td align="left">52830</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">uridine phosphorylase 1</td>
<td align="left">Upp1</td>
<td align="left">22271</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">guanine nucleotide binding protein (G protein), gamma 10</td>
<td align="left">Gng10</td>
<td align="left">14700</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">moesin</td>
<td align="left">Msn</td>
<td align="left">17698</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">expressed sequence AI662270</td>
<td align="left">AI662270</td>
<td align="left">ENSMUSG00000087107</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">expressed sequence AI662270</td>
<td align="left">AI662270</td>
<td align="left">100043636</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">coagulation factor II (thrombin) receptor-like 1</td>
<td align="left">F2rl1</td>
<td align="left">14063</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Scm-like with four mbt domains 2</td>
<td align="left">Sfmbt2</td>
<td align="left">353282</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">plastin 3 (T-isoform)</td>
<td align="left">Pls3</td>
<td align="left">102866</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">chloride intracellular channel 1</td>
<td align="left">Clic1</td>
<td align="left">114584</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">mitochondrial fission process 1</td>
<td align="left">Mtfp1</td>
<td align="left">67900</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Rp2h</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">protease, serine 8 (prostasin)</td>
<td align="left">Prss8</td>
<td align="left">76560</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">monoglyceride lipase</td>
<td align="left">Mgll</td>
<td align="left">23945</td>
<td align="left">This gene encodes a monoglyceride lipase, which catalyzes the hydrolysis of monoglycerides into fatty acids and glycerol. This enzyme is also thought to hydrolyze the endocannabinoid 2-arachidonoylglycerol. Alternatively spliced transcript variants have been described.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Kruppel-like factor 6</td>
<td align="left">Klf6</td>
<td align="left">23849</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">retinoic acid induced 14</td>
<td align="left">Rai14</td>
<td align="left">75646</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5</td>
<td align="left">B3gnt5</td>
<td align="left">108105</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">zinc finger CCCH type, antiviral 1</td>
<td align="left">Zc3hav1</td>
<td align="left">78781</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">glutathione S-transferase, alpha 4</td>
<td align="left">Gsta4</td>
<td align="left">14860</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">2810405K02Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">sphingosine phosphate lyase 1</td>
<td align="left">Sgpl1</td>
<td align="left">20397</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">gelsolin</td>
<td align="left">Gsn</td>
<td align="left">227753</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">perilipin 2</td>
<td align="left">Plin2</td>
<td align="left">11520</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ATPase, class I, type 8B, member 1</td>
<td align="left">Atp8b1</td>
<td align="left">54670</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">dual specificity phosphatase 6</td>
<td align="left">Dusp6</td>
<td align="left">67603</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">phosphoglucomutase 2</td>
<td align="left">Pgm2</td>
<td align="left">72157</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">RIKEN cDNA 2510002D24 gene</td>
<td align="left">2510002D24Rik</td>
<td align="left">72307</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">keratin 18</td>
<td align="left">Krt18</td>
<td align="left">16668</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">enoyl coenzyme A hydratase 1, peroxisomal</td>
<td align="left">Ech1</td>
<td align="left">51798</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">fucosidase, alpha-L- 2, plasma</td>
<td align="left">Fuca2</td>
<td align="left">66848</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">acetyl-Coenzyme A acyltransferase 1A</td>
<td align="left">Acaa1a</td>
<td align="left">113868</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">secreted acidic cysteine rich glycoprotein</td>
<td align="left">Sparc</td>
<td align="left">20692</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">glia maturation factor, gamma</td>
<td align="left">Gmfg</td>
<td align="left">63986</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">argininosuccinate lyase</td>
<td align="left">Asl</td>
<td align="left">109900</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">thioredoxin-related transmembrane protein 4</td>
<td align="left">Tmx4</td>
<td align="left">52837</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Eph receptor B3</td>
<td align="left">Ephb3</td>
<td align="left">13845</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">glutathione synthetase</td>
<td align="left">Gss</td>
<td align="left">14854</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">a disintegrin and metallopeptidase domain 19 (meltrin beta)</td>
<td align="left">Adam19</td>
<td align="left">11492</td>
<td align="left">This gene encodes a cell surface glycoprotein and member of the ADAM (a disintegrin and metalloproteinase) family of endopeptidases. The encoded protein may play a role in the ectodomain shedding of neuregulin proteins. Homozygous knockout mice for this gene exhibit heart development defects and perinatal lethality. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that undergoes proteolytic processing to generate a mature protein product.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Cd97</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">LINE-1 type transposase domain containing 1</td>
<td align="left">L1td1</td>
<td align="left">381591</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NIMA (never in mitosis gene a)-related expressed kinase 9</td>
<td align="left">Nek9</td>
<td align="left">217718</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">guanosine monophosphate reductase 2</td>
<td align="left">Gmpr2</td>
<td align="left">105446</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">N-myc downstream regulated gene 1</td>
<td align="left">Ndrg1</td>
<td align="left">17988</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RIKEN cDNA 0610009O20 gene</td>
<td align="left">0610009O20Rik</td>
<td align="left">66839</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">transmembrane protease, serine 2</td>
<td align="left">Tmprss2</td>
<td align="left">50528</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">transmembrane protein 56</td>
<td align="left">Tmem56</td>
<td align="left">99887</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">guanine nucleotide binding protein (G protein), gamma 2</td>
<td align="left">Gng2</td>
<td align="left">14702</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">tubulointerstitial nephritis antigen-like 1</td>
<td align="left">Tinagl1</td>
<td align="left">94242</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">keratin 8</td>
<td align="left">Krt8</td>
<td align="left">16691</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">serine (or cysteine) peptidase inhibitor, clade B, member 6b</td>
<td align="left">Serpinb6b</td>
<td align="left">20708</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">midkine</td>
<td align="left">Mdk</td>
<td align="left">17242</td>
<td align="left">This gene encodes a secreted growth factor that belongs to the pleiotrophin/midkine heparin-binding protein family and functions in a variety of biological processes. The encoded cytokine promotes the growth, differentiation, survival and migration of several target cells including leucocytes involved in inflammation. This protein plays a role in the formation of scar tissue and intraperitoneal adhesions, and promotes neurite outgrowth and neuron survival. The protein encoded by this gene is associated with obesity and inhibition of insulin signaling in fat cells. A pseudogene of this gene is present on chromosome 11. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ribosomal modification protein rimK-like family member B</td>
<td align="left">Rimklb</td>
<td align="left">108653</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ezrin</td>
<td align="left">Ezr</td>
<td align="left">22350</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">S100 calcium binding protein A10 (calpactin)</td>
<td align="left">S100a10</td>
<td align="left">20194</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">RUN and SH3 domain containing 1</td>
<td align="left">Rusc1</td>
<td align="left">72296</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">nuclear factor, erythroid derived 2, like 2</td>
<td align="left">Nfe2l2</td>
<td align="left">18024</td>
<td align="left">This gene encodes a transcription factor which is a member of a small family of basic leucine zipper (bZIP) proteins. The encoded transcription factor regulates genes which contain antioxidant response elements (ARE) in their promoters; many of these genes encode proteins involved in response to injury and inflammation which includes the production of free radicals.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">phosphomevalonate kinase</td>
<td align="left">Pmvk</td>
<td align="left">68603</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">prostaglandin reductase 2</td>
<td align="left">Ptgr2</td>
<td align="left">77219</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">pseudouridylate synthase 10</td>
<td align="left">Pus10</td>
<td align="left">74467</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">low density lipoprotein receptor-related protein 2</td>
<td align="left">Lrp2</td>
<td align="left">14725</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">sphingomyelin phosphodiesterase, acid-like 3B</td>
<td align="left">Smpdl3b</td>
<td align="left">100340</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">KDEL (Lys-Asp-Glu-Leu) containing 2</td>
<td align="left">Kdelc2</td>
<td align="left">68304</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">acyl-CoA thioesterase 2</td>
<td align="left">Acot2</td>
<td align="left">171210</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">phosphoglucomutase 1</td>
<td align="left">Pgm1</td>
<td align="left">66681</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">coiled-coil domain containing 22</td>
<td align="left">Ccdc22</td>
<td align="left">54638</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">crystallin, zeta</td>
<td align="left">Cryz</td>
<td align="left">12972</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">nurim (nuclear envelope membrane protein)</td>
<td align="left">Nrm</td>
<td align="left">106582</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">MYCBP associated protein</td>
<td align="left">Mycbpap</td>
<td align="left">104601</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">tumor necrosis factor (ligand) superfamily, member 13b</td>
<td align="left">Tnfsf13b</td>
<td align="left">24099</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">stearoyl-Coenzyme A desaturase 2</td>
<td align="left">Scd2</td>
<td align="left">20250</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">alcohol dehydrogenase 1 (class I)</td>
<td align="left">Adh1</td>
<td align="left">11522</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">unc-93 homolog A (C. elegans)</td>
<td align="left">Unc93a</td>
<td align="left">381058</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">tensin 1</td>
<td align="left">Tns1</td>
<td align="left">21961</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">lectin, galactose binding, soluble 1</td>
<td align="left">Lgals1</td>
<td align="left">16852</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">GATA binding protein 2</td>
<td align="left">Gata2</td>
<td align="left">14461</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ectonucleotide pyrophosphatase/phosphodiesterase 1</td>
<td align="left">Enpp1</td>
<td align="left">18605</td>
<td align="left">This gene encodes a member of the nucleoside pyrophosphatase/phosphodiesterase family of enzymes that catalyzes the hydrolysis of pyrophosphate and phosphodiester bonds in nucleotide triphosphates and oligonucleotides, respectively, to generate nucleoside 5’-monophosphates. The encoded protein is a type II transmembrane glycoprotein that negatively regulates bone mineralization. Mice harboring a nonsense mutation in this gene, termed tiptoe walking (ttw), exhibit ectopic ossification of the spinal ligaments. The encoded protein binds to the insulin receptor, inhibits downstream signaling events and induces insulin resistance and glucose tolerance. This gene is located adjacent to a paralog on chromosome 10. Alternative splicing results in multiple transcript variants encoding different isoforms.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">eomesodermin</td>
<td align="left">Eomes</td>
<td align="left">13813</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">GLI pathogenesis-related 2</td>
<td align="left">Glipr2</td>
<td align="left">384009</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">methionine sulfoxide reductase B2</td>
<td align="left">Msrb2</td>
<td align="left">76467</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">phosphoglycerate mutase 2</td>
<td align="left">Pgam2</td>
<td align="left">56012</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">eukaryotic translation initiation factor 2, subunit 3, structural gene Y-linked</td>
<td align="left">Eif2s3y</td>
<td align="left">26908</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">lectin, galactose binding, soluble 4</td>
<td align="left">Lgals4</td>
<td align="left">16855</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">serine (or cysteine) peptidase inhibitor, clade B, member 9b</td>
<td align="left">Serpinb9b</td>
<td align="left">20706</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">aldo-keto reductase family 1, member C21</td>
<td align="left">Akr1c21</td>
<td align="left">77337</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)</td>
<td align="left">Agpat4</td>
<td align="left">68262</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">CD38 antigen</td>
<td align="left">Cd38</td>
<td align="left">12494</td>
<td align="left">This gene encodes a non-lineage-restricted, type II transmembrane glycoprotein that synthesizes and hydrolyzes cyclic adenosine 5’-diphosphate-ribose, an intracellular calcium ion mobilizing messenger. The release of soluble protein and the ability of membrane-bound protein to become internalized indicate both extracellular and intracellular functions for the protein. This protein has an N-terminal cytoplasmic tail, a single membrane-spanning domain, and a C-terminal extracellular region with four N-glycosylation sites. Knockout mice deficient for this gene display altered humoral immune responses. In addition, knockout mice exhibit higher locomotor activity and defects in nurturing and social behaviors.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">lactate dehydrogenase A</td>
<td align="left">Ldha</td>
<td align="left">16828</td>
<td align="left">The protein encoded by this gene catalyzes the conversion of L-lactate and NAD to pyruvate and NADH in the final step of anaerobic glycolysis. The protein is found predominantly in muscle tissue and belongs to the lactate dehydrogenase family. Mutations in this gene have been linked to hemolytic anemia and early postimplantation death in mice. Multiple transcript variants encoding different isoforms have been found for this gene. The mouse genome contains multiple pseudogenes of this gene.</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_fac_voom/gene_names_clus_&quot;,2,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-3-annotations-3" class="section level3">
<h3>Factor 3 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[3,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">X_id</th>
<th align="left">query</th>
<th align="left">name</th>
<th align="left">notfound</th>
<th align="left">summary</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">229697</td>
<td align="left">Cym</td>
<td align="left">chymosin</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">17341</td>
<td align="left">Bhlha15</td>
<td align="left">basic helix-loop-helix family, member a15</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">56216</td>
<td align="left">Stx1b</td>
<td align="left">syntaxin 1B</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">68509</td>
<td align="left">Ptx4</td>
<td align="left">pentraxin 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">240590</td>
<td align="left">Dmrt3</td>
<td align="left">doublesex and mab-3 related transcription factor 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Gm216</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">246133</td>
<td align="left">Kcne2</td>
<td align="left">potassium voltage-gated channel, Isk-related subfamily, gene 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">21869</td>
<td align="left">Nkx2-1</td>
<td align="left">NK2 homeobox 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">72792</td>
<td align="left">2810459M11Rik</td>
<td align="left">RIKEN cDNA 2810459M11 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">72324</td>
<td align="left">Plxdc1</td>
<td align="left">plexin domain containing 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">64406</td>
<td align="left">Sp5</td>
<td align="left">trans-acting transcription factor 5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">16691</td>
<td align="left">Krt8</td>
<td align="left">keratin 8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ENSMUSG00000087360</td>
<td align="left">Gm15104</td>
<td align="left">predicted gene 15104</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">333588</td>
<td align="left">Gm15104</td>
<td align="left">predicted gene 15104</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">83434</td>
<td align="left">Rsph6a</td>
<td align="left">radial spoke head 6 homolog A (Chlamydomonas)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">15494</td>
<td align="left">Hsd3b3</td>
<td align="left">hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">13162</td>
<td align="left">Slc6a3</td>
<td align="left">solute carrier family 6 (neurotransmitter transporter, dopamine), member 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">20983</td>
<td align="left">Syt4</td>
<td align="left">synaptotagmin IV</td>
<td align="left">NA</td>
<td align="left">The protein encoded by this gene belongs to the synaptotagmin family. Members of this family are multi-domained, integral membrane proteins of synaptic vesicles, and are thought to serve as Ca2+ sensors in the process of vesicular trafficking and exocytosis. This gene is primarily expressed in the nervous tissues.</td>
</tr>
<tr class="odd">
<td align="left">259073</td>
<td align="left">Olfr603</td>
<td align="left">olfactory receptor 603</td>
<td align="left">NA</td>
<td align="left">Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms.</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Ankrd58</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">381112</td>
<td align="left">Arhgef33</td>
<td align="left">Rho guanine nucleotide exchange factor (GEF) 33</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">330671</td>
<td align="left">B4galnt4</td>
<td align="left">beta-1,4-N-acetyl-galactosaminyl transferase 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ENSMUSG00000103577</td>
<td align="left">9330162B11Rik</td>
<td align="left">RIKEN cDNA 9330162B11 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">320272</td>
<td align="left">9330162B11Rik</td>
<td align="left">RIKEN cDNA 9330162B11 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">330921</td>
<td align="left">Pate2</td>
<td align="left">prostate and testis expressed 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">100041187</td>
<td align="left">Olfr596</td>
<td align="left">olfactory receptor 596</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">19074</td>
<td align="left">Prg2</td>
<td align="left">proteoglycan 2, bone marrow</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">381418</td>
<td align="left">Ctxn2</td>
<td align="left">cortexin 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">435626</td>
<td align="left">Rufy4</td>
<td align="left">RUN and FYVE domain containing 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">14402</td>
<td align="left">Gabrb3</td>
<td align="left">gamma-aminobutyric acid (GABA) A receptor, subunit beta 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">100125586</td>
<td align="left">Vmn2r2</td>
<td align="left">vomeronasal 2, receptor 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">50779</td>
<td align="left">Rgs6</td>
<td align="left">regulator of G-protein signaling 6</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the RGS (regulator of G protein signaling) family of proteins, which are defined by the presence of a RGS domain that confers the GTPase-activating activity of these proteins toward certain G alpha subunits. This protein also belongs to a subfamily of RGS proteins characterized by the presence of DEP (Dishevelled, Egl-10, and Pleckstrin) and GGL (G-protein gamma like)domains, the latter a G beta 5-interacting domain. The RGS proteins negatively regulate G protein signaling, and may modulate neuronal, cardiovascular, lymphocytic activities, and cancer risk. Mice lacking this gene exhibit decreased heart rate. Alternative splicing results in multiple transcript variants, however, the full-length nature of some of these variants is not known.</td>
</tr>
<tr class="odd">
<td align="left">ENSMUSG00000097391</td>
<td align="left">Mirg</td>
<td align="left">miRNA containing gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">100040724</td>
<td align="left">Mirg</td>
<td align="left">miRNA containing gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20254</td>
<td align="left">Scg2</td>
<td align="left">secretogranin II</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">17751</td>
<td align="left">Mt3</td>
<td align="left">metallothionein 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">15139</td>
<td align="left">Hc</td>
<td align="left">hemolytic complement</td>
<td align="left">NA</td>
<td align="left">This gene encodes a component of the complement system, a part of the innate immune system that plays an important role in inflammation, host homeostasis, and host defense against pathogens. The encoded preproprotein is proteolytically processed to generate multiple protein products, including the C5 alpha chain, C5 beta chain, C5a anaphylatoxin and C5b. The C5 protein is comprised of the alpha and beta chains, which are linked by a disulfide bridge. Cleavage of the alpha chain by a convertase enzyme results in the formation of the C5a anaphylatoxin, which possesses potent spasmogenic and chemotactic activity, and the C5b macromolecular cleavage product, a subunit of the membrane attack complex (MAC). Mice with a homozygous mutation in this gene exhibit impaired bone fracture healing and an enhanced inflammatory response in an allergic lung disease model.</td>
</tr>
<tr class="even">
<td align="left">239857</td>
<td align="left">Cadm2</td>
<td align="left">cell adhesion molecule 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">232333</td>
<td align="left">Slc6a1</td>
<td align="left">solute carrier family 6 (neurotransmitter transporter, GABA), member 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">214240</td>
<td align="left">Disp2</td>
<td align="left">dispatched homolog 2 (Drosophila)</td>
<td align="left">NA</td>
<td align="left">The pattern of cellular proliferation and differentiation that leads to normal development of embryonic structures often depends upon the localized production of secreted protein signals. Cells surrounding the source of a particular signal respond in a graded manner according to the effective concentration of the signal, and this response produces the pattern of cell types constituting the mature structure. A segment-polarity gene known as dispatched has been identified in Drosophila and its protein product is required for normal Hedgehog (Hh) signaling.</td>
</tr>
<tr class="odd">
<td align="left">105837</td>
<td align="left">Mtbp</td>
<td align="left">Mdm2, transformed 3T3 cell double minute p53 binding protein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">382097</td>
<td align="left">Gm1123</td>
<td align="left">predicted gene 1123</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">19713</td>
<td align="left">Ret</td>
<td align="left">ret proto-oncogene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12814</td>
<td align="left">Col11a1</td>
<td align="left">collagen, type XI, alpha 1</td>
<td align="left">NA</td>
<td align="left">This gene encodes the alpha-1 subunit of type XI collagen, one of the low abundance fibrillar collagens that is essential for normal embryonic skeletal development and the cohesive properties of cartilage. The encoded protein, in association with the alpha-1 subunit of type II collagen, forms a heterotrimeric type XI procollagen that undergoes proteolytic processing. Mice lacking the encoded protein develop severe chondrodysplasia and die at birth.</td>
</tr>
<tr class="odd">
<td align="left">20614</td>
<td align="left">Snap25</td>
<td align="left">synaptosomal-associated protein 25</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">104001</td>
<td align="left">Rtn1</td>
<td align="left">reticulon 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ENSMUSG00000097129</td>
<td align="left">4930507D05Rik</td>
<td align="left">RIKEN cDNA 4930507D05 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">74706</td>
<td align="left">4930507D05Rik</td>
<td align="left">RIKEN cDNA 4930507D05 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">387285</td>
<td align="left">Hcrtr2</td>
<td align="left">hypocretin (orexin) receptor 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">67663</td>
<td align="left">4930549C01Rik</td>
<td align="left">RIKEN cDNA 4930549C01 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20394</td>
<td align="left">Scg5</td>
<td align="left">secretogranin V</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12565</td>
<td align="left">Cdh9</td>
<td align="left">cadherin 9</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">171224</td>
<td align="left">Vmn1r229</td>
<td align="left">vomeronasal 1 receptor 229</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">56504</td>
<td align="left">Srpk3</td>
<td align="left">serine/arginine-rich protein specific kinase 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">14681</td>
<td align="left">Gnao1</td>
<td align="left">guanine nucleotide binding protein, alpha O</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">99571</td>
<td align="left">Fgg</td>
<td align="left">fibrinogen gamma chain</td>
<td align="left">NA</td>
<td align="left">This gene encodes the gamma subunit of the coagulation factor fibrinogen, which is a component of the blood clot. Mice lacking the encoded protein did not possess detectable amounts of plasma fibrinogen. Pregnant mice lacking the encoded protein die due to heavy bleeding during delivery. This gene is located adjacent to the genes encoding fibrinogen alpha and gamma subunits on chromosome 3. Alternate splicing of this gene results in multiple transcript variants encoding distinct isoforms.</td>
</tr>
<tr class="odd">
<td align="left">18011</td>
<td align="left">Neurl1a</td>
<td align="left">neuralized E3 ubiquitin protein ligase 1A</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12889</td>
<td align="left">Cplx1</td>
<td align="left">complexin 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">78558</td>
<td align="left">Htra3</td>
<td align="left">HtrA serine peptidase 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">56370</td>
<td align="left">Tagln3</td>
<td align="left">transgelin 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">20028</td>
<td align="left">Pdc</td>
<td align="left">phosducin</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">100129</td>
<td align="left">Gpr153</td>
<td align="left">G protein-coupled receptor 153</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">71886</td>
<td align="left">2310002L09Rik</td>
<td align="left">RIKEN cDNA 2310002L09 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">18430</td>
<td align="left">Oxtr</td>
<td align="left">oxytocin receptor</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">110886</td>
<td align="left">Gabra5</td>
<td align="left">gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">Bpil2</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">54483</td>
<td align="left">Mefv</td>
<td align="left">Mediterranean fever</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">170441</td>
<td align="left">Slc2a10</td>
<td align="left">solute carrier family 2 (facilitated glucose transporter), member 10</td>
<td align="left">NA</td>
<td align="left">This gene encodes a class III facilitative glucose transporter. Mutations in the related gene in human are associated with arterial tortuosity syndrome.</td>
</tr>
<tr class="odd">
<td align="left">21345</td>
<td align="left">Tagln</td>
<td align="left">transgelin</td>
<td align="left">NA</td>
<td align="left">This gene encodes a smooth muscle cell-specific cytoskeletal protein. The encoded protein is structurally similar to calponin, an actin-binding protein. In mouse models of atherosclerosis the gene product may be involved in plaque cell and atherosclerotic lesion formation during atherogenesis.</td>
</tr>
<tr class="even">
<td align="left">234072</td>
<td align="left">Adprhl1</td>
<td align="left">ADP-ribosylhydrolase like 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">24069</td>
<td align="left">Sufu</td>
<td align="left">suppressor of fused homolog (Drosophila)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">258805</td>
<td align="left">Olfr1426</td>
<td align="left">olfactory receptor 1426</td>
<td align="left">NA</td>
<td align="left">Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms.</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Cdh29</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">11438</td>
<td align="left">Chrna4</td>
<td align="left">cholinergic receptor, nicotinic, alpha polypeptide 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">64085</td>
<td align="left">Clstn2</td>
<td align="left">calsyntenin 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">67084</td>
<td align="left">Ceacam14</td>
<td align="left">carcinoembryonic antigen-related cell adhesion molecule 14</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">73523</td>
<td align="left">Pebp4</td>
<td align="left">phosphatidylethanolamine binding protein 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">66259</td>
<td align="left">Camk2n1</td>
<td align="left">calcium/calmodulin-dependent protein kinase II inhibitor 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">631990</td>
<td align="left">Cdr1</td>
<td align="left">cerebellar degeneration related antigen 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">73047</td>
<td align="left">Camk2n2</td>
<td align="left">calcium/calmodulin-dependent protein kinase II inhibitor 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">74306</td>
<td align="left">Prss46</td>
<td align="left">protease, serine 46</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">74218</td>
<td align="left">1700016H13Rik</td>
<td align="left">RIKEN cDNA 1700016H13 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">57765</td>
<td align="left">Tbx21</td>
<td align="left">T-box 21</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ENSMUSG00000047938</td>
<td align="left">4930483J18Rik</td>
<td align="left">RIKEN cDNA 4930483J18 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">67638</td>
<td align="left">4930483J18Rik</td>
<td align="left">RIKEN cDNA 4930483J18 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">13175</td>
<td align="left">Dclk1</td>
<td align="left">doublecortin-like kinase 1</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the protein kinase superfamily and the doublecortin family. The protein encoded by this gene contains two N-terminal doublecortin domains, which bind microtubules and regulate microtubule polymerization, a C-terminal serine/threonine protein kinase domain, which shows substantial homology to Ca2+/calmodulin-dependent protein kinase, and a serine/proline-rich domain in between the doublecortin and the protein kinase domains, which mediates multiple protein-protein interactions. The microtubule-polymerizing activity of the encoded protein is independent of its protein kinase activity. The encoded protein is involved in several different cellular processes, including neuronal migration, retrograde transport, neuronal apoptosis and neurogenesis. This gene is up-regulated by brain-derived neurotrophic factor and associated with memory and general cognitive abilities. Multiple transcript variants generated by two alternative promoter usage and alternative splicing have been found, but the biological validity of some variants has not been determined. These variants encode different isoforms, which are differentially expressed and have different kinase activities.</td>
</tr>
<tr class="odd">
<td align="left">15507</td>
<td align="left">Hspb1</td>
<td align="left">heat shock protein 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">11440</td>
<td align="left">Chrna6</td>
<td align="left">cholinergic receptor, nicotinic, alpha polypeptide 6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">229801</td>
<td align="left">Tram1l1</td>
<td align="left">translocation associated membrane protein 1-like 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">236749</td>
<td align="left">Gm4907</td>
<td align="left">predicted gene 4907</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">18417</td>
<td align="left">Cldn11</td>
<td align="left">claudin 11</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets, and also play critical roles in maintaining cell polarity and signal transductions. The protein encoded by this gene is a major component of CNS (central nervous system) myelin and plays an important role in regulating proliferation and migration of oligodendrocytes. The basal cell tight junctions in stria vascularis are primarily composed of this protein, and the gene-null mice suffer severe deafness. This protein is also an obligatory protein for tight junction formation and barrier integrity in the testis and the gene deficiency results in loss of the Sertoli cell epithelial phenotype in the testis.</td>
</tr>
<tr class="even">
<td align="left">12267</td>
<td align="left">C3ar1</td>
<td align="left">complement component 3a receptor 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">53901</td>
<td align="left">Rcan2</td>
<td align="left">regulator of calcineurin 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">269951</td>
<td align="left">Idh2</td>
<td align="left">isocitrate dehydrogenase 2 (NADP+), mitochondrial</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">224694</td>
<td align="left">Zfp81</td>
<td align="left">zinc finger protein 81</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">9030224M15Rik</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">12651</td>
<td align="left">Chkb</td>
<td align="left">choline kinase beta</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">56544</td>
<td align="left">Vmn2r1</td>
<td align="left">vomeronasal 2, receptor 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">26559</td>
<td align="left">Hunk</td>
<td align="left">hormonally upregulated Neu-associated kinase</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">246707</td>
<td align="left">Emilin2</td>
<td align="left">elastin microfibril interfacer 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">Gm2382</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">64176</td>
<td align="left">Sv2b</td>
<td align="left">synaptic vesicle glycoprotein 2 b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ENSMUSG00000076271</td>
<td align="left">Mir697</td>
<td align="left">microRNA 697</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">735277</td>
<td align="left">Mir697</td>
<td align="left">microRNA 697</td>
<td align="left">NA</td>
<td align="left">microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop.</td>
</tr>
<tr class="odd">
<td align="left">434903</td>
<td align="left">Mageb4</td>
<td align="left">melanoma antigen, family B, 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">B3gnt9-ps</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_fac_voom/gene_names_clus_&quot;,3,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-4-annotations-3" class="section level3">
<h3>Factor 4 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[4,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">X_id</th>
<th align="left">name</th>
<th align="left">query</th>
<th align="left">notfound</th>
<th align="left">summary</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">14675</td>
<td align="left">guanine nucleotide binding protein, alpha 14</td>
<td align="left">Gna14</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">243362</td>
<td align="left">StAR-related lipid transfer (START) domain containing 13</td>
<td align="left">Stard13</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Wdr69</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">407786</td>
<td align="left">TATA-box binding protein associated factor 9B</td>
<td align="left">Taf9b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">546157</td>
<td align="left">RIKEN cDNA 7420426K07 gene</td>
<td align="left">7420426K07Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">76390</td>
<td align="left">zinc finger protein 735</td>
<td align="left">Zfp735</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">52570</td>
<td align="left">coiled-coil domain containing 69</td>
<td align="left">Ccdc69</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">30838</td>
<td align="left">F-box and WD-40 domain protein 4</td>
<td align="left">Fbxw4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">29815</td>
<td align="left">breast cancer anti-estrogen resistance 3</td>
<td align="left">Bcar3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">104099</td>
<td align="left">integrin alpha 9</td>
<td align="left">Itga9</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ENSMUSG00000091358</td>
<td align="left">spermatogenesis associated glutamate (E)-rich protein 5, pseudogene 1</td>
<td align="left">Speer5-ps1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">70365</td>
<td align="left">spermatogenesis associated glutamate (E)-rich protein 5, pseudogene 1</td>
<td align="left">Speer5-ps1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">2010002M12Rik</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">327963</td>
<td align="left">zinc finger protein 616</td>
<td align="left">Zfp616</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">13649</td>
<td align="left">epidermal growth factor receptor</td>
<td align="left">Egfr</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">11994</td>
<td align="left">protocadherin 15</td>
<td align="left">Pcdh15</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">320158</td>
<td align="left">zinc finger, matrin type 4</td>
<td align="left">Zmat4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">13837</td>
<td align="left">Eph receptor A3</td>
<td align="left">Epha3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">208982</td>
<td align="left">3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase-like 1</td>
<td align="left">Hmgcll1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">56375</td>
<td align="left">UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 4</td>
<td align="left">B4galt4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">110382</td>
<td align="left">complement component 8, beta polypeptide</td>
<td align="left">C8b</td>
<td align="left">NA</td>
<td align="left">This gene encodes the beta subunit of complement component C8 that participates in the assembly of the complement membrane attack complex. The encoded preproprotein undergoes proteolytic processing to generate the beta subunit, which associates with the alpha and gamma subunits to form a trimeric complement component, C8. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing. This gene is located adjacent to the gene encoding the alpha subunit.</td>
</tr>
<tr class="even">
<td align="left">12482</td>
<td align="left">membrane-spanning 4-domains, subfamily A, member 1</td>
<td align="left">Ms4a1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">327992</td>
<td align="left">heat shock transcription factor family member 5</td>
<td align="left">Hsf5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">16875</td>
<td align="left">LIM homeobox protein 8</td>
<td align="left">Lhx8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">71839</td>
<td align="left">oxidative stress induced growth inhibitor 1</td>
<td align="left">Osgin1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">E330016A19Rik</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">207683</td>
<td align="left">immunoglobulin superfamily, member 11</td>
<td align="left">Igsf11</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">14696</td>
<td align="left">guanine nucleotide binding protein (G protein), beta 4</td>
<td align="left">Gnb4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">52589</td>
<td align="left">neurocalcin delta</td>
<td align="left">Ncald</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Dnahc9</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">338521</td>
<td align="left">fatty acid 2-hydroxylase</td>
<td align="left">Fa2h</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">666528</td>
<td align="left">zinc finger protein 541</td>
<td align="left">Zfp541</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">16680</td>
<td align="left">keratin 84</td>
<td align="left">Krt84</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">19130</td>
<td align="left">prospero homeobox 1</td>
<td align="left">Prox1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">22781</td>
<td align="left">IKAROS family zinc finger 4</td>
<td align="left">Ikzf4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">83675</td>
<td align="left">BicC family RNA binding protein 1</td>
<td align="left">Bicc1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">67455</td>
<td align="left">kelch-like 13</td>
<td align="left">Klhl13</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">381549</td>
<td align="left">zinc finger protein 69</td>
<td align="left">Zfp69</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">12835</td>
<td align="left">collagen, type VI, alpha 3</td>
<td align="left">Col6a3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">57749</td>
<td align="left">piwi-like RNA-mediated gene silencing 1</td>
<td align="left">Piwil1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">269784</td>
<td align="left">contactin 4</td>
<td align="left">Cntn4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">12167</td>
<td align="left">bone morphogenetic protein receptor, type 1B</td>
<td align="left">Bmpr1b</td>
<td align="left">NA</td>
<td align="left">This gene encodes a serine/threonine kinase that functions as a receptor for bone morphogenetic proteins (BMPs). The encoded protein is a type I receptor, and forms a complex of two type II and two type I receptors at the cell membrane. This complex signals downstream to activate SMAD transcriptional regulators. This signaling is important in skeletal and bone development. Alternative splicing results in multiple transcript variants.</td>
</tr>
<tr class="odd">
<td align="left">20255</td>
<td align="left">secretogranin III</td>
<td align="left">Scg3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">54354</td>
<td align="left">Ras association (RalGDS/AF-6) domain family member 5</td>
<td align="left">Rassf5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">236852</td>
<td align="left">melanoma antigen family A, 10</td>
<td align="left">Magea10</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">207798</td>
<td align="left">GRAM domain containing 1C</td>
<td align="left">Gramd1c</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">546336</td>
<td align="left">proline rich Gla (G-carboxyglutamic acid) 1</td>
<td align="left">Prrg1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">76960</td>
<td align="left">breast carcinoma amplified sequence 1</td>
<td align="left">Bcas1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">320590</td>
<td align="left">SV2 related protein homolog (rat)-like</td>
<td align="left">Svopl</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">76820</td>
<td align="left">family with sequence similarity 49, member A</td>
<td align="left">Fam49a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">93695</td>
<td align="left">glycoprotein (transmembrane) nmb</td>
<td align="left">Gpnmb</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">100038657</td>
<td align="left">RIKEN cDNA 7420461P10 gene</td>
<td align="left">7420461P10Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">18806</td>
<td align="left">phospholipase D2</td>
<td align="left">Pld2</td>
<td align="left">NA</td>
<td align="left">This gene is a member of the phospholipase D (PLD) superfamily. The encoded protein catalyzes the hydrolysis of phosphatidylcholine to phosphatidic acid and choline. Phosphatidic acid is an essential intracellular lipid second messenger for many signaling pathways and has been implicated in a variety of physiological processes including cytoskeletal organization and cell proliferation. A similar gene in human may also function as a guanine nucleotide exchange factor (GEF) for the small GTPase Rac2. Alternative splicing results in multiple transcript variants.</td>
</tr>
<tr class="even">
<td align="left">12554</td>
<td align="left">cadherin 13</td>
<td align="left">Cdh13</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the cadherin family of calcium-dependent glycoproteins that mediate cell adhesion and regulate many morphogenetic events during development. The encoded preproprotein is further processed to generate a mature protein. This gene is highly expressed in the vasculature including endothelial cells, smooth muscle cells and pericytes, where the encoded protein binds to adiponectin and has been implicated in the modulation of angiogenesis. Multiple distinct genes of the cadherin family, including this gene, are found on chromosome 8.</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Gm1564</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">71914</td>
<td align="left">anthrax toxin receptor 2</td>
<td align="left">Antxr2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">15893</td>
<td align="left">islet cell autoantigen 1</td>
<td align="left">Ica1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">242819</td>
<td align="left">RUN domain containing 3B</td>
<td align="left">Rundc3b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">19264</td>
<td align="left">protein tyrosine phosphatase, receptor type, C</td>
<td align="left">Ptprc</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">117148</td>
<td align="left">N-terminal EF-hand calcium binding protein 2</td>
<td align="left">Necab2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">69675</td>
<td align="left">peroxidasin</td>
<td align="left">Pxdn</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">213272</td>
<td align="left">thioredoxin domain containing 2 (spermatozoa)</td>
<td align="left">Txndc2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">58250</td>
<td align="left">carbohydrate sulfotransferase 11</td>
<td align="left">Chst11</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">52331</td>
<td align="left">starch binding domain 1</td>
<td align="left">Stbd1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">217410</td>
<td align="left">tribbles pseudokinase 2</td>
<td align="left">Trib2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">56711</td>
<td align="left">pleiomorphic adenoma gene 1</td>
<td align="left">Plag1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">11784</td>
<td align="left">amyloid beta (A4) precursor protein-binding, family A, member 2</td>
<td align="left">Apba2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">14396</td>
<td align="left">gamma-aminobutyric acid (GABA) A receptor, subunit alpha 3</td>
<td align="left">Gabra3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">380916</td>
<td align="left">leucine-rich repeats and calponin homology (CH) domain containing 1</td>
<td align="left">Lrch1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">330723</td>
<td align="left">HtrA serine peptidase 4</td>
<td align="left">Htra4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">57257</td>
<td align="left">vav 3 oncogene</td>
<td align="left">Vav3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">234700</td>
<td align="left">neuritin 1-like</td>
<td align="left">Nrn1l</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">244049</td>
<td align="left">multiple C2 domains, transmembrane 2</td>
<td align="left">Mctp2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">68891</td>
<td align="left">CD177 antigen</td>
<td align="left">Cd177</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">74053</td>
<td align="left">glutamate receptor interacting protein 1</td>
<td align="left">Grip1</td>
<td align="left">NA</td>
<td align="left">This gene encodes a protein containing multiple PDZ (post synaptic density protein, Drosophila disc large tumor suppressor, and zonula occludens-1 protein) domains. The encoded protein acts as a mediator between cytoskeletal and membrane proteins, particularly in neuronal cells, and facilitates complex formation at the cell membrane. Mutation of this gene can cause embryonic lethality resulting from defects of the dermo-epidermal junction. Alternative splicing results in multiple transcript variants.</td>
</tr>
<tr class="even">
<td align="left">14048</td>
<td align="left">EYA transcriptional coactivator and phosphatase 1</td>
<td align="left">Eya1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">68774</td>
<td align="left">membrane-spanning 4-domains, subfamily A, member 6D</td>
<td align="left">Ms4a6d</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">56193</td>
<td align="left">pleckstrin</td>
<td align="left">Plek</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">217480</td>
<td align="left">diacylglycerol kinase, beta</td>
<td align="left">Dgkb</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">54153</td>
<td align="left">RAS p21 protein activator 4</td>
<td align="left">Rasa4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">D0H4S114</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">230857</td>
<td align="left">endothelin converting enzyme 1</td>
<td align="left">Ece1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">89867</td>
<td align="left">SEC16 homolog B (S. cerevisiae)</td>
<td align="left">Sec16b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">15468</td>
<td align="left">protein arginine N-methyltransferase 2</td>
<td align="left">Prmt2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">78473</td>
<td align="left">src family associated phosphoprotein 1</td>
<td align="left">Skap1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">22239</td>
<td align="left">UDP galactosyltransferase 8A</td>
<td align="left">Ugt8a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">18552</td>
<td align="left">proprotein convertase subtilisin/kexin type 5</td>
<td align="left">Pcsk5</td>
<td align="left">NA</td>
<td align="left">This gene encodes a subtilisin-like proprotein convertase that mediates posttranslational endoproteolytic processing of various proprotein substrates traversing the secretory pathway. The encoded protein is an inactive zymogen that undergoes autoproteolytic processing in the endoplasmic reticulum and the Golgi network to generate an active enzyme. Mice lacking the encoded protein die at an early embryonic stage. Conditional inactivation this gene in the epiblast but not in the extraembryonic tissue bypasses embryonic lethality but results in death at birth. Alternative splicing results in multiple transcript variants encoding different isoforms.</td>
</tr>
<tr class="even">
<td align="left">53417</td>
<td align="left">hypoxia inducible factor 3, alpha subunit</td>
<td align="left">Hif3a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">236733</td>
<td align="left">ubiquitin specific peptidase 11</td>
<td align="left">Usp11</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">234878</td>
<td align="left">cDNA sequence BC021891</td>
<td align="left">BC021891</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">54678</td>
<td align="left">zinc finger protein 108</td>
<td align="left">Zfp108</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">14585</td>
<td align="left">glial cell line derived neurotrophic factor family receptor alpha 1</td>
<td align="left">Gfra1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">18606</td>
<td align="left">ectonucleotide pyrophosphatase/phosphodiesterase 2</td>
<td align="left">Enpp2</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the phosphodiesterase and nucleotide pyrophosphatase family of bifunctional enzymes that hydrolize phosphodiester bonds of various nucleotides. The encoded protein undergoes proteolytic processing to generate a mature protein with lysophospholipase D activity, catalyzing the cleavage of the choline group from lysophosphatidylcholine to produce lysophosphatidic acid. This gene is expressed in numerous tissues and participates in neural development, obesity, inflammation and oncogenesis. A complete lack of the encoded protein in mice results in aberrant vascular and neuronal development leading to embryonic lethality. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar processing to generate the mature protein.</td>
</tr>
<tr class="even">
<td align="left">20273</td>
<td align="left">sodium channel, voltage-gated, type VIII, alpha</td>
<td align="left">Scn8a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ENSMUSG00000068180</td>
<td align="left">cDNA sequence AY512915</td>
<td align="left">AY512915</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">414067</td>
<td align="left">cDNA sequence AY512915</td>
<td align="left">AY512915</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">68203</td>
<td align="left">DIRAS family, GTP-binding RAS-like 2</td>
<td align="left">Diras2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">21646</td>
<td align="left">t-complex-associated testis expressed 2</td>
<td align="left">Tcte2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">26437</td>
<td align="left">pregnancy specific glycoprotein 17</td>
<td align="left">Psg17</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">50706</td>
<td align="left">periostin, osteoblast specific factor</td>
<td align="left">Postn</td>
<td align="left">NA</td>
<td align="left">This gene encodes a secreted extracellular matrix protein that functions in tissue development and regeneration, including wound healing and ventricular remodeling following myocardial infarction. The encoded protein binds to integrins to support adhesion and migration of epithelial cells. This protein plays a role in cancer stem cell maintenance and metastasis. Mice lacking this gene exhibit cardiac valve disease, and skeletal and dental defects. Alternative splicing results in multiple transcript variants encoding different isoforms.</td>
</tr>
<tr class="odd">
<td align="left">211232</td>
<td align="left">copine family member IX</td>
<td align="left">Cpne9</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">53885</td>
<td align="left">nephronophthisis 1 (juvenile) homolog (human)</td>
<td align="left">Nphp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_fac_voom/gene_names_clus_&quot;,4,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-5-annotations-3" class="section level3">
<h3>Factor 5 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[5,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">name</th>
<th align="left">X_id</th>
<th align="left">query</th>
<th align="left">notfound</th>
<th align="left">summary</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">predicted pseudogene 4850</td>
<td align="left">ENSMUSG00000100205</td>
<td align="left">Gm4850</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">THO complex 4 pseudogene</td>
<td align="left">226957</td>
<td align="left">Gm4850</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Dub1a</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RIKEN cDNA 1600025M17 gene</td>
<td align="left">ENSMUSG00000085114</td>
<td align="left">1600025M17Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">RIKEN cDNA 1600025M17 gene</td>
<td align="left">72030</td>
<td align="left">1600025M17Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">tumor necrosis factor, alpha-induced protein 8-like 2</td>
<td align="left">69769</td>
<td align="left">Tnfaip8l2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">apolipoprotein L 7b</td>
<td align="left">278679</td>
<td align="left">Apol7b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">spermatogenic leucine zipper 1</td>
<td align="left">79401</td>
<td align="left">Spz1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">apolipoprotein L 7b</td>
<td align="left">278679</td>
<td align="left">Apol7b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">apolipoprotein L 7e</td>
<td align="left">666348</td>
<td align="left">Apol7e</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">REX1, RNA exonuclease 1 homolog pseudogene</td>
<td align="left">100038982</td>
<td align="left">Gm1995</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">trichohyalin</td>
<td align="left">99681</td>
<td align="left">Tchh</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">zinc finger protein 352</td>
<td align="left">236537</td>
<td align="left">Zfp352</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">predicted gene 7104</td>
<td align="left">ENSMUSG00000094635</td>
<td align="left">Gm7104</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">REX1, RNA exonuclease 1 homolog pseudogene</td>
<td align="left">633093</td>
<td align="left">Gm7104</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">predicted gene 12789</td>
<td align="left">381536</td>
<td align="left">Gm12789</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rab interacting lysosomal protein-like 2</td>
<td align="left">80291</td>
<td align="left">Rilpl2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">zinc finger and SCAN domain containing 10</td>
<td align="left">332221</td>
<td align="left">Zscan10</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">caspase recruitment domain family, member 6</td>
<td align="left">239319</td>
<td align="left">Card6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">predicted gene 10697</td>
<td align="left">100042761</td>
<td align="left">Gm10697</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">TD and POZ domain containing 5</td>
<td align="left">399676</td>
<td align="left">Tdpoz5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">F-box protein 36</td>
<td align="left">66153</td>
<td align="left">Fbxo36</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">predicted gene 9125</td>
<td align="left">668359</td>
<td align="left">Gm9125</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">LIM homeobox transcription factor 1 alpha</td>
<td align="left">110648</td>
<td align="left">Lmx1a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Znhit2-ps</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">predicted gene 13119</td>
<td align="left">433779</td>
<td align="left">Gm13119</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Cml2</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">sestrin 2</td>
<td align="left">230784</td>
<td align="left">Sesn2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">cysteine rich protein 2</td>
<td align="left">68337</td>
<td align="left">Crip2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">EP300 interacting inhibitor of differentiation 2</td>
<td align="left">386655</td>
<td align="left">Eid2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Usp17l5</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">oocyte specific homeobox 3</td>
<td align="left">246791</td>
<td align="left">Obox3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">galactose-3-O-sulfotransferase 2</td>
<td align="left">381334</td>
<td align="left">Gal3st2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">expressed sequence AU015228</td>
<td align="left">ENSMUSG00000074804</td>
<td align="left">AU015228</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">expressed sequence AU015228</td>
<td align="left">99169</td>
<td align="left">AU015228</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">predicted gene 2016</td>
<td align="left">100039042</td>
<td align="left">Gm2016</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">zinc finger protein 948</td>
<td align="left">381066</td>
<td align="left">Zfp948</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">predicted gene 5662</td>
<td align="left">435337</td>
<td align="left">Gm5662</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">snail family zinc finger 1</td>
<td align="left">20613</td>
<td align="left">Snai1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RAB43, member RAS oncogene family</td>
<td align="left">69834</td>
<td align="left">Rab43</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">predicted gene 7102</td>
<td align="left">633057</td>
<td align="left">Gm7102</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">predicted gene 5039</td>
<td align="left">ENSMUSG00000093847</td>
<td align="left">Gm5039</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">eukaryotic translation initiation factor 1A pseudogene</td>
<td align="left">266459</td>
<td align="left">Gm5039</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">transmembrane emp24 protein transport domain containing 6</td>
<td align="left">66269</td>
<td align="left">Tmed6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">DIS3 like exosome 3’-5’ exoribonuclease</td>
<td align="left">213550</td>
<td align="left">Dis3l</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">thyrotroph embryonic factor</td>
<td align="left">21685</td>
<td align="left">Tef</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Glt25d2</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 26B</td>
<td align="left">236790</td>
<td align="left">Ddx26b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">predicted gene 11487</td>
<td align="left">433719</td>
<td align="left">Gm11487</td>
<td align="left">NA</td>
<td align="left">This gene belongs to a family of related genes tandemly arranged in two clusters on chromosome 4. This family, which appears to be mouse-specific and composed of multiple highly similar members, is supported by limited transcript data. Members of the family maintain an intact open reading frame although the encoded protein has no known function. This gene is inferred from alignment of paralogous transcripts.</td>
</tr>
<tr class="even">
<td align="left">tubulin-specific chaperone C</td>
<td align="left">72726</td>
<td align="left">Tbcc</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">UDP glucuronosyltransferase 2 family, polypeptide B36</td>
<td align="left">231396</td>
<td align="left">Ugt2b36</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">nicotinamide nucleotide adenylyltransferase 1</td>
<td align="left">66454</td>
<td align="left">Nmnat1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">predicted gene 10696</td>
<td align="left">100043188</td>
<td align="left">Gm10696</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">polycystic kidney disease 1 homolog</td>
<td align="left">18763</td>
<td align="left">Pkd1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">solute carrier family 19, member 3</td>
<td align="left">80721</td>
<td align="left">Slc19a3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RIKEN cDNA B020004J07 gene</td>
<td align="left">545662</td>
<td align="left">B020004J07Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ankyrin repeat domain 35</td>
<td align="left">213121</td>
<td align="left">Ankrd35</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">tigger transposable element derived 3</td>
<td align="left">332359</td>
<td align="left">Tigd3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">deleted in colorectal carcinoma</td>
<td align="left">13176</td>
<td align="left">Dcc</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">interferon regulatory factor 1</td>
<td align="left">16362</td>
<td align="left">Irf1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">expressed sequence AA415398</td>
<td align="left">433752</td>
<td align="left">AA415398</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">expressed sequence BB287469</td>
<td align="left">544881</td>
<td align="left">BB287469</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">RecQ protein-like 4</td>
<td align="left">79456</td>
<td align="left">Recql4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">zinc finger protein 781</td>
<td align="left">331188</td>
<td align="left">Zfp781</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">unc-119 lipid binding chaperone B</td>
<td align="left">106840</td>
<td align="left">Unc119b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">family with sequence similarity 109, member A</td>
<td align="left">231717</td>
<td align="left">Fam109a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">matrix metallopeptidase 19</td>
<td align="left">58223</td>
<td align="left">Mmp19</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the matrix metalloproteinase family of extracellular matrix-degrading enzymes that are involved in tissue remodeling, wound repair, progression of atherosclerosis and tumor invasion. The encoded preproprotein undergoes proteolytic processing to generate a mature, zinc-dependent endopeptidase enzyme. Mice lacking the encoded protein develop a diet-induced obesity due to adipocyte hypertophy, exhibit decreased susceptibility to chemical carcinogen-induced skin tumors and early onset of tumoral angiogenesis. Alternative splicing results in multiple transcript variants encoding different isoforms.</td>
</tr>
<tr class="even">
<td align="left">cleavage stimulation factor, 3’ pre-RNA subunit 2, tau</td>
<td align="left">83410</td>
<td align="left">Cstf2t</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">gap junction protein, alpha 3</td>
<td align="left">14611</td>
<td align="left">Gja3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">coiled coil domain containing 88A</td>
<td align="left">108686</td>
<td align="left">Ccdc88a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">trans-acting transcription factor 6</td>
<td align="left">83395</td>
<td align="left">Sp6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Bardet-Biedl syndrome 2 (human)</td>
<td align="left">67378</td>
<td align="left">Bbs2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">thyroid peroxidase</td>
<td align="left">22018</td>
<td align="left">Tpo</td>
<td align="left">NA</td>
<td align="left">This gene encodes a membrane-bound glycoprotein. The encoded enzyme plays a central role in thyroid gland function. The enzyme functions in the iodination of tyrosine residues in thyroglobulin and phenoxy-ester formation between pairs of iodinated tyrosines to generate the thyroid hormones, thyroxine and triiodothyronine. Mice with homozygous missense mutations in this gene exhibit hypothyroid dwarfism and hearing impairment.</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">6230427J02Rik</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">quiescin Q6 sulfhydryl oxidase 2</td>
<td align="left">227638</td>
<td align="left">Qsox2</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the sulfhydryl oxidase protein family. Members of this family catalyze formation of disulfide bonds. A similar protein in humans may sensitize neuroblastoma cells to interferon gamma-induced cell death. Alternate splicing results in multiple transcript variants.</td>
</tr>
<tr class="even">
<td align="left">thymidine kinase 2, mitochondrial</td>
<td align="left">57813</td>
<td align="left">Tk2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">solute carrier family 25, member 33</td>
<td align="left">70556</td>
<td align="left">Slc25a33</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Yy2 transcription factor</td>
<td align="left">100073351</td>
<td align="left">Yy2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">predicted pseudogene 2022</td>
<td align="left">ENSMUSG00000071217</td>
<td align="left">Gm2022</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">predicted pseudogene 2022</td>
<td align="left">100039052</td>
<td align="left">Gm2022</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">TD and POZ domain containing 4</td>
<td align="left">399675</td>
<td align="left">Tdpoz4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RIKEN cDNA 1700049G17 gene</td>
<td align="left">73430</td>
<td align="left">1700049G17Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">glutaminyl-peptide cyclotransferase-like</td>
<td align="left">67369</td>
<td align="left">Qpctl</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">methyl-CpG binding domain protein 5</td>
<td align="left">109241</td>
<td align="left">Mbd5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">RIC3 acetylcholine receptor chaperone</td>
<td align="left">320360</td>
<td align="left">Ric3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">beta-1,4-N-acetyl-galactosaminyl transferase 2</td>
<td align="left">14422</td>
<td align="left">B4galnt2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">retinol binding protein 7, cellular</td>
<td align="left">63954</td>
<td align="left">Rbp7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">frizzled class receptor 7</td>
<td align="left">14369</td>
<td align="left">Fzd7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">myocyte enhancer factor 2A</td>
<td align="left">17258</td>
<td align="left">Mef2a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">predicted gene 13040</td>
<td align="left">100040854</td>
<td align="left">Gm13040</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">predicted gene 13057</td>
<td align="left">100040861</td>
<td align="left">Gm13057</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">lipase, member O3</td>
<td align="left">329055</td>
<td align="left">Lipo1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Gm13109</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">predicted gene 13101</td>
<td align="left">ENSMUSG00000078510</td>
<td align="left">Gm13101</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">novel protein similar to the preferentially expressed antigen in melanoma like (Pramel) family</td>
<td align="left">626922</td>
<td align="left">Gm13101</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">TD and POZ domain containing 1</td>
<td align="left">207213</td>
<td align="left">Tdpoz1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">BCL6 interacting corepressor</td>
<td align="left">71458</td>
<td align="left">Bcor</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">protein tyrosine phosphatase, non-receptor type 9</td>
<td align="left">56294</td>
<td align="left">Ptpn9</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">signal transducer and activator of transcription 2</td>
<td align="left">20847</td>
<td align="left">Stat2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RIKEN cDNA 1700017B05 gene</td>
<td align="left">74211</td>
<td align="left">1700017B05Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Baat1</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">AT rich interactive domain 5A (MRF1-like)</td>
<td align="left">214855</td>
<td align="left">Arid5a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">zinc finger protein 444</td>
<td align="left">72667</td>
<td align="left">Zfp444</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">histocompatibility 2, Q region locus 10</td>
<td align="left">15007</td>
<td align="left">H2-Q10</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">zinc finger protein 623</td>
<td align="left">78834</td>
<td align="left">Zfp623</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Smad nuclear interacting protein 1 pseudogene</td>
<td align="left">244061</td>
<td align="left">Gm4971</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">tetratricopeptide repeat domain 30B</td>
<td align="left">72421</td>
<td align="left">Ttc30b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">zinc finger protein 775</td>
<td align="left">243372</td>
<td align="left">Zfp775</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">lymphocyte protein tyrosine kinase</td>
<td align="left">16818</td>
<td align="left">Lck</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">predicted gene 4858</td>
<td align="left">229571</td>
<td align="left">Gm4858</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_fac_voom/gene_names_clus_&quot;,5,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-6-annotations-3" class="section level3">
<h3>Factor 6 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[6,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">query</th>
<th align="left">name</th>
<th align="left">X_id</th>
<th align="left">notfound</th>
<th align="left">summary</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Zc3h12c</td>
<td align="left">zinc finger CCCH type containing 12C</td>
<td align="left">244871</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Nin</td>
<td align="left">ninein</td>
<td align="left">18080</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Arrdc1</td>
<td align="left">arrestin domain containing 1</td>
<td align="left">215705</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Nipal1</td>
<td align="left">NIPA-like domain containing 1</td>
<td align="left">70701</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ppt2</td>
<td align="left">palmitoyl-protein thioesterase 2</td>
<td align="left">54397</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tnfsf13b</td>
<td align="left">tumor necrosis factor (ligand) superfamily, member 13b</td>
<td align="left">24099</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Arhgef3</td>
<td align="left">Rho guanine nucleotide exchange factor (GEF) 3</td>
<td align="left">71704</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ddr1</td>
<td align="left">discoidin domain receptor family, member 1</td>
<td align="left">12305</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fbxo34</td>
<td align="left">F-box protein 34</td>
<td align="left">78938</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Arhgef16</td>
<td align="left">Rho guanine nucleotide exchange factor (GEF) 16</td>
<td align="left">230972</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Atxn7</td>
<td align="left">ataxin 7</td>
<td align="left">246103</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Foxa1</td>
<td align="left">forkhead box A1</td>
<td align="left">15375</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">2310033E01Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Plcd3</td>
<td align="left">phospholipase C, delta 3</td>
<td align="left">72469</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rusc1</td>
<td align="left">RUN and SH3 domain containing 1</td>
<td align="left">72296</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cish</td>
<td align="left">cytokine inducible SH2-containing protein</td>
<td align="left">12700</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Avl9</td>
<td align="left">AVL9 homolog (S. cerevisiase)</td>
<td align="left">78937</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Slc12a2</td>
<td align="left">solute carrier family 12, member 2</td>
<td align="left">20496</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rbbp8</td>
<td align="left">retinoblastoma binding protein 8</td>
<td align="left">225182</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Padi6</td>
<td align="left">peptidyl arginine deiminase, type VI</td>
<td align="left">242726</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Zfp821</td>
<td align="left">zinc finger protein 821</td>
<td align="left">75871</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Mast3</td>
<td align="left">microtubule associated serine/threonine kinase 3</td>
<td align="left">546071</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Zdhhc7</td>
<td align="left">zinc finger, DHHC domain containing 7</td>
<td align="left">102193</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">5031439G07Rik</td>
<td align="left">RIKEN cDNA 5031439G07 gene</td>
<td align="left">223739</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">BC053393</td>
<td align="left">cDNA sequence BC053393</td>
<td align="left">407814</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Lrrc42</td>
<td align="left">leucine rich repeat containing 42</td>
<td align="left">77809</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fzd3</td>
<td align="left">frizzled class receptor 3</td>
<td align="left">14365</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">A930001N09Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cux2</td>
<td align="left">cut-like homeobox 2</td>
<td align="left">13048</td>
<td align="left">NA</td>
<td align="left">This gene is a member of the Cut family of transcription factors that have multiple DNA binding domains and regulate cell proliferation and differentiation. This gene is primarily expressed in nervous tissues where it controls the proliferation of neuronal precursors, and may play a role in organogenesis earlier during embryonic development. Mice lacking the encoded protein exhibit smaller spinal cords with deficits in neural progenitor development as well as in neuroblast and interneuron differentiation. Alternative splicing results in multiple transcript variants.</td>
</tr>
<tr class="even">
<td align="left">Nr1d2</td>
<td align="left">nuclear receptor subfamily 1, group D, member 2</td>
<td align="left">353187</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the nuclear hormone receptor family, specifically the NR1 subfamily of receptors. The encoded protein functions as a transcriptional repressor and may play a role in circadian rhythms and carbohydrate and lipid metabolism.</td>
</tr>
<tr class="odd">
<td align="left">9530008L14Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Fam98a</td>
<td align="left">family with sequence similarity 98, member A</td>
<td align="left">72722</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Adprhl2</td>
<td align="left">ADP-ribosylhydrolase like 2</td>
<td align="left">100206</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Lztfl1</td>
<td align="left">leucine zipper transcription factor-like 1</td>
<td align="left">93730</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pla2g4e</td>
<td align="left">phospholipase A2, group IVE</td>
<td align="left">329502</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Xpr1</td>
<td align="left">xenotropic and polytropic retrovirus receptor 1</td>
<td align="left">19775</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tmem56</td>
<td align="left">transmembrane protein 56</td>
<td align="left">99887</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">B230312A22Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Apobec3</td>
<td align="left">apolipoprotein B mRNA editing enzyme, catalytic polypeptide 3</td>
<td align="left">80287</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Spp1</td>
<td align="left">secreted phosphoprotein 1</td>
<td align="left">20750</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Lmo7</td>
<td align="left">LIM domain only 7</td>
<td align="left">380928</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Zfp143</td>
<td align="left">zinc finger protein 143</td>
<td align="left">20841</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Urb1</td>
<td align="left">URB1 ribosome biogenesis 1 homolog (S. cerevisiae)</td>
<td align="left">207932</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Polrmt</td>
<td align="left">polymerase (RNA) mitochondrial (DNA directed)</td>
<td align="left">216151</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tnip1</td>
<td align="left">TNFAIP3 interacting protein 1</td>
<td align="left">57783</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Upp1</td>
<td align="left">uridine phosphorylase 1</td>
<td align="left">22271</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">BC031353</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Mybpc2</td>
<td align="left">myosin binding protein C, fast-type</td>
<td align="left">233199</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Def8</td>
<td align="left">differentially expressed in FDCP 8</td>
<td align="left">23854</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Csrnp2</td>
<td align="left">cysteine-serine-rich nuclear protein 2</td>
<td align="left">207785</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Prkcd</td>
<td align="left">protein kinase C, delta</td>
<td align="left">18753</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Fam134c</td>
<td align="left">family with sequence similarity 134, member C</td>
<td align="left">67998</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ppapdc1b</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Polr1e</td>
<td align="left">polymerase (RNA) I polypeptide E</td>
<td align="left">64424</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ctsz</td>
<td align="left">cathepsin Z</td>
<td align="left">64138</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the peptidase C1 (papain) family of cysteine proteases. The encoded preproprotein is proteolytically processed to generate a mature enzyme with carboxypeptidase activity. An enzymatically inactive form of the protein, that is associated with the propeptide, may be involved in cancer cell invasion and proliferation. Homozygous knockout mice for this gene exhibit impaired cancer cell invasion in a breast cancer model.</td>
</tr>
<tr class="even">
<td align="left">Ccne1</td>
<td align="left">cyclin E1</td>
<td align="left">12447</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Slc25a12</td>
<td align="left">solute carrier family 25 (mitochondrial carrier, Aralar), member 12</td>
<td align="left">78830</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Trim39</td>
<td align="left">tripartite motif-containing 39</td>
<td align="left">79263</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tprn</td>
<td align="left">taperin</td>
<td align="left">97031</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rasl11a</td>
<td align="left">RAS-like, family 11, member A</td>
<td align="left">68895</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Lrrc47</td>
<td align="left">leucine rich repeat containing 47</td>
<td align="left">72946</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ndor1</td>
<td align="left">NADPH dependent diflavin oxidoreductase 1</td>
<td align="left">78797</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Anapc7</td>
<td align="left">anaphase promoting complex subunit 7</td>
<td align="left">56317</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Myst1</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Crnkl1</td>
<td align="left">Crn, crooked neck-like 1 (Drosophila)</td>
<td align="left">66877</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Fam203a</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Zfp740</td>
<td align="left">zinc finger protein 740</td>
<td align="left">68744</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Mospd1</td>
<td align="left">motile sperm domain containing 1</td>
<td align="left">70380</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cep76</td>
<td align="left">centrosomal protein 76</td>
<td align="left">225659</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Nkiras1</td>
<td align="left">NFKB inhibitor interacting Ras-like protein 1</td>
<td align="left">69721</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rimklb</td>
<td align="left">ribosomal modification protein rimK-like family member B</td>
<td align="left">108653</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Mosc2</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">4930432K21Rik</td>
<td align="left">RIKEN cDNA 4930432K21 gene</td>
<td align="left">74666</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Thop1</td>
<td align="left">thimet oligopeptidase 1</td>
<td align="left">50492</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mical3</td>
<td align="left">microtubule associated monooxygenase, calponin and LIM domain containing 3</td>
<td align="left">194401</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gucy2e</td>
<td align="left">guanylate cyclase 2e</td>
<td align="left">14919</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Supt3h</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Med23</td>
<td align="left">mediator complex subunit 23</td>
<td align="left">70208</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Hand1</td>
<td align="left">heart and neural crest derivatives expressed transcript 1</td>
<td align="left">15110</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ezr</td>
<td align="left">ezrin</td>
<td align="left">22350</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pcgf1</td>
<td align="left">polycomb group ring finger 1</td>
<td align="left">69837</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">5830415F09Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Wdtc1</td>
<td align="left">WD and tetratricopeptide repeats 1</td>
<td align="left">230796</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Crb3</td>
<td align="left">crumbs family member 3</td>
<td align="left">224912</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Vps37b</td>
<td align="left">vacuolar protein sorting 37B</td>
<td align="left">330192</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Atg7</td>
<td align="left">autophagy related 7</td>
<td align="left">74244</td>
<td align="left">NA</td>
<td align="left">This gene encodes an E1-like activating enzyme that is essential for autophagy and cytoplasmic to vacuole transport. The encoded protein is also thought to modulate p53-dependent cell cycle pathways during prolonged metabolic stress. It has been associated with multiple functions, including axon membrane trafficking, axonal homeostasis, mitophagy, adipose differentiation, and hematopoietic stem cell maintenance. Alternative splicing results in multiple transcript variants.</td>
</tr>
<tr class="odd">
<td align="left">Pink1</td>
<td align="left">PTEN induced putative kinase 1</td>
<td align="left">68943</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Sirt7</td>
<td align="left">sirtuin 7</td>
<td align="left">209011</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">4931409K22Rik</td>
<td align="left">RIKEN cDNA 4931409K22 gene</td>
<td align="left">231045</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Plekhm1</td>
<td align="left">pleckstrin homology domain containing, family M (with RUN domain) member 1</td>
<td align="left">353047</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">C130074G19Rik</td>
<td align="left">RIKEN cDNA C130074G19 gene</td>
<td align="left">226777</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Slc11a2</td>
<td align="left">solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2</td>
<td align="left">18174</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Osbpl6</td>
<td align="left">oxysterol binding protein-like 6</td>
<td align="left">99031</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pla2g16</td>
<td align="left">phospholipase A2, group XVI</td>
<td align="left">225845</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Klf17</td>
<td align="left">Kruppel-like factor 17</td>
<td align="left">75753</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rpusd2</td>
<td align="left">RNA pseudouridylate synthase domain containing 2</td>
<td align="left">271842</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mgat4a</td>
<td align="left">mannoside acetylglucosaminyltransferase 4, isoenzyme A</td>
<td align="left">269181</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">1110067D22Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Actn2</td>
<td align="left">actinin alpha 2</td>
<td align="left">11472</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Map4k5</td>
<td align="left">mitogen-activated protein kinase kinase kinase kinase 5</td>
<td align="left">399510</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_fac_voom/gene_names_clus_&quot;,6,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-7-annotations-3" class="section level3">
<h3>Factor 7 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[7,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">query</th>
<th align="left">X_id</th>
<th align="left">name</th>
<th align="left">notfound</th>
<th align="left">summary</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Med8</td>
<td align="left">80509</td>
<td align="left">mediator complex subunit 8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">2410015M20Rik</td>
<td align="left">224904</td>
<td align="left">RIKEN cDNA 2410015M20 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Srp19</td>
<td align="left">66384</td>
<td align="left">signal recognition particle 19</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cxcr2</td>
<td align="left">12765</td>
<td align="left">chemokine (C-X-C motif) receptor 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Loxl2</td>
<td align="left">94352</td>
<td align="left">lysyl oxidase-like 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Park7</td>
<td align="left">57320</td>
<td align="left">Parkinson disease (autosomal recessive, early onset) 7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pomp</td>
<td align="left">66537</td>
<td align="left">proteasome maturation protein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">2010109I03Rik</td>
<td align="left">67038</td>
<td align="left">RIKEN cDNA 2010109I03 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Zfp207</td>
<td align="left">22680</td>
<td align="left">zinc finger protein 207</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rpl7l1</td>
<td align="left">66229</td>
<td align="left">ribosomal protein L7-like 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Lgals1</td>
<td align="left">16852</td>
<td align="left">lectin, galactose binding, soluble 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cope</td>
<td align="left">59042</td>
<td align="left">coatomer protein complex, subunit epsilon</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Churc1</td>
<td align="left">211151</td>
<td align="left">churchill domain containing 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Sod1</td>
<td align="left">20655</td>
<td align="left">superoxide dismutase 1, soluble</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Lcmt2</td>
<td align="left">329504</td>
<td align="left">leucine carboxyl methyltransferase 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gm5531</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ndufc1</td>
<td align="left">66377</td>
<td align="left">NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Dcdc2b</td>
<td align="left">100504491</td>
<td align="left">doublecortin domain containing 2b</td>
<td align="left">NA</td>
<td align="left">This gene encodes a member of the doublecortin family. The protein encoded by this gene contains two doublecortin domains. The doublecortin domain has been demonstrated to bind tubulin and enhance microtubule polymerization.</td>
</tr>
<tr class="odd">
<td align="left">Sf3b5</td>
<td align="left">66125</td>
<td align="left">splicing factor 3b, subunit 5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Grpel1</td>
<td align="left">17713</td>
<td align="left">GrpE-like 1, mitochondrial</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Hist1h2ao</td>
<td align="left">665433</td>
<td align="left">histone cluster 1, H2ao</td>
<td align="left">NA</td>
<td align="left">Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. This structure consists of approximately 146 bp of DNA wrapped around a nucleosome, an octamer composed of pairs of each of the four core histones (H2A, H2B, H3, and H4). The chromatin fiber is further compacted through the interaction of a linker histone, H1, with the DNA between the nucleosomes to form higher order chromatin structures. This gene is intronless and encodes a replication-dependent histone that is a member of the histone H2A family. Transcripts from this gene lack polyA tails; instead, they contain a palindromic termination element.</td>
</tr>
<tr class="even">
<td align="left">Chrna1</td>
<td align="left">11435</td>
<td align="left">cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle)</td>
<td align="left">NA</td>
<td align="left">This gene encodes an alpha subunit of the muscle-derived nicotinic acetylcholine receptor, a pentameric neurotransmitter receptor and member of the ligand-gated ion channel superfamily. The alpha subunit plays a role in substrate binding and channel gating.</td>
</tr>
<tr class="odd">
<td align="left">1810009A15Rik</td>
<td align="left">66276</td>
<td align="left">RIKEN cDNA 1810009A15 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">2900060B14Rik</td>
<td align="left">ENSMUSG00000107722</td>
<td align="left">RIKEN cDNA 2900060B14 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">2900060B14Rik</td>
<td align="left">68204</td>
<td align="left">RIKEN cDNA 2900060B14 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Fancf</td>
<td align="left">100040608</td>
<td align="left">Fanconi anemia, complementation group F</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ier3ip1</td>
<td align="left">66191</td>
<td align="left">immediate early response 3 interacting protein 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Nmt1</td>
<td align="left">18107</td>
<td align="left">N-myristoyltransferase 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tomm6</td>
<td align="left">66119</td>
<td align="left">translocase of outer mitochondrial membrane 6 homolog (yeast)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tars</td>
<td align="left">110960</td>
<td align="left">threonyl-tRNA synthetase</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mpv17l</td>
<td align="left">93734</td>
<td align="left">Mpv17 transgene, kidney disease mutant-like</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Anxa2</td>
<td align="left">12306</td>
<td align="left">annexin A2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Psma4</td>
<td align="left">26441</td>
<td align="left">proteasome (prosome, macropain) subunit, alpha type 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ndufb10</td>
<td align="left">68342</td>
<td align="left">NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Snrpd1</td>
<td align="left">20641</td>
<td align="left">small nuclear ribonucleoprotein D1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ccdc48</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mrpl21</td>
<td align="left">353242</td>
<td align="left">mitochondrial ribosomal protein L21</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Dap</td>
<td align="left">223453</td>
<td align="left">death-associated protein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Usmg5</td>
<td align="left">66477</td>
<td align="left">upregulated during skeletal muscle growth 5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ppp2r2c</td>
<td align="left">269643</td>
<td align="left">protein phosphatase 2, regulatory subunit B, gamma</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mir3473</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Vaultrc5</td>
<td align="left">ENSMUSG00000065145</td>
<td align="left">vault RNA component 5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Vaultrc5</td>
<td align="left">378472</td>
<td align="left">vault RNA component 5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Map4k3</td>
<td align="left">225028</td>
<td align="left">mitogen-activated protein kinase kinase kinase kinase 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Atp5h</td>
<td align="left">71679</td>
<td align="left">ATP synthase, H+ transporting, mitochondrial F0 complex, subunit D</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Omd</td>
<td align="left">27047</td>
<td align="left">osteomodulin</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Atxn10</td>
<td align="left">54138</td>
<td align="left">ataxin 10</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gm10069</td>
<td align="left">ENSMUSG00000059659</td>
<td align="left">predicted gene 10069</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm10069</td>
<td align="left">791299</td>
<td align="left">predicted gene 10069</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Mrpl52</td>
<td align="left">68836</td>
<td align="left">mitochondrial ribosomal protein L52</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Phactr1</td>
<td align="left">218194</td>
<td align="left">phosphatase and actin regulator 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Psmd4</td>
<td align="left">19185</td>
<td align="left">proteasome (prosome, macropain) 26S subunit, non-ATPase, 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Psmc1</td>
<td align="left">19179</td>
<td align="left">protease (prosome, macropain) 26S subunit, ATPase 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rps25</td>
<td align="left">75617</td>
<td align="left">ribosomal protein S25</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Atp5j2</td>
<td align="left">57423</td>
<td align="left">ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Psmc4</td>
<td align="left">23996</td>
<td align="left">proteasome (prosome, macropain) 26S subunit, ATPase, 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ptpn13</td>
<td align="left">19249</td>
<td align="left">protein tyrosine phosphatase, non-receptor type 13</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ccdc36</td>
<td align="left">434438</td>
<td align="left">coiled-coil domain containing 36</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">5430405H02Rik</td>
<td align="left">74487</td>
<td align="left">RIKEN cDNA 5430405H02 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">5430405H02Rik</td>
<td align="left">ENSMUSG00000085741</td>
<td align="left">RIKEN cDNA 5430405H02 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Nars</td>
<td align="left">70223</td>
<td align="left">asparaginyl-tRNA synthetase</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ppp1r16b</td>
<td align="left">228852</td>
<td align="left">protein phosphatase 1, regulatory (inhibitor) subunit 16B</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rps5</td>
<td align="left">20103</td>
<td align="left">ribosomal protein S5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Leprel2</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pilra</td>
<td align="left">231805</td>
<td align="left">paired immunoglobin-like type 2 receptor alpha</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Atp6v0d1</td>
<td align="left">11972</td>
<td align="left">ATPase, H+ transporting, lysosomal V0 subunit D1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cntd1</td>
<td align="left">68107</td>
<td align="left">cyclin N-terminal domain containing 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Birc5</td>
<td align="left">11799</td>
<td align="left">baculoviral IAP repeat-containing 5</td>
<td align="left">NA</td>
<td align="left">This gene is a member of the inhibitor of apoptosis (IAP) gene family, which encode negative regulatory proteins that prevent apoptotic cell death. IAP family members usually contain multiple baculovirus IAP repeat (BIR) domains, but this gene encodes proteins with only a single BIR domain. The encoded proteins also lack a C-terminus RING finger domain. In humans, gene expression is high during fetal development and in most tumors yet low in adult tissues. Antisense transcripts have been identified in human that regulate this gene’s expression. At least three transcript variants encoding distinct isoforms have been found for this gene, although at least one of these transcript variants is a nonsense-mediated decay (NMD) candidate.</td>
</tr>
<tr class="odd">
<td align="left">Hnrnpc</td>
<td align="left">15381</td>
<td align="left">heterogeneous nuclear ribonucleoprotein C</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Txndc9</td>
<td align="left">98258</td>
<td align="left">thioredoxin domain containing 9</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">1700084J12Rik</td>
<td align="left">ENSMUSG00000058101</td>
<td align="left">RIKEN cDNA 1700084J12 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">1700084J12Rik</td>
<td align="left">73486</td>
<td align="left">ribosomal protein L7-like 1 pseudogene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm13611</td>
<td align="left">ENSMUSG00000066068</td>
<td align="left">predicted gene 13611</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gm13611</td>
<td align="left">100504319</td>
<td align="left">60S ribosomal protein L36 pseudogene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Eif3g</td>
<td align="left">53356</td>
<td align="left">eukaryotic translation initiation factor 3, subunit G</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Atp5f1</td>
<td align="left">11950</td>
<td align="left">ATP synthase, H+ transporting, mitochondrial F0 complex, subunit B1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Wfdc2</td>
<td align="left">67701</td>
<td align="left">WAP four-disulfide core domain 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Eif3k</td>
<td align="left">73830</td>
<td align="left">eukaryotic translation initiation factor 3, subunit K</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ddt</td>
<td align="left">13202</td>
<td align="left">D-dopachrome tautomerase</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Uqcrc2</td>
<td align="left">67003</td>
<td align="left">ubiquinol cytochrome c reductase core protein 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Psmd12</td>
<td align="left">66997</td>
<td align="left">proteasome (prosome, macropain) 26S subunit, non-ATPase, 12</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Snrpe</td>
<td align="left">20643</td>
<td align="left">small nuclear ribonucleoprotein E</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cngb1</td>
<td align="left">333329</td>
<td align="left">cyclic nucleotide gated channel beta 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Atp5b</td>
<td align="left">11947</td>
<td align="left">ATP synthase, H+ transporting mitochondrial F1 complex, beta subunit</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Slc43a2</td>
<td align="left">215113</td>
<td align="left">solute carrier family 43, member 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Atp5a1</td>
<td align="left">11946</td>
<td align="left">ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tomm7</td>
<td align="left">66169</td>
<td align="left">translocase of outer mitochondrial membrane 7 homolog (yeast)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">1600029O15Rik</td>
<td align="left">ENSMUSG00000057818</td>
<td align="left">RIKEN cDNA 1600029O15 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">1600029O15Rik</td>
<td align="left">665268</td>
<td align="left">ribosomal protein L17 pseudogene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ube2n</td>
<td align="left">93765</td>
<td align="left">ubiquitin-conjugating enzyme E2N</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tpr</td>
<td align="left">108989</td>
<td align="left">translocated promoter region, nuclear basket protein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rpl35</td>
<td align="left">66489</td>
<td align="left">ribosomal protein L35</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Refbp2</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cox5b</td>
<td align="left">12859</td>
<td align="left">cytochrome c oxidase subunit Vb</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rras</td>
<td align="left">20130</td>
<td align="left">related RAS viral (r-ras) oncogene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ghitm</td>
<td align="left">66092</td>
<td align="left">growth hormone inducible transmembrane protein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">A630055G03Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Sf3a1</td>
<td align="left">67465</td>
<td align="left">splicing factor 3a, subunit 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">D130020L05Rik</td>
<td align="left">ENSMUSG00000097121</td>
<td align="left">RIKEN cDNA D130020L05 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">D130020L05Rik</td>
<td align="left">319760</td>
<td align="left">RIKEN cDNA D130020L05 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm16378</td>
<td align="left">ENSMUSG00000095762</td>
<td align="left">predicted gene 16378</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gm16378</td>
<td align="left">100043225</td>
<td align="left">eukaryotic translation initiation factor 1 pseudogene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pfn1</td>
<td align="left">18643</td>
<td align="left">profilin 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rpl32</td>
<td align="left">19951</td>
<td align="left">ribosomal protein L32</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pin4</td>
<td align="left">69713</td>
<td align="left">protein (peptidyl-prolyl cis/trans isomerase) NIMA-interacting, 4 (parvulin)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gm4832</td>
<td align="left">ENSMUSG00000058869</td>
<td align="left">predicted gene 4832</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm4832</td>
<td align="left">225058</td>
<td align="left">predicted gene 4832</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rg9mtd1</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Bzw1</td>
<td align="left">66882</td>
<td align="left">basic leucine zipper and W2 domains 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">H2-T23</td>
<td align="left">15040</td>
<td align="left">histocompatibility 2, T region locus 23</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_fac_voom/gene_names_clus_&quot;,7,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-8-annotations-3" class="section level3">
<h3>Factor 8 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[8,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">query</th>
<th align="left">X_id</th>
<th align="left">name</th>
<th align="left">summary</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Ptprf</td>
<td align="left">19268</td>
<td align="left">protein tyrosine phosphatase, receptor type, F</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Wnk2</td>
<td align="left">75607</td>
<td align="left">WNK lysine deficient protein kinase 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Slc6a14</td>
<td align="left">56774</td>
<td align="left">solute carrier family 6 (neurotransmitter transporter), member 14</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Frk</td>
<td align="left">14302</td>
<td align="left">fyn-related kinase</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pdzk1ip1</td>
<td align="left">67182</td>
<td align="left">PDZK1 interacting protein 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cryab</td>
<td align="left">12955</td>
<td align="left">crystallin, alpha B</td>
<td align="left">This gene encodes a member of the small heat-shock protein (HSP20) family. The encoded protein is a molecular chaperone that protects proteins against thermal denaturation and other stresses. This protein is a component of the eye lens, regulates lens differentiation and functions as a refractive element in the lens. This protein is a negative regulator of inflammation, has anti-apoptotic properties and also plays a role in the formation of muscular tissue. Mice lacking this gene exhibit worse experimental autoimmune encephalomyelitis and inflammation of the central nervous system compared to the wild type. In mouse models, this gene has a critical role in alleviating the pathology of the neurodegenerative Alexander disease. Mutations in the human gene are associated with myofibrillar myopathy 2, fatal infantile hypertonic myofibrillar myopathy, multiple types of cataract and dilated cardiomyopathy. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Parva</td>
<td align="left">57342</td>
<td align="left">parvin, alpha</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Dkkl1</td>
<td align="left">50722</td>
<td align="left">dickkopf-like 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gata3</td>
<td align="left">14462</td>
<td align="left">GATA binding protein 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">E2f8</td>
<td align="left">108961</td>
<td align="left">E2F transcription factor 8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gm4926</td>
<td align="left">ENSMUSG00000086909</td>
<td align="left">predicted gene 4926</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gm4926</td>
<td align="left">237749</td>
<td align="left">T-cell immunoglobulin and mucin domain containing 2 pseudogene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pkp2</td>
<td align="left">67451</td>
<td align="left">plakophilin 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Wnt3a</td>
<td align="left">22416</td>
<td align="left">wingless-type MMTV integration site family, member 3A</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gcnt1</td>
<td align="left">14537</td>
<td align="left">glucosaminyl (N-acetyl) transferase 1, core 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gyltl1b</td>
<td align="left">228366</td>
<td align="left">glycosyltransferase-like 1B</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cdx2</td>
<td align="left">12591</td>
<td align="left">caudal type homeobox 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cdk14</td>
<td align="left">18647</td>
<td align="left">cyclin-dependent kinase 14</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Camk1</td>
<td align="left">52163</td>
<td align="left">calcium/calmodulin-dependent protein kinase I</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Abhd14b</td>
<td align="left">76491</td>
<td align="left">abhydrolase domain containing 14b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Smpdl3a</td>
<td align="left">57319</td>
<td align="left">sphingomyelin phosphodiesterase, acid-like 3A</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">St3gal6</td>
<td align="left">54613</td>
<td align="left">ST3 beta-galactoside alpha-2,3-sialyltransferase 6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ralgds</td>
<td align="left">19730</td>
<td align="left">ral guanine nucleotide dissociation stimulator</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">2010300C02Rik</td>
<td align="left">72097</td>
<td align="left">RIKEN cDNA 2010300C02 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Nek6</td>
<td align="left">59126</td>
<td align="left">NIMA (never in mitosis gene a)-related expressed kinase 6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Wnt7b</td>
<td align="left">22422</td>
<td align="left">wingless-type MMTV integration site family, member 7B</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Csta</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">Vtcn1</td>
<td align="left">242122</td>
<td align="left">V-set domain containing T cell activation inhibitor 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Zfp185</td>
<td align="left">22673</td>
<td align="left">zinc finger protein 185</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">AU021092</td>
<td align="left">239691</td>
<td align="left">expressed sequence AU021092</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Krt7</td>
<td align="left">110310</td>
<td align="left">keratin 7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Csrp1</td>
<td align="left">13007</td>
<td align="left">cysteine and glycine-rich protein 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Dmkn</td>
<td align="left">73712</td>
<td align="left">dermokine</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Glipr1</td>
<td align="left">73690</td>
<td align="left">GLI pathogenesis-related 1 (glioma)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Entpd1</td>
<td align="left">12495</td>
<td align="left">ectonucleoside triphosphate diphosphohydrolase 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cgnl1</td>
<td align="left">68178</td>
<td align="left">cingulin-like 1</td>
<td align="left">This gene encodes a protein localized to the tight junctions and adherens junctions in vertebrate epithelial cells. The encoded protein regulates the activity of Rho family GTPases during junction assembly and at confluence. At the adherens junctions, the encoded protein is part of a protein complex that links E-cadherin to the microtubule cytoskeleton. Alternative splicing of this gene results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Txndc16</td>
<td align="left">70561</td>
<td align="left">thioredoxin domain containing 16</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rgn</td>
<td align="left">19733</td>
<td align="left">regucalcin</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Atp12a</td>
<td align="left">192113</td>
<td align="left">ATPase, H+/K+ transporting, nongastric, alpha polypeptide</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ahnak</td>
<td align="left">66395</td>
<td align="left">AHNAK nucleoprotein (desmoyokin)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Slc44a4</td>
<td align="left">70129</td>
<td align="left">solute carrier family 44, member 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rin3</td>
<td align="left">217835</td>
<td align="left">Ras and Rab interactor 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Msn</td>
<td align="left">17698</td>
<td align="left">moesin</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">P2rx3</td>
<td align="left">228139</td>
<td align="left">purinergic receptor P2X, ligand-gated ion channel, 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Grhl1</td>
<td align="left">195733</td>
<td align="left">grainyhead-like 1 (Drosophila)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Myo1e</td>
<td align="left">71602</td>
<td align="left">myosin IE</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fam59a</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">Cd82</td>
<td align="left">12521</td>
<td align="left">CD82 antigen</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Vgll4</td>
<td align="left">232334</td>
<td align="left">vestigial like family member 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">BC051665</td>
<td align="left">218275</td>
<td align="left">cDNA sequence BC051665</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Skil</td>
<td align="left">20482</td>
<td align="left">SKI-like</td>
<td align="left">This gene encodes a member of a small family of proteins that play a key role in the response of cells to extracellular growth signals. The encoded protein regulates members of the transforming growth factor beta signaling pathway. It is highly expressed in certain cancer cells, where it may have both tumor-suppressing and tumor-promoting roles. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Capn2</td>
<td align="left">12334</td>
<td align="left">calpain 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tmem79</td>
<td align="left">71913</td>
<td align="left">transmembrane protein 79</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pdzd3</td>
<td align="left">170761</td>
<td align="left">PDZ domain containing 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Prkag2</td>
<td align="left">108099</td>
<td align="left">protein kinase, AMP-activated, gamma 2 non-catalytic subunit</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pon2</td>
<td align="left">330260</td>
<td align="left">paraoxonase 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mbnl3</td>
<td align="left">171170</td>
<td align="left">muscleblind-like 3 (Drosophila)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tjp3</td>
<td align="left">27375</td>
<td align="left">tight junction protein 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Slc34a2</td>
<td align="left">20531</td>
<td align="left">solute carrier family 34 (sodium phosphate), member 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Anxa3</td>
<td align="left">11745</td>
<td align="left">annexin A3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Hs3st3b1</td>
<td align="left">54710</td>
<td align="left">heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gulp1</td>
<td align="left">70676</td>
<td align="left">GULP, engulfment adaptor PTB domain containing 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Wdr65</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">Lgals3</td>
<td align="left">16854</td>
<td align="left">lectin, galactose binding, soluble 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fxyd6</td>
<td align="left">59095</td>
<td align="left">FXYD domain-containing ion transport regulator 6</td>
<td align="left">This reference sequence was derived from multiple replicate ESTs and validated by similar human genomic sequence. This gene encodes a member of a family of small membrane proteins that share a 35-amino acid signature sequence domain, beginning with the sequence PFXYD and containing 7 invariant and 6 highly conserved amino acids. The approved human gene nomenclature for the family is FXYD-domain containing ion transport regulator. Transmembrane topology has been established for two family members (FXYD1 and FXYD2), with the N-terminus extracellular and the C-terminus on the cytoplasmic side of the membrane. FXYD2, also known as the gamma subunit of the Na,K-ATPase, regulates the properties of that enzyme. FXYD1 (phospholemman), FXYD2 (gamma), FXYD3 (MAT-8), FXYD4 (CHIF), and FXYD5 (RIC) have been shown to induce channel activity in experimental expression systems. This gene product, Fxyd6, is novel and has not been characterized as a protein. [RefSeq curation by Kathleen J. Sweadner, Ph.D., <a href="mailto:sweadner@helix.mgh.harvard.edu">sweadner@helix.mgh.harvard.edu</a>., Jul 2006].</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Abca3</td>
<td align="left">27410</td>
<td align="left">ATP-binding cassette, sub-family A (ABC1), member 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cldn3</td>
<td align="left">12739</td>
<td align="left">claudin 3</td>
<td align="left">This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets, and also play critical roles in maintaining cell polarity and signal transductions. The protein encoded by this gene is a low-affinity receptor for clostridium perfringens enterotoxin (CPE) produced by the bacterium Clostridium perfringens, and the interaction with CPE results in increased membrane permeability by forming small pores in plasma membrane. This protein is highly overexpressed in uterine carcinosarcoma. This protein is also predominantly present in brain endothelial cells, where it plays a specific role in the establishment and maintenance of blood brain barrier tight junction morphology.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cbs</td>
<td align="left">12411</td>
<td align="left">cystathionine beta-synthase</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">2310030G06Rik</td>
<td align="left">66952</td>
<td align="left">RIKEN cDNA 2310030G06 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cldn4</td>
<td align="left">12740</td>
<td align="left">claudin 4</td>
<td align="left">This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets, and also play critical roles in maintaining cell polarity and signal transductions. The protein encoded by this gene is a high-affinity receptor for clostridium perfringens enterotoxin (CPE) produced by the bacterium Clostridium perfringens, and the interaction with CPE results in increased membrane permeability by forming small pores in plasma membrane. This protein augments alveolar epithelial barrier function and is induced in acute lung injury. It is highly expressed in pancreatic and ovarian cancers.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pak6</td>
<td align="left">214230</td>
<td align="left">p21 protein (Cdc42/Rac)-activated kinase 6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Dab2</td>
<td align="left">13132</td>
<td align="left">disabled 2, mitogen-responsive phosphoprotein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cdx1</td>
<td align="left">12590</td>
<td align="left">caudal type homeobox 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Arhgap22</td>
<td align="left">239027</td>
<td align="left">Rho GTPase activating protein 22</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Erbb2</td>
<td align="left">13866</td>
<td align="left">erb-b2 receptor tyrosine kinase 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Vgll3</td>
<td align="left">73569</td>
<td align="left">vestigial like family member 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Trpv5</td>
<td align="left">194352</td>
<td align="left">transient receptor potential cation channel, subfamily V, member 5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Sh3tc1</td>
<td align="left">231147</td>
<td align="left">SH3 domain and tetratricopeptide repeats 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tmem125</td>
<td align="left">230678</td>
<td align="left">transmembrane protein 125</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Plac1</td>
<td align="left">56096</td>
<td align="left">placental specific protein 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gng2</td>
<td align="left">14702</td>
<td align="left">guanine nucleotide binding protein (G protein), gamma 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Plec</td>
<td align="left">18810</td>
<td align="left">plectin</td>
<td align="left">Plectin is a prominent member of an important family of structurally and in part functionally related proteins, termed plakins or cytolinkers, that are capable of interlinking different elements of the cytoskeleton. Plakins, with their multi-domain structure and enormous size, not only play crucial roles in maintaining cell and tissue integrity and orchestrating dynamic changes in cytoarchitecture and cell shape, but also serve as scaffolding platforms for the assembly, positioning, and regulation of signaling complexes (reviewed in PMID: 9701547, 11854008, 17499243). Plectin is expressed as several protein isoforms in a wide range of cell types and tissues from a single gene located on chromosome 8 in humans (PMID: 8633055, 8698233). Until 2010, this locus was named plectin 1 (symbol PLEC1 in human; Plec1 in mouse and rat) and the gene product had been referred to as ‘hemidesmosomal protein 1’ or ‘plectin 1, intermediate filament binding 500kDa’. These names were superseded by plectin. The plectin gene locus in mouse on chromosome 15 has been analyzed in detail (PMID: 10556294, 14559777), revealing a genomic exon-intron organization with well over 40 exons spanning over 62 kb and an unusual 5’ transcript complexity of plectin isoforms. Eleven exons (1-1j) have been identified that alternatively splice directly into a common exon 2 which is the first exon to encode plectin’s highly conserved actin binding domain (ABD). Three additional exons (-1, 0a, and 0) splice into an alternative first coding exon (1c), and two additional exons (2alpha and 3alpha) are optionally spliced within the exons encoding the acting binding domain (exons 2-8). Analysis of the human locus has identified eight of the eleven alternative 5’ exons found in mouse and rat (PMID: 14672974); exons 1i, 1j and 1h have not been confirmed in human. Furthermore, isoforms lacking the central rod domain encoded by exon 31 have been detected in mouse (<a href="PMID:10556294" class="uri">PMID:10556294</a>), rat (PMID: 9177781), and human (PMID: 11441066, 10780662, 20052759). It has been shown that the short alternative amino-terminal sequences encoded by the different first exons direct the targeting of the various isoforms to distinct subcellular locations (PMID: 14559777). As the expression of specific plectin isoforms was found to be dependent on cell type (tissue) and stage of development (PMID: 10556294, 12542521, 17389230) it appears that each cell type (tissue) contains a unique set (proportion and composition) of plectin isoforms, as if custom-made for specific requirements of the particular cells. Concordantly, individual isoforms were found to carry out distinct and specific functions (PMID: 14559777, 12542521, 18541706). In 1996, a number of groups reported that patients suffering from epidermolysis bullosa simplex with muscular dystrophy (EBS-MD) lacked plectin expression in skin and muscle tissues due to defects in the plectin gene (PMID: 8698233, 8941634, 8636409, 8894687, 8696340). Two other subtypes of plectin-related EBS have been described: EBS-pyloric atresia (PA) and EBS-Ogna. For reviews of plectin-related diseases see PMID: 15810881, 19945614. Mutations in the plectin gene related to human diseases should be named based on the position in NM_000445 (human variant 1, isoform 1c), unless the mutation is located within one of the other alternative first exons, in which case the position in the respective Reference Sequence should be used.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ano6</td>
<td align="left">105722</td>
<td align="left">anoctamin 6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rragd</td>
<td align="left">52187</td>
<td align="left">Ras-related GTP binding D</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Zfp280c</td>
<td align="left">208968</td>
<td align="left">zinc finger protein 280C</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Slco2a1</td>
<td align="left">24059</td>
<td align="left">solute carrier organic anion transporter family, member 2a1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">2510009E07Rik</td>
<td align="left">72190</td>
<td align="left">RIKEN cDNA 2510009E07 gene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Kbtbd13</td>
<td align="left">74492</td>
<td align="left">kelch repeat and BTB (POZ) domain containing 13</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Aktip</td>
<td align="left">14339</td>
<td align="left">thymoma viral proto-oncogene 1 interacting protein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cldn6</td>
<td align="left">54419</td>
<td align="left">claudin 6</td>
<td align="left">This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets, and also play critical roles in maintaining cell polarity and signal transductions. The protein encoded by this gene is essential for blastocyst formation in preimplantation mouse embryos, and is invloved in and is crucial for the formation and maintenance of the epidermal permeability barrier. This gene is adjacent to another family member Cldn9 on chromosome 17.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Myof</td>
<td align="left">226101</td>
<td align="left">myoferlin</td>
<td align="left">The protein encoded by this gene is a member of the ferlin family of proteins, which have been implicated in fusion events in muscle tissue. Members of this family have a carboxy-terminal single pass transmembrane domain and multiple C2 domains, which bind negatively charged phospholipids in the presence of calcium ions. This gene is expressed at high levels in myoblasts and upregulated in damaged skeletal muscle. Mice deficient in this protein display defects in myoblast fusion, muscle regeneration, and angiogenesis. Alternative splicing results in multiple transcript variants encoding different isoforms.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Elf5</td>
<td align="left">13711</td>
<td align="left">E74-like factor 5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Kank1</td>
<td align="left">107351</td>
<td align="left">KN motif and ankyrin repeat domains 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tmem213</td>
<td align="left">77522</td>
<td align="left">transmembrane protein 213</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Trp53bp2</td>
<td align="left">209456</td>
<td align="left">transformation related protein 53 binding protein 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Frmpd1</td>
<td align="left">666060</td>
<td align="left">FERM and PDZ domain containing 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cib2</td>
<td align="left">56506</td>
<td align="left">calcium and integrin binding family member 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Emp2</td>
<td align="left">13731</td>
<td align="left">epithelial membrane protein 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Serpinh1</td>
<td align="left">12406</td>
<td align="left">serine (or cysteine) peptidase inhibitor, clade H, member 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Blnk</td>
<td align="left">17060</td>
<td align="left">B cell linker</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Slco4c1</td>
<td align="left">227394</td>
<td align="left">solute carrier organic anion transporter family, member 4C1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_fac_voom/gene_names_clus_&quot;,8,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-9-annotations-3" class="section level3">
<h3>Factor 9 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[9,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">query</th>
<th align="left">X_id</th>
<th align="left">name</th>
<th align="left">summary</th>
<th align="left">notfound</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Cd34</td>
<td align="left">12490</td>
<td align="left">CD34 antigen</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Arhgdib</td>
<td align="left">11857</td>
<td align="left">Rho, GDP dissociation inhibitor (GDI) beta</td>
<td align="left">The protein encoded by this gene is a member of the Rho guanine nucleotide dissociation inhibitor (GDI) family. This gene is expressed at high levels in hematopoietic cells. This protein is cytosolic, and dissociation of Rho from this protein is required for membrane association and activation of Rho by Guanine Nucleotide Exchange Factors (GEFs). C-terminal truncations of this gene product have been reported to promote metastasis. Multiple transcript variants and protein isoforms exist.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ctla2a</td>
<td align="left">13024</td>
<td align="left">cytotoxic T lymphocyte-associated protein 2 alpha</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cd53</td>
<td align="left">12508</td>
<td align="left">CD53 antigen</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rgs18</td>
<td align="left">64214</td>
<td align="left">regulator of G-protein signaling 18</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Samsn1</td>
<td align="left">67742</td>
<td align="left">SAM domain, SH3 domain and nuclear localization signals, 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cd93</td>
<td align="left">17064</td>
<td align="left">CD93 antigen</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Itm2a</td>
<td align="left">16431</td>
<td align="left">integral membrane protein 2A</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mpo</td>
<td align="left">17523</td>
<td align="left">myeloperoxidase</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ets1</td>
<td align="left">23871</td>
<td align="left">E26 avian leukemia oncogene 1, 5’ domain</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fxyd5</td>
<td align="left">18301</td>
<td align="left">FXYD domain-containing ion transport regulator 5</td>
<td align="left">This gene encodes a precursor protein that is member of the FXYD family of transmembrane glycoproteins. Like most members of the FXYD family, the encoded protein is a subunit of the sodium-potassium adenosine triphosphatase pump. FXYD family members have tissue-specific expression and differentially regulate the activity of this pump. The protein encoded by this gene also plays a role in cell adhesion and motility. The orthologous human protein inhibits epithelial cadherin, a calcium-dependent adhesion protein and is associated with cancer (promotes metastasis). Alternative splicing of this mouse gene results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rbp1</td>
<td align="left">19659</td>
<td align="left">retinol binding protein 1, cellular</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fli1</td>
<td align="left">14247</td>
<td align="left">Friend leukemia integration 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rgs1</td>
<td align="left">50778</td>
<td align="left">regulator of G-protein signaling 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Myct1</td>
<td align="left">68632</td>
<td align="left">myc target 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gimap4</td>
<td align="left">107526</td>
<td align="left">GTPase, IMAP family member 4</td>
<td align="left">This gene encodes a protein belonging to the GTP-binding superfamily and to the immuno-associated nucleotide (IAN) subfamily of nucleotide-binding proteins. This gene exists within a cluster of other related genes located on mouse chromosome 6. This family member encodes a lymphoid signaling protein that functions to accelerate programmed T-cell death, which appears to correlate with the phosphorylation status of the protein. Alternative splicing results in multiple transcript variants.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Eltd1</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">St8sia4</td>
<td align="left">20452</td>
<td align="left">ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gpr97</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">Car2</td>
<td align="left">12349</td>
<td align="left">carbonic anhydrase 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ifi47</td>
<td align="left">15953</td>
<td align="left">interferon gamma inducible protein 47</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Srgn</td>
<td align="left">19073</td>
<td align="left">serglycin</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rac2</td>
<td align="left">19354</td>
<td align="left">RAS-related C3 botulinum substrate 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Parvg</td>
<td align="left">64099</td>
<td align="left">parvin, gamma</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tspan32</td>
<td align="left">27027</td>
<td align="left">tetraspanin 32</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Irf2</td>
<td align="left">16363</td>
<td align="left">interferon regulatory factor 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Emcn</td>
<td align="left">59308</td>
<td align="left">endomucin</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ctla2b</td>
<td align="left">13025</td>
<td align="left">cytotoxic T lymphocyte-associated protein 2 beta</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fundc2</td>
<td align="left">67391</td>
<td align="left">FUN14 domain containing 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Fam64a</td>
<td align="left">109212</td>
<td align="left">family with sequence similarity 64, member A</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cd37</td>
<td align="left">12493</td>
<td align="left">CD37 antigen</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Sash3</td>
<td align="left">74131</td>
<td align="left">SAM and SH3 domain containing 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Arhgap25</td>
<td align="left">232201</td>
<td align="left">Rho GTPase activating protein 25</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ripk3</td>
<td align="left">56532</td>
<td align="left">receptor-interacting serine-threonine kinase 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Emp3</td>
<td align="left">13732</td>
<td align="left">epithelial membrane protein 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Nmi</td>
<td align="left">64685</td>
<td align="left">N-myc (and STAT) interactor</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cd69</td>
<td align="left">12515</td>
<td align="left">CD69 antigen</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Emp1</td>
<td align="left">13730</td>
<td align="left">epithelial membrane protein 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Itgb2</td>
<td align="left">16414</td>
<td align="left">integrin beta 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cyth4</td>
<td align="left">72318</td>
<td align="left">cytohesin 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fyb</td>
<td align="left">23880</td>
<td align="left">FYN binding protein</td>
<td align="left">The protein encoded by this gene is an adapter molecule that affects T cell receptor signaling and contains multiple protein-protein interaction domains. It is thought to couple T cell receptor stimulation with activation of integrin function. Alternative splicing results in multiple transcript variants encoding different isoforms.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Sla</td>
<td align="left">20491</td>
<td align="left">src-like adaptor</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fut7</td>
<td align="left">14347</td>
<td align="left">fucosyltransferase 7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Thsd1</td>
<td align="left">56229</td>
<td align="left">thrombospondin, type I, domain 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ecscr</td>
<td align="left">68545</td>
<td align="left">endothelial cell surface expressed chemotaxis and apoptosis regulator</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Peg12</td>
<td align="left">27412</td>
<td align="left">paternally expressed 12</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Mgst1</td>
<td align="left">56615</td>
<td align="left">microsomal glutathione S-transferase 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Il12a</td>
<td align="left">16159</td>
<td align="left">interleukin 12a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pik3cg</td>
<td align="left">30955</td>
<td align="left">phosphoinositide-3-kinase, catalytic, gamma polypeptide</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Alox5ap</td>
<td align="left">11690</td>
<td align="left">arachidonate 5-lipoxygenase activating protein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Robo4</td>
<td align="left">74144</td>
<td align="left">roundabout guidance receptor 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Trim30a</td>
<td align="left">20128</td>
<td align="left">tripartite motif-containing 30A</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cd27</td>
<td align="left">21940</td>
<td align="left">CD27 antigen</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Tnfrsf26</td>
<td align="left">244237</td>
<td align="left">tumor necrosis factor receptor superfamily, member 26</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rasgrp3</td>
<td align="left">240168</td>
<td align="left">RAS, guanyl releasing protein 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Trim16</td>
<td align="left">94092</td>
<td align="left">tripartite motif-containing 16</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Klk8</td>
<td align="left">259277</td>
<td align="left">kallikrein related-peptidase 8</td>
<td align="left">This gene encodes a member of the kallikrein subfamily of serine proteases that are involved in diverse physiological functions such as skin desquamation, tooth enamel formation, seminal liquefaction, synaptic neural plasticity and brain function. The encoded preproprotein undergoes proteolytic cleavage of the activation peptide to generate the functional enzyme. Mice lacking the encoded protein exhibit impaired long-term potentiation and increased anxiety, as well as a hyperkeratosis phenotype. This gene is located in a cluster of several related kallikrein genes on chromosome 7.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Vamp5</td>
<td align="left">53620</td>
<td align="left">vesicle-associated membrane protein 5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pctp</td>
<td align="left">18559</td>
<td align="left">phosphatidylcholine transfer protein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ptprc</td>
<td align="left">19264</td>
<td align="left">protein tyrosine phosphatase, receptor type, C</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tnfaip8l1</td>
<td align="left">66443</td>
<td align="left">tumor necrosis factor, alpha-induced protein 8-like 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Serpina3g</td>
<td align="left">ENSMUSG00000041481</td>
<td align="left">serine (or cysteine) peptidase inhibitor, clade A, member 3G</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Serpina3g</td>
<td align="left">20715</td>
<td align="left">serine (or cysteine) peptidase inhibitor, clade A, member 3G</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Fcer1g</td>
<td align="left">14127</td>
<td align="left">Fc receptor, IgE, high affinity I, gamma polypeptide</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pld4</td>
<td align="left">104759</td>
<td align="left">phospholipase D family, member 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ifi203</td>
<td align="left">15950</td>
<td align="left">interferon activated gene 203</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ctsw</td>
<td align="left">13041</td>
<td align="left">cathepsin W</td>
<td align="left">This gene encodes a member of the peptidase C1 (papain) family of cysteine proteases. The encoded preproprotein is proteolytically processed to generate a mature protein product. Expression of the encoded protein is upregulated following lymphocyte activation. Data from a human cell line suggests that the encoded enzyme may be important for viral entry into host cells.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gimap8</td>
<td align="left">243374</td>
<td align="left">GTPase, IMAP family member 8</td>
<td align="left">This gene encodes a protein belonging to the GTP-binding superfamily and to the immuno-associated nucleotide (IAN) subfamily of nucleotide-binding proteins. The encoded protein is larger than the other gene family members and includes three AIG1 domains (corresponding to the AIG1 protein from Arabidopsis thaliana) whereas other family members have one AIG1 domain. In humans, the IAN subfamily genes are located in a cluster at 7q36.1.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Tyrobp</td>
<td align="left">22177</td>
<td align="left">TYRO protein tyrosine kinase binding protein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Abi3</td>
<td align="left">66610</td>
<td align="left">ABI gene family, member 3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Casp1</td>
<td align="left">12362</td>
<td align="left">caspase 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cd79b</td>
<td align="left">15985</td>
<td align="left">CD79B antigen</td>
<td align="left">The B lymphocyte antigen receptor is a multimeric complex that includes the antigen-specific component, surface immunoglobulin (Ig). Surface Ig non-covalently associates with two other proteins, Ig-alpha and Ig-beta, which are necessary for expression and function of the B-cell antigen receptor. This gene encodes the Ig-beta protein of the B-cell antigen component. Alternatively spliced transcript variants encoding different isoforms have been described.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Ccrl2</td>
<td align="left">54199</td>
<td align="left">chemokine (C-C motif) receptor-like 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ms4a6b</td>
<td align="left">69774</td>
<td align="left">membrane-spanning 4-domains, subfamily A, member 6B</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Unc93b1</td>
<td align="left">54445</td>
<td align="left">unc-93 homolog B1 (C. elegans)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Gngt2</td>
<td align="left">14710</td>
<td align="left">guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Acap1</td>
<td align="left">216859</td>
<td align="left">ArfGAP with coiled-coil, ankyrin repeat and PH domains 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cd48</td>
<td align="left">12506</td>
<td align="left">CD48 antigen</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Lgals3bp</td>
<td align="left">19039</td>
<td align="left">lectin, galactoside-binding, soluble, 3 binding protein</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ikzf2</td>
<td align="left">22779</td>
<td align="left">IKAROS family zinc finger 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Vwa5a</td>
<td align="left">67776</td>
<td align="left">von Willebrand factor A domain containing 5A</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Myb</td>
<td align="left">17863</td>
<td align="left">myeloblastosis oncogene</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Sqrdl</td>
<td align="left">59010</td>
<td align="left">sulfide quinone reductase-like (yeast)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ptgs1</td>
<td align="left">19224</td>
<td align="left">prostaglandin-endoperoxide synthase 1</td>
<td align="left">This is one of two genes encoding similar enzymes that catalyze the conversion of arachinodate to prostaglandin. The encoded protein regulates angiogenesis in endothelial cells, and is inhibited by nonsteroidal anti-inflammatory drugs such as aspirin. Based on its ability to function as both a cyclooxygenase and as a peroxidase, the encoded protein has been identified as a moonlighting protein.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Myo1f</td>
<td align="left">17916</td>
<td align="left">myosin IF</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Stap1</td>
<td align="left">56792</td>
<td align="left">signal transducing adaptor family member 1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Igfbp4</td>
<td align="left">16010</td>
<td align="left">insulin-like growth factor binding protein 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Laptm5</td>
<td align="left">16792</td>
<td align="left">lysosomal-associated protein transmembrane 5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Cd33</td>
<td align="left">12489</td>
<td align="left">CD33 antigen</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ms4a6c</td>
<td align="left">73656</td>
<td align="left">membrane-spanning 4-domains, subfamily A, member 6C</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Gp9</td>
<td align="left">54368</td>
<td align="left">glycoprotein 9 (platelet)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Pf4</td>
<td align="left">56744</td>
<td align="left">platelet factor 4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Igtp</td>
<td align="left">16145</td>
<td align="left">interferon gamma induced GTPase</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Fam109b</td>
<td align="left">338368</td>
<td align="left">family with sequence similarity 109, member B</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Treml2</td>
<td align="left">328833</td>
<td align="left">triggering receptor expressed on myeloid cells-like 2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ltbr</td>
<td align="left">17000</td>
<td align="left">lymphotoxin B receptor</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Zfp831</td>
<td align="left">100043757</td>
<td align="left">zinc finger protein 831</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Bcl11a</td>
<td align="left">14025</td>
<td align="left">B cell CLL/lymphoma 11A (zinc finger protein)</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Chst15</td>
<td align="left">77590</td>
<td align="left">carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ikzf1</td>
<td align="left">22778</td>
<td align="left">IKAROS family zinc finger 1</td>
<td align="left">The protein encoded by this gene belongs to a family of transcription factors that are characterized by a set of four DNA-binding zinc fingers at the N-terminus and two C-terminal zinc fingers involved in protein dimerization. It is regulated by both epigenetic and transcription factors. This protein is a transcriptional regulator of hematopoietic cell development and homeostasis. In addition, it is required to confer temporal competence to retinal progenitor cells during embryogenesis, demonstrating an essential function in nervous system development. Alternative splicing results in multiple transcript variants encoding different isoforms.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Fkbp7</td>
<td align="left">14231</td>
<td align="left">FK506 binding protein 7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_fac_voom/gene_names_clus_&quot;,9,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
<div id="factor-10-annotations-3" class="section level3">
<h3>Factor 10 annotations</h3>
<pre class="r"><code>out &lt;- mygene::queryMany(top_gene_names[10,],  scopes=&quot;symbol&quot;, fields=c(&quot;name&quot;, &quot;summary&quot;), species=&quot;mouse&quot;);</code></pre>
<pre><code>## Finished
## Pass returnall=TRUE to return lists of duplicate or missing query terms.</code></pre>
<pre class="r"><code>kable(as.data.frame(out))</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">name</th>
<th align="left">X_id</th>
<th align="left">query</th>
<th align="left">notfound</th>
<th align="left">summary</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">glutaredoxin</td>
<td align="left">93692</td>
<td align="left">Glrx</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">TBC1 domain family, member 9</td>
<td align="left">71310</td>
<td align="left">Tbc1d9</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Nhedc1</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">oocyte specific homeobox 6</td>
<td align="left">252830</td>
<td align="left">Obox6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">RIKEN cDNA C130074G19 gene</td>
<td align="left">226777</td>
<td align="left">C130074G19Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">C2 calcium-dependent domain containing 2-like</td>
<td align="left">71764</td>
<td align="left">C2cd2l</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">hydroxysteroid (17-beta) dehydrogenase 14</td>
<td align="left">66065</td>
<td align="left">Hsd17b14</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">haloacid dehalogenase-like hydrolase domain containing 2</td>
<td align="left">76987</td>
<td align="left">Hdhd2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">nitrilase family, member 2</td>
<td align="left">52633</td>
<td align="left">Nit2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">vacuolar protein sorting 45</td>
<td align="left">22365</td>
<td align="left">Vps45</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">GATA binding protein 1</td>
<td align="left">14460</td>
<td align="left">Gata1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">nth (endonuclease III)-like 1 (E.coli)</td>
<td align="left">18207</td>
<td align="left">Nthl1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">acyl-Coenzyme A dehydrogenase family, member 11</td>
<td align="left">102632</td>
<td align="left">Acad11</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">O-sialoglycoprotein endopeptidase-like 1</td>
<td align="left">72085</td>
<td align="left">Osgepl1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">centrosomal protein 57-like 1</td>
<td align="left">103268</td>
<td align="left">Cep57l1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Mterf</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">RIKEN cDNA 2310040G24 gene</td>
<td align="left">ENSMUSG00000101655</td>
<td align="left">2310040G24Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RIKEN cDNA 2310040G24 gene</td>
<td align="left">381792</td>
<td align="left">2310040G24Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">trafficking protein particle complex 5</td>
<td align="left">66682</td>
<td align="left">Trappc5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">potassium channel, subfamily K, member 5</td>
<td align="left">16529</td>
<td align="left">Kcnk5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Spnb3</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">syntaxin 8</td>
<td align="left">55943</td>
<td align="left">Stx8</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Gm13718</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">RIKEN cDNA 3110009E18 gene</td>
<td align="left">73103</td>
<td align="left">3110009E18Rik</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">DNA cross-link repair 1A</td>
<td align="left">55947</td>
<td align="left">Dclre1a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">cystinosis, nephropathic</td>
<td align="left">83429</td>
<td align="left">Ctns</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">abhydrolase domain containing 6</td>
<td align="left">66082</td>
<td align="left">Abhd6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ligase I, DNA, ATP-dependent</td>
<td align="left">16881</td>
<td align="left">Lig1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">2010317E24Rik</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">gamma-aminobutyric acid (GABA) A receptor-associated protein-like 1</td>
<td align="left">57436</td>
<td align="left">Gabarapl1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">methyltransferase like 15</td>
<td align="left">76894</td>
<td align="left">Mettl15</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">dual specificity phosphatase 19</td>
<td align="left">68082</td>
<td align="left">Dusp19</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">zinc finger protein 64</td>
<td align="left">22722</td>
<td align="left">Zfp64</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">solute carrier family 25 (mitochondrial carrier, citrate transporter), member 1</td>
<td align="left">13358</td>
<td align="left">Slc25a1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">zinc ribbon domain containing 1, antisense</td>
<td align="left">76416</td>
<td align="left">Znrd1as</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Gm9897</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">mutS homolog 2</td>
<td align="left">17685</td>
<td align="left">Msh2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">COMM domain containing 1</td>
<td align="left">17846</td>
<td align="left">Commd1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">proline-rich coiled-coil 1</td>
<td align="left">73137</td>
<td align="left">Prrc1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">zinc finger with UFM1-specific peptidase domain</td>
<td align="left">72580</td>
<td align="left">Zufsp</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">DEAH (Asp-Glu-Ala-His) box polypeptide 35</td>
<td align="left">71715</td>
<td align="left">Dhx35</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">peptidyl-tRNA hydrolase 1 homolog</td>
<td align="left">329384</td>
<td align="left">Ptrh1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">protein phosphatase 1, regulatory (inhibitor) subunit 11</td>
<td align="left">76497</td>
<td align="left">Ppp1r11</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">proteasome (prosome, macropain) subunit, beta type 6</td>
<td align="left">19175</td>
<td align="left">Psmb6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">peroxisomal biogenesis factor 7</td>
<td align="left">18634</td>
<td align="left">Pex7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">chondroitin polymerizing factor</td>
<td align="left">74241</td>
<td align="left">Chpf</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">phospholipase A2, group XVI</td>
<td align="left">225845</td>
<td align="left">Pla2g16</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">peroxisomal biogenesis factor 5</td>
<td align="left">19305</td>
<td align="left">Pex5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">DNA segment, Chr 10, Johns Hopkins University 81 expressed</td>
<td align="left">28295</td>
<td align="left">D10Jhu81e</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">centrosomal protein 72</td>
<td align="left">74470</td>
<td align="left">Cep72</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit</td>
<td align="left">97212</td>
<td align="left">Hadha</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Rabl5</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">hyaluronoglucosaminidase 2</td>
<td align="left">15587</td>
<td align="left">Hyal2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">protein kinase, AMP-activated, beta 2 non-catalytic subunit</td>
<td align="left">108097</td>
<td align="left">Prkab2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">tripartite motif-containing 7</td>
<td align="left">94089</td>
<td align="left">Trim7</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">H2-K region expressed gene 6</td>
<td align="left">14979</td>
<td align="left">H2-Ke6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">glia maturation factor, beta</td>
<td align="left">63985</td>
<td align="left">Gmfb</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">solute carrier family 35, member E4</td>
<td align="left">103710</td>
<td align="left">Slc35e4</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">ARP5 actin-related protein 5</td>
<td align="left">109275</td>
<td align="left">Actr5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">postmeiotic segregation increased 1 (S. cerevisiae)</td>
<td align="left">227099</td>
<td align="left">Pms1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">SH3 and cysteine rich domain 2</td>
<td align="left">217154</td>
<td align="left">Stac2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">fidgetin-like 1</td>
<td align="left">60530</td>
<td align="left">Fignl1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">transmembrane protein 126B</td>
<td align="left">68472</td>
<td align="left">Tmem126b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">4930473A06Rik</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">GDP-mannose pyrophosphorylase A</td>
<td align="left">69080</td>
<td align="left">Gmppa</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">glutaredoxin 2 (thioltransferase)</td>
<td align="left">69367</td>
<td align="left">Glrx2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">canopy FGF signaling regulator 2</td>
<td align="left">56530</td>
<td align="left">Cnpy2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">MON1 homolog A, secretory traffciking associated</td>
<td align="left">72825</td>
<td align="left">Mon1a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">COMM domain containing 10</td>
<td align="left">69456</td>
<td align="left">Commd10</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">ribosomal protein S6 kinase polypeptide 1</td>
<td align="left">320119</td>
<td align="left">Rps6kc1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">N-acetyltransferase 6</td>
<td align="left">56441</td>
<td align="left">Nat6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">secernin 3</td>
<td align="left">74616</td>
<td align="left">Scrn3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">F-box protein 25</td>
<td align="left">66822</td>
<td align="left">Fbxo25</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">sphingosine-1-phosphate phosphatase 1</td>
<td align="left">81535</td>
<td align="left">Sgpp1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Jub</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Rho GDP dissociation inhibitor (GDI) alpha</td>
<td align="left">192662</td>
<td align="left">Arhgdia</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">major facilitator superfamily domain containing 5</td>
<td align="left">106073</td>
<td align="left">Mfsd5</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">MIT, microtubule interacting and transport, domain containing 1</td>
<td align="left">69028</td>
<td align="left">Mitd1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">glutathione transferase zeta 1 (maleylacetoacetate isomerase)</td>
<td align="left">14874</td>
<td align="left">Gstz1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">mitochondrial ribosomal protein S35</td>
<td align="left">232536</td>
<td align="left">Mrps35</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">DTW domain containing 1</td>
<td align="left">69185</td>
<td align="left">Dtwd1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">fumarate hydratase 1</td>
<td align="left">14194</td>
<td align="left">Fh1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">solute carrier family 31, member 2</td>
<td align="left">20530</td>
<td align="left">Slc31a2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">DnaJ heat shock protein family (Hsp40) member B9</td>
<td align="left">27362</td>
<td align="left">Dnajb9</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">zinc finger, FYVE domain containing 19</td>
<td align="left">72008</td>
<td align="left">Zfyve19</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2</td>
<td align="left">20500</td>
<td align="left">Slc13a2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">golgi associated PDZ and coiled-coil motif containing</td>
<td align="left">94221</td>
<td align="left">Gopc</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">cyclin E1</td>
<td align="left">12447</td>
<td align="left">Ccne1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">predicted gene 428</td>
<td align="left">242502</td>
<td align="left">Gm428</td>
<td align="left">NA</td>
<td align="left">This gene belongs to a family of related genes tandemly arranged in two clusters on chromosome 4. This family, which appears to be mouse-specific and composed of multiple highly similar members, is supported by limited transcript data. Members of the family maintain an intact open reading frame although the encoded protein has no known function. This gene is supported by alignment of transcripts.</td>
</tr>
<tr class="even">
<td align="left">RWD domain containing 3</td>
<td align="left">66568</td>
<td align="left">Rwdd3</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Yip1 interacting factor homolog A (S. cerevisiae)</td>
<td align="left">68090</td>
<td align="left">Yif1a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">vesicle transport through interaction with t-SNAREs 1A</td>
<td align="left">53611</td>
<td align="left">Vti1a</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">BCL2/adenovirus E1B interacting protein 1</td>
<td align="left">224630</td>
<td align="left">Bnip1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">titin</td>
<td align="left">22138</td>
<td align="left">Ttn</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Rieske (Fe-S) domain containing</td>
<td align="left">218341</td>
<td align="left">Rfesd</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Ts translation elongation factor, mitochondrial</td>
<td align="left">66399</td>
<td align="left">Tsfm</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">plasmacytoma variant translocation 1</td>
<td align="left">ENSMUSG00000097039</td>
<td align="left">Pvt1</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">plasmacytoma variant translocation 1</td>
<td align="left">19296</td>
<td align="left">Pvt1</td>
<td align="left">NA</td>
<td align="left">This gene produces a long non-coding RNA that has been identified as a candidate oncogene. In humans, increased copy number and overexpression of this gene are associated with many types of cancers including breast and ovarian cancers, acute myeloid leukemia and Hodgkin lymphoma. Consistently, transcription of this gene is regulated by the tumor suppressor p53 through a canonical p53-binding site, and it has been implicated in regulating levels of the proto-oncogene MYC to promote tumorigenesis. In mouse, this gene has also been found to be a potential regulator of cardiac hypertrophy. Alternative splicing results in multiple transcript variants.</td>
</tr>
<tr class="odd">
<td align="left">oxysterol binding protein-like 6</td>
<td align="left">99031</td>
<td align="left">Osbpl6</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">NA</td>
<td align="left">NA</td>
<td align="left">Wdr85</td>
<td align="left">TRUE</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">SEC22 homolog B, vesicle trafficking protein</td>
<td align="left">20333</td>
<td align="left">Sec22b</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">phenylalanine-tRNA synthetase 2 (mitochondrial)</td>
<td align="left">69955</td>
<td align="left">Fars2</td>
<td align="left">NA</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<pre class="r"><code>write.table(as.factor(out$query), paste0(&quot;../utilities/Deng2014_sparse_fac_voom/gene_names_clus_&quot;,10,&quot;.txt&quot;), col.names = FALSE,
            row.names=FALSE, quote=FALSE);</code></pre>
</div>
</div>




</div>

<script>

// add bootstrap table styles to pandoc tables
$(document).ready(function () {
  $('tr.header').parent('thead').parent('table').addClass('table table-condensed');
});

</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
